data_5h3m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5h3m _Structure_validation_residue.Date_analyzed 2017-10-27 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -65.02 -41.41 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.32 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.48 142.38 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.36 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.7 43.07 3.46 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -119.02 2.63 11.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.49 ' OE2' ' O ' ' A' ' 12' ' ' PRO . 2.1 pp20? -171.52 141.45 1.29 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.25 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HA ' ' HG1' ' A' ' 46' ' ' THR . 55.8 Cg_endo -73.27 178.33 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.42 2.08 . . . . 0.0 112.175 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -135.23 12.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.484 HD12 ' CD1' ' A' ' 106' ' ' TYR . 5.9 tt -134.57 133.06 39.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -1.091 . . . . 0.0 109.782 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.416 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 3.3 mt-30 -124.56 145.47 49.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.623 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.5 OUTLIER -125.23 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 110.167 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.9 m-90 -145.47 147.65 32.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.423 -0.798 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -106.64 130.68 54.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.445 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -81.7 143.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.447 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -148.71 96.98 2.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.436 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.9 tttm 50.86 37.09 16.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.7 m-85 68.98 46.25 0.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.563 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 24' ' ' LEU . 2.8 m-20 -127.03 -21.25 4.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 23' ' ' ASP . 17.0 mt 56.03 122.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.516 -0.74 . . . . 0.0 109.665 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -140.29 108.16 6.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.84 117.94 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.448 2.099 . . . . 0.0 112.144 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.34 133.84 88.24 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -40.78 117.88 0.56 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.484 2.122 . . . . 0.0 112.392 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -67.93 -25.66 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -53.57 -50.72 64.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.394 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -78.86 -53.8 6.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.396 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 54.75 93.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.381 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.51 -26.9 5.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 34' ' ' ASP . 19.3 p-10 -62.44 141.15 58.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -1.13 . . . . 0.0 109.17 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 33' ' ' GLY . 62.8 m-85 -145.3 137.81 25.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.936 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.33 112.21 24.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 108.993 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.8 p -68.82 87.21 0.35 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.81 -29.73 0.06 OUTLIER Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -107.51 -153.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -1.049 . . . . 0.0 108.846 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -138.6 140.78 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -116.1 147.96 40.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.23 133.57 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.38 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 15' ' ' GLN . 2.0 mt -134.0 145.75 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.944 . . . . 0.0 109.715 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 41.4 mt -122.12 149.35 43.72 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HZ3' HG23 ' A' ' 102' ' ' THR . 11.4 ttpt -137.31 94.17 2.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.612 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -81.56 106.94 13.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 109.013 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.36 164.76 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.428 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.624 ' N ' ' CD2' ' A' ' 54' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -132.77 115.97 15.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.224 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.612 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.41 131.82 35.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.585 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -108.37 131.74 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.98 -1.075 . . . . 0.0 108.915 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.448 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 10.7 mt -93.5 134.51 35.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.61 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.713 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 43.3 m-70 -146.57 108.79 4.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.235 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.727 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.22 127.46 52.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.007 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -95.95 124.21 39.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -0.849 . . . . 0.0 110.114 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.718 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.4 mt -121.99 107.21 11.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.97 13.02 0.05 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.718 ' H ' ' C ' ' A' ' 62' ' ' LEU . 5.2 t-20 64.14 1.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 109.838 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 63' ' ' GLY . 1.3 mm-40 -107.09 9.98 30.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 108.934 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.0 t -104.94 138.66 40.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.578 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.8 p -56.74 161.17 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -75.24 -25.95 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.42 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.81 -41.43 86.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.522 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -87.2 -34.81 18.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 t -59.21 -57.98 10.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 0.0 109.376 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.72 -40.65 96.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.01 -47.82 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -1.178 . . . . 0.0 109.391 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -49.85 69.81 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.277 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -60.03 -24.22 64.34 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mm -81.33 -57.77 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 109.673 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.46 -38.69 88.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 108.947 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -68.55 -41.5 79.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.386 -0.821 . . . . 0.0 109.757 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 75' ' ' ALA . 50.7 t -71.97 -55.34 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -52.28 -59.7 4.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.129 -0.982 . . . . 0.0 109.948 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -52.76 -41.98 64.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.05 -1.031 . . . . 0.0 109.012 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.451 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -47.13 -49.1 22.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.857 -1.152 . . . . 0.0 108.135 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.451 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.2 m-20 -60.39 -31.6 70.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.557 ' N ' ' O ' ' A' ' 81' ' ' LEU . 28.7 t80 -74.48 -23.5 58.88 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 tp -83.69 -54.65 4.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 86' ' ' ASN . 0.6 OUTLIER -122.33 -42.33 2.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.183 -0.948 . . . . 0.0 110.167 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.07 -33.06 3.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 2.2 mmp_? -127.9 -84.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -1.105 . . . . 0.0 109.236 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 88' ' ' ARG . . . 78.82 178.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.759 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.94 150.61 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.865 . . . . 0.0 109.261 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.79 123.91 50.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.914 . . . . 0.0 109.863 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.713 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 36.5 m-70 -133.89 121.93 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.338 -0.851 . . . . 0.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -113.14 119.56 38.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.522 ' N ' ' OE2' ' A' ' 94' ' ' GLU . 57.2 mp0 -109.89 94.32 4.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 96' ' ' GLN . 8.5 t -83.6 37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 95' ' ' VAL . 2.9 tt0 49.81 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.42 -55.88 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -124.33 66.07 1.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -1.108 . . . . 0.0 109.474 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.417 ' OE2' ' CE1' ' A' ' 103' ' ' PHE . 13.7 mt-10 -69.9 -176.94 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 109.479 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.59 175.84 6.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.86 44.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.484 HG23 ' HZ3' ' A' ' 45' ' ' LYS . 22.4 m -63.16 -37.0 85.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CE1' ' OE2' ' A' ' 99' ' ' GLU . 41.8 t80 -68.59 -49.33 60.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.91 -19.11 65.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.951 . . . . 0.0 109.442 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.43 8.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.484 ' CD1' HD12 ' A' ' 14' ' ' LEU . 4.3 t80 -78.12 -25.07 47.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -1.14 . . . . 0.0 109.625 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -116.56 68.32 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.475 ' HG3' ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -60.48 -58.7 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.905 . . . . 0.0 109.286 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.475 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 1.4 t -105.32 10.01 33.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.501 ' C ' HD11 ' A' ' 111' ' ' LEU . . . -75.62 55.76 2.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.501 HD11 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.57 91.88 2.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -1.109 . . . . 0.0 109.322 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 35' ' ' PHE . 8.5 ttmt -126.21 110.19 13.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -81.81 107.97 14.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -124.66 108.93 12.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.392 -0.818 . . . . 0.0 109.176 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 115' ' ' LYS . 33.2 pttt . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.591 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.324 0.583 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.06 147.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.32 81.22 37.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.54 125.88 16.58 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 0.0 112.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.87 167.29 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.538 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -55.97 -17.27 6.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.421 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.43 -25.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -46.99 -43.31 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.95 -28.6 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.49 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.19 0.519 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -71.64 -31.58 67.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.88 156.59 36.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 56' ' ' TYR . . . 87.86 17.0 58.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -142.09 -23.38 0.69 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -1.189 . . . . 0.0 109.704 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.515 ' O ' ' OH ' ' A' ' 56' ' ' TYR . 16.5 mm-40 -93.49 117.11 67.29 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.312 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.24 162.38 31.33 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.23 1.953 . . . . 0.0 112.21 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.29 -120.95 7.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.37 145.35 45.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -1.158 . . . . 0.0 109.988 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.429 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 14.1 mt-30 -136.62 144.63 44.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.835 . . . . 0.0 109.057 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.592 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 18.2 mt -124.52 134.02 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.095 -1.003 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.5 m0 -141.63 115.88 9.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.781 . . . . 0.0 108.995 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 25' ' ' VAL . 39.7 ttp180 -92.2 145.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.847 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.75 143.38 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' PHE . 58.3 tt0 -129.08 112.29 13.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.0 109.35 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tttp 62.82 -69.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' GLU . 75.7 t80 -163.09 20.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.613 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.8 p-10 -127.07 115.32 18.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -55.24 148.37 14.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.435 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' ARG . 44.4 t -142.48 134.18 13.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.253 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.83 161.82 42.74 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.308 2.005 . . . . 0.0 112.154 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.37 133.79 17.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.249 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.16 107.53 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.374 2.049 . . . . 0.0 112.14 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 96.4 m -56.07 -22.81 29.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 5.7 p-10 -82.29 -22.47 35.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.913 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 30' ' ' ASN . 6.6 mp -121.35 13.4 11.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.753 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.723 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.99 -105.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.649 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 56.75 7.65 2.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.603 ' OD2' ' N ' ' A' ' 35' ' ' PHE . 8.3 t0 -150.54 150.14 30.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -1.099 . . . . 0.0 109.426 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.697 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -146.39 161.11 41.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.726 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CE1' ' NH2' ' A' ' 18' ' ' ARG . 5.1 m-85 -90.72 128.34 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.461 ' OG1' ' OE2' ' A' ' 65' ' ' GLU . 10.1 p -77.23 -30.41 54.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.649 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -78.08 -17.6 78.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -101.11 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -1.157 . . . . 0.0 109.422 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.7 142.72 38.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 2.0 m-85 -118.12 121.7 41.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.561 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.38 135.89 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 108.966 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -129.74 143.42 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.43 118.58 33.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 55' ' ' GLN . 17.1 ttmt -115.67 94.58 4.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.882 -1.136 . . . . 0.0 110.894 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.637 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -80.35 105.12 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -96.82 164.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.624 -0.673 . . . . 0.0 109.69 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 C--N 1.299 -1.599 0 O-C-N 121.578 -0.701 . . . . 0.0 109.479 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LYS . 12.6 tp60 -139.78 116.43 10.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.957 -1.089 . . . . 0.0 110.333 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.637 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 0.7 OUTLIER -83.57 116.84 22.78 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 2.6 m-20 -89.01 128.36 35.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.623 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.517 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 1.7 mm? -99.69 102.9 14.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.843 . . . . 0.0 109.012 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.715 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 17.8 m-70 -111.72 108.69 18.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 110.15 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -108.71 112.32 24.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.535 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 15.9 t90 -105.25 138.64 41.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 110.516 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.726 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -128.14 117.11 21.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.567 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -61.65 24.95 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.726 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.5 t-20 56.09 2.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.336 -1.097 . . . . 0.0 110.029 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 63' ' ' GLY . 78.2 mt-10 -103.09 2.47 34.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 108.902 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 36.1 t -95.38 145.82 24.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 109.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 69' ' ' ASP . 93.5 p -83.92 140.2 32.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 109.554 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 67' ' ' SER . 17.7 pt20 -44.4 -24.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.4 m-20 -57.32 -57.96 10.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -87.61 -39.68 14.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 108.921 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.72 -59.65 4.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.27 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -40.18 48.88 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.58 59.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -1.125 . . . . 0.0 109.194 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -53.66 -46.16 70.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 0.0 109.005 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.87 -23.43 67.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.046 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -81.07 -53.99 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.862 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 16.2 m-85 -67.29 -30.35 70.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 55.2 m -72.87 -41.71 64.43 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.35 -54.99 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.98 -1.075 . . . . 0.0 109.747 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -61.51 -59.59 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.461 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -53.42 -43.14 67.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.068 -1.02 . . . . 0.0 108.901 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' THR . 7.3 t0 -48.7 -48.68 40.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.088 -1.008 . . . . 0.0 108.749 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -59.28 -35.11 73.15 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.527 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 10.0 t80 -74.49 -22.43 59.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.3 tp -82.17 -54.78 4.99 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -122.89 -42.7 2.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.735 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.23 -13.69 62.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -156.17 19.8 0.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.3 -172.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.63 150.02 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.19 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -110.9 110.7 21.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.997 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 7.7 m-70 -110.23 120.32 42.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 108.909 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.512 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 8.6 ptt180 -114.43 125.96 54.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.288 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.606 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -126.64 120.3 29.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.96 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 96' ' ' GLN . 3.6 t -112.55 37.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.36 -0.838 . . . . 0.0 109.841 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' O ' ' A' ' 95' ' ' VAL . 11.3 tt0 58.82 124.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.506 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.46 -36.87 4.1 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -132.21 51.97 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -1.104 . . . . 0.0 109.596 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -58.58 179.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.6 m -103.54 156.0 18.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.72 83.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 m -65.42 -48.22 73.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.13 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 107' ' ' PHE . 30.1 t80 -58.33 -44.16 88.57 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.314 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.73 -30.74 71.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.1 91.64 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -49.54 65.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -1.185 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.427 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 45.6 m-85 -98.13 65.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -87.52 -34.41 18.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -96.6 2.46 52.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -86.36 -104.44 0.77 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.525 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.7 mm? 54.57 101.69 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.328 -1.101 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 11.9 tttt -168.15 91.79 0.32 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.86 108.02 15.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.402 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -96.47 113.01 24.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.597 ' ND1' ' N ' ' A' ' 124' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.86 132.95 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.187 -0.945 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -99.12 110.99 59.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.369 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 128' ' ' ASN . 77.8 Cg_exo -46.38 150.83 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.419 2.079 . . . . 0.0 112.21 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -43.14 153.4 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 131' ' ' VAL . 25.0 tt0 -56.5 -17.11 7.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.91 -17.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 129' ' ' GLU . 10.8 p -57.0 -34.0 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.96 -28.15 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.489 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.303 0.573 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 8' ' ' ALA . 81.9 mttt -104.65 -46.92 4.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.36 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.598 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 55.21 29.47 52.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.1 ptpt -42.3 -25.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 109.595 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 9' ' ' GLY . 6.0 mt-10 -147.86 148.96 31.85 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.5 134.67 6.9 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.725 2.283 . . . . 0.0 112.156 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -158.05 24.69 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.48 143.1 50.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -1.059 . . . . 0.0 109.4 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.598 HE21 ' N ' ' A' ' 9' ' ' GLY . 21.0 mt-30 -130.34 146.29 51.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 41.0 mt -116.07 137.7 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.852 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.582 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.2 m0 -142.44 111.71 6.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.16 145.23 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 109.645 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.83 143.58 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 17.5 tt0 -158.13 81.08 0.84 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.516 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.8 tttp 72.22 33.27 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.9 OUTLIER 66.57 17.0 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.5 t70 -95.74 -27.12 15.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER 62.9 134.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -149.63 134.11 9.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.087 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 27' ' ' VAL . 37.8 Cg_endo -69.99 110.14 2.53 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.282 1.988 . . . . 0.0 112.209 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' PRO . 9.8 p -40.8 135.59 1.59 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.081 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.66 127.74 24.64 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.271 1.98 . . . . 0.0 112.349 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 30' ' ' ASN . 17.6 m -63.21 -32.51 73.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.378 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 29' ' ' THR . 42.6 t30 -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.178 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 8.6 mp -99.19 -55.2 2.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' LEU . 2.7 t80 47.46 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.463 -0.773 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.579 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.82 -13.3 8.14 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.24 143.91 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 109.185 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 18.2 m-85 -141.34 142.76 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.442 ' HB2' ' HH ' ' A' ' 41' ' ' TYR . 4.8 m-85 -86.8 106.81 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 0.0 108.941 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.615 ' C ' ' H ' ' A' ' 39' ' ' ASP . 23.8 p -51.93 -52.5 49.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.869 . . . . 0.0 110.035 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . -61.56 7.86 0.14 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.615 ' H ' ' C ' ' A' ' 37' ' ' THR . 0.5 OUTLIER -133.81 172.51 12.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -1.182 . . . . 0.0 109.476 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.98 151.81 30.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.908 . . . . 0.0 109.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.442 ' HH ' ' HB2' ' A' ' 36' ' ' PHE . 50.2 m-85 -131.06 121.86 25.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.616 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.71 118.93 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.081 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.426 HG21 ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -117.08 143.2 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.553 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -124.96 129.46 50.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.77 -0.581 . . . . 0.0 109.836 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.12 93.61 4.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 109.648 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.433 HG21 HD22 ' A' ' 54' ' ' LEU . 2.4 m -72.78 103.06 3.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.513 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -102.63 164.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.559 -0.713 . . . . 0.0 109.28 179.73 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -135.45 141.27 45.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.573 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -99.71 119.36 37.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.208 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.592 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 6.6 m-20 -73.38 120.23 18.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.5 ' CD1' ' C ' ' A' ' 58' ' ' LEU . 2.0 tm? -93.7 115.44 27.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.592 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -132.88 121.5 22.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.379 -0.826 . . . . 0.0 109.811 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CE1' ' HA ' ' A' ' 93' ' ' ARG . 0.3 OUTLIER -99.19 129.65 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.034 . . . . 0.0 108.792 178.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.44 ' C ' ' CD2' ' A' ' 62' ' ' LEU . 18.3 t90 -108.85 126.65 53.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.831 . . . . 0.0 110.156 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.642 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -133.76 116.3 15.57 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -68.24 34.25 0.25 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.0 t-20 49.73 10.9 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -1.025 . . . . 0.0 110.08 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.492 ' H ' ' C ' ' A' ' 63' ' ' GLY . 59.5 mt-10 -110.41 4.59 20.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 108.934 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.68 144.03 28.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.593 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 69' ' ' ASP . 2.0 p -67.41 125.5 26.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -50.69 -9.18 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.562 ' H ' ' C ' ' A' ' 67' ' ' SER . 17.9 t0 -75.5 -44.12 45.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.494 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -87.25 -45.72 10.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.256 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -51.71 -50.34 60.71 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.92 -52.09 51.14 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.45 -39.15 6.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.84 -39.87 83.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.99 . . . . 0.0 109.213 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.57 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -67.49 -31.0 70.83 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.284 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.79 -48.55 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 0.0 110.181 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.33 -33.67 76.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 109.296 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -81.35 -47.14 13.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.571 ' N ' ' CG2' ' A' ' 78' ' ' THR . 61.6 t -61.47 -45.66 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.903 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.22 -57.82 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.513 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 84' ' ' TYR . 2.2 tm? -52.33 -49.72 63.7 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.009 -1.057 . . . . 0.0 108.835 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 78' ' ' THR . 20.2 m-20 -46.56 -49.48 18.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 0.0 108.41 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 87' ' ' GLY . 7.6 m-20 -54.61 -31.95 57.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 81' ' ' LEU . 9.7 t80 -65.39 -28.81 69.53 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.92 -58.11 2.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.626 ' C ' ' H ' ' A' ' 88' ' ' ARG . 9.2 t-20 -121.76 13.46 10.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.135 -0.978 . . . . 0.0 110.666 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 51.32 5.96 0.14 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.626 ' H ' ' C ' ' A' ' 86' ' ' ASN . 34.1 mtp180 -147.19 -83.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.369 -1.077 . . . . 0.0 109.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 60.09 141.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.94 139.61 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -102.59 138.14 39.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 58' ' ' LEU . 20.5 m-70 -140.09 135.71 32.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 7.8 ptp85 -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 22.5 mt-10 -129.26 81.04 2.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.313 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.478 HG11 ' O ' ' A' ' 95' ' ' VAL . 14.5 t -78.95 38.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.875 . . . . 0.0 109.575 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 94' ' ' GLU . 5.7 tt0 63.19 72.39 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.605 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.425 ' O ' ' OE1' ' A' ' 99' ' ' GLU . . . 150.96 -60.86 0.41 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -88.32 57.94 4.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -1.135 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 18.9 mp0 -77.23 -165.14 0.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 94.2 p -133.98 159.9 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.19 78.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.1 m -61.34 -60.29 3.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 44.0 t80 -52.53 -38.0 58.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.06 -31.62 66.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.06 95.42 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.69 -52.38 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -1.196 . . . . 0.0 109.568 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.45 80.61 1.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -96.57 -37.74 10.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.583 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -102.43 9.93 39.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -89.98 -107.99 1.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.5 mm? 51.23 100.36 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.291 -1.123 . . . . 0.0 109.361 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -148.71 114.3 5.64 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.3 OUTLIER -81.93 111.55 18.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.76 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -105.49 113.14 26.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.315 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.419 -179.888 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.374 0.607 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -135.02 125.9 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -125.83 81.61 65.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.564 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.7 165.5 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.818 2.345 . . . . 0.0 112.273 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.426 ' OD1' ' CD ' ' A' ' 129' ' ' GLU . 12.3 t-20 -74.43 -173.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -77.17 -28.82 54.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.389 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.14 -31.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.631 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.81 -54.18 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.602 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.48 -28.52 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.511 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.34 0.591 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -96.48 -59.79 1.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.569 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 59.38 136.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.78 . . . . 0.0 109.407 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.63 ' CA ' ' NE2' ' A' ' 15' ' ' GLN . . . 45.5 46.02 12.01 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLY . 25.9 mtmt -43.22 -33.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -1.11 . . . . 0.0 109.384 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.541 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -140.71 169.29 11.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.847 . . . . 0.0 109.392 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -46.07 134.17 14.82 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.755 2.303 . . . . 0.0 112.328 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.95 -168.48 26.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 tt -123.63 144.03 49.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -1.091 . . . . 0.0 109.393 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.63 ' NE2' ' CA ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -131.05 149.41 52.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 109.448 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.1 mp -124.56 133.0 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.7 m0 -142.08 126.64 17.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.284 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.88 143.89 26.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.089 -1.007 . . . . 0.0 109.363 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.11 143.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 53.5 tt0 -138.28 95.75 3.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 78.78 -62.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 109.009 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 12.1 m-85 -171.72 22.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.667 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.67 111.76 14.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.757 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.6 mp -74.03 132.78 42.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.16 112.33 11.14 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.252 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -45.56 135.04 12.85 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.424 2.083 . . . . 0.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.2 p -78.64 127.54 80.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.12 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.26 122.61 1.26 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.441 2.094 . . . . 0.0 112.442 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 30' ' ' ASN . 7.3 m -64.04 -27.99 69.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.52 ' C ' HD21 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -45.72 -43.3 12.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.079 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 8.2 mp -90.38 -53.63 4.36 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.302 -0.874 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.8 t80 51.62 92.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.542 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.53 -31.31 4.65 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.598 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 45.9 t0 -68.81 134.53 49.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.241 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 25.8 m-85 -142.36 139.89 31.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.623 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -77.74 104.27 8.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -0.868 . . . . 0.0 109.35 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.3 p -45.73 -27.38 0.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.382 -0.824 . . . . 0.0 109.775 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.86 -32.07 41.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.486 ' OD2' ' OE2' ' A' ' 70' ' ' GLU . 35.6 t0 -92.12 172.73 8.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.091 -1.24 . . . . 0.0 109.476 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.93 140.73 46.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.375 -0.828 . . . . 0.0 109.374 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CE1' ' A' ' 36' ' ' PHE . 46.0 m-85 -121.03 135.23 55.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.7 t -111.16 144.21 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.472 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.54 146.19 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -126.51 121.37 32.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.51 94.17 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.935 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.592 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 8.6 m -77.46 103.37 7.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.384 -0.822 . . . . 0.0 109.551 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.5 164.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.243 -0.91 . . . . 0.0 109.316 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 179.963 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -147.98 126.0 12.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.592 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 12.0 m-85 -90.97 130.98 36.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.044 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.26 124.76 37.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 108.781 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 82' ' ' ASP . 9.3 mt -88.76 110.93 21.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.776 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.701 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 19.5 m-70 -124.26 108.7 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.324 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.712 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -103.25 121.3 42.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.165 -0.959 . . . . 0.0 108.668 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -92.39 125.42 37.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.677 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -128.08 105.56 8.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -65.55 17.35 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.677 ' H ' ' C ' ' A' ' 62' ' ' LEU . 40.1 t30 65.95 1.74 1.98 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -1.078 . . . . 0.0 109.82 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 63' ' ' GLY . 40.3 mm-40 -105.11 7.6 33.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.03 . . . . 0.0 109.101 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 15.5 t -101.82 131.02 48.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.602 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 m -52.3 153.76 2.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -73.25 -9.09 58.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.574 ' OD2' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -80.87 -38.2 28.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.588 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.574 ' N ' ' OD2' ' A' ' 69' ' ' ASP . 64.0 tt0 -87.34 -45.74 10.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.202 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.8 t -53.95 -50.34 66.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.498 -0.751 . . . . 0.0 109.266 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -46.42 93.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.89 -45.5 30.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.68 72.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.208 -0.933 . . . . 0.0 109.058 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.36 -20.28 64.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 109.023 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.3 -56.1 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.36 -0.837 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.85 -25.8 65.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.4 m -78.18 -42.55 31.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 0.0 109.438 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 71.8 t -76.09 -41.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.707 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -69.06 -59.35 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.638 ' O ' ' N ' ' A' ' 84' ' ' TYR . 2.1 tm? -53.51 -51.89 61.35 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.615 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.443 ' OD1' ' HB2' ' A' ' 89' ' ' ALA . 4.5 t70 -45.49 -46.39 13.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.39 -33.44 59.24 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' LEU . 28.5 t80 -66.3 -28.58 68.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.1 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.175 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -121.75 -42.39 2.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.173 -0.954 . . . . 0.0 110.255 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.77 -20.15 8.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.467 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 34.0 mtt85 -128.25 -85.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.402 -1.058 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 88' ' ' ARG . . . 72.57 162.64 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.613 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.18 150.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.567 ' N ' ' NE2' ' A' ' 91' ' ' GLN . 2.5 mp0 -109.77 132.7 53.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.701 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 33.1 m-70 -139.34 111.86 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -103.29 124.56 48.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 3.9 mt-10 -117.46 86.48 2.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 0.0 109.366 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.59 37.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.555 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 56.25 91.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.383 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 137.11 -54.55 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -100.37 56.0 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -1.126 . . . . 0.0 109.203 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 5.3 mp0 -83.95 158.26 21.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.9 . . . . 0.0 109.58 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.5 165.23 12.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.313 -0.867 . . . . 0.0 109.287 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -70.47 -30.22 66.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 m -61.92 -60.22 3.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.603 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 36.0 t80 -54.11 -46.61 72.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 109.35 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 104' ' ' LEU . 35.0 mt -67.88 -28.24 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 109.282 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -61.83 -42.93 99.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -69.42 -47.41 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -1.066 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -105.21 52.78 0.73 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 110' ' ' GLY . 12.9 tptt -81.48 -30.08 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 m -57.89 -8.11 0.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.897 . . . . 0.0 109.742 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 100.6 111.6 3.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.575 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -75.89 -106.89 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.312 -1.111 . . . . 0.0 109.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 171.46 112.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.0 107.89 17.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -112.66 143.2 44.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.8 pttp . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.423 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.8 m80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 t -67.98 138.09 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 109.462 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.2 t -128.03 78.32 75.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.377 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.92 127.95 18.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 112.292 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -58.1 127.59 32.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.6 -19.23 57.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.38 -25.32 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.86 -54.13 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -51.8 -29.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.475 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.434 HD11 ' HA ' ' A' ' 6' ' ' LEU . 35.9 tp . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttp -103.24 33.74 3.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.391 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.466 ' HB3' HD23 ' A' ' 44' ' ' LEU . . . -40.26 143.57 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.807 . . . . 0.0 109.619 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.587 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 52.43 56.98 14.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.77 -27.34 11.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.35 157.4 45.42 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.378 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.95 123.31 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.782 2.321 . . . . 0.0 112.272 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.7 -172.24 33.75 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.41 143.08 45.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.398 -1.06 . . . . 0.0 109.524 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.587 HE21 ' N ' ' A' ' 9' ' ' GLY . 13.9 mt-30 -133.89 145.01 49.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.898 . . . . 0.0 109.48 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.603 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 16.2 mt -118.3 139.46 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.603 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.7 m0 -143.37 110.91 5.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -77.9 139.6 39.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.6 143.08 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -0.896 . . . . 0.0 109.202 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' PHE . 24.4 tt0 -158.51 122.2 3.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.54 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 19.1 mmtt 40.59 22.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.51 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' GLU . 2.1 m-85 71.1 44.56 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m-20 -127.09 -13.92 5.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.7 mp 58.81 131.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.2 t -150.91 111.29 3.1 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.06 123.98 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.51 2.14 . . . . 0.0 112.272 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 HG11 HG21 ' A' ' 16' ' ' ILE . 15.0 p -56.36 133.54 76.23 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 109.31 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.49 106.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -58.32 -25.46 61.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -51.74 -47.28 64.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.37 -54.74 4.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.3 t80 53.58 93.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.232 -0.918 . . . . 0.0 109.318 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.44 -4.91 9.4 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.437 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 24.6 t0 -108.23 131.72 54.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.382 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -146.08 167.52 23.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 109.662 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -99.31 122.27 42.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.232 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.7 p -59.64 -27.32 66.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.809 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 26.49 5.92 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.9 t70 -142.69 -166.99 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.308 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.538 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -141.04 140.95 34.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.639 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -123.57 129.45 51.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -100.93 137.55 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.4 mt -132.89 146.39 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.506 HD11 HD23 ' A' ' 58' ' ' LEU . 2.3 mp -128.84 131.14 47.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.544 -0.723 . . . . 0.0 109.569 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -113.72 93.68 4.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.682 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.604 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 5.9 m -78.17 105.66 9.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.658 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.6 164.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.301 -0.874 . . . . 0.0 109.132 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.538 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.89 123.39 23.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.604 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 6.2 m-85 -95.36 126.01 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.594 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.6 m-20 -97.41 119.52 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.927 -1.108 . . . . 0.0 108.962 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.506 HD23 HD11 ' A' ' 44' ' ' LEU . 2.7 mt -83.1 141.35 32.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 11.8 m-70 -145.91 108.72 4.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.21 114.69 28.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 108.624 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -90.51 125.55 35.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.913 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.61 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -129.13 114.35 16.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.449 ' O ' ' NE2' ' A' ' 96' ' ' GLN . . . -67.22 11.44 0.73 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.61 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.1 t-20 67.33 1.72 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.527 -0.984 . . . . 0.0 109.77 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -112.3 9.97 19.96 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.56 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 9.6 p -98.45 126.7 44.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -46.65 123.47 5.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.128 -0.982 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 8.3 pm0 -48.19 -25.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.511 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -53.94 -43.34 69.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -87.41 -31.52 20.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.152 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.18 -59.74 4.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.377 -0.827 . . . . 0.0 109.499 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -54.78 -52.3 47.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.66 -41.07 9.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.381 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.66 92.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.164 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.51 86.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.209 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.58 -45.63 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 109.637 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -68.28 -35.68 78.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.5 m -75.64 -41.9 52.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.7 t -74.18 -43.87 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.166 -0.959 . . . . 0.0 109.943 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -67.91 -59.35 3.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.615 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.8 tm? -53.92 -51.88 62.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.911 -1.118 . . . . 0.0 108.881 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 81' ' ' LEU . 4.7 t70 -45.98 -45.81 15.96 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 108.567 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -58.64 -30.85 67.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 27.0 t80 -69.31 -23.15 63.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.2 mt -83.58 -61.28 1.88 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.422 -0.799 . . . . 0.0 110.948 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.513 ' ND2' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -123.04 -43.41 2.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.976 -1.078 . . . . 0.0 111.361 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.87 -3.37 58.74 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.57 62.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -1.191 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -102.63 168.37 9.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.288 -0.882 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.51 150.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -115.5 136.13 53.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.057 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.422 ' HB2' ' ND1' ' A' ' 59' ' ' HIS . 31.5 m-70 -136.45 124.22 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -114.09 121.54 44.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.862 . . . . 0.0 109.798 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -114.25 93.44 4.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.278 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.5 37.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.615 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 63' ' ' GLY . 4.0 tt0 61.53 110.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.42 -38.55 3.28 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.06 50.29 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.181 . . . . 0.0 109.534 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.87 155.91 39.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 153.8 21.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.57 70.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 m -65.71 -62.93 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 3.5 t80 -51.85 -30.74 24.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.353 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 105' ' ' GLY . 7.8 mt -73.13 -57.39 4.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 104' ' ' LEU . . . -45.19 -34.92 4.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -75.62 -59.71 2.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.492 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.482 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 19.6 m-85 -96.35 57.48 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.594 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -84.89 -33.39 22.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 t -96.06 -11.59 26.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -79.49 -104.11 0.24 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 110' ' ' GLY . 81.6 mt 48.5 98.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.21 -1.17 . . . . 0.0 109.329 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -152.93 116.23 4.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -91.87 107.82 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -112.27 108.74 18.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.0 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 -179.773 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.2 t60 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.0 t -80.09 130.37 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.94 87.72 6.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.579 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 129' ' ' GLU . 53.0 Cg_exo -51.46 130.15 32.0 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.698 2.265 . . . . 0.0 112.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.3 p-10 -60.49 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.155 -0.965 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 127' ' ' PRO . 29.9 mt-10 -87.97 -17.83 30.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.873 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.4 t -50.55 -47.94 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.7 -42.65 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.1 -28.13 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.497 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.468 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -108.51 -28.74 9.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 109.717 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 51.97 62.84 2.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.681 ' N ' ' NE2' ' A' ' 15' ' ' GLN . . . 106.74 38.46 2.2 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.9 pttp -41.66 -23.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.625 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -138.93 157.7 71.12 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.371 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -39.82 136.5 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.799 2.333 . . . . 0.0 112.184 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.14 179.37 24.05 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 4.3 tt -115.45 148.33 39.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -1.012 . . . . 0.0 109.735 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.681 ' NE2' ' N ' ' A' ' 9' ' ' GLY . 31.2 mt-30 -145.03 154.68 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 0.0 109.682 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.619 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -126.93 152.26 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.769 -0.582 . . . . 0.0 110.06 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.4 m-90 -155.08 110.91 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.425 -0.797 . . . . 0.0 109.233 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HD3' ' HH ' ' A' ' 41' ' ' TYR . 3.1 ttp180 -75.49 127.64 33.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 109.345 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -69.8 144.17 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.159 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 22' ' ' PHE . 13.8 tp10 -155.83 121.44 4.94 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.547 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 43.6 tttt 44.07 23.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 109.399 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 70.19 41.46 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 24' ' ' LEU . 11.6 t70 -127.14 -13.14 5.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' ASP . 13.0 mt 56.43 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.6 t -138.02 125.04 13.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.219 -0.925 . . . . 0.0 109.183 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.44 140.93 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.477 2.118 . . . . 0.0 112.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -79.3 134.27 59.13 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -0.847 . . . . 0.0 109.347 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.529 ' CB ' ' OD1' ' A' ' 30' ' ' ASN . 77.7 Cg_exo -40.2 103.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.477 2.118 . . . . 0.0 112.18 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -49.27 -37.93 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 1.2 p30 -45.52 -39.72 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 6.2 mp -86.15 -55.58 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 31' ' ' LEU . 44.2 t80 45.19 90.73 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.593 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.7 -31.3 4.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 1.1 m-20 -85.97 137.5 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.085 -1.244 . . . . 0.0 109.249 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 22.9 m-85 -146.07 153.72 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -76.91 128.21 34.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 108.901 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 p -74.22 -26.46 60.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 110.021 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.01 -22.9 62.57 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.1 t70 -94.94 -160.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -136.26 141.0 43.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.377 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.538 ' HH ' ' HD3' ' A' ' 18' ' ' ARG . 26.5 m-85 -125.21 125.59 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.9 t -93.87 127.83 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -138.28 145.08 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 109.163 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.573 ' CB ' ' O ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -144.55 167.06 23.41 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.048 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 1.7 tmmm? -146.28 94.31 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.458 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 63.7 m -72.16 126.88 30.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.374 -0.829 . . . . 0.0 109.833 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.44 164.79 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.636 -0.665 . . . . 0.0 109.515 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.6 -0.687 . . . . 0.0 109.203 179.792 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.485 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.6 tt0 -127.21 117.39 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -0.949 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.531 ' OH ' ' O ' ' A' ' 9' ' ' GLY . 5.2 m-85 -71.75 108.73 5.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 87.1 m-20 -72.56 118.05 15.0 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.924 -1.11 . . . . 0.0 108.152 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 1.7 mm? -102.81 119.21 38.43 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.071 -1.018 . . . . 0.0 109.747 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.473 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -144.29 116.91 8.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 109.657 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.734 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.45 140.33 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 108.819 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.425 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 7.2 t90 -100.65 127.02 47.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.678 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -127.69 108.67 10.95 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.537 ' O ' ' NE2' ' A' ' 96' ' ' GLN . . . -63.09 12.58 0.11 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.678 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.2 t-20 66.53 1.87 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -1.13 . . . . 0.0 109.845 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.97 5.32 32.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.067 -1.021 . . . . 0.0 108.973 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 67' ' ' SER . 34.5 t -101.15 116.8 33.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 66' ' ' CYS . 12.7 p -42.23 125.32 3.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.508 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 1.6 mp0 -45.01 -28.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.62 -42.11 82.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.596 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -87.5 -38.89 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.487 ' OG ' HD12 ' A' ' 62' ' ' LEU . 1.9 t -59.53 -57.59 12.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.13 -40.53 36.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.95 -52.65 62.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.294 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.98 65.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.181 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -72.59 -20.3 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -81.0 -46.89 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -66.38 -36.08 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.51 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.24 -41.46 61.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 78' ' ' THR . 24.5 t -61.37 -52.12 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.731 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.91 -59.61 5.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 109.783 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.615 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -53.14 -44.37 67.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 108.738 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' LEU . 10.9 t0 -46.72 -48.25 20.38 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.923 -1.11 . . . . 0.0 108.114 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.77 -27.91 69.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 37.9 t80 -75.91 -24.09 55.57 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.03 -53.88 6.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.895 . . . . 0.0 109.574 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -121.84 -42.32 2.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.4 -0.812 . . . . 0.0 109.891 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.33 -22.42 7.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.4 mtp180 -142.39 -85.39 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.386 -1.067 . . . . 0.0 109.278 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 58.68 161.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.4 t -98.39 135.31 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.507 ' OE1' ' OH ' ' A' ' 60' ' ' TYR . 1.1 pp0? -121.98 133.28 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.301 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.634 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -135.59 159.83 40.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.308 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -121.75 136.54 54.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 96' ' ' GLN . 23.7 mt-10 -108.43 87.54 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.528 -0.733 . . . . 0.0 109.145 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.2 t -74.48 37.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.867 . . . . 0.0 109.885 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 63' ' ' GLY . 2.8 tt0 54.73 106.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.78 -54.87 0.69 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 99' ' ' GLU . 13.8 m-85 -115.19 36.53 3.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -1.104 . . . . 0.0 109.254 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 98' ' ' PHE . 13.1 mt-10 -44.28 169.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 t -95.98 165.81 12.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.96 67.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.4 m -66.76 -49.96 64.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' ' CD1' ' A' ' 61' ' ' TRP . 67.8 t80 -64.0 -46.45 84.5 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 108' ' ' LYS . 26.7 mt -68.77 -32.67 72.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.65 -55.13 32.52 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.76 -47.01 87.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -1.115 . . . . 0.0 109.327 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.45 48.89 0.85 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' LEU . 42.6 tttm -68.97 -23.61 64.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 t -76.21 3.69 10.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.71 110.58 2.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.614 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.1 -101.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -1.116 . . . . 0.0 109.188 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 172.07 107.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.107 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.69 107.94 17.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -105.18 122.59 46.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.67 146.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.482 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.35 86.18 21.34 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 109.343 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.04 126.01 14.37 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.767 2.311 . . . . 0.0 112.224 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -79.41 -172.57 3.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.33 -29.04 21.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.98 -27.38 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.08 -40.24 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.942 . . . . 0.0 109.416 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.58 -27.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.414 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.253 0.549 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 8' ' ' ALA . 33.4 tttm -82.56 -19.53 38.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 9' ' ' GLY . . . -43.62 130.44 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.075 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.469 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 41.68 40.84 3.11 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -48.75 -26.12 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -1.11 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -135.18 157.96 75.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.88 118.9 5.24 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.792 2.328 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.5 -158.02 29.45 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.17 148.27 48.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -1.021 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.469 HE21 ' N ' ' A' ' 9' ' ' GLY . 20.6 mt-30 -143.98 141.77 30.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.221 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.36 123.98 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.927 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.444 ' O ' HG22 ' A' ' 42' ' ' VAL . 1.9 m0 -131.06 129.75 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HG3' ' CZ ' ' A' ' 41' ' ' TYR . 7.2 ttm180 -87.17 144.92 26.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.917 . . . . 0.0 109.584 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' N ' ' HG2' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -85.45 143.34 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' A' ' 23' ' ' ASP . 25.0 tt0 -151.54 99.89 2.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 6.4 ttmm 48.48 38.49 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.378 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 66.29 20.67 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 24' ' ' LEU . 7.0 m-20 -98.74 -21.67 16.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.1 mt 57.21 122.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.48 133.47 23.65 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 109.219 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.93 117.66 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.343 2.029 . . . . 0.0 112.379 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.24 134.62 90.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.17 136.07 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.275 1.983 . . . . 0.0 112.328 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -57.65 -30.26 65.26 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -45.86 -42.11 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 32' ' ' TYR . 8.4 mp -90.34 -55.73 3.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.208 -0.932 . . . . 0.0 109.268 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.8 t80 36.2 83.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.585 -0.697 . . . . 0.0 109.888 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.68 -31.38 4.6 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -91.48 126.22 36.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.248 . . . . 0.0 109.151 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.686 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.61 168.26 21.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.918 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -80.56 158.13 25.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.093 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -101.68 -11.19 19.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.64 -7.73 61.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.58 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.3 t70 -105.58 -155.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -1.149 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.58 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.71 141.4 31.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.543 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 25.0 m-85 -124.36 121.94 36.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 17' ' ' TRP . 0.5 OUTLIER -103.22 135.7 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.4 mt -121.52 146.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.796 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 44' ' ' LEU . 4.0 mm? -118.74 125.38 49.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' GLN . 7.6 ttpp -120.82 93.79 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.053 -1.03 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.642 ' OG1' ' CE1' ' A' ' 56' ' ' TYR . 91.7 m -85.98 101.34 12.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.581 -0.699 . . . . 0.0 109.455 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.22 164.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.35 -0.844 . . . . 0.0 109.15 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.748 . . . . 0.0 109.603 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.494 ' H ' HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.521 ' O ' ' O ' ' A' ' 45' ' ' LYS . 4.1 tp-100 -131.43 110.75 11.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.642 ' CE1' ' OG1' ' A' ' 46' ' ' THR . 7.7 m-85 -86.32 109.67 19.14 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.618 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -84.01 127.59 33.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.602 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 1.1 mm? -96.51 107.25 19.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.548 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.647 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 75.3 m-70 -115.96 108.57 16.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.717 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.7 120.27 39.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.676 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.686 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 56.5 t90 -102.34 124.91 48.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.987 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.775 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -128.93 118.67 23.04 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.0 16.95 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.775 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER 61.77 2.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -1.031 . . . . 0.0 109.815 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.3 mt-10 -109.4 13.14 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.165 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.7 t -99.91 140.16 34.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.604 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.2 t -61.25 146.54 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.607 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -62.68 -23.48 67.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.11 -49.77 76.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.731 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.49 -43.65 11.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.316 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -55.89 -53.82 52.13 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -60.18 -51.24 60.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.51 -35.14 3.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -1.191 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.19 -45.81 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -62.02 -31.77 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.2 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.48 -52.47 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -58.44 -44.41 89.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.249 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -67.15 -44.55 79.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.554 ' N ' ' CG2' ' A' ' 78' ' ' THR . 58.4 t -69.62 -65.11 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' VAL . 6.1 mm-40 -43.36 -59.42 2.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.104 -0.998 . . . . 0.0 109.422 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -52.12 -37.05 53.02 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.069 -1.019 . . . . 0.0 108.641 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -52.01 -52.59 49.68 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.057 -1.027 . . . . 0.0 108.725 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.547 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 7.4 t70 -57.78 -30.52 65.72 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -79.24 -23.73 43.5 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.0 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 56' ' ' TYR . 11.4 tp -84.74 -46.04 11.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 110.101 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -122.02 -42.21 2.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 109.987 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.93 -15.8 51.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -154.06 24.21 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.77 -179.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.63 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.45 150.19 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -108.44 133.31 52.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.953 . . . . 0.0 109.682 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.647 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 15.8 m-70 -132.35 121.2 23.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.243 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.401 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 58.3 ttt180 -108.48 127.75 54.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.565 ' C ' ' H ' ' A' ' 96' ' ' GLN . 8.3 mp0 -126.62 78.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.416 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.8 t -68.75 37.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.565 ' H ' ' C ' ' A' ' 94' ' ' GLU . 7.2 tp-100 39.27 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.461 -0.775 . . . . 0.0 109.615 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 150.3 -19.24 1.05 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 29.9 m-85 -162.95 47.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.39 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' CE2' ' A' ' 103' ' ' PHE . 2.3 mt-10 -62.65 -179.41 0.26 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.17 172.39 7.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.434 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.35 -31.36 71.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.506 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -63.17 -62.62 1.57 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.582 ' CE2' ' OE1' ' A' ' 99' ' ' GLU . 16.6 t80 -52.52 -38.27 59.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.88 -24.72 61.71 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.06 -43.24 57.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.403 ' CZ ' ' HD2' ' A' ' 45' ' ' LYS . 27.1 m-85 -70.33 -42.54 71.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -1.214 . . . . 0.0 109.639 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.54 73.25 0.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.434 ' HZ3' ' HB2' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -98.37 -31.55 11.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -104.12 7.99 36.35 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -102.14 -111.75 3.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 110' ' ' GLY . 8.5 mp 53.09 102.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.334 -1.097 . . . . 0.0 109.405 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -145.37 108.39 4.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -82.34 107.98 15.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 0.0 109.614 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.01 108.91 16.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 109.298 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.889 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.48 111.03 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 126' ' ' VAL . 12.2 p -100.64 117.33 62.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -44.77 129.2 9.29 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -62.6 136.41 57.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -52.31 -17.48 1.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.0 t -46.87 -34.92 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.7 t -49.66 -60.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.12 -27.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.522 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -64.85 -43.61 92.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.454 ' HB2' ' CH2' ' A' ' 17' ' ' TRP . . . -50.88 145.29 7.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.03 57.21 2.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 12.5 mmtp -132.89 -10.33 3.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.241 -1.152 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 58.0 mt-10 -160.17 150.41 15.03 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.284 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.61 156.36 57.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.55 2.166 . . . . 0.0 111.916 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.29 -141.47 15.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 15' ' ' GLN . 2.4 tt -127.86 144.9 51.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.406 -1.055 . . . . 0.0 110.062 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.409 ' O ' HG21 ' A' ' 43' ' ' ILE . 3.9 mt-30 -135.78 150.55 49.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 109.057 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 43' ' ' ILE . 1.9 mp -124.96 145.32 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.83 . . . . 0.0 110.409 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -146.37 110.89 5.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.421 -0.799 . . . . 0.0 108.942 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' VAL . 12.4 ttp85 -81.09 129.63 34.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 0.0 109.672 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -87.06 143.64 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 12.2 tm-20 -153.8 88.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? 60.6 50.51 5.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 53.6 47.61 23.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.516 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 24' ' ' LEU . 49.9 t0 -126.99 -25.91 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.4 mp 59.39 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.4 -0.812 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' ARG . 51.7 t -145.94 103.22 4.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 27' ' ' VAL . 63.3 Cg_exo -47.77 108.28 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.287 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 26' ' ' PRO . 10.1 t -43.34 107.49 0.57 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.417 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.99 137.74 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.406 2.07 . . . . 0.0 112.223 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 m -62.0 -24.93 67.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.13 -45.29 32.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.258 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -94.94 -55.46 3.09 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 31' ' ' LEU . 12.4 t80 42.24 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 109.75 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.597 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.43 -30.87 4.82 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -79.83 137.66 37.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.083 -1.245 . . . . 0.0 109.392 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 57.2 m-85 -136.95 160.46 38.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.05 105.54 15.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.385 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.2 p -57.85 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.95 -30.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.8 m-20 -111.23 -153.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.45 -1.03 . . . . 0.0 109.014 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.7 145.38 44.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.532 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.4 ' CE1' ' HG3' ' A' ' 18' ' ' ARG . 65.6 m-85 -121.2 127.62 51.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.419 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.68 103.87 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -121.39 144.34 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 109.193 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 1.1 pt? -147.55 172.43 14.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 110.193 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -145.82 99.88 3.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 111.489 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -72.52 118.91 16.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 108.908 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.07 164.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.497 -0.752 . . . . 0.0 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.538 -0.726 . . . . 0.0 109.258 179.708 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.435 ' H ' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -126.05 114.11 17.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.653 ' CG ' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.61 109.87 17.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.079 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -86.76 103.0 14.78 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.636 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 1.1 mt -95.95 143.1 27.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.172 -0.955 . . . . 0.0 110.444 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 43' ' ' ILE . 1.5 p-80 -154.1 131.83 11.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.465 -0.772 . . . . 0.0 109.623 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.739 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -98.02 118.62 35.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 108.921 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.677 ' NE1' ' CE1' ' A' ' 103' ' ' PHE . 12.1 t90 -85.35 130.36 34.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.302 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.662 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -131.4 111.51 11.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 15.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.662 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER 66.65 1.83 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.341 -1.093 . . . . 0.0 109.713 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -107.3 10.79 29.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 108.983 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 18.4 t -105.0 146.1 29.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -73.67 166.22 23.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.862 . . . . 0.0 109.359 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -76.35 -8.98 58.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.3 -46.52 49.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.12 -36.74 17.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 109.456 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.9 t -60.72 -58.31 9.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.582 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.13 -41.38 78.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -49.93 61.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.436 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.05 87.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.542 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -69.45 -20.46 63.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.134 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mm -79.49 -52.25 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -33.1 73.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 108.994 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 16.4 m -74.33 -36.55 63.67 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.242 -0.911 . . . . 0.0 109.6 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 75' ' ' ALA . 47.4 t -75.18 -54.61 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -61.75 -59.49 5.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.692 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.1 tm? -51.97 -47.14 64.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.101 -0.999 . . . . 0.0 108.792 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.584 ' OD2' ' NE2' ' A' ' 91' ' ' GLN . 5.0 t0 -46.37 -47.66 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.971 -1.08 . . . . 0.0 108.523 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.11 -30.77 69.49 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.571 ' N ' ' O ' ' A' ' 81' ' ' LEU . 31.7 t80 -75.86 -23.57 55.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.467 ' C ' HD21 ' A' ' 86' ' ' ASN . 8.0 mt -78.07 -52.49 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.573 HD21 ' N ' ' A' ' 86' ' ' ASN . 1.1 m-80 -122.02 -42.2 2.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.04 -11.0 57.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 -150.2 18.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -1.175 . . . . 0.0 109.8 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.51 -178.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.516 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.543 ' C ' ' NE2' ' A' ' 91' ' ' GLN . 3.7 t -114.1 145.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.357 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.584 ' NE2' ' OD2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -136.69 126.78 26.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.688 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -125.26 160.24 29.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.861 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.404 ' CB ' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -111.37 136.78 50.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.112 -0.993 . . . . 0.0 109.939 -179.324 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.9 mm-40 -118.81 101.81 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 95' ' ' VAL . 8.3 p -88.46 37.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.241 -0.912 . . . . 0.0 109.693 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 57.12 66.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.398 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.39 -59.7 0.29 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -92.22 33.12 1.1 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.457 ' OE2' ' CD1' ' A' ' 61' ' ' TRP . 2.6 mt-10 -72.28 -154.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.425 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -138.05 156.87 47.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 109.385 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.27 -21.07 12.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.6 m -61.6 -60.57 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.095 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.677 ' CE1' ' NE1' ' A' ' 61' ' ' TRP . 72.3 t80 -61.12 -50.28 73.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.525 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -70.34 -18.68 63.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.157 -0.964 . . . . 0.0 109.142 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -69.81 -41.95 71.78 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -71.92 -43.38 65.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -1.112 . . . . 0.0 109.052 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -107.51 54.21 0.67 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.596 ' C ' ' H ' ' A' ' 110' ' ' GLY . 25.8 tttm -81.39 -33.5 32.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.912 . . . . 0.0 109.678 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.0 t -60.7 3.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.74 109.58 2.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.48 ' O ' ' CB ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -72.39 -101.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -1.173 . . . . 0.0 109.15 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.48 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 6.7 mttm 165.26 136.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.65 107.89 17.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.494 -0.754 . . . . 0.0 109.235 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -114.26 132.06 56.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.903 . . . . 0.0 109.554 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 109.385 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 4.9 p -122.36 129.08 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.429 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.37 82.46 23.14 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' ASN . 59.4 Cg_endo -79.01 132.99 10.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.666 2.244 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' PRO . 10.5 m-20 -41.29 146.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -88.07 -17.2 31.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.36 -22.24 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.72 -34.65 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.3 -29.63 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.427 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.436 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 8' ' ' ALA . 8.4 ttmt -104.93 23.43 13.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.212 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -37.55 140.24 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.445 -0.784 . . . . 0.0 109.803 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.559 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 78.48 51.45 5.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -61.96 1.43 0.29 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -1.2 . . . . 0.0 109.172 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 9' ' ' GLY . 2.6 mt-10 176.35 138.66 0.21 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.448 -0.783 . . . . 0.0 108.938 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -39.77 125.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.574 2.183 . . . . 0.0 112.223 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.02 -157.18 27.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.53 HD11 ' HZ2' ' A' ' 45' ' ' LYS . 5.8 tt -112.43 133.65 54.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -119.73 157.7 28.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.366 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.568 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.6 mt -134.98 142.59 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.707 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.3 m-90 -149.46 110.69 4.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' VAL . 6.3 ttt180 -89.21 139.41 30.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.88 143.33 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 69.5 tt0 -136.0 111.29 9.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.484 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 26.2 tttp 51.36 43.7 29.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 4.5 t80 73.88 25.72 1.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 20' ' ' GLU . 2.5 m-20 -126.96 111.76 14.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 tp -58.71 141.57 52.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.494 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 18' ' ' ARG . 73.8 t -138.64 121.42 10.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.185 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.25 115.2 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.34 2.026 . . . . 0.0 112.342 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.72 135.06 23.25 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.139 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 32' ' ' TYR . 31.0 Cg_endo -67.13 97.94 0.43 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.3 2.0 . . . . 0.0 112.183 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 46.9 m -52.19 -24.46 7.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.566 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -19.73 57.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mt -132.2 13.55 4.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.791 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -71.29 -104.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 67.76 -17.09 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 32' ' ' TYR . 18.9 t0 -102.49 140.2 37.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.133 -1.216 . . . . 0.0 109.379 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -129.9 119.79 23.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.107 -0.996 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -76.32 102.78 6.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 113' ' ' TYR . 82.1 p -61.32 -31.59 71.44 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 110.075 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.9 24.53 5.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.582 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 24.8 t0 -143.29 -156.42 0.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -1.124 . . . . 0.0 109.294 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.582 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.6 140.73 31.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -121.87 124.35 43.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.623 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 46.5 t -101.47 115.11 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.074 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -116.14 145.22 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.264 -0.898 . . . . 0.0 109.872 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.4 mp -126.55 151.27 48.12 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HZ2' HD11 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -140.45 93.35 2.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.791 -1.193 . . . . 0.0 110.833 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.599 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 29.9 m -89.88 98.63 11.88 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.53 164.63 2.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.32 -0.862 . . . . 0.0 109.812 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.649 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.494 HD11 ' N ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' LYS . 8.7 tt0 -117.36 98.86 6.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.484 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 9.5 m-85 -75.83 123.53 25.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.534 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -103.0 147.59 26.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.932 -1.105 . . . . 0.0 108.64 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' HIS . 0.7 OUTLIER -124.66 109.1 12.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.361 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -131.17 116.17 17.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 109.528 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.714 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.87 129.32 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -101.69 127.24 48.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 110.167 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.702 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -129.44 108.93 10.65 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -64.43 20.05 0.1 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.1 t-20 59.54 2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.079 . . . . 0.0 110.016 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 63' ' ' GLY . 17.8 mt-10 -102.29 2.38 36.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.968 -1.083 . . . . 0.0 108.898 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.437 ' SG ' ' CG ' ' A' ' 70' ' ' GLU . 48.1 t -100.72 140.13 35.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -67.28 155.35 39.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.594 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.9 -8.88 24.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.49 -52.1 20.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' CG ' ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -87.57 -37.15 17.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 62' ' ' LEU . 7.6 t -62.5 -60.08 4.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.514 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.53 37.4 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.8 -37.65 6.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.391 -1.064 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.54 -39.16 85.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.202 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.538 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -69.69 -32.82 71.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 109.446 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.13 -43.51 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.42 -40.64 97.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.89 -44.31 32.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.694 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.545 ' N ' ' CG2' ' A' ' 78' ' ' THR . 55.9 t -62.79 -45.77 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 110.214 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 14.7 pt20 -67.62 -50.57 57.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.992 -1.068 . . . . 0.0 110.217 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -62.33 -47.04 85.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.779 -1.201 . . . . 0.0 108.357 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' LEU . 1.6 t0 -45.87 -46.95 16.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.74 -32.16 71.45 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 81' ' ' LEU . 41.6 t80 -69.57 -23.05 63.5 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.448 HD13 ' HB1' ' A' ' 8' ' ' ALA . 46.5 mt -83.08 -62.01 1.71 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.414 -0.803 . . . . 0.0 110.762 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -122.57 -43.19 2.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.995 -1.066 . . . . 0.0 111.293 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.57 6.67 63.93 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -149.52 10.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -1.12 . . . . 0.0 109.906 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -56.0 177.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.46 133.8 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.157 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.502 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 3.1 mp0 -97.63 138.0 35.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 110.193 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.549 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 9.7 m-70 -139.5 129.82 25.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -0.814 . . . . 0.0 109.249 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -113.25 126.02 54.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.985 . . . . 0.0 109.819 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.469 ' OE2' ' O ' ' A' ' 60' ' ' TYR . 2.0 mp0 -127.15 84.56 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' HG22 ' A' ' 95' ' ' VAL . 8.9 p -81.64 37.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 2.0 tt0 70.66 52.66 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.39 -53.39 0.25 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -94.13 55.62 2.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.4 mp0 -78.99 -161.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -138.81 170.87 15.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.48 -30.46 64.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.8 m -66.38 -39.5 89.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.372 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -73.52 -51.1 18.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.36 -0.837 . . . . 0.0 109.491 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.404 ' HA ' HD21 ' A' ' 104' ' ' LEU . 92.3 mt -68.53 -17.52 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.15 -40.65 13.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD1' HD12 ' A' ' 14' ' ' LEU . 1.6 t80 -82.43 -32.72 28.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -1.128 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -101.35 96.46 7.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.464 ' HG3' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -96.87 -63.63 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.173 -0.954 . . . . 0.0 109.402 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.464 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 3.2 m -100.96 11.96 38.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.395 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.495 ' N ' HD23 ' A' ' 111' ' ' LEU . . . -102.98 65.14 0.39 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -147.07 95.05 2.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.316 -1.108 . . . . 0.0 109.0 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.61 114.32 21.01 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.525 ' HB3' HG21 ' A' ' 37' ' ' THR . 1.0 OUTLIER -81.43 107.65 14.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.382 -0.823 . . . . 0.0 109.8 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -111.86 109.03 18.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.313 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 pttt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.462 -179.887 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.275 0.559 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.97 147.1 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.21 71.86 76.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.452 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.02 150.66 9.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.814 2.343 . . . . 0.0 112.266 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -75.21 141.6 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.519 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -76.6 -26.34 54.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.486 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -65.4 -23.86 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.15 -30.71 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.03 -30.2 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.448 179.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.249 0.547 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -104.86 -56.89 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.437 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 59.47 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.402 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 50.68 27.08 11.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' GLY . 1.6 pttt -42.33 -21.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 109.231 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -130.98 157.99 76.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.53 119.92 7.37 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.7 2.267 . . . . 0.0 112.006 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.19 -150.25 21.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.5 HD12 ' CD2' ' A' ' 106' ' ' TYR . 3.4 tt -132.38 144.81 50.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 0.0 109.591 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.527 HE21 ' N ' ' A' ' 9' ' ' GLY . 24.4 mt-30 -136.61 148.21 47.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.458 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -121.3 138.41 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.593 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.6 m0 -141.98 111.0 6.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.45 HH22 HG12 ' A' ' 25' ' ' VAL . 3.6 ttt-85 -71.45 135.85 47.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.49 143.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -0.997 . . . . 0.0 109.426 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 89.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.311 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 63.38 28.56 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER 71.03 16.98 6.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 24' ' ' LEU . 73.0 m-20 -99.83 -14.29 18.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.6 mt 57.25 136.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.45 HG12 HH22 ' A' ' 18' ' ' ARG . 47.3 t -142.72 115.73 6.21 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.74 143.83 6.09 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.362 2.041 . . . . 0.0 112.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.44 125.02 81.89 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.45 111.84 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.487 2.125 . . . . 0.0 112.148 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.2 m -63.83 -25.51 68.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -45.71 -41.11 10.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.306 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.31 -54.98 2.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CZ ' HD11 ' A' ' 16' ' ' ILE . 14.4 t80 55.62 95.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.353 -0.842 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.49 -31.03 4.76 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.4 m-20 -89.93 128.37 36.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -1.119 . . . . 0.0 109.191 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.698 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.27 167.92 22.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.915 . . . . 0.0 109.777 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CD1' ' OH ' ' A' ' 41' ' ' TYR . 3.9 m-85 -85.14 154.91 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.346 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.434 HG22 HE21 ' A' ' 96' ' ' GLN . 5.0 p -95.14 -9.44 33.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.528 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.0 26.79 22.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.09 -162.13 1.32 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -1.163 . . . . 0.0 109.324 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.35 141.08 33.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 22.2 m-85 -128.79 122.51 30.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.359 -0.838 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.6 t -96.57 141.65 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.437 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.71 146.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 109.363 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 mp -129.71 131.63 46.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.685 . . . . 0.0 109.586 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -114.53 94.19 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.596 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 7.6 m -77.24 101.77 6.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.323 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.449 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -99.14 164.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.6 -0.688 . . . . 0.0 109.274 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.449 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -137.96 134.8 35.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.805 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.596 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 11.7 m-85 -92.82 128.8 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 108.824 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CG ' ' NE2' ' A' ' 59' ' ' HIS . 34.8 t0 -91.09 116.3 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 108.92 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.0 mp -81.76 126.53 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.692 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.72 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 27.5 m-70 -142.44 108.53 5.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.112 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.713 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.42 129.17 50.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.022 . . . . 0.0 108.961 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.698 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 6.0 t90 -96.71 129.56 44.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.375 -0.828 . . . . 0.0 110.03 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.706 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.1 mt -134.44 106.34 7.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.7 9.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.706 ' H ' ' C ' ' A' ' 62' ' ' LEU . 4.7 t-20 69.23 1.22 3.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -1.091 . . . . 0.0 109.607 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -113.65 12.59 18.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.48 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 3.0 p -97.86 134.6 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.537 -0.727 . . . . 0.0 109.406 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 66' ' ' CYS . 1.3 m -43.65 152.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.18 -20.69 57.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.152 -0.967 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -68.59 -35.06 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -87.03 -28.63 22.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -64.32 -60.05 3.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 0.0 109.385 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.76 -46.49 91.76 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -46.6 -43.71 17.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -1.116 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.59 50.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 109.036 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.499 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -58.42 -20.09 41.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 108.89 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mm -81.59 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.33 -0.856 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.3 -26.8 68.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 108.446 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 37.5 m -76.78 -50.59 13.15 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.682 -0.636 . . . . 0.0 109.382 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.51 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 87.1 t -67.89 -36.36 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.834 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -66.07 -58.84 4.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.633 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -55.04 -46.48 75.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.935 -1.103 . . . . 0.0 109.193 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -47.64 -47.41 29.24 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.741 -1.224 . . . . 0.0 108.145 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.7 t70 -63.01 -24.44 67.92 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.633 ' N ' ' O ' ' A' ' 81' ' ' LEU . 37.0 t80 -78.13 -23.71 47.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 36.1 mt -83.35 -53.94 5.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.232 -0.917 . . . . 0.0 109.777 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -122.0 -42.37 2.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.184 -0.948 . . . . 0.0 110.094 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.16 -8.42 8.52 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.403 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 59.8 mtt-85 -144.07 -84.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -1.099 . . . . 0.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 88' ' ' ARG . . . 68.11 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.586 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.59 149.85 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.66 143.08 45.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.293 -0.879 . . . . 0.0 109.912 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.72 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 36.2 m-70 -142.39 121.91 13.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.468 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 15.7 ptt180 -108.9 121.24 44.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 96' ' ' GLN . 6.5 mp0 -112.52 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.45 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.434 HE21 HG22 ' A' ' 37' ' ' THR . 13.1 tt0 66.29 53.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.544 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 99' ' ' GLU . . . 162.78 -53.23 0.3 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -77.28 30.67 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.503 ' OE2' HD23 ' A' ' 104' ' ' LEU . 7.7 mt-10 -59.81 150.83 27.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.8 t -99.88 162.69 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.46 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.4 m -63.65 -62.71 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.364 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.559 ' CE1' ' CD2' ' A' ' 107' ' ' PHE . 69.4 t80 -54.69 -37.0 65.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.407 -0.808 . . . . 0.0 109.491 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.503 HD23 ' OE2' ' A' ' 99' ' ' GLU . 98.3 mt -71.84 -22.67 61.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.5 -30.16 46.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.5 ' CD2' HD12 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -85.81 -41.38 15.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.559 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 96.8 m-85 -105.11 76.15 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.508 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.9 -30.89 11.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -98.82 8.73 44.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -101.88 -111.06 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 110' ' ' GLY . 72.7 mt 44.52 96.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.272 -1.134 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -155.4 110.55 3.01 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 107.85 16.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.392 -0.818 . . . . 0.0 109.587 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -103.84 108.83 20.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.3 pttm . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 109.468 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.268 0.556 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.45 147.12 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 t -138.06 110.95 8.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 109.365 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 128' ' ' ASN . 78.3 Cg_exo -45.93 133.66 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.389 2.059 . . . . 0.0 112.335 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 127' ' ' PRO . 2.0 m120 -43.12 147.71 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.25 -22.93 59.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 t -52.63 -37.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.29 -36.35 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.19 -27.4 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.503 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.417 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 8' ' ' ALA . 15.4 mtmm -125.16 -53.16 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.608 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 58.86 150.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.153 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.526 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 43.13 40.81 4.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.45 ' HZ3' ' HB2' ' A' ' 10' ' ' LYS . 18.7 mtmm -42.06 -28.14 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.419 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.554 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -145.64 149.05 38.87 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.249 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -39.85 123.01 1.15 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.628 2.219 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 -168.04 34.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' LEU . 7.2 tt -120.65 129.54 53.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -1.018 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.526 HE21 ' N ' ' A' ' 9' ' ' GLY . 20.9 mt-30 -124.4 163.96 20.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.594 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.2 mt -136.42 137.02 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 109.778 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.594 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.2 m0 -141.6 131.36 24.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.458 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 25' ' ' VAL . 59.9 ttp180 -95.24 144.88 25.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.898 . . . . 0.0 109.599 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.428 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 0.4 OUTLIER -108.45 143.38 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.2 tp10 -130.04 91.5 3.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.5 tttp 78.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.606 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 77' ' ' PHE . 10.5 t80 -160.8 16.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.909 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -127.47 114.89 18.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 109.716 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.8 mp -59.6 149.0 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ARG . 60.5 t -154.1 118.29 2.67 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.11 152.16 0.66 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.455 2.104 . . . . 0.0 112.199 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -102.13 132.78 21.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.481 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -42.42 136.79 3.99 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.536 2.157 . . . . 0.0 112.353 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -70.2 -28.42 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.335 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -60.68 -40.33 91.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' O ' ' C ' ' A' ' 32' ' ' TYR . 7.8 mp -76.85 -55.46 5.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.862 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 31' ' ' LEU . 9.9 t80 35.4 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.522 -0.736 . . . . 0.0 109.928 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.455 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 115.28 -31.45 6.21 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.23 120.48 27.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -1.186 . . . . 0.0 109.189 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.684 ' CD1' ' CH2' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.67 168.49 21.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 110.043 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' GLY . 22.6 m-85 -86.29 106.95 17.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 109.276 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -46.93 -10.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . -91.05 19.09 48.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.56 -164.65 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -1.175 . . . . 0.0 109.394 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.4 140.61 37.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.663 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -131.05 164.18 25.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.818 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.437 HG12 ' HG1' ' A' ' 78' ' ' THR . 2.1 t -138.6 131.34 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.875 . . . . 0.0 109.407 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.407 HD12 HG21 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -115.94 145.62 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.296 -0.878 . . . . 0.0 109.648 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.84 147.99 45.27 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -145.69 93.34 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.027 -1.046 . . . . 0.0 110.297 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.611 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 32.1 m -88.58 108.52 19.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.491 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.53 163.9 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.297 -0.877 . . . . 0.0 108.95 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.612 0.72 . . . . 0.0 110.657 -179.166 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -124.69 102.31 7.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.147 -0.971 . . . . 0.0 110.765 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.611 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 6.9 m-85 -82.08 109.47 16.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.416 ' HB3' ' HZ1' ' A' ' 45' ' ' LYS . 21.8 t0 -83.45 148.66 27.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.978 -1.076 . . . . 0.0 108.551 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.488 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -130.18 125.9 36.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -137.01 108.91 7.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 109.575 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.705 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.54 114.29 25.01 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 108.558 179.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.684 ' CH2' ' CD1' ' A' ' 35' ' ' PHE . 68.8 t90 -86.69 118.38 26.06 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.358 -0.839 . . . . 0.0 109.688 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.653 ' C ' ' H ' ' A' ' 64' ' ' ASN . 1.0 OUTLIER -123.2 105.92 10.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.55 -0.719 . . . . 0.0 109.097 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 64' ' ' ASN . . . -56.58 1.19 0.11 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.653 ' H ' ' C ' ' A' ' 62' ' ' LEU . 13.4 t-20 70.3 1.65 3.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.509 -0.995 . . . . 0.0 109.731 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -111.88 15.05 20.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 108.896 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.3 t -105.62 145.99 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 109.622 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.2 t -55.36 156.96 3.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.05 -26.45 48.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.184 -0.947 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -41.15 78.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.696 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 19' ' ' VAL . 33.4 tt0 -87.32 -42.66 12.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 t -57.71 -54.05 51.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.728 . . . . 0.0 109.512 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.52 -53.42 43.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.49 -39.27 7.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.462 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.33 86.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.179 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.7 -32.6 74.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.384 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.72 -48.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.802 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 22' ' ' PHE . 1.5 m-85 -62.75 -42.45 99.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.955 . . . . 0.0 109.372 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -68.73 -41.82 78.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.51 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 78' ' ' THR . 52.0 t -73.03 -61.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.438 -0.789 . . . . 0.0 110.02 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -56.87 -59.63 4.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.912 . . . . 0.0 110.06 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.5 tm? -51.82 -47.71 64.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.147 . . . . 0.0 108.937 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 81' ' ' LEU . 3.1 t0 -46.85 -48.69 20.95 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.876 -1.14 . . . . 0.0 108.496 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.24 -31.67 65.77 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' A' ' 81' ' ' LEU . 38.5 t80 -70.81 -23.67 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.11 -59.37 2.8 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -122.21 -42.4 2.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.343 -0.848 . . . . 0.0 110.14 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 -21.5 6.66 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.7 mtp85 -138.2 -85.5 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -1.114 . . . . 0.0 109.296 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.33 176.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.71 150.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -123.88 140.25 53.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -0.873 . . . . 0.0 109.818 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.506 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 11.5 m-70 -137.59 137.99 39.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 109.204 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 ptp180 -120.24 124.83 46.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -119.6 94.66 4.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.184 -0.948 . . . . 0.0 109.539 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.3 37.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 61.4 105.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.462 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 103.01 -36.29 4.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -107.2 32.09 4.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.8 mp0 -70.39 -177.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 p -110.6 168.02 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.358 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -69.65 -32.73 71.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.6 m -60.83 -57.65 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.094 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 40.4 t80 -53.91 -48.94 69.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.494 -0.754 . . . . 0.0 109.259 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.94 -24.36 64.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 109.042 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -60.68 -50.34 68.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 107' ' ' PHE . 22.2 m-85 -69.29 -44.32 72.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -134.29 86.81 2.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.169 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.492 ' O ' HD21 ' A' ' 111' ' ' LEU . 2.0 pttt -89.3 -63.84 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.463 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 2.0 t -105.86 9.81 32.71 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.527 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.37 63.16 0.28 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.704 ' O ' ' CB ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -137.81 -115.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.189 -1.183 . . . . 0.0 108.858 179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.704 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 6.6 tptm 138.28 121.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.476 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 1.8 p90 -103.22 107.98 19.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.472 -0.768 . . . . 0.0 109.524 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -101.93 120.54 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.4 mttt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.495 -179.903 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.7 t -69.75 146.99 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 75.7 t -155.34 88.25 3.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 128' ' ' ASN . 52.7 Cg_exo -49.06 166.17 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.626 2.217 . . . . 0.0 112.252 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 127' ' ' PRO . 84.2 m-20 -39.87 109.69 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.625 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -50.75 -25.67 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.496 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.3 t -50.67 -25.24 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.373 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.74 -47.69 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.477 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.5 -31.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.478 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -64.8 -31.12 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.55 161.35 30.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.363 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.37 53.21 46.11 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 20.2 mtpp -142.16 -8.68 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 63.9 mt-10 -158.52 149.69 16.47 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.409 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.82 170.34 20.59 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.627 2.218 . . . . 0.0 112.173 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.66 -137.2 13.9 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.3 142.17 35.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -1.127 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.536 ' O ' HG21 ' A' ' 43' ' ' ILE . 3.7 mp0 -127.54 146.93 50.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.274 -0.891 . . . . 0.0 109.343 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.545 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 24.8 mt -117.63 135.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.72 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.8 m0 -141.84 110.85 6.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -83.09 131.31 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.543 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.95 143.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.353 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -152.81 111.85 3.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.2 ttmt 46.77 31.62 1.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.416 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.1 m-85 68.61 51.38 0.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 24' ' ' LEU . 66.5 m-20 -127.17 -24.54 3.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.3 mt 57.92 130.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -149.54 134.6 9.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.164 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.08 124.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.345 2.03 . . . . 0.0 112.289 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 t -60.09 114.77 10.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.374 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.33 123.89 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.327 2.018 . . . . 0.0 112.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.1 m -59.43 -23.71 62.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -49.18 -47.38 46.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.175 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 7.1 mp -92.01 -55.05 3.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.5 t80 44.95 89.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.567 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.63 3.3 8.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.22 143.19 27.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.154 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -140.3 123.04 16.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 109.921 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.2 m-30 -83.6 102.97 12.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.533 HG23 ' HH2' ' A' ' 61' ' ' TRP . 30.4 p -57.21 87.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 177.86 -29.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.06 -154.89 0.55 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.388 -1.066 . . . . 0.0 108.943 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.96 141.98 32.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.402 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 22.8 m-85 -115.82 124.37 50.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.787 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.83 118.51 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.841 . . . . 0.0 108.904 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -118.91 144.91 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.072 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.563 HD23 ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -121.95 151.43 40.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -143.9 94.65 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.093 -1.005 . . . . 0.0 110.392 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.615 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 1.2 m -87.49 114.67 24.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.471 -0.768 . . . . 0.0 109.288 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -92.09 164.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.581 0.705 . . . . 0.0 110.558 -179.341 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.466 ' H ' ' CD2' ' A' ' 54' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.69 ' HB3' HG22 ' A' ' 47' ' ' VAL . 49.1 tt0 -104.46 92.84 4.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.304 -0.873 . . . . 0.0 110.235 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.615 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 0.3 OUTLIER -79.0 116.72 19.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 109.073 179.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -100.13 119.74 38.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.608 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 7.8 tt -110.64 133.85 52.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.985 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.607 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -152.63 133.78 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.358 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.723 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -100.6 126.08 47.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 0.0 108.775 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.533 ' HH2' HG23 ' A' ' 37' ' ' THR . 77.5 t90 -92.54 134.62 34.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.629 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.3 mt -137.39 118.59 14.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.448 -0.783 . . . . 0.0 109.208 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' CA ' ' CH2' ' A' ' 61' ' ' TRP . . . -69.39 25.14 0.35 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 62' ' ' LEU . 59.5 t30 58.86 6.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.442 -1.034 . . . . 0.0 110.089 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 63' ' ' GLY . 19.7 mt-10 -110.38 10.93 23.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 109.143 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.2 t -105.09 146.1 29.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.682 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 t -85.9 170.4 12.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.463 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -69.16 -16.34 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 1.2 t70 -61.48 -58.31 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -87.85 -35.82 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.8 t -70.4 -60.61 2.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.577 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -52.79 -43.33 60.31 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.44 -52.04 63.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -1.162 . . . . 0.0 109.501 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.7 -47.69 63.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.288 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.547 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -61.8 -22.98 65.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 109.232 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -83.92 -55.84 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -61.36 -34.75 75.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.381 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -75.13 -43.81 50.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.872 . . . . 0.0 109.74 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 75' ' ' ALA . 27.9 t -63.62 -55.96 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.846 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.3 -59.62 5.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.591 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -53.11 -48.45 67.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.031 -1.043 . . . . 0.0 108.927 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 78' ' ' THR . 10.0 t0 -45.64 -45.02 13.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.103 -0.998 . . . . 0.0 108.807 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.28 -30.86 71.92 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 17.7 t80 -79.1 -22.92 44.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.2 tp -83.91 -47.7 10.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.333 -0.855 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -122.0 -41.92 2.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 110.025 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.86 -20.56 40.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' ALA . 3.6 ptt180 -136.55 -80.88 0.39 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.386 -1.067 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 88' ' ' ARG . . . 41.89 -155.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.328 -0.858 . . . . 0.0 109.388 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -146.44 133.31 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.589 ' O ' ' NE2' ' A' ' 91' ' ' GLN . 3.0 pp0? -118.85 115.84 25.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.702 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -120.8 159.61 25.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.725 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' HE ' ' CD1' ' A' ' 62' ' ' LEU . 42.3 ttt180 -110.52 130.05 55.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.892 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' A' ' 96' ' ' GLN . 2.5 mm-40 -115.32 86.2 2.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.058 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.52 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.1 t -68.29 37.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.599 ' H ' ' C ' ' A' ' 94' ' ' GLU . 5.1 tm0? 48.82 103.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.496 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.91 -52.37 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 98' ' ' PHE . 60.0 t80 -108.77 31.29 5.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -1.043 . . . . 0.0 109.234 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 98' ' ' PHE . 4.1 mt-10 -53.18 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.391 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.7 t -115.85 170.51 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.93 65.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.1 m -68.56 -53.93 19.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 14.1 t80 -62.0 -39.18 91.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.8 mt -72.36 -36.36 68.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.583 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.81 -37.3 94.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.82 -50.52 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.515 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -103.43 61.95 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -84.75 -29.45 25.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -99.6 1.85 44.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.65 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.54 -109.18 2.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 110' ' ' GLY . 16.9 mt 53.34 100.6 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -144.13 100.86 3.63 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.78 108.04 15.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.875 . . . . 0.0 109.574 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -119.41 140.7 49.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 109.362 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.6 m170 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 2.9 t -89.77 122.91 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.451 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 126' ' ' VAL . 69.4 t -155.51 82.28 3.83 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.82 133.27 11.24 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.773 2.315 . . . . 0.0 112.325 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.67 ' N ' ' ND2' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -63.8 150.22 45.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.526 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 131' ' ' VAL . 1.5 pp20? -88.05 -21.89 24.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 109.552 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 p -47.04 -16.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 129' ' ' GLU . 61.4 t -68.57 -40.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.55 -29.42 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.521 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.428 0.633 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.527 ' O ' ' O ' ' A' ' 8' ' ' ALA . 41.9 mttt -98.17 -55.83 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.379 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.91 134.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.631 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 56.98 54.2 38.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -63.4 0.42 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -1.086 . . . . 0.0 109.404 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 9' ' ' GLY . 11.6 pt-20 -176.44 150.72 1.02 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -39.89 126.29 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.639 2.226 . . . . 0.0 112.1 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.63 -158.5 27.78 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.8 141.81 51.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -1.062 . . . . 0.0 109.652 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.405 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 2.4 mm100 -127.84 156.64 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.247 -0.908 . . . . 0.0 109.35 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.9 mp -131.36 137.0 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.204 -0.935 . . . . 0.0 109.961 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.2 m-90 -144.9 113.41 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 0.0 109.32 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.404 HH11 ' CG ' ' A' ' 39' ' ' ASP . 46.2 ttt180 -80.98 140.03 35.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.0 143.18 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' PHE . 14.0 mm-40 -146.15 112.3 5.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.091 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 20.4 ttpp 57.86 -76.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.339 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 6.8 m-85 -175.83 33.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.318 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.7 t70 -127.31 -1.64 6.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 109.803 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.4 tp 59.25 146.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 109.312 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.1 t -154.39 111.41 2.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.652 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.42 147.38 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.44 2.093 . . . . 0.0 112.173 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' THR . 6.8 p -76.93 133.34 69.66 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.102 -0.999 . . . . 0.0 109.394 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -41.27 89.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.527 2.151 . . . . 0.0 112.292 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 27' ' ' VAL . 24.4 m -51.74 -26.55 9.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.407 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.63 HD21 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -51.34 -43.46 61.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.408 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.6 mt -93.86 -54.19 3.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.299 -0.875 . . . . 0.0 109.639 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 65.47 100.44 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 123.67 -27.32 5.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -65.84 139.71 58.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.333 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 33' ' ' GLY . 73.7 m-85 -143.6 143.03 31.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.846 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.61 103.27 15.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.06 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 39' ' ' ASP . 15.0 p -54.89 -45.26 74.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.808 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.19 10.13 0.29 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 37' ' ' THR . 3.4 m-20 -133.73 -156.24 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -1.173 . . . . 0.0 109.283 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.44 140.91 25.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 109.689 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 15.3 m-85 -123.83 146.21 48.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.825 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.83 116.09 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.168 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.439 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -112.37 142.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.252 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -122.3 145.25 48.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.568 -0.707 . . . . 0.0 109.891 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -125.47 93.21 3.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.499 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 86.2 m -73.86 106.76 5.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -107.02 164.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.414 179.865 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -134.1 144.8 48.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 2.3 m-85 -100.89 118.91 37.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 108.848 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.488 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 3.5 m-20 -77.81 120.39 22.64 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.5 OUTLIER -97.11 122.61 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.0 110.087 -178.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -138.24 110.98 7.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.44 129.94 35.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 108.95 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.34 111.49 23.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.659 ' C ' ' H ' ' A' ' 64' ' ' ASN . 1.1 mt -116.1 105.62 12.81 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -65.98 14.54 0.29 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.659 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 62.64 1.87 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 109.783 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.6 mt-10 -103.46 4.17 35.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.091 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 67' ' ' SER . 45.6 t -103.41 122.08 44.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.573 ' C ' ' H ' ' A' ' 69' ' ' ASP . 69.6 m -43.02 126.16 3.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.43 -8.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 67' ' ' SER . 10.9 t0 -68.24 -43.38 78.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.613 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -87.35 -33.52 19.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.416 ' OG ' HD22 ' A' ' 62' ' ' LEU . 5.7 t -57.77 -56.61 19.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.84 82.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.81 -48.13 50.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.257 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.13 96.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.159 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.423 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -63.2 -20.59 65.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.01 -57.44 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 109.99 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -61.28 -32.91 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.334 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.76 -44.01 51.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.147 -0.971 . . . . 0.0 109.588 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.531 ' N ' ' CG2' ' A' ' 78' ' ' THR . 45.2 t -69.93 -52.52 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.9 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -60.92 -59.52 5.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.721 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.1 tm? -53.29 -48.66 68.16 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.98 -1.075 . . . . 0.0 108.66 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 89' ' ' ALA . 4.4 t0 -44.89 -45.82 10.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.111 -0.993 . . . . 0.0 108.801 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.28 -31.93 72.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 81' ' ' LEU . 11.5 t80 -77.06 -23.17 52.0 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.492 HD21 ' O ' ' A' ' 7' ' ' LYS . 3.6 tp -82.89 -51.35 7.7 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.279 -0.888 . . . . 0.0 109.902 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -122.4 -42.05 2.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.255 -0.903 . . . . 0.0 109.985 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.03 -15.51 16.04 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.7 mtp-105 -144.52 -85.29 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.435 -1.039 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 56.58 156.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.647 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.454 ' C ' ' NE2' ' A' ' 91' ' ' GLN . 17.7 t -91.54 150.23 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.147 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.454 ' NE2' ' C ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -134.7 122.95 22.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.0 110.137 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.637 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -136.42 159.98 40.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.302 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -121.12 144.59 48.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.954 . . . . 0.0 109.931 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 96' ' ' GLN . 4.9 mm-40 -115.1 85.29 2.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.4 t -71.89 37.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.695 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.525 ' H ' ' C ' ' A' ' 94' ' ' GLU . 1.7 tt0 58.14 118.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.51 -35.9 4.66 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -113.58 45.0 1.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -1.137 . . . . 0.0 109.436 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -71.04 178.93 2.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 m -101.14 160.13 14.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.0 109.441 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.39 65.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.489 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.7 m -71.77 -52.98 14.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -61.2 -37.69 83.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 109.594 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mt -72.19 -27.85 62.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.542 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.58 -25.21 39.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.87 -14.34 29.84 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.187 -1.184 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -134.88 93.81 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.637 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -78.19 -63.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -92.16 9.87 31.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.236 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.498 ' C ' HD11 ' A' ' 111' ' ' LEU . . . -80.46 56.97 4.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.498 HD11 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.71 92.03 2.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.471 -1.017 . . . . 0.0 109.218 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 35' ' ' PHE . 25.1 tttt -130.02 108.6 10.22 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.653 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -82.19 107.88 15.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.999 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -108.03 108.54 19.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 108.901 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 -179.853 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.5 138.16 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.92 113.16 5.56 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.485 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 57.3 Cg_exo -46.89 153.29 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 127' ' ' PRO . 35.4 m-80 -165.67 102.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.538 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.1 -25.41 59.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.69 -20.21 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.29 -23.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.817 . . . . 0.0 109.609 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.2 t -51.72 -32.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.439 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 8' ' ' ALA . 5.6 mptp? -94.82 -60.98 1.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 109.443 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 59.08 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.386 -0.821 . . . . 0.0 109.324 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.562 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 42.2 43.55 4.61 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' GLY . 2.4 pttm -45.56 -23.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' GLY . 11.2 pt-20 -146.48 149.98 39.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -39.78 123.58 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.679 2.252 . . . . 0.0 112.223 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.4 -167.7 31.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.17 147.03 40.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -1.024 . . . . 0.0 109.555 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.562 HE21 ' N ' ' A' ' 9' ' ' GLY . 17.2 mt-30 -141.98 151.58 42.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.05 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -128.81 135.86 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -141.94 110.58 6.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.501 ' CD ' ' CZ ' ' A' ' 41' ' ' TYR . 21.4 ttp180 -79.77 139.02 37.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.386 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.69 142.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.91 . . . . 0.0 109.352 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -159.62 97.09 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.441 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 12.2 ttmm 63.74 25.86 14.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.394 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.2 m-85 70.09 14.64 7.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.614 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' LEU . 9.8 t70 -98.29 -15.27 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' ASP . 1.9 mp 59.84 136.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.02 127.06 12.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.865 . . . . 0.0 109.012 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.57 126.05 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.29 1.993 . . . . 0.0 112.364 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.41 134.78 81.7 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.52 130.26 16.95 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.401 2.067 . . . . 0.0 112.145 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' ASN . 20.5 m -60.0 -26.37 66.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 29' ' ' THR . 57.1 t30 -44.17 -38.84 3.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.974 . . . . 0.0 109.229 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 32' ' ' TYR . 42.2 mt -108.81 -55.15 2.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.481 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 31' ' ' LEU . 6.2 t80 47.92 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.451 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 123.73 -30.74 4.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.597 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 15.3 m-20 -80.88 146.55 30.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.238 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 m-85 -146.1 152.22 38.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 0.0 109.843 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.54 ' CD2' ' C ' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -90.27 104.55 17.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.089 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.6 p -59.07 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.94 -30.66 0.06 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 19.6 t0 -107.44 -152.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.505 -0.997 . . . . 0.0 108.725 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.446 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -137.48 140.46 41.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.501 ' CZ ' ' CD ' ' A' ' 18' ' ' ARG . 18.8 m-85 -117.72 124.93 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.4 130.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -123.46 145.95 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -124.85 133.24 53.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 55' ' ' GLN . 12.0 ttpt -129.91 94.0 3.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.006 . . . . 0.0 110.031 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.613 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 64.5 m -84.99 106.75 16.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.22 164.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.356 -0.84 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.538 0.685 . . . . 0.0 110.627 -179.33 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.1 tt0 -105.31 96.59 6.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.054 -1.029 . . . . 0.0 110.513 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.613 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 27.8 m-85 -76.61 109.65 10.53 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.513 ' OD1' ' NE2' ' A' ' 59' ' ' HIS . 22.6 t0 -83.61 126.97 33.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.977 -1.077 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 82' ' ' ASP . 4.0 mp -97.19 119.82 36.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.69 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 18.7 m-70 -134.1 108.76 8.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.705 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.66 119.58 39.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.422 ' CZ3' ' CB ' ' A' ' 35' ' ' PHE . 78.1 t90 -96.41 126.51 41.65 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 110.243 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.723 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.9 mt -122.52 109.39 14.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -59.3 10.32 0.03 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.723 ' H ' ' C ' ' A' ' 62' ' ' LEU . 28.9 t30 67.45 1.79 2.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -108.32 11.29 27.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.549 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.4 t -104.45 146.02 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 m -77.38 164.88 25.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.616 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -68.96 -8.87 48.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -68.87 -56.11 8.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -87.22 -38.86 15.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 t -58.62 -56.04 27.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.482 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.91 50.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.29 -36.38 4.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -1.178 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.49 70.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.322 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.546 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -68.4 -33.63 74.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mt -79.57 -44.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.821 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.5 -40.24 96.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.984 -1.072 . . . . 0.0 109.452 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -76.34 -45.03 34.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.548 ' N ' ' CG2' ' A' ' 78' ' ' THR . 49.9 t -61.72 -54.33 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.797 . . . . 0.0 110.143 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.572 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 12.0 pt20 -62.56 -50.55 70.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 110.143 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.615 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -59.82 -51.26 70.48 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.745 -1.222 . . . . 0.0 108.647 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.582 ' OD2' ' ND2' ' A' ' 86' ' ' ASN . 3.1 t0 -43.76 -43.47 6.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.004 -1.06 . . . . 0.0 108.358 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.08 -36.77 80.53 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.6 t80 -73.19 -23.6 60.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 tt -81.38 -52.2 7.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.254 -0.904 . . . . 0.0 109.961 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.582 ' ND2' ' OD2' ' A' ' 82' ' ' ASP . 2.2 p30 -122.12 -42.33 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.112 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.18 -10.65 26.77 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -149.96 -81.1 0.12 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -1.083 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.89 170.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.9 t -97.99 150.16 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.241 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.445 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 7.1 pt20 -113.62 147.86 37.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 0.0 109.953 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.69 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 27.0 m-70 -146.23 122.78 11.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 23.7 ptt85 -111.5 118.75 36.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.821 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.6 mp0 -114.82 100.16 8.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.273 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 2.2 t -87.12 37.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.65 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 24.8 tt0 72.04 107.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.416 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 93.31 -29.81 7.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -97.38 37.57 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 1.1 mp0 -63.25 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.9 m -131.57 -169.97 2.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -61.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 98.5 m -55.45 -37.33 67.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -67.46 -45.96 74.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.63 -10.35 59.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.46 -39.06 8.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.26 -33.92 37.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.54 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -103.4 107.18 17.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -99.38 -12.54 20.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.1 m -53.43 -36.1 61.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.53 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 93.59 35.9 6.04 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.613 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.2 mm? 53.71 103.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -95.4 119.09 33.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -81.96 107.73 14.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.843 . . . . 0.0 109.645 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -115.84 108.57 16.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.233 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.5 mttp . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.499 -179.807 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -96.43 146.69 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.7 t -92.55 114.79 63.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 75.9 Cg_exo -45.24 143.03 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.424 2.083 . . . . 0.0 112.19 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 12.6 m-20 -44.32 169.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -80.07 -21.72 43.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.3 t -47.15 -33.93 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.05 -43.92 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.406 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.98 -27.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.405 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -69.34 -32.81 72.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.19 142.54 54.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.54 44.47 4.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -107.5 -23.24 12.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -1.098 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -152.14 150.99 26.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.868 . . . . 0.0 109.275 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.19 172.37 16.14 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.605 2.203 . . . . 0.0 112.314 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.47 -125.63 8.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.461 HD12 ' CD1' ' A' ' 106' ' ' TYR . 4.0 tt -137.11 146.87 45.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.733 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.431 ' O ' HG21 ' A' ' 43' ' ' ILE . 17.1 mt-30 -137.29 139.46 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.608 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 8.7 mt -111.3 145.2 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.938 . . . . 0.0 109.885 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.7 m0 -148.76 110.74 4.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' VAL . 3.4 tmm_? -85.92 131.44 34.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.187 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.3 143.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.164 -0.96 . . . . 0.0 110.111 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 22' ' ' PHE . 30.3 tt0 -144.46 124.69 13.74 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 24.0 tttp 60.99 -74.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.958 . . . . 0.0 109.016 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' GLU . 10.7 m-85 -168.57 19.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 109.877 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.99 111.27 13.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.11 -0.994 . . . . 0.0 109.693 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mp -48.99 159.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.362 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ARG . 48.0 t -153.6 90.79 3.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.605 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.32 127.17 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.722 2.281 . . . . 0.0 112.207 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -106.83 133.63 20.19 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 109.383 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -41.11 93.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.542 2.161 . . . . 0.0 112.318 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.434 ' OG1' ' CD1' ' A' ' 16' ' ' ILE . 28.0 m -71.38 -12.12 61.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.521 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -77.21 -23.62 51.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.616 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 31' ' ' LEU . 10.4 tp -136.25 13.53 3.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.256 -0.903 . . . . 0.0 109.605 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -56.63 -96.77 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.16 -0.963 . . . . 0.0 109.833 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 64.73 11.48 49.67 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' OD2' ' C ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -161.84 147.01 13.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -1.081 . . . . 0.0 108.985 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.488 ' CE2' ' CH2' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -146.4 161.04 41.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.918 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.553 ' H ' ' HH ' ' A' ' 41' ' ' TYR . 3.0 m-85 -77.29 158.57 30.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 108.964 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 39' ' ' ASP . 8.3 p -107.13 -30.26 8.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.673 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.36 20.46 5.97 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 37' ' ' THR . 17.3 m-20 -139.43 -157.39 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -1.066 . . . . 0.0 109.312 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.83 140.8 31.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.553 ' HH ' ' H ' ' A' ' 36' ' ' PHE . 34.1 m-85 -119.44 121.91 40.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.574 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.56 130.82 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -129.54 139.87 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.651 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.83 145.18 43.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -130.84 93.77 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.094 -1.004 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.632 ' OG1' ' CE1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -78.05 106.01 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.95 164.92 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.405 -0.809 . . . . 0.0 109.407 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 . . . . . 0 C--N 1.3 -1.559 0 O-C-N 121.664 -0.648 . . . . 0.0 109.288 179.833 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.477 HD11 ' N ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.5 tt0 -131.36 113.64 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.744 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.632 ' CE1' ' OG1' ' A' ' 46' ' ' THR . 0.5 OUTLIER -86.89 110.29 19.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 108.954 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 1.1 m-20 -88.47 119.15 28.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.012 -1.055 . . . . 0.0 108.84 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.51 HD11 ' O ' ' A' ' 58' ' ' LEU . 3.1 pp -96.81 131.46 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.844 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.573 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -135.35 127.88 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.538 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.65 114.84 29.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.096 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.566 ' CD1' ' CZ ' ' A' ' 103' ' ' PHE . 32.1 t90 -93.21 117.39 30.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 109.468 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.652 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.4 mt -117.69 118.53 32.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 108.994 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -67.78 21.5 0.26 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.652 ' H ' ' C ' ' A' ' 62' ' ' LEU . 10.5 t30 57.01 1.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.019 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.539 ' H ' ' C ' ' A' ' 63' ' ' GLY . 15.8 mm-40 -111.71 10.16 20.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 0.0 108.539 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.0 p -98.46 146.07 26.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.621 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 t -67.39 154.86 40.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.414 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -75.84 -9.02 58.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.657 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.32 -45.73 45.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.686 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -87.3 -35.77 18.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.303 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 t -58.7 -53.53 57.35 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.495 -0.753 . . . . 0.0 109.458 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.68 42.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.7 -38.71 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.655 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.11 83.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.511 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -67.93 -41.81 82.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.11 -39.43 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.31 -47.15 85.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.104 -0.998 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -75.54 -42.24 52.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 75' ' ' ALA . 54.1 t -62.38 -49.06 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.937 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -65.26 -59.85 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.875 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -56.03 -43.83 78.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 0.0 108.587 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 78' ' ' THR . 6.9 t70 -47.3 -46.98 25.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.139 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.49 -28.79 70.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 81' ' ' LEU . 45.9 t80 -75.02 -24.37 58.34 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.64 -54.59 6.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.428 ' OD1' ' C ' ' A' ' 86' ' ' ASN . 22.5 t-20 -122.07 -42.03 2.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.939 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.48 1.95 24.52 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.9 mtm-85 -155.13 -78.27 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.425 -1.044 . . . . 0.0 109.263 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 55.7 178.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.59 146.84 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.63 140.09 38.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.424 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 52.9 m-70 -138.78 119.36 13.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.554 ' HE ' ' CG2' ' A' ' 95' ' ' VAL . 35.8 ttt180 -103.95 126.59 51.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 109.273 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 96' ' ' GLN . 12.7 mp0 -127.27 78.67 1.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.948 . . . . 0.0 109.802 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.554 ' CG2' ' HE ' ' A' ' 93' ' ' ARG . 2.1 t -78.68 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.116 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' A' ' 94' ' ' GLU . 0.9 OUTLIER 42.28 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 98' ' ' PHE . . . 156.36 -35.5 0.6 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 97' ' ' GLY . 2.3 m-85 -135.88 54.68 1.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -1.077 . . . . 0.0 109.276 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.595 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 28.3 mt-10 -71.56 171.49 11.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.562 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 t -110.95 178.92 4.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.394 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -67.74 -26.37 66.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.594 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 m -63.39 -62.9 1.38 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.32 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD1' ' OE2' ' A' ' 99' ' ' GLU . 36.9 t80 -54.6 -41.98 70.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.69 -26.25 61.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.92 . . . . 0.0 109.384 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -63.95 -44.27 96.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.461 ' CD1' HD12 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -76.22 -50.96 13.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -1.114 . . . . 0.0 109.319 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.72 71.68 9.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -88.77 -40.78 12.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -105.7 8.03 32.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -90.18 -107.95 1.31 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.5 mm? 53.42 101.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.346 -1.091 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -166.07 95.96 0.59 Allowed 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.641 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -82.42 107.76 15.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.5 -0.75 . . . . 0.0 109.45 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -112.07 118.05 34.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 40.7 m80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.45 146.65 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.9 83.97 31.11 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 53.6 Cg_exo -48.45 149.82 6.36 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.74 2.293 . . . . 0.0 112.237 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 18.4 m120 -42.86 166.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -87.67 -28.58 21.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.406 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -48.55 -32.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 t -50.15 -60.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -73.93 -27.77 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.951 . . . . 0.0 109.587 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.488 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 8' ' ' ALA . 47.8 mttt -103.94 -45.31 4.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.519 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 58.54 135.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.509 -0.745 . . . . 0.0 109.643 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 50.73 53.57 25.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -58.02 -0.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.17 . . . . 0.0 109.361 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.584 ' H ' ' C ' ' A' ' 9' ' ' GLY . 9.8 pt-20 -170.04 149.15 3.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.49 122.05 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.682 2.255 . . . . 0.0 112.252 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.78 -156.4 27.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.5 144.76 49.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.531 HE21 ' H ' ' A' ' 9' ' ' GLY . 24.3 mt-30 -138.53 150.49 46.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.228 -0.92 . . . . 0.0 109.676 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.2 mt -119.05 137.58 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 0.0 109.779 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.7 m0 -142.27 110.82 6.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.3 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.03 137.73 37.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.588 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.58 143.28 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 0.0 109.496 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -155.77 88.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 tttm 65.53 33.85 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.492 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' N ' ' A' ' 22' ' ' PHE . 1.3 m-85 66.2 17.16 10.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 24' ' ' LEU . 55.7 m-20 -102.65 -14.89 16.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.7 mt 57.43 144.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 109.633 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.2 t -154.15 110.25 2.46 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.363 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.83 112.9 0.55 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.388 2.058 . . . . 0.0 112.164 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.549 HG11 ' O ' ' A' ' 27' ' ' VAL . 13.1 p -47.52 133.61 10.32 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -40.91 101.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.509 2.139 . . . . 0.0 112.325 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.5 m -59.0 -25.65 63.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -50.42 -47.29 56.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -88.17 -54.98 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.85 . . . . 0.0 109.444 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.0 t80 55.54 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 109.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.26 17.08 3.35 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -117.28 144.46 44.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -1.172 . . . . 0.0 109.358 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.581 ' N ' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -146.14 133.92 21.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.773 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 38' ' ' GLY . 26.6 m-85 -92.14 103.03 15.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.059 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' A' ' 37' ' ' THR . 16.3 p -52.19 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.643 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . 177.96 -29.43 0.07 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.464 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 4.0 p30 -107.93 -154.3 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.369 -1.077 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.15 141.07 34.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.464 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.464 ' CE2' ' OD1' ' A' ' 39' ' ' ASP . 88.5 m-85 -116.52 122.04 43.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.24 114.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.463 ' HB ' ' ND1' ' A' ' 59' ' ' HIS . 1.8 mt -114.58 145.95 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.551 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 1.1 mp -123.0 143.6 49.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.797 -0.565 . . . . 0.0 109.566 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 55' ' ' GLN . 5.0 ttmm -127.23 94.17 3.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.672 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.62 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 43.0 m -81.2 110.96 17.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -94.12 164.36 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.695 0.76 . . . . 0.0 110.803 -179.245 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 45' ' ' LYS . 3.4 tt0 -100.59 98.85 9.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.101 -1.0 . . . . 0.0 110.422 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.62 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 29.6 m-85 -80.75 109.58 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 35.9 t0 -76.33 140.8 41.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 108.684 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 2.1 mm? -107.48 103.12 12.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.845 . . . . 0.0 109.546 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.68 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -122.24 112.19 17.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.72 125.99 48.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -98.79 132.38 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.871 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.664 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.8 mt -134.88 115.41 13.59 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -65.85 17.79 0.19 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.664 ' H ' ' C ' ' A' ' 62' ' ' LEU . 23.8 t30 63.12 1.91 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 109.887 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 63' ' ' GLY . 9.8 mm-40 -106.06 10.33 32.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 109.242 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.11 131.85 46.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.442 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 t -49.74 157.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -75.69 -11.83 60.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.4 p30 -79.24 -40.39 30.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 36.2 tt0 -87.33 -33.81 19.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.286 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.5 t -68.11 -60.41 2.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.54 -39.0 29.27 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -58.07 -56.89 16.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -1.156 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.44 -40.88 19.14 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.118 -0.988 . . . . 0.0 109.028 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -70.64 -21.39 62.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.347 -0.846 . . . . 0.0 109.024 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.6 mm -84.51 -49.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -61.88 -36.58 81.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 109.322 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.29 -46.02 29.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.625 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.571 ' N ' ' CG2' ' A' ' 78' ' ' THR . 55.0 t -64.39 -52.38 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.96 -59.55 4.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.648 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.591 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.1 tm? -52.71 -48.85 66.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 108.764 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 81' ' ' LEU . 6.1 t70 -44.8 -45.93 10.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.565 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.71 -33.85 73.5 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 5.5 t80 -74.68 -23.43 58.63 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.471 HD11 ' HB1' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -80.22 -52.93 7.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.564 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 86' ' ' ASN . 3.1 t-20 -122.1 -42.01 2.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.12 -14.88 21.11 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -145.54 -72.9 0.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -1.036 . . . . 0.0 109.245 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.1 -171.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 109.472 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.84 150.15 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.389 -0.819 . . . . 0.0 109.391 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.562 ' OE1' ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -108.33 133.0 53.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.716 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.591 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 12.4 m-70 -139.74 124.39 18.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.405 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 7.9 ptm180 -110.0 132.37 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 109.688 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.595 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 2.7 mt-10 -130.47 91.71 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.18 37.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 56.45 90.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.46 -32.04 2.52 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -125.12 56.86 1.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.445 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -85.72 167.55 15.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.6 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -100.28 161.01 13.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.47 77.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -62.23 -60.66 3.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 51.1 t80 -52.76 -38.8 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.463 -0.773 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 104' ' ' LEU . 85.0 mt -69.29 -26.17 64.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.62 55.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -43.59 60.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.391 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 88.8 m-85 -106.33 76.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.551 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -100.8 -35.86 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -91.14 -3.31 57.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -91.09 -107.69 1.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 110' ' ' GLY . 85.0 mt 53.37 100.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.36 -1.083 . . . . 0.0 109.527 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.554 ' HZ3' ' NZ ' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -151.67 90.97 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.85 107.72 14.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.516 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.554 ' NZ ' ' HZ3' ' A' ' 112' ' ' LYS . 22.4 mttm -112.37 108.92 18.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 5.5 ptpp? . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.36 0.6 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.6 t -70.16 122.76 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.531 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.67 98.58 38.0 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 129' ' ' GLU . 58.9 Cg_endo -79.09 162.5 25.97 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.463 2.108 . . . . 0.0 112.253 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -59.09 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 127' ' ' PRO . 37.9 tt0 -88.07 -17.23 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 133' ' ' GLN . 9.4 p -57.13 -42.75 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.454 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 12.9 p -46.95 -30.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.461 ' O ' ' NE2' ' A' ' 133' ' ' GLN . 15.0 t -71.66 -27.77 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 130' ' ' VAL . 85.1 mm-40 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.7 tp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.526 ' O ' ' O ' ' A' ' 8' ' ' ALA . 27.4 mttm -102.4 -61.11 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.526 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.91 137.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.749 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 47.39 38.55 13.32 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -42.74 -23.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -1.167 . . . . 0.0 109.62 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' GLY . 34.0 mm-40 -143.79 153.67 58.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -41.65 122.84 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.76 2.306 . . . . 0.0 112.341 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.38 -167.09 33.92 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.501 ' C ' ' CD2' ' A' ' 14' ' ' LEU . 6.7 tt -124.3 124.0 41.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -1.081 . . . . 0.0 109.217 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.749 HE21 ' N ' ' A' ' 9' ' ' GLY . 15.3 mt-30 -115.08 150.05 36.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 109.575 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.607 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.8 OUTLIER -123.6 140.45 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.792 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.607 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.9 m-90 -144.89 111.78 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -79.93 146.01 32.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.707 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.0 143.31 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.11 -0.994 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.9 tp10 -142.9 95.05 2.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.438 -0.789 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.544 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.6 tptp 71.6 40.26 0.81 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.298 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 2.4 m-85 72.82 21.43 3.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.656 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 22' ' ' PHE . 1.4 m-20 -127.31 111.5 13.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.36 137.47 57.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.6 t -144.0 121.16 6.6 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.895 . . . . 0.0 109.283 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -44.08 148.06 1.19 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.271 1.981 . . . . 0.0 112.513 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.41 134.21 28.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.186 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -39.15 108.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -61.17 -29.11 69.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -46.77 -41.93 16.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.344 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.437 HD23 ' OD1' ' A' ' 34' ' ' ASP . 13.3 mt -91.22 -53.13 4.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.22 -0.925 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.3 t80 50.26 91.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 16.44 3.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.607 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 1.3 m-20 -128.96 135.7 49.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -1.155 . . . . 0.0 109.159 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 1.9 m-85 -146.07 161.26 40.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -85.3 145.49 27.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.324 -0.86 . . . . 0.0 109.173 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 p -89.9 -22.37 22.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.94 -15.87 69.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.548 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -103.75 -161.51 0.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -1.103 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.548 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -134.53 140.88 46.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.6 148.44 43.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.456 -0.777 . . . . 0.0 109.772 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.444 HG13 ' HG1' ' A' ' 78' ' ' THR . 2.3 t -122.76 138.19 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 109.347 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 mt -136.39 146.32 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.467 HD23 ' HB3' ' A' ' 8' ' ' ALA . 4.1 mp -127.15 124.21 38.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.64 -0.662 . . . . 0.0 109.572 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -105.26 93.99 4.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.658 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.596 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 5.7 m -79.28 109.85 14.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -104.34 164.76 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.211 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 C--N 1.3 -1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.542 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.406 ' O ' HG22 ' A' ' 47' ' ' VAL . 27.7 tt0 -133.14 112.61 11.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.053 -1.029 . . . . 0.0 109.89 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.596 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 18.8 m-85 -90.69 129.17 36.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 15.9 m-20 -95.11 126.6 40.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 108.964 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.517 HD11 ' OG1' ' A' ' 78' ' ' THR . 4.1 mm? -86.99 102.54 14.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.727 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.716 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 23.7 m-70 -116.9 108.67 16.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 0.0 109.567 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.708 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.37 124.21 49.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -0.983 . . . . 0.0 108.686 179.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -95.92 128.78 43.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.147 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.726 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -129.7 106.4 8.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.57 16.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.726 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 61.27 1.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.734 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 63' ' ' GLY . 40.0 mt-10 -104.88 5.82 33.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.98 . . . . 0.0 109.083 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.8 t -101.61 129.16 47.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.546 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 t -51.16 144.39 9.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.444 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -64.62 -8.7 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -73.58 -44.78 56.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -86.86 -37.98 17.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.301 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.6 t -60.08 -51.8 68.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.45 -0.781 . . . . 0.0 109.379 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.51 -40.5 69.86 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -57.0 -55.15 38.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.64 44.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.123 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.509 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -70.15 -20.28 63.16 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.2 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.5 mm -84.42 -49.19 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.35 -33.45 76.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.976 . . . . 0.0 109.373 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.536 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -77.85 -43.78 29.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.536 ' N ' ' CG2' ' A' ' 78' ' ' THR . 53.1 t -68.09 -44.32 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -66.13 -59.62 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -54.45 -45.32 73.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.986 -1.071 . . . . 0.0 108.538 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.469 ' OD2' ' HB1' ' A' ' 89' ' ' ALA . 3.5 t0 -47.16 -48.01 23.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 108.607 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.0 -30.58 70.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 81' ' ' LEU . 16.9 t80 -78.43 -23.1 46.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 7' ' ' LYS . 3.8 tp -83.94 -49.91 8.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.263 -0.898 . . . . 0.0 109.921 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -122.3 -42.21 2.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.204 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.71 -19.86 20.9 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -140.97 -68.78 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -1.056 . . . . 0.0 109.351 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.469 ' HB1' ' OD2' ' A' ' 82' ' ' ASP . . . 54.63 -169.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.858 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.06 150.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.326 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -107.73 129.42 55.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.814 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.716 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 24.0 m-70 -135.88 113.5 10.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.276 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.473 HH21 ' HB2' ' A' ' 93' ' ' ARG . 19.6 ttp-105 -107.63 125.53 51.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.751 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.593 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 22.2 mt-10 -122.21 89.03 3.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -85.92 37.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -0.875 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 53.9 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.02 -64.99 0.3 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 21.0 m-85 -122.89 49.25 1.67 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.4 -1.059 . . . . 0.0 109.338 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.5 mp0 -51.61 170.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.62 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -87.07 165.44 15.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -29.54 57.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.5 m -65.86 -50.2 65.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.109 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 38.9 t80 -63.48 -48.81 76.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.431 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 108' ' ' LYS . 29.8 mt -63.81 -38.38 90.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.174 -0.953 . . . . 0.0 109.305 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -69.77 -38.16 76.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.238 -1.154 . . . . 0.0 109.26 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -124.27 50.97 1.62 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.421 -0.799 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 110' ' ' GLY . 2.8 tptm -78.15 -28.99 48.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 m -59.51 0.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.75 110.31 2.68 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.588 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -74.48 -104.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -1.165 . . . . 0.0 109.301 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tptp 179.1 113.0 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 109.156 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.02 107.71 19.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.79 . . . . 0.0 109.416 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -110.53 128.02 55.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.284 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 pttt . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.245 -0.91 . . . . 0.0 109.613 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.464 ' CE1' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.74 115.16 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.464 ' CG2' ' CE1' ' A' ' 124' ' ' HIS . 21.1 t -142.11 72.79 22.55 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.29 165.17 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.842 2.361 . . . . 0.0 112.144 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -140.39 35.99 1.87 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.29 -26.39 65.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.421 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.72 -35.85 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.9 -39.56 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.13 -30.09 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.49 179.914 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -65.12 -31.7 73.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.22 -0.925 . . . . 0.0 109.307 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.42 ' CB ' ' CH2' ' A' ' 17' ' ' TRP . . . -74.19 113.5 11.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.314 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.49 ' H ' HE22 ' A' ' 15' ' ' GLN . . . 99.32 49.01 1.62 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -140.24 -14.09 1.02 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -155.01 148.05 18.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.0 109.298 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.49 170.81 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.648 2.232 . . . . 0.0 112.252 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.9 -163.03 12.67 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 106' ' ' TYR . 3.5 tt -110.86 117.06 32.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -1.07 . . . . 0.0 109.598 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.49 HE22 ' H ' ' A' ' 9' ' ' GLY . 27.1 mt-30 -96.63 157.32 15.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.393 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mt -143.87 113.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 17' ' ' TRP . 8.2 p90 -140.76 137.09 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 0.0 109.113 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -90.04 146.43 24.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.81 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.19 143.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.174 -0.954 . . . . 0.0 109.316 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ASP . 24.2 tt0 -150.52 103.86 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.529 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 44.43 35.82 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.905 . . . . 0.0 109.461 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.3 m-85 68.76 26.89 5.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.633 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.9 t70 -109.42 -20.27 12.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' ASP . 2.3 mp 59.63 138.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.57 128.79 5.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.044 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.78 125.39 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.249 1.966 . . . . 0.0 112.041 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.68 132.9 84.92 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.13 127.41 3.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.7 m -65.98 -25.71 67.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.26 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -53.3 -50.14 65.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.359 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.549 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 6.7 mp -78.0 -55.37 5.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.155 -0.966 . . . . 0.0 109.365 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' O ' ' A' ' 31' ' ' LEU . 34.6 t80 46.91 91.82 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.536 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.88 -30.96 4.69 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -51.81 146.26 8.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.049 -1.266 . . . . 0.0 109.102 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 112' ' ' LYS . 28.6 m-85 -137.77 120.14 15.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.014 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.84 107.43 17.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 108.896 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 p -70.86 87.61 0.72 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.672 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.65 -30.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -112.45 -152.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.927 . . . . 0.0 108.625 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.76 140.11 45.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.002 . . . . 0.0 109.617 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -112.72 124.82 53.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.265 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' A' ' 78' ' ' THR . 74.8 t -102.99 119.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -118.97 146.21 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.246 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.459 HD12 ' CZ2' ' A' ' 17' ' ' TRP . 1.5 mp -126.2 152.91 45.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 0.0 109.482 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -140.53 93.83 2.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.161 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.614 ' OG1' ' CE1' ' A' ' 56' ' ' TYR . 1.2 m -88.49 111.42 21.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -0.812 . . . . 0.0 109.212 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.32 164.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.762 . . . . 0.0 109.092 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.549 -0.719 . . . . 0.0 109.443 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -134.42 104.42 6.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 110.489 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.614 ' CE1' ' OG1' ' A' ' 46' ' ' THR . 0.8 OUTLIER -77.95 123.37 26.71 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.092 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.585 ' OD2' ' CD2' ' A' ' 92' ' ' HIS . 3.8 t0 -103.23 122.08 44.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.033 . . . . 0.0 108.494 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 10.4 mp -94.78 143.18 26.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.44 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -149.1 108.42 3.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.65 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.04 115.22 28.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 108.857 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.459 ' CE2' HD13 ' A' ' 111' ' ' LEU . 26.8 t90 -90.13 126.79 35.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.359 -0.838 . . . . 0.0 109.991 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.683 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.9 mt -122.6 108.02 12.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -63.44 15.7 0.1 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.683 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.1 t-20 62.53 1.9 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -1.083 . . . . 0.0 109.962 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 63' ' ' GLY . 9.7 mm-40 -106.01 8.99 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.0 . . . . 0.0 109.12 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.1 t -104.36 141.03 37.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 m -57.24 146.87 26.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -64.23 -26.75 68.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.02 -32.07 72.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -87.22 -45.16 10.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.295 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -53.34 -49.76 66.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -59.68 -48.27 86.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -46.0 -43.53 14.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -1.122 . . . . 0.0 109.24 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.42 -56.09 19.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.41 -20.5 30.35 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.366 -0.834 . . . . 0.0 108.935 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -82.42 -59.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.269 -0.894 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -63.18 -25.28 68.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.893 . . . . 0.0 108.716 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.45 ' OG1' ' CG2' ' A' ' 42' ' ' VAL . 5.3 m -75.91 -50.4 15.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.627 -0.671 . . . . 0.0 109.535 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.6 t -73.65 -27.81 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -71.56 -59.78 2.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.647 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -58.64 -46.96 85.97 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.986 -1.071 . . . . 0.0 108.414 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.549 ' OD2' ' CB ' ' A' ' 89' ' ' ALA . 5.4 t70 -47.22 -45.75 23.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 13.5 t70 -61.66 -27.85 68.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.647 ' N ' ' O ' ' A' ' 81' ' ' LEU . 20.4 t80 -74.85 -23.85 58.49 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.9 mt -83.88 -54.11 5.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.841 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.479 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.1 OUTLIER -121.71 -42.36 2.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 109.994 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.408 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . 126.11 -44.28 1.27 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.448 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 52.7 mtt85 -112.34 -85.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' CB ' ' OD2' ' A' ' 82' ' ' ASP . . . 71.69 150.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.64 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.57 150.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -122.95 130.26 52.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 109.891 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.585 ' CD2' ' OD2' ' A' ' 57' ' ' ASP . 20.0 m-70 -124.99 129.46 50.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -107.32 126.86 52.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 109.86 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 100.54 7.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.411 HG11 HD21 ' A' ' 64' ' ' ASN . 2.3 t -96.49 38.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 1.8 tt0 52.23 80.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.1 -62.34 0.37 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -94.94 60.78 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.471 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -67.04 159.4 28.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 m -91.82 170.03 10.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.95 -61.06 1.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -48.91 -47.94 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 109.251 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 21.7 t80 -55.07 -49.52 71.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.63 -16.26 62.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.31 -31.88 26.92 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.417 ' CE2' HD21 ' A' ' 14' ' ' LEU . 2.5 t80 -82.45 -34.59 28.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.681 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -105.21 113.86 27.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 109.722 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -103.99 -12.49 16.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.9 p -53.27 -29.63 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 109.459 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 87.09 40.62 6.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 2.8 mm? 52.01 102.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.095 -1.238 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 35' ' ' PHE . 4.2 tmtm? -94.23 117.53 30.25 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -81.81 107.77 14.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 0.0 109.736 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -107.98 108.83 20.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mptt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.863 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -103.54 120.88 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.65 113.39 59.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.386 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.473 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 61.0 Cg_endo -78.72 125.78 6.96 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.167 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.473 ' CG ' ' O ' ' A' ' 127' ' ' PRO . 15.9 m-20 -175.36 64.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.12 -17.28 62.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.01 -23.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.77 -26.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.11 -27.84 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.525 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tp . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' O ' ' O ' ' A' ' 8' ' ' ALA . 35.3 mttm -108.45 -61.37 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.621 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.64 133.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.528 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 56.3 44.66 89.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' GLY . 38.2 mttp -42.57 -22.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -1.066 . . . . 0.0 109.418 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' GLY . 33.3 mt-10 -152.87 152.95 29.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -39.68 120.09 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.665 2.243 . . . . 0.0 112.15 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.97 -162.08 32.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -126.55 143.22 51.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -1.05 . . . . 0.0 109.678 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.528 HE21 ' H ' ' A' ' 9' ' ' GLY . 25.5 mt-30 -137.52 156.17 48.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.591 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -126.49 137.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.0 109.808 -179.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.4 m0 -142.59 111.08 6.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.293 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.67 146.13 44.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.148 -0.97 . . . . 0.0 109.501 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 40' ' ' ALA . 1.6 t -80.29 143.91 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.0 109.39 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 21' ' ' LYS . 6.6 tp10 -159.18 109.6 1.99 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.448 -0.783 . . . . 0.0 109.461 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 20' ' ' GLU . 19.3 mttp 41.54 41.11 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 55.78 45.95 23.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 24' ' ' LEU . 25.7 t0 -126.47 -19.38 4.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 23' ' ' ASP . 9.6 mp 57.2 123.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.64 122.18 10.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.142 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.22 139.6 3.97 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.386 2.057 . . . . 0.0 112.501 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.16 127.89 93.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -40.16 101.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.476 2.118 . . . . 0.0 112.346 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 m -49.41 -27.43 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.376 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.38 -41.94 14.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.212 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.98 -53.86 2.84 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 t80 51.51 91.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . 123.5 -22.35 7.0 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.592 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 11.1 m-20 -92.53 147.74 22.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -1.206 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 9.1 m-85 -145.68 150.44 36.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.95 . . . . 0.0 109.749 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 38' ' ' GLY . 67.9 m-85 -87.48 109.83 19.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.168 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 114' ' ' LYS . 16.6 p -60.28 87.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 179.02 -29.79 0.06 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.2 t0 -107.52 -153.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -1.058 . . . . 0.0 108.873 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -139.41 147.91 42.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 11.9 m-85 -128.54 141.1 51.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.585 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.439 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 47.1 t -115.8 128.18 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.581 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.6 mt -123.14 146.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.25 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.442 HD21 ' HD2' ' A' ' 56' ' ' TYR . 3.8 mp -124.58 151.86 44.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -142.8 93.77 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 109.95 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.618 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 94.6 m -85.6 117.24 24.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.738 . . . . 0.0 109.615 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.86 164.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.276 -0.89 . . . . 0.0 109.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.565 -0.709 . . . . 0.0 109.154 179.73 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -125.54 106.32 9.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 110.125 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 12.2 m-85 -77.83 130.02 36.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.599 ' OD1' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.1 117.84 33.72 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.623 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 5.8 mp -96.11 143.82 26.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 110.779 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.466 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.4 m-70 -145.6 111.84 5.72 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -93.2 116.17 28.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 0.0 108.842 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 25.5 t90 -91.49 129.06 37.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 110.041 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.69 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -131.53 111.87 12.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -62.55 14.22 0.08 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.69 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.2 t-20 65.22 1.78 1.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.447 -1.031 . . . . 0.0 109.862 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 63' ' ' GLY . 10.8 mt-10 -107.16 10.32 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 108.984 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 28.8 t -104.41 146.21 29.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.463 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 p -70.43 140.64 52.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.455 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLN . 34.0 tt0 -63.03 -8.86 8.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 47.1 t0 -70.73 -49.51 46.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -87.24 -40.41 14.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 109.417 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.44 ' HG ' HD13 ' A' ' 62' ' ' LEU . 7.6 t -57.05 -54.41 47.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 109.469 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.34 -45.32 35.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.19 -51.93 60.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.68 -45.75 58.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.5 -21.54 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 109.224 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.27 -52.01 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -58.93 -38.95 80.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -0.972 . . . . 0.0 109.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.595 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 4.8 t -72.6 -48.24 41.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.762 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.595 ' N ' ' CG2' ' A' ' 78' ' ' THR . 40.9 t -64.17 -56.26 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.855 . . . . 0.0 109.906 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -54.1 -58.91 5.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -50.24 -47.51 55.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.067 -1.02 . . . . 0.0 109.278 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.444 ' OD2' ' C ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -46.95 -47.6 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.861 -1.149 . . . . 0.0 108.399 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.59 -28.28 69.24 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LEU . 26.9 t80 -78.29 -23.47 47.15 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.49 -51.07 7.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.618 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.589 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.2 OUTLIER -122.33 -42.16 2.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.221 -0.924 . . . . 0.0 109.955 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.18 -18.4 6.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.434 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 1.6 mmm180 -141.94 -84.56 0.18 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.411 -1.053 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.434 ' O ' ' OE1' ' A' ' 91' ' ' GLN . . . 65.34 145.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.6 150.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.307 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -124.56 158.01 34.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.599 ' CD2' ' OD1' ' A' ' 57' ' ' ASP . 26.2 m-70 -138.29 143.56 40.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 109.42 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -114.97 127.12 55.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.587 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -126.88 89.77 3.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.97 37.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.57 84.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 109.354 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.97 -54.99 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -94.32 58.6 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -93.13 150.78 20.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 109.371 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 m -91.11 176.99 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -73.73 -27.28 61.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -64.01 -53.39 50.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.003 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.47 ' C ' ' CD2' ' A' ' 103' ' ' PHE . 18.8 t80 -62.88 -50.38 71.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.453 -0.779 . . . . 0.0 109.38 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -66.92 -26.18 66.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.197 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -62.7 -48.16 83.48 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -48.79 69.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -1.16 . . . . 0.0 109.209 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -106.23 67.58 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -93.16 -16.96 24.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.935 . . . . 0.0 109.592 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 m -67.18 -3.91 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.918 . . . . 0.0 109.663 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.66 109.79 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.578 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.74 -102.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -1.159 . . . . 0.0 109.215 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 7.2 mttm 163.79 117.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.462 -0.773 . . . . 0.0 109.126 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -94.31 107.99 19.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' THR . 69.1 mttt -113.77 136.2 53.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.438 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.1 mttp . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.932 . . . . 0.0 109.442 -179.903 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.337 0.589 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 t -140.96 132.27 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.14 113.25 64.54 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.12 142.72 8.22 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.373 2.048 . . . . 0.0 112.28 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.454 ' H ' ' ND2' ' A' ' 128' ' ' ASN . 1.7 p30 -64.9 130.53 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -87.96 -17.45 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 t -49.13 -56.52 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.2 p -52.35 -37.88 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.474 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.6 t -69.89 -27.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.476 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.9 tp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.212 0.53 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.7 ptpp? -105.86 -42.47 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 109.794 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 58.55 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -0.816 . . . . 0.0 109.395 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.589 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 56.26 46.84 85.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -46.24 -27.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -1.167 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -149.78 154.82 38.0 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -40.65 129.52 2.64 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.754 2.303 . . . . 0.0 112.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.69 29.88 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.515 ' C ' ' CD2' ' A' ' 14' ' ' LEU . 6.3 tt -124.78 127.06 46.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.123 . . . . 0.0 109.396 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.589 HE21 ' N ' ' A' ' 9' ' ' GLY . 22.4 mt-30 -118.07 138.9 51.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.9 OUTLIER -109.64 140.19 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.599 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.9 m0 -142.43 110.86 6.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.108 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -81.38 138.47 35.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.634 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.6 142.76 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 22' ' ' PHE . 10.3 tp10 -159.5 123.3 3.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.549 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 20' ' ' GLU . 11.4 tptm 42.48 26.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.6 m-85 66.57 44.88 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 24' ' ' LEU . 26.7 t0 -117.12 -25.11 7.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.512 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.8 mt 57.6 124.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -145.28 126.71 7.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.365 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.06 123.33 7.21 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.45 2.1 . . . . 0.0 112.339 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -97.75 130.43 29.02 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -42.48 103.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.486 2.124 . . . . 0.0 112.405 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -48.72 -40.12 27.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -63.14 -53.74 48.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 tp -84.71 12.7 6.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.622 ' C ' ' H ' ' A' ' 34' ' ' ASP . 46.0 t80 -83.74 -110.37 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 109.074 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.57 ' N ' ' CG ' ' A' ' 32' ' ' TYR . . . 56.38 -3.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 32' ' ' TYR . 1.1 t70 -111.78 164.76 12.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 109.61 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.586 ' CD2' ' OH ' ' A' ' 32' ' ' TYR . 7.4 m-85 -144.75 120.07 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.6 114.45 17.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 37' ' ' THR . 17.3 p -75.57 87.14 2.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.41 -28.38 0.07 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -115.17 -155.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 108.807 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 140.91 38.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -112.3 121.85 46.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.646 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.0 t -96.77 121.28 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.407 -0.808 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.28 145.9 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 8' ' ' ALA . 2.0 mp -127.52 125.16 39.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.626 -0.671 . . . . 0.0 109.295 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 55' ' ' GLN . 16.9 ttpt -106.02 93.68 4.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.691 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.558 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 31.2 m -77.71 100.52 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.49 164.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.292 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.546 -0.721 . . . . 0.0 109.349 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' LYS . 42.9 tt0 -129.08 117.62 21.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.766 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 5.9 m-85 -91.52 123.07 34.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.856 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -91.75 119.84 31.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.08 -1.012 . . . . 0.0 109.052 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.72 128.99 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.889 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.684 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 22.1 m-70 -139.43 108.12 5.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -102.01 112.15 24.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 108.544 179.1 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.414 ' CH2' ' CA ' ' A' ' 63' ' ' GLY . 73.3 t90 -93.66 129.18 40.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 110.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -127.79 130.55 48.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -82.81 23.83 5.56 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.7 t30 60.88 1.86 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -1.066 . . . . 0.0 109.896 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 63' ' ' GLY . 2.8 mm-40 -108.18 10.4 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -0.999 . . . . 0.0 108.848 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 7.2 p -105.34 132.6 51.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.526 -0.734 . . . . 0.0 109.558 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -54.52 155.98 3.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.54 -8.9 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.384 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 4.5 t0 -77.03 -36.4 56.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.728 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -87.09 -28.03 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.7 t -69.05 -60.01 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.51 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.97 49.18 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.4 -44.52 24.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -1.183 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.93 -57.35 10.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.154 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.545 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -59.03 -19.83 47.53 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 109.171 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mm -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.95 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -57.51 -35.53 70.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.641 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.579 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.5 t -80.13 -47.23 15.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.884 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.579 ' N ' ' CG2' ' A' ' 78' ' ' THR . 55.7 t -61.27 -47.47 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.741 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -69.72 -59.54 2.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.8 tm? -53.45 -51.8 61.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.93 -1.106 . . . . 0.0 108.807 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.537 ' OD2' ' CB ' ' A' ' 89' ' ' ALA . 6.1 t0 -46.01 -47.19 16.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.006 -1.059 . . . . 0.0 108.355 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -56.65 -30.07 62.94 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.637 ' N ' ' O ' ' A' ' 81' ' ' LEU . 35.7 t80 -71.03 -23.94 62.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.8 mt -82.38 -55.19 4.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 110.211 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.647 ' ND2' ' H ' ' A' ' 88' ' ' ARG . 3.9 p-10 -121.62 -42.31 2.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.29 0.91 31.3 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.647 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 24.0 mtp180 -138.31 -83.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -1.127 . . . . 0.0 109.581 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.598 ' N ' ' ND2' ' A' ' 86' ' ' ASN . . . 56.3 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.849 . . . . 0.0 109.794 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 2.6 t -91.43 150.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.56 133.87 52.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.879 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.684 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 35.4 m-70 -138.14 122.31 18.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.235 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.423 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 14.4 ptp180 -110.6 122.17 47.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.957 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.588 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -117.75 90.54 3.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 108.996 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.4 37.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.625 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 68.55 77.8 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.31 -56.5 0.61 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.485 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 8.0 m-85 -87.69 55.22 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.106 . . . . 0.0 109.376 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 30.3 mm-40 -66.83 -178.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.458 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.0 m -117.49 157.2 26.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.4 -0.812 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.39 70.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.571 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.0 m -57.35 -52.08 66.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 44.7 t80 -56.5 -37.87 70.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.487 -0.758 . . . . 0.0 109.6 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -71.28 -31.14 67.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.515 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.23 81.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.431 ' CD2' HD12 ' A' ' 14' ' ' LEU . 1.7 t80 -74.86 -47.54 29.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -1.144 . . . . 0.0 109.568 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -109.49 82.62 1.62 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.521 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -98.28 -34.15 10.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.545 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -101.27 9.18 42.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.24 -108.89 2.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.4 mm? 53.1 101.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.243 -1.151 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -149.93 97.52 2.6 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.555 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -81.69 107.99 14.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.462 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -118.81 154.46 32.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.349 -0.845 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.466 ' CD ' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 22.2 m170 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t -141.76 128.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.31 115.88 28.17 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.08 135.92 10.67 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.41 2.073 . . . . 0.0 112.214 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.0 t30 61.33 90.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.459 ' OE2' ' N ' ' A' ' 129' ' ' GLU . 54.8 mp0 -79.79 -17.77 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 t -47.82 -19.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 129' ' ' GLU . 88.8 t -65.45 -44.35 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.94 -28.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.469 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.56 155.42 36.2 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.463 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.11 139.5 42.63 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.792 2.328 . . . . 0.0 112.219 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 7' ' ' LYS . 24.0 mt-10 -83.05 -53.12 6.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.685 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.509 ' CD2' ' N ' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -43.69 -37.32 2.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 109.492 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp -83.25 -21.78 33.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.287 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' GLU . 26.8 tttt -65.02 -41.41 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.32 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.48 142.38 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.36 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.7 43.07 3.46 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -119.02 2.63 11.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.49 ' OE2' ' O ' ' A' ' 12' ' ' PRO . 2.1 pp20? -171.52 141.45 1.29 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.25 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HA ' ' HG1' ' A' ' 46' ' ' THR . 55.8 Cg_endo -73.27 178.33 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.42 2.08 . . . . 0.0 112.175 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -135.23 12.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.484 HD12 ' CD1' ' A' ' 106' ' ' TYR . 5.9 tt -134.57 133.06 39.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -1.091 . . . . 0.0 109.782 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.416 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 3.3 mt-30 -124.56 145.47 49.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.623 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.5 OUTLIER -125.23 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 110.167 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.9 m-90 -145.47 147.65 32.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.423 -0.798 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -106.64 130.68 54.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.445 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -81.7 143.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.447 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -148.71 96.98 2.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.436 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.9 tttm 50.86 37.09 16.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.7 m-85 68.98 46.25 0.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.563 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 24' ' ' LEU . 2.8 m-20 -127.03 -21.25 4.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 23' ' ' ASP . 17.0 mt 56.03 122.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.516 -0.74 . . . . 0.0 109.665 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -140.29 108.16 6.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.84 117.94 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.448 2.099 . . . . 0.0 112.144 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.34 133.84 88.24 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -40.78 117.88 0.56 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.484 2.122 . . . . 0.0 112.392 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -67.93 -25.66 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -53.57 -50.72 64.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.394 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -78.86 -53.8 6.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.396 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 54.75 93.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.381 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.51 -26.9 5.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 34' ' ' ASP . 19.3 p-10 -62.44 141.15 58.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -1.13 . . . . 0.0 109.17 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 33' ' ' GLY . 62.8 m-85 -145.3 137.81 25.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.936 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.33 112.21 24.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 108.993 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.8 p -68.82 87.21 0.35 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.81 -29.73 0.06 OUTLIER Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -107.51 -153.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -1.049 . . . . 0.0 108.846 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -138.6 140.78 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -116.1 147.96 40.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.23 133.57 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.38 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 15' ' ' GLN . 2.0 mt -134.0 145.75 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.944 . . . . 0.0 109.715 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 41.4 mt -122.12 149.35 43.72 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HZ3' HG23 ' A' ' 102' ' ' THR . 11.4 ttpt -137.31 94.17 2.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.612 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -81.56 106.94 13.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 109.013 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.36 164.76 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -116.28 116.44 27.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.428 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.409 HD13 ' ND2' ' A' ' 53' ' ' ASN . 12.0 mt -68.35 -98.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.59 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -84.93 -63.33 1.35 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.091 -1.006 . . . . 0.0 109.748 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -172.83 24.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.403 -0.811 . . . . 0.0 109.167 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.49 -53.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.673 HD21 ' N ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -64.74 152.51 42.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.491 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.673 ' N ' HD21 ' A' ' 53' ' ' ASN . 1.4 pt? -141.71 150.28 41.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.418 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -132.77 115.97 15.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.224 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.612 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.41 131.82 35.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.585 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -108.37 131.74 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.98 -1.075 . . . . 0.0 108.915 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.448 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 10.7 mt -93.5 134.51 35.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.61 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.713 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 43.3 m-70 -146.57 108.79 4.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.235 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.727 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.22 127.46 52.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.007 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -95.95 124.21 39.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -0.849 . . . . 0.0 110.114 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.718 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.4 mt -121.99 107.21 11.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.97 13.02 0.05 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.718 ' H ' ' C ' ' A' ' 62' ' ' LEU . 5.2 t-20 64.14 1.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 109.838 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 63' ' ' GLY . 1.3 mm-40 -107.09 9.98 30.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 108.934 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.0 t -104.94 138.66 40.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.578 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.8 p -56.74 161.17 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -75.24 -25.95 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.42 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.81 -41.43 86.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.522 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -87.2 -34.81 18.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 t -59.21 -57.98 10.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 0.0 109.376 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.72 -40.65 96.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.01 -47.82 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -1.178 . . . . 0.0 109.391 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -49.85 69.81 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.277 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -60.03 -24.22 64.34 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mm -81.33 -57.77 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 109.673 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.46 -38.69 88.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 108.947 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.6 m -68.55 -41.5 79.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.386 -0.821 . . . . 0.0 109.757 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 75' ' ' ALA . 50.7 t -71.97 -55.34 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -52.28 -59.7 4.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.129 -0.982 . . . . 0.0 109.948 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -52.76 -41.98 64.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.05 -1.031 . . . . 0.0 109.012 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.451 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -47.13 -49.1 22.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.857 -1.152 . . . . 0.0 108.135 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.451 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.2 m-20 -60.39 -31.6 70.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.557 ' N ' ' O ' ' A' ' 81' ' ' LEU . 28.7 t80 -74.48 -23.5 58.88 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.4 tp -83.69 -54.65 4.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 86' ' ' ASN . 0.6 OUTLIER -122.33 -42.33 2.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.183 -0.948 . . . . 0.0 110.167 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.07 -33.06 3.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 2.2 mmp_? -127.9 -84.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -1.105 . . . . 0.0 109.236 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 88' ' ' ARG . . . 78.82 178.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.759 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.94 150.61 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.865 . . . . 0.0 109.261 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.79 123.91 50.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.914 . . . . 0.0 109.863 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.713 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 36.5 m-70 -133.89 121.93 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.338 -0.851 . . . . 0.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -113.14 119.56 38.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.522 ' N ' ' OE2' ' A' ' 94' ' ' GLU . 57.2 mp0 -109.89 94.32 4.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 96' ' ' GLN . 8.5 t -83.6 37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 95' ' ' VAL . 2.9 tt0 49.81 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.42 -55.88 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -124.33 66.07 1.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -1.108 . . . . 0.0 109.474 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.417 ' OE2' ' CE1' ' A' ' 103' ' ' PHE . 13.7 mt-10 -69.9 -176.94 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 109.479 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.59 175.84 6.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.86 44.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.484 HG23 ' HZ3' ' A' ' 45' ' ' LYS . 22.4 m -63.16 -37.0 85.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CE1' ' OE2' ' A' ' 99' ' ' GLU . 41.8 t80 -68.59 -49.33 60.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.91 -19.11 65.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.951 . . . . 0.0 109.442 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.43 8.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.484 ' CD1' HD12 ' A' ' 14' ' ' LEU . 4.3 t80 -78.12 -25.07 47.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -1.14 . . . . 0.0 109.625 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -116.56 68.32 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.475 ' HG3' ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -60.48 -58.7 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.905 . . . . 0.0 109.286 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.475 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 1.4 t -105.32 10.01 33.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.501 ' C ' HD11 ' A' ' 111' ' ' LEU . . . -75.62 55.76 2.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.501 HD11 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.57 91.88 2.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -1.109 . . . . 0.0 109.322 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 35' ' ' PHE . 8.5 ttmt -126.21 110.19 13.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -81.81 107.97 14.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -124.66 108.93 12.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.392 -0.818 . . . . 0.0 109.176 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 115' ' ' LYS . 33.2 pttt -68.06 120.94 15.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.591 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 160.56 -149.15 18.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.49 -135.61 1.93 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.4 t -123.93 -65.2 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -1.135 . . . . 0.0 109.451 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.31 -29.49 57.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.589 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -86.57 6.12 32.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.309 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -21.34 78.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -75.85 -36.05 59.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -1.166 . . . . 0.0 109.46 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -86.27 -20.13 28.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 62.12 59.24 1.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.06 147.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.32 81.22 37.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.54 125.88 16.58 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 0.0 112.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.87 167.29 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.538 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -55.97 -17.27 6.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.421 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.43 -25.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -46.99 -43.31 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.95 -28.6 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.49 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -148.88 61.97 5.86 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 7' ' ' LYS . 56.9 Cg_endo -74.91 12.46 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.857 2.371 . . . . 0.0 112.193 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -50.97 -49.57 59.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -62.68 -34.95 78.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.903 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.4 mm? -80.82 -26.4 37.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.298 -0.876 . . . . 0.0 109.678 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 3' ' ' PRO . 6.1 mmtm -71.64 -31.58 67.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.88 156.59 36.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 56' ' ' TYR . . . 87.86 17.0 58.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -142.09 -23.38 0.69 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -1.189 . . . . 0.0 109.704 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.515 ' O ' ' OH ' ' A' ' 56' ' ' TYR . 16.5 mm-40 -93.49 117.11 67.29 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.312 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.24 162.38 31.33 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.23 1.953 . . . . 0.0 112.21 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.29 -120.95 7.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.37 145.35 45.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -1.158 . . . . 0.0 109.988 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.429 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 14.1 mt-30 -136.62 144.63 44.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.835 . . . . 0.0 109.057 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.592 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 18.2 mt -124.52 134.02 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.095 -1.003 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.5 m0 -141.63 115.88 9.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.781 . . . . 0.0 108.995 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 25' ' ' VAL . 39.7 ttp180 -92.2 145.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.847 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.75 143.38 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' PHE . 58.3 tt0 -129.08 112.29 13.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.0 109.35 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tttp 62.82 -69.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' GLU . 75.7 t80 -163.09 20.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.613 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.8 p-10 -127.07 115.32 18.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -55.24 148.37 14.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.435 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' ARG . 44.4 t -142.48 134.18 13.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.253 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.83 161.82 42.74 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.308 2.005 . . . . 0.0 112.154 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.37 133.79 17.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.249 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.16 107.53 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.374 2.049 . . . . 0.0 112.14 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 96.4 m -56.07 -22.81 29.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 5.7 p-10 -82.29 -22.47 35.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.913 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 30' ' ' ASN . 6.6 mp -121.35 13.4 11.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.753 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.723 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.99 -105.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.649 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 56.75 7.65 2.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.603 ' OD2' ' N ' ' A' ' 35' ' ' PHE . 8.3 t0 -150.54 150.14 30.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -1.099 . . . . 0.0 109.426 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.697 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -146.39 161.11 41.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.726 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CE1' ' NH2' ' A' ' 18' ' ' ARG . 5.1 m-85 -90.72 128.34 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.461 ' OG1' ' OE2' ' A' ' 65' ' ' GLU . 10.1 p -77.23 -30.41 54.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.649 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -78.08 -17.6 78.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -101.11 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -1.157 . . . . 0.0 109.422 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.7 142.72 38.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 2.0 m-85 -118.12 121.7 41.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.561 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.38 135.89 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 108.966 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -129.74 143.42 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.43 118.58 33.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 55' ' ' GLN . 17.1 ttmt -115.67 94.58 4.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.882 -1.136 . . . . 0.0 110.894 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.637 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -80.35 105.12 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -96.82 164.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.624 -0.673 . . . . 0.0 109.69 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -108.62 104.38 13.68 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.578 -0.701 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.5 mt -46.13 -87.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.4 mtm105 -139.66 -63.31 0.51 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.259 -0.9 . . . . 0.0 109.605 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -152.81 40.38 0.56 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.379 -0.825 . . . . 0.0 109.477 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.26 -101.66 0.63 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -107.24 -162.11 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -1.08 . . . . 0.0 109.787 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -131.21 -173.33 3.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.101 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LYS . 12.6 tp60 -139.78 116.43 10.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.957 -1.089 . . . . 0.0 110.333 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.637 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 0.7 OUTLIER -83.57 116.84 22.78 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 2.6 m-20 -89.01 128.36 35.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.623 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.517 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 1.7 mm? -99.69 102.9 14.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.843 . . . . 0.0 109.012 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.715 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 17.8 m-70 -111.72 108.69 18.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 110.15 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -108.71 112.32 24.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.535 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 15.9 t90 -105.25 138.64 41.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 110.516 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.726 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -128.14 117.11 21.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.567 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -61.65 24.95 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.726 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.5 t-20 56.09 2.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.336 -1.097 . . . . 0.0 110.029 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 63' ' ' GLY . 78.2 mt-10 -103.09 2.47 34.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 108.902 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 36.1 t -95.38 145.82 24.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 109.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 69' ' ' ASP . 93.5 p -83.92 140.2 32.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 109.554 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 67' ' ' SER . 17.7 pt20 -44.4 -24.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.4 m-20 -57.32 -57.96 10.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -87.61 -39.68 14.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 108.921 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.72 -59.65 4.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.27 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -40.18 48.88 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.58 59.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -1.125 . . . . 0.0 109.194 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -53.66 -46.16 70.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 0.0 109.005 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.87 -23.43 67.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.046 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -81.07 -53.99 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.862 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 16.2 m-85 -67.29 -30.35 70.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 55.2 m -72.87 -41.71 64.43 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.35 -54.99 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.98 -1.075 . . . . 0.0 109.747 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -61.51 -59.59 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.461 ' CB ' ' O ' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -53.42 -43.14 67.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.068 -1.02 . . . . 0.0 108.901 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' THR . 7.3 t0 -48.7 -48.68 40.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.088 -1.008 . . . . 0.0 108.749 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -59.28 -35.11 73.15 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.527 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 10.0 t80 -74.49 -22.43 59.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.3 tp -82.17 -54.78 4.99 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -122.89 -42.7 2.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.735 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.23 -13.69 62.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -156.17 19.8 0.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.3 -172.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.63 150.02 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.19 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -110.9 110.7 21.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.997 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 7.7 m-70 -110.23 120.32 42.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 108.909 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.512 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 8.6 ptt180 -114.43 125.96 54.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.288 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.606 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -126.64 120.3 29.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.96 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 96' ' ' GLN . 3.6 t -112.55 37.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.36 -0.838 . . . . 0.0 109.841 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' O ' ' A' ' 95' ' ' VAL . 11.3 tt0 58.82 124.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.506 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.46 -36.87 4.1 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -132.21 51.97 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -1.104 . . . . 0.0 109.596 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -58.58 179.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.6 m -103.54 156.0 18.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.72 83.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 m -65.42 -48.22 73.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.13 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 107' ' ' PHE . 30.1 t80 -58.33 -44.16 88.57 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.314 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.73 -30.74 71.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.1 91.64 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -49.54 65.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -1.185 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.427 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 45.6 m-85 -98.13 65.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -87.52 -34.41 18.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -96.6 2.46 52.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -86.36 -104.44 0.77 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.525 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.7 mm? 54.57 101.69 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.328 -1.101 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 11.9 tttt -168.15 91.79 0.32 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.86 108.02 15.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.402 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -96.47 113.01 24.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.28 139.35 55.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 117' ' ' GLY . . . -151.62 -50.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 116' ' ' GLY . . . 42.97 31.28 1.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.4 t -49.63 -26.5 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 109.399 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.09 68.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -84.19 6.15 23.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.302 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -51.53 -24.8 12.37 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.51 -26.64 55.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.202 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 125' ' ' VAL . 25.4 mttm -70.99 -51.5 25.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.426 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.597 ' ND1' ' N ' ' A' ' 124' ' ' HIS . 0.5 OUTLIER -72.23 43.89 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.425 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' A' ' 123' ' ' LYS . 7.4 p -89.86 132.95 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.187 -0.945 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -99.12 110.99 59.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.369 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 128' ' ' ASN . 77.8 Cg_exo -46.38 150.83 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.419 2.079 . . . . 0.0 112.21 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -43.14 153.4 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 131' ' ' VAL . 25.0 tt0 -56.5 -17.11 7.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.91 -17.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 129' ' ' GLU . 10.8 p -57.0 -34.0 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.96 -28.15 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.489 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 2' ' ' HIS . 16.7 tt0 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.492 ' ND1' ' N ' ' A' ' 2' ' ' HIS . 1.0 OUTLIER -43.49 154.92 0.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.41 138.98 36.95 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.593 2.195 . . . . 0.0 112.281 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.51 -25.22 66.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CD2' ' CD2' ' A' ' 24' ' ' LEU . 41.5 t80 -56.38 -24.83 47.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.78 -31.17 70.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.232 -0.918 . . . . 0.0 109.462 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 8' ' ' ALA . 81.9 mttt -104.65 -46.92 4.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.36 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.598 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 55.21 29.47 52.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.1 ptpt -42.3 -25.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 109.595 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 9' ' ' GLY . 6.0 mt-10 -147.86 148.96 31.85 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.5 134.67 6.9 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.725 2.283 . . . . 0.0 112.156 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -158.05 24.69 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.48 143.1 50.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -1.059 . . . . 0.0 109.4 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.598 HE21 ' N ' ' A' ' 9' ' ' GLY . 21.0 mt-30 -130.34 146.29 51.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 41.0 mt -116.07 137.7 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.852 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.582 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.2 m0 -142.44 111.71 6.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.16 145.23 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 109.645 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.83 143.58 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 17.5 tt0 -158.13 81.08 0.84 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.516 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.8 tttp 72.22 33.27 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.9 OUTLIER 66.57 17.0 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.5 t70 -95.74 -27.12 15.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' CD2' ' CD2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER 62.9 134.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -149.63 134.11 9.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.087 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 27' ' ' VAL . 37.8 Cg_endo -69.99 110.14 2.53 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.282 1.988 . . . . 0.0 112.209 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' PRO . 9.8 p -40.8 135.59 1.59 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.081 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.66 127.74 24.64 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.271 1.98 . . . . 0.0 112.349 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 30' ' ' ASN . 17.6 m -63.21 -32.51 73.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.378 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 29' ' ' THR . 42.6 t30 -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.178 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 8.6 mp -99.19 -55.2 2.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' LEU . 2.7 t80 47.46 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.463 -0.773 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.579 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.82 -13.3 8.14 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.24 143.91 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 109.185 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 18.2 m-85 -141.34 142.76 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.442 ' HB2' ' HH ' ' A' ' 41' ' ' TYR . 4.8 m-85 -86.8 106.81 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 0.0 108.941 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.615 ' C ' ' H ' ' A' ' 39' ' ' ASP . 23.8 p -51.93 -52.5 49.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.869 . . . . 0.0 110.035 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . -61.56 7.86 0.14 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.615 ' H ' ' C ' ' A' ' 37' ' ' THR . 0.5 OUTLIER -133.81 172.51 12.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -1.182 . . . . 0.0 109.476 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.98 151.81 30.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.908 . . . . 0.0 109.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.442 ' HH ' ' HB2' ' A' ' 36' ' ' PHE . 50.2 m-85 -131.06 121.86 25.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.616 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.71 118.93 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.081 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.426 HG21 ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -117.08 143.2 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.553 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -124.96 129.46 50.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.77 -0.581 . . . . 0.0 109.836 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.12 93.61 4.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 109.648 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.433 HG21 HD22 ' A' ' 54' ' ' LEU . 2.4 m -72.78 103.06 3.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.513 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -102.63 164.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -125.43 129.93 50.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.559 -0.713 . . . . 0.0 109.28 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.4 mt -66.62 -98.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.0 mtp85 -134.75 -49.51 0.76 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -157.38 31.92 0.28 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.366 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' O ' ' ND2' ' A' ' 53' ' ' ASN . . . -116.33 -88.03 1.39 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 52' ' ' GLY . 3.7 m120 -143.32 -162.31 1.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -1.166 . . . . 0.0 109.433 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -132.45 163.81 27.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.322 -0.861 . . . . 0.0 109.439 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -135.45 141.27 45.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.573 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -99.71 119.36 37.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.208 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 6.6 m-20 -73.38 120.23 18.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.5 ' CD1' ' C ' ' A' ' 58' ' ' LEU . 2.0 tm? -93.7 115.44 27.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.592 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -132.88 121.5 22.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.379 -0.826 . . . . 0.0 109.811 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CE1' ' HA ' ' A' ' 93' ' ' ARG . 0.3 OUTLIER -99.19 129.65 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.034 . . . . 0.0 108.792 178.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.44 ' C ' ' CD2' ' A' ' 62' ' ' LEU . 18.3 t90 -108.85 126.65 53.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.831 . . . . 0.0 110.156 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.642 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -133.76 116.3 15.57 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -68.24 34.25 0.25 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.0 t-20 49.73 10.9 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -1.025 . . . . 0.0 110.08 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.492 ' H ' ' C ' ' A' ' 63' ' ' GLY . 59.5 mt-10 -110.41 4.59 20.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 108.934 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.68 144.03 28.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.593 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 69' ' ' ASP . 2.0 p -67.41 125.5 26.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -50.69 -9.18 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.562 ' H ' ' C ' ' A' ' 67' ' ' SER . 17.9 t0 -75.5 -44.12 45.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.494 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -87.25 -45.72 10.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.256 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -51.71 -50.34 60.71 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.92 -52.09 51.14 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.45 -39.15 6.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.84 -39.87 83.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.99 . . . . 0.0 109.213 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.57 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -67.49 -31.0 70.83 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.284 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.79 -48.55 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 0.0 110.181 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.33 -33.67 76.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 109.296 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -81.35 -47.14 13.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.571 ' N ' ' CG2' ' A' ' 78' ' ' THR . 61.6 t -61.47 -45.66 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.903 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.22 -57.82 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.513 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 84' ' ' TYR . 2.2 tm? -52.33 -49.72 63.7 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.009 -1.057 . . . . 0.0 108.835 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 78' ' ' THR . 20.2 m-20 -46.56 -49.48 18.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 0.0 108.41 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 87' ' ' GLY . 7.6 m-20 -54.61 -31.95 57.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 81' ' ' LEU . 9.7 t80 -65.39 -28.81 69.53 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.92 -58.11 2.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.626 ' C ' ' H ' ' A' ' 88' ' ' ARG . 9.2 t-20 -121.76 13.46 10.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.135 -0.978 . . . . 0.0 110.666 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 51.32 5.96 0.14 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.626 ' H ' ' C ' ' A' ' 86' ' ' ASN . 34.1 mtp180 -147.19 -83.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.369 -1.077 . . . . 0.0 109.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 60.09 141.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.94 139.61 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -102.59 138.14 39.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 58' ' ' LEU . 20.5 m-70 -140.09 135.71 32.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 7.8 ptp85 -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 22.5 mt-10 -129.26 81.04 2.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.313 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.478 HG11 ' O ' ' A' ' 95' ' ' VAL . 14.5 t -78.95 38.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.875 . . . . 0.0 109.575 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 94' ' ' GLU . 5.7 tt0 63.19 72.39 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.605 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.425 ' O ' ' OE1' ' A' ' 99' ' ' GLU . . . 150.96 -60.86 0.41 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -88.32 57.94 4.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -1.135 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 18.9 mp0 -77.23 -165.14 0.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 94.2 p -133.98 159.9 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.19 78.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.1 m -61.34 -60.29 3.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 44.0 t80 -52.53 -38.0 58.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.06 -31.62 66.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.06 95.42 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.69 -52.38 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -1.196 . . . . 0.0 109.568 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.45 80.61 1.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -96.57 -37.74 10.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.583 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -102.43 9.93 39.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -89.98 -107.99 1.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.5 mm? 51.23 100.36 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.291 -1.123 . . . . 0.0 109.361 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -148.71 114.3 5.64 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.3 OUTLIER -81.93 111.55 18.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.76 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -105.49 113.14 26.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.315 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -53.9 125.56 19.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.419 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -101.03 -124.29 5.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.74 27.89 64.09 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.14 -19.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -1.175 . . . . 0.0 109.553 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.17 -24.43 66.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 t -104.3 6.01 35.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.99 -24.44 64.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.581 ' C ' ' H ' ' A' ' 124' ' ' HIS . 32.6 m-85 -57.35 -20.29 28.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -1.128 . . . . 0.0 109.419 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 124' ' ' HIS . 18.1 mtpp -62.13 4.19 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' A' ' 122' ' ' PHE . 1.6 t-80 77.36 111.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.454 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -135.02 125.9 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -125.83 81.61 65.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.564 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.7 165.5 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.818 2.345 . . . . 0.0 112.273 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.426 ' OD1' ' CD ' ' A' ' 129' ' ' GLU . 12.3 t-20 -74.43 -173.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -77.17 -28.82 54.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.389 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.14 -31.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.631 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.81 -54.18 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.602 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.48 -28.52 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.511 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.42 ' C ' ' H ' ' A' ' 4' ' ' GLU . 19.6 m-70 48.93 63.53 10.25 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.487 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.2 24.29 0.31 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.821 2.347 . . . . 0.0 112.102 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 2' ' ' HIS . 6.9 tp10 -71.64 -41.08 69.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.454 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.408 ' CD2' ' C ' ' A' ' 5' ' ' PHE . 33.7 p90 -66.33 -27.55 67.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.67 -34.51 75.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.45 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -96.48 -59.79 1.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.569 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 59.38 136.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.78 . . . . 0.0 109.407 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.63 ' CA ' ' NE2' ' A' ' 15' ' ' GLN . . . 45.5 46.02 12.01 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLY . 25.9 mtmt -43.22 -33.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -1.11 . . . . 0.0 109.384 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.541 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -140.71 169.29 11.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.847 . . . . 0.0 109.392 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -46.07 134.17 14.82 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.755 2.303 . . . . 0.0 112.328 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.95 -168.48 26.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 tt -123.63 144.03 49.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -1.091 . . . . 0.0 109.393 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.63 ' NE2' ' CA ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -131.05 149.41 52.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 109.448 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.1 mp -124.56 133.0 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.7 m0 -142.08 126.64 17.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.284 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.88 143.89 26.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.089 -1.007 . . . . 0.0 109.363 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.11 143.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 53.5 tt0 -138.28 95.75 3.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 78.78 -62.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 109.009 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 12.1 m-85 -171.72 22.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.667 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.67 111.76 14.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.757 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.6 mp -74.03 132.78 42.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.16 112.33 11.14 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.252 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -45.56 135.04 12.85 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.424 2.083 . . . . 0.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.2 p -78.64 127.54 80.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.12 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.26 122.61 1.26 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.441 2.094 . . . . 0.0 112.442 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 30' ' ' ASN . 7.3 m -64.04 -27.99 69.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.52 ' C ' HD21 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -45.72 -43.3 12.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.079 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 8.2 mp -90.38 -53.63 4.36 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.302 -0.874 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.8 t80 51.62 92.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.542 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.53 -31.31 4.65 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.598 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 45.9 t0 -68.81 134.53 49.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.241 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 25.8 m-85 -142.36 139.89 31.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.623 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -77.74 104.27 8.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -0.868 . . . . 0.0 109.35 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.3 p -45.73 -27.38 0.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.382 -0.824 . . . . 0.0 109.775 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.86 -32.07 41.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.486 ' OD2' ' OE2' ' A' ' 70' ' ' GLU . 35.6 t0 -92.12 172.73 8.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.091 -1.24 . . . . 0.0 109.476 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.93 140.73 46.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.375 -0.828 . . . . 0.0 109.374 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CE1' ' A' ' 36' ' ' PHE . 46.0 m-85 -121.03 135.23 55.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.7 t -111.16 144.21 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.472 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.54 146.19 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -126.51 121.37 32.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.51 94.17 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.935 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.592 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 8.6 m -77.46 103.37 7.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.384 -0.822 . . . . 0.0 109.551 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.5 164.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.243 -0.91 . . . . 0.0 109.316 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -111.46 103.29 11.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt -48.35 -57.37 6.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.443 ' O ' ' CG ' ' A' ' 51' ' ' ASN . 23.8 mtp180 -140.22 -63.35 0.49 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.348 -0.845 . . . . 0.0 109.54 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.443 ' CG ' ' O ' ' A' ' 50' ' ' ARG . 9.7 m120 -168.0 23.35 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.229 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' O ' HD21 ' A' ' 54' ' ' LEU . . . -156.89 -58.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -82.52 138.59 34.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -1.175 . . . . 0.0 109.719 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.495 HD21 ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -130.75 176.97 7.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.322 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -147.98 126.0 12.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.592 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 12.0 m-85 -90.97 130.98 36.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.044 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.26 124.76 37.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 108.781 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 82' ' ' ASP . 9.3 mt -88.76 110.93 21.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.776 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.701 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 19.5 m-70 -124.26 108.7 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.324 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.712 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -103.25 121.3 42.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.165 -0.959 . . . . 0.0 108.668 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -92.39 125.42 37.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.677 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -128.08 105.56 8.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -65.55 17.35 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.677 ' H ' ' C ' ' A' ' 62' ' ' LEU . 40.1 t30 65.95 1.74 1.98 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -1.078 . . . . 0.0 109.82 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 63' ' ' GLY . 40.3 mm-40 -105.11 7.6 33.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.03 . . . . 0.0 109.101 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 15.5 t -101.82 131.02 48.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.602 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 m -52.3 153.76 2.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -73.25 -9.09 58.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.574 ' OD2' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -80.87 -38.2 28.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.588 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.574 ' N ' ' OD2' ' A' ' 69' ' ' ASP . 64.0 tt0 -87.34 -45.74 10.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.202 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.8 t -53.95 -50.34 66.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.498 -0.751 . . . . 0.0 109.266 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -46.42 93.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.89 -45.5 30.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.68 72.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.208 -0.933 . . . . 0.0 109.058 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.36 -20.28 64.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 109.023 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.3 -56.1 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.36 -0.837 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.85 -25.8 65.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.4 m -78.18 -42.55 31.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 0.0 109.438 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 71.8 t -76.09 -41.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.707 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -69.06 -59.35 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.638 ' O ' ' N ' ' A' ' 84' ' ' TYR . 2.1 tm? -53.51 -51.89 61.35 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.615 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.443 ' OD1' ' HB2' ' A' ' 89' ' ' ALA . 4.5 t70 -45.49 -46.39 13.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.39 -33.44 59.24 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' LEU . 28.5 t80 -66.3 -28.58 68.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.1 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.175 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -121.75 -42.39 2.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.173 -0.954 . . . . 0.0 110.255 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.77 -20.15 8.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.467 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 34.0 mtt85 -128.25 -85.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.402 -1.058 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 88' ' ' ARG . . . 72.57 162.64 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.613 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.18 150.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.567 ' N ' ' NE2' ' A' ' 91' ' ' GLN . 2.5 mp0 -109.77 132.7 53.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.701 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 33.1 m-70 -139.34 111.86 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -103.29 124.56 48.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 3.9 mt-10 -117.46 86.48 2.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 0.0 109.366 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.59 37.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.555 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 56.25 91.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.383 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 137.11 -54.55 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -100.37 56.0 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -1.126 . . . . 0.0 109.203 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 5.3 mp0 -83.95 158.26 21.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.9 . . . . 0.0 109.58 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.5 165.23 12.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.313 -0.867 . . . . 0.0 109.287 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -70.47 -30.22 66.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 m -61.92 -60.22 3.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.603 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 36.0 t80 -54.11 -46.61 72.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 109.35 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 104' ' ' LEU . 35.0 mt -67.88 -28.24 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 109.282 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -61.83 -42.93 99.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -69.42 -47.41 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -1.066 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -105.21 52.78 0.73 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 110' ' ' GLY . 12.9 tptt -81.48 -30.08 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 m -57.89 -8.11 0.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.897 . . . . 0.0 109.742 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 100.6 111.6 3.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.575 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -75.89 -106.89 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.312 -1.111 . . . . 0.0 109.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 171.46 112.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.0 107.89 17.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -112.66 143.2 44.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.8 pttp -70.33 137.07 50.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.423 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -86.07 178.68 49.6 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 140.35 56.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -92.04 -24.12 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -1.107 . . . . 0.0 109.474 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -81.86 -23.16 36.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.9 m -74.23 6.33 3.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -71.67 -41.73 56.16 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 124' ' ' HIS . 1.2 p90 -46.11 -23.31 0.3 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.534 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 122' ' ' PHE . 35.3 ttpt -35.36 -30.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 109.806 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 122' ' ' PHE . 8.8 m80 -64.89 127.23 30.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.299 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 t -67.98 138.09 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 109.462 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.2 t -128.03 78.32 75.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.377 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.92 127.95 18.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 112.292 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -58.1 127.59 32.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.6 -19.23 57.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.38 -25.32 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.86 -54.13 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -51.8 -29.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.475 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.7 pm0 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -81.92 149.76 63.96 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.375 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.14 84.87 1.28 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.622 2.214 . . . . 0.0 112.344 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -50.89 -24.75 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.157 -0.964 . . . . 0.0 109.272 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -45.43 -41.01 8.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.417 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.434 HD11 ' HA ' ' A' ' 6' ' ' LEU . 35.9 tp -95.03 -32.23 13.24 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.346 -0.846 . . . . 0.0 109.422 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttp -103.24 33.74 3.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.391 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -40.26 143.57 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.807 . . . . 0.0 109.619 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.587 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 52.43 56.98 14.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.77 -27.34 11.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.35 157.4 45.42 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.378 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.95 123.31 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.782 2.321 . . . . 0.0 112.272 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.7 -172.24 33.75 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.41 143.08 45.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.398 -1.06 . . . . 0.0 109.524 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.587 HE21 ' N ' ' A' ' 9' ' ' GLY . 13.9 mt-30 -133.89 145.01 49.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.898 . . . . 0.0 109.48 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.603 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 16.2 mt -118.3 139.46 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.603 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.7 m0 -143.37 110.91 5.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -77.9 139.6 39.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.6 143.08 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -0.896 . . . . 0.0 109.202 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' PHE . 24.4 tt0 -158.51 122.2 3.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.54 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 19.1 mmtt 40.59 22.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.51 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' GLU . 2.1 m-85 71.1 44.56 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m-20 -127.09 -13.92 5.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.7 mp 58.81 131.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.2 t -150.91 111.29 3.1 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.06 123.98 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.51 2.14 . . . . 0.0 112.272 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 HG11 HG21 ' A' ' 16' ' ' ILE . 15.0 p -56.36 133.54 76.23 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 109.31 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.49 106.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -58.32 -25.46 61.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -51.74 -47.28 64.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.37 -54.74 4.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.3 t80 53.58 93.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.232 -0.918 . . . . 0.0 109.318 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.44 -4.91 9.4 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 24.6 t0 -108.23 131.72 54.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.382 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -146.08 167.52 23.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 109.662 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -99.31 122.27 42.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.232 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.7 p -59.64 -27.32 66.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.809 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 26.49 5.92 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.9 t70 -142.69 -166.99 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.308 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -141.04 140.95 34.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.639 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -123.57 129.45 51.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -100.93 137.55 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.4 mt -132.89 146.39 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.506 HD11 HD23 ' A' ' 58' ' ' LEU . 2.3 mp -128.84 131.14 47.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.544 -0.723 . . . . 0.0 109.569 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -113.72 93.68 4.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.682 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.604 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 5.9 m -78.17 105.66 9.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.658 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.6 164.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.301 -0.874 . . . . 0.0 109.132 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -121.13 140.78 51.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.538 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.0 mt -80.19 -95.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -140.16 -34.05 0.55 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.235 -0.915 . . . . 0.0 109.524 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.493 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 29.0 t-20 -175.11 33.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.309 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.43 -89.5 1.12 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -136.45 -155.15 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -1.103 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -134.16 171.73 13.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 109.378 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.89 123.39 23.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.604 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 6.2 m-85 -95.36 126.01 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.594 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.6 m-20 -97.41 119.52 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.927 -1.108 . . . . 0.0 108.962 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.506 HD23 HD11 ' A' ' 44' ' ' LEU . 2.7 mt -83.1 141.35 32.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 11.8 m-70 -145.91 108.72 4.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.21 114.69 28.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 108.624 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -90.51 125.55 35.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.913 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.61 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -129.13 114.35 16.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.449 ' O ' ' NE2' ' A' ' 96' ' ' GLN . . . -67.22 11.44 0.73 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.61 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.1 t-20 67.33 1.72 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.527 -0.984 . . . . 0.0 109.77 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -112.3 9.97 19.96 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.56 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 9.6 p -98.45 126.7 44.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -46.65 123.47 5.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.128 -0.982 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 8.3 pm0 -48.19 -25.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.511 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -53.94 -43.34 69.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -87.41 -31.52 20.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.152 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.18 -59.74 4.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.377 -0.827 . . . . 0.0 109.499 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -54.78 -52.3 47.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.66 -41.07 9.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.381 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.66 92.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.164 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.51 86.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.209 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.58 -45.63 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 109.637 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -68.28 -35.68 78.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.5 m -75.64 -41.9 52.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.7 t -74.18 -43.87 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.166 -0.959 . . . . 0.0 109.943 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -67.91 -59.35 3.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.615 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.8 tm? -53.92 -51.88 62.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.911 -1.118 . . . . 0.0 108.881 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 81' ' ' LEU . 4.7 t70 -45.98 -45.81 15.96 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 108.567 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -58.64 -30.85 67.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 27.0 t80 -69.31 -23.15 63.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.2 mt -83.58 -61.28 1.88 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.422 -0.799 . . . . 0.0 110.948 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.513 ' ND2' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -123.04 -43.41 2.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.976 -1.078 . . . . 0.0 111.361 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.87 -3.37 58.74 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.57 62.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -1.191 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -102.63 168.37 9.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.288 -0.882 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.51 150.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -115.5 136.13 53.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.057 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.422 ' HB2' ' ND1' ' A' ' 59' ' ' HIS . 31.5 m-70 -136.45 124.22 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -114.09 121.54 44.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.862 . . . . 0.0 109.798 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -114.25 93.44 4.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.278 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.5 37.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.615 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 63' ' ' GLY . 4.0 tt0 61.53 110.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.42 -38.55 3.28 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.06 50.29 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.181 . . . . 0.0 109.534 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.87 155.91 39.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 153.8 21.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.57 70.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 m -65.71 -62.93 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.544 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 3.5 t80 -51.85 -30.74 24.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.353 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 105' ' ' GLY . 7.8 mt -73.13 -57.39 4.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 104' ' ' LEU . . . -45.19 -34.92 4.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -75.62 -59.71 2.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.492 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.482 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 19.6 m-85 -96.35 57.48 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.594 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -84.89 -33.39 22.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 t -96.06 -11.59 26.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -79.49 -104.11 0.24 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 110' ' ' GLY . 81.6 mt 48.5 98.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.21 -1.17 . . . . 0.0 109.329 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -152.93 116.23 4.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -91.87 107.82 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -112.27 108.74 18.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.0 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -54.14 120.27 6.24 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.91 -37.47 6.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 112.82 21.92 5.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.69 -16.69 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.205 -1.173 . . . . 0.0 109.43 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -55.32 -21.87 16.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.7 m -66.0 6.06 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -52.09 -19.98 6.11 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -59.72 -23.78 63.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -1.175 . . . . 0.0 109.432 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -52.64 -33.88 48.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.421 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -94.18 104.75 16.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.305 -0.872 . . . . 0.0 109.506 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.0 t -80.09 130.37 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.94 87.72 6.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.579 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 129' ' ' GLU . 53.0 Cg_exo -51.46 130.15 32.0 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.698 2.265 . . . . 0.0 112.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.3 p-10 -60.49 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.155 -0.965 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 127' ' ' PRO . 29.9 mt-10 -87.97 -17.83 30.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.873 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.4 t -50.55 -47.94 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.7 -42.65 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.1 -28.13 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.497 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.468 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.442 ' H1 ' ' H ' ' A' ' 2' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.442 ' H ' ' H1 ' ' A' ' 1' ' ' GLU . 18.1 t-80 -167.22 73.06 1.02 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.181 -0.949 . . . . 0.0 109.507 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.62 135.79 41.37 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.841 2.361 . . . . 0.0 112.175 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.06 -28.63 69.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -62.32 -30.58 71.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -48.72 -35.22 13.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 0.0 109.348 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -108.51 -28.74 9.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 109.717 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 51.97 62.84 2.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.681 ' N ' ' NE2' ' A' ' 15' ' ' GLN . . . 106.74 38.46 2.2 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.9 pttp -41.66 -23.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.625 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -138.93 157.7 71.12 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.371 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -39.82 136.5 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.799 2.333 . . . . 0.0 112.184 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.14 179.37 24.05 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 4.3 tt -115.45 148.33 39.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -1.012 . . . . 0.0 109.735 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.681 ' NE2' ' N ' ' A' ' 9' ' ' GLY . 31.2 mt-30 -145.03 154.68 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 0.0 109.682 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.619 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -126.93 152.26 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.769 -0.582 . . . . 0.0 110.06 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.4 m-90 -155.08 110.91 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.425 -0.797 . . . . 0.0 109.233 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HD3' ' HH ' ' A' ' 41' ' ' TYR . 3.1 ttp180 -75.49 127.64 33.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 109.345 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -69.8 144.17 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.159 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 22' ' ' PHE . 13.8 tp10 -155.83 121.44 4.94 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.547 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 43.6 tttt 44.07 23.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 109.399 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 70.19 41.46 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 24' ' ' LEU . 11.6 t70 -127.14 -13.14 5.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' ASP . 13.0 mt 56.43 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.6 t -138.02 125.04 13.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.219 -0.925 . . . . 0.0 109.183 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.44 140.93 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.477 2.118 . . . . 0.0 112.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -79.3 134.27 59.13 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -0.847 . . . . 0.0 109.347 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.529 ' CB ' ' OD1' ' A' ' 30' ' ' ASN . 77.7 Cg_exo -40.2 103.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.477 2.118 . . . . 0.0 112.18 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -49.27 -37.93 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 1.2 p30 -45.52 -39.72 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 6.2 mp -86.15 -55.58 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 31' ' ' LEU . 44.2 t80 45.19 90.73 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.593 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.7 -31.3 4.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 1.1 m-20 -85.97 137.5 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.085 -1.244 . . . . 0.0 109.249 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 22.9 m-85 -146.07 153.72 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -76.91 128.21 34.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 108.901 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 p -74.22 -26.46 60.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 110.021 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.01 -22.9 62.57 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.1 t70 -94.94 -160.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -136.26 141.0 43.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.377 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.538 ' HH ' ' HD3' ' A' ' 18' ' ' ARG . 26.5 m-85 -125.21 125.59 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.9 t -93.87 127.83 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -138.28 145.08 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 109.163 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.573 ' CB ' ' O ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -144.55 167.06 23.41 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.048 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 1.7 tmmm? -146.28 94.31 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.458 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 63.7 m -72.16 126.88 30.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.374 -0.829 . . . . 0.0 109.833 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.44 164.79 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.636 -0.665 . . . . 0.0 109.515 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.461 ' O ' ' C ' ' A' ' 49' ' ' LEU . 9.5 tt0 -126.26 102.01 6.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.6 -0.687 . . . . 0.0 109.203 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 48' ' ' GLN . 80.0 mt -40.09 -82.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -0.955 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 -139.72 -54.48 0.55 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.394 -0.816 . . . . 0.0 109.426 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.81 24.1 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.2 -78.58 1.05 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 18.2 p-10 -137.86 158.0 45.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -1.194 . . . . 0.0 109.597 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.485 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -110.9 167.15 10.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.354 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.6 tt0 -127.21 117.39 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -0.949 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.531 ' OH ' ' O ' ' A' ' 9' ' ' GLY . 5.2 m-85 -71.75 108.73 5.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 87.1 m-20 -72.56 118.05 15.0 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.924 -1.11 . . . . 0.0 108.152 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 1.7 mm? -102.81 119.21 38.43 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.071 -1.018 . . . . 0.0 109.747 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.473 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -144.29 116.91 8.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 109.657 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.734 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.45 140.33 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 108.819 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.425 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 7.2 t90 -100.65 127.02 47.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.678 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -127.69 108.67 10.95 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.537 ' O ' ' NE2' ' A' ' 96' ' ' GLN . . . -63.09 12.58 0.11 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.678 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.2 t-20 66.53 1.87 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -1.13 . . . . 0.0 109.845 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.97 5.32 32.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.067 -1.021 . . . . 0.0 108.973 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 67' ' ' SER . 34.5 t -101.15 116.8 33.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 66' ' ' CYS . 12.7 p -42.23 125.32 3.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.508 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 1.6 mp0 -45.01 -28.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.62 -42.11 82.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.596 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -87.5 -38.89 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.487 ' OG ' HD12 ' A' ' 62' ' ' LEU . 1.9 t -59.53 -57.59 12.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.13 -40.53 36.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.95 -52.65 62.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.294 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.98 65.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.181 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -72.59 -20.3 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -81.0 -46.89 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -66.38 -36.08 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.51 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.24 -41.46 61.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 78' ' ' THR . 24.5 t -61.37 -52.12 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.731 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.91 -59.61 5.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 109.783 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.615 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -53.14 -44.37 67.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 108.738 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' LEU . 10.9 t0 -46.72 -48.25 20.38 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.923 -1.11 . . . . 0.0 108.114 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.77 -27.91 69.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 37.9 t80 -75.91 -24.09 55.57 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.03 -53.88 6.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.895 . . . . 0.0 109.574 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -121.84 -42.32 2.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.4 -0.812 . . . . 0.0 109.891 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.33 -22.42 7.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.4 mtp180 -142.39 -85.39 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.386 -1.067 . . . . 0.0 109.278 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 58.68 161.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.4 t -98.39 135.31 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.507 ' OE1' ' OH ' ' A' ' 60' ' ' TYR . 1.1 pp0? -121.98 133.28 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.301 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.634 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -135.59 159.83 40.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.308 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -121.75 136.54 54.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 96' ' ' GLN . 23.7 mt-10 -108.43 87.54 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.528 -0.733 . . . . 0.0 109.145 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.2 t -74.48 37.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.867 . . . . 0.0 109.885 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 63' ' ' GLY . 2.8 tt0 54.73 106.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.78 -54.87 0.69 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 99' ' ' GLU . 13.8 m-85 -115.19 36.53 3.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -1.104 . . . . 0.0 109.254 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 98' ' ' PHE . 13.1 mt-10 -44.28 169.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 t -95.98 165.81 12.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.96 67.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.4 m -66.76 -49.96 64.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' ' CD1' ' A' ' 61' ' ' TRP . 67.8 t80 -64.0 -46.45 84.5 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 108' ' ' LYS . 26.7 mt -68.77 -32.67 72.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.65 -55.13 32.52 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.76 -47.01 87.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -1.115 . . . . 0.0 109.327 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.45 48.89 0.85 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' LEU . 42.6 tttm -68.97 -23.61 64.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 t -76.21 3.69 10.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.71 110.58 2.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.614 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.1 -101.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -1.116 . . . . 0.0 109.188 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 172.07 107.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.107 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.69 107.94 17.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -105.18 122.59 46.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -60.39 166.18 3.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.1 124.7 1.35 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -102.24 24.12 32.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.8 t -51.77 -28.5 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -1.218 . . . . 0.0 109.442 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.2 -24.6 54.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.195 -0.941 . . . . 0.0 109.433 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.2 t -84.24 6.07 24.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 124' ' ' HIS . . . -75.95 -50.85 7.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -54.24 -30.31 49.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -1.189 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -78.93 1.43 23.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.892 . . . . 0.0 109.615 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 121' ' ' GLY . 2.4 t-160 -146.03 129.15 16.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.945 . . . . 0.0 109.393 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.67 146.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.482 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.35 86.18 21.34 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 109.343 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.04 126.01 14.37 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.767 2.311 . . . . 0.0 112.224 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -79.41 -172.57 3.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.33 -29.04 21.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.98 -27.38 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.08 -40.24 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.942 . . . . 0.0 109.416 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.58 -27.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.414 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.453 ' CG ' ' H ' ' A' ' 2' ' ' HIS . 3.6 tp10 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.335 0.588 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.453 ' H ' ' CG ' ' A' ' 1' ' ' GLU . 12.4 m80 -146.3 67.05 11.64 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.15 109.77 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.813 2.342 . . . . 0.0 112.242 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.12 -15.25 51.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 109.427 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -54.66 -35.4 63.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.408 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.8 mm? -95.46 -12.14 26.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.276 -0.89 . . . . 0.0 109.527 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 8' ' ' ALA . 33.4 tttm -82.56 -19.53 38.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 9' ' ' GLY . . . -43.62 130.44 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.075 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.469 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 41.68 40.84 3.11 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -48.75 -26.12 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -1.11 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -135.18 157.96 75.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.88 118.9 5.24 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.792 2.328 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.5 -158.02 29.45 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.17 148.27 48.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -1.021 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.469 HE21 ' N ' ' A' ' 9' ' ' GLY . 20.6 mt-30 -143.98 141.77 30.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.221 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.36 123.98 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.927 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.444 ' O ' HG22 ' A' ' 42' ' ' VAL . 1.9 m0 -131.06 129.75 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HG3' ' CZ ' ' A' ' 41' ' ' TYR . 7.2 ttm180 -87.17 144.92 26.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.917 . . . . 0.0 109.584 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' N ' ' HG2' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -85.45 143.34 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' A' ' 23' ' ' ASP . 25.0 tt0 -151.54 99.89 2.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 6.4 ttmm 48.48 38.49 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.378 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 66.29 20.67 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 24' ' ' LEU . 7.0 m-20 -98.74 -21.67 16.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.1 mt 57.21 122.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.48 133.47 23.65 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 109.219 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.93 117.66 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.343 2.029 . . . . 0.0 112.379 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.24 134.62 90.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.17 136.07 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.275 1.983 . . . . 0.0 112.328 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -57.65 -30.26 65.26 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -45.86 -42.11 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 32' ' ' TYR . 8.4 mp -90.34 -55.73 3.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.208 -0.932 . . . . 0.0 109.268 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.8 t80 36.2 83.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.585 -0.697 . . . . 0.0 109.888 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.68 -31.38 4.6 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -91.48 126.22 36.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.248 . . . . 0.0 109.151 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.686 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.61 168.26 21.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.918 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -80.56 158.13 25.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.093 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -101.68 -11.19 19.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.64 -7.73 61.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.58 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.3 t70 -105.58 -155.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -1.149 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.58 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.71 141.4 31.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.543 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 25.0 m-85 -124.36 121.94 36.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 17' ' ' TRP . 0.5 OUTLIER -103.22 135.7 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.4 mt -121.52 146.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.796 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 44' ' ' LEU . 4.0 mm? -118.74 125.38 49.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' GLN . 7.6 ttpp -120.82 93.79 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.053 -1.03 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.642 ' OG1' ' CE1' ' A' ' 56' ' ' TYR . 91.7 m -85.98 101.34 12.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.581 -0.699 . . . . 0.0 109.455 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.22 164.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.35 -0.844 . . . . 0.0 109.15 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.592 ' OE1' ' N ' ' A' ' 50' ' ' ARG . 1.1 tm0? -120.55 112.6 19.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.748 . . . . 0.0 109.603 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 48' ' ' GLN . 12.6 mt -46.27 -88.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.152 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.592 ' N ' ' OE1' ' A' ' 48' ' ' GLN . 6.8 mmt85 -134.85 -41.51 0.76 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.335 -0.853 . . . . 0.0 109.215 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -176.36 29.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.35 -103.42 2.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.596 ' CG ' ' H ' ' A' ' 54' ' ' LEU . 10.6 t-20 -102.19 -178.63 3.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 109.782 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.596 ' H ' ' CG ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -119.28 172.41 7.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.465 -0.772 . . . . 0.0 109.323 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.521 ' O ' ' O ' ' A' ' 45' ' ' LYS . 4.1 tp-100 -131.43 110.75 11.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.642 ' CE1' ' OG1' ' A' ' 46' ' ' THR . 7.7 m-85 -86.32 109.67 19.14 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.618 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -84.01 127.59 33.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.602 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 1.1 mm? -96.51 107.25 19.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.548 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.647 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 75.3 m-70 -115.96 108.57 16.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.717 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.7 120.27 39.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.676 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.686 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 56.5 t90 -102.34 124.91 48.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.987 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.775 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -128.93 118.67 23.04 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.0 16.95 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.775 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER 61.77 2.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -1.031 . . . . 0.0 109.815 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.3 mt-10 -109.4 13.14 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.165 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.7 t -99.91 140.16 34.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.604 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.2 t -61.25 146.54 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.607 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -62.68 -23.48 67.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.11 -49.77 76.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.731 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.49 -43.65 11.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.316 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -55.89 -53.82 52.13 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -60.18 -51.24 60.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.51 -35.14 3.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -1.191 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.19 -45.81 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -62.02 -31.77 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.2 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.48 -52.47 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -58.44 -44.41 89.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.249 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -67.15 -44.55 79.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.554 ' N ' ' CG2' ' A' ' 78' ' ' THR . 58.4 t -69.62 -65.11 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' VAL . 6.1 mm-40 -43.36 -59.42 2.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.104 -0.998 . . . . 0.0 109.422 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -52.12 -37.05 53.02 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.069 -1.019 . . . . 0.0 108.641 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -52.01 -52.59 49.68 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.057 -1.027 . . . . 0.0 108.725 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.547 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 7.4 t70 -57.78 -30.52 65.72 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -79.24 -23.73 43.5 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.0 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 56' ' ' TYR . 11.4 tp -84.74 -46.04 11.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 110.101 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -122.02 -42.21 2.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 109.987 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.93 -15.8 51.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -154.06 24.21 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.77 -179.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.63 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.45 150.19 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -108.44 133.31 52.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.953 . . . . 0.0 109.682 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.647 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 15.8 m-70 -132.35 121.2 23.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.243 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.401 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 58.3 ttt180 -108.48 127.75 54.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.565 ' C ' ' H ' ' A' ' 96' ' ' GLN . 8.3 mp0 -126.62 78.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.416 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.8 t -68.75 37.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.565 ' H ' ' C ' ' A' ' 94' ' ' GLU . 7.2 tp-100 39.27 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.461 -0.775 . . . . 0.0 109.615 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 150.3 -19.24 1.05 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 29.9 m-85 -162.95 47.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.39 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' CE2' ' A' ' 103' ' ' PHE . 2.3 mt-10 -62.65 -179.41 0.26 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.17 172.39 7.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.434 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.35 -31.36 71.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.506 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -63.17 -62.62 1.57 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.582 ' CE2' ' OE1' ' A' ' 99' ' ' GLU . 16.6 t80 -52.52 -38.27 59.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.88 -24.72 61.71 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.06 -43.24 57.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.403 ' CZ ' ' HD2' ' A' ' 45' ' ' LYS . 27.1 m-85 -70.33 -42.54 71.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -1.214 . . . . 0.0 109.639 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.54 73.25 0.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.434 ' HZ3' ' HB2' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -98.37 -31.55 11.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -104.12 7.99 36.35 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -102.14 -111.75 3.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 110' ' ' GLY . 8.5 mp 53.09 102.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.334 -1.097 . . . . 0.0 109.405 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -145.37 108.39 4.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -82.34 107.98 15.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 0.0 109.614 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.01 108.91 16.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 109.298 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -83.4 130.96 35.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 145.63 -133.4 5.01 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 120' ' ' SER . . . 168.55 86.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 117' ' ' GLY . 22.6 t -43.93 -28.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -78.56 -27.01 45.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 117' ' ' GLY . 70.7 m -65.53 6.15 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -82.13 -59.52 2.28 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.42 ' O ' ' C ' ' A' ' 123' ' ' LYS . 3.2 m-85 -85.84 -19.76 30.14 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.215 -1.167 . . . . 0.0 109.451 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 124' ' ' HIS . 20.6 tttp -42.87 -52.19 5.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 109.505 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.495 ' O ' ' O ' ' A' ' 123' ' ' LYS . 2.2 m-70 54.24 166.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.42 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.48 111.03 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 126' ' ' VAL . 12.2 p -100.64 117.33 62.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -44.77 129.2 9.29 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -62.6 136.41 57.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -52.31 -17.48 1.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.0 t -46.87 -34.92 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.7 t -49.66 -60.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.12 -27.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.522 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.628 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -77.11 -42.49 2.63 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 26.9 Cg_exo -59.53 -33.71 97.02 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.704 2.269 . . . . 0.0 112.149 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 7' ' ' LYS . 1.0 OUTLIER -53.94 -57.14 12.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -47.53 -36.14 9.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.138 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.0 mp -79.89 -23.99 41.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.361 -0.837 . . . . 0.0 109.26 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 4' ' ' GLU . 2.0 ttmp? -64.85 -43.61 92.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.454 ' HB2' ' CH2' ' A' ' 17' ' ' TRP . . . -50.88 145.29 7.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.03 57.21 2.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 12.5 mmtp -132.89 -10.33 3.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.241 -1.152 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 58.0 mt-10 -160.17 150.41 15.03 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.284 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.61 156.36 57.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.55 2.166 . . . . 0.0 111.916 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.29 -141.47 15.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 15' ' ' GLN . 2.4 tt -127.86 144.9 51.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.406 -1.055 . . . . 0.0 110.062 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.409 ' O ' HG21 ' A' ' 43' ' ' ILE . 3.9 mt-30 -135.78 150.55 49.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 109.057 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 43' ' ' ILE . 1.9 mp -124.96 145.32 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.83 . . . . 0.0 110.409 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -146.37 110.89 5.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.421 -0.799 . . . . 0.0 108.942 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' VAL . 12.4 ttp85 -81.09 129.63 34.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 0.0 109.672 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -87.06 143.64 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 12.2 tm-20 -153.8 88.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? 60.6 50.51 5.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 53.6 47.61 23.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.516 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 24' ' ' LEU . 49.9 t0 -126.99 -25.91 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.4 mp 59.39 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.4 -0.812 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' ARG . 51.7 t -145.94 103.22 4.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 27' ' ' VAL . 63.3 Cg_exo -47.77 108.28 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.287 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 26' ' ' PRO . 10.1 t -43.34 107.49 0.57 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.417 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.99 137.74 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.406 2.07 . . . . 0.0 112.223 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 m -62.0 -24.93 67.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.13 -45.29 32.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.258 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -94.94 -55.46 3.09 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 31' ' ' LEU . 12.4 t80 42.24 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 109.75 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.597 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.43 -30.87 4.82 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -79.83 137.66 37.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.083 -1.245 . . . . 0.0 109.392 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 57.2 m-85 -136.95 160.46 38.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.05 105.54 15.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.385 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.2 p -57.85 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.95 -30.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.8 m-20 -111.23 -153.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.45 -1.03 . . . . 0.0 109.014 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.7 145.38 44.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.532 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.4 ' CE1' ' HG3' ' A' ' 18' ' ' ARG . 65.6 m-85 -121.2 127.62 51.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.419 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.68 103.87 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -121.39 144.34 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 109.193 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 1.1 pt? -147.55 172.43 14.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 110.193 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -145.82 99.88 3.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 111.489 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -72.52 118.91 16.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 108.908 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.07 164.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.497 -0.752 . . . . 0.0 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -126.97 120.88 30.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.538 -0.726 . . . . 0.0 109.258 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.95 -95.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.253 -0.905 . . . . 0.0 109.435 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -140.24 -34.9 0.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.936 . . . . 0.0 109.507 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 51' ' ' ASN . 18.5 t-20 -175.84 32.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.349 -0.845 . . . . 0.0 109.197 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -116.16 -82.69 0.98 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -142.22 -167.37 2.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 109.526 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.435 ' H ' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -126.65 158.94 35.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 109.321 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -126.05 114.11 17.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.653 ' CG ' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.61 109.87 17.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.079 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -86.76 103.0 14.78 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.636 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 1.1 mt -95.95 143.1 27.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.172 -0.955 . . . . 0.0 110.444 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 43' ' ' ILE . 1.5 p-80 -154.1 131.83 11.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.465 -0.772 . . . . 0.0 109.623 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.739 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -98.02 118.62 35.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 108.921 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.677 ' NE1' ' CE1' ' A' ' 103' ' ' PHE . 12.1 t90 -85.35 130.36 34.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.302 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.662 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -131.4 111.51 11.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 15.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.662 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER 66.65 1.83 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.341 -1.093 . . . . 0.0 109.713 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -107.3 10.79 29.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 108.983 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 18.4 t -105.0 146.1 29.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -73.67 166.22 23.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.862 . . . . 0.0 109.359 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -76.35 -8.98 58.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.3 -46.52 49.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.12 -36.74 17.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 109.456 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.9 t -60.72 -58.31 9.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.582 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.13 -41.38 78.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -49.93 61.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.436 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.05 87.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.542 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -69.45 -20.46 63.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.134 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mm -79.49 -52.25 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -33.1 73.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 108.994 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 16.4 m -74.33 -36.55 63.67 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.242 -0.911 . . . . 0.0 109.6 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 75' ' ' ALA . 47.4 t -75.18 -54.61 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -61.75 -59.49 5.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.692 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.1 tm? -51.97 -47.14 64.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.101 -0.999 . . . . 0.0 108.792 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.584 ' OD2' ' NE2' ' A' ' 91' ' ' GLN . 5.0 t0 -46.37 -47.66 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.971 -1.08 . . . . 0.0 108.523 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.11 -30.77 69.49 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.571 ' N ' ' O ' ' A' ' 81' ' ' LEU . 31.7 t80 -75.86 -23.57 55.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.467 ' C ' HD21 ' A' ' 86' ' ' ASN . 8.0 mt -78.07 -52.49 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.573 HD21 ' N ' ' A' ' 86' ' ' ASN . 1.1 m-80 -122.02 -42.2 2.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.04 -11.0 57.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 -150.2 18.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -1.175 . . . . 0.0 109.8 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.51 -178.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.516 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.543 ' C ' ' NE2' ' A' ' 91' ' ' GLN . 3.7 t -114.1 145.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.357 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.584 ' NE2' ' OD2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -136.69 126.78 26.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.688 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -125.26 160.24 29.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.861 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.404 ' CB ' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -111.37 136.78 50.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.112 -0.993 . . . . 0.0 109.939 -179.324 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.9 mm-40 -118.81 101.81 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 95' ' ' VAL . 8.3 p -88.46 37.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.241 -0.912 . . . . 0.0 109.693 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 57.12 66.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.398 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.39 -59.7 0.29 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -92.22 33.12 1.1 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.457 ' OE2' ' CD1' ' A' ' 61' ' ' TRP . 2.6 mt-10 -72.28 -154.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.425 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -138.05 156.87 47.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 109.385 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.27 -21.07 12.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.6 m -61.6 -60.57 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.095 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.677 ' CE1' ' NE1' ' A' ' 61' ' ' TRP . 72.3 t80 -61.12 -50.28 73.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.525 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -70.34 -18.68 63.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.157 -0.964 . . . . 0.0 109.142 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -69.81 -41.95 71.78 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -71.92 -43.38 65.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -1.112 . . . . 0.0 109.052 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -107.51 54.21 0.67 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.596 ' C ' ' H ' ' A' ' 110' ' ' GLY . 25.8 tttm -81.39 -33.5 32.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.912 . . . . 0.0 109.678 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.0 t -60.7 3.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.74 109.58 2.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' O ' ' CB ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -72.39 -101.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -1.173 . . . . 0.0 109.15 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.48 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 6.7 mttm 165.26 136.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.65 107.89 17.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.494 -0.754 . . . . 0.0 109.235 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -114.26 132.06 56.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.903 . . . . 0.0 109.554 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 116' ' ' GLY . 29.0 mtmt -65.12 110.02 2.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 109.385 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -42.77 161.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.17 60.21 5.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.36 -28.27 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.333 -1.098 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.76 71.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.439 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 m -97.63 6.18 48.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.329 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 124' ' ' HIS . . . -61.41 -27.9 68.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -62.52 -32.77 73.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -86.5 -4.89 59.24 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 121' ' ' GLY . 23.2 m-70 -134.77 117.67 16.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.385 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 4.9 p -122.36 129.08 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.429 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.37 82.46 23.14 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' ASN . 59.4 Cg_endo -79.01 132.99 10.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.666 2.244 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' PRO . 10.5 m-20 -41.29 146.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -88.07 -17.2 31.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.36 -22.24 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.72 -34.65 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.3 -29.63 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.427 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.436 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.493 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.8 pm0 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -72.75 134.12 81.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.887 . . . . 0.0 109.373 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.66 95.19 0.87 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.515 2.143 . . . . 0.0 112.26 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 8' ' ' ALA . 15.4 mt-10 -83.05 -51.43 7.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.502 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 4' ' ' GLU . 12.5 p90 -44.86 -33.65 2.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.969 . . . . 0.0 109.393 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt -75.37 -36.72 60.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 8' ' ' ALA . 8.4 ttmt -104.93 23.43 13.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.212 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -37.55 140.24 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.445 -0.784 . . . . 0.0 109.803 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.559 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 78.48 51.45 5.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.442 ' HZ1' ' HG2' ' A' ' 4' ' ' GLU . 34.4 mttm -61.96 1.43 0.29 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -1.2 . . . . 0.0 109.172 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 9' ' ' GLY . 2.6 mt-10 176.35 138.66 0.21 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.448 -0.783 . . . . 0.0 108.938 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -39.77 125.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.574 2.183 . . . . 0.0 112.223 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.02 -157.18 27.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.53 HD11 ' HZ2' ' A' ' 45' ' ' LYS . 5.8 tt -112.43 133.65 54.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -119.73 157.7 28.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.366 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.568 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.6 mt -134.98 142.59 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.707 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.3 m-90 -149.46 110.69 4.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' VAL . 6.3 ttt180 -89.21 139.41 30.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.88 143.33 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 69.5 tt0 -136.0 111.29 9.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.484 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 26.2 tttp 51.36 43.7 29.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 4.5 t80 73.88 25.72 1.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 20' ' ' GLU . 2.5 m-20 -126.96 111.76 14.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.415 HD23 ' HB3' ' A' ' 5' ' ' PHE . 3.9 tp -58.71 141.57 52.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.494 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 18' ' ' ARG . 73.8 t -138.64 121.42 10.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.185 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.25 115.2 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.34 2.026 . . . . 0.0 112.342 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.72 135.06 23.25 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.139 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 32' ' ' TYR . 31.0 Cg_endo -67.13 97.94 0.43 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.3 2.0 . . . . 0.0 112.183 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 46.9 m -52.19 -24.46 7.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.566 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -19.73 57.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mt -132.2 13.55 4.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.791 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -71.29 -104.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 67.76 -17.09 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 32' ' ' TYR . 18.9 t0 -102.49 140.2 37.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.133 -1.216 . . . . 0.0 109.379 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -129.9 119.79 23.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.107 -0.996 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -76.32 102.78 6.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 113' ' ' TYR . 82.1 p -61.32 -31.59 71.44 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 110.075 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.9 24.53 5.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.582 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 24.8 t0 -143.29 -156.42 0.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -1.124 . . . . 0.0 109.294 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.582 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.6 140.73 31.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -121.87 124.35 43.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.623 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 46.5 t -101.47 115.11 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.074 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -116.14 145.22 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.264 -0.898 . . . . 0.0 109.872 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.4 mp -126.55 151.27 48.12 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HZ2' HD11 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -140.45 93.35 2.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.791 -1.193 . . . . 0.0 110.833 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.599 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 29.9 m -89.88 98.63 11.88 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.53 164.63 2.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.32 -0.862 . . . . 0.0 109.812 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -125.56 127.25 46.09 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.83 -100.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.133 -0.979 . . . . 0.0 109.491 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -140.23 -34.54 0.53 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.176 -0.953 . . . . 0.0 109.549 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -167.54 42.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.372 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.84 -98.24 0.96 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -134.06 -155.44 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -1.181 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.494 HD11 ' N ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -126.47 157.21 39.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.389 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' LYS . 8.7 tt0 -117.36 98.86 6.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.484 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 9.5 m-85 -75.83 123.53 25.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -103.0 147.59 26.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.932 -1.105 . . . . 0.0 108.64 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' HIS . 0.7 OUTLIER -124.66 109.1 12.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.361 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -131.17 116.17 17.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 109.528 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.714 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.87 129.32 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -101.69 127.24 48.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 110.167 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.702 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -129.44 108.93 10.65 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -64.43 20.05 0.1 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.1 t-20 59.54 2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.079 . . . . 0.0 110.016 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 63' ' ' GLY . 17.8 mt-10 -102.29 2.38 36.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.968 -1.083 . . . . 0.0 108.898 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.437 ' SG ' ' CG ' ' A' ' 70' ' ' GLU . 48.1 t -100.72 140.13 35.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -67.28 155.35 39.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.594 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.9 -8.88 24.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.49 -52.1 20.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' CG ' ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -87.57 -37.15 17.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 62' ' ' LEU . 7.6 t -62.5 -60.08 4.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.514 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.53 37.4 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.8 -37.65 6.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.391 -1.064 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.54 -39.16 85.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.202 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.538 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -69.69 -32.82 71.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 109.446 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.13 -43.51 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.42 -40.64 97.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.89 -44.31 32.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.694 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.545 ' N ' ' CG2' ' A' ' 78' ' ' THR . 55.9 t -62.79 -45.77 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 110.214 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 14.7 pt20 -67.62 -50.57 57.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.992 -1.068 . . . . 0.0 110.217 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -62.33 -47.04 85.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.779 -1.201 . . . . 0.0 108.357 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' LEU . 1.6 t0 -45.87 -46.95 16.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.74 -32.16 71.45 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 81' ' ' LEU . 41.6 t80 -69.57 -23.05 63.5 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.448 HD13 ' HB1' ' A' ' 8' ' ' ALA . 46.5 mt -83.08 -62.01 1.71 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.414 -0.803 . . . . 0.0 110.762 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -122.57 -43.19 2.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.995 -1.066 . . . . 0.0 111.293 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.57 6.67 63.93 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -149.52 10.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -1.12 . . . . 0.0 109.906 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -56.0 177.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.46 133.8 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.157 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.502 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 3.1 mp0 -97.63 138.0 35.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 110.193 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.549 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 9.7 m-70 -139.5 129.82 25.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -0.814 . . . . 0.0 109.249 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -113.25 126.02 54.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.985 . . . . 0.0 109.819 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.469 ' OE2' ' O ' ' A' ' 60' ' ' TYR . 2.0 mp0 -127.15 84.56 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' HG22 ' A' ' 95' ' ' VAL . 8.9 p -81.64 37.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 2.0 tt0 70.66 52.66 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.39 -53.39 0.25 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -94.13 55.62 2.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.4 mp0 -78.99 -161.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -138.81 170.87 15.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.48 -30.46 64.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.8 m -66.38 -39.5 89.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.372 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -73.52 -51.1 18.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.36 -0.837 . . . . 0.0 109.491 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.404 ' HA ' HD21 ' A' ' 104' ' ' LEU . 92.3 mt -68.53 -17.52 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.15 -40.65 13.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD1' HD12 ' A' ' 14' ' ' LEU . 1.6 t80 -82.43 -32.72 28.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -1.128 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -101.35 96.46 7.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.464 ' HG3' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -96.87 -63.63 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.173 -0.954 . . . . 0.0 109.402 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.464 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 3.2 m -100.96 11.96 38.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.395 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.495 ' N ' HD23 ' A' ' 111' ' ' LEU . . . -102.98 65.14 0.39 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -147.07 95.05 2.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.316 -1.108 . . . . 0.0 109.0 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.61 114.32 21.01 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.525 ' HB3' HG21 ' A' ' 37' ' ' THR . 1.0 OUTLIER -81.43 107.65 14.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.382 -0.823 . . . . 0.0 109.8 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -111.86 109.03 18.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.313 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -64.44 135.99 56.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.34 132.26 2.53 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 121' ' ' GLY . . . -137.25 101.82 0.36 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 117' ' ' GLY . 57.7 t -43.14 -31.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -1.121 . . . . 0.0 109.457 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.08 -32.17 39.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 117' ' ' GLY . 8.5 t -104.17 6.14 35.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.905 . . . . 0.0 109.414 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 117' ' ' GLY . . . -81.74 -20.89 62.68 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -80.03 -20.89 44.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -1.173 . . . . 0.0 109.446 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -53.62 -53.28 54.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.441 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -99.7 168.59 9.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 109.531 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.97 147.1 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.21 71.86 76.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.452 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.02 150.66 9.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.814 2.343 . . . . 0.0 112.266 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -75.21 141.6 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.519 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -76.6 -26.34 54.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.486 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -65.4 -23.86 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.15 -30.71 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.03 -30.2 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.448 179.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.322 0.582 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.686 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.6 OUTLIER -92.81 -38.8 0.35 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 109.728 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 26.1 Cg_exo -60.04 113.16 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.619 2.213 . . . . 0.0 112.123 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -65.0 -12.87 55.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.446 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -50.92 -22.97 2.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 mt -67.82 -21.65 65.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.546 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -104.86 -56.89 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.437 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 59.47 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.402 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 50.68 27.08 11.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' GLY . 1.6 pttt -42.33 -21.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 109.231 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -130.98 157.99 76.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.53 119.92 7.37 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.7 2.267 . . . . 0.0 112.006 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.19 -150.25 21.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.5 HD12 ' CD2' ' A' ' 106' ' ' TYR . 3.4 tt -132.38 144.81 50.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 0.0 109.591 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.527 HE21 ' N ' ' A' ' 9' ' ' GLY . 24.4 mt-30 -136.61 148.21 47.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.458 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -121.3 138.41 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.593 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.6 m0 -141.98 111.0 6.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.45 HH22 HG12 ' A' ' 25' ' ' VAL . 3.6 ttt-85 -71.45 135.85 47.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.49 143.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -0.997 . . . . 0.0 109.426 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 89.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.311 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 63.38 28.56 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER 71.03 16.98 6.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 24' ' ' LEU . 73.0 m-20 -99.83 -14.29 18.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.6 mt 57.25 136.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.45 HG12 HH22 ' A' ' 18' ' ' ARG . 47.3 t -142.72 115.73 6.21 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.74 143.83 6.09 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.362 2.041 . . . . 0.0 112.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.44 125.02 81.89 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.45 111.84 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.487 2.125 . . . . 0.0 112.148 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.2 m -63.83 -25.51 68.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -45.71 -41.11 10.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.306 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.31 -54.98 2.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CZ ' HD11 ' A' ' 16' ' ' ILE . 14.4 t80 55.62 95.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.353 -0.842 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.49 -31.03 4.76 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.4 m-20 -89.93 128.37 36.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -1.119 . . . . 0.0 109.191 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.698 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.27 167.92 22.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.915 . . . . 0.0 109.777 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CD1' ' OH ' ' A' ' 41' ' ' TYR . 3.9 m-85 -85.14 154.91 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.346 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.434 HG22 HE21 ' A' ' 96' ' ' GLN . 5.0 p -95.14 -9.44 33.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.528 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.0 26.79 22.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.09 -162.13 1.32 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -1.163 . . . . 0.0 109.324 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.35 141.08 33.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 22.2 m-85 -128.79 122.51 30.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.359 -0.838 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.6 t -96.57 141.65 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.437 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.71 146.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 109.363 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 mp -129.71 131.63 46.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.685 . . . . 0.0 109.586 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -114.53 94.19 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.596 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 7.6 m -77.24 101.77 6.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.323 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.449 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -99.14 164.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -126.47 117.44 22.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.6 -0.688 . . . . 0.0 109.274 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.4 mt -54.29 -92.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -140.31 -38.0 0.46 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.28 -0.887 . . . . 0.0 109.677 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -174.49 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.91 -82.9 1.2 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -145.44 160.28 41.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -1.177 . . . . 0.0 109.468 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.449 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -99.56 167.35 10.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.387 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -137.96 134.8 35.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.805 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.596 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 11.7 m-85 -92.82 128.8 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 108.824 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CG ' ' NE2' ' A' ' 59' ' ' HIS . 34.8 t0 -91.09 116.3 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 108.92 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.0 mp -81.76 126.53 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.692 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.72 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 27.5 m-70 -142.44 108.53 5.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.112 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.713 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.42 129.17 50.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.022 . . . . 0.0 108.961 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.698 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 6.0 t90 -96.71 129.56 44.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.375 -0.828 . . . . 0.0 110.03 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.706 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.1 mt -134.44 106.34 7.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.7 9.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.706 ' H ' ' C ' ' A' ' 62' ' ' LEU . 4.7 t-20 69.23 1.22 3.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -1.091 . . . . 0.0 109.607 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -113.65 12.59 18.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.48 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 3.0 p -97.86 134.6 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.537 -0.727 . . . . 0.0 109.406 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 66' ' ' CYS . 1.3 m -43.65 152.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.18 -20.69 57.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.152 -0.967 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -68.59 -35.06 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -87.03 -28.63 22.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -64.32 -60.05 3.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 0.0 109.385 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.76 -46.49 91.76 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -46.6 -43.71 17.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -1.116 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.59 50.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 109.036 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.499 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -58.42 -20.09 41.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 108.89 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mm -81.59 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.33 -0.856 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.3 -26.8 68.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 108.446 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 37.5 m -76.78 -50.59 13.15 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.682 -0.636 . . . . 0.0 109.382 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.51 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 87.1 t -67.89 -36.36 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.834 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -66.07 -58.84 4.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.633 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -55.04 -46.48 75.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.935 -1.103 . . . . 0.0 109.193 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -47.64 -47.41 29.24 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.741 -1.224 . . . . 0.0 108.145 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.7 t70 -63.01 -24.44 67.92 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.633 ' N ' ' O ' ' A' ' 81' ' ' LEU . 37.0 t80 -78.13 -23.71 47.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 36.1 mt -83.35 -53.94 5.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.232 -0.917 . . . . 0.0 109.777 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -122.0 -42.37 2.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.184 -0.948 . . . . 0.0 110.094 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.16 -8.42 8.52 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.403 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 59.8 mtt-85 -144.07 -84.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -1.099 . . . . 0.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 88' ' ' ARG . . . 68.11 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.586 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.59 149.85 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.66 143.08 45.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.293 -0.879 . . . . 0.0 109.912 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.72 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 36.2 m-70 -142.39 121.91 13.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.468 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 15.7 ptt180 -108.9 121.24 44.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 96' ' ' GLN . 6.5 mp0 -112.52 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.45 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.434 HE21 HG22 ' A' ' 37' ' ' THR . 13.1 tt0 66.29 53.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.544 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 99' ' ' GLU . . . 162.78 -53.23 0.3 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -77.28 30.67 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.503 ' OE2' HD23 ' A' ' 104' ' ' LEU . 7.7 mt-10 -59.81 150.83 27.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.8 t -99.88 162.69 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.46 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.4 m -63.65 -62.71 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.364 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.559 ' CE1' ' CD2' ' A' ' 107' ' ' PHE . 69.4 t80 -54.69 -37.0 65.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.407 -0.808 . . . . 0.0 109.491 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.503 HD23 ' OE2' ' A' ' 99' ' ' GLU . 98.3 mt -71.84 -22.67 61.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.5 -30.16 46.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.5 ' CD2' HD12 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -85.81 -41.38 15.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.559 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 96.8 m-85 -105.11 76.15 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.508 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.9 -30.89 11.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -98.82 8.73 44.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -101.88 -111.06 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 110' ' ' GLY . 72.7 mt 44.52 96.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.272 -1.134 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -155.4 110.55 3.01 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 107.85 16.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.392 -0.818 . . . . 0.0 109.587 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -103.84 108.83 20.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -65.24 134.05 52.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 109.468 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.33 176.8 14.54 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 120' ' ' SER . . . -152.33 117.11 0.79 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 117' ' ' GLY . 73.8 t -43.15 -65.15 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -1.124 . . . . 0.0 109.454 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.413 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -50.24 -25.97 4.22 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.497 -0.752 . . . . 0.0 109.493 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 117' ' ' GLY . 3.5 t -75.4 6.18 4.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.414 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -49.4 -40.38 30.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -72.91 -26.3 61.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -1.145 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -72.39 -33.23 67.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -143.56 117.9 9.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.45 147.12 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 t -138.06 110.95 8.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 109.365 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 128' ' ' ASN . 78.3 Cg_exo -45.93 133.66 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.389 2.059 . . . . 0.0 112.335 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 127' ' ' PRO . 2.0 m120 -43.12 147.71 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.25 -22.93 59.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 t -52.63 -37.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.29 -36.35 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.19 -27.4 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.503 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.417 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.592 ' OE2' ' ND1' ' A' ' 2' ' ' HIS . 1.1 tm-20 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.592 ' ND1' ' OE2' ' A' ' 1' ' ' GLU . 6.4 m170 52.92 63.76 8.13 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.41 111.61 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.809 2.339 . . . . 0.0 112.151 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -80.53 -28.86 37.25 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' CD2' ' A' ' 5' ' ' PHE . 7.2 t80 -53.83 -22.94 10.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -79.63 -8.43 59.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.568 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 8' ' ' ALA . 15.4 mtmm -125.16 -53.16 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.608 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 58.86 150.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.153 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.526 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 43.13 40.81 4.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.45 ' HZ3' ' HB2' ' A' ' 10' ' ' LYS . 18.7 mtmm -42.06 -28.14 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.419 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.554 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -145.64 149.05 38.87 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.249 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -39.85 123.01 1.15 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.628 2.219 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 -168.04 34.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' LEU . 7.2 tt -120.65 129.54 53.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -1.018 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.526 HE21 ' N ' ' A' ' 9' ' ' GLY . 20.9 mt-30 -124.4 163.96 20.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.594 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.2 mt -136.42 137.02 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 109.778 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.594 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.2 m0 -141.6 131.36 24.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.458 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 25' ' ' VAL . 59.9 ttp180 -95.24 144.88 25.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.898 . . . . 0.0 109.599 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.428 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 0.4 OUTLIER -108.45 143.38 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.2 tp10 -130.04 91.5 3.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.5 tttp 78.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.606 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 77' ' ' PHE . 10.5 t80 -160.8 16.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.909 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -127.47 114.89 18.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 109.716 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.8 mp -59.6 149.0 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ARG . 60.5 t -154.1 118.29 2.67 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.11 152.16 0.66 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.455 2.104 . . . . 0.0 112.199 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -102.13 132.78 21.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.481 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -42.42 136.79 3.99 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.536 2.157 . . . . 0.0 112.353 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -70.2 -28.42 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.335 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -60.68 -40.33 91.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' O ' ' C ' ' A' ' 32' ' ' TYR . 7.8 mp -76.85 -55.46 5.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.862 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 31' ' ' LEU . 9.9 t80 35.4 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.522 -0.736 . . . . 0.0 109.928 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 115.28 -31.45 6.21 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.23 120.48 27.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -1.186 . . . . 0.0 109.189 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.684 ' CD1' ' CH2' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.67 168.49 21.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 110.043 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' GLY . 22.6 m-85 -86.29 106.95 17.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 109.276 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -46.93 -10.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . -91.05 19.09 48.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.56 -164.65 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -1.175 . . . . 0.0 109.394 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.4 140.61 37.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.663 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -131.05 164.18 25.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.818 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.437 HG12 ' HG1' ' A' ' 78' ' ' THR . 2.1 t -138.6 131.34 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.875 . . . . 0.0 109.407 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.407 HD12 HG21 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -115.94 145.62 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.296 -0.878 . . . . 0.0 109.648 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.84 147.99 45.27 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -145.69 93.34 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.027 -1.046 . . . . 0.0 110.297 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.611 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 32.1 m -88.58 108.52 19.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.491 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.53 163.9 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.297 -0.877 . . . . 0.0 108.95 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -67.58 157.8 33.56 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.612 0.72 . . . . 0.0 110.657 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 52' ' ' GLY . 2.9 mp -69.47 -34.13 73.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.551 -0.718 . . . . 0.0 109.52 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.434 ' H ' ' HG2' ' A' ' 50' ' ' ARG . 15.7 mmp_? -46.87 -34.13 5.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 108.95 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -76.85 -21.58 54.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.503 -0.748 . . . . 0.0 109.068 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 146.0 65.0 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 54' ' ' LEU . 3.8 t-20 62.18 139.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -1.177 . . . . 0.0 109.721 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.474 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.3 pp -41.42 128.39 3.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.444 -0.785 . . . . 0.0 108.944 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -124.69 102.31 7.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.147 -0.971 . . . . 0.0 110.765 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.611 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 6.9 m-85 -82.08 109.47 16.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' HB3' ' HZ1' ' A' ' 45' ' ' LYS . 21.8 t0 -83.45 148.66 27.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.978 -1.076 . . . . 0.0 108.551 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.488 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -130.18 125.9 36.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -137.01 108.91 7.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 109.575 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.705 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.54 114.29 25.01 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 108.558 179.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.684 ' CH2' ' CD1' ' A' ' 35' ' ' PHE . 68.8 t90 -86.69 118.38 26.06 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.358 -0.839 . . . . 0.0 109.688 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.653 ' C ' ' H ' ' A' ' 64' ' ' ASN . 1.0 OUTLIER -123.2 105.92 10.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.55 -0.719 . . . . 0.0 109.097 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 64' ' ' ASN . . . -56.58 1.19 0.11 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.653 ' H ' ' C ' ' A' ' 62' ' ' LEU . 13.4 t-20 70.3 1.65 3.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.509 -0.995 . . . . 0.0 109.731 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -111.88 15.05 20.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 108.896 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.3 t -105.62 145.99 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 109.622 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.2 t -55.36 156.96 3.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.05 -26.45 48.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.184 -0.947 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -41.15 78.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.696 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 19' ' ' VAL . 33.4 tt0 -87.32 -42.66 12.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 t -57.71 -54.05 51.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.728 . . . . 0.0 109.512 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.52 -53.42 43.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.49 -39.27 7.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.462 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.33 86.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.179 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.7 -32.6 74.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.384 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.72 -48.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.802 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 22' ' ' PHE . 1.5 m-85 -62.75 -42.45 99.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.955 . . . . 0.0 109.372 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -68.73 -41.82 78.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.51 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 78' ' ' THR . 52.0 t -73.03 -61.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.438 -0.789 . . . . 0.0 110.02 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -56.87 -59.63 4.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.912 . . . . 0.0 110.06 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.5 tm? -51.82 -47.71 64.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.147 . . . . 0.0 108.937 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 81' ' ' LEU . 3.1 t0 -46.85 -48.69 20.95 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.876 -1.14 . . . . 0.0 108.496 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.24 -31.67 65.77 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' A' ' 81' ' ' LEU . 38.5 t80 -70.81 -23.67 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.11 -59.37 2.8 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -122.21 -42.4 2.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.343 -0.848 . . . . 0.0 110.14 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 -21.5 6.66 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.7 mtp85 -138.2 -85.5 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -1.114 . . . . 0.0 109.296 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.33 176.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.71 150.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -123.88 140.25 53.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -0.873 . . . . 0.0 109.818 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.506 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 11.5 m-70 -137.59 137.99 39.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 109.204 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 ptp180 -120.24 124.83 46.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -119.6 94.66 4.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.184 -0.948 . . . . 0.0 109.539 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.3 37.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 61.4 105.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.462 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 103.01 -36.29 4.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -107.2 32.09 4.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.8 mp0 -70.39 -177.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 p -110.6 168.02 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.358 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -69.65 -32.73 71.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.6 m -60.83 -57.65 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.094 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 40.4 t80 -53.91 -48.94 69.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.494 -0.754 . . . . 0.0 109.259 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.94 -24.36 64.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 109.042 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -60.68 -50.34 68.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 107' ' ' PHE . 22.2 m-85 -69.29 -44.32 72.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -134.29 86.81 2.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.169 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.492 ' O ' HD21 ' A' ' 111' ' ' LEU . 2.0 pttt -89.3 -63.84 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.463 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 2.0 t -105.86 9.81 32.71 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.527 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.37 63.16 0.28 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.704 ' O ' ' CB ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -137.81 -115.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.189 -1.183 . . . . 0.0 108.858 179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.704 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 6.6 tptm 138.28 121.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.476 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 1.8 p90 -103.22 107.98 19.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.472 -0.768 . . . . 0.0 109.524 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -101.93 120.54 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -53.8 132.92 42.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.495 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.03 -123.48 2.23 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.53 17.27 60.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.12 -53.48 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -1.163 . . . . 0.0 109.556 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.4 -32.11 64.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.381 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.8 m -101.38 6.15 42.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.77 -28.04 71.4 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -66.24 -29.81 70.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -1.135 . . . . 0.0 109.458 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.48 -3.34 36.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -66.13 86.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.412 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.7 t -69.75 146.99 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 75.7 t -155.34 88.25 3.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 128' ' ' ASN . 52.7 Cg_exo -49.06 166.17 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.626 2.217 . . . . 0.0 112.252 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 127' ' ' PRO . 84.2 m-20 -39.87 109.69 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.625 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -50.75 -25.67 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.496 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.3 t -50.67 -25.24 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.373 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.74 -47.69 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.477 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.5 -31.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.478 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.586 ' O ' ' ND1' ' A' ' 2' ' ' HIS . 23.4 tt0 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.586 ' ND1' ' O ' ' A' ' 1' ' ' GLU . 2.8 m-70 -141.77 65.68 20.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.154 -0.966 . . . . 0.0 109.424 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.59 59.76 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.755 2.303 . . . . 0.0 112.348 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.01 -30.97 27.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.377 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -48.37 -31.81 6.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.8 mm? -82.41 -29.6 30.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -64.8 -31.12 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.55 161.35 30.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.363 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.37 53.21 46.11 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 20.2 mtpp -142.16 -8.68 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 63.9 mt-10 -158.52 149.69 16.47 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.409 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.82 170.34 20.59 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.627 2.218 . . . . 0.0 112.173 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.66 -137.2 13.9 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.3 142.17 35.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -1.127 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.536 ' O ' HG21 ' A' ' 43' ' ' ILE . 3.7 mp0 -127.54 146.93 50.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.274 -0.891 . . . . 0.0 109.343 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.545 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 24.8 mt -117.63 135.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.72 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.8 m0 -141.84 110.85 6.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -83.09 131.31 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.543 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.95 143.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.353 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -152.81 111.85 3.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.2 ttmt 46.77 31.62 1.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.416 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.1 m-85 68.61 51.38 0.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 24' ' ' LEU . 66.5 m-20 -127.17 -24.54 3.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.3 mt 57.92 130.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -149.54 134.6 9.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.164 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.08 124.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.345 2.03 . . . . 0.0 112.289 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 t -60.09 114.77 10.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.374 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.33 123.89 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.327 2.018 . . . . 0.0 112.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.1 m -59.43 -23.71 62.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -49.18 -47.38 46.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.175 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 7.1 mp -92.01 -55.05 3.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.5 t80 44.95 89.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.567 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.63 3.3 8.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.22 143.19 27.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.154 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -140.3 123.04 16.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 109.921 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.2 m-30 -83.6 102.97 12.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.533 HG23 ' HH2' ' A' ' 61' ' ' TRP . 30.4 p -57.21 87.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 177.86 -29.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.06 -154.89 0.55 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.388 -1.066 . . . . 0.0 108.943 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.96 141.98 32.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.402 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 22.8 m-85 -115.82 124.37 50.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.787 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.83 118.51 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.841 . . . . 0.0 108.904 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -118.91 144.91 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.072 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.563 HD23 ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -121.95 151.43 40.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -143.9 94.65 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.093 -1.005 . . . . 0.0 110.392 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.615 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 1.2 m -87.49 114.67 24.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.471 -0.768 . . . . 0.0 109.288 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -92.09 164.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.44 ' NE2' ' ND2' ' A' ' 51' ' ' ASN . 11.4 pt20 -58.29 157.71 8.16 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.581 0.705 . . . . 0.0 110.558 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.8 mp -71.73 -38.28 70.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.33 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 49' ' ' LEU . 62.1 mtt85 -43.54 -33.52 1.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.316 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.531 ' N ' HD21 ' A' ' 51' ' ' ASN . 1.1 m120 -76.73 -27.21 55.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 109.162 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 153.55 61.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' C ' ' A' ' 54' ' ' LEU . 6.6 t-20 60.21 149.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -1.134 . . . . 0.0 109.426 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.508 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -39.36 114.59 0.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 108.951 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.69 ' HB3' HG22 ' A' ' 47' ' ' VAL . 49.1 tt0 -104.46 92.84 4.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.304 -0.873 . . . . 0.0 110.235 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.615 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 0.3 OUTLIER -79.0 116.72 19.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 109.073 179.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -100.13 119.74 38.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.608 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 7.8 tt -110.64 133.85 52.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.985 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.607 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -152.63 133.78 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.358 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.723 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -100.6 126.08 47.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 0.0 108.775 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.533 ' HH2' HG23 ' A' ' 37' ' ' THR . 77.5 t90 -92.54 134.62 34.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.629 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.3 mt -137.39 118.59 14.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.448 -0.783 . . . . 0.0 109.208 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' CA ' ' CH2' ' A' ' 61' ' ' TRP . . . -69.39 25.14 0.35 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 62' ' ' LEU . 59.5 t30 58.86 6.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.442 -1.034 . . . . 0.0 110.089 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 63' ' ' GLY . 19.7 mt-10 -110.38 10.93 23.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 109.143 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.2 t -105.09 146.1 29.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.682 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 t -85.9 170.4 12.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.463 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -69.16 -16.34 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 1.2 t70 -61.48 -58.31 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -87.85 -35.82 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.8 t -70.4 -60.61 2.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.577 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -52.79 -43.33 60.31 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.44 -52.04 63.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -1.162 . . . . 0.0 109.501 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.7 -47.69 63.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.288 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.547 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -61.8 -22.98 65.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 109.232 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -83.92 -55.84 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -61.36 -34.75 75.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.381 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -75.13 -43.81 50.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.872 . . . . 0.0 109.74 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 75' ' ' ALA . 27.9 t -63.62 -55.96 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.846 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.3 -59.62 5.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.591 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.9 OUTLIER -53.11 -48.45 67.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.031 -1.043 . . . . 0.0 108.927 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 78' ' ' THR . 10.0 t0 -45.64 -45.02 13.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.103 -0.998 . . . . 0.0 108.807 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.28 -30.86 71.92 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 17.7 t80 -79.1 -22.92 44.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.2 tp -83.91 -47.7 10.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.333 -0.855 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -122.0 -41.92 2.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 110.025 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.86 -20.56 40.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' ALA . 3.6 ptt180 -136.55 -80.88 0.39 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.386 -1.067 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 88' ' ' ARG . . . 41.89 -155.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.328 -0.858 . . . . 0.0 109.388 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -146.44 133.31 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.589 ' O ' ' NE2' ' A' ' 91' ' ' GLN . 3.0 pp0? -118.85 115.84 25.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.702 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -120.8 159.61 25.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.725 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' HE ' ' CD1' ' A' ' 62' ' ' LEU . 42.3 ttt180 -110.52 130.05 55.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.892 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' A' ' 96' ' ' GLN . 2.5 mm-40 -115.32 86.2 2.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.058 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.52 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.1 t -68.29 37.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.599 ' H ' ' C ' ' A' ' 94' ' ' GLU . 5.1 tm0? 48.82 103.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.496 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.91 -52.37 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 98' ' ' PHE . 60.0 t80 -108.77 31.29 5.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -1.043 . . . . 0.0 109.234 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 98' ' ' PHE . 4.1 mt-10 -53.18 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.391 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.7 t -115.85 170.51 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.93 65.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.1 m -68.56 -53.93 19.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 14.1 t80 -62.0 -39.18 91.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.8 mt -72.36 -36.36 68.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.583 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.81 -37.3 94.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.82 -50.52 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.515 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -103.43 61.95 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -84.75 -29.45 25.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -99.6 1.85 44.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.65 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.54 -109.18 2.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 110' ' ' GLY . 16.9 mt 53.34 100.6 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -144.13 100.86 3.63 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.78 108.04 15.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.875 . . . . 0.0 109.574 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -119.41 140.7 49.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 109.362 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -54.16 145.58 16.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.46 -2.61 90.64 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.37 128.27 9.42 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.17 -18.83 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 109.51 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.5 -23.41 6.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.554 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 t -76.91 6.22 6.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.934 . . . . 0.0 109.411 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.99 -47.25 39.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -51.23 -26.25 6.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -1.143 . . . . 0.0 109.443 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -73.38 -38.12 65.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -99.7 88.88 3.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.506 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 2.9 t -89.77 122.91 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.451 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 126' ' ' VAL . 69.4 t -155.51 82.28 3.83 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.82 133.27 11.24 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.773 2.315 . . . . 0.0 112.325 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.67 ' N ' ' ND2' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -63.8 150.22 45.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.526 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 131' ' ' VAL . 1.5 pp20? -88.05 -21.89 24.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 109.552 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 p -47.04 -16.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 129' ' ' GLU . 61.4 t -68.57 -40.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.55 -29.42 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.521 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 2.2 mp0 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.7 m80 52.65 82.95 0.23 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.539 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.4 -16.59 13.48 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.629 2.219 . . . . 0.0 112.208 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -64.13 -39.47 94.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.382 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' CG ' HD22 ' A' ' 24' ' ' LEU . 29.0 t80 -72.79 -32.93 65.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 tp -55.23 -21.94 16.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.896 . . . . 0.0 109.299 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.527 ' O ' ' O ' ' A' ' 8' ' ' ALA . 41.9 mttt -98.17 -55.83 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.379 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.91 134.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.631 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 56.98 54.2 38.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -63.4 0.42 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -1.086 . . . . 0.0 109.404 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 9' ' ' GLY . 11.6 pt-20 -176.44 150.72 1.02 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -39.89 126.29 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.639 2.226 . . . . 0.0 112.1 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.63 -158.5 27.78 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.8 141.81 51.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -1.062 . . . . 0.0 109.652 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.405 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 2.4 mm100 -127.84 156.64 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.247 -0.908 . . . . 0.0 109.35 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.9 mp -131.36 137.0 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.204 -0.935 . . . . 0.0 109.961 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.2 m-90 -144.9 113.41 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 0.0 109.32 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.404 HH11 ' CG ' ' A' ' 39' ' ' ASP . 46.2 ttt180 -80.98 140.03 35.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.0 143.18 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' PHE . 14.0 mm-40 -146.15 112.3 5.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.091 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 20.4 ttpp 57.86 -76.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.339 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 6.8 m-85 -175.83 33.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.318 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.7 t70 -127.31 -1.64 6.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 109.803 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.504 HD22 ' CG ' ' A' ' 5' ' ' PHE . 4.4 tp 59.25 146.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 109.312 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.1 t -154.39 111.41 2.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.652 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.42 147.38 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.44 2.093 . . . . 0.0 112.173 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' THR . 6.8 p -76.93 133.34 69.66 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.102 -0.999 . . . . 0.0 109.394 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -41.27 89.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.527 2.151 . . . . 0.0 112.292 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 27' ' ' VAL . 24.4 m -51.74 -26.55 9.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.407 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.63 HD21 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -51.34 -43.46 61.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.408 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.6 mt -93.86 -54.19 3.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.299 -0.875 . . . . 0.0 109.639 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 65.47 100.44 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 123.67 -27.32 5.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -65.84 139.71 58.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.333 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 33' ' ' GLY . 73.7 m-85 -143.6 143.03 31.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.846 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.61 103.27 15.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.06 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 39' ' ' ASP . 15.0 p -54.89 -45.26 74.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.808 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.19 10.13 0.29 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 37' ' ' THR . 3.4 m-20 -133.73 -156.24 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -1.173 . . . . 0.0 109.283 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.44 140.91 25.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 109.689 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 15.3 m-85 -123.83 146.21 48.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.825 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.83 116.09 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.168 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.439 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -112.37 142.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.252 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -122.3 145.25 48.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.568 -0.707 . . . . 0.0 109.891 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -125.47 93.21 3.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.499 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 86.2 m -73.86 106.76 5.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -107.02 164.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -121.78 137.0 54.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.414 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.94 -101.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -140.08 -34.01 0.56 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.45 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -171.49 36.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.34 -79.05 0.27 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.591 ' ND2' ' H ' ' A' ' 54' ' ' LEU . 9.0 t30 -152.06 -165.13 2.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -1.133 . . . . 0.0 109.514 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.591 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -130.45 164.97 23.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 109.369 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -134.1 144.8 48.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 2.3 m-85 -100.89 118.91 37.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 108.848 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.488 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 3.5 m-20 -77.81 120.39 22.64 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.5 OUTLIER -97.11 122.61 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.0 110.087 -178.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -138.24 110.98 7.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.44 129.94 35.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 108.95 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.34 111.49 23.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.659 ' C ' ' H ' ' A' ' 64' ' ' ASN . 1.1 mt -116.1 105.62 12.81 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -65.98 14.54 0.29 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.659 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 62.64 1.87 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 109.783 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.6 mt-10 -103.46 4.17 35.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.091 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 67' ' ' SER . 45.6 t -103.41 122.08 44.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.573 ' C ' ' H ' ' A' ' 69' ' ' ASP . 69.6 m -43.02 126.16 3.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.43 -8.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 67' ' ' SER . 10.9 t0 -68.24 -43.38 78.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.613 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -87.35 -33.52 19.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.416 ' OG ' HD22 ' A' ' 62' ' ' LEU . 5.7 t -57.77 -56.61 19.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.84 82.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.81 -48.13 50.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.257 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.13 96.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.159 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.423 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -63.2 -20.59 65.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.01 -57.44 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 109.99 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -61.28 -32.91 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.334 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.76 -44.01 51.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.147 -0.971 . . . . 0.0 109.588 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.531 ' N ' ' CG2' ' A' ' 78' ' ' THR . 45.2 t -69.93 -52.52 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.9 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -60.92 -59.52 5.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.721 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.1 tm? -53.29 -48.66 68.16 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.98 -1.075 . . . . 0.0 108.66 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 89' ' ' ALA . 4.4 t0 -44.89 -45.82 10.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.111 -0.993 . . . . 0.0 108.801 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.28 -31.93 72.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 81' ' ' LEU . 11.5 t80 -77.06 -23.17 52.0 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.492 HD21 ' O ' ' A' ' 7' ' ' LYS . 3.6 tp -82.89 -51.35 7.7 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.279 -0.888 . . . . 0.0 109.902 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -122.4 -42.05 2.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.255 -0.903 . . . . 0.0 109.985 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.03 -15.51 16.04 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.7 mtp-105 -144.52 -85.29 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.435 -1.039 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 56.58 156.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.647 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.454 ' C ' ' NE2' ' A' ' 91' ' ' GLN . 17.7 t -91.54 150.23 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.147 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.454 ' NE2' ' C ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -134.7 122.95 22.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.0 110.137 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.637 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -136.42 159.98 40.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.302 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -121.12 144.59 48.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.954 . . . . 0.0 109.931 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 96' ' ' GLN . 4.9 mm-40 -115.1 85.29 2.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.4 t -71.89 37.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.695 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.525 ' H ' ' C ' ' A' ' 94' ' ' GLU . 1.7 tt0 58.14 118.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.51 -35.9 4.66 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -113.58 45.0 1.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -1.137 . . . . 0.0 109.436 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -71.04 178.93 2.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 m -101.14 160.13 14.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.0 109.441 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.39 65.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.489 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.7 m -71.77 -52.98 14.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -61.2 -37.69 83.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 109.594 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mt -72.19 -27.85 62.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.542 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.58 -25.21 39.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.87 -14.34 29.84 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.187 -1.184 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -134.88 93.81 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.637 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -78.19 -63.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -92.16 9.87 31.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.236 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.498 ' C ' HD11 ' A' ' 111' ' ' LEU . . . -80.46 56.97 4.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.498 HD11 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.71 92.03 2.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.471 -1.017 . . . . 0.0 109.218 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 35' ' ' PHE . 25.1 tttt -130.02 108.6 10.22 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.653 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -82.19 107.88 15.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.999 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -108.03 108.54 19.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 108.901 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.82 109.99 1.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.29 61.2 1.47 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.37 33.94 5.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -94.59 -34.33 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -1.111 . . . . 0.0 109.376 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -82.54 -25.48 33.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.6 m -71.22 6.02 1.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.817 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -60.63 -27.49 66.31 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -83.8 -27.28 28.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -1.133 . . . . 0.0 109.526 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -57.8 -30.11 65.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.447 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -89.36 94.78 10.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.334 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.5 138.16 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.92 113.16 5.56 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.485 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 57.3 Cg_exo -46.89 153.29 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 127' ' ' PRO . 35.4 m-80 -165.67 102.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.538 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.1 -25.41 59.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.69 -20.21 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.29 -23.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.817 . . . . 0.0 109.609 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.2 t -51.72 -32.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.439 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -141.18 70.93 27.88 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.462 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.57 5.84 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.705 2.27 . . . . 0.0 112.271 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -52.46 -15.63 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.359 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 24' ' ' LEU . 46.9 t80 -63.29 -28.84 70.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.469 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -62.42 -23.24 66.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.402 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 8' ' ' ALA . 5.6 mptp? -94.82 -60.98 1.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 109.443 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 59.08 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.386 -0.821 . . . . 0.0 109.324 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.562 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 42.2 43.55 4.61 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' GLY . 2.4 pttm -45.56 -23.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' GLY . 11.2 pt-20 -146.48 149.98 39.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -39.78 123.58 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.679 2.252 . . . . 0.0 112.223 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.4 -167.7 31.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.17 147.03 40.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -1.024 . . . . 0.0 109.555 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.562 HE21 ' N ' ' A' ' 9' ' ' GLY . 17.2 mt-30 -141.98 151.58 42.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.05 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -128.81 135.86 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -141.94 110.58 6.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.501 ' CD ' ' CZ ' ' A' ' 41' ' ' TYR . 21.4 ttp180 -79.77 139.02 37.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.386 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.69 142.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.91 . . . . 0.0 109.352 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -159.62 97.09 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.441 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 12.2 ttmm 63.74 25.86 14.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.394 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.2 m-85 70.09 14.64 7.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.614 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' LEU . 9.8 t70 -98.29 -15.27 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' ASP . 1.9 mp 59.84 136.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.02 127.06 12.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.865 . . . . 0.0 109.012 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.57 126.05 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.29 1.993 . . . . 0.0 112.364 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.41 134.78 81.7 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.52 130.26 16.95 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.401 2.067 . . . . 0.0 112.145 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' ASN . 20.5 m -60.0 -26.37 66.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 29' ' ' THR . 57.1 t30 -44.17 -38.84 3.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.974 . . . . 0.0 109.229 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 32' ' ' TYR . 42.2 mt -108.81 -55.15 2.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.481 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 31' ' ' LEU . 6.2 t80 47.92 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.451 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 123.73 -30.74 4.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.597 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 15.3 m-20 -80.88 146.55 30.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.238 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 m-85 -146.1 152.22 38.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 0.0 109.843 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.546 ' CE1' ' O ' ' A' ' 116' ' ' GLY . 0.5 OUTLIER -90.27 104.55 17.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.089 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.6 p -59.07 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.94 -30.66 0.06 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 19.6 t0 -107.44 -152.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.505 -0.997 . . . . 0.0 108.725 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.446 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -137.48 140.46 41.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.501 ' CZ ' ' CD ' ' A' ' 18' ' ' ARG . 18.8 m-85 -117.72 124.93 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.4 130.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -123.46 145.95 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -124.85 133.24 53.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 55' ' ' GLN . 12.0 ttpt -129.91 94.0 3.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.006 . . . . 0.0 110.031 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.613 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 64.5 m -84.99 106.75 16.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.22 164.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.356 -0.84 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -60.79 157.76 14.28 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.538 0.685 . . . . 0.0 110.627 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 52' ' ' GLY . 2.7 mp -67.97 -34.8 77.24 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 49' ' ' LEU . 36.1 mtp180 -42.84 -34.21 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.223 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -78.3 -28.1 47.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.855 . . . . 0.0 109.174 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 152.65 67.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' C ' ' A' ' 54' ' ' LEU . 8.3 t-20 58.98 150.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -1.121 . . . . 0.0 109.48 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.499 ' C ' ' O ' ' A' ' 53' ' ' ASN . 14.2 mt -39.95 113.73 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.927 . . . . 0.0 108.787 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.1 tt0 -105.31 96.59 6.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.054 -1.029 . . . . 0.0 110.513 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.613 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 27.8 m-85 -76.61 109.65 10.53 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.513 ' OD1' ' NE2' ' A' ' 59' ' ' HIS . 22.6 t0 -83.61 126.97 33.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.977 -1.077 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 82' ' ' ASP . 4.0 mp -97.19 119.82 36.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.69 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 18.7 m-70 -134.1 108.76 8.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.705 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.66 119.58 39.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.422 ' CZ3' ' CB ' ' A' ' 35' ' ' PHE . 78.1 t90 -96.41 126.51 41.65 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 110.243 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.723 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.9 mt -122.52 109.39 14.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -59.3 10.32 0.03 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.723 ' H ' ' C ' ' A' ' 62' ' ' LEU . 28.9 t30 67.45 1.79 2.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -108.32 11.29 27.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.549 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.4 t -104.45 146.02 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 m -77.38 164.88 25.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.616 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -68.96 -8.87 48.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -68.87 -56.11 8.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -87.22 -38.86 15.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 t -58.62 -56.04 27.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.482 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.91 50.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.29 -36.38 4.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -1.178 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.49 70.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.322 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.546 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -68.4 -33.63 74.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mt -79.57 -44.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.821 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.5 -40.24 96.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.984 -1.072 . . . . 0.0 109.452 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -76.34 -45.03 34.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.548 ' N ' ' CG2' ' A' ' 78' ' ' THR . 49.9 t -61.72 -54.33 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.797 . . . . 0.0 110.143 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.572 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 12.0 pt20 -62.56 -50.55 70.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 110.143 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.615 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -59.82 -51.26 70.48 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.745 -1.222 . . . . 0.0 108.647 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.582 ' OD2' ' ND2' ' A' ' 86' ' ' ASN . 3.1 t0 -43.76 -43.47 6.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.004 -1.06 . . . . 0.0 108.358 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.08 -36.77 80.53 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.6 t80 -73.19 -23.6 60.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 tt -81.38 -52.2 7.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.254 -0.904 . . . . 0.0 109.961 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.582 ' ND2' ' OD2' ' A' ' 82' ' ' ASP . 2.2 p30 -122.12 -42.33 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.112 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.18 -10.65 26.77 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -149.96 -81.1 0.12 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -1.083 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.89 170.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.9 t -97.99 150.16 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.241 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.445 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 7.1 pt20 -113.62 147.86 37.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 0.0 109.953 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.69 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 27.0 m-70 -146.23 122.78 11.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.473 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 23.7 ptt85 -111.5 118.75 36.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.821 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.6 mp0 -114.82 100.16 8.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.273 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 2.2 t -87.12 37.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.65 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 24.8 tt0 72.04 107.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 93.31 -29.81 7.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -97.38 37.57 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 1.1 mp0 -63.25 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.9 m -131.57 -169.97 2.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -61.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 98.5 m -55.45 -37.33 67.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -67.46 -45.96 74.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.63 -10.35 59.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.46 -39.06 8.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.26 -33.92 37.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.54 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -103.4 107.18 17.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -99.38 -12.54 20.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.1 m -53.43 -36.1 61.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.53 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 93.59 35.9 6.04 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.613 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.2 mm? 53.71 103.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -95.4 119.09 33.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -81.96 107.73 14.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.843 . . . . 0.0 109.645 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -115.84 108.57 16.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.233 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -60.84 112.31 1.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.499 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.546 ' O ' ' CE1' ' A' ' 36' ' ' PHE . . . -128.05 144.41 15.2 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.04 -27.68 14.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.87 -33.32 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.423 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.63 -35.1 63.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.501 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.1 m -111.11 6.12 20.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.64 -26.37 65.42 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -80.55 -22.71 40.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -1.207 . . . . 0.0 109.483 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 124' ' ' HIS . 28.4 tttp -76.7 -30.42 56.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.879 . . . . 0.0 109.53 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.472 ' O ' ' O ' ' A' ' 123' ' ' LYS . 17.7 m-70 -53.22 -170.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.337 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -96.43 146.69 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.7 t -92.55 114.79 63.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 75.9 Cg_exo -45.24 143.03 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.424 2.083 . . . . 0.0 112.19 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 12.6 m-20 -44.32 169.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -80.07 -21.72 43.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.3 t -47.15 -33.93 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.05 -43.92 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.406 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.98 -27.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.405 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 4' ' ' GLU . 5.6 t-80 44.96 65.31 6.49 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.71 75.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.894 2.396 . . . . 0.0 112.31 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 2' ' ' HIS . 29.4 mt-10 -61.52 -29.5 70.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.129 -0.982 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -47.38 -35.11 7.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.079 -1.013 . . . . 0.0 109.429 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.7 mm? -84.61 -21.87 30.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.273 -0.892 . . . . 0.0 109.42 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 4' ' ' GLU . 12.1 tttm -69.34 -32.81 72.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.19 142.54 54.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.54 44.47 4.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -107.5 -23.24 12.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -1.098 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -152.14 150.99 26.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.868 . . . . 0.0 109.275 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.19 172.37 16.14 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.605 2.203 . . . . 0.0 112.314 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.47 -125.63 8.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.461 HD12 ' CD1' ' A' ' 106' ' ' TYR . 4.0 tt -137.11 146.87 45.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.733 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.431 ' O ' HG21 ' A' ' 43' ' ' ILE . 17.1 mt-30 -137.29 139.46 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.608 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 8.7 mt -111.3 145.2 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.938 . . . . 0.0 109.885 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.7 m0 -148.76 110.74 4.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' VAL . 3.4 tmm_? -85.92 131.44 34.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.187 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.3 143.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.164 -0.96 . . . . 0.0 110.111 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 22' ' ' PHE . 30.3 tt0 -144.46 124.69 13.74 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 24.0 tttp 60.99 -74.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.958 . . . . 0.0 109.016 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' GLU . 10.7 m-85 -168.57 19.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 109.877 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.99 111.27 13.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.11 -0.994 . . . . 0.0 109.693 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mp -48.99 159.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.362 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ARG . 48.0 t -153.6 90.79 3.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.605 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.32 127.17 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.722 2.281 . . . . 0.0 112.207 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -106.83 133.63 20.19 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 109.383 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -41.11 93.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.542 2.161 . . . . 0.0 112.318 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.434 ' OG1' ' CD1' ' A' ' 16' ' ' ILE . 28.0 m -71.38 -12.12 61.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.521 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -77.21 -23.62 51.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.616 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 31' ' ' LEU . 10.4 tp -136.25 13.53 3.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.256 -0.903 . . . . 0.0 109.605 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -56.63 -96.77 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.16 -0.963 . . . . 0.0 109.833 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 64.73 11.48 49.67 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' OD2' ' C ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -161.84 147.01 13.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -1.081 . . . . 0.0 108.985 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.488 ' CE2' ' CH2' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -146.4 161.04 41.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.918 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.553 ' H ' ' HH ' ' A' ' 41' ' ' TYR . 3.0 m-85 -77.29 158.57 30.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 108.964 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 39' ' ' ASP . 8.3 p -107.13 -30.26 8.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.673 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.36 20.46 5.97 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 37' ' ' THR . 17.3 m-20 -139.43 -157.39 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -1.066 . . . . 0.0 109.312 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.83 140.8 31.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.553 ' HH ' ' H ' ' A' ' 36' ' ' PHE . 34.1 m-85 -119.44 121.91 40.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.574 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.56 130.82 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -129.54 139.87 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.651 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.83 145.18 43.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -130.84 93.77 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.094 -1.004 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.632 ' OG1' ' CE1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -78.05 106.01 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.95 164.92 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.405 -0.809 . . . . 0.0 109.407 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 49' ' ' LEU . 30.8 tt0 -120.37 101.56 7.87 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.664 -0.648 . . . . 0.0 109.288 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 48' ' ' GLN . 14.1 mt -43.22 -86.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 109.377 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -140.21 -43.53 0.42 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.328 -0.857 . . . . 0.0 109.502 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -174.62 26.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.287 -0.883 . . . . 0.0 109.266 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.96 -95.66 2.36 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -118.62 -163.45 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.368 -1.078 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.477 HD11 ' N ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -124.94 168.48 13.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 109.443 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.5 tt0 -131.36 113.64 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.744 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.632 ' CE1' ' OG1' ' A' ' 46' ' ' THR . 0.5 OUTLIER -86.89 110.29 19.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 108.954 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 1.1 m-20 -88.47 119.15 28.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.012 -1.055 . . . . 0.0 108.84 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.51 HD11 ' O ' ' A' ' 58' ' ' LEU . 3.1 pp -96.81 131.46 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.844 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.573 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -135.35 127.88 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.538 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.65 114.84 29.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.096 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.566 ' CD1' ' CZ ' ' A' ' 103' ' ' PHE . 32.1 t90 -93.21 117.39 30.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 109.468 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.652 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.4 mt -117.69 118.53 32.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 108.994 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -67.78 21.5 0.26 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.652 ' H ' ' C ' ' A' ' 62' ' ' LEU . 10.5 t30 57.01 1.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.019 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.539 ' H ' ' C ' ' A' ' 63' ' ' GLY . 15.8 mm-40 -111.71 10.16 20.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 0.0 108.539 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.0 p -98.46 146.07 26.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.621 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 t -67.39 154.86 40.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.414 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -75.84 -9.02 58.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.657 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.32 -45.73 45.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.686 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -87.3 -35.77 18.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.303 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 t -58.7 -53.53 57.35 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.495 -0.753 . . . . 0.0 109.458 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.68 42.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.7 -38.71 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.655 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.11 83.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.511 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -67.93 -41.81 82.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.11 -39.43 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.31 -47.15 85.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.104 -0.998 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -75.54 -42.24 52.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 75' ' ' ALA . 54.1 t -62.38 -49.06 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.937 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -65.26 -59.85 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.875 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -56.03 -43.83 78.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 0.0 108.587 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 78' ' ' THR . 6.9 t70 -47.3 -46.98 25.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.139 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.49 -28.79 70.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 81' ' ' LEU . 45.9 t80 -75.02 -24.37 58.34 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.64 -54.59 6.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.428 ' OD1' ' C ' ' A' ' 86' ' ' ASN . 22.5 t-20 -122.07 -42.03 2.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.939 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.48 1.95 24.52 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.9 mtm-85 -155.13 -78.27 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.425 -1.044 . . . . 0.0 109.263 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 55.7 178.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.59 146.84 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.63 140.09 38.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.424 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 52.9 m-70 -138.78 119.36 13.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.554 ' HE ' ' CG2' ' A' ' 95' ' ' VAL . 35.8 ttt180 -103.95 126.59 51.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 109.273 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 96' ' ' GLN . 12.7 mp0 -127.27 78.67 1.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.948 . . . . 0.0 109.802 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.554 ' CG2' ' HE ' ' A' ' 93' ' ' ARG . 2.1 t -78.68 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.116 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' A' ' 94' ' ' GLU . 0.9 OUTLIER 42.28 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 98' ' ' PHE . . . 156.36 -35.5 0.6 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 97' ' ' GLY . 2.3 m-85 -135.88 54.68 1.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -1.077 . . . . 0.0 109.276 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.595 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 28.3 mt-10 -71.56 171.49 11.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.562 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 t -110.95 178.92 4.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.394 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -67.74 -26.37 66.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.594 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 m -63.39 -62.9 1.38 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.32 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD1' ' OE2' ' A' ' 99' ' ' GLU . 36.9 t80 -54.6 -41.98 70.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.69 -26.25 61.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.92 . . . . 0.0 109.384 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -63.95 -44.27 96.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.461 ' CD1' HD12 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -76.22 -50.96 13.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -1.114 . . . . 0.0 109.319 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.72 71.68 9.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -88.77 -40.78 12.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -105.7 8.03 32.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -90.18 -107.95 1.31 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.5 mm? 53.42 101.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.346 -1.091 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -166.07 95.96 0.59 Allowed 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.641 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -82.42 107.76 15.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.5 -0.75 . . . . 0.0 109.45 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -112.07 118.05 34.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.04 136.55 55.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 118' ' ' VAL . . . -93.76 0.4 67.4 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.73 -1.7 2.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.522 ' H ' ' C ' ' A' ' 116' ' ' GLY . 94.0 t -64.12 -13.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.147 . . . . 0.0 109.462 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -51.48 -27.58 10.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.4 t -66.85 6.19 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -55.11 -24.31 35.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -69.4 -29.95 67.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -1.183 . . . . 0.0 109.473 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -59.5 -33.42 71.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -67.94 164.53 19.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.45 146.65 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.9 83.97 31.11 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 53.6 Cg_exo -48.45 149.82 6.36 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.74 2.293 . . . . 0.0 112.237 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 18.4 m120 -42.86 166.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -87.67 -28.58 21.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.406 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -48.55 -32.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 t -50.15 -60.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -73.93 -27.77 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.951 . . . . 0.0 109.587 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.488 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.487 ' OE2' ' O ' ' A' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.586 ' O ' ' N ' ' A' ' 4' ' ' GLU . 19.6 m-70 -144.77 75.17 14.61 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.91 75.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.863 2.375 . . . . 0.0 112.169 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 2' ' ' HIS . 31.8 tt0 -79.56 -45.62 18.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.452 ' CG ' HD13 ' A' ' 24' ' ' LEU . 39.2 t80 -45.99 -23.28 0.28 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -66.28 -35.35 80.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.233 -0.917 . . . . 0.0 109.247 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 8' ' ' ALA . 47.8 mttt -103.94 -45.31 4.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.519 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 58.54 135.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.509 -0.745 . . . . 0.0 109.643 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 50.73 53.57 25.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -58.02 -0.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.17 . . . . 0.0 109.361 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.584 ' H ' ' C ' ' A' ' 9' ' ' GLY . 9.8 pt-20 -170.04 149.15 3.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.49 122.05 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.682 2.255 . . . . 0.0 112.252 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.78 -156.4 27.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.5 144.76 49.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.531 HE21 ' H ' ' A' ' 9' ' ' GLY . 24.3 mt-30 -138.53 150.49 46.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.228 -0.92 . . . . 0.0 109.676 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.2 mt -119.05 137.58 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 0.0 109.779 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.7 m0 -142.27 110.82 6.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.3 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.03 137.73 37.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.588 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.58 143.28 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 0.0 109.496 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -155.77 88.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 tttm 65.53 33.85 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.492 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' N ' ' A' ' 22' ' ' PHE . 1.3 m-85 66.2 17.16 10.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 24' ' ' LEU . 55.7 m-20 -102.65 -14.89 16.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.7 mt 57.43 144.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 109.633 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.2 t -154.15 110.25 2.46 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.363 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.83 112.9 0.55 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.388 2.058 . . . . 0.0 112.164 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.549 HG11 ' O ' ' A' ' 27' ' ' VAL . 13.1 p -47.52 133.61 10.32 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -40.91 101.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.509 2.139 . . . . 0.0 112.325 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.5 m -59.0 -25.65 63.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -50.42 -47.29 56.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -88.17 -54.98 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.85 . . . . 0.0 109.444 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.0 t80 55.54 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 109.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.26 17.08 3.35 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -117.28 144.46 44.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -1.172 . . . . 0.0 109.358 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.581 ' N ' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -146.14 133.92 21.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.773 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 38' ' ' GLY . 26.6 m-85 -92.14 103.03 15.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.059 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' A' ' 37' ' ' THR . 16.3 p -52.19 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.643 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . 177.96 -29.43 0.07 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.464 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 4.0 p30 -107.93 -154.3 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.369 -1.077 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.15 141.07 34.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.464 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.464 ' CE2' ' OD1' ' A' ' 39' ' ' ASP . 88.5 m-85 -116.52 122.04 43.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.24 114.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.463 ' HB ' ' ND1' ' A' ' 59' ' ' HIS . 1.8 mt -114.58 145.95 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.551 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 1.1 mp -123.0 143.6 49.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.797 -0.565 . . . . 0.0 109.566 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 55' ' ' GLN . 5.0 ttmm -127.23 94.17 3.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.672 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.62 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 43.0 m -81.2 110.96 17.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -94.12 164.36 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -54.11 158.0 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.695 0.76 . . . . 0.0 110.803 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.5 mp -67.52 -33.66 75.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.547 -0.721 . . . . 0.0 109.44 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LEU . 2.3 mtm180 -44.87 -38.7 4.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.359 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.53 -23.24 61.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.191 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 146.01 64.87 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.699 HD21 ' N ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER 57.99 153.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.275 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.699 ' N ' HD21 ' A' ' 53' ' ' ASN . 11.8 mt -36.4 107.0 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 108.815 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 45' ' ' LYS . 3.4 tt0 -100.59 98.85 9.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.101 -1.0 . . . . 0.0 110.422 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.62 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 29.6 m-85 -80.75 109.58 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 35.9 t0 -76.33 140.8 41.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 108.684 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 2.1 mm? -107.48 103.12 12.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.845 . . . . 0.0 109.546 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.68 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -122.24 112.19 17.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.72 125.99 48.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -98.79 132.38 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.871 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.664 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.8 mt -134.88 115.41 13.59 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -65.85 17.79 0.19 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.664 ' H ' ' C ' ' A' ' 62' ' ' LEU . 23.8 t30 63.12 1.91 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 109.887 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 63' ' ' GLY . 9.8 mm-40 -106.06 10.33 32.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 109.242 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.11 131.85 46.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.442 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 t -49.74 157.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -75.69 -11.83 60.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.4 p30 -79.24 -40.39 30.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 36.2 tt0 -87.33 -33.81 19.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.286 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.5 t -68.11 -60.41 2.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.54 -39.0 29.27 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -58.07 -56.89 16.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -1.156 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.44 -40.88 19.14 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.118 -0.988 . . . . 0.0 109.028 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -70.64 -21.39 62.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.347 -0.846 . . . . 0.0 109.024 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.6 mm -84.51 -49.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -61.88 -36.58 81.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 109.322 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.29 -46.02 29.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.625 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.571 ' N ' ' CG2' ' A' ' 78' ' ' THR . 55.0 t -64.39 -52.38 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.96 -59.55 4.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.648 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.591 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.1 tm? -52.71 -48.85 66.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 108.764 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 81' ' ' LEU . 6.1 t70 -44.8 -45.93 10.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.565 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.71 -33.85 73.5 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 5.5 t80 -74.68 -23.43 58.63 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.471 HD11 ' HB1' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -80.22 -52.93 7.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.564 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 86' ' ' ASN . 3.1 t-20 -122.1 -42.01 2.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.12 -14.88 21.11 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -145.54 -72.9 0.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -1.036 . . . . 0.0 109.245 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.1 -171.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 109.472 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.84 150.15 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.389 -0.819 . . . . 0.0 109.391 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.562 ' OE1' ' N ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -108.33 133.0 53.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.716 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.591 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 12.4 m-70 -139.74 124.39 18.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.405 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 7.9 ptm180 -110.0 132.37 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 109.688 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.595 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 2.7 mt-10 -130.47 91.71 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.18 37.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 56.45 90.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.46 -32.04 2.52 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -125.12 56.86 1.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.445 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -85.72 167.55 15.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.6 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -100.28 161.01 13.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.47 77.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -62.23 -60.66 3.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 51.1 t80 -52.76 -38.8 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.463 -0.773 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 104' ' ' LEU . 85.0 mt -69.29 -26.17 64.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.62 55.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -43.59 60.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.391 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.436 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 88.8 m-85 -106.33 76.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.551 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -100.8 -35.86 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -91.14 -3.31 57.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -91.09 -107.69 1.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 110' ' ' GLY . 85.0 mt 53.37 100.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.36 -1.083 . . . . 0.0 109.527 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.554 ' HZ3' ' NZ ' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -151.67 90.97 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.85 107.72 14.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.516 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.554 ' NZ ' ' HZ3' ' A' ' 112' ' ' LYS . 22.4 mttm -112.37 108.92 18.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 5.5 ptpp? -63.61 127.07 29.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.19 -51.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.51 75.95 0.21 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.92 -12.05 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 0.0 109.498 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.44 -25.3 50.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 109.511 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.9 t -88.66 6.14 39.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.33 -0.856 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.89 71.5 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -53.57 -26.39 21.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -1.154 . . . . 0.0 109.503 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -57.71 -23.23 50.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -70.68 72.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.6 t -70.16 122.76 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.531 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.67 98.58 38.0 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 129' ' ' GLU . 58.9 Cg_endo -79.09 162.5 25.97 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.463 2.108 . . . . 0.0 112.253 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -59.09 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 127' ' ' PRO . 37.9 tt0 -88.07 -17.23 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 133' ' ' GLN . 9.4 p -57.13 -42.75 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.454 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 12.9 p -46.95 -30.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.461 ' O ' ' NE2' ' A' ' 133' ' ' GLN . 15.0 t -71.66 -27.77 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 130' ' ' VAL . 85.1 mm-40 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.463 ' C ' ' CG ' ' A' ' 2' ' ' HIS . 27.6 tp10 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.345 0.593 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 2' ' ' HIS . 0.2 OUTLIER 61.88 149.15 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.421 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.26 76.91 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.705 2.27 . . . . 0.0 112.242 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -68.81 -26.03 64.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.887 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 6' ' ' LEU . 41.1 p90 -63.57 -31.3 72.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.334 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 49.7 tp -49.78 -29.41 7.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.341 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.526 ' O ' ' O ' ' A' ' 8' ' ' ALA . 27.4 mttm -102.4 -61.11 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.526 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.91 137.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.749 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 47.39 38.55 13.32 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -42.74 -23.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -1.167 . . . . 0.0 109.62 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' GLY . 34.0 mm-40 -143.79 153.67 58.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -41.65 122.84 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.76 2.306 . . . . 0.0 112.341 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.38 -167.09 33.92 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.501 ' C ' ' CD2' ' A' ' 14' ' ' LEU . 6.7 tt -124.3 124.0 41.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -1.081 . . . . 0.0 109.217 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.749 HE21 ' N ' ' A' ' 9' ' ' GLY . 15.3 mt-30 -115.08 150.05 36.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 109.575 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.607 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.8 OUTLIER -123.6 140.45 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.792 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.607 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.9 m-90 -144.89 111.78 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -79.93 146.01 32.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.707 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.0 143.31 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.11 -0.994 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.9 tp10 -142.9 95.05 2.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.438 -0.789 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.544 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.6 tptp 71.6 40.26 0.81 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.298 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 2.4 m-85 72.82 21.43 3.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.656 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 22' ' ' PHE . 1.4 m-20 -127.31 111.5 13.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.36 137.47 57.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.6 t -144.0 121.16 6.6 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.895 . . . . 0.0 109.283 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -44.08 148.06 1.19 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.271 1.981 . . . . 0.0 112.513 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -92.41 134.21 28.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.186 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -39.15 108.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -61.17 -29.11 69.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -46.77 -41.93 16.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.344 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.437 HD23 ' OD1' ' A' ' 34' ' ' ASP . 13.3 mt -91.22 -53.13 4.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.22 -0.925 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.3 t80 50.26 91.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 16.44 3.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.607 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 1.3 m-20 -128.96 135.7 49.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -1.155 . . . . 0.0 109.159 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 1.9 m-85 -146.07 161.26 40.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -85.3 145.49 27.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.324 -0.86 . . . . 0.0 109.173 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 p -89.9 -22.37 22.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.94 -15.87 69.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.548 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -103.75 -161.51 0.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -1.103 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.548 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -134.53 140.88 46.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.6 148.44 43.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.456 -0.777 . . . . 0.0 109.772 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.444 HG13 ' HG1' ' A' ' 78' ' ' THR . 2.3 t -122.76 138.19 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 109.347 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 mt -136.39 146.32 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.467 HD23 ' HB3' ' A' ' 8' ' ' ALA . 4.1 mp -127.15 124.21 38.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.64 -0.662 . . . . 0.0 109.572 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -105.26 93.99 4.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.658 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.596 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 5.7 m -79.28 109.85 14.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -104.34 164.76 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.211 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -97.19 107.12 19.58 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.542 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.3 mt -56.78 -92.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.216 -0.927 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.419 ' HG3' HH21 ' A' ' 50' ' ' ARG . 44.1 mtt85 -102.68 -63.38 1.17 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.227 -0.92 . . . . 0.0 109.614 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -172.32 24.91 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.527 -0.733 . . . . 0.0 109.149 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -148.79 -64.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.004 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.647 HD22 HD22 ' A' ' 86' ' ' ASN . 4.0 t30 -87.4 155.26 20.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -1.154 . . . . 0.0 109.736 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.512 HD21 ' C ' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -118.92 175.89 5.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.837 . . . . 0.0 109.182 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.406 ' O ' HG22 ' A' ' 47' ' ' VAL . 27.7 tt0 -133.14 112.61 11.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.053 -1.029 . . . . 0.0 109.89 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.596 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 18.8 m-85 -90.69 129.17 36.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 15.9 m-20 -95.11 126.6 40.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 108.964 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.517 HD11 ' OG1' ' A' ' 78' ' ' THR . 4.1 mm? -86.99 102.54 14.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.727 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.716 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 23.7 m-70 -116.9 108.67 16.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 0.0 109.567 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.708 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.37 124.21 49.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -0.983 . . . . 0.0 108.686 179.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -95.92 128.78 43.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.147 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.726 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -129.7 106.4 8.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.57 16.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.726 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 61.27 1.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.734 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 63' ' ' GLY . 40.0 mt-10 -104.88 5.82 33.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.98 . . . . 0.0 109.083 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.8 t -101.61 129.16 47.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.546 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 t -51.16 144.39 9.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.444 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -64.62 -8.7 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -73.58 -44.78 56.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -86.86 -37.98 17.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.301 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.6 t -60.08 -51.8 68.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.45 -0.781 . . . . 0.0 109.379 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.51 -40.5 69.86 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -57.0 -55.15 38.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.64 44.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.123 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.509 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -70.15 -20.28 63.16 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.2 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.5 mm -84.42 -49.19 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.35 -33.45 76.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.976 . . . . 0.0 109.373 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.536 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -77.85 -43.78 29.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.536 ' N ' ' CG2' ' A' ' 78' ' ' THR . 53.1 t -68.09 -44.32 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -66.13 -59.62 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -54.45 -45.32 73.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.986 -1.071 . . . . 0.0 108.538 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.469 ' OD2' ' HB1' ' A' ' 89' ' ' ALA . 3.5 t0 -47.16 -48.01 23.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 108.607 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.0 -30.58 70.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 81' ' ' LEU . 16.9 t80 -78.43 -23.1 46.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 7' ' ' LYS . 3.8 tp -83.94 -49.91 8.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.263 -0.898 . . . . 0.0 109.921 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.647 HD22 HD22 ' A' ' 53' ' ' ASN . 13.5 t-20 -122.3 -42.21 2.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.204 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.71 -19.86 20.9 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -140.97 -68.78 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -1.056 . . . . 0.0 109.351 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.469 ' HB1' ' OD2' ' A' ' 82' ' ' ASP . . . 54.63 -169.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.858 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.06 150.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.326 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -107.73 129.42 55.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.814 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.716 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 24.0 m-70 -135.88 113.5 10.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.276 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.473 HH21 ' HB2' ' A' ' 93' ' ' ARG . 19.6 ttp-105 -107.63 125.53 51.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.751 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.593 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 22.2 mt-10 -122.21 89.03 3.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -85.92 37.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -0.875 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 53.9 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.02 -64.99 0.3 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 21.0 m-85 -122.89 49.25 1.67 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.4 -1.059 . . . . 0.0 109.338 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.5 mp0 -51.61 170.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.62 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -87.07 165.44 15.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -29.54 57.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.5 m -65.86 -50.2 65.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.109 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 38.9 t80 -63.48 -48.81 76.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.431 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 108' ' ' LYS . 29.8 mt -63.81 -38.38 90.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.174 -0.953 . . . . 0.0 109.305 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -69.77 -38.16 76.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.238 -1.154 . . . . 0.0 109.26 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -124.27 50.97 1.62 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.421 -0.799 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 110' ' ' GLY . 2.8 tptm -78.15 -28.99 48.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 m -59.51 0.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.75 110.31 2.68 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.588 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -74.48 -104.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -1.165 . . . . 0.0 109.301 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tptp 179.1 113.0 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 109.156 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.02 107.71 19.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.79 . . . . 0.0 109.416 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -110.53 128.02 55.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.284 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -77.47 156.05 31.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.245 -0.91 . . . . 0.0 109.613 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.33 115.27 3.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 178.5 -38.34 0.08 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.5 t -55.58 -31.01 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -1.112 . . . . 0.0 109.3 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.19 -28.87 31.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.331 -0.855 . . . . 0.0 109.414 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.1 m -78.49 6.06 9.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.7 -19.89 69.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -76.49 -29.53 56.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -1.162 . . . . 0.0 109.369 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 124' ' ' HIS . 38.1 mttp -74.09 -2.66 25.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.464 ' CE1' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER 54.29 101.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 109.468 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.74 115.16 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.464 ' CG2' ' CE1' ' A' ' 124' ' ' HIS . 21.1 t -142.11 72.79 22.55 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.29 165.17 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.842 2.361 . . . . 0.0 112.144 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -140.39 35.99 1.87 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.29 -26.39 65.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.421 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.72 -35.85 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.9 -39.56 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.13 -30.09 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.49 179.914 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.324 0.583 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.603 ' C ' ' H ' ' A' ' 4' ' ' GLU . 3.8 m-70 -129.99 90.26 43.11 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 4' ' ' GLU . 52.5 Cg_exo -49.09 -1.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.677 2.251 . . . . 0.0 112.278 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.603 ' H ' ' C ' ' A' ' 2' ' ' HIS . 59.1 mm-40 -43.32 -44.87 5.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.394 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -48.42 -40.96 27.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.406 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.6 mm? -78.75 -24.86 44.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.347 -0.845 . . . . 0.0 109.342 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -65.12 -31.7 73.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.22 -0.925 . . . . 0.0 109.307 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' CB ' ' CH2' ' A' ' 17' ' ' TRP . . . -74.19 113.5 11.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.314 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.49 ' H ' HE22 ' A' ' 15' ' ' GLN . . . 99.32 49.01 1.62 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -140.24 -14.09 1.02 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -155.01 148.05 18.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.0 109.298 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.49 170.81 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.648 2.232 . . . . 0.0 112.252 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.9 -163.03 12.67 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 106' ' ' TYR . 3.5 tt -110.86 117.06 32.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -1.07 . . . . 0.0 109.598 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.49 HE22 ' H ' ' A' ' 9' ' ' GLY . 27.1 mt-30 -96.63 157.32 15.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.393 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mt -143.87 113.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 17' ' ' TRP . 8.2 p90 -140.76 137.09 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 0.0 109.113 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -90.04 146.43 24.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.81 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.19 143.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.174 -0.954 . . . . 0.0 109.316 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ASP . 24.2 tt0 -150.52 103.86 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.529 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 44.43 35.82 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.905 . . . . 0.0 109.461 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.3 m-85 68.76 26.89 5.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.633 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.9 t70 -109.42 -20.27 12.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' ASP . 2.3 mp 59.63 138.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.57 128.79 5.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.044 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.78 125.39 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.249 1.966 . . . . 0.0 112.041 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.68 132.9 84.92 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.13 127.41 3.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.7 m -65.98 -25.71 67.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.26 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -53.3 -50.14 65.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.359 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.549 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 6.7 mp -78.0 -55.37 5.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.155 -0.966 . . . . 0.0 109.365 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' O ' ' A' ' 31' ' ' LEU . 34.6 t80 46.91 91.82 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.536 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.88 -30.96 4.69 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -51.81 146.26 8.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.049 -1.266 . . . . 0.0 109.102 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 112' ' ' LYS . 28.6 m-85 -137.77 120.14 15.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.014 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.84 107.43 17.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 108.896 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 p -70.86 87.61 0.72 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.672 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.65 -30.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -112.45 -152.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.927 . . . . 0.0 108.625 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.76 140.11 45.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.002 . . . . 0.0 109.617 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -112.72 124.82 53.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.265 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' A' ' 78' ' ' THR . 74.8 t -102.99 119.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -118.97 146.21 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.246 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.459 HD12 ' CZ2' ' A' ' 17' ' ' TRP . 1.5 mp -126.2 152.91 45.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 0.0 109.482 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -140.53 93.83 2.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.161 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.614 ' OG1' ' CE1' ' A' ' 56' ' ' TYR . 1.2 m -88.49 111.42 21.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -0.812 . . . . 0.0 109.212 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.32 164.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.762 . . . . 0.0 109.092 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.437 HE21 ' HA ' ' A' ' 51' ' ' ASN . 34.7 tt0 -104.51 119.23 38.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.549 -0.719 . . . . 0.0 109.443 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.6 mt -74.32 -99.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 51' ' ' ASN . 83.3 mtt180 -88.72 -63.37 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.713 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.437 ' HA ' HE21 ' A' ' 48' ' ' GLN . 51.8 m-20 -168.54 23.21 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.414 -0.804 . . . . 0.0 109.326 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.71 -52.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -70.69 144.99 50.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -133.52 168.25 18.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 109.297 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -134.42 104.42 6.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 110.489 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.614 ' CE1' ' OG1' ' A' ' 46' ' ' THR . 0.8 OUTLIER -77.95 123.37 26.71 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.092 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.585 ' OD2' ' CD2' ' A' ' 92' ' ' HIS . 3.8 t0 -103.23 122.08 44.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.033 . . . . 0.0 108.494 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 10.4 mp -94.78 143.18 26.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.44 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -149.1 108.42 3.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.65 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.04 115.22 28.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 108.857 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.459 ' CE2' HD13 ' A' ' 111' ' ' LEU . 26.8 t90 -90.13 126.79 35.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.359 -0.838 . . . . 0.0 109.991 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.683 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.9 mt -122.6 108.02 12.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -63.44 15.7 0.1 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.683 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.1 t-20 62.53 1.9 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -1.083 . . . . 0.0 109.962 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 63' ' ' GLY . 9.7 mm-40 -106.01 8.99 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.0 . . . . 0.0 109.12 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.1 t -104.36 141.03 37.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 m -57.24 146.87 26.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -64.23 -26.75 68.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.02 -32.07 72.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -87.22 -45.16 10.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.295 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -53.34 -49.76 66.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -59.68 -48.27 86.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -46.0 -43.53 14.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -1.122 . . . . 0.0 109.24 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.42 -56.09 19.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.41 -20.5 30.35 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.366 -0.834 . . . . 0.0 108.935 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -82.42 -59.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.269 -0.894 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -63.18 -25.28 68.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.893 . . . . 0.0 108.716 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.45 ' OG1' ' CG2' ' A' ' 42' ' ' VAL . 5.3 m -75.91 -50.4 15.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.627 -0.671 . . . . 0.0 109.535 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.6 t -73.65 -27.81 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -71.56 -59.78 2.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.647 ' O ' ' N ' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -58.64 -46.96 85.97 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.986 -1.071 . . . . 0.0 108.414 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.549 ' OD2' ' CB ' ' A' ' 89' ' ' ALA . 5.4 t70 -47.22 -45.75 23.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 13.5 t70 -61.66 -27.85 68.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.647 ' N ' ' O ' ' A' ' 81' ' ' LEU . 20.4 t80 -74.85 -23.85 58.49 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.9 mt -83.88 -54.11 5.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.841 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.479 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.1 OUTLIER -121.71 -42.36 2.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 109.994 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.408 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . 126.11 -44.28 1.27 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.448 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 52.7 mtt85 -112.34 -85.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' CB ' ' OD2' ' A' ' 82' ' ' ASP . . . 71.69 150.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.64 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.57 150.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -122.95 130.26 52.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 109.891 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.585 ' CD2' ' OD2' ' A' ' 57' ' ' ASP . 20.0 m-70 -124.99 129.46 50.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -107.32 126.86 52.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 109.86 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 100.54 7.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.411 HG11 HD21 ' A' ' 64' ' ' ASN . 2.3 t -96.49 38.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 1.8 tt0 52.23 80.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.1 -62.34 0.37 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -94.94 60.78 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.471 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -67.04 159.4 28.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 m -91.82 170.03 10.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.95 -61.06 1.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -48.91 -47.94 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 109.251 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 21.7 t80 -55.07 -49.52 71.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.63 -16.26 62.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.31 -31.88 26.92 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.417 ' CE2' HD21 ' A' ' 14' ' ' LEU . 2.5 t80 -82.45 -34.59 28.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.681 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -105.21 113.86 27.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 109.722 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -103.99 -12.49 16.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.9 p -53.27 -29.63 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 109.459 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 87.09 40.62 6.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 2.8 mm? 52.01 102.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.095 -1.238 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 35' ' ' PHE . 4.2 tmtm? -94.23 117.53 30.25 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -81.81 107.77 14.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 0.0 109.736 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -107.98 108.83 20.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.478 ' O ' ' CG2' ' A' ' 118' ' ' VAL . 14.3 mptt -57.38 117.76 4.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.63 -178.76 46.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.84 18.11 79.75 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 115' ' ' LYS . 2.1 t -81.71 -20.5 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -1.173 . . . . 0.0 109.521 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -46.48 -25.66 0.72 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.202 -0.936 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.3 m -72.17 6.13 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.584 ' O ' ' CG ' ' A' ' 124' ' ' HIS . . . -69.84 -51.48 24.26 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -50.26 -26.53 4.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -1.167 . . . . 0.0 109.428 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -72.98 2.92 6.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.405 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.584 ' CG ' ' O ' ' A' ' 121' ' ' GLY . 0.1 OUTLIER -75.15 167.13 22.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.518 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -103.54 120.88 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.65 113.39 59.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.386 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.473 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 61.0 Cg_endo -78.72 125.78 6.96 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.167 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.473 ' CG ' ' O ' ' A' ' 127' ' ' PRO . 15.9 m-20 -175.36 64.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.12 -17.28 62.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.01 -23.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.77 -26.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.11 -27.84 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.525 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.458 ' ND1' ' N ' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -142.36 65.86 18.55 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 0.0 109.569 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 7' ' ' LYS . 48.9 Cg_exo -51.84 -29.64 35.34 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.77 2.314 . . . . 0.0 112.052 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.492 ' HA ' ' H ' ' A' ' 8' ' ' ALA . 12.7 pt-20 -56.99 -29.36 63.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 5' ' ' PHE . 3.8 t80 -66.79 -44.19 81.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tp -89.66 -19.26 25.08 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' O ' ' O ' ' A' ' 8' ' ' ALA . 35.3 mttm -108.45 -61.37 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.621 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.64 133.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.528 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 56.3 44.66 89.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' GLY . 38.2 mttp -42.57 -22.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -1.066 . . . . 0.0 109.418 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' GLY . 33.3 mt-10 -152.87 152.95 29.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -39.68 120.09 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.665 2.243 . . . . 0.0 112.15 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.97 -162.08 32.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -126.55 143.22 51.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -1.05 . . . . 0.0 109.678 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.528 HE21 ' H ' ' A' ' 9' ' ' GLY . 25.5 mt-30 -137.52 156.17 48.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.591 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -126.49 137.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.0 109.808 -179.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.4 m0 -142.59 111.08 6.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.293 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.67 146.13 44.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.148 -0.97 . . . . 0.0 109.501 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 40' ' ' ALA . 1.6 t -80.29 143.91 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.0 109.39 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 21' ' ' LYS . 6.6 tp10 -159.18 109.6 1.99 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.448 -0.783 . . . . 0.0 109.461 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 20' ' ' GLU . 19.3 mttp 41.54 41.11 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 55.78 45.95 23.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 24' ' ' LEU . 25.7 t0 -126.47 -19.38 4.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 23' ' ' ASP . 9.6 mp 57.2 123.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.64 122.18 10.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.142 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.22 139.6 3.97 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.386 2.057 . . . . 0.0 112.501 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.16 127.89 93.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -40.16 101.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.476 2.118 . . . . 0.0 112.346 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 m -49.41 -27.43 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.376 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.38 -41.94 14.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.212 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.98 -53.86 2.84 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 t80 51.51 91.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . 123.5 -22.35 7.0 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.592 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 11.1 m-20 -92.53 147.74 22.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -1.206 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 9.1 m-85 -145.68 150.44 36.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.95 . . . . 0.0 109.749 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 38' ' ' GLY . 67.9 m-85 -87.48 109.83 19.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.168 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 114' ' ' LYS . 16.6 p -60.28 87.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 179.02 -29.79 0.06 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.2 t0 -107.52 -153.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -1.058 . . . . 0.0 108.873 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -139.41 147.91 42.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 11.9 m-85 -128.54 141.1 51.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.585 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.439 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 47.1 t -115.8 128.18 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.581 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 44' ' ' LEU . 1.6 mt -123.14 146.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.25 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.442 HD21 ' HD2' ' A' ' 56' ' ' TYR . 3.8 mp -124.58 151.86 44.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -142.8 93.77 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 109.95 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.618 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 94.6 m -85.6 117.24 24.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.738 . . . . 0.0 109.615 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.86 164.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.276 -0.89 . . . . 0.0 109.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -125.64 110.8 14.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.565 -0.709 . . . . 0.0 109.154 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -52.3 -91.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.234 -0.916 . . . . 0.0 109.418 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 51' ' ' ASN . 0.9 OUTLIER -140.23 -38.03 0.46 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.179 -0.951 . . . . 0.0 109.54 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 14.1 t30 -173.7 30.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -0.85 . . . . 0.0 109.365 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.47 -97.13 2.31 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -125.44 -165.33 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -1.16 . . . . 0.0 109.509 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.13 161.12 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.796 . . . . 0.0 109.305 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -125.54 106.32 9.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 110.125 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 12.2 m-85 -77.83 130.02 36.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.599 ' OD1' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.1 117.84 33.72 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.623 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 5.8 mp -96.11 143.82 26.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 110.779 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.466 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.4 m-70 -145.6 111.84 5.72 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -93.2 116.17 28.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 0.0 108.842 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 25.5 t90 -91.49 129.06 37.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 110.041 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.69 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -131.53 111.87 12.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -62.55 14.22 0.08 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.69 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.2 t-20 65.22 1.78 1.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.447 -1.031 . . . . 0.0 109.862 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 63' ' ' GLY . 10.8 mt-10 -107.16 10.32 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 108.984 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 28.8 t -104.41 146.21 29.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.463 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 p -70.43 140.64 52.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.455 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLN . 34.0 tt0 -63.03 -8.86 8.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 47.1 t0 -70.73 -49.51 46.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -87.24 -40.41 14.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 109.417 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.44 ' HG ' HD13 ' A' ' 62' ' ' LEU . 7.6 t -57.05 -54.41 47.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 109.469 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.34 -45.32 35.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.19 -51.93 60.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.68 -45.75 58.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.5 -21.54 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 109.224 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.27 -52.01 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -58.93 -38.95 80.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -0.972 . . . . 0.0 109.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.595 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 4.8 t -72.6 -48.24 41.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.762 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.595 ' N ' ' CG2' ' A' ' 78' ' ' THR . 40.9 t -64.17 -56.26 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.855 . . . . 0.0 109.906 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -54.1 -58.91 5.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -50.24 -47.51 55.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.067 -1.02 . . . . 0.0 109.278 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.444 ' OD2' ' C ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -46.95 -47.6 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.861 -1.149 . . . . 0.0 108.399 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.59 -28.28 69.24 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LEU . 26.9 t80 -78.29 -23.47 47.15 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.49 -51.07 7.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.618 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.589 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.2 OUTLIER -122.33 -42.16 2.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.221 -0.924 . . . . 0.0 109.955 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.18 -18.4 6.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.434 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 1.6 mmm180 -141.94 -84.56 0.18 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.411 -1.053 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.434 ' O ' ' OE1' ' A' ' 91' ' ' GLN . . . 65.34 145.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.6 150.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.307 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -124.56 158.01 34.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.599 ' CD2' ' OD1' ' A' ' 57' ' ' ASP . 26.2 m-70 -138.29 143.56 40.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 109.42 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -114.97 127.12 55.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.587 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -126.88 89.77 3.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.97 37.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.57 84.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 109.354 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.97 -54.99 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -94.32 58.6 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -93.13 150.78 20.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 109.371 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 m -91.11 176.99 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -73.73 -27.28 61.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -64.01 -53.39 50.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.003 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.47 ' C ' ' CD2' ' A' ' 103' ' ' PHE . 18.8 t80 -62.88 -50.38 71.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.453 -0.779 . . . . 0.0 109.38 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -66.92 -26.18 66.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.197 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -62.7 -48.16 83.48 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -48.79 69.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -1.16 . . . . 0.0 109.209 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -106.23 67.58 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -93.16 -16.96 24.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.935 . . . . 0.0 109.592 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 m -67.18 -3.91 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.918 . . . . 0.0 109.663 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.66 109.79 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.578 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.74 -102.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -1.159 . . . . 0.0 109.215 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 7.2 mttm 163.79 117.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.462 -0.773 . . . . 0.0 109.126 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -94.31 107.99 19.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' THR . 69.1 mttt -113.77 136.2 53.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.438 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -62.79 114.63 3.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.932 . . . . 0.0 109.442 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.39 128.79 9.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 119' ' ' ALA . . . -179.3 37.17 0.07 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 117' ' ' GLY . 41.0 t -42.78 -21.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.125 . . . . 0.0 109.436 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.564 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -53.28 -21.88 6.17 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.1 t -67.88 6.26 0.72 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.415 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -80.7 -23.34 60.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -49.86 -17.94 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -1.173 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 124' ' ' HIS . 32.4 tttm -69.32 -42.59 75.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.531 ' O ' ' O ' ' A' ' 123' ' ' LYS . 16.1 m-70 57.99 137.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.83 . . . . 0.0 109.635 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 t -140.96 132.27 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.14 113.25 64.54 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.12 142.72 8.22 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.373 2.048 . . . . 0.0 112.28 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.454 ' H ' ' ND2' ' A' ' 128' ' ' ASN . 1.7 p30 -64.9 130.53 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -87.96 -17.45 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 t -49.13 -56.52 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.2 p -52.35 -37.88 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.474 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.6 t -69.89 -27.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.476 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -136.44 72.89 57.3 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.21 143.02 24.94 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.697 2.265 . . . . 0.0 112.26 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 6' ' ' LEU . 55.6 mt-10 -56.82 -18.69 13.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.603 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 4' ' ' GLU . 73.5 t80 -41.62 -22.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.498 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 4' ' ' GLU . 27.9 tp -74.25 -33.46 63.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.824 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.7 ptpp? -105.86 -42.47 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 109.794 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 58.55 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -0.816 . . . . 0.0 109.395 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.589 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 56.26 46.84 85.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -46.24 -27.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -1.167 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -149.78 154.82 38.0 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -40.65 129.52 2.64 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.754 2.303 . . . . 0.0 112.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.69 29.88 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' C ' ' CD2' ' A' ' 14' ' ' LEU . 6.3 tt -124.78 127.06 46.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.123 . . . . 0.0 109.396 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.589 HE21 ' N ' ' A' ' 9' ' ' GLY . 22.4 mt-30 -118.07 138.9 51.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.9 OUTLIER -109.64 140.19 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.599 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.9 m0 -142.43 110.86 6.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.108 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -81.38 138.47 35.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.634 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.6 142.76 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 22' ' ' PHE . 10.3 tp10 -159.5 123.3 3.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.549 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 20' ' ' GLU . 11.4 tptm 42.48 26.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.6 m-85 66.57 44.88 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 24' ' ' LEU . 26.7 t0 -117.12 -25.11 7.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.512 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.8 mt 57.6 124.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -145.28 126.71 7.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.365 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.06 123.33 7.21 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.45 2.1 . . . . 0.0 112.339 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -97.75 130.43 29.02 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -42.48 103.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.486 2.124 . . . . 0.0 112.405 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -48.72 -40.12 27.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -63.14 -53.74 48.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 tp -84.71 12.7 6.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.622 ' C ' ' H ' ' A' ' 34' ' ' ASP . 46.0 t80 -83.74 -110.37 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 109.074 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.57 ' N ' ' CG ' ' A' ' 32' ' ' TYR . . . 56.38 -3.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 32' ' ' TYR . 1.1 t70 -111.78 164.76 12.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 109.61 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.586 ' CD2' ' OH ' ' A' ' 32' ' ' TYR . 7.4 m-85 -144.75 120.07 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.6 114.45 17.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 37' ' ' THR . 17.3 p -75.57 87.14 2.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.41 -28.38 0.07 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -115.17 -155.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 108.807 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 140.91 38.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -112.3 121.85 46.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.646 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.0 t -96.77 121.28 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.407 -0.808 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.28 145.9 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 8' ' ' ALA . 2.0 mp -127.52 125.16 39.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.626 -0.671 . . . . 0.0 109.295 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 55' ' ' GLN . 16.9 ttpt -106.02 93.68 4.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.691 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.558 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 31.2 m -77.71 100.52 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.49 164.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.292 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -123.44 124.87 43.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.546 -0.721 . . . . 0.0 109.349 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.8 mt -65.28 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 69.3 mtm-85 -140.04 -34.73 0.54 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -173.74 32.17 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 109.395 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -116.26 -98.13 2.08 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -127.6 -160.06 0.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.115 . . . . 0.0 109.419 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.68 164.52 18.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.434 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' LYS . 42.9 tt0 -129.08 117.62 21.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.766 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 5.9 m-85 -91.52 123.07 34.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.856 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -91.75 119.84 31.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.08 -1.012 . . . . 0.0 109.052 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.72 128.99 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.889 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.684 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 22.1 m-70 -139.43 108.12 5.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -102.01 112.15 24.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 108.544 179.1 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.414 ' CH2' ' CA ' ' A' ' 63' ' ' GLY . 73.3 t90 -93.66 129.18 40.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 110.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -127.79 130.55 48.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -82.81 23.83 5.56 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.7 t30 60.88 1.86 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -1.066 . . . . 0.0 109.896 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 63' ' ' GLY . 2.8 mm-40 -108.18 10.4 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -0.999 . . . . 0.0 108.848 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 7.2 p -105.34 132.6 51.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.526 -0.734 . . . . 0.0 109.558 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -54.52 155.98 3.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.54 -8.9 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.384 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 4.5 t0 -77.03 -36.4 56.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.728 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -87.09 -28.03 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.7 t -69.05 -60.01 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.51 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.97 49.18 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.4 -44.52 24.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -1.183 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.93 -57.35 10.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.154 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.545 ' O ' ' CG2' ' A' ' 79' ' ' VAL . . . -59.03 -19.83 47.53 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 109.171 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mm -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.95 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -57.51 -35.53 70.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.641 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.579 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.5 t -80.13 -47.23 15.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.884 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.579 ' N ' ' CG2' ' A' ' 78' ' ' THR . 55.7 t -61.27 -47.47 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.741 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -69.72 -59.54 2.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' A' ' 84' ' ' TYR . 1.8 tm? -53.45 -51.8 61.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.93 -1.106 . . . . 0.0 108.807 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.537 ' OD2' ' CB ' ' A' ' 89' ' ' ALA . 6.1 t0 -46.01 -47.19 16.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.006 -1.059 . . . . 0.0 108.355 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -56.65 -30.07 62.94 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.637 ' N ' ' O ' ' A' ' 81' ' ' LEU . 35.7 t80 -71.03 -23.94 62.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.8 mt -82.38 -55.19 4.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 110.211 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.647 ' ND2' ' H ' ' A' ' 88' ' ' ARG . 3.9 p-10 -121.62 -42.31 2.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.29 0.91 31.3 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.647 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 24.0 mtp180 -138.31 -83.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -1.127 . . . . 0.0 109.581 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.598 ' N ' ' ND2' ' A' ' 86' ' ' ASN . . . 56.3 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.849 . . . . 0.0 109.794 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 2.6 t -91.43 150.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.56 133.87 52.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.879 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.684 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 35.4 m-70 -138.14 122.31 18.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.235 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.423 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 14.4 ptp180 -110.6 122.17 47.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.957 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.588 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -117.75 90.54 3.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 108.996 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.4 37.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.625 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 68.55 77.8 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.31 -56.5 0.61 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.485 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 8.0 m-85 -87.69 55.22 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.106 . . . . 0.0 109.376 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 30.3 mm-40 -66.83 -178.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.458 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.0 m -117.49 157.2 26.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.4 -0.812 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.39 70.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.571 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.0 m -57.35 -52.08 66.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 44.7 t80 -56.5 -37.87 70.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.487 -0.758 . . . . 0.0 109.6 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -71.28 -31.14 67.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.515 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.23 81.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.431 ' CD2' HD12 ' A' ' 14' ' ' LEU . 1.7 t80 -74.86 -47.54 29.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -1.144 . . . . 0.0 109.568 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -109.49 82.62 1.62 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.521 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -98.28 -34.15 10.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.545 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -101.27 9.18 42.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.24 -108.89 2.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.4 mm? 53.1 101.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.243 -1.151 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -149.93 97.52 2.6 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.555 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -81.69 107.99 14.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.462 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -118.81 154.46 32.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.349 -0.845 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' CD ' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -73.07 160.19 32.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -145.77 99.48 0.21 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.8 34.84 4.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.7 -34.57 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -1.153 . . . . 0.0 109.387 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.69 -30.54 32.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.7 m -86.28 6.13 31.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.37 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.42 -34.8 39.21 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.32 -27.26 27.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -1.21 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -71.18 0.62 7.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.183 -0.948 . . . . 0.0 109.419 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -82.26 125.31 30.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.87 . . . . 0.0 109.351 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t -141.76 128.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.31 115.88 28.17 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.08 135.92 10.67 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.41 2.073 . . . . 0.0 112.214 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.0 t30 61.33 90.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.459 ' OE2' ' N ' ' A' ' 129' ' ' GLU . 54.8 mp0 -79.79 -17.77 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 t -47.82 -19.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 129' ' ' GLU . 88.8 t -65.45 -44.35 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.94 -28.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.469 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -65.02 -41.41 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.32 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.48 142.38 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.36 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.7 43.07 3.46 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -119.02 2.63 11.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.49 ' OE2' ' O ' ' A' ' 12' ' ' PRO . 2.1 pp20? -171.52 141.45 1.29 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.25 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' O ' ' OE2' ' A' ' 11' ' ' GLU . 55.8 Cg_endo -73.27 178.33 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.42 2.08 . . . . 0.0 112.175 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -135.23 12.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 106' ' ' TYR . 5.9 tt -134.57 133.06 39.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -1.091 . . . . 0.0 109.782 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 43' ' ' ILE . 5.5 mt-30 -124.56 145.47 49.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.623 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.5 OUTLIER -125.23 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 110.167 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.9 m-90 -145.47 147.65 32.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.423 -0.798 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -106.64 130.68 54.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.445 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -81.7 143.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.447 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -148.71 96.98 2.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.436 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.9 tttm 50.86 37.09 16.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.7 m-85 68.98 46.25 0.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.563 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 24' ' ' LEU . 2.8 m-20 -127.03 -21.25 4.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 23' ' ' ASP . 17.0 mt 56.03 122.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.516 -0.74 . . . . 0.0 109.665 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -140.29 108.16 6.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.84 117.94 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.448 2.099 . . . . 0.0 112.144 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 27' ' ' VAL . 14.5 p -59.34 133.84 88.24 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -40.78 117.88 0.56 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.484 2.122 . . . . 0.0 112.392 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -67.93 -25.66 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -53.57 -50.72 64.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.394 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -78.86 -53.8 6.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.396 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 54.75 93.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.381 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.51 -26.9 5.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 34' ' ' ASP . 19.3 p-10 -62.44 141.15 58.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -1.13 . . . . 0.0 109.17 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 33' ' ' GLY . 62.8 m-85 -145.3 137.81 25.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.936 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.33 112.21 24.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 108.993 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 37' ' ' THR . 14.8 p -68.82 87.21 0.35 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.81 -29.73 0.06 OUTLIER Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -107.51 -153.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -1.049 . . . . 0.0 108.846 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.492 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -138.6 140.78 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -116.1 147.96 40.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.23 133.57 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.38 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 15' ' ' GLN . 2.0 mt -134.0 145.75 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.944 . . . . 0.0 109.715 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.637 ' CD2' HD23 ' A' ' 58' ' ' LEU . 41.4 mt -122.12 149.35 43.72 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' NZ ' ' CG2' ' A' ' 102' ' ' THR . 11.4 ttpt -137.31 94.17 2.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.599 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -81.56 106.94 13.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 109.013 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -91.36 164.76 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.428 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 54' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 47' ' ' VAL . 32.7 tt0 -132.77 115.97 15.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.224 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.41 131.82 35.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -108.37 131.74 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.98 -1.075 . . . . 0.0 108.915 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.637 HD23 ' CD2' ' A' ' 44' ' ' LEU . 10.7 mt -93.5 134.51 35.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.61 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.551 ' CD2' ' CB ' ' A' ' 92' ' ' HIS . 59.4 m80 -146.57 108.79 4.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.235 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.727 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.22 127.46 52.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.007 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -95.95 124.21 39.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -0.849 . . . . 0.0 110.114 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.659 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.4 mt -121.99 107.21 11.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.97 13.02 0.05 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.659 ' H ' ' C ' ' A' ' 62' ' ' LEU . 39.3 t30 64.14 1.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 109.838 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.09 9.98 30.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 108.934 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.0 t -104.94 138.66 40.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.578 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.8 p -56.74 161.17 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -75.24 -25.95 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.42 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.81 -41.43 86.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.522 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -87.2 -34.81 18.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.579 ' OG ' HD13 ' A' ' 62' ' ' LEU . 3.3 t -59.21 -57.98 10.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 0.0 109.376 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.72 -40.65 96.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.01 -47.82 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -1.178 . . . . 0.0 109.391 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -49.85 69.81 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.277 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -60.03 -24.22 64.34 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mm -81.33 -57.77 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 109.673 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.46 -38.69 88.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 108.947 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.54 HG22 HD22 ' A' ' 58' ' ' LEU . 19.6 m -68.55 -41.5 79.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.386 -0.821 . . . . 0.0 109.757 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 75' ' ' ALA . 50.7 t -71.97 -55.34 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -52.28 -59.7 4.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.129 -0.982 . . . . 0.0 109.948 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.751 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -52.76 -41.98 64.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.05 -1.031 . . . . 0.0 109.012 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.609 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -47.13 -49.1 22.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.857 -1.152 . . . . 0.0 108.135 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.451 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.2 m-20 -60.39 -31.6 70.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.751 ' HB3' HD13 ' A' ' 81' ' ' LEU . 28.7 t80 -74.48 -23.5 58.88 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 81' ' ' LEU . 1.4 tp -83.69 -54.65 4.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -122.33 -42.33 2.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.183 -0.948 . . . . 0.0 110.167 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.07 -33.06 3.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.726 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 2.2 mmp_? -127.9 -84.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -1.105 . . . . 0.0 109.236 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 78.82 178.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.759 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.94 150.61 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.865 . . . . 0.0 109.261 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.79 123.91 50.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.914 . . . . 0.0 109.863 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.551 ' CB ' ' CD2' ' A' ' 59' ' ' HIS . 36.5 m-70 -133.89 121.93 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.338 -0.851 . . . . 0.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -113.14 119.56 38.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 94' ' ' GLU . 57.2 mp0 -109.89 94.32 4.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 96' ' ' GLN . 8.5 t -83.6 37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 95' ' ' VAL . 2.9 tt0 49.81 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.42 -55.88 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -124.33 66.07 1.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -1.108 . . . . 0.0 109.474 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.417 ' OE2' ' CE1' ' A' ' 103' ' ' PHE . 13.7 mt-10 -69.9 -176.94 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 109.479 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.59 175.84 6.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.86 44.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.459 ' CG2' ' NZ ' ' A' ' 45' ' ' LYS . 22.4 m -63.16 -37.0 85.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CE1' ' OE2' ' A' ' 99' ' ' GLU . 41.8 t80 -68.59 -49.33 60.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.91 -19.11 65.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.951 . . . . 0.0 109.442 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.43 8.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.484 ' CD1' HD13 ' A' ' 14' ' ' LEU . 4.3 t80 -78.12 -25.07 47.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -1.14 . . . . 0.0 109.625 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -116.56 68.32 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.469 ' CB ' ' NZ ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -60.48 -58.7 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.905 . . . . 0.0 109.286 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.421 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 1.4 t -105.32 10.01 33.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.5 ' C ' HD12 ' A' ' 111' ' ' LEU . . . -75.62 55.76 2.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.57 91.88 2.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -1.109 . . . . 0.0 109.322 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 35' ' ' PHE . 8.5 ttmt -126.21 110.19 13.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -81.81 107.97 14.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -124.66 108.93 12.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.392 -0.818 . . . . 0.0 109.176 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 115' ' ' LYS . 33.2 pttt . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.591 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.324 0.583 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.06 147.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.32 81.22 37.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.54 125.88 16.58 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 0.0 112.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.87 167.29 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.538 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -55.97 -17.27 6.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.421 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.43 -25.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -46.99 -43.31 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.95 -28.6 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.49 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.686 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.19 0.519 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -71.64 -31.58 67.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.88 156.59 36.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' ' 56' ' ' TYR . . . 87.86 17.0 58.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -142.09 -23.38 0.69 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -1.189 . . . . 0.0 109.704 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.472 ' O ' ' OH ' ' A' ' 56' ' ' TYR . 16.5 mm-40 -93.49 117.11 67.29 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.312 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.24 162.38 31.33 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.23 1.953 . . . . 0.0 112.21 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.29 -120.95 7.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.37 145.35 45.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -1.158 . . . . 0.0 109.988 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.429 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 14.1 mt-30 -136.62 144.63 44.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.835 . . . . 0.0 109.057 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.592 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 18.2 mt -124.52 134.02 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.095 -1.003 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.5 m0 -141.63 115.88 9.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.781 . . . . 0.0 108.995 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 25' ' ' VAL . 39.7 ttp180 -92.2 145.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.847 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.75 143.38 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' PHE . 58.3 tt0 -129.08 112.29 13.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.0 109.35 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tttp 62.82 -69.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' GLU . 75.7 t80 -163.09 20.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.613 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.8 p-10 -127.07 115.32 18.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -55.24 148.37 14.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.435 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' ARG . 44.4 t -142.48 134.18 13.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.253 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.83 161.82 42.74 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.308 2.005 . . . . 0.0 112.154 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.37 133.79 17.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.249 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.16 107.53 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.374 2.049 . . . . 0.0 112.14 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 96.4 m -56.07 -22.81 29.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 5.7 p-10 -82.29 -22.47 35.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.913 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 30' ' ' ASN . 6.6 mp -121.35 13.4 11.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.753 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.723 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.99 -105.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.649 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 56.75 7.65 2.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.603 ' OD2' ' N ' ' A' ' 35' ' ' PHE . 8.3 t0 -150.54 150.14 30.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -1.099 . . . . 0.0 109.426 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.697 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -146.39 161.11 41.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.726 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CE1' ' NH2' ' A' ' 18' ' ' ARG . 5.1 m-85 -90.72 128.34 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -77.23 -30.41 54.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.649 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -78.08 -17.6 78.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -101.11 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -1.157 . . . . 0.0 109.422 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.7 142.72 38.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 2.0 m-85 -118.12 121.7 41.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.561 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.38 135.89 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 108.966 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -129.74 143.42 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.709 HD12 ' CD2' ' A' ' 56' ' ' TYR . 2.0 mm? -115.43 118.58 33.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' NZ ' HG22 ' A' ' 102' ' ' THR . 17.1 ttmt -115.67 94.58 4.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.882 -1.136 . . . . 0.0 110.894 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.62 HG23 ' CD1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -80.35 105.12 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -96.82 164.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.624 -0.673 . . . . 0.0 109.69 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 C--N 1.299 -1.599 0 O-C-N 121.578 -0.701 . . . . 0.0 109.479 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LYS . 12.6 tp60 -139.78 116.43 10.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.957 -1.089 . . . . 0.0 110.333 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.709 ' CD2' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -83.57 116.84 22.78 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 2.6 m-20 -89.01 128.36 35.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.623 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 1.7 mm? -99.69 102.9 14.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.843 . . . . 0.0 109.012 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.715 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 17.8 m-70 -111.72 108.69 18.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 110.15 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -108.71 112.32 24.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.235 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.903 ' C ' HD23 ' A' ' 62' ' ' LEU . 15.9 t90 -105.25 138.64 41.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 110.516 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.903 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -128.14 117.11 21.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -61.65 24.95 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.687 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.5 t-20 56.09 2.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.336 -1.097 . . . . 0.0 110.029 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 63' ' ' GLY . 78.2 mt-10 -103.09 2.47 34.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 108.902 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 36.1 t -95.38 145.82 24.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 109.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 69' ' ' ASP . 93.5 p -83.92 140.2 32.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 109.554 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 67' ' ' SER . 17.7 pt20 -44.4 -24.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.4 m-20 -57.32 -57.96 10.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -87.61 -39.68 14.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 108.921 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.72 -59.65 4.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.27 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -40.18 48.88 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.58 59.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -1.125 . . . . 0.0 109.194 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.66 -46.16 70.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 0.0 109.005 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.87 -23.43 67.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.046 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -81.07 -53.99 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.862 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 16.2 m-85 -67.29 -30.35 70.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.502 ' CG2' HD12 ' A' ' 58' ' ' LEU . 55.2 m -72.87 -41.71 64.43 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.35 -54.99 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.98 -1.075 . . . . 0.0 109.747 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -61.51 -59.59 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.783 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -53.42 -43.14 67.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.068 -1.02 . . . . 0.0 108.901 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' THR . 7.3 t0 -48.7 -48.68 40.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.088 -1.008 . . . . 0.0 108.749 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -59.28 -35.11 73.15 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.527 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 10.0 t80 -74.49 -22.43 59.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.3 tp -82.17 -54.78 4.99 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 89' ' ' ALA . 5.6 m120 -122.89 -42.7 2.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.735 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.23 -13.69 62.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -156.17 19.8 0.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -58.3 -172.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.63 150.02 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.19 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -110.9 110.7 21.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.997 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 7.7 m-70 -110.23 120.32 42.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 108.909 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 8.6 ptt180 -114.43 125.96 54.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.288 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.606 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -126.64 120.3 29.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.96 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 96' ' ' GLN . 3.6 t -112.55 37.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.36 -0.838 . . . . 0.0 109.841 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' O ' ' A' ' 95' ' ' VAL . 11.3 tt0 58.82 124.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.506 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.46 -36.87 4.1 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -132.21 51.97 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -1.104 . . . . 0.0 109.596 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -58.58 179.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.6 m -103.54 156.0 18.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.72 83.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.509 HG22 ' NZ ' ' A' ' 45' ' ' LYS . 1.3 m -65.42 -48.22 73.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.13 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 107' ' ' PHE . 30.1 t80 -58.33 -44.16 88.57 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.314 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.73 -30.74 71.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.1 91.64 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -49.54 65.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -1.185 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.427 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 45.6 m-85 -98.13 65.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -87.52 -34.41 18.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -96.6 2.46 52.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -86.36 -104.44 0.77 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.7 mm? 54.57 101.69 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.328 -1.101 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 11.9 tttt -168.15 91.79 0.32 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.86 108.02 15.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.402 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -96.47 113.01 24.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.708 ' N ' ' HD1' ' A' ' 124' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.86 132.95 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.187 -0.945 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -99.12 110.99 59.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.369 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 128' ' ' ASN . 77.8 Cg_exo -46.38 150.83 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.419 2.079 . . . . 0.0 112.21 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 127' ' ' PRO . 5.7 p30 -43.14 153.4 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 131' ' ' VAL . 25.0 tt0 -56.5 -17.11 7.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.91 -17.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 129' ' ' GLU . 10.8 p -57.0 -34.0 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.96 -28.15 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.489 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.1 tt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.303 0.573 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 8' ' ' ALA . 81.9 mttt -104.65 -46.92 4.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.603 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.36 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 55.21 29.47 52.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.1 ptpt -42.3 -25.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 109.595 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 9' ' ' GLY . 6.0 mt-10 -147.86 148.96 31.85 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.5 134.67 6.9 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.725 2.283 . . . . 0.0 112.156 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -158.05 24.69 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.48 143.1 50.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -1.059 . . . . 0.0 109.4 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HB2' ' CZ2' ' A' ' 17' ' ' TRP . 9.2 mt-30 -130.34 146.29 51.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 41.0 mt -116.07 137.7 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.852 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.603 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 6.2 m0 -142.44 111.71 6.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.16 145.23 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 109.645 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -84.83 143.58 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 17.5 tt0 -158.13 81.08 0.84 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.516 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.8 tttp 72.22 33.27 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER 66.57 17.0 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.5 t70 -95.74 -27.12 15.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER 62.9 134.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -149.63 134.11 9.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.087 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 27' ' ' VAL . 37.8 Cg_endo -69.99 110.14 2.53 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.282 1.988 . . . . 0.0 112.209 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' PRO . 9.8 p -40.8 135.59 1.59 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.081 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.66 127.74 24.64 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.271 1.98 . . . . 0.0 112.349 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 30' ' ' ASN . 17.6 m -63.21 -32.51 73.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.378 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 29' ' ' THR . 42.6 t30 -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.178 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.6 mp -99.19 -55.2 2.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' LEU . 2.7 t80 47.46 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.463 -0.773 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.579 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.82 -13.3 8.14 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.24 143.91 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 109.185 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 18.2 m-85 -141.34 142.76 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 114' ' ' LYS . 4.8 m-85 -86.8 106.81 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 0.0 108.941 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.557 ' C ' ' H ' ' A' ' 39' ' ' ASP . 23.8 p -51.93 -52.5 49.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.869 . . . . 0.0 110.035 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . -61.56 7.86 0.14 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 37' ' ' THR . 0.5 OUTLIER -133.81 172.51 12.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -1.182 . . . . 0.0 109.476 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.98 151.81 30.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.908 . . . . 0.0 109.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -131.06 121.86 25.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.616 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.47 HG11 ' OG1' ' A' ' 78' ' ' THR . 21.4 t -97.71 118.93 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.081 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -117.08 143.2 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.553 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -124.96 129.46 50.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.77 -0.581 . . . . 0.0 109.836 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.12 93.61 4.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 109.648 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.421 ' CG2' HD22 ' A' ' 54' ' ' LEU . 2.4 m -72.78 103.06 3.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.513 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -102.63 164.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.559 -0.713 . . . . 0.0 109.28 179.73 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -135.45 141.27 45.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.573 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -99.71 119.36 37.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.208 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.592 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 6.6 m-20 -73.38 120.23 18.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.768 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.0 tm? -93.7 115.44 27.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.592 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -132.88 121.5 22.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.379 -0.826 . . . . 0.0 109.811 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 93' ' ' ARG . 0.3 OUTLIER -99.19 129.65 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.034 . . . . 0.0 108.792 178.599 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.887 ' C ' HD23 ' A' ' 62' ' ' LEU . 18.3 t90 -108.85 126.65 53.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.831 . . . . 0.0 110.156 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.887 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -133.76 116.3 15.57 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 65' ' ' GLU . . . -68.24 34.25 0.25 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.577 ' H ' ' C ' ' A' ' 62' ' ' LEU . 30.5 t30 49.73 10.9 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -1.025 . . . . 0.0 110.08 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 63' ' ' GLY . 59.5 mt-10 -110.41 4.59 20.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 108.934 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.68 144.03 28.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.593 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 69' ' ' ASP . 2.0 p -67.41 125.5 26.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -50.69 -9.18 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 67' ' ' SER . 17.9 t0 -75.5 -44.12 45.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.494 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -87.25 -45.72 10.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.256 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.602 ' OG ' HD13 ' A' ' 62' ' ' LEU . 6.9 t -51.71 -50.34 60.71 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.92 -52.09 51.14 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.45 -39.15 6.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.84 -39.87 83.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.99 . . . . 0.0 109.213 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -67.49 -31.0 70.83 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.284 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.79 -48.55 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 0.0 110.181 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.33 -33.67 76.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 109.296 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -81.35 -47.14 13.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 75' ' ' ALA . 61.6 t -61.47 -45.66 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.903 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.22 -57.82 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.513 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 81' ' ' LEU . 2.2 tm? -52.33 -49.72 63.7 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.009 -1.057 . . . . 0.0 108.835 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 78' ' ' THR . 20.2 m-20 -46.56 -49.48 18.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 0.0 108.41 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 87' ' ' GLY . 7.6 m-20 -54.61 -31.95 57.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 81' ' ' LEU . 9.7 t80 -65.39 -28.81 69.53 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 81' ' ' LEU . 16.4 mt -83.92 -58.11 2.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -121.76 13.46 10.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.135 -0.978 . . . . 0.0 110.666 -179.024 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 51.32 5.96 0.14 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 86' ' ' ASN . 34.1 mtp180 -147.19 -83.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.369 -1.077 . . . . 0.0 109.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 60.09 141.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 90' ' ' VAL . 2.8 t -73.94 139.61 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -102.59 138.14 39.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 58' ' ' LEU . 20.5 m-70 -140.09 135.71 32.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 7.8 ptp85 -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 22.5 mt-10 -129.26 81.04 2.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.313 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 95' ' ' VAL . 14.5 t -78.95 38.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.875 . . . . 0.0 109.575 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 63.19 72.39 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.605 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.425 ' O ' ' OE1' ' A' ' 99' ' ' GLU . . . 150.96 -60.86 0.41 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -88.32 57.94 4.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -1.135 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 18.9 mp0 -77.23 -165.14 0.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 94.2 p -133.98 159.9 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.19 78.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.1 m -61.34 -60.29 3.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 44.0 t80 -52.53 -38.0 58.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.06 -31.62 66.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.06 95.42 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.69 -52.38 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -1.196 . . . . 0.0 109.568 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.45 80.61 1.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -96.57 -37.74 10.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.583 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -102.43 9.93 39.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -89.98 -107.99 1.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.657 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.5 mm? 51.23 100.36 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.291 -1.123 . . . . 0.0 109.361 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -148.71 114.3 5.64 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.3 OUTLIER -81.93 111.55 18.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.76 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 1.8 mmpt? -105.49 113.14 26.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.315 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.419 -179.888 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.374 0.607 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -135.02 125.9 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -125.83 81.61 65.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.564 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.7 165.5 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.818 2.345 . . . . 0.0 112.273 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.426 ' OD1' ' CD ' ' A' ' 129' ' ' GLU . 12.3 t-20 -74.43 -173.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.653 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -77.17 -28.82 54.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.389 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.14 -31.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.631 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.81 -54.18 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.602 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.48 -28.52 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.511 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.34 0.591 . . . . 0.0 109.45 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -96.48 -59.79 1.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.569 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.639 ' HB3' HD21 ' A' ' 85' ' ' LEU . . . 59.38 136.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.78 . . . . 0.0 109.407 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.63 ' CA ' ' NE2' ' A' ' 15' ' ' GLN . . . 45.5 46.02 12.01 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLY . 25.9 mtmt -43.22 -33.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -1.11 . . . . 0.0 109.384 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.541 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -140.71 169.29 11.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.847 . . . . 0.0 109.392 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -46.07 134.17 14.82 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.755 2.303 . . . . 0.0 112.328 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.95 -168.48 26.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 tt -123.63 144.03 49.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -1.091 . . . . 0.0 109.393 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.63 ' NE2' ' CA ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -131.05 149.41 52.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 109.448 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.1 mp -124.56 133.0 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.7 m0 -142.08 126.64 17.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.284 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.88 143.89 26.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.089 -1.007 . . . . 0.0 109.363 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.11 143.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 53.5 tt0 -138.28 95.75 3.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 78.78 -62.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 109.009 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 12.1 m-85 -171.72 22.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.667 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.67 111.76 14.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.757 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp -74.03 132.78 42.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.16 112.33 11.14 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.252 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -45.56 135.04 12.85 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.424 2.083 . . . . 0.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 27' ' ' VAL . 1.2 p -78.64 127.54 80.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.12 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.26 122.61 1.26 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.441 2.094 . . . . 0.0 112.442 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 30' ' ' ASN . 7.3 m -64.04 -27.99 69.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 29' ' ' THR . 31.1 t-20 -45.72 -43.3 12.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.079 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.691 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.2 mp -90.38 -53.63 4.36 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.302 -0.874 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.8 t80 51.62 92.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.542 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.53 -31.31 4.65 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.598 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 45.9 t0 -68.81 134.53 49.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.241 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 25.8 m-85 -142.36 139.89 31.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.623 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -77.74 104.27 8.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -0.868 . . . . 0.0 109.35 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.3 p -45.73 -27.38 0.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.382 -0.824 . . . . 0.0 109.775 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.86 -32.07 41.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.486 ' OD2' ' OE2' ' A' ' 70' ' ' GLU . 35.6 t0 -92.12 172.73 8.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.091 -1.24 . . . . 0.0 109.476 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.93 140.73 46.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.375 -0.828 . . . . 0.0 109.374 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CE1' ' A' ' 36' ' ' PHE . 46.0 m-85 -121.03 135.23 55.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.631 HG21 ' OG1' ' A' ' 78' ' ' THR . 33.7 t -111.16 144.21 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.54 146.19 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -126.51 121.37 32.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.51 94.17 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.935 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.538 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 8.6 m -77.46 103.37 7.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.384 -0.822 . . . . 0.0 109.551 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -91.5 164.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.243 -0.91 . . . . 0.0 109.316 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 179.963 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' HG23 ' A' ' 47' ' ' VAL . 6.5 tp60 -147.98 126.0 12.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.538 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 12.0 m-85 -90.97 130.98 36.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.044 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.26 124.76 37.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 108.781 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.54 HD11 ' CG ' ' A' ' 82' ' ' ASP . 9.3 mt -88.76 110.93 21.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.776 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.701 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 19.5 m-70 -124.26 108.7 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.324 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.712 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -103.25 121.3 42.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.165 -0.959 . . . . 0.0 108.668 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.827 ' C ' HD23 ' A' ' 62' ' ' LEU . 3.7 t90 -92.39 125.42 37.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.827 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -128.08 105.56 8.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.55 17.35 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.622 ' H ' ' C ' ' A' ' 62' ' ' LEU . 40.1 t30 65.95 1.74 1.98 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -1.078 . . . . 0.0 109.82 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -105.11 7.6 33.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.03 . . . . 0.0 109.101 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 15.5 t -101.82 131.02 48.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.602 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 m -52.3 153.76 2.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -73.25 -9.09 58.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.574 ' OD2' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -80.87 -38.2 28.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.588 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.574 ' N ' ' OD2' ' A' ' 69' ' ' ASP . 64.0 tt0 -87.34 -45.74 10.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.202 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.452 ' OG ' HD13 ' A' ' 62' ' ' LEU . 12.8 t -53.95 -50.34 66.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.498 -0.751 . . . . 0.0 109.266 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -46.42 93.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.89 -45.5 30.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.68 72.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.208 -0.933 . . . . 0.0 109.058 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.36 -20.28 64.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 109.023 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.3 -56.1 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.36 -0.837 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.85 -25.8 65.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.631 ' OG1' HG21 ' A' ' 42' ' ' VAL . 45.4 m -78.18 -42.55 31.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 0.0 109.438 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 75' ' ' ALA . 71.8 t -76.09 -41.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.707 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -69.06 -59.35 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 81' ' ' LEU . 2.1 tm? -53.51 -51.89 61.35 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.615 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.54 ' CG ' HD11 ' A' ' 58' ' ' LEU . 4.5 t70 -45.49 -46.39 13.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.39 -33.44 59.24 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' LEU . 28.5 t80 -66.3 -28.58 68.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.639 HD21 ' HB3' ' A' ' 8' ' ' ALA . 2.7 mp -76.1 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.175 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -121.75 -42.39 2.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.173 -0.954 . . . . 0.0 110.255 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.77 -20.15 8.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.647 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 34.0 mtt85 -128.25 -85.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.402 -1.058 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 72.57 162.64 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.613 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.18 150.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.567 ' NE2' ' N ' ' A' ' 91' ' ' GLN . 2.5 mp0 -109.77 132.7 53.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.701 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 33.1 m-70 -139.34 111.86 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -103.29 124.56 48.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 3.9 mt-10 -117.46 86.48 2.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 0.0 109.366 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.59 37.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.555 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 56.25 91.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.383 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 137.11 -54.55 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -100.37 56.0 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -1.126 . . . . 0.0 109.203 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 5.3 mp0 -83.95 158.26 21.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.9 . . . . 0.0 109.58 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.5 165.23 12.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.313 -0.867 . . . . 0.0 109.287 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.47 -30.22 66.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 m -61.92 -60.22 3.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.603 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 36.0 t80 -54.11 -46.61 72.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 109.35 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 104' ' ' LEU . 35.0 mt -67.88 -28.24 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 109.282 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.83 -42.93 99.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -69.42 -47.41 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -1.066 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -105.21 52.78 0.73 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -81.48 -30.08 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 m -57.89 -8.11 0.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.897 . . . . 0.0 109.742 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.6 111.6 3.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.676 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -75.89 -106.89 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.312 -1.111 . . . . 0.0 109.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 171.46 112.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.0 107.89 17.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -112.66 143.2 44.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.8 pttp . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.423 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.8 m80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 t -67.98 138.09 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 109.462 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.2 t -128.03 78.32 75.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.377 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.92 127.95 18.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 112.292 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -58.1 127.59 32.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.6 -19.23 57.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.38 -25.32 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.86 -54.13 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -51.8 -29.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.475 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 6' ' ' LEU . 35.9 tp . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttp -103.24 33.74 3.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.391 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.611 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -40.26 143.57 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.807 . . . . 0.0 109.619 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 52.43 56.98 14.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.77 -27.34 11.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.35 157.4 45.42 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.378 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.95 123.31 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.782 2.321 . . . . 0.0 112.272 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.7 -172.24 33.75 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.41 143.08 45.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.398 -1.06 . . . . 0.0 109.524 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -133.89 145.01 49.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.898 . . . . 0.0 109.48 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.603 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 16.2 mt -118.3 139.46 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.611 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 6.7 m0 -143.37 110.91 5.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -77.9 139.6 39.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -84.6 143.08 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -0.896 . . . . 0.0 109.202 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' PHE . 24.4 tt0 -158.51 122.2 3.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.54 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 19.1 mmtt 40.59 22.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.51 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' GLU . 2.1 m-85 71.1 44.56 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m-20 -127.09 -13.92 5.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.7 mp 58.81 131.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.2 t -150.91 111.29 3.1 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.06 123.98 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.51 2.14 . . . . 0.0 112.272 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 27' ' ' VAL . 15.0 p -56.36 133.54 76.23 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 109.31 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.49 106.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -58.32 -25.46 61.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -51.74 -47.28 64.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.37 -54.74 4.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.3 t80 53.58 93.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.232 -0.918 . . . . 0.0 109.318 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.44 -4.91 9.4 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.437 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 24.6 t0 -108.23 131.72 54.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.382 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -146.08 167.52 23.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 109.662 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -99.31 122.27 42.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.232 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.7 p -59.64 -27.32 66.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.809 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 26.49 5.92 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.9 t70 -142.69 -166.99 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.308 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -141.04 140.95 34.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.639 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 23.8 m-85 -123.57 129.45 51.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -100.93 137.55 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.4 mt -132.89 146.39 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.3 mp -128.84 131.14 47.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.544 -0.723 . . . . 0.0 109.569 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -113.72 93.68 4.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.682 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.585 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 5.9 m -78.17 105.66 9.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.658 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -100.6 164.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.301 -0.874 . . . . 0.0 109.132 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.538 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 47' ' ' VAL . 35.7 tt0 -134.89 123.39 23.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.941 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 6.2 m-85 -95.36 126.01 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.594 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.6 m-20 -97.41 119.52 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.927 -1.108 . . . . 0.0 108.962 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.481 HD11 ' CG ' ' A' ' 82' ' ' ASP . 2.7 mt -83.1 141.35 32.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 11.8 m-70 -145.91 108.72 4.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.21 114.69 28.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 108.624 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.677 ' C ' HD23 ' A' ' 62' ' ' LEU . 77.3 t90 -90.51 125.55 35.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.913 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.677 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -129.13 114.35 16.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' CD ' ' A' ' 96' ' ' GLN . . . -67.22 11.44 0.73 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.549 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.5 t30 67.33 1.72 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.527 -0.984 . . . . 0.0 109.77 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -112.3 9.97 19.96 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.56 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 9.6 p -98.45 126.7 44.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -46.65 123.47 5.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.128 -0.982 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.455 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 8.3 pm0 -48.19 -25.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.511 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -53.94 -43.34 69.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -87.41 -31.52 20.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.152 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.524 ' OG ' HD13 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -62.18 -59.74 4.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.377 -0.827 . . . . 0.0 109.499 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -54.78 -52.3 47.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.66 -41.07 9.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.381 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.66 92.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.164 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -66.81 -38.51 86.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.209 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.58 -45.63 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 109.637 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -68.28 -35.68 78.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.5 m -75.64 -41.9 52.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 75' ' ' ALA . 80.7 t -74.18 -43.87 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.166 -0.959 . . . . 0.0 109.943 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -67.91 -59.35 3.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.8 tm? -53.92 -51.88 62.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.911 -1.118 . . . . 0.0 108.881 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.481 ' CG ' HD11 ' A' ' 58' ' ' LEU . 4.7 t70 -45.98 -45.81 15.96 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 108.567 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -58.64 -30.85 67.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 27.0 t80 -69.31 -23.15 63.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.436 HD21 HD11 ' A' ' 81' ' ' LEU . 46.2 mt -83.58 -61.28 1.88 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.422 -0.799 . . . . 0.0 110.948 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.513 ' ND2' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -123.04 -43.41 2.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.976 -1.078 . . . . 0.0 111.361 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.87 -3.37 58.74 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.57 62.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -1.191 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.941 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -102.63 168.37 9.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.288 -0.882 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.51 150.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -115.5 136.13 53.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.057 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.474 ' CB ' ' HD1' ' A' ' 59' ' ' HIS . 31.5 m-70 -136.45 124.22 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -114.09 121.54 44.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.862 . . . . 0.0 109.798 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -114.25 93.44 4.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.278 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.5 37.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.615 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.436 ' CD ' ' O ' ' A' ' 63' ' ' GLY . 17.4 tt0 61.53 110.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.42 -38.55 3.28 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.06 50.29 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.181 . . . . 0.0 109.534 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.87 155.91 39.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 153.8 21.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.57 70.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 m -65.71 -62.93 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 3.5 t80 -51.85 -30.74 24.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.353 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 105' ' ' GLY . 7.8 mt -73.13 -57.39 4.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 104' ' ' LEU . . . -45.19 -34.92 4.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -75.62 -59.71 2.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.492 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.482 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 19.6 m-85 -96.35 57.48 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.594 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -84.89 -33.39 22.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 t -96.06 -11.59 26.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -79.49 -104.11 0.24 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 110' ' ' GLY . 81.6 mt 48.5 98.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.21 -1.17 . . . . 0.0 109.329 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -152.93 116.23 4.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -91.87 107.82 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -112.27 108.74 18.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.0 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 -179.773 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.2 t60 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.0 t -80.09 130.37 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.94 87.72 6.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.579 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 129' ' ' GLU . 53.0 Cg_exo -51.46 130.15 32.0 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.698 2.265 . . . . 0.0 112.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.3 p-10 -60.49 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.155 -0.965 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 127' ' ' PRO . 29.9 mt-10 -87.97 -17.83 30.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.873 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.4 t -50.55 -47.94 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.524 HG13 ' N ' ' A' ' 132' ' ' VAL . 7.1 p -68.7 -42.65 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.524 ' N ' HG13 ' A' ' 131' ' ' VAL . 98.9 t -67.1 -28.13 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.497 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.468 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.604 ' O ' HD22 ' A' ' 85' ' ' LEU . 33.8 mmtt -108.51 -28.74 9.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 109.717 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.599 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 51.97 62.84 2.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.536 ' N ' ' OE1' ' A' ' 15' ' ' GLN . . . 106.74 38.46 2.2 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.9 pttp -41.66 -23.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.625 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -138.93 157.7 71.12 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.371 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -39.82 136.5 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.799 2.333 . . . . 0.0 112.184 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.14 179.37 24.05 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 4.3 tt -115.45 148.33 39.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -1.012 . . . . 0.0 109.735 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.536 ' OE1' ' N ' ' A' ' 9' ' ' GLY . 25.5 mt-30 -145.03 154.68 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 0.0 109.682 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.619 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -126.93 152.26 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.769 -0.582 . . . . 0.0 110.06 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.4 m-90 -155.08 110.91 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.425 -0.797 . . . . 0.0 109.233 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.469 HH11 ' CD ' ' A' ' 28' ' ' PRO . 3.1 ttp180 -75.49 127.64 33.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 109.345 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -69.8 144.17 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.159 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 22' ' ' PHE . 13.8 tp10 -155.83 121.44 4.94 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.547 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 43.6 tttt 44.07 23.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 109.399 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 70.19 41.46 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 24' ' ' LEU . 11.6 t70 -127.14 -13.14 5.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' ASP . 13.0 mt 56.43 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.6 t -138.02 125.04 13.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.219 -0.925 . . . . 0.0 109.183 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.44 140.93 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.477 2.118 . . . . 0.0 112.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 27' ' ' VAL . 14.2 p -79.3 134.27 59.13 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -0.847 . . . . 0.0 109.347 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.529 ' CB ' ' OD1' ' A' ' 30' ' ' ASN . 77.7 Cg_exo -40.2 103.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.477 2.118 . . . . 0.0 112.18 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -49.27 -37.93 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 1.2 p30 -45.52 -39.72 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 6.2 mp -86.15 -55.58 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 31' ' ' LEU . 44.2 t80 45.19 90.73 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.593 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.7 -31.3 4.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 1.1 m-20 -85.97 137.5 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.085 -1.244 . . . . 0.0 109.249 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 22.9 m-85 -146.07 153.72 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -76.91 128.21 34.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 108.901 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 p -74.22 -26.46 60.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 110.021 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.01 -22.9 62.57 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.1 t70 -94.94 -160.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.685 ' HB3' HG11 ' A' ' 19' ' ' VAL . . . -136.26 141.0 43.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.377 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -125.21 125.59 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.448 HG11 ' OG1' ' A' ' 78' ' ' THR . 16.9 t -93.87 127.83 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.476 HG23 HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -138.28 145.08 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 109.163 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -144.55 167.06 23.41 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.048 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 1.7 tmmm? -146.28 94.31 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.458 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 63.7 m -72.16 126.88 30.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.374 -0.829 . . . . 0.0 109.833 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.44 164.79 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.636 -0.665 . . . . 0.0 109.515 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.6 -0.687 . . . . 0.0 109.203 179.792 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.6 tt0 -127.21 117.39 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -0.949 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.531 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 5.2 m-85 -71.75 108.73 5.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 87.1 m-20 -72.56 118.05 15.0 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.924 -1.11 . . . . 0.0 108.152 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -102.81 119.21 38.43 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.071 -1.018 . . . . 0.0 109.747 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.624 ' CE1' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -144.29 116.91 8.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 109.657 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.734 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.45 140.33 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 108.819 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.777 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.2 t90 -100.65 127.02 47.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.777 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -127.69 108.67 10.95 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.09 12.58 0.11 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.618 ' H ' ' C ' ' A' ' 62' ' ' LEU . 41.9 t30 66.53 1.87 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -1.13 . . . . 0.0 109.845 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.97 5.32 32.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.067 -1.021 . . . . 0.0 108.973 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 67' ' ' SER . 34.5 t -101.15 116.8 33.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 66' ' ' CYS . 12.7 p -42.23 125.32 3.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.554 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 1.6 mp0 -45.01 -28.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.62 -42.11 82.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.596 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -87.5 -38.89 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.486 ' OG ' HD13 ' A' ' 62' ' ' LEU . 1.9 t -59.53 -57.59 12.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.13 -40.53 36.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.95 -52.65 62.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.294 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.98 65.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.181 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -72.59 -20.3 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -81.0 -46.89 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -66.38 -36.08 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.51 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.24 -41.46 61.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 75' ' ' ALA . 24.5 t -61.37 -52.12 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.731 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.91 -59.61 5.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 109.783 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.764 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -53.14 -44.37 67.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 108.738 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' LEU . 10.9 t0 -46.72 -48.25 20.38 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.923 -1.11 . . . . 0.0 108.114 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.77 -27.91 69.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.764 ' HB3' HD13 ' A' ' 81' ' ' LEU . 37.9 t80 -75.91 -24.09 55.57 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 7' ' ' LYS . 39.6 mt -81.03 -53.88 6.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.895 . . . . 0.0 109.574 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -121.84 -42.32 2.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.4 -0.812 . . . . 0.0 109.891 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.33 -22.42 7.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.4 mtp180 -142.39 -85.39 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.386 -1.067 . . . . 0.0 109.278 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 58.68 161.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.4 t -98.39 135.31 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.507 ' OE1' ' OH ' ' A' ' 60' ' ' TYR . 1.1 pp0? -121.98 133.28 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.301 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.556 ' CD2' ' HB3' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -135.59 159.83 40.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.308 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -121.75 136.54 54.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 96' ' ' GLN . 23.7 mt-10 -108.43 87.54 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.528 -0.733 . . . . 0.0 109.145 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.2 t -74.48 37.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.867 . . . . 0.0 109.885 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 95' ' ' VAL . 2.1 tt0 54.73 106.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.78 -54.87 0.69 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 99' ' ' GLU . 13.8 m-85 -115.19 36.53 3.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -1.104 . . . . 0.0 109.254 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 98' ' ' PHE . 13.1 mt-10 -44.28 169.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 t -95.98 165.81 12.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.96 67.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.4 m -66.76 -49.96 64.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' ' CD1' ' A' ' 61' ' ' TRP . 67.8 t80 -64.0 -46.45 84.5 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 108' ' ' LYS . 26.7 mt -68.77 -32.67 72.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.65 -55.13 32.52 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.76 -47.01 87.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -1.115 . . . . 0.0 109.327 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.45 48.89 0.85 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' LEU . 42.6 tttm -68.97 -23.61 64.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 t -76.21 3.69 10.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.71 110.58 2.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.728 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.1 -101.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -1.116 . . . . 0.0 109.188 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 172.07 107.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.107 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.69 107.94 17.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -105.18 122.59 46.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.67 146.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.482 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.35 86.18 21.34 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 109.343 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.04 126.01 14.37 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.767 2.311 . . . . 0.0 112.224 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -79.41 -172.57 3.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.33 -29.04 21.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.98 -27.38 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.08 -40.24 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.942 . . . . 0.0 109.416 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.58 -27.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.414 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.253 0.549 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 8' ' ' ALA . 33.4 tttm -82.56 -19.53 38.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.53 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -43.62 130.44 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.075 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 8' ' ' ALA . . . 41.68 40.84 3.11 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -48.75 -26.12 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -1.11 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -135.18 157.96 75.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.88 118.9 5.24 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.792 2.328 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.5 -158.02 29.45 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.17 148.27 48.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -1.021 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.416 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 9.1 mt-30 -143.98 141.77 30.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.221 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.36 123.98 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.927 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.53 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 1.9 m0 -131.06 129.75 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -87.17 144.92 26.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.917 . . . . 0.0 109.584 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.45 143.34 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' A' ' 23' ' ' ASP . 25.0 tt0 -151.54 99.89 2.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 6.4 ttmm 48.48 38.49 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.378 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 66.29 20.67 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 24' ' ' LEU . 7.0 m-20 -98.74 -21.67 16.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.1 mt 57.21 122.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.48 133.47 23.65 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 109.219 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.93 117.66 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.343 2.029 . . . . 0.0 112.379 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.24 134.62 90.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.17 136.07 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.275 1.983 . . . . 0.0 112.328 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -57.65 -30.26 65.26 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -45.86 -42.11 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 32' ' ' TYR . 8.4 mp -90.34 -55.73 3.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.208 -0.932 . . . . 0.0 109.268 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.8 t80 36.2 83.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.585 -0.697 . . . . 0.0 109.888 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.68 -31.38 4.6 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -91.48 126.22 36.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.248 . . . . 0.0 109.151 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.686 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.61 168.26 21.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.918 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.542 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -80.56 158.13 25.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.093 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -101.68 -11.19 19.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.64 -7.73 61.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.3 t70 -105.58 -155.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -1.149 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.71 141.4 31.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.543 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -124.36 121.94 36.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.22 135.7 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.529 ' O ' HD22 ' A' ' 44' ' ' LEU . 2.4 mt -121.52 146.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.796 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 43' ' ' ILE . 4.0 mm? -118.74 125.38 49.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' GLN . 7.6 ttpp -120.82 93.79 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.053 -1.03 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.655 HG23 ' CE2' ' A' ' 56' ' ' TYR . 91.7 m -85.98 101.34 12.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.581 -0.699 . . . . 0.0 109.455 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.22 164.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.35 -0.844 . . . . 0.0 109.15 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.748 . . . . 0.0 109.603 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.521 ' O ' ' O ' ' A' ' 45' ' ' LYS . 4.1 tp-100 -131.43 110.75 11.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.655 ' CE2' HG23 ' A' ' 46' ' ' THR . 7.7 m-85 -86.32 109.67 19.14 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.618 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -84.01 127.59 33.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 1.1 mm? -96.51 107.25 19.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.548 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.647 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 75.3 m-70 -115.96 108.57 16.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.717 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.7 120.27 39.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.676 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.686 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 56.5 t90 -102.34 124.91 48.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.987 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.719 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -128.93 118.67 23.04 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.0 16.95 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.719 ' H ' ' C ' ' A' ' 62' ' ' LEU . 34.5 t-20 61.77 2.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -1.031 . . . . 0.0 109.815 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.3 mt-10 -109.4 13.14 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.165 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.7 t -99.91 140.16 34.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.604 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.2 t -61.25 146.54 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.67 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -62.68 -23.48 67.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.11 -49.77 76.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.731 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.49 -43.65 11.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.316 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -55.89 -53.82 52.13 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -60.18 -51.24 60.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.51 -35.14 3.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -1.191 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.19 -45.81 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.02 -31.77 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.2 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.48 -52.47 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -58.44 -44.41 89.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.249 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -67.15 -44.55 79.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 75' ' ' ALA . 58.4 t -69.62 -65.11 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' VAL . 8.3 mm100 -43.36 -59.42 2.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.104 -0.998 . . . . 0.0 109.422 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -52.12 -37.05 53.02 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.069 -1.019 . . . . 0.0 108.641 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -52.01 -52.59 49.68 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.057 -1.027 . . . . 0.0 108.725 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.547 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 7.4 t70 -57.78 -30.52 65.72 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -79.24 -23.73 43.5 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.0 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.54 HD23 ' CD1' ' A' ' 56' ' ' TYR . 11.4 tp -84.74 -46.04 11.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 110.101 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -122.02 -42.21 2.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 109.987 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.93 -15.8 51.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -154.06 24.21 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -52.77 -179.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.63 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.45 150.19 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.442 ' HG2' ' H ' ' A' ' 91' ' ' GLN . 15.9 pt20 -108.44 133.31 52.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.953 . . . . 0.0 109.682 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.647 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 15.8 m-70 -132.35 121.2 23.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.243 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -108.48 127.75 54.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.963 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 96' ' ' GLN . 8.3 mp0 -126.62 78.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.416 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.8 t -68.75 37.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.507 ' O ' ' O ' ' A' ' 95' ' ' VAL . 39.2 tp60 39.27 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.461 -0.775 . . . . 0.0 109.615 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 150.3 -19.24 1.05 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 29.9 m-85 -162.95 47.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.39 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' CE2' ' A' ' 103' ' ' PHE . 2.3 mt-10 -62.65 -179.41 0.26 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.17 172.39 7.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.434 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.35 -31.36 71.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.506 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -63.17 -62.62 1.57 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.582 ' CE2' ' OE1' ' A' ' 99' ' ' GLU . 16.6 t80 -52.52 -38.27 59.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.88 -24.72 61.71 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.06 -43.24 57.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -70.33 -42.54 71.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -1.214 . . . . 0.0 109.639 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.54 73.25 0.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -98.37 -31.55 11.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -104.12 7.99 36.35 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -102.14 -111.75 3.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 110' ' ' GLY . 8.5 mp 53.09 102.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.334 -1.097 . . . . 0.0 109.405 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -145.37 108.39 4.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -82.34 107.98 15.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 0.0 109.614 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.01 108.91 16.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 109.298 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.889 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.48 111.03 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 126' ' ' VAL . 12.2 p -100.64 117.33 62.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -44.77 129.2 9.29 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -62.6 136.41 57.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -52.31 -17.48 1.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.0 t -46.87 -34.92 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.7 t -49.66 -60.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.12 -27.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.522 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 6' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -64.85 -43.61 92.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -50.88 145.29 7.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.03 57.21 2.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 12.5 mmtp -132.89 -10.33 3.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.241 -1.152 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 58.0 mt-10 -160.17 150.41 15.03 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.284 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.61 156.36 57.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.55 2.166 . . . . 0.0 111.916 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.29 -141.47 15.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 15' ' ' GLN . 2.4 tt -127.86 144.9 51.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.406 -1.055 . . . . 0.0 110.062 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.409 ' N ' ' HG ' ' A' ' 14' ' ' LEU . 3.9 mt-30 -135.78 150.55 49.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 109.057 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.619 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.9 mp -124.96 145.32 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.83 . . . . 0.0 110.409 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -146.37 110.89 5.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.421 -0.799 . . . . 0.0 108.942 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' VAL . 12.4 ttp85 -81.09 129.63 34.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 0.0 109.672 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -87.06 143.64 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 12.2 tm-20 -153.8 88.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? 60.6 50.51 5.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 53.6 47.61 23.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.516 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 24' ' ' LEU . 49.9 t0 -126.99 -25.91 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.4 mp 59.39 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.4 -0.812 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' ARG . 51.7 t -145.94 103.22 4.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 27' ' ' VAL . 63.3 Cg_exo -47.77 108.28 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.287 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 26' ' ' PRO . 10.1 t -43.34 107.49 0.57 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.417 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.99 137.74 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.406 2.07 . . . . 0.0 112.223 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 m -62.0 -24.93 67.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -48.13 -45.29 32.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.258 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -94.94 -55.46 3.09 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 31' ' ' LEU . 12.4 t80 42.24 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 109.75 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.597 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.43 -30.87 4.82 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -79.83 137.66 37.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.083 -1.245 . . . . 0.0 109.392 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 57.2 m-85 -136.95 160.46 38.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.05 105.54 15.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.385 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.2 p -57.85 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.95 -30.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.8 m-20 -111.23 -153.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.45 -1.03 . . . . 0.0 109.014 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.7 145.38 44.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.532 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -121.2 127.62 51.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.419 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.68 103.87 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.61 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -121.39 144.34 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 109.193 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.736 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.1 pt? -147.55 172.43 14.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 110.193 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -145.82 99.88 3.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 111.489 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -72.52 118.91 16.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 108.908 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.07 164.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.497 -0.752 . . . . 0.0 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.538 -0.726 . . . . 0.0 109.258 179.708 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -126.05 114.11 17.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.653 ' CG ' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.61 109.87 17.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.079 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.612 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -86.76 103.0 14.78 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.444 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 1.1 mt -95.95 143.1 27.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.172 -0.955 . . . . 0.0 110.444 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.628 ' HB3' ' CD2' ' A' ' 92' ' ' HIS . 1.5 p-80 -154.1 131.83 11.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.465 -0.772 . . . . 0.0 109.623 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.739 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -98.02 118.62 35.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 108.921 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.804 ' O ' HD23 ' A' ' 62' ' ' LEU . 12.1 t90 -85.35 130.36 34.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.302 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 61' ' ' TRP . 0.6 OUTLIER -131.4 111.51 11.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 15.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.616 ' H ' ' C ' ' A' ' 62' ' ' LEU . 12.4 t-20 66.65 1.83 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.341 -1.093 . . . . 0.0 109.713 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -107.3 10.79 29.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 108.983 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 18.4 t -105.0 146.1 29.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -73.67 166.22 23.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.862 . . . . 0.0 109.359 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -76.35 -8.98 58.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.3 -46.52 49.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.12 -36.74 17.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 109.456 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.655 ' OG ' HD13 ' A' ' 62' ' ' LEU . 16.9 t -60.72 -58.31 9.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.13 -41.38 78.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -49.93 61.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.436 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.05 87.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -69.45 -20.46 63.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.134 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mm -79.49 -52.25 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -33.1 73.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 108.994 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 16.4 m -74.33 -36.55 63.67 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.242 -0.911 . . . . 0.0 109.6 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 75' ' ' ALA . 47.4 t -75.18 -54.61 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -61.75 -59.49 5.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.692 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.736 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -51.97 -47.14 64.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.101 -0.999 . . . . 0.0 108.792 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.728 ' OD1' ' HB3' ' A' ' 89' ' ' ALA . 5.0 t0 -46.37 -47.66 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.971 -1.08 . . . . 0.0 108.523 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.11 -30.77 69.49 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' A' ' 81' ' ' LEU . 31.7 t80 -75.86 -23.57 55.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mt -78.07 -52.49 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -122.02 -42.2 2.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.04 -11.0 57.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 -150.2 18.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -1.175 . . . . 0.0 109.8 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.728 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . -63.51 -178.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.516 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.1 145.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.357 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.427 ' OE1' ' OD2' ' A' ' 82' ' ' ASP . 2.3 pm0 -136.69 126.78 26.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.628 ' CD2' ' HB3' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -125.26 160.24 29.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.861 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.404 ' CB ' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -111.37 136.78 50.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.112 -0.993 . . . . 0.0 109.939 -179.324 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.9 mm-40 -118.81 101.81 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 95' ' ' VAL . 8.3 p -88.46 37.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.241 -0.912 . . . . 0.0 109.693 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 57.12 66.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.398 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.39 -59.7 0.29 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -92.22 33.12 1.1 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.457 ' OE2' ' CD1' ' A' ' 61' ' ' TRP . 2.6 mt-10 -72.28 -154.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.425 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -138.05 156.87 47.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 109.385 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.27 -21.07 12.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.6 m -61.6 -60.57 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.095 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.677 ' CE1' ' NE1' ' A' ' 61' ' ' TRP . 72.3 t80 -61.12 -50.28 73.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.525 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 104' ' ' LEU . 89.3 mt -70.34 -18.68 63.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.157 -0.964 . . . . 0.0 109.142 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -69.81 -41.95 71.78 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -71.92 -43.38 65.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -1.112 . . . . 0.0 109.052 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -107.51 54.21 0.67 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.532 ' C ' ' H ' ' A' ' 110' ' ' GLY . 25.8 tttm -81.39 -33.5 32.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.912 . . . . 0.0 109.678 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.0 t -60.7 3.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.74 109.58 2.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.481 HD13 ' H ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -72.39 -101.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -1.173 . . . . 0.0 109.15 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.481 ' H ' HD13 ' A' ' 111' ' ' LEU . 6.7 mttm 165.26 136.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.65 107.89 17.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.494 -0.754 . . . . 0.0 109.235 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -114.26 132.06 56.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.903 . . . . 0.0 109.554 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 109.385 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 125' ' ' VAL . 4.9 p -122.36 129.08 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.429 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.37 82.46 23.14 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' ASN . 59.4 Cg_endo -79.01 132.99 10.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.666 2.244 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' PRO . 10.5 m-20 -41.29 146.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -88.07 -17.2 31.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.36 -22.24 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.72 -34.65 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.3 -29.63 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.427 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.436 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 8' ' ' ALA . 8.4 ttmt -104.93 23.43 13.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.212 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.55 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -37.55 140.24 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.445 -0.784 . . . . 0.0 109.803 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 78.48 51.45 5.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -61.96 1.43 0.29 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -1.2 . . . . 0.0 109.172 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 9' ' ' GLY . 2.6 mt-10 176.35 138.66 0.21 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.448 -0.783 . . . . 0.0 108.938 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -39.77 125.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.574 2.183 . . . . 0.0 112.223 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.02 -157.18 27.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.414 HD12 ' NZ ' ' A' ' 45' ' ' LYS . 5.8 tt -112.43 133.65 54.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 3.9 mm-40 -119.73 157.7 28.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.366 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.568 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.6 mt -134.98 142.59 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.707 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.3 m-90 -149.46 110.69 4.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' VAL . 6.3 ttt180 -89.21 139.41 30.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.88 143.33 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 69.5 tt0 -136.0 111.29 9.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.484 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 26.2 tttp 51.36 43.7 29.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 4.5 t80 73.88 25.72 1.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 20' ' ' GLU . 2.5 m-20 -126.96 111.76 14.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 tp -58.71 141.57 52.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.494 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 18' ' ' ARG . 73.8 t -138.64 121.42 10.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.185 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.25 115.2 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.34 2.026 . . . . 0.0 112.342 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.72 135.06 23.25 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.139 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 32' ' ' TYR . 31.0 Cg_endo -67.13 97.94 0.43 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.3 2.0 . . . . 0.0 112.183 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 46.9 m -52.19 -24.46 7.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.566 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -76.74 -19.73 57.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mt -132.2 13.55 4.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.791 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -71.29 -104.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 67.76 -17.09 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.555 ' H ' ' C ' ' A' ' 32' ' ' TYR . 18.9 t0 -102.49 140.2 37.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.133 -1.216 . . . . 0.0 109.379 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -129.9 119.79 23.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.107 -0.996 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -76.32 102.78 6.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.52 HG21 ' HB3' ' A' ' 113' ' ' TYR . 82.1 p -61.32 -31.59 71.44 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 110.075 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.9 24.53 5.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 24.8 t0 -143.29 -156.42 0.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -1.124 . . . . 0.0 109.294 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.53 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.6 140.73 31.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CZ ' ' HD2' ' A' ' 18' ' ' ARG . 34.3 m-85 -121.87 124.35 43.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.623 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 46.5 t -101.47 115.11 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.074 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -116.14 145.22 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.264 -0.898 . . . . 0.0 109.872 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.4 mp -126.55 151.27 48.12 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -140.45 93.35 2.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.791 -1.193 . . . . 0.0 110.833 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.599 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 29.9 m -89.88 98.63 11.88 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.53 164.63 2.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.32 -0.862 . . . . 0.0 109.812 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.649 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' LYS . 8.7 tt0 -117.36 98.86 6.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.484 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 9.5 m-85 -75.83 123.53 25.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -103.0 147.59 26.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.932 -1.105 . . . . 0.0 108.64 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' HIS . 0.7 OUTLIER -124.66 109.1 12.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.361 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -131.17 116.17 17.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 109.528 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.714 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.87 129.32 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.793 ' C ' HD23 ' A' ' 62' ' ' LEU . 15.8 t90 -101.69 127.24 48.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 110.167 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.793 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -129.44 108.93 10.65 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -64.43 20.05 0.1 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 62' ' ' LEU . 38.5 t30 59.54 2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.079 . . . . 0.0 110.016 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 63' ' ' GLY . 17.8 mt-10 -102.29 2.38 36.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.968 -1.083 . . . . 0.0 108.898 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.437 ' SG ' ' CG ' ' A' ' 70' ' ' GLU . 48.1 t -100.72 140.13 35.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -67.28 155.35 39.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.594 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.9 -8.88 24.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.49 -52.1 20.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' CG ' ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -87.57 -37.15 17.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 62' ' ' LEU . 7.6 t -62.5 -60.08 4.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.514 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.53 37.4 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.8 -37.65 6.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.391 -1.064 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.54 -39.16 85.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.202 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -69.69 -32.82 71.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 109.446 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.411 HG22 ' OE1' ' A' ' 80' ' ' GLN . 3.3 mt -79.13 -43.51 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.42 -40.64 97.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.89 -44.31 32.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.694 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.9 t -62.79 -45.77 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 110.214 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 14.7 pt20 -67.62 -50.57 57.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.992 -1.068 . . . . 0.0 110.217 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -62.33 -47.04 85.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.779 -1.201 . . . . 0.0 108.357 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' LEU . 1.6 t0 -45.87 -46.95 16.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.74 -32.16 71.45 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.723 ' HB3' HD13 ' A' ' 81' ' ' LEU . 41.6 t80 -69.57 -23.05 63.5 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 8' ' ' ALA . 46.5 mt -83.08 -62.01 1.71 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.414 -0.803 . . . . 0.0 110.762 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -122.57 -43.19 2.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.995 -1.066 . . . . 0.0 111.293 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.57 6.67 63.93 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -149.52 10.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -1.12 . . . . 0.0 109.906 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -56.0 177.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.46 133.8 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.157 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.541 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 3.1 mp0 -97.63 138.0 35.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 110.193 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.549 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 9.7 m-70 -139.5 129.82 25.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -0.814 . . . . 0.0 109.249 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -113.25 126.02 54.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.985 . . . . 0.0 109.819 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.469 ' OE2' ' O ' ' A' ' 60' ' ' TYR . 2.0 mp0 -127.15 84.56 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 95' ' ' VAL . 8.9 p -81.64 37.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 7.7 tt0 70.66 52.66 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.39 -53.39 0.25 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -94.13 55.62 2.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.4 mp0 -78.99 -161.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -138.81 170.87 15.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.48 -30.46 64.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.8 m -66.38 -39.5 89.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.372 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -73.52 -51.1 18.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.36 -0.837 . . . . 0.0 109.491 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 104' ' ' LEU . 92.3 mt -68.53 -17.52 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.15 -40.65 13.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD1' HD13 ' A' ' 14' ' ' LEU . 1.6 t80 -82.43 -32.72 28.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -1.128 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -101.35 96.46 7.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.643 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -96.87 -63.63 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.173 -0.954 . . . . 0.0 109.402 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -100.96 11.96 38.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.395 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.714 ' C ' HD23 ' A' ' 111' ' ' LEU . . . -102.98 65.14 0.39 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.714 HD23 ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -147.07 95.05 2.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.316 -1.108 . . . . 0.0 109.0 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.61 114.32 21.01 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.52 ' HB3' HG21 ' A' ' 37' ' ' THR . 1.0 OUTLIER -81.43 107.65 14.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.382 -0.823 . . . . 0.0 109.8 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -111.86 109.03 18.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.313 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 pttt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.462 -179.887 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.275 0.559 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.97 147.1 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.21 71.86 76.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.452 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.02 150.66 9.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.814 2.343 . . . . 0.0 112.266 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -75.21 141.6 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.519 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -76.6 -26.34 54.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.486 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -65.4 -23.86 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.15 -30.71 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.03 -30.2 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.448 179.977 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.249 0.547 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -104.86 -56.89 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.437 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.545 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 59.47 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.402 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 50.68 27.08 11.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' GLY . 1.6 pttt -42.33 -21.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 109.231 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -130.98 157.99 76.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.53 119.92 7.37 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.7 2.267 . . . . 0.0 112.006 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.19 -150.25 21.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.499 HD13 ' CD2' ' A' ' 106' ' ' TYR . 3.4 tt -132.38 144.81 50.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 0.0 109.591 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -136.61 148.21 47.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.458 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -121.3 138.41 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.593 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.6 m0 -141.98 111.0 6.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.458 HH22 HG11 ' A' ' 25' ' ' VAL . 3.6 ttt-85 -71.45 135.85 47.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -78.49 143.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -0.997 . . . . 0.0 109.426 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 89.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.311 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 63.38 28.56 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER 71.03 16.98 6.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 24' ' ' LEU . 73.0 m-20 -99.83 -14.29 18.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.6 mt 57.25 136.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.458 HG11 HH22 ' A' ' 18' ' ' ARG . 47.3 t -142.72 115.73 6.21 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.74 143.83 6.09 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.362 2.041 . . . . 0.0 112.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.44 125.02 81.89 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.45 111.84 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.487 2.125 . . . . 0.0 112.148 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.2 m -63.83 -25.51 68.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -45.71 -41.11 10.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.306 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.31 -54.98 2.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.4 t80 55.62 95.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.353 -0.842 . . . . 0.0 109.369 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.49 -31.03 4.76 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.4 m-20 -89.93 128.37 36.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -1.119 . . . . 0.0 109.191 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.698 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.27 167.92 22.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.915 . . . . 0.0 109.777 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CD1' ' OH ' ' A' ' 41' ' ' TYR . 3.9 m-85 -85.14 154.91 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.346 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 p -95.14 -9.44 33.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.528 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.0 26.79 22.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.09 -162.13 1.32 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -1.163 . . . . 0.0 109.324 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.35 141.08 33.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 22.2 m-85 -128.79 122.51 30.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.359 -0.838 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.506 HG21 ' OG1' ' A' ' 78' ' ' THR . 38.6 t -96.57 141.65 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.437 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.569 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 mt -137.71 146.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 109.363 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.3 mp -129.71 131.63 46.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.685 . . . . 0.0 109.586 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -114.53 94.19 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.595 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 7.6 m -77.24 101.77 6.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.323 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.449 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -99.14 164.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.6 -0.688 . . . . 0.0 109.274 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -137.96 134.8 35.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.805 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.595 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 11.7 m-85 -92.82 128.8 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 108.824 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.614 ' CG ' ' HE2' ' A' ' 59' ' ' HIS . 34.8 t0 -91.09 116.3 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 108.92 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' CD2' HG22 ' A' ' 78' ' ' THR . 6.0 mp -81.76 126.53 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.692 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.72 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 27.5 m-70 -142.44 108.53 5.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.112 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.713 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.42 129.17 50.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.022 . . . . 0.0 108.961 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.698 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 6.0 t90 -96.71 129.56 44.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.375 -0.828 . . . . 0.0 110.03 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.647 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.1 mt -134.44 106.34 7.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.7 9.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.647 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER 69.23 1.22 3.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -1.091 . . . . 0.0 109.607 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -113.65 12.59 18.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.48 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 3.0 p -97.86 134.6 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.537 -0.727 . . . . 0.0 109.406 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 66' ' ' CYS . 1.3 m -43.65 152.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.18 -20.69 57.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.152 -0.967 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -68.59 -35.06 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -87.03 -28.63 22.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.518 ' OG ' HD13 ' A' ' 62' ' ' LEU . 22.8 t -64.32 -60.05 3.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 0.0 109.385 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.76 -46.49 91.76 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -46.6 -43.71 17.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -1.116 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.59 50.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 109.036 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.42 -20.09 41.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 108.89 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mm -81.59 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.33 -0.856 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.3 -26.8 68.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 108.446 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.599 HG22 ' CD2' ' A' ' 58' ' ' LEU . 37.5 m -76.78 -50.59 13.15 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.682 -0.636 . . . . 0.0 109.382 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 75' ' ' ALA . 87.1 t -67.89 -36.36 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.834 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -66.07 -58.84 4.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.744 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -55.04 -46.48 75.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.935 -1.103 . . . . 0.0 109.193 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.549 ' HB3' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -47.64 -47.41 29.24 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.741 -1.224 . . . . 0.0 108.145 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.7 t70 -63.01 -24.44 67.92 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.744 ' HB3' HD13 ' A' ' 81' ' ' LEU . 37.0 t80 -78.13 -23.71 47.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD21 HD12 ' A' ' 81' ' ' LEU . 36.1 mt -83.35 -53.94 5.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.232 -0.917 . . . . 0.0 109.777 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -122.0 -42.37 2.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.184 -0.948 . . . . 0.0 110.094 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.16 -8.42 8.52 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.575 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 59.8 mtt-85 -144.07 -84.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -1.099 . . . . 0.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 68.11 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.586 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.59 149.85 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.66 143.08 45.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.293 -0.879 . . . . 0.0 109.912 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.72 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 36.2 m-70 -142.39 121.91 13.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.468 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 15.7 ptt180 -108.9 121.24 44.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -112.52 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.409 HG12 ' OD1' ' A' ' 64' ' ' ASN . 2.1 t -80.45 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 66.29 53.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.544 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 99' ' ' GLU . . . 162.78 -53.23 0.3 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -77.28 30.67 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.503 ' OE2' HD21 ' A' ' 104' ' ' LEU . 7.7 mt-10 -59.81 150.83 27.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.8 t -99.88 162.69 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.46 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.4 m -63.65 -62.71 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.364 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.559 ' CE1' ' CD2' ' A' ' 107' ' ' PHE . 69.4 t80 -54.69 -37.0 65.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.407 -0.808 . . . . 0.0 109.491 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.503 HD21 ' OE2' ' A' ' 99' ' ' GLU . 98.3 mt -71.84 -22.67 61.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.5 -30.16 46.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.499 ' CD2' HD13 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -85.81 -41.38 15.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.559 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 96.8 m-85 -105.11 76.15 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.508 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.9 -30.89 11.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -98.82 8.73 44.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -101.88 -111.06 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 110' ' ' GLY . 72.7 mt 44.52 96.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.272 -1.134 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -155.4 110.55 3.01 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 107.85 16.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.392 -0.818 . . . . 0.0 109.587 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -103.84 108.83 20.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.3 pttm . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 109.468 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.268 0.556 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.45 147.12 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 t -138.06 110.95 8.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 109.365 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 128' ' ' ASN . 78.3 Cg_exo -45.93 133.66 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.389 2.059 . . . . 0.0 112.335 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 127' ' ' PRO . 29.4 m-20 -43.12 147.71 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.25 -22.93 59.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 130' ' ' VAL . 14.4 t -52.63 -37.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.29 -36.35 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.19 -27.4 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.503 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.417 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 8' ' ' ALA . 15.4 mtmm -125.16 -53.16 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.608 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.585 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 58.86 150.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.153 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 10' ' ' LYS . . . 43.13 40.81 4.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HZ3' ' HB2' ' A' ' 10' ' ' LYS . 18.7 mtmm -42.06 -28.14 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.419 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.554 ' OE2' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -145.64 149.05 38.87 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.249 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -39.85 123.01 1.15 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.628 2.219 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 -168.04 34.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 14' ' ' LEU . 7.2 tt -120.65 129.54 53.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -1.018 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.66 ' N ' HD23 ' A' ' 14' ' ' LEU . 10.9 mt-30 -124.4 163.96 20.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.594 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.2 mt -136.42 137.02 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 109.778 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.594 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.2 m0 -141.6 131.36 24.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.458 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 25' ' ' VAL . 59.9 ttp180 -95.24 144.88 25.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.898 . . . . 0.0 109.599 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.428 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 0.4 OUTLIER -108.45 143.38 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.2 tp10 -130.04 91.5 3.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.5 tttp 78.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.606 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 77' ' ' PHE . 10.5 t80 -160.8 16.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.909 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -127.47 114.89 18.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 109.716 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.8 mp -59.6 149.0 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ARG . 60.5 t -154.1 118.29 2.67 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.11 152.16 0.66 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.455 2.104 . . . . 0.0 112.199 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 27' ' ' VAL . 12.7 p -102.13 132.78 21.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -42.42 136.79 3.99 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.536 2.157 . . . . 0.0 112.353 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -70.2 -28.42 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.335 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -60.68 -40.33 91.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' O ' ' C ' ' A' ' 32' ' ' TYR . 7.8 mp -76.85 -55.46 5.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.862 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 31' ' ' LEU . 9.9 t80 35.4 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.522 -0.736 . . . . 0.0 109.928 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.455 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 115.28 -31.45 6.21 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.23 120.48 27.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -1.186 . . . . 0.0 109.189 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.684 ' CD1' ' CH2' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.67 168.49 21.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 110.043 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' GLY . 22.6 m-85 -86.29 106.95 17.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 109.276 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -46.93 -10.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . -91.05 19.09 48.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.56 -164.65 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -1.175 . . . . 0.0 109.394 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.4 140.61 37.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.663 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -131.05 164.18 25.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.818 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.6 131.34 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.875 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.407 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -115.94 145.62 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.296 -0.878 . . . . 0.0 109.648 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -121.84 147.99 45.27 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HZ1' ' HB3' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -145.69 93.34 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.027 -1.046 . . . . 0.0 110.297 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.611 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 32.1 m -88.58 108.52 19.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.491 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.53 163.9 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.297 -0.877 . . . . 0.0 108.95 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.612 0.72 . . . . 0.0 110.657 -179.166 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' LYS . 3.4 tt0 -124.69 102.31 7.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.147 -0.971 . . . . 0.0 110.765 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.677 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 6.9 m-85 -82.08 109.47 16.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.455 ' HB3' ' HZ1' ' A' ' 45' ' ' LYS . 21.8 t0 -83.45 148.66 27.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.978 -1.076 . . . . 0.0 108.551 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.488 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -130.18 125.9 36.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -137.01 108.91 7.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 109.575 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.705 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.54 114.29 25.01 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 108.558 179.292 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.684 ' CH2' ' CD1' ' A' ' 35' ' ' PHE . 68.8 t90 -86.69 118.38 26.06 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.358 -0.839 . . . . 0.0 109.688 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' ASN . 1.0 OUTLIER -123.2 105.92 10.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.55 -0.719 . . . . 0.0 109.097 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 64' ' ' ASN . . . -56.58 1.19 0.11 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' LEU . 13.4 t-20 70.3 1.65 3.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.509 -0.995 . . . . 0.0 109.731 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -111.88 15.05 20.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 108.896 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.3 t -105.62 145.99 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 109.622 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.2 t -55.36 156.96 3.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.05 -26.45 48.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.184 -0.947 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -41.15 78.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.696 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 19' ' ' VAL . 33.4 tt0 -87.32 -42.66 12.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 t -57.71 -54.05 51.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.728 . . . . 0.0 109.512 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.52 -53.42 43.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.49 -39.27 7.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.462 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.33 86.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.179 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.7 -32.6 74.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.384 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.72 -48.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.802 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 22' ' ' PHE . 1.5 m-85 -62.75 -42.45 99.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.955 . . . . 0.0 109.372 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -68.73 -41.82 78.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.51 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 78' ' ' THR . 52.0 t -73.03 -61.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.438 -0.789 . . . . 0.0 110.02 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -56.87 -59.63 4.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.912 . . . . 0.0 110.06 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.5 tm? -51.82 -47.71 64.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.147 . . . . 0.0 108.937 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 81' ' ' LEU . 3.1 t0 -46.85 -48.69 20.95 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.876 -1.14 . . . . 0.0 108.496 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.24 -31.67 65.77 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.55 ' N ' ' O ' ' A' ' 81' ' ' LEU . 38.5 t80 -70.81 -23.67 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.11 -59.37 2.8 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -122.21 -42.4 2.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.343 -0.848 . . . . 0.0 110.14 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 -21.5 6.66 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 29.7 mtp85 -138.2 -85.5 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -1.114 . . . . 0.0 109.296 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 65.33 176.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.71 150.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -123.88 140.25 53.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -0.873 . . . . 0.0 109.818 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.506 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 11.5 m-70 -137.59 137.99 39.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 109.204 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 ptp180 -120.24 124.83 46.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -119.6 94.66 4.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.184 -0.948 . . . . 0.0 109.539 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.3 37.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 61.4 105.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.462 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 103.01 -36.29 4.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -107.2 32.09 4.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.8 mp0 -70.39 -177.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 p -110.6 168.02 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.358 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -69.65 -32.73 71.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.6 m -60.83 -57.65 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.094 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 40.4 t80 -53.91 -48.94 69.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.494 -0.754 . . . . 0.0 109.259 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.94 -24.36 64.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 109.042 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -60.68 -50.34 68.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 107' ' ' PHE . 22.2 m-85 -69.29 -44.32 72.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -134.29 86.81 2.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.169 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.526 ' O ' HD21 ' A' ' 111' ' ' LEU . 2.0 pttt -89.3 -63.84 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.401 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 2.0 t -105.86 9.81 32.71 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.527 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.37 63.16 0.28 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.704 ' O ' ' CB ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -137.81 -115.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.189 -1.183 . . . . 0.0 108.858 179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.704 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 6.6 tptm 138.28 121.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.476 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 1.8 p90 -103.22 107.98 19.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.472 -0.768 . . . . 0.0 109.524 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -101.93 120.54 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.4 mttt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.495 -179.903 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 126' ' ' VAL . 6.7 t -69.75 146.99 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 125' ' ' VAL . 75.7 t -155.34 88.25 3.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 128' ' ' ASN . 52.7 Cg_exo -49.06 166.17 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.626 2.217 . . . . 0.0 112.252 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 127' ' ' PRO . 84.2 m-20 -39.87 109.69 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.625 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -50.75 -25.67 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.496 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.3 t -50.67 -25.24 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.373 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.74 -47.69 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.477 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.5 -31.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.478 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.618 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -64.8 -31.12 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.55 161.35 30.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.363 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.476 ' CA ' HD21 ' A' ' 85' ' ' LEU . . . 61.37 53.21 46.11 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 20.2 mtpp -142.16 -8.68 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 63.9 mt-10 -158.52 149.69 16.47 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.409 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.82 170.34 20.59 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.627 2.218 . . . . 0.0 112.173 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.66 -137.2 13.9 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.3 142.17 35.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -1.127 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 3.7 mp0 -127.54 146.93 50.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.274 -0.891 . . . . 0.0 109.343 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.545 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 24.8 mt -117.63 135.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.72 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.8 m0 -141.84 110.85 6.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -83.09 131.31 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.543 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -91.95 143.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.353 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -152.81 111.85 3.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.2 ttmt 46.77 31.62 1.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.416 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.1 m-85 68.61 51.38 0.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 24' ' ' LEU . 66.5 m-20 -127.17 -24.54 3.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.3 mt 57.92 130.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -149.54 134.6 9.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.164 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.08 124.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.345 2.03 . . . . 0.0 112.289 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 t -60.09 114.77 10.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.374 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.33 123.89 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.327 2.018 . . . . 0.0 112.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.1 m -59.43 -23.71 62.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -49.18 -47.38 46.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.175 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 7.1 mp -92.01 -55.05 3.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.5 t80 44.95 89.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.567 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.63 3.3 8.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.22 143.19 27.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.154 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -140.3 123.04 16.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 109.921 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.2 m-30 -83.6 102.97 12.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' HH2' ' A' ' 61' ' ' TRP . 30.4 p -57.21 87.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 177.86 -29.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.06 -154.89 0.55 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.388 -1.066 . . . . 0.0 108.943 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.96 141.98 32.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.402 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 22.8 m-85 -115.82 124.37 50.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.787 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.83 118.51 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.841 . . . . 0.0 108.904 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HB ' ' NE2' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -118.91 144.91 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.072 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.896 HD11 HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -121.95 151.43 40.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -143.9 94.65 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.093 -1.005 . . . . 0.0 110.392 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.615 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 1.2 m -87.49 114.67 24.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.471 -0.768 . . . . 0.0 109.288 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -92.09 164.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.515 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.581 0.705 . . . . 0.0 110.558 -179.341 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 45' ' ' LYS . 49.1 tt0 -104.46 92.84 4.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.304 -0.873 . . . . 0.0 110.235 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.615 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 0.3 OUTLIER -79.0 116.72 19.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 109.073 179.548 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -100.13 119.74 38.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.982 HD11 ' OG1' ' A' ' 78' ' ' THR . 7.8 tt -110.64 133.85 52.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.985 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.633 ' HB3' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -152.63 133.78 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.358 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.723 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -100.6 126.08 47.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 0.0 108.775 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.934 ' O ' HD23 ' A' ' 62' ' ' LEU . 77.5 t90 -92.54 134.62 34.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.934 HD23 ' O ' ' A' ' 61' ' ' TRP . 2.3 mt -137.39 118.59 14.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.448 -0.783 . . . . 0.0 109.208 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' CA ' ' CH2' ' A' ' 61' ' ' TRP . . . -69.39 25.14 0.35 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.58 ' H ' ' C ' ' A' ' 62' ' ' LEU . 59.5 t30 58.86 6.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.442 -1.034 . . . . 0.0 110.089 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -110.38 10.93 23.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 109.143 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.2 t -105.09 146.1 29.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.682 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 t -85.9 170.4 12.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.463 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -69.16 -16.34 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 1.2 t70 -61.48 -58.31 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -87.85 -35.82 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.593 ' OG ' HD13 ' A' ' 62' ' ' LEU . 8.8 t -70.4 -60.61 2.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.577 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -52.79 -43.33 60.31 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.44 -52.04 63.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -1.162 . . . . 0.0 109.501 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.7 -47.69 63.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.288 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -61.8 -22.98 65.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 109.232 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -83.92 -55.84 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -61.36 -34.75 75.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.381 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.982 ' OG1' HD11 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -75.13 -43.81 50.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.872 . . . . 0.0 109.74 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 75' ' ' ALA . 27.9 t -63.62 -55.96 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.846 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.3 -59.62 5.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -53.11 -48.45 67.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.031 -1.043 . . . . 0.0 108.927 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 78' ' ' THR . 10.0 t0 -45.64 -45.02 13.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.103 -0.998 . . . . 0.0 108.807 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.28 -30.86 71.92 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 17.7 t80 -79.1 -22.92 44.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.476 HD21 ' CA ' ' A' ' 9' ' ' GLY . 3.2 tp -83.91 -47.7 10.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.333 -0.855 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -122.0 -41.92 2.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 110.025 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.86 -20.56 40.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' ALA . 3.6 ptt180 -136.55 -80.88 0.39 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.386 -1.067 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 88' ' ' ARG . . . 41.89 -155.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.328 -0.858 . . . . 0.0 109.388 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -146.44 133.31 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.589 ' NE2' ' O ' ' A' ' 91' ' ' GLN . 3.0 pp0? -118.85 115.84 25.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.633 ' CD2' ' HB3' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -120.8 159.61 25.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.725 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.567 ' HE ' HD11 ' A' ' 62' ' ' LEU . 42.3 ttt180 -110.52 130.05 55.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.892 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 96' ' ' GLN . 2.5 mm-40 -115.32 86.2 2.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.058 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.52 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.1 t -68.29 37.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.543 ' H ' ' C ' ' A' ' 94' ' ' GLU . 5.1 tm0? 48.82 103.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.496 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.91 -52.37 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 98' ' ' PHE . 60.0 t80 -108.77 31.29 5.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -1.043 . . . . 0.0 109.234 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 98' ' ' PHE . 4.1 mt-10 -53.18 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.391 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.7 t -115.85 170.51 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.93 65.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.1 m -68.56 -53.93 19.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.465 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 14.1 t80 -62.0 -39.18 91.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.443 HD21 ' OE2' ' A' ' 99' ' ' GLU . 94.8 mt -72.36 -36.36 68.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.81 -37.3 94.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.82 -50.52 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.515 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -103.43 61.95 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -84.75 -29.45 25.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -99.6 1.85 44.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.65 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.54 -109.18 2.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 110' ' ' GLY . 16.9 mt 53.34 100.6 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -144.13 100.86 3.63 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.78 108.04 15.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.875 . . . . 0.0 109.574 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -119.41 140.7 49.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 109.362 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.6 m170 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.9 t -89.77 122.91 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.451 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 126' ' ' VAL . 69.4 t -155.51 82.28 3.83 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.82 133.27 11.24 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.773 2.315 . . . . 0.0 112.325 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -63.8 150.22 45.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.526 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 131' ' ' VAL . 1.5 pp20? -88.05 -21.89 24.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 109.552 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 p -47.04 -16.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 129' ' ' GLU . 61.4 t -68.57 -40.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.55 -29.42 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.521 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.428 0.633 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.919 ' O ' HD11 ' A' ' 85' ' ' LEU . 41.9 mttt -98.17 -55.83 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.379 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.551 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.91 134.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.631 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 56.98 54.2 38.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -63.4 0.42 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -1.086 . . . . 0.0 109.404 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' GLY . 11.6 pt-20 -176.44 150.72 1.02 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -39.89 126.29 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.639 2.226 . . . . 0.0 112.1 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.63 -158.5 27.78 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.8 141.81 51.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -1.062 . . . . 0.0 109.652 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 4.3 mm-40 -127.84 156.64 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.247 -0.908 . . . . 0.0 109.35 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.9 mp -131.36 137.0 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.204 -0.935 . . . . 0.0 109.961 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.2 m-90 -144.9 113.41 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 0.0 109.32 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.414 HH11 ' CG ' ' A' ' 39' ' ' ASP . 46.2 ttt180 -80.98 140.03 35.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.0 143.18 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' PHE . 14.0 mm-40 -146.15 112.3 5.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.091 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 20.4 ttpp 57.86 -76.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.339 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 6.8 m-85 -175.83 33.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.318 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.7 t70 -127.31 -1.64 6.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 109.803 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.4 tp 59.25 146.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 109.312 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 24' ' ' LEU . 42.1 t -154.39 111.41 2.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.652 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.42 147.38 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.44 2.093 . . . . 0.0 112.173 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' THR . 6.8 p -76.93 133.34 69.66 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.102 -0.999 . . . . 0.0 109.394 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -41.27 89.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.527 2.151 . . . . 0.0 112.292 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 27' ' ' VAL . 24.4 m -51.74 -26.55 9.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.407 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -51.34 -43.46 61.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.408 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.6 mt -93.86 -54.19 3.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.299 -0.875 . . . . 0.0 109.639 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 65.47 100.44 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 123.67 -27.32 5.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -65.84 139.71 58.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.333 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 33' ' ' GLY . 73.7 m-85 -143.6 143.03 31.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.846 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.61 103.27 15.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.06 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.561 ' C ' ' H ' ' A' ' 39' ' ' ASP . 15.0 p -54.89 -45.26 74.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.808 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.19 10.13 0.29 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 37' ' ' THR . 3.4 m-20 -133.73 -156.24 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -1.173 . . . . 0.0 109.283 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.44 140.91 25.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 109.689 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 15.3 m-85 -123.83 146.21 48.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.825 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.83 116.09 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.168 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' HB ' ' CD2' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -112.37 142.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.252 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.621 HD11 ' CD2' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -122.3 145.25 48.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.568 -0.707 . . . . 0.0 109.891 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -125.47 93.21 3.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.452 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 86.2 m -73.86 106.76 5.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -107.02 164.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.414 179.865 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -134.1 144.8 48.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 2.3 m-85 -100.89 118.91 37.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 108.848 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.688 ' O ' ' CE1' ' A' ' 59' ' ' HIS . 3.5 m-20 -77.81 120.39 22.64 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.621 ' CD2' HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -97.11 122.61 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.0 110.087 -178.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.688 ' CE1' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -138.24 110.98 7.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.44 129.94 35.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 108.95 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.34 111.49 23.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' A' ' 60' ' ' TYR . 1.1 mt -116.1 105.62 12.81 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -65.98 14.54 0.29 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 62.64 1.87 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 109.783 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.6 mt-10 -103.46 4.17 35.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.091 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 67' ' ' SER . 45.6 t -103.41 122.08 44.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 69' ' ' ASP . 69.6 m -43.02 126.16 3.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.43 -8.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 67' ' ' SER . 10.9 t0 -68.24 -43.38 78.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.613 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -87.35 -33.52 19.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.53 ' OG ' HD13 ' A' ' 62' ' ' LEU . 5.7 t -57.77 -56.61 19.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.84 82.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.81 -48.13 50.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.257 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.13 96.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.159 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -63.2 -20.59 65.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.01 -57.44 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 109.99 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -61.28 -32.91 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.334 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.76 -44.01 51.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.147 -0.971 . . . . 0.0 109.588 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.531 ' N ' ' CG2' ' A' ' 78' ' ' THR . 45.2 t -69.93 -52.52 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.9 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -60.92 -59.52 5.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.721 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -53.29 -48.66 68.16 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.98 -1.075 . . . . 0.0 108.66 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 4.4 t0 -44.89 -45.82 10.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.111 -0.993 . . . . 0.0 108.801 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.28 -31.93 72.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 81' ' ' LEU . 11.5 t80 -77.06 -23.17 52.0 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.919 HD11 ' O ' ' A' ' 7' ' ' LYS . 3.6 tp -82.89 -51.35 7.7 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.279 -0.888 . . . . 0.0 109.902 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -122.4 -42.05 2.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.255 -0.903 . . . . 0.0 109.985 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.03 -15.51 16.04 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.7 mtp-105 -144.52 -85.29 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.435 -1.039 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 56.58 156.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.647 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.7 t -91.54 150.23 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.147 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.7 122.95 22.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.0 110.137 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.51 ' CD2' ' HB3' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -136.42 159.98 40.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.302 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -121.12 144.59 48.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.954 . . . . 0.0 109.931 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 96' ' ' GLN . 4.9 mm-40 -115.1 85.29 2.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.4 t -71.89 37.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.695 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 95' ' ' VAL . 1.7 tt0 58.14 118.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.51 -35.9 4.66 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -113.58 45.0 1.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -1.137 . . . . 0.0 109.436 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -71.04 178.93 2.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 m -101.14 160.13 14.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.0 109.441 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.39 65.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.489 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.7 m -71.77 -52.98 14.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -61.2 -37.69 83.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 109.594 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mt -72.19 -27.85 62.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.542 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.58 -25.21 39.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.87 -14.34 29.84 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.187 -1.184 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -134.88 93.81 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.637 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -78.19 -63.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -92.16 9.87 31.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.236 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 111' ' ' LEU . . . -80.46 56.97 4.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.71 92.03 2.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.471 -1.017 . . . . 0.0 109.218 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 35' ' ' PHE . 25.1 tttt -130.02 108.6 10.22 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.653 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -82.19 107.88 15.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.999 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -108.03 108.54 19.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 108.901 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 -179.853 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.5 138.16 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.478 ' H ' HG23 ' A' ' 126' ' ' VAL . 2.1 t -56.92 113.16 5.56 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.485 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 57.3 Cg_exo -46.89 153.29 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.443 ' O ' HG12 ' A' ' 131' ' ' VAL . 10.2 m120 -165.67 102.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.538 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.1 -25.41 59.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.69 -20.21 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 128' ' ' ASN . 7.6 p -49.29 -23.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.817 . . . . 0.0 109.609 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.2 t -51.72 -32.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.439 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 8' ' ' ALA . 5.6 mptp? -94.82 -60.98 1.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 109.443 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.567 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 59.08 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.386 -0.821 . . . . 0.0 109.324 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 8' ' ' ALA . . . 42.2 43.55 4.61 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' GLY . 2.4 pttm -45.56 -23.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' GLY . 11.2 pt-20 -146.48 149.98 39.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -39.78 123.58 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.679 2.252 . . . . 0.0 112.223 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.4 -167.7 31.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.17 147.03 40.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -1.024 . . . . 0.0 109.555 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.412 ' CB ' ' CZ2' ' A' ' 17' ' ' TRP . 7.2 mt-30 -141.98 151.58 42.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.05 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -128.81 135.86 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -141.94 110.58 6.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.501 ' CD ' ' CZ ' ' A' ' 41' ' ' TYR . 21.4 ttp180 -79.77 139.02 37.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.386 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -82.69 142.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.91 . . . . 0.0 109.352 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -159.62 97.09 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.441 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 12.2 ttmm 63.74 25.86 14.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.394 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.2 m-85 70.09 14.64 7.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.614 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' LEU . 9.8 t70 -98.29 -15.27 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' ASP . 1.9 mp 59.84 136.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.02 127.06 12.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.865 . . . . 0.0 109.012 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.57 126.05 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.29 1.993 . . . . 0.0 112.364 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.41 134.78 81.7 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.52 130.26 16.95 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.401 2.067 . . . . 0.0 112.145 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' ASN . 20.5 m -60.0 -26.37 66.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 29' ' ' THR . 57.1 t30 -44.17 -38.84 3.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.974 . . . . 0.0 109.229 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 32' ' ' TYR . 42.2 mt -108.81 -55.15 2.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.481 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 31' ' ' LEU . 6.2 t80 47.92 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.451 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 123.73 -30.74 4.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.597 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 15.3 m-20 -80.88 146.55 30.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.238 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 m-85 -146.1 152.22 38.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 0.0 109.843 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.54 ' CD2' ' C ' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -90.27 104.55 17.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.089 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.6 p -59.07 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.94 -30.66 0.06 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -107.44 -152.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.505 -0.997 . . . . 0.0 108.725 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -137.48 140.46 41.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.501 ' CZ ' ' CD ' ' A' ' 18' ' ' ARG . 18.8 m-85 -117.72 124.93 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.4 130.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.63 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.6 mt -123.46 145.95 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 43' ' ' ILE . 2.3 mm? -124.85 133.24 53.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 55' ' ' GLN . 12.0 ttpt -129.91 94.0 3.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.006 . . . . 0.0 110.031 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.613 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 64.5 m -84.99 106.75 16.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.22 164.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.356 -0.84 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.538 0.685 . . . . 0.0 110.627 -179.33 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.1 tt0 -105.31 96.59 6.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.054 -1.029 . . . . 0.0 110.513 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.673 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 27.8 m-85 -76.61 109.65 10.53 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.602 ' CG ' ' HE2' ' A' ' 59' ' ' HIS . 22.6 t0 -83.61 126.97 33.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.977 -1.077 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 82' ' ' ASP . 4.0 mp -97.19 119.82 36.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.69 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 18.7 m-70 -134.1 108.76 8.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.705 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.66 119.58 39.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.537 ' NE1' HD12 ' A' ' 111' ' ' LEU . 78.1 t90 -96.41 126.51 41.65 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 110.243 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.667 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.9 mt -122.52 109.39 14.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -59.3 10.32 0.03 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 62' ' ' LEU . 28.9 t30 67.45 1.79 2.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -108.32 11.29 27.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.549 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.4 t -104.45 146.02 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 m -77.38 164.88 25.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.616 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -68.96 -8.87 48.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -68.87 -56.11 8.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -87.22 -38.86 15.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 t -58.62 -56.04 27.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.482 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.91 50.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.29 -36.38 4.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -1.178 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.49 70.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.322 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -68.4 -33.63 74.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mt -79.57 -44.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.821 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.5 -40.24 96.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.984 -1.072 . . . . 0.0 109.452 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -76.34 -45.03 34.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 75' ' ' ALA . 49.9 t -61.72 -54.33 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.797 . . . . 0.0 110.143 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.572 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 12.0 pt20 -62.56 -50.55 70.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 110.143 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -59.82 -51.26 70.48 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.745 -1.222 . . . . 0.0 108.647 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.582 ' OD2' ' ND2' ' A' ' 86' ' ' ASN . 3.1 t0 -43.76 -43.47 6.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.004 -1.06 . . . . 0.0 108.358 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.08 -36.77 80.53 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.6 t80 -73.19 -23.6 60.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.501 HD11 ' O ' ' A' ' 7' ' ' LYS . 1.1 tt -81.38 -52.2 7.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.254 -0.904 . . . . 0.0 109.961 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.582 ' ND2' ' OD2' ' A' ' 82' ' ' ASP . 2.2 p30 -122.12 -42.33 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.112 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.18 -10.65 26.77 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -149.96 -81.1 0.12 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -1.083 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.673 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 56.89 170.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.9 t -97.99 150.16 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.241 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -113.62 147.86 37.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 0.0 109.953 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.69 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 44.4 m80 -146.23 122.78 11.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 23.7 ptt85 -111.5 118.75 36.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.821 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.6 mp0 -114.82 100.16 8.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.273 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 2.2 t -87.12 37.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.65 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 24.8 tt0 72.04 107.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.416 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 93.31 -29.81 7.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -97.38 37.57 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 1.1 mp0 -63.25 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.9 m -131.57 -169.97 2.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -61.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 98.5 m -55.45 -37.33 67.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -67.46 -45.96 74.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.63 -10.35 59.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.46 -39.06 8.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.26 -33.92 37.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.54 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -103.4 107.18 17.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -99.38 -12.54 20.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.1 m -53.43 -36.1 61.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.53 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 93.59 35.9 6.04 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.73 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.2 mm? 53.71 103.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -95.4 119.09 33.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -81.96 107.73 14.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.843 . . . . 0.0 109.645 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -115.84 108.57 16.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.233 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.5 mttp . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.499 -179.807 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -96.43 146.69 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.7 t -92.55 114.79 63.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 75.9 Cg_exo -45.24 143.03 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.424 2.083 . . . . 0.0 112.19 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 12.6 m-20 -44.32 169.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -80.07 -21.72 43.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.3 t -47.15 -33.93 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.05 -43.92 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.406 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.98 -27.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.405 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -69.34 -32.81 72.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.19 142.54 54.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.54 44.47 4.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -107.5 -23.24 12.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -1.098 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -152.14 150.99 26.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.868 . . . . 0.0 109.275 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.19 172.37 16.14 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.605 2.203 . . . . 0.0 112.314 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.47 -125.63 8.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 106' ' ' TYR . 4.0 tt -137.11 146.87 45.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.733 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 20.1 mt-30 -137.29 139.46 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.608 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 8.7 mt -111.3 145.2 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.938 . . . . 0.0 109.885 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.7 m0 -148.76 110.74 4.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' VAL . 3.4 tmm_? -85.92 131.44 34.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.187 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.3 143.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.164 -0.96 . . . . 0.0 110.111 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 22' ' ' PHE . 30.3 tt0 -144.46 124.69 13.74 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 24.0 tttp 60.99 -74.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.958 . . . . 0.0 109.016 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' GLU . 10.7 m-85 -168.57 19.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 109.877 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.99 111.27 13.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.11 -0.994 . . . . 0.0 109.693 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 25' ' ' VAL . 9.0 mp -48.99 159.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.362 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ARG . 48.0 t -153.6 90.79 3.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.605 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.32 127.17 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.722 2.281 . . . . 0.0 112.207 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.5 p -106.83 133.63 20.19 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 109.383 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -41.11 93.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.542 2.161 . . . . 0.0 112.318 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.602 ' OG1' HD12 ' A' ' 16' ' ' ILE . 28.0 m -71.38 -12.12 61.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.521 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -77.21 -23.62 51.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.616 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 31' ' ' LEU . 10.4 tp -136.25 13.53 3.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.256 -0.903 . . . . 0.0 109.605 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -56.63 -96.77 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.16 -0.963 . . . . 0.0 109.833 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 64.73 11.48 49.67 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' C ' ' OD2' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -161.84 147.01 13.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -1.081 . . . . 0.0 108.985 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.488 ' CE2' ' CH2' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -146.4 161.04 41.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.918 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -77.29 158.57 30.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 108.964 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 p -107.13 -30.26 8.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.673 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.36 20.46 5.97 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -139.43 -157.39 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -1.066 . . . . 0.0 109.312 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.83 140.8 31.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -119.44 121.91 40.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.574 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.56 130.82 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 139.87 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.651 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.609 HD23 ' CD1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -115.83 145.18 43.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -130.84 93.77 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.094 -1.004 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.636 HG23 ' CD2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -78.05 106.01 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -96.95 164.92 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.405 -0.809 . . . . 0.0 109.407 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 . . . . . 0 C--N 1.3 -1.559 0 O-C-N 121.664 -0.648 . . . . 0.0 109.288 179.833 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.5 tt0 -131.36 113.64 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.744 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.768 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -86.89 110.29 19.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 108.954 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 1.1 m-20 -88.47 119.15 28.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.012 -1.055 . . . . 0.0 108.84 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 58' ' ' LEU . 3.1 pp -96.81 131.46 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.844 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.573 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -135.35 127.88 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.538 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.65 114.84 29.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.096 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.566 ' CD1' ' CZ ' ' A' ' 103' ' ' PHE . 32.1 t90 -93.21 117.39 30.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 109.468 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.4 mt -117.69 118.53 32.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 108.994 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -67.78 21.5 0.26 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' LEU . 28.9 t-20 57.01 1.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.019 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 63' ' ' GLY . 15.8 mm-40 -111.71 10.16 20.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 0.0 108.539 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.0 p -98.46 146.07 26.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.621 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 t -67.39 154.86 40.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.414 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -75.84 -9.02 58.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.657 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.32 -45.73 45.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.686 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -87.3 -35.77 18.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.303 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.595 ' OG ' HD22 ' A' ' 62' ' ' LEU . 2.9 t -58.7 -53.53 57.35 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.495 -0.753 . . . . 0.0 109.458 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.68 42.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.7 -38.71 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.655 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.11 83.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -67.93 -41.81 82.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.11 -39.43 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.31 -47.15 85.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.104 -0.998 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -75.54 -42.24 52.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 75' ' ' ALA . 54.1 t -62.38 -49.06 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.937 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -65.26 -59.85 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.875 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -56.03 -43.83 78.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 0.0 108.587 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 78' ' ' THR . 6.9 t70 -47.3 -46.98 25.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.139 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.49 -28.79 70.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.778 ' HB3' HD13 ' A' ' 81' ' ' LEU . 45.9 t80 -75.02 -24.37 58.34 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.64 -54.59 6.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 86' ' ' ASN . 22.5 t-20 -122.07 -42.03 2.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.939 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.48 1.95 24.52 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.9 mtm-85 -155.13 -78.27 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.425 -1.044 . . . . 0.0 109.263 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.768 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 55.7 178.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.59 146.84 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.63 140.09 38.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.424 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 52.9 m-70 -138.78 119.36 13.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.602 ' HE ' HG22 ' A' ' 95' ' ' VAL . 35.8 ttt180 -103.95 126.59 51.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 109.273 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 12.7 mp0 -127.27 78.67 1.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.948 . . . . 0.0 109.802 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.602 HG22 ' HE ' ' A' ' 93' ' ' ARG . 2.1 t -78.68 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.116 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.439 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 0.9 OUTLIER 42.28 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 98' ' ' PHE . . . 156.36 -35.5 0.6 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 97' ' ' GLY . 2.3 m-85 -135.88 54.68 1.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -1.077 . . . . 0.0 109.276 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.595 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 28.3 mt-10 -71.56 171.49 11.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.562 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 t -110.95 178.92 4.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.394 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -67.74 -26.37 66.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.594 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 m -63.39 -62.9 1.38 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.32 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD1' ' OE2' ' A' ' 99' ' ' GLU . 36.9 t80 -54.6 -41.98 70.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.69 -26.25 61.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.92 . . . . 0.0 109.384 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -63.95 -44.27 96.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' CD1' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -76.22 -50.96 13.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -1.114 . . . . 0.0 109.319 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.72 71.68 9.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -88.77 -40.78 12.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -105.7 8.03 32.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -90.18 -107.95 1.31 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.5 mm? 53.42 101.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.346 -1.091 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -166.07 95.96 0.59 Allowed 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.641 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -82.42 107.76 15.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.5 -0.75 . . . . 0.0 109.45 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -112.07 118.05 34.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 40.7 m80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.45 146.65 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.9 83.97 31.11 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 53.6 Cg_exo -48.45 149.82 6.36 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.74 2.293 . . . . 0.0 112.237 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 90.0 m-20 -42.86 166.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -87.67 -28.58 21.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.406 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -48.55 -32.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 131' ' ' VAL . 17.6 t -50.15 -60.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -73.93 -27.77 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.951 . . . . 0.0 109.587 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.488 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 8' ' ' ALA . 47.8 mttt -103.94 -45.31 4.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.782 ' HB3' HD11 ' A' ' 85' ' ' LEU . . . 58.54 135.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.509 -0.745 . . . . 0.0 109.643 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 50.73 53.57 25.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -58.02 -0.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.17 . . . . 0.0 109.361 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 9' ' ' GLY . 9.8 pt-20 -170.04 149.15 3.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.49 122.05 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.682 2.255 . . . . 0.0 112.252 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.78 -156.4 27.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.5 144.76 49.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -138.53 150.49 46.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.228 -0.92 . . . . 0.0 109.676 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.2 mt -119.05 137.58 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 0.0 109.779 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.7 m0 -142.27 110.82 6.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.3 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.03 137.73 37.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.588 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.58 143.28 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 0.0 109.496 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -155.77 88.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 tttm 65.53 33.85 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.492 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' N ' ' A' ' 22' ' ' PHE . 1.3 m-85 66.2 17.16 10.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 24' ' ' LEU . 55.7 m-20 -102.65 -14.89 16.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.7 mt 57.43 144.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 109.633 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.2 t -154.15 110.25 2.46 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.363 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.83 112.9 0.55 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.388 2.058 . . . . 0.0 112.164 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 27' ' ' VAL . 13.1 p -47.52 133.61 10.32 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -40.91 101.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.509 2.139 . . . . 0.0 112.325 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.5 m -59.0 -25.65 63.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -50.42 -47.29 56.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.56 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -88.17 -54.98 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.85 . . . . 0.0 109.444 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.0 t80 55.54 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 109.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.26 17.08 3.35 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -117.28 144.46 44.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -1.172 . . . . 0.0 109.358 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.581 ' N ' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -146.14 133.92 21.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.773 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 38' ' ' GLY . 26.6 m-85 -92.14 103.03 15.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.059 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.459 ' H ' HG23 ' A' ' 37' ' ' THR . 16.3 p -52.19 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.643 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . 177.96 -29.43 0.07 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.464 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 4.0 p30 -107.93 -154.3 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.369 -1.077 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.15 141.07 34.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.464 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.464 ' CE2' ' OD1' ' A' ' 39' ' ' ASP . 88.5 m-85 -116.52 122.04 43.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.24 114.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.463 ' HB ' ' ND1' ' A' ' 59' ' ' HIS . 1.8 mt -114.58 145.95 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.551 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 1.1 mp -123.0 143.6 49.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.797 -0.565 . . . . 0.0 109.566 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 55' ' ' GLN . 5.0 ttmm -127.23 94.17 3.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.672 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.594 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 43.0 m -81.2 110.96 17.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.12 164.36 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.695 0.76 . . . . 0.0 110.803 -179.245 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 45' ' ' LYS . 3.4 tt0 -100.59 98.85 9.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.101 -1.0 . . . . 0.0 110.422 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.825 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 29.6 m-85 -80.75 109.58 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.483 ' C ' HD22 ' A' ' 58' ' ' LEU . 35.9 t0 -76.33 140.8 41.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 108.684 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 82' ' ' ASP . 2.1 mm? -107.48 103.12 12.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.845 . . . . 0.0 109.546 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.68 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -122.24 112.19 17.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.72 125.99 48.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.582 ' O ' HD23 ' A' ' 62' ' ' LEU . 39.7 t90 -98.79 132.38 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.871 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.596 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.8 mt -134.88 115.41 13.59 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.85 17.79 0.19 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 62' ' ' LEU . 23.8 t30 63.12 1.91 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 109.887 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -106.06 10.33 32.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 109.242 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.11 131.85 46.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.442 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 t -49.74 157.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -75.69 -11.83 60.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.4 p30 -79.24 -40.39 30.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 36.2 tt0 -87.33 -33.81 19.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.286 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.59 ' OG ' HD13 ' A' ' 62' ' ' LEU . 37.5 t -68.11 -60.41 2.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.54 -39.0 29.27 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -58.07 -56.89 16.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -1.156 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.44 -40.88 19.14 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.118 -0.988 . . . . 0.0 109.028 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.621 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -70.64 -21.39 62.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.347 -0.846 . . . . 0.0 109.024 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.6 mm -84.51 -49.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -61.88 -36.58 81.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 109.322 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.29 -46.02 29.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.625 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.0 t -64.39 -52.38 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.96 -59.55 4.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.648 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -52.71 -48.85 66.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 108.764 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HB2' HD11 ' A' ' 58' ' ' LEU . 6.1 t70 -44.8 -45.93 10.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.565 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.71 -33.85 73.5 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 5.5 t80 -74.68 -23.43 58.63 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -80.22 -52.93 7.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.564 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -122.1 -42.01 2.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.12 -14.88 21.11 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -145.54 -72.9 0.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -1.036 . . . . 0.0 109.245 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 56.1 -171.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 109.472 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.84 150.15 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.389 -0.819 . . . . 0.0 109.391 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.562 ' N ' ' OE1' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -108.33 133.0 53.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.716 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.591 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 25.9 m80 -139.74 124.39 18.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.403 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 7.9 ptm180 -110.0 132.37 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 109.688 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.595 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 2.7 mt-10 -130.47 91.71 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.18 37.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 56.45 90.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.46 -32.04 2.52 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -125.12 56.86 1.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.445 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -85.72 167.55 15.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.6 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -100.28 161.01 13.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.47 77.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -62.23 -60.66 3.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 51.1 t80 -52.76 -38.8 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.463 -0.773 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 104' ' ' LEU . 85.0 mt -69.29 -26.17 64.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.62 55.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -43.59 60.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.391 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 88.8 m-85 -106.33 76.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.551 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -100.8 -35.86 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -91.14 -3.31 57.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -91.09 -107.69 1.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 110' ' ' GLY . 85.0 mt 53.37 100.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.36 -1.083 . . . . 0.0 109.527 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.617 ' NZ ' ' HZ1' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -151.67 90.97 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.85 107.72 14.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.516 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.617 ' HZ1' ' NZ ' ' A' ' 112' ' ' LYS . 22.4 mttm -112.37 108.92 18.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 5.5 ptpp? . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.36 0.6 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.6 t -70.16 122.76 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.531 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.67 98.58 38.0 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 129' ' ' GLU . 58.9 Cg_endo -79.09 162.5 25.97 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.463 2.108 . . . . 0.0 112.253 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -59.09 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 127' ' ' PRO . 37.9 tt0 -88.07 -17.23 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 131' ' ' VAL . 9.4 p -57.13 -42.75 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.558 ' N ' HG13 ' A' ' 130' ' ' VAL . 12.9 p -46.95 -30.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.461 ' O ' ' NE2' ' A' ' 133' ' ' GLN . 15.0 t -71.66 -27.77 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 130' ' ' VAL . 85.1 mm-40 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.412 HD11 ' CE2' ' A' ' 84' ' ' TYR . 49.7 tp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.786 ' O ' HD11 ' A' ' 85' ' ' LEU . 27.4 mttm -102.4 -61.11 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.562 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.91 137.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 47.39 38.55 13.32 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HG3' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -42.74 -23.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -1.167 . . . . 0.0 109.62 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' GLY . 34.0 mm-40 -143.79 153.67 58.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -41.65 122.84 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.76 2.306 . . . . 0.0 112.341 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.38 -167.09 33.92 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.782 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.7 tt -124.3 124.0 41.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -1.081 . . . . 0.0 109.217 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.471 ' N ' HD23 ' A' ' 14' ' ' LEU . 4.6 mt-30 -115.08 150.05 36.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 109.575 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.607 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.8 OUTLIER -123.6 140.45 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.792 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.607 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.9 m-90 -144.89 111.78 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -79.93 146.01 32.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.707 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.0 143.31 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.11 -0.994 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.9 tp10 -142.9 95.05 2.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.438 -0.789 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.544 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.6 tptp 71.6 40.26 0.81 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.298 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 2.4 m-85 72.82 21.43 3.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.656 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 22' ' ' PHE . 1.4 m-20 -127.31 111.5 13.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.36 137.47 57.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.6 t -144.0 121.16 6.6 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.895 . . . . 0.0 109.283 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -44.08 148.06 1.19 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.271 1.981 . . . . 0.0 112.513 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 27' ' ' VAL . 11.7 p -92.41 134.21 28.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.186 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -39.15 108.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -61.17 -29.11 69.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -46.77 -41.93 16.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.344 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.437 HD22 ' OD1' ' A' ' 34' ' ' ASP . 13.3 mt -91.22 -53.13 4.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.22 -0.925 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.3 t80 50.26 91.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 16.44 3.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.607 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 1.3 m-20 -128.96 135.7 49.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -1.155 . . . . 0.0 109.159 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 1.9 m-85 -146.07 161.26 40.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -85.3 145.49 27.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.324 -0.86 . . . . 0.0 109.173 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 p -89.9 -22.37 22.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.94 -15.87 69.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -103.75 -161.51 0.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -1.103 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -134.53 140.88 46.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 9.4 m-85 -120.6 148.44 43.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.456 -0.777 . . . . 0.0 109.772 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.76 138.19 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 109.347 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.591 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.4 mt -136.39 146.32 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 43' ' ' ILE . 4.1 mp -127.15 124.21 38.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.64 -0.662 . . . . 0.0 109.572 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -105.26 93.99 4.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.658 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.498 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 5.7 m -79.28 109.85 14.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -104.34 164.76 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.211 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.3 -1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.542 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 47' ' ' VAL . 27.7 tt0 -133.14 112.61 11.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.053 -1.029 . . . . 0.0 109.89 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.519 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 18.8 m-85 -90.69 129.17 36.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 15.9 m-20 -95.11 126.6 40.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 108.964 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.1 mm? -86.99 102.54 14.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.727 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.716 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 23.7 m-70 -116.9 108.67 16.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 0.0 109.567 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.708 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.37 124.21 49.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -0.983 . . . . 0.0 108.686 179.176 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.776 ' O ' HD23 ' A' ' 62' ' ' LEU . 5.6 t90 -95.92 128.78 43.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.147 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.776 HD23 ' O ' ' A' ' 61' ' ' TRP . 0.7 OUTLIER -129.7 106.4 8.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.57 16.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.664 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 61.27 1.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.734 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 63' ' ' GLY . 40.0 mt-10 -104.88 5.82 33.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.98 . . . . 0.0 109.083 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.8 t -101.61 129.16 47.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.546 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 t -51.16 144.39 9.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.444 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -64.62 -8.7 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -73.58 -44.78 56.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -86.86 -37.98 17.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.301 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.613 ' OG ' HD13 ' A' ' 62' ' ' LEU . 8.6 t -60.08 -51.8 68.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.45 -0.781 . . . . 0.0 109.379 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.51 -40.5 69.86 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -57.0 -55.15 38.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.64 44.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.123 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -70.15 -20.28 63.16 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.2 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.5 mm -84.42 -49.19 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.35 -33.45 76.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.976 . . . . 0.0 109.373 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.536 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -77.85 -43.78 29.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 75' ' ' ALA . 53.1 t -68.09 -44.32 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -66.13 -59.62 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -54.45 -45.32 73.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.986 -1.071 . . . . 0.0 108.538 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.411 ' OD2' ' C ' ' A' ' 82' ' ' ASP . 3.5 t0 -47.16 -48.01 23.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 108.607 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.0 -30.58 70.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 81' ' ' LEU . 16.9 t80 -78.43 -23.1 46.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.786 HD11 ' O ' ' A' ' 7' ' ' LYS . 3.8 tp -83.94 -49.91 8.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.263 -0.898 . . . . 0.0 109.921 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -122.3 -42.21 2.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.204 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.71 -19.86 20.9 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -140.97 -68.78 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -1.056 . . . . 0.0 109.351 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 54.63 -169.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.858 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.06 150.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.326 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -107.73 129.42 55.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.814 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.716 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 24.0 m-70 -135.88 113.5 10.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.276 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.492 HH21 ' HB2' ' A' ' 93' ' ' ARG . 19.6 ttp-105 -107.63 125.53 51.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.751 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.593 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 22.2 mt-10 -122.21 89.03 3.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -85.92 37.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -0.875 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 53.9 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.02 -64.99 0.3 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 21.0 m-85 -122.89 49.25 1.67 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.4 -1.059 . . . . 0.0 109.338 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.5 mp0 -51.61 170.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.62 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -87.07 165.44 15.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -29.54 57.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.5 m -65.86 -50.2 65.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.109 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 38.9 t80 -63.48 -48.81 76.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.431 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 108' ' ' LYS . 29.8 mt -63.81 -38.38 90.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.174 -0.953 . . . . 0.0 109.305 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -69.77 -38.16 76.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.238 -1.154 . . . . 0.0 109.26 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -124.27 50.97 1.62 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.421 -0.799 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 110' ' ' GLY . 2.8 tptm -78.15 -28.99 48.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 m -59.51 0.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.75 110.31 2.68 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.674 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -74.48 -104.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -1.165 . . . . 0.0 109.301 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tptp 179.1 113.0 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 109.156 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.02 107.71 19.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.79 . . . . 0.0 109.416 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -110.53 128.02 55.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.284 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 pttt . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.245 -0.91 . . . . 0.0 109.613 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.464 ' CE1' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.74 115.16 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.464 ' CG2' ' CE1' ' A' ' 124' ' ' HIS . 21.1 t -142.11 72.79 22.55 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.29 165.17 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.842 2.361 . . . . 0.0 112.144 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -140.39 35.99 1.87 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.29 -26.39 65.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.421 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 131' ' ' VAL . 9.0 p -57.72 -35.85 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.411 ' N ' HG13 ' A' ' 130' ' ' VAL . 3.0 t -65.9 -39.56 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.13 -30.09 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.49 179.914 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.655 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -65.12 -31.7 73.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.22 -0.925 . . . . 0.0 109.307 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.42 ' CB ' ' CH2' ' A' ' 17' ' ' TRP . . . -74.19 113.5 11.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.314 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.32 49.01 1.62 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -140.24 -14.09 1.02 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -155.01 148.05 18.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.0 109.298 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.49 170.81 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.648 2.232 . . . . 0.0 112.252 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.9 -163.03 12.67 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 106' ' ' TYR . 3.5 tt -110.86 117.06 32.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -1.07 . . . . 0.0 109.598 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -96.63 157.32 15.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.393 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 43' ' ' ILE . 1.9 mt -143.87 113.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.594 ' HH2' HD22 ' A' ' 44' ' ' LEU . 8.2 p90 -140.76 137.09 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 0.0 109.113 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -90.04 146.43 24.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.81 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -85.19 143.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.174 -0.954 . . . . 0.0 109.316 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ASP . 24.2 tt0 -150.52 103.86 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.529 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 44.43 35.82 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.905 . . . . 0.0 109.461 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.3 m-85 68.76 26.89 5.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.633 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.9 t70 -109.42 -20.27 12.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' ASP . 2.3 mp 59.63 138.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.57 128.79 5.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.044 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.78 125.39 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.249 1.966 . . . . 0.0 112.041 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 27' ' ' VAL . 10.8 p -71.68 132.9 84.92 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.13 127.41 3.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.7 m -65.98 -25.71 67.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.26 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -53.3 -50.14 65.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.359 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.7 mp -78.0 -55.37 5.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.155 -0.966 . . . . 0.0 109.365 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' O ' ' A' ' 31' ' ' LEU . 34.6 t80 46.91 91.82 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.536 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.88 -30.96 4.69 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' OD1' HD23 ' A' ' 31' ' ' LEU . 2.5 m-20 -51.81 146.26 8.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.049 -1.266 . . . . 0.0 109.102 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 112' ' ' LYS . 28.6 m-85 -137.77 120.14 15.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.014 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.84 107.43 17.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 108.896 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 p -70.86 87.61 0.72 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.672 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.65 -30.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -112.45 -152.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.927 . . . . 0.0 108.625 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.76 140.11 45.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.002 . . . . 0.0 109.617 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -112.72 124.82 53.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.265 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' A' ' 78' ' ' THR . 74.8 t -102.99 119.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -118.97 146.21 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.246 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.704 HD23 ' CD1' ' A' ' 56' ' ' TYR . 1.5 mp -126.2 152.91 45.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 0.0 109.482 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -140.53 93.83 2.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.161 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.614 ' OG1' ' CE1' ' A' ' 56' ' ' TYR . 1.2 m -88.49 111.42 21.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -0.812 . . . . 0.0 109.212 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.32 164.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.762 . . . . 0.0 109.092 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.549 -0.719 . . . . 0.0 109.443 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -134.42 104.42 6.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 110.489 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.704 ' CD1' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -77.95 123.37 26.71 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.092 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HB3' ' NE2' ' A' ' 59' ' ' HIS . 3.8 t0 -103.23 122.08 44.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.033 . . . . 0.0 108.494 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.826 HD23 HG22 ' A' ' 78' ' ' THR . 10.4 mp -94.78 143.18 26.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.427 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -149.1 108.42 3.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.65 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.04 115.22 28.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 108.857 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.53 ' CE2' HD12 ' A' ' 111' ' ' LEU . 26.8 t90 -90.13 126.79 35.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.359 -0.838 . . . . 0.0 109.991 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.665 HD13 ' OG ' ' A' ' 71' ' ' SER . 3.9 mt -122.6 108.02 12.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -63.44 15.7 0.1 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.64 ' H ' ' C ' ' A' ' 62' ' ' LEU . 5.3 t30 62.53 1.9 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -1.083 . . . . 0.0 109.962 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 63' ' ' GLY . 9.7 mm-40 -106.01 8.99 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.0 . . . . 0.0 109.12 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.1 t -104.36 141.03 37.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 m -57.24 146.87 26.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -64.23 -26.75 68.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.02 -32.07 72.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -87.22 -45.16 10.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.295 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.665 ' OG ' HD13 ' A' ' 62' ' ' LEU . 33.2 t -53.34 -49.76 66.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -59.68 -48.27 86.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -46.0 -43.53 14.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -1.122 . . . . 0.0 109.24 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 19' ' ' VAL . . . -63.42 -56.09 19.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -57.41 -20.5 30.35 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.366 -0.834 . . . . 0.0 108.935 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -82.42 -59.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.269 -0.894 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -63.18 -25.28 68.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.893 . . . . 0.0 108.716 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.826 HG22 HD23 ' A' ' 58' ' ' LEU . 5.3 m -75.91 -50.4 15.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.627 -0.671 . . . . 0.0 109.535 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 75' ' ' ALA . 51.6 t -73.65 -27.81 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -71.56 -59.78 2.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -58.64 -46.96 85.97 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.986 -1.071 . . . . 0.0 108.414 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.726 ' HB2' HD21 ' A' ' 58' ' ' LEU . 5.4 t70 -47.22 -45.75 23.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 13.5 t70 -61.66 -27.85 68.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.731 ' HB3' HD13 ' A' ' 81' ' ' LEU . 20.4 t80 -74.85 -23.85 58.49 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.9 mt -83.88 -54.11 5.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.841 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -121.71 -42.36 2.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 109.994 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.408 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . 126.11 -44.28 1.27 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 52.7 mtt85 -112.34 -85.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . 71.69 150.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.64 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 90' ' ' VAL . 1.6 t -79.57 150.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -122.95 130.26 52.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 109.891 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.4 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 24.7 m80 -124.99 129.46 50.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -107.32 126.86 52.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 109.86 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 100.54 7.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.49 38.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 1.8 tt0 52.23 80.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.1 -62.34 0.37 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -94.94 60.78 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.471 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -67.04 159.4 28.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 m -91.82 170.03 10.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.95 -61.06 1.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -48.91 -47.94 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 109.251 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.45 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 21.7 t80 -55.07 -49.52 71.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.63 -16.26 62.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.31 -31.88 26.92 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.405 ' CE2' HD22 ' A' ' 14' ' ' LEU . 2.5 t80 -82.45 -34.59 28.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.681 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -105.21 113.86 27.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 109.722 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -103.99 -12.49 16.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.9 p -53.27 -29.63 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 109.459 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 87.09 40.62 6.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.798 ' N ' HD22 ' A' ' 111' ' ' LEU . 2.8 mm? 52.01 102.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.095 -1.238 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 35' ' ' PHE . 4.2 tmtm? -94.23 117.53 30.25 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -81.81 107.77 14.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 0.0 109.736 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -107.98 108.83 20.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mptt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.863 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.591 ' C ' ' HD1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -103.54 120.88 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.65 113.39 59.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.386 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.473 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 61.0 Cg_endo -78.72 125.78 6.96 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.167 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.473 ' CG ' ' O ' ' A' ' 127' ' ' PRO . 15.9 m-20 -175.36 64.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.12 -17.28 62.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.01 -23.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.77 -26.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.11 -27.84 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.525 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tp . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' O ' ' O ' ' A' ' 8' ' ' ALA . 35.3 mttm -108.45 -61.37 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.621 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.64 133.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 56.3 44.66 89.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' GLY . 38.2 mttp -42.57 -22.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -1.066 . . . . 0.0 109.418 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' GLY . 33.3 mt-10 -152.87 152.95 29.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -39.68 120.09 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.665 2.243 . . . . 0.0 112.15 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.97 -162.08 32.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -126.55 143.22 51.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -1.05 . . . . 0.0 109.678 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -137.52 156.17 48.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.591 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -126.49 137.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.0 109.808 -179.672 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.4 m0 -142.59 111.08 6.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.293 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.67 146.13 44.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.148 -0.97 . . . . 0.0 109.501 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' A' ' 74' ' ' ALA . 1.6 t -80.29 143.91 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.0 109.39 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 21' ' ' LYS . 6.6 tp10 -159.18 109.6 1.99 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.448 -0.783 . . . . 0.0 109.461 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 20' ' ' GLU . 19.3 mttp 41.54 41.11 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 55.78 45.95 23.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 24' ' ' LEU . 25.7 t0 -126.47 -19.38 4.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 23' ' ' ASP . 9.6 mp 57.2 123.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.64 122.18 10.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.142 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.22 139.6 3.97 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.386 2.057 . . . . 0.0 112.501 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.16 127.89 93.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -40.16 101.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.476 2.118 . . . . 0.0 112.346 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 m -49.41 -27.43 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.376 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.38 -41.94 14.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.212 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.98 -53.86 2.84 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 t80 51.51 91.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . 123.5 -22.35 7.0 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.592 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 11.1 m-20 -92.53 147.74 22.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -1.206 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 9.1 m-85 -145.68 150.44 36.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.95 . . . . 0.0 109.749 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 38' ' ' GLY . 67.9 m-85 -87.48 109.83 19.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.168 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 114' ' ' LYS . 16.6 p -60.28 87.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 179.02 -29.79 0.06 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.2 t0 -107.52 -153.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -1.058 . . . . 0.0 108.873 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -139.41 147.91 42.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 11.9 m-85 -128.54 141.1 51.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.585 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.439 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 47.1 t -115.8 128.18 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.581 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.6 mt -123.14 146.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.25 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' A' ' 56' ' ' TYR . 3.8 mp -124.58 151.86 44.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -142.8 93.77 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 109.95 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.618 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 94.6 m -85.6 117.24 24.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.738 . . . . 0.0 109.615 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.86 164.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.276 -0.89 . . . . 0.0 109.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.565 -0.709 . . . . 0.0 109.154 179.73 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -125.54 106.32 9.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 110.125 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 12.2 m-85 -77.83 130.02 36.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.599 ' OD1' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.1 117.84 33.72 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.8 mp -96.11 143.82 26.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 110.779 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.4 m-70 -145.6 111.84 5.72 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -93.2 116.17 28.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 0.0 108.842 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.782 ' C ' HD23 ' A' ' 62' ' ' LEU . 25.5 t90 -91.49 129.06 37.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 110.041 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.782 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -131.53 111.87 12.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.55 14.22 0.08 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 62' ' ' LEU . 41.0 t30 65.22 1.78 1.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.447 -1.031 . . . . 0.0 109.862 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -107.16 10.32 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 108.984 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 28.8 t -104.41 146.21 29.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.463 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 p -70.43 140.64 52.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.455 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLN . 34.0 tt0 -63.03 -8.86 8.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 47.1 t0 -70.73 -49.51 46.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -87.24 -40.41 14.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 109.417 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.6 t -57.05 -54.41 47.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.34 -45.32 35.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.19 -51.93 60.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 19' ' ' VAL . . . -50.68 -45.75 58.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.5 -21.54 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 109.224 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.27 -52.01 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -58.93 -38.95 80.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -0.972 . . . . 0.0 109.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.603 HG23 ' N ' ' A' ' 79' ' ' VAL . 4.8 t -72.6 -48.24 41.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.762 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.603 ' N ' HG23 ' A' ' 78' ' ' THR . 40.9 t -64.17 -56.26 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.855 . . . . 0.0 109.906 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -54.1 -58.91 5.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -50.24 -47.51 55.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.067 -1.02 . . . . 0.0 109.278 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.629 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -46.95 -47.6 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.861 -1.149 . . . . 0.0 108.399 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.59 -28.28 69.24 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LEU . 26.9 t80 -78.29 -23.47 47.15 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.49 -51.07 7.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.618 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -122.33 -42.16 2.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.221 -0.924 . . . . 0.0 109.955 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.18 -18.4 6.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.497 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.6 mmm180 -141.94 -84.56 0.18 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.411 -1.053 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.629 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . 65.34 145.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.6 150.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.307 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.584 ' NE2' ' O ' ' A' ' 89' ' ' ALA . 5.2 mp0 -124.56 158.01 34.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.599 ' CD2' ' OD1' ' A' ' 57' ' ' ASP . 26.2 m-70 -138.29 143.56 40.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 109.42 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -114.97 127.12 55.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.587 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -126.88 89.77 3.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.97 37.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.57 84.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 109.354 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.97 -54.99 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -94.32 58.6 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -93.13 150.78 20.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 109.371 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 m -91.11 176.99 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -73.73 -27.28 61.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -64.01 -53.39 50.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.003 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.47 ' C ' ' CD2' ' A' ' 103' ' ' PHE . 18.8 t80 -62.88 -50.38 71.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.453 -0.779 . . . . 0.0 109.38 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -66.92 -26.18 66.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.197 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -62.7 -48.16 83.48 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -48.79 69.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -1.16 . . . . 0.0 109.209 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -106.23 67.58 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -93.16 -16.96 24.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.935 . . . . 0.0 109.592 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 m -67.18 -3.91 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.918 . . . . 0.0 109.663 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.66 109.79 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.702 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.74 -102.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -1.159 . . . . 0.0 109.215 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 7.2 mttm 163.79 117.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.462 -0.773 . . . . 0.0 109.126 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 37' ' ' THR . 0.2 OUTLIER -94.31 107.99 19.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' THR . 69.1 mttt -113.77 136.2 53.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.438 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.1 mttp . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.932 . . . . 0.0 109.442 -179.903 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.337 0.589 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 t -140.96 132.27 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.14 113.25 64.54 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.12 142.72 8.22 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.373 2.048 . . . . 0.0 112.28 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -64.9 130.53 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -87.96 -17.45 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 130' ' ' VAL . 23.0 t -49.13 -56.52 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 132' ' ' VAL . 14.2 p -52.35 -37.88 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.474 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.455 ' N ' HG13 ' A' ' 131' ' ' VAL . 16.6 t -69.89 -27.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.476 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.9 tp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.212 0.53 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.7 ptpp? -105.86 -42.47 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 109.794 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 58.55 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -0.816 . . . . 0.0 109.395 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.26 46.84 85.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -46.24 -27.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -1.167 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -149.78 154.82 38.0 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -40.65 129.52 2.64 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.754 2.303 . . . . 0.0 112.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.69 29.88 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.788 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.3 tt -124.78 127.06 46.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.123 . . . . 0.0 109.396 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.512 ' N ' HD23 ' A' ' 14' ' ' LEU . 11.1 mt-30 -118.07 138.9 51.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.9 OUTLIER -109.64 140.19 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.601 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 7.9 m0 -142.43 110.86 6.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.108 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -81.38 138.47 35.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.634 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -93.6 142.76 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 22' ' ' PHE . 10.3 tp10 -159.5 123.3 3.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.549 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 20' ' ' GLU . 11.4 tptm 42.48 26.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.6 m-85 66.57 44.88 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 24' ' ' LEU . 26.7 t0 -117.12 -25.11 7.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.512 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.8 mt 57.6 124.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -145.28 126.71 7.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.365 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.06 123.33 7.21 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.45 2.1 . . . . 0.0 112.339 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -97.75 130.43 29.02 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -42.48 103.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.486 2.124 . . . . 0.0 112.405 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -48.72 -40.12 27.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -63.14 -53.74 48.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 tp -84.71 12.7 6.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 34' ' ' ASP . 46.0 t80 -83.74 -110.37 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 109.074 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.57 ' N ' ' CG ' ' A' ' 32' ' ' TYR . . . 56.38 -3.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 32' ' ' TYR . 1.1 t70 -111.78 164.76 12.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 109.61 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.571 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 7.4 m-85 -144.75 120.07 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.6 114.45 17.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 ' HH2' ' A' ' 61' ' ' TRP . 17.3 p -75.57 87.14 2.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.41 -28.38 0.07 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -115.17 -155.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 108.807 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 140.91 38.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -112.3 121.85 46.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.646 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.0 t -96.77 121.28 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.407 -0.808 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.598 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.1 mt -121.28 145.9 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.765 HD11 HD23 ' A' ' 58' ' ' LEU . 2.0 mp -127.52 125.16 39.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.626 -0.671 . . . . 0.0 109.295 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 55' ' ' GLN . 16.9 ttpt -106.02 93.68 4.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.691 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.512 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 31.2 m -77.71 100.52 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -94.49 164.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.292 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.546 -0.721 . . . . 0.0 109.349 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' LYS . 42.9 tt0 -129.08 117.62 21.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.766 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 56' ' ' TYR . 5.9 m-85 -91.52 123.07 34.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.856 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -91.75 119.84 31.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.08 -1.012 . . . . 0.0 109.052 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.765 HD23 HD11 ' A' ' 44' ' ' LEU . 12.5 mt -82.72 128.99 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.889 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.684 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 22.1 m-70 -139.43 108.12 5.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -102.01 112.15 24.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 108.544 179.1 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.789 ' C ' HD23 ' A' ' 62' ' ' LEU . 73.3 t90 -93.66 129.18 40.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 110.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.789 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -127.79 130.55 48.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -82.81 23.83 5.56 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.7 t30 60.88 1.86 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -1.066 . . . . 0.0 109.896 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 63' ' ' GLY . 2.8 mm-40 -108.18 10.4 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -0.999 . . . . 0.0 108.848 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.487 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 7.2 p -105.34 132.6 51.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.526 -0.734 . . . . 0.0 109.558 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -54.52 155.98 3.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.54 -8.9 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.384 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 4.5 t0 -77.03 -36.4 56.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.728 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -87.09 -28.03 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.615 ' OG ' HD13 ' A' ' 62' ' ' LEU . 30.7 t -69.05 -60.01 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.51 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.97 49.18 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.4 -44.52 24.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -1.183 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.93 -57.35 10.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.154 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -59.03 -19.83 47.53 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 109.171 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mm -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.95 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -57.51 -35.53 70.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.641 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.579 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.5 t -80.13 -47.23 15.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.884 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.7 t -61.27 -47.47 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.741 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -69.72 -59.54 2.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.8 tm? -53.45 -51.8 61.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.93 -1.106 . . . . 0.0 108.807 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.632 ' HB2' HD21 ' A' ' 58' ' ' LEU . 6.1 t0 -46.01 -47.19 16.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.006 -1.059 . . . . 0.0 108.355 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -56.65 -30.07 62.94 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 81' ' ' LEU . 35.7 t80 -71.03 -23.94 62.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.46 HD21 HD11 ' A' ' 81' ' ' LEU . 46.8 mt -82.38 -55.19 4.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 110.211 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.484 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -121.62 -42.31 2.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.29 0.91 31.3 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 89' ' ' ALA . 24.0 mtp180 -138.31 -83.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -1.127 . . . . 0.0 109.581 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.537 ' CB ' ' OD2' ' A' ' 82' ' ' ASP . . . 56.3 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.849 . . . . 0.0 109.794 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 2.6 t -91.43 150.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.56 133.87 52.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.879 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.684 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 35.4 m-70 -138.14 122.31 18.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.235 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.423 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 14.4 ptp180 -110.6 122.17 47.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.957 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.588 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -117.75 90.54 3.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 108.996 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.4 37.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.625 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 68.55 77.8 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.31 -56.5 0.61 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.485 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 8.0 m-85 -87.69 55.22 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.106 . . . . 0.0 109.376 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 30.3 mm-40 -66.83 -178.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.458 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.0 m -117.49 157.2 26.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.4 -0.812 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.39 70.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.571 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.0 m -57.35 -52.08 66.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 44.7 t80 -56.5 -37.87 70.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.487 -0.758 . . . . 0.0 109.6 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -71.28 -31.14 67.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.515 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.23 81.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.432 ' CD2' HD13 ' A' ' 14' ' ' LEU . 1.7 t80 -74.86 -47.54 29.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -1.144 . . . . 0.0 109.568 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -109.49 82.62 1.62 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.521 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -98.28 -34.15 10.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.545 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -101.27 9.18 42.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.24 -108.89 2.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.613 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.4 mm? 53.1 101.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.243 -1.151 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -149.93 97.52 2.6 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.555 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -81.69 107.99 14.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.462 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -118.81 154.46 32.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.349 -0.845 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.52 ' H ' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 22.2 m170 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t -141.76 128.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.31 115.88 28.17 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.08 135.92 10.67 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.41 2.073 . . . . 0.0 112.214 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 61.33 90.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.451 ' OE2' ' N ' ' A' ' 129' ' ' GLU . 54.8 mp0 -79.79 -17.77 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.429 ' H ' HG23 ' A' ' 130' ' ' VAL . 2.5 t -47.82 -19.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 129' ' ' GLU . 88.8 t -65.45 -44.35 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.94 -28.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.469 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.56 155.42 36.2 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.463 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.11 139.5 42.63 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.792 2.328 . . . . 0.0 112.219 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 7' ' ' LYS . 24.0 mt-10 -83.05 -53.12 6.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.685 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.434 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.7 OUTLIER -43.69 -37.32 2.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 109.492 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp -83.25 -21.78 33.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.287 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' GLU . 26.8 tttt -65.02 -41.41 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.32 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.48 142.38 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.36 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.7 43.07 3.46 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -119.02 2.63 11.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.49 ' OE2' ' O ' ' A' ' 12' ' ' PRO . 2.1 pp20? -171.52 141.45 1.29 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.25 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' O ' ' OE2' ' A' ' 11' ' ' GLU . 55.8 Cg_endo -73.27 178.33 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.42 2.08 . . . . 0.0 112.175 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -135.23 12.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 106' ' ' TYR . 5.9 tt -134.57 133.06 39.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -1.091 . . . . 0.0 109.782 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 43' ' ' ILE . 5.5 mt-30 -124.56 145.47 49.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.623 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.5 OUTLIER -125.23 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 110.167 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.9 m-90 -145.47 147.65 32.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.423 -0.798 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -106.64 130.68 54.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.445 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -81.7 143.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.447 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -148.71 96.98 2.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.436 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.9 tttm 50.86 37.09 16.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.7 m-85 68.98 46.25 0.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.563 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 24' ' ' LEU . 2.8 m-20 -127.03 -21.25 4.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 23' ' ' ASP . 17.0 mt 56.03 122.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.516 -0.74 . . . . 0.0 109.665 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -140.29 108.16 6.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.84 117.94 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.448 2.099 . . . . 0.0 112.144 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 27' ' ' VAL . 14.5 p -59.34 133.84 88.24 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -40.78 117.88 0.56 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.484 2.122 . . . . 0.0 112.392 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -67.93 -25.66 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -53.57 -50.72 64.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.394 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -78.86 -53.8 6.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.396 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 54.75 93.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.381 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.51 -26.9 5.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 34' ' ' ASP . 19.3 p-10 -62.44 141.15 58.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -1.13 . . . . 0.0 109.17 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 33' ' ' GLY . 62.8 m-85 -145.3 137.81 25.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.936 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.33 112.21 24.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 108.993 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 37' ' ' THR . 14.8 p -68.82 87.21 0.35 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.81 -29.73 0.06 OUTLIER Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -107.51 -153.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -1.049 . . . . 0.0 108.846 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.492 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -138.6 140.78 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -116.1 147.96 40.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.23 133.57 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.38 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 15' ' ' GLN . 2.0 mt -134.0 145.75 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.944 . . . . 0.0 109.715 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.637 ' CD2' HD23 ' A' ' 58' ' ' LEU . 41.4 mt -122.12 149.35 43.72 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' NZ ' ' CG2' ' A' ' 102' ' ' THR . 11.4 ttpt -137.31 94.17 2.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.599 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -81.56 106.94 13.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 109.013 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -91.36 164.76 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -116.28 116.44 27.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.428 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.433 HD12 ' HB3' ' A' ' 53' ' ' ASN . 12.0 mt -68.35 -98.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.59 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.416 ' H ' ' HB2' ' A' ' 49' ' ' LEU . 12.0 mtt-85 -84.93 -63.33 1.35 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.091 -1.006 . . . . 0.0 109.748 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.51 ' O ' ' ND2' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -172.83 24.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.403 -0.811 . . . . 0.0 109.167 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.49 -53.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.433 ' HB3' HD12 ' A' ' 49' ' ' LEU . 18.9 t-20 -64.74 152.51 42.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.491 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 54' ' ' LEU . 1.4 pt? -141.71 150.28 41.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.418 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 47' ' ' VAL . 32.7 tt0 -132.77 115.97 15.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.224 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.41 131.82 35.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -108.37 131.74 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.98 -1.075 . . . . 0.0 108.915 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.637 HD23 ' CD2' ' A' ' 44' ' ' LEU . 10.7 mt -93.5 134.51 35.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.61 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.551 ' CD2' ' CB ' ' A' ' 92' ' ' HIS . 59.4 m80 -146.57 108.79 4.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.235 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.727 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.22 127.46 52.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.007 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -95.95 124.21 39.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -0.849 . . . . 0.0 110.114 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.659 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.4 mt -121.99 107.21 11.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.97 13.02 0.05 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.659 ' H ' ' C ' ' A' ' 62' ' ' LEU . 39.3 t30 64.14 1.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 109.838 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.09 9.98 30.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 108.934 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.0 t -104.94 138.66 40.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.578 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.8 p -56.74 161.17 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -75.24 -25.95 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.42 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.81 -41.43 86.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.522 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -87.2 -34.81 18.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.579 ' OG ' HD13 ' A' ' 62' ' ' LEU . 3.3 t -59.21 -57.98 10.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 0.0 109.376 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.72 -40.65 96.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.01 -47.82 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -1.178 . . . . 0.0 109.391 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -49.85 69.81 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.277 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -60.03 -24.22 64.34 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mm -81.33 -57.77 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 109.673 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.46 -38.69 88.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 108.947 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.54 HG22 HD22 ' A' ' 58' ' ' LEU . 19.6 m -68.55 -41.5 79.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.386 -0.821 . . . . 0.0 109.757 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 75' ' ' ALA . 50.7 t -71.97 -55.34 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -52.28 -59.7 4.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.129 -0.982 . . . . 0.0 109.948 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.751 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -52.76 -41.98 64.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.05 -1.031 . . . . 0.0 109.012 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.609 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -47.13 -49.1 22.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.857 -1.152 . . . . 0.0 108.135 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.451 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.2 m-20 -60.39 -31.6 70.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.751 ' HB3' HD13 ' A' ' 81' ' ' LEU . 28.7 t80 -74.48 -23.5 58.88 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 81' ' ' LEU . 1.4 tp -83.69 -54.65 4.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -122.33 -42.33 2.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.183 -0.948 . . . . 0.0 110.167 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.07 -33.06 3.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.726 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 2.2 mmp_? -127.9 -84.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -1.105 . . . . 0.0 109.236 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 78.82 178.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.759 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.94 150.61 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.865 . . . . 0.0 109.261 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.79 123.91 50.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.914 . . . . 0.0 109.863 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.551 ' CB ' ' CD2' ' A' ' 59' ' ' HIS . 36.5 m-70 -133.89 121.93 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.338 -0.851 . . . . 0.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -113.14 119.56 38.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 94' ' ' GLU . 57.2 mp0 -109.89 94.32 4.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 96' ' ' GLN . 8.5 t -83.6 37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 95' ' ' VAL . 2.9 tt0 49.81 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.42 -55.88 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -124.33 66.07 1.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -1.108 . . . . 0.0 109.474 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.417 ' OE2' ' CE1' ' A' ' 103' ' ' PHE . 13.7 mt-10 -69.9 -176.94 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 109.479 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.59 175.84 6.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.86 44.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.459 ' CG2' ' NZ ' ' A' ' 45' ' ' LYS . 22.4 m -63.16 -37.0 85.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CE1' ' OE2' ' A' ' 99' ' ' GLU . 41.8 t80 -68.59 -49.33 60.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.91 -19.11 65.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.951 . . . . 0.0 109.442 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.43 8.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.484 ' CD1' HD13 ' A' ' 14' ' ' LEU . 4.3 t80 -78.12 -25.07 47.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -1.14 . . . . 0.0 109.625 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -116.56 68.32 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.469 ' CB ' ' NZ ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -60.48 -58.7 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.905 . . . . 0.0 109.286 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.421 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 1.4 t -105.32 10.01 33.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.5 ' C ' HD12 ' A' ' 111' ' ' LEU . . . -75.62 55.76 2.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.57 91.88 2.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -1.109 . . . . 0.0 109.322 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 35' ' ' PHE . 8.5 ttmt -126.21 110.19 13.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -81.81 107.97 14.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -124.66 108.93 12.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.392 -0.818 . . . . 0.0 109.176 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 115' ' ' LYS . 33.2 pttt -68.06 120.94 15.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.591 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 160.56 -149.15 18.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.49 -135.61 1.93 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.4 t -123.93 -65.2 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -1.135 . . . . 0.0 109.451 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.31 -29.49 57.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.589 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -86.57 6.12 32.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.309 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -21.34 78.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -75.85 -36.05 59.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -1.166 . . . . 0.0 109.46 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -86.27 -20.13 28.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 62.12 59.24 1.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.06 147.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.32 81.22 37.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.54 125.88 16.58 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 0.0 112.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.87 167.29 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.538 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -55.97 -17.27 6.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.421 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.43 -25.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -46.99 -43.31 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.95 -28.6 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.49 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -148.88 61.97 5.86 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 7' ' ' LYS . 56.9 Cg_endo -74.91 12.46 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.857 2.371 . . . . 0.0 112.193 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -50.97 -49.57 59.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -62.68 -34.95 78.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.903 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.686 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.4 mm? -80.82 -26.4 37.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.298 -0.876 . . . . 0.0 109.678 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 3' ' ' PRO . 6.1 mmtm -71.64 -31.58 67.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.88 156.59 36.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' ' 56' ' ' TYR . . . 87.86 17.0 58.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -142.09 -23.38 0.69 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -1.189 . . . . 0.0 109.704 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' O ' ' OH ' ' A' ' 56' ' ' TYR . 16.5 mm-40 -93.49 117.11 67.29 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.312 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.24 162.38 31.33 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.23 1.953 . . . . 0.0 112.21 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.29 -120.95 7.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.37 145.35 45.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -1.158 . . . . 0.0 109.988 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.429 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 14.1 mt-30 -136.62 144.63 44.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.835 . . . . 0.0 109.057 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.592 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 18.2 mt -124.52 134.02 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.095 -1.003 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.5 m0 -141.63 115.88 9.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.781 . . . . 0.0 108.995 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 25' ' ' VAL . 39.7 ttp180 -92.2 145.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.847 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.75 143.38 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' PHE . 58.3 tt0 -129.08 112.29 13.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.0 109.35 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tttp 62.82 -69.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' GLU . 75.7 t80 -163.09 20.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.613 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.8 p-10 -127.07 115.32 18.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -55.24 148.37 14.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.435 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' ARG . 44.4 t -142.48 134.18 13.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.253 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.83 161.82 42.74 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.308 2.005 . . . . 0.0 112.154 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.37 133.79 17.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.249 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.16 107.53 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.374 2.049 . . . . 0.0 112.14 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 96.4 m -56.07 -22.81 29.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 5.7 p-10 -82.29 -22.47 35.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.913 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 30' ' ' ASN . 6.6 mp -121.35 13.4 11.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.753 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.723 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.99 -105.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.649 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 56.75 7.65 2.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.603 ' OD2' ' N ' ' A' ' 35' ' ' PHE . 8.3 t0 -150.54 150.14 30.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -1.099 . . . . 0.0 109.426 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.697 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -146.39 161.11 41.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.726 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CE1' ' NH2' ' A' ' 18' ' ' ARG . 5.1 m-85 -90.72 128.34 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -77.23 -30.41 54.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.649 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -78.08 -17.6 78.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -101.11 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -1.157 . . . . 0.0 109.422 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.7 142.72 38.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 2.0 m-85 -118.12 121.7 41.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.561 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.38 135.89 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 108.966 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -129.74 143.42 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.709 HD12 ' CD2' ' A' ' 56' ' ' TYR . 2.0 mm? -115.43 118.58 33.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' NZ ' HG22 ' A' ' 102' ' ' THR . 17.1 ttmt -115.67 94.58 4.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.882 -1.136 . . . . 0.0 110.894 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.62 HG23 ' CD1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -80.35 105.12 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -96.82 164.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.624 -0.673 . . . . 0.0 109.69 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -108.62 104.38 13.68 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.578 -0.701 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.5 mt -46.13 -87.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.4 mtm105 -139.66 -63.31 0.51 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.259 -0.9 . . . . 0.0 109.605 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -152.81 40.38 0.56 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.379 -0.825 . . . . 0.0 109.477 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.26 -101.66 0.63 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -107.24 -162.11 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -1.08 . . . . 0.0 109.787 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -131.21 -173.33 3.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.101 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LYS . 12.6 tp60 -139.78 116.43 10.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.957 -1.089 . . . . 0.0 110.333 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.709 ' CD2' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -83.57 116.84 22.78 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 2.6 m-20 -89.01 128.36 35.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.623 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 1.7 mm? -99.69 102.9 14.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.843 . . . . 0.0 109.012 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.715 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 17.8 m-70 -111.72 108.69 18.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 110.15 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -108.71 112.32 24.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.235 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.903 ' C ' HD23 ' A' ' 62' ' ' LEU . 15.9 t90 -105.25 138.64 41.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 110.516 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.903 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -128.14 117.11 21.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -61.65 24.95 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.687 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.5 t-20 56.09 2.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.336 -1.097 . . . . 0.0 110.029 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 63' ' ' GLY . 78.2 mt-10 -103.09 2.47 34.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 108.902 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 36.1 t -95.38 145.82 24.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 109.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 69' ' ' ASP . 93.5 p -83.92 140.2 32.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 109.554 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 67' ' ' SER . 17.7 pt20 -44.4 -24.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.4 m-20 -57.32 -57.96 10.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -87.61 -39.68 14.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 108.921 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.72 -59.65 4.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.27 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -40.18 48.88 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.58 59.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -1.125 . . . . 0.0 109.194 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.66 -46.16 70.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 0.0 109.005 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.87 -23.43 67.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.046 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -81.07 -53.99 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.862 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 16.2 m-85 -67.29 -30.35 70.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.502 ' CG2' HD12 ' A' ' 58' ' ' LEU . 55.2 m -72.87 -41.71 64.43 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.35 -54.99 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.98 -1.075 . . . . 0.0 109.747 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -61.51 -59.59 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.783 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -53.42 -43.14 67.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.068 -1.02 . . . . 0.0 108.901 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' THR . 7.3 t0 -48.7 -48.68 40.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.088 -1.008 . . . . 0.0 108.749 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -59.28 -35.11 73.15 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.527 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 10.0 t80 -74.49 -22.43 59.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.3 tp -82.17 -54.78 4.99 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 89' ' ' ALA . 5.6 m120 -122.89 -42.7 2.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.735 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.23 -13.69 62.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -156.17 19.8 0.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -58.3 -172.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.63 150.02 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.19 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -110.9 110.7 21.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.997 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 7.7 m-70 -110.23 120.32 42.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 108.909 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 8.6 ptt180 -114.43 125.96 54.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.288 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.606 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -126.64 120.3 29.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.96 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 96' ' ' GLN . 3.6 t -112.55 37.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.36 -0.838 . . . . 0.0 109.841 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' O ' ' A' ' 95' ' ' VAL . 11.3 tt0 58.82 124.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.506 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.46 -36.87 4.1 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -132.21 51.97 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -1.104 . . . . 0.0 109.596 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -58.58 179.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.6 m -103.54 156.0 18.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.72 83.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.509 HG22 ' NZ ' ' A' ' 45' ' ' LYS . 1.3 m -65.42 -48.22 73.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.13 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 107' ' ' PHE . 30.1 t80 -58.33 -44.16 88.57 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.314 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.73 -30.74 71.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.1 91.64 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -49.54 65.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -1.185 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.427 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 45.6 m-85 -98.13 65.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -87.52 -34.41 18.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -96.6 2.46 52.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -86.36 -104.44 0.77 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.7 mm? 54.57 101.69 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.328 -1.101 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 11.9 tttt -168.15 91.79 0.32 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.86 108.02 15.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.402 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -96.47 113.01 24.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.28 139.35 55.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 117' ' ' GLY . . . -151.62 -50.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 116' ' ' GLY . . . 42.97 31.28 1.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.4 t -49.63 -26.5 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 109.399 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.09 68.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -84.19 6.15 23.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.302 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -51.53 -24.8 12.37 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.51 -26.64 55.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.202 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -70.99 -51.5 25.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.426 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.597 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 0.5 OUTLIER -72.23 43.89 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.425 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.86 132.95 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.187 -0.945 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -99.12 110.99 59.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.369 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 128' ' ' ASN . 77.8 Cg_exo -46.38 150.83 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.419 2.079 . . . . 0.0 112.21 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 127' ' ' PRO . 5.7 p30 -43.14 153.4 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 131' ' ' VAL . 25.0 tt0 -56.5 -17.11 7.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.91 -17.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 129' ' ' GLU . 10.8 p -57.0 -34.0 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.96 -28.15 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.489 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 2' ' ' HIS . 16.7 tt0 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.492 ' ND1' ' N ' ' A' ' 2' ' ' HIS . 1.0 OUTLIER -43.49 154.92 0.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.41 138.98 36.95 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.593 2.195 . . . . 0.0 112.281 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 4' ' ' GLU . 2.6 pt-20 -66.51 -25.22 66.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CD2' ' CD2' ' A' ' 24' ' ' LEU . 41.5 t80 -56.38 -24.83 47.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.1 tt -60.78 -31.17 70.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.232 -0.918 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 8' ' ' ALA . 81.9 mttt -104.65 -46.92 4.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.603 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.36 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 55.21 29.47 52.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.1 ptpt -42.3 -25.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 109.595 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 9' ' ' GLY . 6.0 mt-10 -147.86 148.96 31.85 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.5 134.67 6.9 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.725 2.283 . . . . 0.0 112.156 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -158.05 24.69 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.48 143.1 50.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -1.059 . . . . 0.0 109.4 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HB2' ' CZ2' ' A' ' 17' ' ' TRP . 9.2 mt-30 -130.34 146.29 51.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 41.0 mt -116.07 137.7 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.852 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.603 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 6.2 m0 -142.44 111.71 6.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.16 145.23 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 109.645 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -84.83 143.58 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 17.5 tt0 -158.13 81.08 0.84 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.516 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.8 tttp 72.22 33.27 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER 66.57 17.0 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.5 t70 -95.74 -27.12 15.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' CD2' ' CD2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER 62.9 134.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -149.63 134.11 9.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.087 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 27' ' ' VAL . 37.8 Cg_endo -69.99 110.14 2.53 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.282 1.988 . . . . 0.0 112.209 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' PRO . 9.8 p -40.8 135.59 1.59 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.081 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.66 127.74 24.64 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.271 1.98 . . . . 0.0 112.349 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 30' ' ' ASN . 17.6 m -63.21 -32.51 73.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.378 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 29' ' ' THR . 42.6 t30 -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.178 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.6 mp -99.19 -55.2 2.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' LEU . 2.7 t80 47.46 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.463 -0.773 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.579 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.82 -13.3 8.14 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.24 143.91 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 109.185 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 18.2 m-85 -141.34 142.76 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 114' ' ' LYS . 4.8 m-85 -86.8 106.81 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 0.0 108.941 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.557 ' C ' ' H ' ' A' ' 39' ' ' ASP . 23.8 p -51.93 -52.5 49.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.869 . . . . 0.0 110.035 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . -61.56 7.86 0.14 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 37' ' ' THR . 0.5 OUTLIER -133.81 172.51 12.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -1.182 . . . . 0.0 109.476 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.98 151.81 30.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.908 . . . . 0.0 109.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -131.06 121.86 25.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.616 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.47 HG11 ' OG1' ' A' ' 78' ' ' THR . 21.4 t -97.71 118.93 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.081 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -117.08 143.2 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.553 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -124.96 129.46 50.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.77 -0.581 . . . . 0.0 109.836 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.12 93.61 4.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 109.648 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.421 ' CG2' HD22 ' A' ' 54' ' ' LEU . 2.4 m -72.78 103.06 3.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.513 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -102.63 164.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -125.43 129.93 50.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.559 -0.713 . . . . 0.0 109.28 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.4 mt -66.62 -98.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.0 mtp85 -134.75 -49.51 0.76 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -157.38 31.92 0.28 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.366 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.401 ' O ' ' OD1' ' A' ' 53' ' ' ASN . . . -116.33 -88.03 1.39 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 52' ' ' GLY . 9.2 m-20 -143.32 -162.31 1.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -1.166 . . . . 0.0 109.433 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -132.45 163.81 27.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.322 -0.861 . . . . 0.0 109.439 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -135.45 141.27 45.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.573 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -99.71 119.36 37.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.208 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 6.6 m-20 -73.38 120.23 18.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.768 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.0 tm? -93.7 115.44 27.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.592 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -132.88 121.5 22.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.379 -0.826 . . . . 0.0 109.811 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 93' ' ' ARG . 0.3 OUTLIER -99.19 129.65 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.034 . . . . 0.0 108.792 178.599 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.887 ' C ' HD23 ' A' ' 62' ' ' LEU . 18.3 t90 -108.85 126.65 53.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.831 . . . . 0.0 110.156 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.887 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -133.76 116.3 15.57 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 65' ' ' GLU . . . -68.24 34.25 0.25 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.577 ' H ' ' C ' ' A' ' 62' ' ' LEU . 30.5 t30 49.73 10.9 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -1.025 . . . . 0.0 110.08 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 63' ' ' GLY . 59.5 mt-10 -110.41 4.59 20.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 108.934 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.68 144.03 28.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.593 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 69' ' ' ASP . 2.0 p -67.41 125.5 26.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -50.69 -9.18 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 67' ' ' SER . 17.9 t0 -75.5 -44.12 45.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.494 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -87.25 -45.72 10.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.256 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.602 ' OG ' HD13 ' A' ' 62' ' ' LEU . 6.9 t -51.71 -50.34 60.71 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.92 -52.09 51.14 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.45 -39.15 6.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.84 -39.87 83.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.99 . . . . 0.0 109.213 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -67.49 -31.0 70.83 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.284 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.79 -48.55 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 0.0 110.181 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.33 -33.67 76.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 109.296 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -81.35 -47.14 13.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 75' ' ' ALA . 61.6 t -61.47 -45.66 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.903 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.22 -57.82 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.513 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 81' ' ' LEU . 2.2 tm? -52.33 -49.72 63.7 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.009 -1.057 . . . . 0.0 108.835 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 78' ' ' THR . 20.2 m-20 -46.56 -49.48 18.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 0.0 108.41 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 87' ' ' GLY . 7.6 m-20 -54.61 -31.95 57.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 81' ' ' LEU . 9.7 t80 -65.39 -28.81 69.53 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 81' ' ' LEU . 16.4 mt -83.92 -58.11 2.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -121.76 13.46 10.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.135 -0.978 . . . . 0.0 110.666 -179.024 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 51.32 5.96 0.14 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 86' ' ' ASN . 34.1 mtp180 -147.19 -83.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.369 -1.077 . . . . 0.0 109.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 60.09 141.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 90' ' ' VAL . 2.8 t -73.94 139.61 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -102.59 138.14 39.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 58' ' ' LEU . 20.5 m-70 -140.09 135.71 32.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 7.8 ptp85 -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 22.5 mt-10 -129.26 81.04 2.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.313 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 95' ' ' VAL . 14.5 t -78.95 38.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.875 . . . . 0.0 109.575 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 63.19 72.39 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.605 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.425 ' O ' ' OE1' ' A' ' 99' ' ' GLU . . . 150.96 -60.86 0.41 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -88.32 57.94 4.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -1.135 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 18.9 mp0 -77.23 -165.14 0.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 94.2 p -133.98 159.9 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.19 78.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.1 m -61.34 -60.29 3.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 44.0 t80 -52.53 -38.0 58.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.06 -31.62 66.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.06 95.42 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.69 -52.38 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -1.196 . . . . 0.0 109.568 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.45 80.61 1.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -96.57 -37.74 10.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.583 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -102.43 9.93 39.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -89.98 -107.99 1.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.657 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.5 mm? 51.23 100.36 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.291 -1.123 . . . . 0.0 109.361 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -148.71 114.3 5.64 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.3 OUTLIER -81.93 111.55 18.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.76 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 1.8 mmpt? -105.49 113.14 26.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.315 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -53.9 125.56 19.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.419 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -101.03 -124.29 5.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.74 27.89 64.09 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.14 -19.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -1.175 . . . . 0.0 109.553 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.17 -24.43 66.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 t -104.3 6.01 35.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.99 -24.44 64.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.525 ' C ' ' H ' ' A' ' 124' ' ' HIS . 32.6 m-85 -57.35 -20.29 28.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -1.128 . . . . 0.0 109.419 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 124' ' ' HIS . 18.1 mtpp -62.13 4.19 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.525 ' H ' ' C ' ' A' ' 122' ' ' PHE . 1.6 t-80 77.36 111.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.454 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -135.02 125.9 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -125.83 81.61 65.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.564 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.7 165.5 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.818 2.345 . . . . 0.0 112.273 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.426 ' OD1' ' CD ' ' A' ' 129' ' ' GLU . 12.3 t-20 -74.43 -173.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.653 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -77.17 -28.82 54.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.389 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.14 -31.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.631 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.81 -54.18 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.602 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.48 -28.52 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.511 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 48.93 63.53 10.25 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.487 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.2 24.29 0.31 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.821 2.347 . . . . 0.0 112.102 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -71.64 -41.08 69.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.454 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.408 ' CD2' ' C ' ' A' ' 5' ' ' PHE . 33.7 p90 -66.33 -27.55 67.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -68.67 -34.51 75.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.45 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -96.48 -59.79 1.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.569 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.639 ' HB3' HD21 ' A' ' 85' ' ' LEU . . . 59.38 136.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.78 . . . . 0.0 109.407 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.63 ' CA ' ' NE2' ' A' ' 15' ' ' GLN . . . 45.5 46.02 12.01 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLY . 25.9 mtmt -43.22 -33.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -1.11 . . . . 0.0 109.384 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.541 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -140.71 169.29 11.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.847 . . . . 0.0 109.392 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -46.07 134.17 14.82 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.755 2.303 . . . . 0.0 112.328 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.95 -168.48 26.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 tt -123.63 144.03 49.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -1.091 . . . . 0.0 109.393 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.63 ' NE2' ' CA ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -131.05 149.41 52.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 109.448 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.1 mp -124.56 133.0 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.7 m0 -142.08 126.64 17.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.284 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.88 143.89 26.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.089 -1.007 . . . . 0.0 109.363 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.11 143.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 53.5 tt0 -138.28 95.75 3.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 78.78 -62.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 109.009 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 12.1 m-85 -171.72 22.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.667 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.67 111.76 14.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.757 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp -74.03 132.78 42.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.16 112.33 11.14 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.252 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -45.56 135.04 12.85 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.424 2.083 . . . . 0.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 27' ' ' VAL . 1.2 p -78.64 127.54 80.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.12 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.26 122.61 1.26 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.441 2.094 . . . . 0.0 112.442 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 30' ' ' ASN . 7.3 m -64.04 -27.99 69.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 29' ' ' THR . 31.1 t-20 -45.72 -43.3 12.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.079 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.691 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.2 mp -90.38 -53.63 4.36 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.302 -0.874 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.8 t80 51.62 92.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.542 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.53 -31.31 4.65 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.598 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 45.9 t0 -68.81 134.53 49.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.241 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 25.8 m-85 -142.36 139.89 31.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.623 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -77.74 104.27 8.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -0.868 . . . . 0.0 109.35 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.3 p -45.73 -27.38 0.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.382 -0.824 . . . . 0.0 109.775 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.86 -32.07 41.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.486 ' OD2' ' OE2' ' A' ' 70' ' ' GLU . 35.6 t0 -92.12 172.73 8.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.091 -1.24 . . . . 0.0 109.476 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.93 140.73 46.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.375 -0.828 . . . . 0.0 109.374 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CE1' ' A' ' 36' ' ' PHE . 46.0 m-85 -121.03 135.23 55.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.631 HG21 ' OG1' ' A' ' 78' ' ' THR . 33.7 t -111.16 144.21 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.54 146.19 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -126.51 121.37 32.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.51 94.17 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.935 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.538 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 8.6 m -77.46 103.37 7.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.384 -0.822 . . . . 0.0 109.551 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -91.5 164.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.243 -0.91 . . . . 0.0 109.316 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -111.46 103.29 11.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt -48.35 -57.37 6.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.443 ' O ' ' CG ' ' A' ' 51' ' ' ASN . 23.8 mtp180 -140.22 -63.35 0.49 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.348 -0.845 . . . . 0.0 109.54 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.443 ' CG ' ' O ' ' A' ' 50' ' ' ARG . 9.7 m120 -168.0 23.35 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.229 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 54' ' ' LEU . . . -156.89 -58.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -82.52 138.59 34.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -1.175 . . . . 0.0 109.719 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -130.75 176.97 7.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.322 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' HG23 ' A' ' 47' ' ' VAL . 6.5 tp60 -147.98 126.0 12.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.538 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 12.0 m-85 -90.97 130.98 36.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.044 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.26 124.76 37.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 108.781 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.54 HD11 ' CG ' ' A' ' 82' ' ' ASP . 9.3 mt -88.76 110.93 21.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.776 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.701 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 19.5 m-70 -124.26 108.7 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.324 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.712 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -103.25 121.3 42.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.165 -0.959 . . . . 0.0 108.668 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.827 ' C ' HD23 ' A' ' 62' ' ' LEU . 3.7 t90 -92.39 125.42 37.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.827 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -128.08 105.56 8.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.55 17.35 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.622 ' H ' ' C ' ' A' ' 62' ' ' LEU . 40.1 t30 65.95 1.74 1.98 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -1.078 . . . . 0.0 109.82 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -105.11 7.6 33.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.03 . . . . 0.0 109.101 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 15.5 t -101.82 131.02 48.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.602 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 m -52.3 153.76 2.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -73.25 -9.09 58.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.574 ' OD2' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -80.87 -38.2 28.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.588 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.574 ' N ' ' OD2' ' A' ' 69' ' ' ASP . 64.0 tt0 -87.34 -45.74 10.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.202 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.452 ' OG ' HD13 ' A' ' 62' ' ' LEU . 12.8 t -53.95 -50.34 66.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.498 -0.751 . . . . 0.0 109.266 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -46.42 93.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.89 -45.5 30.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.68 72.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.208 -0.933 . . . . 0.0 109.058 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.36 -20.28 64.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 109.023 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.3 -56.1 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.36 -0.837 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.85 -25.8 65.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.631 ' OG1' HG21 ' A' ' 42' ' ' VAL . 45.4 m -78.18 -42.55 31.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 0.0 109.438 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 75' ' ' ALA . 71.8 t -76.09 -41.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.707 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -69.06 -59.35 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 81' ' ' LEU . 2.1 tm? -53.51 -51.89 61.35 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.615 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.54 ' CG ' HD11 ' A' ' 58' ' ' LEU . 4.5 t70 -45.49 -46.39 13.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.39 -33.44 59.24 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' LEU . 28.5 t80 -66.3 -28.58 68.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.639 HD21 ' HB3' ' A' ' 8' ' ' ALA . 2.7 mp -76.1 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.175 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -121.75 -42.39 2.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.173 -0.954 . . . . 0.0 110.255 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.77 -20.15 8.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.647 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 34.0 mtt85 -128.25 -85.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.402 -1.058 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 72.57 162.64 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.613 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.18 150.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.567 ' NE2' ' N ' ' A' ' 91' ' ' GLN . 2.5 mp0 -109.77 132.7 53.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.701 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 33.1 m-70 -139.34 111.86 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -103.29 124.56 48.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 3.9 mt-10 -117.46 86.48 2.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 0.0 109.366 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.59 37.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.555 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 56.25 91.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.383 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 137.11 -54.55 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -100.37 56.0 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -1.126 . . . . 0.0 109.203 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 5.3 mp0 -83.95 158.26 21.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.9 . . . . 0.0 109.58 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.5 165.23 12.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.313 -0.867 . . . . 0.0 109.287 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.47 -30.22 66.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 m -61.92 -60.22 3.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.603 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 36.0 t80 -54.11 -46.61 72.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 109.35 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 104' ' ' LEU . 35.0 mt -67.88 -28.24 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 109.282 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.83 -42.93 99.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -69.42 -47.41 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -1.066 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -105.21 52.78 0.73 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -81.48 -30.08 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 m -57.89 -8.11 0.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.897 . . . . 0.0 109.742 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.6 111.6 3.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.676 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -75.89 -106.89 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.312 -1.111 . . . . 0.0 109.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 171.46 112.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.0 107.89 17.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -112.66 143.2 44.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.8 pttp -70.33 137.07 50.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.423 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -86.07 178.68 49.6 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 140.35 56.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -92.04 -24.12 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -1.107 . . . . 0.0 109.474 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.86 -23.16 36.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.9 m -74.23 6.33 3.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 123' ' ' LYS . . . -71.67 -41.73 56.16 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 124' ' ' HIS . 1.2 p90 -46.11 -23.31 0.3 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.534 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 122' ' ' PHE . 35.3 ttpt -35.36 -30.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 109.806 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 122' ' ' PHE . 8.8 m80 -64.89 127.23 30.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.299 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 t -67.98 138.09 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 109.462 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.2 t -128.03 78.32 75.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.377 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.92 127.95 18.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 112.292 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -58.1 127.59 32.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.6 -19.23 57.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.38 -25.32 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.86 -54.13 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -51.8 -29.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.475 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.7 pm0 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -81.92 149.76 63.96 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.375 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.14 84.87 1.28 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.622 2.214 . . . . 0.0 112.344 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -50.89 -24.75 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.157 -0.964 . . . . 0.0 109.272 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -45.43 -41.01 8.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.417 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 6' ' ' LEU . 35.9 tp -95.03 -32.23 13.24 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.346 -0.846 . . . . 0.0 109.422 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttp -103.24 33.74 3.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.391 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.611 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -40.26 143.57 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.807 . . . . 0.0 109.619 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 52.43 56.98 14.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.77 -27.34 11.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.35 157.4 45.42 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.378 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.95 123.31 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.782 2.321 . . . . 0.0 112.272 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.7 -172.24 33.75 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.41 143.08 45.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.398 -1.06 . . . . 0.0 109.524 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -133.89 145.01 49.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.898 . . . . 0.0 109.48 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.603 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 16.2 mt -118.3 139.46 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.611 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 6.7 m0 -143.37 110.91 5.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -77.9 139.6 39.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -84.6 143.08 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -0.896 . . . . 0.0 109.202 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' PHE . 24.4 tt0 -158.51 122.2 3.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.54 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 19.1 mmtt 40.59 22.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.51 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' GLU . 2.1 m-85 71.1 44.56 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m-20 -127.09 -13.92 5.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.7 mp 58.81 131.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.2 t -150.91 111.29 3.1 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.06 123.98 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.51 2.14 . . . . 0.0 112.272 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 27' ' ' VAL . 15.0 p -56.36 133.54 76.23 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 109.31 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.49 106.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -58.32 -25.46 61.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -51.74 -47.28 64.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.37 -54.74 4.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.3 t80 53.58 93.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.232 -0.918 . . . . 0.0 109.318 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.44 -4.91 9.4 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 24.6 t0 -108.23 131.72 54.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.382 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -146.08 167.52 23.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 109.662 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -99.31 122.27 42.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.232 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.7 p -59.64 -27.32 66.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.809 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 26.49 5.92 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.9 t70 -142.69 -166.99 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.308 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -141.04 140.95 34.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.639 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 23.8 m-85 -123.57 129.45 51.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -100.93 137.55 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.4 mt -132.89 146.39 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.3 mp -128.84 131.14 47.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.544 -0.723 . . . . 0.0 109.569 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -113.72 93.68 4.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.682 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.585 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 5.9 m -78.17 105.66 9.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.658 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -100.6 164.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.301 -0.874 . . . . 0.0 109.132 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -121.13 140.78 51.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.538 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.0 mt -80.19 -95.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -140.16 -34.05 0.55 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.235 -0.915 . . . . 0.0 109.524 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.493 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 29.0 t-20 -175.11 33.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.309 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.43 -89.5 1.12 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -136.45 -155.15 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -1.103 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.833 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -134.16 171.73 13.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 109.378 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 47' ' ' VAL . 35.7 tt0 -134.89 123.39 23.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.941 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 6.2 m-85 -95.36 126.01 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.594 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.6 m-20 -97.41 119.52 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.927 -1.108 . . . . 0.0 108.962 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.481 HD11 ' CG ' ' A' ' 82' ' ' ASP . 2.7 mt -83.1 141.35 32.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 11.8 m-70 -145.91 108.72 4.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.21 114.69 28.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 108.624 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.677 ' C ' HD23 ' A' ' 62' ' ' LEU . 77.3 t90 -90.51 125.55 35.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.913 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.677 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -129.13 114.35 16.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' CD ' ' A' ' 96' ' ' GLN . . . -67.22 11.44 0.73 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.549 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.5 t30 67.33 1.72 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.527 -0.984 . . . . 0.0 109.77 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -112.3 9.97 19.96 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.56 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 9.6 p -98.45 126.7 44.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -46.65 123.47 5.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.128 -0.982 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.455 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 8.3 pm0 -48.19 -25.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.511 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -53.94 -43.34 69.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -87.41 -31.52 20.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.152 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.524 ' OG ' HD13 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -62.18 -59.74 4.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.377 -0.827 . . . . 0.0 109.499 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -54.78 -52.3 47.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.66 -41.07 9.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.381 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.66 92.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.164 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -66.81 -38.51 86.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.209 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.58 -45.63 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 109.637 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -68.28 -35.68 78.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.5 m -75.64 -41.9 52.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 75' ' ' ALA . 80.7 t -74.18 -43.87 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.166 -0.959 . . . . 0.0 109.943 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -67.91 -59.35 3.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.8 tm? -53.92 -51.88 62.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.911 -1.118 . . . . 0.0 108.881 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.481 ' CG ' HD11 ' A' ' 58' ' ' LEU . 4.7 t70 -45.98 -45.81 15.96 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 108.567 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -58.64 -30.85 67.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 27.0 t80 -69.31 -23.15 63.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.436 HD21 HD11 ' A' ' 81' ' ' LEU . 46.2 mt -83.58 -61.28 1.88 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.422 -0.799 . . . . 0.0 110.948 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.513 ' ND2' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -123.04 -43.41 2.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.976 -1.078 . . . . 0.0 111.361 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.87 -3.37 58.74 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.57 62.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -1.191 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.941 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -102.63 168.37 9.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.288 -0.882 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.51 150.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -115.5 136.13 53.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.057 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.474 ' CB ' ' HD1' ' A' ' 59' ' ' HIS . 31.5 m-70 -136.45 124.22 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -114.09 121.54 44.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.862 . . . . 0.0 109.798 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -114.25 93.44 4.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.278 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.5 37.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.615 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.436 ' CD ' ' O ' ' A' ' 63' ' ' GLY . 17.4 tt0 61.53 110.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.42 -38.55 3.28 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.06 50.29 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.181 . . . . 0.0 109.534 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.87 155.91 39.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 153.8 21.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.57 70.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 m -65.71 -62.93 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 3.5 t80 -51.85 -30.74 24.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.353 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 105' ' ' GLY . 7.8 mt -73.13 -57.39 4.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 104' ' ' LEU . . . -45.19 -34.92 4.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -75.62 -59.71 2.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.492 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.482 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 19.6 m-85 -96.35 57.48 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.594 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -84.89 -33.39 22.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 t -96.06 -11.59 26.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -79.49 -104.11 0.24 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 110' ' ' GLY . 81.6 mt 48.5 98.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.21 -1.17 . . . . 0.0 109.329 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -152.93 116.23 4.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -91.87 107.82 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -112.27 108.74 18.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.0 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -54.14 120.27 6.24 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.91 -37.47 6.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 112.82 21.92 5.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.69 -16.69 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.205 -1.173 . . . . 0.0 109.43 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -55.32 -21.87 16.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.7 m -66.0 6.06 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -52.09 -19.98 6.11 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -59.72 -23.78 63.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -1.175 . . . . 0.0 109.432 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -52.64 -33.88 48.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.421 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -94.18 104.75 16.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.305 -0.872 . . . . 0.0 109.506 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.0 t -80.09 130.37 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.94 87.72 6.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.579 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 129' ' ' GLU . 53.0 Cg_exo -51.46 130.15 32.0 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.698 2.265 . . . . 0.0 112.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.3 p-10 -60.49 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.155 -0.965 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 127' ' ' PRO . 29.9 mt-10 -87.97 -17.83 30.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.873 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.4 t -50.55 -47.94 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.524 HG13 ' N ' ' A' ' 132' ' ' VAL . 7.1 p -68.7 -42.65 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.524 ' N ' HG13 ' A' ' 131' ' ' VAL . 98.9 t -67.1 -28.13 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.497 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.468 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.494 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -167.22 73.06 1.02 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.181 -0.949 . . . . 0.0 109.507 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.62 135.79 41.37 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.841 2.361 . . . . 0.0 112.175 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.06 -28.63 69.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -62.32 -30.58 71.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -48.72 -35.22 13.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 0.0 109.348 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.604 ' O ' HD22 ' A' ' 85' ' ' LEU . 33.8 mmtt -108.51 -28.74 9.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 109.717 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.599 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 51.97 62.84 2.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.536 ' N ' ' OE1' ' A' ' 15' ' ' GLN . . . 106.74 38.46 2.2 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.9 pttp -41.66 -23.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.625 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -138.93 157.7 71.12 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.371 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -39.82 136.5 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.799 2.333 . . . . 0.0 112.184 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.14 179.37 24.05 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 4.3 tt -115.45 148.33 39.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -1.012 . . . . 0.0 109.735 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.536 ' OE1' ' N ' ' A' ' 9' ' ' GLY . 25.5 mt-30 -145.03 154.68 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 0.0 109.682 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.619 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -126.93 152.26 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.769 -0.582 . . . . 0.0 110.06 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.4 m-90 -155.08 110.91 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.425 -0.797 . . . . 0.0 109.233 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.469 HH11 ' CD ' ' A' ' 28' ' ' PRO . 3.1 ttp180 -75.49 127.64 33.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 109.345 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -69.8 144.17 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.159 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 22' ' ' PHE . 13.8 tp10 -155.83 121.44 4.94 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.547 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 43.6 tttt 44.07 23.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 109.399 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 70.19 41.46 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 24' ' ' LEU . 11.6 t70 -127.14 -13.14 5.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' ASP . 13.0 mt 56.43 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.6 t -138.02 125.04 13.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.219 -0.925 . . . . 0.0 109.183 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.44 140.93 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.477 2.118 . . . . 0.0 112.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 27' ' ' VAL . 14.2 p -79.3 134.27 59.13 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -0.847 . . . . 0.0 109.347 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.529 ' CB ' ' OD1' ' A' ' 30' ' ' ASN . 77.7 Cg_exo -40.2 103.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.477 2.118 . . . . 0.0 112.18 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -49.27 -37.93 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 1.2 p30 -45.52 -39.72 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 6.2 mp -86.15 -55.58 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 31' ' ' LEU . 44.2 t80 45.19 90.73 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.593 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.7 -31.3 4.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 1.1 m-20 -85.97 137.5 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.085 -1.244 . . . . 0.0 109.249 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 22.9 m-85 -146.07 153.72 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -76.91 128.21 34.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 108.901 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 p -74.22 -26.46 60.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 110.021 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.01 -22.9 62.57 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.1 t70 -94.94 -160.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.685 ' HB3' HG11 ' A' ' 19' ' ' VAL . . . -136.26 141.0 43.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.377 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -125.21 125.59 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.448 HG11 ' OG1' ' A' ' 78' ' ' THR . 16.9 t -93.87 127.83 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.476 HG23 HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -138.28 145.08 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 109.163 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -144.55 167.06 23.41 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.048 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 1.7 tmmm? -146.28 94.31 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.458 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 63.7 m -72.16 126.88 30.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.374 -0.829 . . . . 0.0 109.833 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.44 164.79 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.636 -0.665 . . . . 0.0 109.515 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.461 ' O ' ' C ' ' A' ' 49' ' ' LEU . 62.9 tt0 -126.26 102.01 6.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.6 -0.687 . . . . 0.0 109.203 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 48' ' ' GLN . 80.0 mt -40.09 -82.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -0.955 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 -139.72 -54.48 0.55 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.394 -0.816 . . . . 0.0 109.426 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -168.81 24.1 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 109.36 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.2 -78.58 1.05 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 18.2 p-10 -137.86 158.0 45.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -1.194 . . . . 0.0 109.597 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -110.9 167.15 10.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.354 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.6 tt0 -127.21 117.39 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -0.949 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.531 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 5.2 m-85 -71.75 108.73 5.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 87.1 m-20 -72.56 118.05 15.0 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.924 -1.11 . . . . 0.0 108.152 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -102.81 119.21 38.43 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.071 -1.018 . . . . 0.0 109.747 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.624 ' CE1' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -144.29 116.91 8.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 109.657 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.734 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.45 140.33 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 108.819 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.777 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.2 t90 -100.65 127.02 47.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.777 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -127.69 108.67 10.95 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.09 12.58 0.11 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.618 ' H ' ' C ' ' A' ' 62' ' ' LEU . 41.9 t30 66.53 1.87 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -1.13 . . . . 0.0 109.845 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.97 5.32 32.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.067 -1.021 . . . . 0.0 108.973 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 67' ' ' SER . 34.5 t -101.15 116.8 33.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 66' ' ' CYS . 12.7 p -42.23 125.32 3.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.554 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 1.6 mp0 -45.01 -28.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.62 -42.11 82.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.596 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -87.5 -38.89 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.486 ' OG ' HD13 ' A' ' 62' ' ' LEU . 1.9 t -59.53 -57.59 12.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.13 -40.53 36.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.95 -52.65 62.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.294 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.98 65.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.181 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -72.59 -20.3 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -81.0 -46.89 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -66.38 -36.08 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.51 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.24 -41.46 61.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 75' ' ' ALA . 24.5 t -61.37 -52.12 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.731 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.91 -59.61 5.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 109.783 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.764 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -53.14 -44.37 67.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 108.738 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' LEU . 10.9 t0 -46.72 -48.25 20.38 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.923 -1.11 . . . . 0.0 108.114 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.77 -27.91 69.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.764 ' HB3' HD13 ' A' ' 81' ' ' LEU . 37.9 t80 -75.91 -24.09 55.57 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 7' ' ' LYS . 39.6 mt -81.03 -53.88 6.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.895 . . . . 0.0 109.574 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -121.84 -42.32 2.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.4 -0.812 . . . . 0.0 109.891 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.33 -22.42 7.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.4 mtp180 -142.39 -85.39 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.386 -1.067 . . . . 0.0 109.278 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 58.68 161.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.4 t -98.39 135.31 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.507 ' OE1' ' OH ' ' A' ' 60' ' ' TYR . 1.1 pp0? -121.98 133.28 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.301 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.556 ' CD2' ' HB3' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -135.59 159.83 40.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.308 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -121.75 136.54 54.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 96' ' ' GLN . 23.7 mt-10 -108.43 87.54 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.528 -0.733 . . . . 0.0 109.145 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.2 t -74.48 37.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.867 . . . . 0.0 109.885 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 95' ' ' VAL . 2.1 tt0 54.73 106.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.78 -54.87 0.69 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 99' ' ' GLU . 13.8 m-85 -115.19 36.53 3.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -1.104 . . . . 0.0 109.254 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 98' ' ' PHE . 13.1 mt-10 -44.28 169.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 t -95.98 165.81 12.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.96 67.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.4 m -66.76 -49.96 64.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' ' CD1' ' A' ' 61' ' ' TRP . 67.8 t80 -64.0 -46.45 84.5 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 108' ' ' LYS . 26.7 mt -68.77 -32.67 72.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.65 -55.13 32.52 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.76 -47.01 87.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -1.115 . . . . 0.0 109.327 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.45 48.89 0.85 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' LEU . 42.6 tttm -68.97 -23.61 64.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 t -76.21 3.69 10.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.71 110.58 2.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.728 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.1 -101.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -1.116 . . . . 0.0 109.188 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 172.07 107.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.107 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.69 107.94 17.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -105.18 122.59 46.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -60.39 166.18 3.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.1 124.7 1.35 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -102.24 24.12 32.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.8 t -51.77 -28.5 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -1.218 . . . . 0.0 109.442 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.2 -24.6 54.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.195 -0.941 . . . . 0.0 109.433 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.2 t -84.24 6.07 24.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 124' ' ' HIS . . . -75.95 -50.85 7.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -54.24 -30.31 49.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -1.189 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -78.93 1.43 23.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.892 . . . . 0.0 109.615 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 121' ' ' GLY . 2.4 t-160 -146.03 129.15 16.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.945 . . . . 0.0 109.393 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.67 146.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.482 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.35 86.18 21.34 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 109.343 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.04 126.01 14.37 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.767 2.311 . . . . 0.0 112.224 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -79.41 -172.57 3.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.33 -29.04 21.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.98 -27.38 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.08 -40.24 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.942 . . . . 0.0 109.416 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.58 -27.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.414 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.335 0.588 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -146.3 67.05 11.64 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.15 109.77 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.813 2.342 . . . . 0.0 112.242 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.12 -15.25 51.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 109.427 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.481 ' C ' HD22 ' A' ' 6' ' ' LEU . 8.2 m-85 -54.66 -35.4 63.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.408 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.8 mm? -95.46 -12.14 26.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.276 -0.89 . . . . 0.0 109.527 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 8' ' ' ALA . 33.4 tttm -82.56 -19.53 38.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.53 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -43.62 130.44 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.075 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 8' ' ' ALA . . . 41.68 40.84 3.11 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -48.75 -26.12 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -1.11 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -135.18 157.96 75.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.88 118.9 5.24 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.792 2.328 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.5 -158.02 29.45 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.17 148.27 48.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -1.021 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.416 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 9.1 mt-30 -143.98 141.77 30.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.221 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.36 123.98 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.927 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.53 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 1.9 m0 -131.06 129.75 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -87.17 144.92 26.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.917 . . . . 0.0 109.584 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.45 143.34 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' A' ' 23' ' ' ASP . 25.0 tt0 -151.54 99.89 2.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 6.4 ttmm 48.48 38.49 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.378 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 66.29 20.67 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 24' ' ' LEU . 7.0 m-20 -98.74 -21.67 16.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.1 mt 57.21 122.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.48 133.47 23.65 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 109.219 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.93 117.66 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.343 2.029 . . . . 0.0 112.379 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.24 134.62 90.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.17 136.07 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.275 1.983 . . . . 0.0 112.328 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -57.65 -30.26 65.26 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -45.86 -42.11 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 32' ' ' TYR . 8.4 mp -90.34 -55.73 3.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.208 -0.932 . . . . 0.0 109.268 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.8 t80 36.2 83.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.585 -0.697 . . . . 0.0 109.888 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.68 -31.38 4.6 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -91.48 126.22 36.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.248 . . . . 0.0 109.151 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.686 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.61 168.26 21.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.918 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.542 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -80.56 158.13 25.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.093 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -101.68 -11.19 19.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.64 -7.73 61.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.3 t70 -105.58 -155.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -1.149 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.71 141.4 31.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.543 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -124.36 121.94 36.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.22 135.7 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.529 ' O ' HD22 ' A' ' 44' ' ' LEU . 2.4 mt -121.52 146.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.796 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 43' ' ' ILE . 4.0 mm? -118.74 125.38 49.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' GLN . 7.6 ttpp -120.82 93.79 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.053 -1.03 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.655 HG23 ' CE2' ' A' ' 56' ' ' TYR . 91.7 m -85.98 101.34 12.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.581 -0.699 . . . . 0.0 109.455 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.22 164.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.35 -0.844 . . . . 0.0 109.15 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.592 ' OE1' ' N ' ' A' ' 50' ' ' ARG . 1.1 tm0? -120.55 112.6 19.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.748 . . . . 0.0 109.603 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 48' ' ' GLN . 12.6 mt -46.27 -88.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.152 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.592 ' N ' ' OE1' ' A' ' 48' ' ' GLN . 6.8 mmt85 -134.85 -41.51 0.76 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.335 -0.853 . . . . 0.0 109.215 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -176.36 29.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.35 -103.42 2.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.542 ' CG ' ' H ' ' A' ' 54' ' ' LEU . 45.9 t30 -102.19 -178.63 3.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 109.782 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.542 ' H ' ' CG ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -119.28 172.41 7.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.465 -0.772 . . . . 0.0 109.323 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.521 ' O ' ' O ' ' A' ' 45' ' ' LYS . 4.1 tp-100 -131.43 110.75 11.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.655 ' CE2' HG23 ' A' ' 46' ' ' THR . 7.7 m-85 -86.32 109.67 19.14 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.618 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -84.01 127.59 33.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 1.1 mm? -96.51 107.25 19.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.548 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.647 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 75.3 m-70 -115.96 108.57 16.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.717 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.7 120.27 39.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.676 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.686 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 56.5 t90 -102.34 124.91 48.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.987 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.719 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -128.93 118.67 23.04 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.0 16.95 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.719 ' H ' ' C ' ' A' ' 62' ' ' LEU . 34.5 t-20 61.77 2.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -1.031 . . . . 0.0 109.815 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.3 mt-10 -109.4 13.14 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.165 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.7 t -99.91 140.16 34.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.604 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.2 t -61.25 146.54 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.67 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -62.68 -23.48 67.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.11 -49.77 76.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.731 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.49 -43.65 11.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.316 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -55.89 -53.82 52.13 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -60.18 -51.24 60.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.51 -35.14 3.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -1.191 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.19 -45.81 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.02 -31.77 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.2 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.48 -52.47 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -58.44 -44.41 89.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.249 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -67.15 -44.55 79.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 75' ' ' ALA . 58.4 t -69.62 -65.11 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' VAL . 8.3 mm100 -43.36 -59.42 2.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.104 -0.998 . . . . 0.0 109.422 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -52.12 -37.05 53.02 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.069 -1.019 . . . . 0.0 108.641 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -52.01 -52.59 49.68 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.057 -1.027 . . . . 0.0 108.725 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.547 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 7.4 t70 -57.78 -30.52 65.72 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -79.24 -23.73 43.5 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.0 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.54 HD23 ' CD1' ' A' ' 56' ' ' TYR . 11.4 tp -84.74 -46.04 11.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 110.101 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -122.02 -42.21 2.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 109.987 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.93 -15.8 51.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -154.06 24.21 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -52.77 -179.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.63 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.45 150.19 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.442 ' HG2' ' H ' ' A' ' 91' ' ' GLN . 15.9 pt20 -108.44 133.31 52.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.953 . . . . 0.0 109.682 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.647 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 15.8 m-70 -132.35 121.2 23.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.243 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -108.48 127.75 54.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.963 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 96' ' ' GLN . 8.3 mp0 -126.62 78.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.416 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.8 t -68.75 37.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.507 ' O ' ' O ' ' A' ' 95' ' ' VAL . 39.2 tp60 39.27 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.461 -0.775 . . . . 0.0 109.615 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 150.3 -19.24 1.05 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 29.9 m-85 -162.95 47.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.39 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' CE2' ' A' ' 103' ' ' PHE . 2.3 mt-10 -62.65 -179.41 0.26 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.17 172.39 7.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.434 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.35 -31.36 71.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.506 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -63.17 -62.62 1.57 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.582 ' CE2' ' OE1' ' A' ' 99' ' ' GLU . 16.6 t80 -52.52 -38.27 59.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.88 -24.72 61.71 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.06 -43.24 57.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -70.33 -42.54 71.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -1.214 . . . . 0.0 109.639 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.54 73.25 0.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -98.37 -31.55 11.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -104.12 7.99 36.35 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -102.14 -111.75 3.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 110' ' ' GLY . 8.5 mp 53.09 102.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.334 -1.097 . . . . 0.0 109.405 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -145.37 108.39 4.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -82.34 107.98 15.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 0.0 109.614 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.01 108.91 16.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 109.298 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -83.4 130.96 35.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 145.63 -133.4 5.01 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 120' ' ' SER . . . 168.55 86.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 117' ' ' GLY . 22.6 t -43.93 -28.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -78.56 -27.01 45.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 117' ' ' GLY . 70.7 m -65.53 6.15 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -82.13 -59.52 2.28 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.42 ' O ' ' C ' ' A' ' 123' ' ' LYS . 3.2 m-85 -85.84 -19.76 30.14 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.215 -1.167 . . . . 0.0 109.451 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 124' ' ' HIS . 20.6 tttp -42.87 -52.19 5.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 109.505 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.495 ' O ' ' O ' ' A' ' 123' ' ' LYS . 2.2 m-70 54.24 166.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.42 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.48 111.03 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 126' ' ' VAL . 12.2 p -100.64 117.33 62.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -44.77 129.2 9.29 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -62.6 136.41 57.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -52.31 -17.48 1.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.0 t -46.87 -34.92 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.7 t -49.66 -60.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.12 -27.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.522 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.628 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -77.11 -42.49 2.63 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 26.9 Cg_exo -59.53 -33.71 97.02 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.704 2.269 . . . . 0.0 112.149 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 7' ' ' LYS . 1.0 OUTLIER -53.94 -57.14 12.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -47.53 -36.14 9.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.138 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 6' ' ' LEU . 11.0 mp -79.89 -23.99 41.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.361 -0.837 . . . . 0.0 109.26 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 4' ' ' GLU . 2.0 ttmp? -64.85 -43.61 92.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -50.88 145.29 7.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.03 57.21 2.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 12.5 mmtp -132.89 -10.33 3.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.241 -1.152 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 58.0 mt-10 -160.17 150.41 15.03 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.284 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.61 156.36 57.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.55 2.166 . . . . 0.0 111.916 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.29 -141.47 15.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 15' ' ' GLN . 2.4 tt -127.86 144.9 51.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.406 -1.055 . . . . 0.0 110.062 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.409 ' N ' ' HG ' ' A' ' 14' ' ' LEU . 3.9 mt-30 -135.78 150.55 49.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 109.057 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.619 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.9 mp -124.96 145.32 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.83 . . . . 0.0 110.409 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -146.37 110.89 5.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.421 -0.799 . . . . 0.0 108.942 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' VAL . 12.4 ttp85 -81.09 129.63 34.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 0.0 109.672 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -87.06 143.64 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 12.2 tm-20 -153.8 88.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? 60.6 50.51 5.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 53.6 47.61 23.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.516 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 24' ' ' LEU . 49.9 t0 -126.99 -25.91 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.4 mp 59.39 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.4 -0.812 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' ARG . 51.7 t -145.94 103.22 4.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 27' ' ' VAL . 63.3 Cg_exo -47.77 108.28 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.287 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 26' ' ' PRO . 10.1 t -43.34 107.49 0.57 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.417 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.99 137.74 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.406 2.07 . . . . 0.0 112.223 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 m -62.0 -24.93 67.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -48.13 -45.29 32.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.258 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -94.94 -55.46 3.09 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 31' ' ' LEU . 12.4 t80 42.24 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 109.75 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.597 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.43 -30.87 4.82 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -79.83 137.66 37.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.083 -1.245 . . . . 0.0 109.392 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 57.2 m-85 -136.95 160.46 38.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.05 105.54 15.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.385 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.2 p -57.85 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.95 -30.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.8 m-20 -111.23 -153.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.45 -1.03 . . . . 0.0 109.014 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.7 145.38 44.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.532 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -121.2 127.62 51.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.419 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.68 103.87 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.61 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -121.39 144.34 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 109.193 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.736 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.1 pt? -147.55 172.43 14.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 110.193 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -145.82 99.88 3.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 111.489 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -72.52 118.91 16.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 108.908 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.07 164.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.497 -0.752 . . . . 0.0 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -126.97 120.88 30.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.538 -0.726 . . . . 0.0 109.258 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.95 -95.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.253 -0.905 . . . . 0.0 109.435 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -140.24 -34.9 0.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.936 . . . . 0.0 109.507 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.457 ' O ' ' CG ' ' A' ' 51' ' ' ASN . 18.5 t-20 -175.84 32.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.349 -0.845 . . . . 0.0 109.197 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -116.16 -82.69 0.98 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -142.22 -167.37 2.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 109.526 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -126.65 158.94 35.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 109.321 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -126.05 114.11 17.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.653 ' CG ' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.61 109.87 17.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.079 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.612 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -86.76 103.0 14.78 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.444 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 1.1 mt -95.95 143.1 27.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.172 -0.955 . . . . 0.0 110.444 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.628 ' HB3' ' CD2' ' A' ' 92' ' ' HIS . 1.5 p-80 -154.1 131.83 11.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.465 -0.772 . . . . 0.0 109.623 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.739 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -98.02 118.62 35.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 108.921 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.804 ' O ' HD23 ' A' ' 62' ' ' LEU . 12.1 t90 -85.35 130.36 34.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.302 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 61' ' ' TRP . 0.6 OUTLIER -131.4 111.51 11.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 15.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.616 ' H ' ' C ' ' A' ' 62' ' ' LEU . 12.4 t-20 66.65 1.83 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.341 -1.093 . . . . 0.0 109.713 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -107.3 10.79 29.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 108.983 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 18.4 t -105.0 146.1 29.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -73.67 166.22 23.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.862 . . . . 0.0 109.359 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -76.35 -8.98 58.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.3 -46.52 49.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.12 -36.74 17.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 109.456 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.655 ' OG ' HD13 ' A' ' 62' ' ' LEU . 16.9 t -60.72 -58.31 9.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.13 -41.38 78.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -49.93 61.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.436 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.05 87.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -69.45 -20.46 63.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.134 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mm -79.49 -52.25 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -33.1 73.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 108.994 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 16.4 m -74.33 -36.55 63.67 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.242 -0.911 . . . . 0.0 109.6 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 75' ' ' ALA . 47.4 t -75.18 -54.61 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -61.75 -59.49 5.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.692 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.736 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -51.97 -47.14 64.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.101 -0.999 . . . . 0.0 108.792 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.728 ' OD1' ' HB3' ' A' ' 89' ' ' ALA . 5.0 t0 -46.37 -47.66 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.971 -1.08 . . . . 0.0 108.523 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.11 -30.77 69.49 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' A' ' 81' ' ' LEU . 31.7 t80 -75.86 -23.57 55.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mt -78.07 -52.49 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -122.02 -42.2 2.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.04 -11.0 57.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 -150.2 18.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -1.175 . . . . 0.0 109.8 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.728 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . -63.51 -178.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.516 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.1 145.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.357 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.427 ' OE1' ' OD2' ' A' ' 82' ' ' ASP . 2.3 pm0 -136.69 126.78 26.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.628 ' CD2' ' HB3' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -125.26 160.24 29.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.861 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.404 ' CB ' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -111.37 136.78 50.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.112 -0.993 . . . . 0.0 109.939 -179.324 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.9 mm-40 -118.81 101.81 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 95' ' ' VAL . 8.3 p -88.46 37.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.241 -0.912 . . . . 0.0 109.693 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 57.12 66.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.398 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.39 -59.7 0.29 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -92.22 33.12 1.1 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.457 ' OE2' ' CD1' ' A' ' 61' ' ' TRP . 2.6 mt-10 -72.28 -154.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.425 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -138.05 156.87 47.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 109.385 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.27 -21.07 12.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.6 m -61.6 -60.57 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.095 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.677 ' CE1' ' NE1' ' A' ' 61' ' ' TRP . 72.3 t80 -61.12 -50.28 73.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.525 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 104' ' ' LEU . 89.3 mt -70.34 -18.68 63.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.157 -0.964 . . . . 0.0 109.142 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -69.81 -41.95 71.78 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -71.92 -43.38 65.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -1.112 . . . . 0.0 109.052 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -107.51 54.21 0.67 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.532 ' C ' ' H ' ' A' ' 110' ' ' GLY . 25.8 tttm -81.39 -33.5 32.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.912 . . . . 0.0 109.678 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.0 t -60.7 3.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.74 109.58 2.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.481 HD13 ' H ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -72.39 -101.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -1.173 . . . . 0.0 109.15 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.481 ' H ' HD13 ' A' ' 111' ' ' LEU . 6.7 mttm 165.26 136.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.65 107.89 17.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.494 -0.754 . . . . 0.0 109.235 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -114.26 132.06 56.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.903 . . . . 0.0 109.554 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 116' ' ' GLY . 29.0 mtmt -65.12 110.02 2.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 109.385 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -42.77 161.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.17 60.21 5.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.36 -28.27 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.333 -1.098 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.76 71.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.439 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 m -97.63 6.18 48.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.329 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 124' ' ' HIS . . . -61.41 -27.9 68.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -62.52 -32.77 73.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -86.5 -4.89 59.24 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 121' ' ' GLY . 23.2 m-70 -134.77 117.67 16.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.385 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 125' ' ' VAL . 4.9 p -122.36 129.08 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.429 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.37 82.46 23.14 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' ASN . 59.4 Cg_endo -79.01 132.99 10.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.666 2.244 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' PRO . 10.5 m-20 -41.29 146.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -88.07 -17.2 31.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.36 -22.24 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.72 -34.65 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.3 -29.63 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.427 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.436 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.493 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.8 pm0 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -72.75 134.12 81.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.887 . . . . 0.0 109.373 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.66 95.19 0.87 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.515 2.143 . . . . 0.0 112.26 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 8' ' ' ALA . 15.4 mt-10 -83.05 -51.43 7.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.502 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 4' ' ' GLU . 12.5 p90 -44.86 -33.65 2.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.969 . . . . 0.0 109.393 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt -75.37 -36.72 60.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 8' ' ' ALA . 8.4 ttmt -104.93 23.43 13.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.212 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.55 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -37.55 140.24 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.445 -0.784 . . . . 0.0 109.803 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 78.48 51.45 5.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -61.96 1.43 0.29 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -1.2 . . . . 0.0 109.172 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 9' ' ' GLY . 2.6 mt-10 176.35 138.66 0.21 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.448 -0.783 . . . . 0.0 108.938 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -39.77 125.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.574 2.183 . . . . 0.0 112.223 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.02 -157.18 27.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.414 HD12 ' NZ ' ' A' ' 45' ' ' LYS . 5.8 tt -112.43 133.65 54.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 3.9 mm-40 -119.73 157.7 28.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.366 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.568 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.6 mt -134.98 142.59 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.707 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.3 m-90 -149.46 110.69 4.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' VAL . 6.3 ttt180 -89.21 139.41 30.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.88 143.33 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 69.5 tt0 -136.0 111.29 9.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.484 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 26.2 tttp 51.36 43.7 29.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 4.5 t80 73.88 25.72 1.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 20' ' ' GLU . 2.5 m-20 -126.96 111.76 14.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.405 HD22 ' HB3' ' A' ' 5' ' ' PHE . 3.9 tp -58.71 141.57 52.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.494 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 18' ' ' ARG . 73.8 t -138.64 121.42 10.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.185 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.25 115.2 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.34 2.026 . . . . 0.0 112.342 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.72 135.06 23.25 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.139 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 32' ' ' TYR . 31.0 Cg_endo -67.13 97.94 0.43 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.3 2.0 . . . . 0.0 112.183 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 46.9 m -52.19 -24.46 7.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.566 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -76.74 -19.73 57.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mt -132.2 13.55 4.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.791 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -71.29 -104.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 67.76 -17.09 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.555 ' H ' ' C ' ' A' ' 32' ' ' TYR . 18.9 t0 -102.49 140.2 37.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.133 -1.216 . . . . 0.0 109.379 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -129.9 119.79 23.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.107 -0.996 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -76.32 102.78 6.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.52 HG21 ' HB3' ' A' ' 113' ' ' TYR . 82.1 p -61.32 -31.59 71.44 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 110.075 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.9 24.53 5.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 24.8 t0 -143.29 -156.42 0.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -1.124 . . . . 0.0 109.294 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.53 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.6 140.73 31.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CZ ' ' HD2' ' A' ' 18' ' ' ARG . 34.3 m-85 -121.87 124.35 43.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.623 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 46.5 t -101.47 115.11 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.074 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -116.14 145.22 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.264 -0.898 . . . . 0.0 109.872 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.4 mp -126.55 151.27 48.12 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -140.45 93.35 2.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.791 -1.193 . . . . 0.0 110.833 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.599 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 29.9 m -89.88 98.63 11.88 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.53 164.63 2.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.32 -0.862 . . . . 0.0 109.812 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -125.56 127.25 46.09 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.83 -100.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.133 -0.979 . . . . 0.0 109.491 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -140.23 -34.54 0.53 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.176 -0.953 . . . . 0.0 109.549 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -167.54 42.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.372 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.84 -98.24 0.96 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -134.06 -155.44 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -1.181 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -126.47 157.21 39.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.389 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' LYS . 8.7 tt0 -117.36 98.86 6.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.484 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 9.5 m-85 -75.83 123.53 25.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -103.0 147.59 26.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.932 -1.105 . . . . 0.0 108.64 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' HIS . 0.7 OUTLIER -124.66 109.1 12.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.361 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -131.17 116.17 17.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 109.528 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.714 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.87 129.32 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.793 ' C ' HD23 ' A' ' 62' ' ' LEU . 15.8 t90 -101.69 127.24 48.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 110.167 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.793 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -129.44 108.93 10.65 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -64.43 20.05 0.1 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 62' ' ' LEU . 38.5 t30 59.54 2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.079 . . . . 0.0 110.016 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 63' ' ' GLY . 17.8 mt-10 -102.29 2.38 36.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.968 -1.083 . . . . 0.0 108.898 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.437 ' SG ' ' CG ' ' A' ' 70' ' ' GLU . 48.1 t -100.72 140.13 35.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -67.28 155.35 39.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.594 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.9 -8.88 24.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.49 -52.1 20.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' CG ' ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -87.57 -37.15 17.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 62' ' ' LEU . 7.6 t -62.5 -60.08 4.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.514 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.53 37.4 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.8 -37.65 6.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.391 -1.064 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.54 -39.16 85.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.202 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -69.69 -32.82 71.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 109.446 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.411 HG22 ' OE1' ' A' ' 80' ' ' GLN . 3.3 mt -79.13 -43.51 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.42 -40.64 97.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.89 -44.31 32.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.694 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.9 t -62.79 -45.77 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 110.214 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 14.7 pt20 -67.62 -50.57 57.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.992 -1.068 . . . . 0.0 110.217 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -62.33 -47.04 85.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.779 -1.201 . . . . 0.0 108.357 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' LEU . 1.6 t0 -45.87 -46.95 16.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.74 -32.16 71.45 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.723 ' HB3' HD13 ' A' ' 81' ' ' LEU . 41.6 t80 -69.57 -23.05 63.5 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 8' ' ' ALA . 46.5 mt -83.08 -62.01 1.71 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.414 -0.803 . . . . 0.0 110.762 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -122.57 -43.19 2.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.995 -1.066 . . . . 0.0 111.293 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.57 6.67 63.93 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -149.52 10.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -1.12 . . . . 0.0 109.906 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -56.0 177.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.46 133.8 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.157 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.541 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 3.1 mp0 -97.63 138.0 35.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 110.193 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.549 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 9.7 m-70 -139.5 129.82 25.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -0.814 . . . . 0.0 109.249 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -113.25 126.02 54.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.985 . . . . 0.0 109.819 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.469 ' OE2' ' O ' ' A' ' 60' ' ' TYR . 2.0 mp0 -127.15 84.56 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 95' ' ' VAL . 8.9 p -81.64 37.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 7.7 tt0 70.66 52.66 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.39 -53.39 0.25 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -94.13 55.62 2.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.4 mp0 -78.99 -161.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -138.81 170.87 15.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.48 -30.46 64.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.8 m -66.38 -39.5 89.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.372 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -73.52 -51.1 18.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.36 -0.837 . . . . 0.0 109.491 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 104' ' ' LEU . 92.3 mt -68.53 -17.52 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.15 -40.65 13.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD1' HD13 ' A' ' 14' ' ' LEU . 1.6 t80 -82.43 -32.72 28.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -1.128 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -101.35 96.46 7.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.643 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -96.87 -63.63 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.173 -0.954 . . . . 0.0 109.402 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -100.96 11.96 38.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.395 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.714 ' C ' HD23 ' A' ' 111' ' ' LEU . . . -102.98 65.14 0.39 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.714 HD23 ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -147.07 95.05 2.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.316 -1.108 . . . . 0.0 109.0 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.61 114.32 21.01 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.52 ' HB3' HG21 ' A' ' 37' ' ' THR . 1.0 OUTLIER -81.43 107.65 14.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.382 -0.823 . . . . 0.0 109.8 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -111.86 109.03 18.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.313 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -64.44 135.99 56.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.34 132.26 2.53 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 121' ' ' GLY . . . -137.25 101.82 0.36 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 117' ' ' GLY . 57.7 t -43.14 -31.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -1.121 . . . . 0.0 109.457 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.08 -32.17 39.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 117' ' ' GLY . 8.5 t -104.17 6.14 35.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.905 . . . . 0.0 109.414 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 117' ' ' GLY . . . -81.74 -20.89 62.68 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -80.03 -20.89 44.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -1.173 . . . . 0.0 109.446 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -53.62 -53.28 54.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.441 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -99.7 168.59 9.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 109.531 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.97 147.1 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.21 71.86 76.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.452 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.02 150.66 9.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.814 2.343 . . . . 0.0 112.266 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -75.21 141.6 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.519 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -76.6 -26.34 54.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.486 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -65.4 -23.86 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.15 -30.71 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.03 -30.2 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.448 179.977 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.322 0.582 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.686 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.6 OUTLIER -92.81 -38.8 0.35 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 109.728 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 26.1 Cg_exo -60.04 113.16 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.619 2.213 . . . . 0.0 112.123 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -65.0 -12.87 55.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.446 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -50.92 -22.97 2.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 mt -67.82 -21.65 65.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.546 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -104.86 -56.89 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.437 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.545 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 59.47 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.402 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 50.68 27.08 11.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' GLY . 1.6 pttt -42.33 -21.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 109.231 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -130.98 157.99 76.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.53 119.92 7.37 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.7 2.267 . . . . 0.0 112.006 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.19 -150.25 21.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.499 HD13 ' CD2' ' A' ' 106' ' ' TYR . 3.4 tt -132.38 144.81 50.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 0.0 109.591 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -136.61 148.21 47.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.458 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -121.3 138.41 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.593 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.6 m0 -141.98 111.0 6.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.458 HH22 HG11 ' A' ' 25' ' ' VAL . 3.6 ttt-85 -71.45 135.85 47.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -78.49 143.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -0.997 . . . . 0.0 109.426 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 89.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.311 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 63.38 28.56 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER 71.03 16.98 6.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 24' ' ' LEU . 73.0 m-20 -99.83 -14.29 18.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.6 mt 57.25 136.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.458 HG11 HH22 ' A' ' 18' ' ' ARG . 47.3 t -142.72 115.73 6.21 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.74 143.83 6.09 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.362 2.041 . . . . 0.0 112.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.44 125.02 81.89 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.45 111.84 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.487 2.125 . . . . 0.0 112.148 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.2 m -63.83 -25.51 68.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -45.71 -41.11 10.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.306 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.31 -54.98 2.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.4 t80 55.62 95.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.353 -0.842 . . . . 0.0 109.369 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.49 -31.03 4.76 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.4 m-20 -89.93 128.37 36.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -1.119 . . . . 0.0 109.191 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.698 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.27 167.92 22.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.915 . . . . 0.0 109.777 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CD1' ' OH ' ' A' ' 41' ' ' TYR . 3.9 m-85 -85.14 154.91 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.346 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 p -95.14 -9.44 33.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.528 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.0 26.79 22.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.09 -162.13 1.32 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -1.163 . . . . 0.0 109.324 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.35 141.08 33.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 22.2 m-85 -128.79 122.51 30.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.359 -0.838 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.506 HG21 ' OG1' ' A' ' 78' ' ' THR . 38.6 t -96.57 141.65 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.437 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.569 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 mt -137.71 146.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 109.363 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.3 mp -129.71 131.63 46.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.685 . . . . 0.0 109.586 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -114.53 94.19 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.595 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 7.6 m -77.24 101.77 6.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.323 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.449 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -99.14 164.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -126.47 117.44 22.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.6 -0.688 . . . . 0.0 109.274 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.4 mt -54.29 -92.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -140.31 -38.0 0.46 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.28 -0.887 . . . . 0.0 109.677 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -174.49 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.91 -82.9 1.2 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -145.44 160.28 41.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -1.177 . . . . 0.0 109.468 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -99.56 167.35 10.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.387 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -137.96 134.8 35.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.805 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.595 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 11.7 m-85 -92.82 128.8 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 108.824 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.614 ' CG ' ' HE2' ' A' ' 59' ' ' HIS . 34.8 t0 -91.09 116.3 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 108.92 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' CD2' HG22 ' A' ' 78' ' ' THR . 6.0 mp -81.76 126.53 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.692 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.72 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 27.5 m-70 -142.44 108.53 5.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.112 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.713 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.42 129.17 50.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.022 . . . . 0.0 108.961 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.698 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 6.0 t90 -96.71 129.56 44.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.375 -0.828 . . . . 0.0 110.03 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.647 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.1 mt -134.44 106.34 7.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.7 9.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.647 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER 69.23 1.22 3.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -1.091 . . . . 0.0 109.607 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -113.65 12.59 18.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.48 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 3.0 p -97.86 134.6 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.537 -0.727 . . . . 0.0 109.406 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 66' ' ' CYS . 1.3 m -43.65 152.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.18 -20.69 57.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.152 -0.967 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -68.59 -35.06 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -87.03 -28.63 22.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.518 ' OG ' HD13 ' A' ' 62' ' ' LEU . 22.8 t -64.32 -60.05 3.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 0.0 109.385 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.76 -46.49 91.76 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -46.6 -43.71 17.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -1.116 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.59 50.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 109.036 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.42 -20.09 41.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 108.89 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mm -81.59 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.33 -0.856 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.3 -26.8 68.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 108.446 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.599 HG22 ' CD2' ' A' ' 58' ' ' LEU . 37.5 m -76.78 -50.59 13.15 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.682 -0.636 . . . . 0.0 109.382 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 75' ' ' ALA . 87.1 t -67.89 -36.36 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.834 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -66.07 -58.84 4.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.744 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -55.04 -46.48 75.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.935 -1.103 . . . . 0.0 109.193 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.549 ' HB3' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -47.64 -47.41 29.24 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.741 -1.224 . . . . 0.0 108.145 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.7 t70 -63.01 -24.44 67.92 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.744 ' HB3' HD13 ' A' ' 81' ' ' LEU . 37.0 t80 -78.13 -23.71 47.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD21 HD12 ' A' ' 81' ' ' LEU . 36.1 mt -83.35 -53.94 5.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.232 -0.917 . . . . 0.0 109.777 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -122.0 -42.37 2.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.184 -0.948 . . . . 0.0 110.094 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.16 -8.42 8.52 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.575 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 59.8 mtt-85 -144.07 -84.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -1.099 . . . . 0.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 68.11 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.586 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.59 149.85 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.66 143.08 45.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.293 -0.879 . . . . 0.0 109.912 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.72 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 36.2 m-70 -142.39 121.91 13.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.468 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 15.7 ptt180 -108.9 121.24 44.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -112.52 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.409 HG12 ' OD1' ' A' ' 64' ' ' ASN . 2.1 t -80.45 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 66.29 53.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.544 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 99' ' ' GLU . . . 162.78 -53.23 0.3 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -77.28 30.67 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.503 ' OE2' HD21 ' A' ' 104' ' ' LEU . 7.7 mt-10 -59.81 150.83 27.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.8 t -99.88 162.69 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.46 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.4 m -63.65 -62.71 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.364 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.559 ' CE1' ' CD2' ' A' ' 107' ' ' PHE . 69.4 t80 -54.69 -37.0 65.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.407 -0.808 . . . . 0.0 109.491 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.503 HD21 ' OE2' ' A' ' 99' ' ' GLU . 98.3 mt -71.84 -22.67 61.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.5 -30.16 46.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.499 ' CD2' HD13 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -85.81 -41.38 15.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.559 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 96.8 m-85 -105.11 76.15 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.508 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.9 -30.89 11.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -98.82 8.73 44.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -101.88 -111.06 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 110' ' ' GLY . 72.7 mt 44.52 96.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.272 -1.134 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -155.4 110.55 3.01 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 107.85 16.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.392 -0.818 . . . . 0.0 109.587 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -103.84 108.83 20.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -65.24 134.05 52.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 109.468 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.33 176.8 14.54 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 120' ' ' SER . . . -152.33 117.11 0.79 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 117' ' ' GLY . 73.8 t -43.15 -65.15 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -1.124 . . . . 0.0 109.454 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.24 -25.97 4.22 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.497 -0.752 . . . . 0.0 109.493 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 117' ' ' GLY . 3.5 t -75.4 6.18 4.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.414 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -49.4 -40.38 30.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -72.91 -26.3 61.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -1.145 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -72.39 -33.23 67.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -143.56 117.9 9.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.45 147.12 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 t -138.06 110.95 8.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 109.365 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 128' ' ' ASN . 78.3 Cg_exo -45.93 133.66 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.389 2.059 . . . . 0.0 112.335 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 127' ' ' PRO . 29.4 m-20 -43.12 147.71 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.25 -22.93 59.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 130' ' ' VAL . 14.4 t -52.63 -37.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.29 -36.35 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.19 -27.4 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.503 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.417 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.592 ' OE2' ' ND1' ' A' ' 2' ' ' HIS . 1.1 tm-20 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.592 ' ND1' ' OE2' ' A' ' 1' ' ' GLU . 6.4 m170 52.92 63.76 8.13 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.41 111.61 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.809 2.339 . . . . 0.0 112.151 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -80.53 -28.86 37.25 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.676 ' CD2' HD22 ' A' ' 24' ' ' LEU . 7.2 t80 -53.83 -22.94 10.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -79.63 -8.43 59.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.568 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 8' ' ' ALA . 15.4 mtmm -125.16 -53.16 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.608 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.585 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 58.86 150.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.153 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 10' ' ' LYS . . . 43.13 40.81 4.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HZ3' ' HB2' ' A' ' 10' ' ' LYS . 18.7 mtmm -42.06 -28.14 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.419 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.554 ' OE2' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -145.64 149.05 38.87 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.249 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -39.85 123.01 1.15 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.628 2.219 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 -168.04 34.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 14' ' ' LEU . 7.2 tt -120.65 129.54 53.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -1.018 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.66 ' N ' HD23 ' A' ' 14' ' ' LEU . 10.9 mt-30 -124.4 163.96 20.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.594 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.2 mt -136.42 137.02 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 109.778 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.594 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.2 m0 -141.6 131.36 24.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.458 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 25' ' ' VAL . 59.9 ttp180 -95.24 144.88 25.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.898 . . . . 0.0 109.599 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.428 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 0.4 OUTLIER -108.45 143.38 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.2 tp10 -130.04 91.5 3.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.5 tttp 78.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.606 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 77' ' ' PHE . 10.5 t80 -160.8 16.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.909 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -127.47 114.89 18.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 109.716 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.676 HD22 ' CD2' ' A' ' 5' ' ' PHE . 8.8 mp -59.6 149.0 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ARG . 60.5 t -154.1 118.29 2.67 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.11 152.16 0.66 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.455 2.104 . . . . 0.0 112.199 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 27' ' ' VAL . 12.7 p -102.13 132.78 21.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -42.42 136.79 3.99 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.536 2.157 . . . . 0.0 112.353 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -70.2 -28.42 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.335 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -60.68 -40.33 91.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' O ' ' C ' ' A' ' 32' ' ' TYR . 7.8 mp -76.85 -55.46 5.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.862 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 31' ' ' LEU . 9.9 t80 35.4 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.522 -0.736 . . . . 0.0 109.928 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 115.28 -31.45 6.21 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.23 120.48 27.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -1.186 . . . . 0.0 109.189 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.684 ' CD1' ' CH2' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.67 168.49 21.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 110.043 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' GLY . 22.6 m-85 -86.29 106.95 17.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 109.276 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -46.93 -10.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . -91.05 19.09 48.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.56 -164.65 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -1.175 . . . . 0.0 109.394 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.4 140.61 37.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.663 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -131.05 164.18 25.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.818 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.6 131.34 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.875 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.407 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -115.94 145.62 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.296 -0.878 . . . . 0.0 109.648 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -121.84 147.99 45.27 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HZ1' ' HB3' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -145.69 93.34 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.027 -1.046 . . . . 0.0 110.297 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.611 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 32.1 m -88.58 108.52 19.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.491 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.53 163.9 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.297 -0.877 . . . . 0.0 108.95 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -67.58 157.8 33.56 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.612 0.72 . . . . 0.0 110.657 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.636 ' H ' HD12 ' A' ' 49' ' ' LEU . 2.9 mp -69.47 -34.13 73.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.551 -0.718 . . . . 0.0 109.52 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' H ' ' HG2' ' A' ' 50' ' ' ARG . 15.7 mmp_? -46.87 -34.13 5.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 108.95 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -76.85 -21.58 54.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.503 -0.748 . . . . 0.0 109.068 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 146.0 65.0 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 54' ' ' LEU . 3.8 t-20 62.18 139.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -1.177 . . . . 0.0 109.721 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.474 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.3 pp -41.42 128.39 3.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.444 -0.785 . . . . 0.0 108.944 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' LYS . 3.4 tt0 -124.69 102.31 7.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.147 -0.971 . . . . 0.0 110.765 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.677 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 6.9 m-85 -82.08 109.47 16.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.455 ' HB3' ' HZ1' ' A' ' 45' ' ' LYS . 21.8 t0 -83.45 148.66 27.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.978 -1.076 . . . . 0.0 108.551 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.488 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -130.18 125.9 36.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -137.01 108.91 7.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 109.575 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.705 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.54 114.29 25.01 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 108.558 179.292 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.684 ' CH2' ' CD1' ' A' ' 35' ' ' PHE . 68.8 t90 -86.69 118.38 26.06 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.358 -0.839 . . . . 0.0 109.688 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' ASN . 1.0 OUTLIER -123.2 105.92 10.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.55 -0.719 . . . . 0.0 109.097 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 64' ' ' ASN . . . -56.58 1.19 0.11 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' LEU . 13.4 t-20 70.3 1.65 3.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.509 -0.995 . . . . 0.0 109.731 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -111.88 15.05 20.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 108.896 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.3 t -105.62 145.99 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 109.622 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.2 t -55.36 156.96 3.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.05 -26.45 48.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.184 -0.947 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -41.15 78.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.696 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 19' ' ' VAL . 33.4 tt0 -87.32 -42.66 12.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 t -57.71 -54.05 51.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.728 . . . . 0.0 109.512 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.52 -53.42 43.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.49 -39.27 7.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.462 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.33 86.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.179 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.7 -32.6 74.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.384 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.72 -48.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.802 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 22' ' ' PHE . 1.5 m-85 -62.75 -42.45 99.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.955 . . . . 0.0 109.372 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -68.73 -41.82 78.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.51 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 78' ' ' THR . 52.0 t -73.03 -61.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.438 -0.789 . . . . 0.0 110.02 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -56.87 -59.63 4.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.912 . . . . 0.0 110.06 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.5 tm? -51.82 -47.71 64.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.147 . . . . 0.0 108.937 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 81' ' ' LEU . 3.1 t0 -46.85 -48.69 20.95 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.876 -1.14 . . . . 0.0 108.496 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.24 -31.67 65.77 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.55 ' N ' ' O ' ' A' ' 81' ' ' LEU . 38.5 t80 -70.81 -23.67 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.11 -59.37 2.8 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -122.21 -42.4 2.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.343 -0.848 . . . . 0.0 110.14 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 -21.5 6.66 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 29.7 mtp85 -138.2 -85.5 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -1.114 . . . . 0.0 109.296 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 65.33 176.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.71 150.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -123.88 140.25 53.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -0.873 . . . . 0.0 109.818 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.506 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 11.5 m-70 -137.59 137.99 39.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 109.204 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 ptp180 -120.24 124.83 46.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -119.6 94.66 4.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.184 -0.948 . . . . 0.0 109.539 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.3 37.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 61.4 105.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.462 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 103.01 -36.29 4.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -107.2 32.09 4.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.8 mp0 -70.39 -177.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 p -110.6 168.02 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.358 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -69.65 -32.73 71.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.6 m -60.83 -57.65 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.094 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 40.4 t80 -53.91 -48.94 69.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.494 -0.754 . . . . 0.0 109.259 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.94 -24.36 64.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 109.042 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -60.68 -50.34 68.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 107' ' ' PHE . 22.2 m-85 -69.29 -44.32 72.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -134.29 86.81 2.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.169 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.526 ' O ' HD21 ' A' ' 111' ' ' LEU . 2.0 pttt -89.3 -63.84 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.401 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 2.0 t -105.86 9.81 32.71 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.527 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.37 63.16 0.28 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.704 ' O ' ' CB ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -137.81 -115.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.189 -1.183 . . . . 0.0 108.858 179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.704 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 6.6 tptm 138.28 121.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.476 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 1.8 p90 -103.22 107.98 19.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.472 -0.768 . . . . 0.0 109.524 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -101.93 120.54 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -53.8 132.92 42.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.495 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.03 -123.48 2.23 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.53 17.27 60.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.12 -53.48 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -1.163 . . . . 0.0 109.556 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.4 -32.11 64.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.381 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.8 m -101.38 6.15 42.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.77 -28.04 71.4 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -66.24 -29.81 70.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -1.135 . . . . 0.0 109.458 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.48 -3.34 36.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -66.13 86.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.412 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 126' ' ' VAL . 6.7 t -69.75 146.99 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 125' ' ' VAL . 75.7 t -155.34 88.25 3.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 128' ' ' ASN . 52.7 Cg_exo -49.06 166.17 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.626 2.217 . . . . 0.0 112.252 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 127' ' ' PRO . 84.2 m-20 -39.87 109.69 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.625 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -50.75 -25.67 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.496 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.3 t -50.67 -25.24 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.373 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.74 -47.69 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.477 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.5 -31.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.478 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.586 ' O ' ' ND1' ' A' ' 2' ' ' HIS . 23.4 tt0 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.586 ' ND1' ' O ' ' A' ' 1' ' ' GLU . 2.8 m-70 -141.77 65.68 20.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.154 -0.966 . . . . 0.0 109.424 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.59 59.76 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.755 2.303 . . . . 0.0 112.348 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.01 -30.97 27.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.377 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -48.37 -31.81 6.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.618 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.8 mm? -82.41 -29.6 30.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -64.8 -31.12 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.55 161.35 30.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.363 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.476 ' CA ' HD21 ' A' ' 85' ' ' LEU . . . 61.37 53.21 46.11 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 20.2 mtpp -142.16 -8.68 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 63.9 mt-10 -158.52 149.69 16.47 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.409 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.82 170.34 20.59 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.627 2.218 . . . . 0.0 112.173 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.66 -137.2 13.9 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.3 142.17 35.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -1.127 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 3.7 mp0 -127.54 146.93 50.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.274 -0.891 . . . . 0.0 109.343 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.545 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 24.8 mt -117.63 135.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.72 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.8 m0 -141.84 110.85 6.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -83.09 131.31 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.543 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -91.95 143.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.353 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -152.81 111.85 3.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.2 ttmt 46.77 31.62 1.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.416 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.1 m-85 68.61 51.38 0.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 24' ' ' LEU . 66.5 m-20 -127.17 -24.54 3.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.3 mt 57.92 130.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -149.54 134.6 9.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.164 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.08 124.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.345 2.03 . . . . 0.0 112.289 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 t -60.09 114.77 10.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.374 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.33 123.89 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.327 2.018 . . . . 0.0 112.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.1 m -59.43 -23.71 62.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -49.18 -47.38 46.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.175 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 7.1 mp -92.01 -55.05 3.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.5 t80 44.95 89.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.567 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.63 3.3 8.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.22 143.19 27.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.154 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -140.3 123.04 16.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 109.921 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.2 m-30 -83.6 102.97 12.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' HH2' ' A' ' 61' ' ' TRP . 30.4 p -57.21 87.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 177.86 -29.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.06 -154.89 0.55 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.388 -1.066 . . . . 0.0 108.943 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.96 141.98 32.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.402 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 22.8 m-85 -115.82 124.37 50.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.787 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.83 118.51 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.841 . . . . 0.0 108.904 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HB ' ' NE2' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -118.91 144.91 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.072 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.896 HD11 HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -121.95 151.43 40.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -143.9 94.65 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.093 -1.005 . . . . 0.0 110.392 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.615 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 1.2 m -87.49 114.67 24.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.471 -0.768 . . . . 0.0 109.288 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -92.09 164.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.515 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -58.29 157.71 8.16 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.581 0.705 . . . . 0.0 110.558 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 49' ' ' LEU . 4.8 mp -71.73 -38.28 70.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.33 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 49' ' ' LEU . 62.1 mtt85 -43.54 -33.52 1.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.316 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -76.73 -27.21 55.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 109.162 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 153.55 61.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' C ' ' A' ' 54' ' ' LEU . 6.6 t-20 60.21 149.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -1.134 . . . . 0.0 109.426 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.778 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -39.36 114.59 0.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 108.951 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 45' ' ' LYS . 49.1 tt0 -104.46 92.84 4.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.304 -0.873 . . . . 0.0 110.235 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.615 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 0.3 OUTLIER -79.0 116.72 19.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 109.073 179.548 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -100.13 119.74 38.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.982 HD11 ' OG1' ' A' ' 78' ' ' THR . 7.8 tt -110.64 133.85 52.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.985 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.633 ' HB3' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -152.63 133.78 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.358 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.723 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -100.6 126.08 47.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 0.0 108.775 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.934 ' O ' HD23 ' A' ' 62' ' ' LEU . 77.5 t90 -92.54 134.62 34.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.934 HD23 ' O ' ' A' ' 61' ' ' TRP . 2.3 mt -137.39 118.59 14.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.448 -0.783 . . . . 0.0 109.208 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' CA ' ' CH2' ' A' ' 61' ' ' TRP . . . -69.39 25.14 0.35 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.58 ' H ' ' C ' ' A' ' 62' ' ' LEU . 59.5 t30 58.86 6.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.442 -1.034 . . . . 0.0 110.089 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -110.38 10.93 23.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 109.143 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.2 t -105.09 146.1 29.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.682 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 t -85.9 170.4 12.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.463 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -69.16 -16.34 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 1.2 t70 -61.48 -58.31 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -87.85 -35.82 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.593 ' OG ' HD13 ' A' ' 62' ' ' LEU . 8.8 t -70.4 -60.61 2.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.577 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -52.79 -43.33 60.31 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.44 -52.04 63.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -1.162 . . . . 0.0 109.501 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.7 -47.69 63.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.288 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -61.8 -22.98 65.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 109.232 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -83.92 -55.84 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -61.36 -34.75 75.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.381 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.982 ' OG1' HD11 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -75.13 -43.81 50.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.872 . . . . 0.0 109.74 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 75' ' ' ALA . 27.9 t -63.62 -55.96 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.846 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.3 -59.62 5.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -53.11 -48.45 67.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.031 -1.043 . . . . 0.0 108.927 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 78' ' ' THR . 10.0 t0 -45.64 -45.02 13.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.103 -0.998 . . . . 0.0 108.807 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.28 -30.86 71.92 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 17.7 t80 -79.1 -22.92 44.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.476 HD21 ' CA ' ' A' ' 9' ' ' GLY . 3.2 tp -83.91 -47.7 10.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.333 -0.855 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -122.0 -41.92 2.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 110.025 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.86 -20.56 40.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' ALA . 3.6 ptt180 -136.55 -80.88 0.39 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.386 -1.067 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 88' ' ' ARG . . . 41.89 -155.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.328 -0.858 . . . . 0.0 109.388 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -146.44 133.31 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.589 ' NE2' ' O ' ' A' ' 91' ' ' GLN . 3.0 pp0? -118.85 115.84 25.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.633 ' CD2' ' HB3' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -120.8 159.61 25.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.725 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.567 ' HE ' HD11 ' A' ' 62' ' ' LEU . 42.3 ttt180 -110.52 130.05 55.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.892 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 96' ' ' GLN . 2.5 mm-40 -115.32 86.2 2.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.058 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.52 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.1 t -68.29 37.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.543 ' H ' ' C ' ' A' ' 94' ' ' GLU . 5.1 tm0? 48.82 103.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.496 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.91 -52.37 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 98' ' ' PHE . 60.0 t80 -108.77 31.29 5.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -1.043 . . . . 0.0 109.234 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 98' ' ' PHE . 4.1 mt-10 -53.18 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.391 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.7 t -115.85 170.51 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.93 65.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.1 m -68.56 -53.93 19.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.465 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 14.1 t80 -62.0 -39.18 91.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.443 HD21 ' OE2' ' A' ' 99' ' ' GLU . 94.8 mt -72.36 -36.36 68.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.81 -37.3 94.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.82 -50.52 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.515 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -103.43 61.95 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -84.75 -29.45 25.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -99.6 1.85 44.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.65 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.54 -109.18 2.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 110' ' ' GLY . 16.9 mt 53.34 100.6 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -144.13 100.86 3.63 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.78 108.04 15.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.875 . . . . 0.0 109.574 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -119.41 140.7 49.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 109.362 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -54.16 145.58 16.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.46 -2.61 90.64 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.37 128.27 9.42 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.17 -18.83 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 109.51 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.5 -23.41 6.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.554 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 t -76.91 6.22 6.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.934 . . . . 0.0 109.411 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.99 -47.25 39.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -51.23 -26.25 6.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -1.143 . . . . 0.0 109.443 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -73.38 -38.12 65.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -99.7 88.88 3.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.506 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.9 t -89.77 122.91 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.451 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 126' ' ' VAL . 69.4 t -155.51 82.28 3.83 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.82 133.27 11.24 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.773 2.315 . . . . 0.0 112.325 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -63.8 150.22 45.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.526 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 131' ' ' VAL . 1.5 pp20? -88.05 -21.89 24.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 109.552 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 p -47.04 -16.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 129' ' ' GLU . 61.4 t -68.57 -40.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.55 -29.42 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.521 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 2.2 mp0 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.7 m80 52.65 82.95 0.23 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.539 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.4 -16.59 13.48 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.629 2.219 . . . . 0.0 112.208 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -64.13 -39.47 94.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.382 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.506 ' CG ' HD22 ' A' ' 24' ' ' LEU . 29.0 t80 -72.79 -32.93 65.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 tp -55.23 -21.94 16.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.896 . . . . 0.0 109.299 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.919 ' O ' HD11 ' A' ' 85' ' ' LEU . 41.9 mttt -98.17 -55.83 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.379 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.551 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.91 134.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.631 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 56.98 54.2 38.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -63.4 0.42 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -1.086 . . . . 0.0 109.404 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' GLY . 11.6 pt-20 -176.44 150.72 1.02 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -39.89 126.29 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.639 2.226 . . . . 0.0 112.1 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.63 -158.5 27.78 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.8 141.81 51.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -1.062 . . . . 0.0 109.652 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 4.3 mm-40 -127.84 156.64 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.247 -0.908 . . . . 0.0 109.35 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.9 mp -131.36 137.0 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.204 -0.935 . . . . 0.0 109.961 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.2 m-90 -144.9 113.41 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 0.0 109.32 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.414 HH11 ' CG ' ' A' ' 39' ' ' ASP . 46.2 ttt180 -80.98 140.03 35.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.0 143.18 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' PHE . 14.0 mm-40 -146.15 112.3 5.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.091 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 20.4 ttpp 57.86 -76.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.339 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 6.8 m-85 -175.83 33.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.318 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.7 t70 -127.31 -1.64 6.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 109.803 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.506 HD22 ' CG ' ' A' ' 5' ' ' PHE . 4.4 tp 59.25 146.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 109.312 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 24' ' ' LEU . 42.1 t -154.39 111.41 2.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.652 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.42 147.38 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.44 2.093 . . . . 0.0 112.173 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' THR . 6.8 p -76.93 133.34 69.66 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.102 -0.999 . . . . 0.0 109.394 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -41.27 89.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.527 2.151 . . . . 0.0 112.292 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 27' ' ' VAL . 24.4 m -51.74 -26.55 9.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.407 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -51.34 -43.46 61.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.408 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.6 mt -93.86 -54.19 3.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.299 -0.875 . . . . 0.0 109.639 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 65.47 100.44 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 123.67 -27.32 5.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -65.84 139.71 58.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.333 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 33' ' ' GLY . 73.7 m-85 -143.6 143.03 31.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.846 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.61 103.27 15.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.06 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.561 ' C ' ' H ' ' A' ' 39' ' ' ASP . 15.0 p -54.89 -45.26 74.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.808 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.19 10.13 0.29 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 37' ' ' THR . 3.4 m-20 -133.73 -156.24 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -1.173 . . . . 0.0 109.283 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.44 140.91 25.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 109.689 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 15.3 m-85 -123.83 146.21 48.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.825 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.83 116.09 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.168 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' HB ' ' CD2' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -112.37 142.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.252 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.621 HD11 ' CD2' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -122.3 145.25 48.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.568 -0.707 . . . . 0.0 109.891 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -125.47 93.21 3.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.452 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 86.2 m -73.86 106.76 5.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -107.02 164.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -121.78 137.0 54.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.414 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.94 -101.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -140.08 -34.01 0.56 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.45 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -171.49 36.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.34 -79.05 0.27 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -152.06 -165.13 2.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -1.133 . . . . 0.0 109.514 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -130.45 164.97 23.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 109.369 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -134.1 144.8 48.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 2.3 m-85 -100.89 118.91 37.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 108.848 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.688 ' O ' ' CE1' ' A' ' 59' ' ' HIS . 3.5 m-20 -77.81 120.39 22.64 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.621 ' CD2' HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -97.11 122.61 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.0 110.087 -178.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.688 ' CE1' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -138.24 110.98 7.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.44 129.94 35.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 108.95 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.34 111.49 23.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' A' ' 60' ' ' TYR . 1.1 mt -116.1 105.62 12.81 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -65.98 14.54 0.29 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 62.64 1.87 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 109.783 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.6 mt-10 -103.46 4.17 35.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.091 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 67' ' ' SER . 45.6 t -103.41 122.08 44.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 69' ' ' ASP . 69.6 m -43.02 126.16 3.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.43 -8.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 67' ' ' SER . 10.9 t0 -68.24 -43.38 78.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.613 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -87.35 -33.52 19.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.53 ' OG ' HD13 ' A' ' 62' ' ' LEU . 5.7 t -57.77 -56.61 19.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.84 82.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.81 -48.13 50.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.257 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.13 96.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.159 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -63.2 -20.59 65.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.01 -57.44 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 109.99 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -61.28 -32.91 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.334 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.76 -44.01 51.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.147 -0.971 . . . . 0.0 109.588 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.531 ' N ' ' CG2' ' A' ' 78' ' ' THR . 45.2 t -69.93 -52.52 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.9 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -60.92 -59.52 5.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.721 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -53.29 -48.66 68.16 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.98 -1.075 . . . . 0.0 108.66 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 4.4 t0 -44.89 -45.82 10.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.111 -0.993 . . . . 0.0 108.801 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.28 -31.93 72.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 81' ' ' LEU . 11.5 t80 -77.06 -23.17 52.0 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.919 HD11 ' O ' ' A' ' 7' ' ' LYS . 3.6 tp -82.89 -51.35 7.7 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.279 -0.888 . . . . 0.0 109.902 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -122.4 -42.05 2.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.255 -0.903 . . . . 0.0 109.985 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.03 -15.51 16.04 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.7 mtp-105 -144.52 -85.29 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.435 -1.039 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 56.58 156.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.647 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.7 t -91.54 150.23 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.147 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.7 122.95 22.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.0 110.137 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.51 ' CD2' ' HB3' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -136.42 159.98 40.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.302 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -121.12 144.59 48.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.954 . . . . 0.0 109.931 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 96' ' ' GLN . 4.9 mm-40 -115.1 85.29 2.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.4 t -71.89 37.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.695 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 95' ' ' VAL . 1.7 tt0 58.14 118.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.51 -35.9 4.66 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -113.58 45.0 1.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -1.137 . . . . 0.0 109.436 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -71.04 178.93 2.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 m -101.14 160.13 14.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.0 109.441 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.39 65.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.489 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.7 m -71.77 -52.98 14.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -61.2 -37.69 83.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 109.594 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mt -72.19 -27.85 62.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.542 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.58 -25.21 39.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.87 -14.34 29.84 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.187 -1.184 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -134.88 93.81 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.637 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -78.19 -63.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -92.16 9.87 31.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.236 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 111' ' ' LEU . . . -80.46 56.97 4.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.71 92.03 2.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.471 -1.017 . . . . 0.0 109.218 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 35' ' ' PHE . 25.1 tttt -130.02 108.6 10.22 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.653 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -82.19 107.88 15.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.999 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -108.03 108.54 19.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 108.901 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.82 109.99 1.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.29 61.2 1.47 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.37 33.94 5.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -94.59 -34.33 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -1.111 . . . . 0.0 109.376 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -82.54 -25.48 33.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.6 m -71.22 6.02 1.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.817 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -60.63 -27.49 66.31 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -83.8 -27.28 28.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -1.133 . . . . 0.0 109.526 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -57.8 -30.11 65.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.447 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -89.36 94.78 10.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.334 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.5 138.16 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.478 ' H ' HG23 ' A' ' 126' ' ' VAL . 2.1 t -56.92 113.16 5.56 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.485 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 57.3 Cg_exo -46.89 153.29 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.443 ' O ' HG12 ' A' ' 131' ' ' VAL . 10.2 m120 -165.67 102.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.538 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.1 -25.41 59.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.69 -20.21 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 128' ' ' ASN . 7.6 p -49.29 -23.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.817 . . . . 0.0 109.609 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.2 t -51.72 -32.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.439 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -141.18 70.93 27.88 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.462 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.57 5.84 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.705 2.27 . . . . 0.0 112.271 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -52.46 -15.63 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.359 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.42 ' CD2' HD21 ' A' ' 24' ' ' LEU . 46.9 t80 -63.29 -28.84 70.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.469 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -62.42 -23.24 66.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.402 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 8' ' ' ALA . 5.6 mptp? -94.82 -60.98 1.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 109.443 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.567 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 59.08 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.386 -0.821 . . . . 0.0 109.324 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 8' ' ' ALA . . . 42.2 43.55 4.61 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' GLY . 2.4 pttm -45.56 -23.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' GLY . 11.2 pt-20 -146.48 149.98 39.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -39.78 123.58 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.679 2.252 . . . . 0.0 112.223 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.4 -167.7 31.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.17 147.03 40.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -1.024 . . . . 0.0 109.555 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.412 ' CB ' ' CZ2' ' A' ' 17' ' ' TRP . 7.2 mt-30 -141.98 151.58 42.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.05 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -128.81 135.86 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -141.94 110.58 6.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.501 ' CD ' ' CZ ' ' A' ' 41' ' ' TYR . 21.4 ttp180 -79.77 139.02 37.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.386 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -82.69 142.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.91 . . . . 0.0 109.352 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -159.62 97.09 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.441 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 12.2 ttmm 63.74 25.86 14.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.394 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.2 m-85 70.09 14.64 7.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.614 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' LEU . 9.8 t70 -98.29 -15.27 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' ASP . 1.9 mp 59.84 136.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.02 127.06 12.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.865 . . . . 0.0 109.012 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.57 126.05 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.29 1.993 . . . . 0.0 112.364 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.41 134.78 81.7 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.52 130.26 16.95 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.401 2.067 . . . . 0.0 112.145 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' ASN . 20.5 m -60.0 -26.37 66.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 29' ' ' THR . 57.1 t30 -44.17 -38.84 3.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.974 . . . . 0.0 109.229 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 32' ' ' TYR . 42.2 mt -108.81 -55.15 2.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.481 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 31' ' ' LEU . 6.2 t80 47.92 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.451 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 123.73 -30.74 4.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.597 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 15.3 m-20 -80.88 146.55 30.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.238 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 m-85 -146.1 152.22 38.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 0.0 109.843 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.546 ' CE1' ' O ' ' A' ' 116' ' ' GLY . 0.5 OUTLIER -90.27 104.55 17.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.089 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.6 p -59.07 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.94 -30.66 0.06 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -107.44 -152.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.505 -0.997 . . . . 0.0 108.725 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -137.48 140.46 41.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.501 ' CZ ' ' CD ' ' A' ' 18' ' ' ARG . 18.8 m-85 -117.72 124.93 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.4 130.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.63 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.6 mt -123.46 145.95 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 43' ' ' ILE . 2.3 mm? -124.85 133.24 53.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 55' ' ' GLN . 12.0 ttpt -129.91 94.0 3.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.006 . . . . 0.0 110.031 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.613 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 64.5 m -84.99 106.75 16.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.22 164.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.356 -0.84 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -60.79 157.76 14.28 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.538 0.685 . . . . 0.0 110.627 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.709 ' H ' HD12 ' A' ' 49' ' ' LEU . 2.7 mp -67.97 -34.8 77.24 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 49' ' ' LEU . 36.1 mtp180 -42.84 -34.21 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.223 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -78.3 -28.1 47.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.855 . . . . 0.0 109.174 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 152.65 67.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' C ' ' A' ' 54' ' ' LEU . 8.3 t-20 58.98 150.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -1.121 . . . . 0.0 109.48 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.499 ' C ' ' O ' ' A' ' 53' ' ' ASN . 14.2 mt -39.95 113.73 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.927 . . . . 0.0 108.787 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.1 tt0 -105.31 96.59 6.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.054 -1.029 . . . . 0.0 110.513 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.673 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 27.8 m-85 -76.61 109.65 10.53 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.602 ' CG ' ' HE2' ' A' ' 59' ' ' HIS . 22.6 t0 -83.61 126.97 33.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.977 -1.077 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 82' ' ' ASP . 4.0 mp -97.19 119.82 36.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.69 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 18.7 m-70 -134.1 108.76 8.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.705 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.66 119.58 39.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.537 ' NE1' HD12 ' A' ' 111' ' ' LEU . 78.1 t90 -96.41 126.51 41.65 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 110.243 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.667 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.9 mt -122.52 109.39 14.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -59.3 10.32 0.03 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 62' ' ' LEU . 28.9 t30 67.45 1.79 2.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -108.32 11.29 27.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.549 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.4 t -104.45 146.02 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 m -77.38 164.88 25.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.616 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -68.96 -8.87 48.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -68.87 -56.11 8.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -87.22 -38.86 15.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 t -58.62 -56.04 27.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.482 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.91 50.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.29 -36.38 4.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -1.178 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.49 70.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.322 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -68.4 -33.63 74.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mt -79.57 -44.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.821 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.5 -40.24 96.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.984 -1.072 . . . . 0.0 109.452 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -76.34 -45.03 34.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 75' ' ' ALA . 49.9 t -61.72 -54.33 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.797 . . . . 0.0 110.143 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.572 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 12.0 pt20 -62.56 -50.55 70.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 110.143 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -59.82 -51.26 70.48 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.745 -1.222 . . . . 0.0 108.647 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.582 ' OD2' ' ND2' ' A' ' 86' ' ' ASN . 3.1 t0 -43.76 -43.47 6.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.004 -1.06 . . . . 0.0 108.358 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.08 -36.77 80.53 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.6 t80 -73.19 -23.6 60.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.501 HD11 ' O ' ' A' ' 7' ' ' LYS . 1.1 tt -81.38 -52.2 7.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.254 -0.904 . . . . 0.0 109.961 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.582 ' ND2' ' OD2' ' A' ' 82' ' ' ASP . 2.2 p30 -122.12 -42.33 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.112 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.18 -10.65 26.77 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -149.96 -81.1 0.12 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -1.083 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.673 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 56.89 170.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.9 t -97.99 150.16 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.241 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -113.62 147.86 37.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 0.0 109.953 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.69 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 44.4 m80 -146.23 122.78 11.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 23.7 ptt85 -111.5 118.75 36.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.821 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.6 mp0 -114.82 100.16 8.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.273 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 2.2 t -87.12 37.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.65 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 24.8 tt0 72.04 107.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 93.31 -29.81 7.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -97.38 37.57 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 1.1 mp0 -63.25 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.9 m -131.57 -169.97 2.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -61.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 98.5 m -55.45 -37.33 67.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -67.46 -45.96 74.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.63 -10.35 59.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.46 -39.06 8.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.26 -33.92 37.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.54 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -103.4 107.18 17.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -99.38 -12.54 20.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.1 m -53.43 -36.1 61.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.53 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 93.59 35.9 6.04 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.73 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.2 mm? 53.71 103.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -95.4 119.09 33.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -81.96 107.73 14.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.843 . . . . 0.0 109.645 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -115.84 108.57 16.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.233 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -60.84 112.31 1.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.499 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.546 ' O ' ' CE1' ' A' ' 36' ' ' PHE . . . -128.05 144.41 15.2 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.04 -27.68 14.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.445 ' H ' HG22 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -54.87 -33.32 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.423 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.63 -35.1 63.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.501 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.1 m -111.11 6.12 20.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.64 -26.37 65.42 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -80.55 -22.71 40.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -1.207 . . . . 0.0 109.483 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 124' ' ' HIS . 28.4 tttp -76.7 -30.42 56.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.879 . . . . 0.0 109.53 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.472 ' O ' ' O ' ' A' ' 123' ' ' LYS . 17.7 m-70 -53.22 -170.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.337 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -96.43 146.69 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.7 t -92.55 114.79 63.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 75.9 Cg_exo -45.24 143.03 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.424 2.083 . . . . 0.0 112.19 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 12.6 m-20 -44.32 169.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -80.07 -21.72 43.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.3 t -47.15 -33.93 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.05 -43.92 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.406 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.98 -27.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.405 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 4' ' ' GLU . 5.6 t-80 44.96 65.31 6.49 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.71 75.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.894 2.396 . . . . 0.0 112.31 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 2' ' ' HIS . 29.4 mt-10 -61.52 -29.5 70.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.129 -0.982 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -47.38 -35.11 7.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.079 -1.013 . . . . 0.0 109.429 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.7 mm? -84.61 -21.87 30.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.273 -0.892 . . . . 0.0 109.42 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 4' ' ' GLU . 12.1 tttm -69.34 -32.81 72.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.19 142.54 54.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.54 44.47 4.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -107.5 -23.24 12.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -1.098 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -152.14 150.99 26.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.868 . . . . 0.0 109.275 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.19 172.37 16.14 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.605 2.203 . . . . 0.0 112.314 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.47 -125.63 8.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 106' ' ' TYR . 4.0 tt -137.11 146.87 45.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.733 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 20.1 mt-30 -137.29 139.46 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.608 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 8.7 mt -111.3 145.2 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.938 . . . . 0.0 109.885 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.7 m0 -148.76 110.74 4.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' VAL . 3.4 tmm_? -85.92 131.44 34.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.187 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.3 143.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.164 -0.96 . . . . 0.0 110.111 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 22' ' ' PHE . 30.3 tt0 -144.46 124.69 13.74 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 24.0 tttp 60.99 -74.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.958 . . . . 0.0 109.016 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' GLU . 10.7 m-85 -168.57 19.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 109.877 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.99 111.27 13.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.11 -0.994 . . . . 0.0 109.693 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 25' ' ' VAL . 9.0 mp -48.99 159.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.362 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ARG . 48.0 t -153.6 90.79 3.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.605 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.32 127.17 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.722 2.281 . . . . 0.0 112.207 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.5 p -106.83 133.63 20.19 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 109.383 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -41.11 93.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.542 2.161 . . . . 0.0 112.318 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.602 ' OG1' HD12 ' A' ' 16' ' ' ILE . 28.0 m -71.38 -12.12 61.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.521 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -77.21 -23.62 51.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.616 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 31' ' ' LEU . 10.4 tp -136.25 13.53 3.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.256 -0.903 . . . . 0.0 109.605 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -56.63 -96.77 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.16 -0.963 . . . . 0.0 109.833 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 64.73 11.48 49.67 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' C ' ' OD2' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -161.84 147.01 13.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -1.081 . . . . 0.0 108.985 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.488 ' CE2' ' CH2' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -146.4 161.04 41.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.918 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -77.29 158.57 30.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 108.964 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 p -107.13 -30.26 8.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.673 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.36 20.46 5.97 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -139.43 -157.39 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -1.066 . . . . 0.0 109.312 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.83 140.8 31.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -119.44 121.91 40.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.574 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.56 130.82 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 139.87 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.651 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.609 HD23 ' CD1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -115.83 145.18 43.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -130.84 93.77 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.094 -1.004 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.636 HG23 ' CD2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -78.05 106.01 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -96.95 164.92 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.405 -0.809 . . . . 0.0 109.407 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 49' ' ' LEU . 30.8 tt0 -120.37 101.56 7.87 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.664 -0.648 . . . . 0.0 109.288 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 48' ' ' GLN . 14.1 mt -43.22 -86.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 109.377 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -140.21 -43.53 0.42 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.328 -0.857 . . . . 0.0 109.502 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -174.62 26.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.287 -0.883 . . . . 0.0 109.266 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.96 -95.66 2.36 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -118.62 -163.45 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.368 -1.078 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -124.94 168.48 13.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 109.443 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.5 tt0 -131.36 113.64 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.744 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.768 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -86.89 110.29 19.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 108.954 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 1.1 m-20 -88.47 119.15 28.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.012 -1.055 . . . . 0.0 108.84 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 58' ' ' LEU . 3.1 pp -96.81 131.46 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.844 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.573 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -135.35 127.88 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.538 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.65 114.84 29.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.096 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.566 ' CD1' ' CZ ' ' A' ' 103' ' ' PHE . 32.1 t90 -93.21 117.39 30.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 109.468 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.4 mt -117.69 118.53 32.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 108.994 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -67.78 21.5 0.26 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' LEU . 28.9 t-20 57.01 1.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.019 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 63' ' ' GLY . 15.8 mm-40 -111.71 10.16 20.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 0.0 108.539 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.0 p -98.46 146.07 26.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.621 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 t -67.39 154.86 40.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.414 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -75.84 -9.02 58.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.657 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.32 -45.73 45.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.686 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -87.3 -35.77 18.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.303 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.595 ' OG ' HD22 ' A' ' 62' ' ' LEU . 2.9 t -58.7 -53.53 57.35 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.495 -0.753 . . . . 0.0 109.458 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.68 42.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.7 -38.71 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.655 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.11 83.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -67.93 -41.81 82.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.11 -39.43 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.31 -47.15 85.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.104 -0.998 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -75.54 -42.24 52.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 75' ' ' ALA . 54.1 t -62.38 -49.06 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.937 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -65.26 -59.85 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.875 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -56.03 -43.83 78.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 0.0 108.587 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 78' ' ' THR . 6.9 t70 -47.3 -46.98 25.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.139 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.49 -28.79 70.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.778 ' HB3' HD13 ' A' ' 81' ' ' LEU . 45.9 t80 -75.02 -24.37 58.34 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.64 -54.59 6.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 86' ' ' ASN . 22.5 t-20 -122.07 -42.03 2.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.939 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.48 1.95 24.52 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.9 mtm-85 -155.13 -78.27 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.425 -1.044 . . . . 0.0 109.263 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.768 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 55.7 178.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.59 146.84 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.63 140.09 38.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.424 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 52.9 m-70 -138.78 119.36 13.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.602 ' HE ' HG22 ' A' ' 95' ' ' VAL . 35.8 ttt180 -103.95 126.59 51.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 109.273 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 12.7 mp0 -127.27 78.67 1.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.948 . . . . 0.0 109.802 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.602 HG22 ' HE ' ' A' ' 93' ' ' ARG . 2.1 t -78.68 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.116 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.439 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 0.9 OUTLIER 42.28 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 98' ' ' PHE . . . 156.36 -35.5 0.6 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 97' ' ' GLY . 2.3 m-85 -135.88 54.68 1.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -1.077 . . . . 0.0 109.276 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.595 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 28.3 mt-10 -71.56 171.49 11.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.562 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 t -110.95 178.92 4.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.394 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -67.74 -26.37 66.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.594 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 m -63.39 -62.9 1.38 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.32 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD1' ' OE2' ' A' ' 99' ' ' GLU . 36.9 t80 -54.6 -41.98 70.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.69 -26.25 61.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.92 . . . . 0.0 109.384 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -63.95 -44.27 96.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' CD1' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -76.22 -50.96 13.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -1.114 . . . . 0.0 109.319 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.72 71.68 9.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -88.77 -40.78 12.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -105.7 8.03 32.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -90.18 -107.95 1.31 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.5 mm? 53.42 101.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.346 -1.091 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -166.07 95.96 0.59 Allowed 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.641 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -82.42 107.76 15.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.5 -0.75 . . . . 0.0 109.45 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -112.07 118.05 34.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.04 136.55 55.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 118' ' ' VAL . . . -93.76 0.4 67.4 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.73 -1.7 2.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' A' ' 116' ' ' GLY . 94.0 t -64.12 -13.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.147 . . . . 0.0 109.462 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -51.48 -27.58 10.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.4 t -66.85 6.19 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -55.11 -24.31 35.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -69.4 -29.95 67.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -1.183 . . . . 0.0 109.473 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -59.5 -33.42 71.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -67.94 164.53 19.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.45 146.65 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.9 83.97 31.11 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 53.6 Cg_exo -48.45 149.82 6.36 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.74 2.293 . . . . 0.0 112.237 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 90.0 m-20 -42.86 166.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -87.67 -28.58 21.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.406 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -48.55 -32.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 131' ' ' VAL . 17.6 t -50.15 -60.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -73.93 -27.77 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.951 . . . . 0.0 109.587 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.488 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.487 ' OE2' ' O ' ' A' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.586 ' O ' ' N ' ' A' ' 4' ' ' GLU . 19.6 m-70 -144.77 75.17 14.61 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.91 75.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.863 2.375 . . . . 0.0 112.169 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 2' ' ' HIS . 31.8 tt0 -79.56 -45.62 18.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.452 ' CG ' HD13 ' A' ' 24' ' ' LEU . 39.2 t80 -45.99 -23.28 0.28 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -66.28 -35.35 80.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.233 -0.917 . . . . 0.0 109.247 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 8' ' ' ALA . 47.8 mttt -103.94 -45.31 4.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.782 ' HB3' HD11 ' A' ' 85' ' ' LEU . . . 58.54 135.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.509 -0.745 . . . . 0.0 109.643 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 50.73 53.57 25.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -58.02 -0.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.17 . . . . 0.0 109.361 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 9' ' ' GLY . 9.8 pt-20 -170.04 149.15 3.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.49 122.05 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.682 2.255 . . . . 0.0 112.252 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.78 -156.4 27.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.5 144.76 49.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -138.53 150.49 46.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.228 -0.92 . . . . 0.0 109.676 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.2 mt -119.05 137.58 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 0.0 109.779 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.7 m0 -142.27 110.82 6.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.3 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.03 137.73 37.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.588 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.58 143.28 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 0.0 109.496 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -155.77 88.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 tttm 65.53 33.85 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.492 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' N ' ' A' ' 22' ' ' PHE . 1.3 m-85 66.2 17.16 10.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 24' ' ' LEU . 55.7 m-20 -102.65 -14.89 16.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.7 mt 57.43 144.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 109.633 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.2 t -154.15 110.25 2.46 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.363 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.83 112.9 0.55 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.388 2.058 . . . . 0.0 112.164 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 27' ' ' VAL . 13.1 p -47.52 133.61 10.32 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -40.91 101.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.509 2.139 . . . . 0.0 112.325 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.5 m -59.0 -25.65 63.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -50.42 -47.29 56.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.56 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -88.17 -54.98 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.85 . . . . 0.0 109.444 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.0 t80 55.54 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 109.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.26 17.08 3.35 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -117.28 144.46 44.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -1.172 . . . . 0.0 109.358 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.581 ' N ' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -146.14 133.92 21.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.773 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 38' ' ' GLY . 26.6 m-85 -92.14 103.03 15.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.059 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.459 ' H ' HG23 ' A' ' 37' ' ' THR . 16.3 p -52.19 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.643 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . 177.96 -29.43 0.07 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.464 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 4.0 p30 -107.93 -154.3 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.369 -1.077 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.15 141.07 34.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.464 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.464 ' CE2' ' OD1' ' A' ' 39' ' ' ASP . 88.5 m-85 -116.52 122.04 43.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.24 114.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.463 ' HB ' ' ND1' ' A' ' 59' ' ' HIS . 1.8 mt -114.58 145.95 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.551 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 1.1 mp -123.0 143.6 49.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.797 -0.565 . . . . 0.0 109.566 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 55' ' ' GLN . 5.0 ttmm -127.23 94.17 3.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.672 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.594 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 43.0 m -81.2 110.96 17.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.12 164.36 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -54.11 158.0 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.695 0.76 . . . . 0.0 110.803 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.681 ' H ' HD12 ' A' ' 49' ' ' LEU . 4.5 mp -67.52 -33.66 75.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.547 -0.721 . . . . 0.0 109.44 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LEU . 2.3 mtm180 -44.87 -38.7 4.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.359 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.53 -23.24 61.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.191 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 146.01 64.87 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.533 ' O ' ' C ' ' A' ' 54' ' ' LEU . 4.9 t-20 57.99 153.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.275 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.533 ' C ' ' O ' ' A' ' 53' ' ' ASN . 11.8 mt -36.4 107.0 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 108.815 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 45' ' ' LYS . 3.4 tt0 -100.59 98.85 9.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.101 -1.0 . . . . 0.0 110.422 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.825 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 29.6 m-85 -80.75 109.58 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.483 ' C ' HD22 ' A' ' 58' ' ' LEU . 35.9 t0 -76.33 140.8 41.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 108.684 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 82' ' ' ASP . 2.1 mm? -107.48 103.12 12.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.845 . . . . 0.0 109.546 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.68 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -122.24 112.19 17.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.72 125.99 48.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.582 ' O ' HD23 ' A' ' 62' ' ' LEU . 39.7 t90 -98.79 132.38 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.871 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.596 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.8 mt -134.88 115.41 13.59 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.85 17.79 0.19 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 62' ' ' LEU . 23.8 t30 63.12 1.91 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 109.887 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -106.06 10.33 32.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 109.242 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.11 131.85 46.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.442 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 t -49.74 157.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -75.69 -11.83 60.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.4 p30 -79.24 -40.39 30.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 36.2 tt0 -87.33 -33.81 19.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.286 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.59 ' OG ' HD13 ' A' ' 62' ' ' LEU . 37.5 t -68.11 -60.41 2.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.54 -39.0 29.27 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -58.07 -56.89 16.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -1.156 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.44 -40.88 19.14 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.118 -0.988 . . . . 0.0 109.028 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.621 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -70.64 -21.39 62.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.347 -0.846 . . . . 0.0 109.024 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.6 mm -84.51 -49.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -61.88 -36.58 81.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 109.322 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.29 -46.02 29.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.625 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.0 t -64.39 -52.38 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.96 -59.55 4.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.648 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -52.71 -48.85 66.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 108.764 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HB2' HD11 ' A' ' 58' ' ' LEU . 6.1 t70 -44.8 -45.93 10.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.565 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.71 -33.85 73.5 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 5.5 t80 -74.68 -23.43 58.63 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -80.22 -52.93 7.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.564 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -122.1 -42.01 2.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.12 -14.88 21.11 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -145.54 -72.9 0.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -1.036 . . . . 0.0 109.245 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 56.1 -171.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 109.472 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.84 150.15 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.389 -0.819 . . . . 0.0 109.391 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.562 ' N ' ' OE1' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -108.33 133.0 53.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.716 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.591 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 25.9 m80 -139.74 124.39 18.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.403 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 7.9 ptm180 -110.0 132.37 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 109.688 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.595 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 2.7 mt-10 -130.47 91.71 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.18 37.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 56.45 90.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.46 -32.04 2.52 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -125.12 56.86 1.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.445 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -85.72 167.55 15.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.6 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -100.28 161.01 13.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.47 77.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -62.23 -60.66 3.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 51.1 t80 -52.76 -38.8 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.463 -0.773 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 104' ' ' LEU . 85.0 mt -69.29 -26.17 64.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.62 55.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -43.59 60.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.391 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.436 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 88.8 m-85 -106.33 76.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.551 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -100.8 -35.86 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -91.14 -3.31 57.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -91.09 -107.69 1.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 110' ' ' GLY . 85.0 mt 53.37 100.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.36 -1.083 . . . . 0.0 109.527 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.617 ' NZ ' ' HZ1' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -151.67 90.97 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.85 107.72 14.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.516 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.617 ' HZ1' ' NZ ' ' A' ' 112' ' ' LYS . 22.4 mttm -112.37 108.92 18.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 5.5 ptpp? -63.61 127.07 29.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.19 -51.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.51 75.95 0.21 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.92 -12.05 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 0.0 109.498 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.44 -25.3 50.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 109.511 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.9 t -88.66 6.14 39.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.33 -0.856 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.89 71.5 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -53.57 -26.39 21.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -1.154 . . . . 0.0 109.503 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -57.71 -23.23 50.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -70.68 72.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.6 t -70.16 122.76 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.531 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.67 98.58 38.0 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 129' ' ' GLU . 58.9 Cg_endo -79.09 162.5 25.97 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.463 2.108 . . . . 0.0 112.253 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -59.09 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 127' ' ' PRO . 37.9 tt0 -88.07 -17.23 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 131' ' ' VAL . 9.4 p -57.13 -42.75 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.558 ' N ' HG13 ' A' ' 130' ' ' VAL . 12.9 p -46.95 -30.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.461 ' O ' ' NE2' ' A' ' 133' ' ' GLN . 15.0 t -71.66 -27.77 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 130' ' ' VAL . 85.1 mm-40 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.463 ' C ' ' CG ' ' A' ' 2' ' ' HIS . 27.6 tp10 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.345 0.593 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.463 ' CG ' ' C ' ' A' ' 1' ' ' GLU . 0.3 OUTLIER 61.88 149.15 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.421 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.26 76.91 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.705 2.27 . . . . 0.0 112.242 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -68.81 -26.03 64.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.887 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 6' ' ' LEU . 41.1 p90 -63.57 -31.3 72.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.334 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 49.7 tp -49.78 -29.41 7.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.341 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.786 ' O ' HD11 ' A' ' 85' ' ' LEU . 27.4 mttm -102.4 -61.11 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.562 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.91 137.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 47.39 38.55 13.32 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HG3' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -42.74 -23.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -1.167 . . . . 0.0 109.62 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' GLY . 34.0 mm-40 -143.79 153.67 58.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -41.65 122.84 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.76 2.306 . . . . 0.0 112.341 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.38 -167.09 33.92 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.782 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.7 tt -124.3 124.0 41.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -1.081 . . . . 0.0 109.217 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.471 ' N ' HD23 ' A' ' 14' ' ' LEU . 4.6 mt-30 -115.08 150.05 36.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 109.575 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.607 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.8 OUTLIER -123.6 140.45 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.792 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.607 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.9 m-90 -144.89 111.78 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -79.93 146.01 32.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.707 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.0 143.31 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.11 -0.994 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.9 tp10 -142.9 95.05 2.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.438 -0.789 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.544 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.6 tptp 71.6 40.26 0.81 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.298 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 2.4 m-85 72.82 21.43 3.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.656 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 22' ' ' PHE . 1.4 m-20 -127.31 111.5 13.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.36 137.47 57.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.6 t -144.0 121.16 6.6 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.895 . . . . 0.0 109.283 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -44.08 148.06 1.19 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.271 1.981 . . . . 0.0 112.513 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 27' ' ' VAL . 11.7 p -92.41 134.21 28.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.186 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -39.15 108.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -61.17 -29.11 69.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -46.77 -41.93 16.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.344 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.437 HD22 ' OD1' ' A' ' 34' ' ' ASP . 13.3 mt -91.22 -53.13 4.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.22 -0.925 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.3 t80 50.26 91.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 16.44 3.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.607 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 1.3 m-20 -128.96 135.7 49.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -1.155 . . . . 0.0 109.159 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 1.9 m-85 -146.07 161.26 40.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -85.3 145.49 27.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.324 -0.86 . . . . 0.0 109.173 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 p -89.9 -22.37 22.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.94 -15.87 69.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -103.75 -161.51 0.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -1.103 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -134.53 140.88 46.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 9.4 m-85 -120.6 148.44 43.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.456 -0.777 . . . . 0.0 109.772 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.76 138.19 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 109.347 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.591 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.4 mt -136.39 146.32 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 43' ' ' ILE . 4.1 mp -127.15 124.21 38.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.64 -0.662 . . . . 0.0 109.572 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -105.26 93.99 4.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.658 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.498 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 5.7 m -79.28 109.85 14.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -104.34 164.76 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.211 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -97.19 107.12 19.58 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.542 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.3 mt -56.78 -92.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.216 -0.927 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HG3' HH21 ' A' ' 50' ' ' ARG . 44.1 mtt85 -102.68 -63.38 1.17 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.227 -0.92 . . . . 0.0 109.614 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -172.32 24.91 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.527 -0.733 . . . . 0.0 109.149 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -148.79 -64.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.004 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.511 ' C ' HD23 ' A' ' 54' ' ' LEU . 3.6 t-20 -87.4 155.26 20.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -1.154 . . . . 0.0 109.736 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.511 HD23 ' C ' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -118.92 175.89 5.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.837 . . . . 0.0 109.182 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 47' ' ' VAL . 27.7 tt0 -133.14 112.61 11.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.053 -1.029 . . . . 0.0 109.89 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.519 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 18.8 m-85 -90.69 129.17 36.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 15.9 m-20 -95.11 126.6 40.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 108.964 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.1 mm? -86.99 102.54 14.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.727 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.716 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 23.7 m-70 -116.9 108.67 16.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 0.0 109.567 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.708 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.37 124.21 49.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -0.983 . . . . 0.0 108.686 179.176 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.776 ' O ' HD23 ' A' ' 62' ' ' LEU . 5.6 t90 -95.92 128.78 43.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.147 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.776 HD23 ' O ' ' A' ' 61' ' ' TRP . 0.7 OUTLIER -129.7 106.4 8.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.57 16.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.664 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 61.27 1.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.734 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 63' ' ' GLY . 40.0 mt-10 -104.88 5.82 33.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.98 . . . . 0.0 109.083 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.8 t -101.61 129.16 47.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.546 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 t -51.16 144.39 9.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.444 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -64.62 -8.7 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -73.58 -44.78 56.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -86.86 -37.98 17.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.301 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.613 ' OG ' HD13 ' A' ' 62' ' ' LEU . 8.6 t -60.08 -51.8 68.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.45 -0.781 . . . . 0.0 109.379 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.51 -40.5 69.86 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -57.0 -55.15 38.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.64 44.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.123 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -70.15 -20.28 63.16 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.2 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.5 mm -84.42 -49.19 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.35 -33.45 76.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.976 . . . . 0.0 109.373 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.536 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -77.85 -43.78 29.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 75' ' ' ALA . 53.1 t -68.09 -44.32 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -66.13 -59.62 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -54.45 -45.32 73.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.986 -1.071 . . . . 0.0 108.538 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.411 ' OD2' ' C ' ' A' ' 82' ' ' ASP . 3.5 t0 -47.16 -48.01 23.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 108.607 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.0 -30.58 70.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 81' ' ' LEU . 16.9 t80 -78.43 -23.1 46.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.786 HD11 ' O ' ' A' ' 7' ' ' LYS . 3.8 tp -83.94 -49.91 8.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.263 -0.898 . . . . 0.0 109.921 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -122.3 -42.21 2.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.204 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.71 -19.86 20.9 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -140.97 -68.78 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -1.056 . . . . 0.0 109.351 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 54.63 -169.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.858 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.06 150.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.326 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -107.73 129.42 55.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.814 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.716 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 24.0 m-70 -135.88 113.5 10.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.276 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.492 HH21 ' HB2' ' A' ' 93' ' ' ARG . 19.6 ttp-105 -107.63 125.53 51.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.751 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.593 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 22.2 mt-10 -122.21 89.03 3.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -85.92 37.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -0.875 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 53.9 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.02 -64.99 0.3 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 21.0 m-85 -122.89 49.25 1.67 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.4 -1.059 . . . . 0.0 109.338 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.5 mp0 -51.61 170.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.62 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -87.07 165.44 15.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -29.54 57.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.5 m -65.86 -50.2 65.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.109 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 38.9 t80 -63.48 -48.81 76.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.431 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 108' ' ' LYS . 29.8 mt -63.81 -38.38 90.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.174 -0.953 . . . . 0.0 109.305 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -69.77 -38.16 76.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.238 -1.154 . . . . 0.0 109.26 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -124.27 50.97 1.62 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.421 -0.799 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 110' ' ' GLY . 2.8 tptm -78.15 -28.99 48.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 m -59.51 0.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.75 110.31 2.68 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.674 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -74.48 -104.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -1.165 . . . . 0.0 109.301 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tptp 179.1 113.0 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 109.156 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.02 107.71 19.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.79 . . . . 0.0 109.416 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -110.53 128.02 55.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.284 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -77.47 156.05 31.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.245 -0.91 . . . . 0.0 109.613 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.33 115.27 3.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 178.5 -38.34 0.08 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.5 t -55.58 -31.01 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -1.112 . . . . 0.0 109.3 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.19 -28.87 31.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.331 -0.855 . . . . 0.0 109.414 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.1 m -78.49 6.06 9.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.7 -19.89 69.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -76.49 -29.53 56.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -1.162 . . . . 0.0 109.369 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 124' ' ' HIS . 38.1 mttp -74.09 -2.66 25.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.464 ' CE1' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER 54.29 101.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 109.468 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.74 115.16 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.464 ' CG2' ' CE1' ' A' ' 124' ' ' HIS . 21.1 t -142.11 72.79 22.55 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.29 165.17 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.842 2.361 . . . . 0.0 112.144 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -140.39 35.99 1.87 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.29 -26.39 65.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.421 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 131' ' ' VAL . 9.0 p -57.72 -35.85 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.411 ' N ' HG13 ' A' ' 130' ' ' VAL . 3.0 t -65.9 -39.56 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.13 -30.09 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.49 179.914 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.324 0.583 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.548 ' C ' ' H ' ' A' ' 4' ' ' GLU . 3.8 m-70 -129.99 90.26 43.11 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 4' ' ' GLU . 52.5 Cg_exo -49.09 -1.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.677 2.251 . . . . 0.0 112.278 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.548 ' H ' ' C ' ' A' ' 2' ' ' HIS . 59.1 mm-40 -43.32 -44.87 5.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.394 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -48.42 -40.96 27.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.406 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.655 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.6 mm? -78.75 -24.86 44.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.347 -0.845 . . . . 0.0 109.342 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -65.12 -31.7 73.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.22 -0.925 . . . . 0.0 109.307 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' CB ' ' CH2' ' A' ' 17' ' ' TRP . . . -74.19 113.5 11.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.314 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.32 49.01 1.62 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -140.24 -14.09 1.02 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -155.01 148.05 18.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.0 109.298 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.49 170.81 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.648 2.232 . . . . 0.0 112.252 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.9 -163.03 12.67 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 106' ' ' TYR . 3.5 tt -110.86 117.06 32.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -1.07 . . . . 0.0 109.598 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -96.63 157.32 15.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.393 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 43' ' ' ILE . 1.9 mt -143.87 113.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.594 ' HH2' HD22 ' A' ' 44' ' ' LEU . 8.2 p90 -140.76 137.09 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 0.0 109.113 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -90.04 146.43 24.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.81 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -85.19 143.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.174 -0.954 . . . . 0.0 109.316 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ASP . 24.2 tt0 -150.52 103.86 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.529 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 44.43 35.82 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.905 . . . . 0.0 109.461 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.3 m-85 68.76 26.89 5.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.633 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.9 t70 -109.42 -20.27 12.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' ASP . 2.3 mp 59.63 138.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.57 128.79 5.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.044 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.78 125.39 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.249 1.966 . . . . 0.0 112.041 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 27' ' ' VAL . 10.8 p -71.68 132.9 84.92 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.13 127.41 3.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.7 m -65.98 -25.71 67.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.26 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -53.3 -50.14 65.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.359 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.7 mp -78.0 -55.37 5.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.155 -0.966 . . . . 0.0 109.365 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' O ' ' A' ' 31' ' ' LEU . 34.6 t80 46.91 91.82 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.536 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.88 -30.96 4.69 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' OD1' HD23 ' A' ' 31' ' ' LEU . 2.5 m-20 -51.81 146.26 8.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.049 -1.266 . . . . 0.0 109.102 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 112' ' ' LYS . 28.6 m-85 -137.77 120.14 15.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.014 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.84 107.43 17.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 108.896 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 p -70.86 87.61 0.72 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.672 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.65 -30.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -112.45 -152.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.927 . . . . 0.0 108.625 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.76 140.11 45.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.002 . . . . 0.0 109.617 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -112.72 124.82 53.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.265 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' A' ' 78' ' ' THR . 74.8 t -102.99 119.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -118.97 146.21 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.246 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.704 HD23 ' CD1' ' A' ' 56' ' ' TYR . 1.5 mp -126.2 152.91 45.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 0.0 109.482 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -140.53 93.83 2.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.161 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.614 ' OG1' ' CE1' ' A' ' 56' ' ' TYR . 1.2 m -88.49 111.42 21.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -0.812 . . . . 0.0 109.212 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.32 164.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.762 . . . . 0.0 109.092 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -104.51 119.23 38.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.549 -0.719 . . . . 0.0 109.443 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.6 mt -74.32 -99.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 51' ' ' ASN . 83.3 mtt180 -88.72 -63.37 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.713 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 50' ' ' ARG . 51.8 m-20 -168.54 23.21 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.414 -0.804 . . . . 0.0 109.326 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.71 -52.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -70.69 144.99 50.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.782 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -133.52 168.25 18.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 109.297 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -134.42 104.42 6.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 110.489 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.704 ' CD1' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -77.95 123.37 26.71 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.092 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HB3' ' NE2' ' A' ' 59' ' ' HIS . 3.8 t0 -103.23 122.08 44.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.033 . . . . 0.0 108.494 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.826 HD23 HG22 ' A' ' 78' ' ' THR . 10.4 mp -94.78 143.18 26.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.427 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -149.1 108.42 3.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.65 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.04 115.22 28.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 108.857 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.53 ' CE2' HD12 ' A' ' 111' ' ' LEU . 26.8 t90 -90.13 126.79 35.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.359 -0.838 . . . . 0.0 109.991 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.665 HD13 ' OG ' ' A' ' 71' ' ' SER . 3.9 mt -122.6 108.02 12.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -63.44 15.7 0.1 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.64 ' H ' ' C ' ' A' ' 62' ' ' LEU . 5.3 t30 62.53 1.9 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -1.083 . . . . 0.0 109.962 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 63' ' ' GLY . 9.7 mm-40 -106.01 8.99 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.0 . . . . 0.0 109.12 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.1 t -104.36 141.03 37.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 m -57.24 146.87 26.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -64.23 -26.75 68.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.02 -32.07 72.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -87.22 -45.16 10.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.295 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.665 ' OG ' HD13 ' A' ' 62' ' ' LEU . 33.2 t -53.34 -49.76 66.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -59.68 -48.27 86.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -46.0 -43.53 14.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -1.122 . . . . 0.0 109.24 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 19' ' ' VAL . . . -63.42 -56.09 19.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -57.41 -20.5 30.35 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.366 -0.834 . . . . 0.0 108.935 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -82.42 -59.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.269 -0.894 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -63.18 -25.28 68.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.893 . . . . 0.0 108.716 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.826 HG22 HD23 ' A' ' 58' ' ' LEU . 5.3 m -75.91 -50.4 15.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.627 -0.671 . . . . 0.0 109.535 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 75' ' ' ALA . 51.6 t -73.65 -27.81 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -71.56 -59.78 2.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -58.64 -46.96 85.97 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.986 -1.071 . . . . 0.0 108.414 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.726 ' HB2' HD21 ' A' ' 58' ' ' LEU . 5.4 t70 -47.22 -45.75 23.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 13.5 t70 -61.66 -27.85 68.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.731 ' HB3' HD13 ' A' ' 81' ' ' LEU . 20.4 t80 -74.85 -23.85 58.49 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.9 mt -83.88 -54.11 5.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.841 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -121.71 -42.36 2.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 109.994 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.408 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . 126.11 -44.28 1.27 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 52.7 mtt85 -112.34 -85.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . 71.69 150.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.64 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 90' ' ' VAL . 1.6 t -79.57 150.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -122.95 130.26 52.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 109.891 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.4 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 24.7 m80 -124.99 129.46 50.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -107.32 126.86 52.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 109.86 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 100.54 7.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.49 38.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 1.8 tt0 52.23 80.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.1 -62.34 0.37 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -94.94 60.78 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.471 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -67.04 159.4 28.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 m -91.82 170.03 10.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.95 -61.06 1.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -48.91 -47.94 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 109.251 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.45 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 21.7 t80 -55.07 -49.52 71.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.63 -16.26 62.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.31 -31.88 26.92 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.405 ' CE2' HD22 ' A' ' 14' ' ' LEU . 2.5 t80 -82.45 -34.59 28.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.681 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -105.21 113.86 27.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 109.722 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -103.99 -12.49 16.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.9 p -53.27 -29.63 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 109.459 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 87.09 40.62 6.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.798 ' N ' HD22 ' A' ' 111' ' ' LEU . 2.8 mm? 52.01 102.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.095 -1.238 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 35' ' ' PHE . 4.2 tmtm? -94.23 117.53 30.25 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -81.81 107.77 14.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 0.0 109.736 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -107.98 108.83 20.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.478 ' O ' ' CG2' ' A' ' 118' ' ' VAL . 14.3 mptt -57.38 117.76 4.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.63 -178.76 46.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.84 18.11 79.75 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 115' ' ' LYS . 2.1 t -81.71 -20.5 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -1.173 . . . . 0.0 109.521 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -46.48 -25.66 0.72 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.202 -0.936 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.3 m -72.17 6.13 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.584 ' O ' ' CG ' ' A' ' 124' ' ' HIS . . . -69.84 -51.48 24.26 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -50.26 -26.53 4.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -1.167 . . . . 0.0 109.428 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -72.98 2.92 6.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.405 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.591 ' C ' ' HD1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -75.15 167.13 22.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.518 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -103.54 120.88 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.65 113.39 59.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.386 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.473 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 61.0 Cg_endo -78.72 125.78 6.96 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.167 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.473 ' CG ' ' O ' ' A' ' 127' ' ' PRO . 15.9 m-20 -175.36 64.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.12 -17.28 62.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.01 -23.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.77 -26.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.11 -27.84 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.525 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.458 ' ND1' ' N ' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -142.36 65.86 18.55 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 0.0 109.569 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 7' ' ' LYS . 48.9 Cg_exo -51.84 -29.64 35.34 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.77 2.314 . . . . 0.0 112.052 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.528 ' HA ' ' H ' ' A' ' 8' ' ' ALA . 12.7 pt-20 -56.99 -29.36 63.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 3.8 t80 -66.79 -44.19 81.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tp -89.66 -19.26 25.08 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' O ' ' O ' ' A' ' 8' ' ' ALA . 35.3 mttm -108.45 -61.37 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.621 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.64 133.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 56.3 44.66 89.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' GLY . 38.2 mttp -42.57 -22.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -1.066 . . . . 0.0 109.418 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' GLY . 33.3 mt-10 -152.87 152.95 29.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -39.68 120.09 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.665 2.243 . . . . 0.0 112.15 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.97 -162.08 32.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -126.55 143.22 51.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -1.05 . . . . 0.0 109.678 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -137.52 156.17 48.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.591 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -126.49 137.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.0 109.808 -179.672 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.4 m0 -142.59 111.08 6.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.293 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.67 146.13 44.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.148 -0.97 . . . . 0.0 109.501 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' A' ' 74' ' ' ALA . 1.6 t -80.29 143.91 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.0 109.39 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 21' ' ' LYS . 6.6 tp10 -159.18 109.6 1.99 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.448 -0.783 . . . . 0.0 109.461 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 20' ' ' GLU . 19.3 mttp 41.54 41.11 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 55.78 45.95 23.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 24' ' ' LEU . 25.7 t0 -126.47 -19.38 4.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 23' ' ' ASP . 9.6 mp 57.2 123.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.64 122.18 10.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.142 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.22 139.6 3.97 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.386 2.057 . . . . 0.0 112.501 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.16 127.89 93.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -40.16 101.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.476 2.118 . . . . 0.0 112.346 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 m -49.41 -27.43 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.376 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.38 -41.94 14.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.212 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.98 -53.86 2.84 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 t80 51.51 91.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . 123.5 -22.35 7.0 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.592 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 11.1 m-20 -92.53 147.74 22.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -1.206 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 9.1 m-85 -145.68 150.44 36.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.95 . . . . 0.0 109.749 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 38' ' ' GLY . 67.9 m-85 -87.48 109.83 19.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.168 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 114' ' ' LYS . 16.6 p -60.28 87.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 179.02 -29.79 0.06 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.2 t0 -107.52 -153.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -1.058 . . . . 0.0 108.873 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -139.41 147.91 42.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 11.9 m-85 -128.54 141.1 51.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.585 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.439 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 47.1 t -115.8 128.18 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.581 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.6 mt -123.14 146.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.25 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' A' ' 56' ' ' TYR . 3.8 mp -124.58 151.86 44.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -142.8 93.77 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 109.95 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.618 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 94.6 m -85.6 117.24 24.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.738 . . . . 0.0 109.615 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.86 164.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.276 -0.89 . . . . 0.0 109.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -125.64 110.8 14.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.565 -0.709 . . . . 0.0 109.154 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -52.3 -91.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.234 -0.916 . . . . 0.0 109.418 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.23 -38.03 0.46 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.179 -0.951 . . . . 0.0 109.54 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -173.7 30.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -0.85 . . . . 0.0 109.365 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.47 -97.13 2.31 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -125.44 -165.33 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -1.16 . . . . 0.0 109.509 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.627 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -125.13 161.12 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.796 . . . . 0.0 109.305 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -125.54 106.32 9.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 110.125 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 12.2 m-85 -77.83 130.02 36.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.599 ' OD1' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.1 117.84 33.72 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.8 mp -96.11 143.82 26.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 110.779 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.4 m-70 -145.6 111.84 5.72 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -93.2 116.17 28.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 0.0 108.842 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.782 ' C ' HD23 ' A' ' 62' ' ' LEU . 25.5 t90 -91.49 129.06 37.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 110.041 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.782 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -131.53 111.87 12.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.55 14.22 0.08 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 62' ' ' LEU . 41.0 t30 65.22 1.78 1.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.447 -1.031 . . . . 0.0 109.862 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -107.16 10.32 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 108.984 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 28.8 t -104.41 146.21 29.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.463 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 p -70.43 140.64 52.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.455 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLN . 34.0 tt0 -63.03 -8.86 8.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 47.1 t0 -70.73 -49.51 46.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -87.24 -40.41 14.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 109.417 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.6 t -57.05 -54.41 47.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.34 -45.32 35.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.19 -51.93 60.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 19' ' ' VAL . . . -50.68 -45.75 58.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.5 -21.54 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 109.224 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.27 -52.01 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -58.93 -38.95 80.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -0.972 . . . . 0.0 109.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.603 HG23 ' N ' ' A' ' 79' ' ' VAL . 4.8 t -72.6 -48.24 41.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.762 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.603 ' N ' HG23 ' A' ' 78' ' ' THR . 40.9 t -64.17 -56.26 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.855 . . . . 0.0 109.906 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -54.1 -58.91 5.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -50.24 -47.51 55.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.067 -1.02 . . . . 0.0 109.278 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.629 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -46.95 -47.6 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.861 -1.149 . . . . 0.0 108.399 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.59 -28.28 69.24 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LEU . 26.9 t80 -78.29 -23.47 47.15 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.49 -51.07 7.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.618 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -122.33 -42.16 2.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.221 -0.924 . . . . 0.0 109.955 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.18 -18.4 6.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.497 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.6 mmm180 -141.94 -84.56 0.18 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.411 -1.053 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.629 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . 65.34 145.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.6 150.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.307 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.584 ' NE2' ' O ' ' A' ' 89' ' ' ALA . 5.2 mp0 -124.56 158.01 34.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.599 ' CD2' ' OD1' ' A' ' 57' ' ' ASP . 26.2 m-70 -138.29 143.56 40.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 109.42 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -114.97 127.12 55.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.587 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -126.88 89.77 3.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.97 37.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.57 84.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 109.354 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.97 -54.99 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -94.32 58.6 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -93.13 150.78 20.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 109.371 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 m -91.11 176.99 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -73.73 -27.28 61.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -64.01 -53.39 50.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.003 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.47 ' C ' ' CD2' ' A' ' 103' ' ' PHE . 18.8 t80 -62.88 -50.38 71.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.453 -0.779 . . . . 0.0 109.38 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -66.92 -26.18 66.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.197 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -62.7 -48.16 83.48 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -48.79 69.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -1.16 . . . . 0.0 109.209 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -106.23 67.58 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -93.16 -16.96 24.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.935 . . . . 0.0 109.592 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 m -67.18 -3.91 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.918 . . . . 0.0 109.663 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.66 109.79 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.702 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.74 -102.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -1.159 . . . . 0.0 109.215 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 7.2 mttm 163.79 117.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.462 -0.773 . . . . 0.0 109.126 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 37' ' ' THR . 0.2 OUTLIER -94.31 107.99 19.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' THR . 69.1 mttt -113.77 136.2 53.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.438 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -62.79 114.63 3.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.932 . . . . 0.0 109.442 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.39 128.79 9.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 119' ' ' ALA . . . -179.3 37.17 0.07 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 117' ' ' GLY . 41.0 t -42.78 -21.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.125 . . . . 0.0 109.436 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 117' ' ' GLY . . . -53.28 -21.88 6.17 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.1 t -67.88 6.26 0.72 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.415 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -80.7 -23.34 60.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -49.86 -17.94 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -1.173 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 124' ' ' HIS . 32.4 tttm -69.32 -42.59 75.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.531 ' O ' ' O ' ' A' ' 123' ' ' LYS . 16.1 m-70 57.99 137.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.83 . . . . 0.0 109.635 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 t -140.96 132.27 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.14 113.25 64.54 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.12 142.72 8.22 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.373 2.048 . . . . 0.0 112.28 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -64.9 130.53 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -87.96 -17.45 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 130' ' ' VAL . 23.0 t -49.13 -56.52 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 132' ' ' VAL . 14.2 p -52.35 -37.88 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.474 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.455 ' N ' HG13 ' A' ' 131' ' ' VAL . 16.6 t -69.89 -27.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.476 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -136.44 72.89 57.3 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.21 143.02 24.94 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.697 2.265 . . . . 0.0 112.26 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 6' ' ' LEU . 55.6 mt-10 -56.82 -18.69 13.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.603 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 4' ' ' GLU . 73.5 t80 -41.62 -22.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.498 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 4' ' ' GLU . 27.9 tp -74.25 -33.46 63.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.824 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.7 ptpp? -105.86 -42.47 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 109.794 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 58.55 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -0.816 . . . . 0.0 109.395 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.26 46.84 85.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -46.24 -27.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -1.167 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -149.78 154.82 38.0 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -40.65 129.52 2.64 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.754 2.303 . . . . 0.0 112.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.69 29.88 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.788 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.3 tt -124.78 127.06 46.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.123 . . . . 0.0 109.396 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.512 ' N ' HD23 ' A' ' 14' ' ' LEU . 11.1 mt-30 -118.07 138.9 51.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.9 OUTLIER -109.64 140.19 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.601 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 7.9 m0 -142.43 110.86 6.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.108 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -81.38 138.47 35.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.634 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -93.6 142.76 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 22' ' ' PHE . 10.3 tp10 -159.5 123.3 3.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.549 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 20' ' ' GLU . 11.4 tptm 42.48 26.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.6 m-85 66.57 44.88 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 24' ' ' LEU . 26.7 t0 -117.12 -25.11 7.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.512 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.8 mt 57.6 124.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -145.28 126.71 7.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.365 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.06 123.33 7.21 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.45 2.1 . . . . 0.0 112.339 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -97.75 130.43 29.02 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -42.48 103.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.486 2.124 . . . . 0.0 112.405 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -48.72 -40.12 27.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -63.14 -53.74 48.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 tp -84.71 12.7 6.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 34' ' ' ASP . 46.0 t80 -83.74 -110.37 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 109.074 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.57 ' N ' ' CG ' ' A' ' 32' ' ' TYR . . . 56.38 -3.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 32' ' ' TYR . 1.1 t70 -111.78 164.76 12.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 109.61 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.571 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 7.4 m-85 -144.75 120.07 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.6 114.45 17.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 ' HH2' ' A' ' 61' ' ' TRP . 17.3 p -75.57 87.14 2.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.41 -28.38 0.07 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -115.17 -155.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 108.807 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 140.91 38.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -112.3 121.85 46.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.646 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.0 t -96.77 121.28 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.407 -0.808 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.598 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.1 mt -121.28 145.9 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.765 HD11 HD23 ' A' ' 58' ' ' LEU . 2.0 mp -127.52 125.16 39.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.626 -0.671 . . . . 0.0 109.295 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 55' ' ' GLN . 16.9 ttpt -106.02 93.68 4.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.691 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.512 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 31.2 m -77.71 100.52 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -94.49 164.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.292 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -123.44 124.87 43.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.546 -0.721 . . . . 0.0 109.349 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.8 mt -65.28 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 69.3 mtm-85 -140.04 -34.73 0.54 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -173.74 32.17 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 109.395 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -116.26 -98.13 2.08 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -127.6 -160.06 0.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.115 . . . . 0.0 109.419 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.528 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.68 164.52 18.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.434 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' LYS . 42.9 tt0 -129.08 117.62 21.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.766 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 56' ' ' TYR . 5.9 m-85 -91.52 123.07 34.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.856 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -91.75 119.84 31.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.08 -1.012 . . . . 0.0 109.052 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.765 HD23 HD11 ' A' ' 44' ' ' LEU . 12.5 mt -82.72 128.99 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.889 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.684 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 22.1 m-70 -139.43 108.12 5.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -102.01 112.15 24.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 108.544 179.1 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.789 ' C ' HD23 ' A' ' 62' ' ' LEU . 73.3 t90 -93.66 129.18 40.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 110.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.789 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -127.79 130.55 48.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -82.81 23.83 5.56 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.7 t30 60.88 1.86 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -1.066 . . . . 0.0 109.896 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 63' ' ' GLY . 2.8 mm-40 -108.18 10.4 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -0.999 . . . . 0.0 108.848 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.487 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 7.2 p -105.34 132.6 51.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.526 -0.734 . . . . 0.0 109.558 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -54.52 155.98 3.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.54 -8.9 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.384 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 4.5 t0 -77.03 -36.4 56.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.728 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -87.09 -28.03 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.615 ' OG ' HD13 ' A' ' 62' ' ' LEU . 30.7 t -69.05 -60.01 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.51 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.97 49.18 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.4 -44.52 24.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -1.183 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.93 -57.35 10.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.154 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -59.03 -19.83 47.53 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 109.171 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mm -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.95 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -57.51 -35.53 70.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.641 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.579 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.5 t -80.13 -47.23 15.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.884 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.7 t -61.27 -47.47 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.741 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -69.72 -59.54 2.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.8 tm? -53.45 -51.8 61.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.93 -1.106 . . . . 0.0 108.807 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.632 ' HB2' HD21 ' A' ' 58' ' ' LEU . 6.1 t0 -46.01 -47.19 16.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.006 -1.059 . . . . 0.0 108.355 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -56.65 -30.07 62.94 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 81' ' ' LEU . 35.7 t80 -71.03 -23.94 62.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.46 HD21 HD11 ' A' ' 81' ' ' LEU . 46.8 mt -82.38 -55.19 4.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 110.211 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.484 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -121.62 -42.31 2.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.29 0.91 31.3 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 89' ' ' ALA . 24.0 mtp180 -138.31 -83.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -1.127 . . . . 0.0 109.581 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.537 ' CB ' ' OD2' ' A' ' 82' ' ' ASP . . . 56.3 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.849 . . . . 0.0 109.794 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 2.6 t -91.43 150.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.56 133.87 52.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.879 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.684 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 35.4 m-70 -138.14 122.31 18.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.235 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.423 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 14.4 ptp180 -110.6 122.17 47.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.957 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.588 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -117.75 90.54 3.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 108.996 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.4 37.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.625 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 68.55 77.8 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.31 -56.5 0.61 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.485 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 8.0 m-85 -87.69 55.22 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.106 . . . . 0.0 109.376 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 30.3 mm-40 -66.83 -178.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.458 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.0 m -117.49 157.2 26.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.4 -0.812 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.39 70.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.571 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.0 m -57.35 -52.08 66.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 44.7 t80 -56.5 -37.87 70.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.487 -0.758 . . . . 0.0 109.6 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -71.28 -31.14 67.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.515 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.23 81.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.432 ' CD2' HD13 ' A' ' 14' ' ' LEU . 1.7 t80 -74.86 -47.54 29.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -1.144 . . . . 0.0 109.568 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -109.49 82.62 1.62 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.521 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -98.28 -34.15 10.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.545 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -101.27 9.18 42.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.24 -108.89 2.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.613 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.4 mm? 53.1 101.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.243 -1.151 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -149.93 97.52 2.6 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.555 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -81.69 107.99 14.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.462 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -118.81 154.46 32.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.349 -0.845 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.52 ' H ' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -73.07 160.19 32.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -145.77 99.48 0.21 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.8 34.84 4.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.7 -34.57 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -1.153 . . . . 0.0 109.387 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.69 -30.54 32.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.7 m -86.28 6.13 31.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.37 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.42 -34.8 39.21 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.32 -27.26 27.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -1.21 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -71.18 0.62 7.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.183 -0.948 . . . . 0.0 109.419 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -82.26 125.31 30.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.87 . . . . 0.0 109.351 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t -141.76 128.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.31 115.88 28.17 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.08 135.92 10.67 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.41 2.073 . . . . 0.0 112.214 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 61.33 90.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' OE2' ' N ' ' A' ' 129' ' ' GLU . 54.8 mp0 -79.79 -17.77 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.429 ' H ' HG23 ' A' ' 130' ' ' VAL . 2.5 t -47.82 -19.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 129' ' ' GLU . 88.8 t -65.45 -44.35 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.94 -28.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.469 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -65.02 -41.41 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.32 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.48 142.38 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.36 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.7 43.07 3.46 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -119.02 2.63 11.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.49 ' OE2' ' O ' ' A' ' 12' ' ' PRO . 2.1 pp20? -171.52 141.45 1.29 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.25 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' O ' ' OE2' ' A' ' 11' ' ' GLU . 55.8 Cg_endo -73.27 178.33 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.42 2.08 . . . . 0.0 112.175 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -135.23 12.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 106' ' ' TYR . 5.9 tt -134.57 133.06 39.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -1.091 . . . . 0.0 109.782 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 43' ' ' ILE . 3.3 mt-30 -124.56 145.47 49.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.623 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.5 OUTLIER -125.23 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 110.167 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.9 m-90 -145.47 147.65 32.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.423 -0.798 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -106.64 130.68 54.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.445 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -81.7 143.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.447 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -148.71 96.98 2.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.436 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.9 tttm 50.86 37.09 16.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.7 m-85 68.98 46.25 0.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.563 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 24' ' ' LEU . 2.8 m-20 -127.03 -21.25 4.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 23' ' ' ASP . 17.0 mt 56.03 122.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.516 -0.74 . . . . 0.0 109.665 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -140.29 108.16 6.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.84 117.94 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.448 2.099 . . . . 0.0 112.144 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 27' ' ' VAL . 14.5 p -59.34 133.84 88.24 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -40.78 117.88 0.56 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.484 2.122 . . . . 0.0 112.392 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -67.93 -25.66 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -53.57 -50.72 64.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.394 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -78.86 -53.8 6.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.396 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 54.75 93.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.381 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.51 -26.9 5.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 34' ' ' ASP . 19.3 p-10 -62.44 141.15 58.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -1.13 . . . . 0.0 109.17 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 33' ' ' GLY . 62.8 m-85 -145.3 137.81 25.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.936 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.33 112.21 24.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 108.993 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 37' ' ' THR . 14.8 p -68.82 87.21 0.35 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.81 -29.73 0.06 OUTLIER Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -107.51 -153.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -1.049 . . . . 0.0 108.846 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.492 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -138.6 140.78 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -116.1 147.96 40.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.23 133.57 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.38 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 15' ' ' GLN . 2.0 mt -134.0 145.75 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.944 . . . . 0.0 109.715 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.637 ' CD2' HD23 ' A' ' 58' ' ' LEU . 41.4 mt -122.12 149.35 43.72 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' NZ ' ' CG2' ' A' ' 102' ' ' THR . 11.4 ttpt -137.31 94.17 2.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.599 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -81.56 106.94 13.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 109.013 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -91.36 164.76 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.428 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 54' ' ' LEU . 1.4 pt? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.5 tt0 -132.77 115.97 15.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.224 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.41 131.82 35.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -108.37 131.74 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.98 -1.075 . . . . 0.0 108.915 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.637 HD23 ' CD2' ' A' ' 44' ' ' LEU . 10.7 mt -93.5 134.51 35.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.61 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.713 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 43.3 m-70 -146.57 108.79 4.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.235 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.727 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.22 127.46 52.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.007 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -95.95 124.21 39.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -0.849 . . . . 0.0 110.114 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.659 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.4 mt -121.99 107.21 11.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.97 13.02 0.05 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.659 ' H ' ' C ' ' A' ' 62' ' ' LEU . 5.2 t-20 64.14 1.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 109.838 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.09 9.98 30.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 108.934 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.0 t -104.94 138.66 40.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.578 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.8 p -56.74 161.17 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -75.24 -25.95 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.42 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.81 -41.43 86.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.522 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -87.2 -34.81 18.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.579 ' OG ' HD13 ' A' ' 62' ' ' LEU . 3.3 t -59.21 -57.98 10.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 0.0 109.376 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.72 -40.65 96.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.01 -47.82 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -1.178 . . . . 0.0 109.391 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -49.85 69.81 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.277 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -60.03 -24.22 64.34 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mm -81.33 -57.77 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 109.673 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.46 -38.69 88.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 108.947 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.54 HG22 HD22 ' A' ' 58' ' ' LEU . 19.6 m -68.55 -41.5 79.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.386 -0.821 . . . . 0.0 109.757 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 75' ' ' ALA . 50.7 t -71.97 -55.34 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -52.28 -59.7 4.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.129 -0.982 . . . . 0.0 109.948 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.751 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -52.76 -41.98 64.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.05 -1.031 . . . . 0.0 109.012 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.609 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -47.13 -49.1 22.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.857 -1.152 . . . . 0.0 108.135 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.451 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.2 m-20 -60.39 -31.6 70.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.751 ' HB3' HD13 ' A' ' 81' ' ' LEU . 28.7 t80 -74.48 -23.5 58.88 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 81' ' ' LEU . 1.4 tp -83.69 -54.65 4.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 0.6 OUTLIER -122.33 -42.33 2.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.183 -0.948 . . . . 0.0 110.167 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.07 -33.06 3.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.726 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 2.2 mmp_? -127.9 -84.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -1.105 . . . . 0.0 109.236 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 78.82 178.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.759 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.94 150.61 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.865 . . . . 0.0 109.261 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.79 123.91 50.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.914 . . . . 0.0 109.863 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.713 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 36.5 m-70 -133.89 121.93 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.338 -0.851 . . . . 0.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -113.14 119.56 38.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 94' ' ' GLU . 57.2 mp0 -109.89 94.32 4.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 96' ' ' GLN . 8.5 t -83.6 37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 95' ' ' VAL . 2.9 tt0 49.81 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.42 -55.88 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -124.33 66.07 1.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -1.108 . . . . 0.0 109.474 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.417 ' OE2' ' CE1' ' A' ' 103' ' ' PHE . 13.7 mt-10 -69.9 -176.94 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 109.479 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.59 175.84 6.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.86 44.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.459 ' CG2' ' NZ ' ' A' ' 45' ' ' LYS . 22.4 m -63.16 -37.0 85.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CE1' ' OE2' ' A' ' 99' ' ' GLU . 41.8 t80 -68.59 -49.33 60.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.91 -19.11 65.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.951 . . . . 0.0 109.442 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.43 8.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.484 ' CD1' HD13 ' A' ' 14' ' ' LEU . 4.3 t80 -78.12 -25.07 47.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -1.14 . . . . 0.0 109.625 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -116.56 68.32 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.469 ' CB ' ' NZ ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -60.48 -58.7 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.905 . . . . 0.0 109.286 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.421 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 1.4 t -105.32 10.01 33.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.5 ' C ' HD12 ' A' ' 111' ' ' LEU . . . -75.62 55.76 2.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.57 91.88 2.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -1.109 . . . . 0.0 109.322 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 35' ' ' PHE . 8.5 ttmt -126.21 110.19 13.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -81.81 107.97 14.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -124.66 108.93 12.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.392 -0.818 . . . . 0.0 109.176 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 115' ' ' LYS . 33.2 pttt . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.591 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.324 0.583 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.06 147.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.32 81.22 37.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.54 125.88 16.58 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 0.0 112.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.87 167.29 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.538 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -55.97 -17.27 6.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.421 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.43 -25.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -46.99 -43.31 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.95 -28.6 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.49 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.686 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.19 0.519 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -71.64 -31.58 67.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.88 156.59 36.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' ' 56' ' ' TYR . . . 87.86 17.0 58.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -142.09 -23.38 0.69 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -1.189 . . . . 0.0 109.704 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.472 ' O ' ' OH ' ' A' ' 56' ' ' TYR . 16.5 mm-40 -93.49 117.11 67.29 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.312 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.24 162.38 31.33 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.23 1.953 . . . . 0.0 112.21 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.29 -120.95 7.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.37 145.35 45.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -1.158 . . . . 0.0 109.988 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.429 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 14.1 mt-30 -136.62 144.63 44.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.835 . . . . 0.0 109.057 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.592 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 18.2 mt -124.52 134.02 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.095 -1.003 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.5 m0 -141.63 115.88 9.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.781 . . . . 0.0 108.995 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 25' ' ' VAL . 39.7 ttp180 -92.2 145.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.847 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.75 143.38 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' PHE . 58.3 tt0 -129.08 112.29 13.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.0 109.35 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tttp 62.82 -69.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' GLU . 75.7 t80 -163.09 20.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.613 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.8 p-10 -127.07 115.32 18.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -55.24 148.37 14.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.435 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' ARG . 44.4 t -142.48 134.18 13.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.253 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.83 161.82 42.74 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.308 2.005 . . . . 0.0 112.154 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.37 133.79 17.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.249 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.16 107.53 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.374 2.049 . . . . 0.0 112.14 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 96.4 m -56.07 -22.81 29.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 5.7 p-10 -82.29 -22.47 35.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.913 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 30' ' ' ASN . 6.6 mp -121.35 13.4 11.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.753 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.723 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.99 -105.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.649 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 56.75 7.65 2.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.603 ' OD2' ' N ' ' A' ' 35' ' ' PHE . 8.3 t0 -150.54 150.14 30.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -1.099 . . . . 0.0 109.426 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.697 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -146.39 161.11 41.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.726 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CE1' ' NH2' ' A' ' 18' ' ' ARG . 5.1 m-85 -90.72 128.34 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -77.23 -30.41 54.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.649 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -78.08 -17.6 78.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -101.11 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -1.157 . . . . 0.0 109.422 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.7 142.72 38.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 2.0 m-85 -118.12 121.7 41.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.561 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.38 135.89 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 108.966 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -129.74 143.42 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.709 HD12 ' CD2' ' A' ' 56' ' ' TYR . 2.0 mm? -115.43 118.58 33.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' NZ ' HG22 ' A' ' 102' ' ' THR . 17.1 ttmt -115.67 94.58 4.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.882 -1.136 . . . . 0.0 110.894 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.62 HG23 ' CD1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -80.35 105.12 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -96.82 164.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.624 -0.673 . . . . 0.0 109.69 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 C--N 1.299 -1.599 0 O-C-N 121.578 -0.701 . . . . 0.0 109.479 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LYS . 12.6 tp60 -139.78 116.43 10.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.957 -1.089 . . . . 0.0 110.333 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.709 ' CD2' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -83.57 116.84 22.78 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 2.6 m-20 -89.01 128.36 35.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.623 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 1.7 mm? -99.69 102.9 14.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.843 . . . . 0.0 109.012 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.715 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 17.8 m-70 -111.72 108.69 18.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 110.15 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -108.71 112.32 24.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.903 ' C ' HD23 ' A' ' 62' ' ' LEU . 15.9 t90 -105.25 138.64 41.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 110.516 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.903 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -128.14 117.11 21.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -61.65 24.95 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.687 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.5 t-20 56.09 2.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.336 -1.097 . . . . 0.0 110.029 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 63' ' ' GLY . 78.2 mt-10 -103.09 2.47 34.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 108.902 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 36.1 t -95.38 145.82 24.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 109.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 69' ' ' ASP . 93.5 p -83.92 140.2 32.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 109.554 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 67' ' ' SER . 17.7 pt20 -44.4 -24.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.4 m-20 -57.32 -57.96 10.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -87.61 -39.68 14.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 108.921 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.72 -59.65 4.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.27 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -40.18 48.88 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.58 59.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -1.125 . . . . 0.0 109.194 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.66 -46.16 70.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 0.0 109.005 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.87 -23.43 67.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.046 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -81.07 -53.99 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.862 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 16.2 m-85 -67.29 -30.35 70.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.502 ' CG2' HD12 ' A' ' 58' ' ' LEU . 55.2 m -72.87 -41.71 64.43 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.35 -54.99 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.98 -1.075 . . . . 0.0 109.747 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -61.51 -59.59 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.783 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -53.42 -43.14 67.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.068 -1.02 . . . . 0.0 108.901 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' THR . 7.3 t0 -48.7 -48.68 40.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.088 -1.008 . . . . 0.0 108.749 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -59.28 -35.11 73.15 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.527 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 10.0 t80 -74.49 -22.43 59.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.3 tp -82.17 -54.78 4.99 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 89' ' ' ALA . 5.6 m120 -122.89 -42.7 2.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.735 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.23 -13.69 62.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -156.17 19.8 0.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -58.3 -172.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.63 150.02 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.19 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -110.9 110.7 21.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.997 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 7.7 m-70 -110.23 120.32 42.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 108.909 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 8.6 ptt180 -114.43 125.96 54.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.288 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.606 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -126.64 120.3 29.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.96 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 96' ' ' GLN . 3.6 t -112.55 37.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.36 -0.838 . . . . 0.0 109.841 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' O ' ' A' ' 95' ' ' VAL . 11.3 tt0 58.82 124.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.506 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.46 -36.87 4.1 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -132.21 51.97 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -1.104 . . . . 0.0 109.596 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -58.58 179.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.6 m -103.54 156.0 18.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.72 83.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.509 HG22 ' NZ ' ' A' ' 45' ' ' LYS . 1.3 m -65.42 -48.22 73.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.13 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 107' ' ' PHE . 30.1 t80 -58.33 -44.16 88.57 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.314 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.73 -30.74 71.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.1 91.64 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -49.54 65.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -1.185 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.427 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 45.6 m-85 -98.13 65.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -87.52 -34.41 18.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -96.6 2.46 52.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -86.36 -104.44 0.77 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.7 mm? 54.57 101.69 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.328 -1.101 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 11.9 tttt -168.15 91.79 0.32 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.86 108.02 15.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.402 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -96.47 113.01 24.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.708 ' N ' ' HD1' ' A' ' 124' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.86 132.95 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.187 -0.945 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -99.12 110.99 59.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.369 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 128' ' ' ASN . 77.8 Cg_exo -46.38 150.83 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.419 2.079 . . . . 0.0 112.21 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -43.14 153.4 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 131' ' ' VAL . 25.0 tt0 -56.5 -17.11 7.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.91 -17.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 129' ' ' GLU . 10.8 p -57.0 -34.0 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.96 -28.15 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.489 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.1 tt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.303 0.573 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 8' ' ' ALA . 81.9 mttt -104.65 -46.92 4.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.603 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.36 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.642 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 55.21 29.47 52.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.1 ptpt -42.3 -25.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 109.595 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 9' ' ' GLY . 6.0 mt-10 -147.86 148.96 31.85 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.5 134.67 6.9 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.725 2.283 . . . . 0.0 112.156 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -158.05 24.69 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.48 143.1 50.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -1.059 . . . . 0.0 109.4 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.642 HE21 ' H ' ' A' ' 9' ' ' GLY . 21.0 mt-30 -130.34 146.29 51.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 41.0 mt -116.07 137.7 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.852 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.603 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 6.2 m0 -142.44 111.71 6.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.16 145.23 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 109.645 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -84.83 143.58 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 17.5 tt0 -158.13 81.08 0.84 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.516 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.8 tttp 72.22 33.27 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER 66.57 17.0 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.5 t70 -95.74 -27.12 15.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER 62.9 134.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -149.63 134.11 9.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.087 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 27' ' ' VAL . 37.8 Cg_endo -69.99 110.14 2.53 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.282 1.988 . . . . 0.0 112.209 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' PRO . 9.8 p -40.8 135.59 1.59 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.081 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.66 127.74 24.64 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.271 1.98 . . . . 0.0 112.349 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 30' ' ' ASN . 17.6 m -63.21 -32.51 73.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.378 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 29' ' ' THR . 42.6 t30 -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.178 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.6 mp -99.19 -55.2 2.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' LEU . 2.7 t80 47.46 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.463 -0.773 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.579 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.82 -13.3 8.14 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.24 143.91 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 109.185 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 18.2 m-85 -141.34 142.76 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 114' ' ' LYS . 4.8 m-85 -86.8 106.81 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 0.0 108.941 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.557 ' C ' ' H ' ' A' ' 39' ' ' ASP . 23.8 p -51.93 -52.5 49.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.869 . . . . 0.0 110.035 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . -61.56 7.86 0.14 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 37' ' ' THR . 0.5 OUTLIER -133.81 172.51 12.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -1.182 . . . . 0.0 109.476 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.98 151.81 30.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.908 . . . . 0.0 109.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -131.06 121.86 25.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.616 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.47 HG11 ' OG1' ' A' ' 78' ' ' THR . 21.4 t -97.71 118.93 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.081 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -117.08 143.2 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.553 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -124.96 129.46 50.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.77 -0.581 . . . . 0.0 109.836 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.12 93.61 4.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 109.648 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.421 ' CG2' HD22 ' A' ' 54' ' ' LEU . 2.4 m -72.78 103.06 3.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.513 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -102.63 164.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.559 -0.713 . . . . 0.0 109.28 179.73 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -135.45 141.27 45.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.573 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -99.71 119.36 37.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.208 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.592 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 6.6 m-20 -73.38 120.23 18.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.768 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.0 tm? -93.7 115.44 27.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.592 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -132.88 121.5 22.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.379 -0.826 . . . . 0.0 109.811 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 93' ' ' ARG . 0.3 OUTLIER -99.19 129.65 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.034 . . . . 0.0 108.792 178.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.887 ' C ' HD23 ' A' ' 62' ' ' LEU . 18.3 t90 -108.85 126.65 53.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.831 . . . . 0.0 110.156 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.887 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -133.76 116.3 15.57 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 65' ' ' GLU . . . -68.24 34.25 0.25 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.579 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.0 t-20 49.73 10.9 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -1.025 . . . . 0.0 110.08 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 63' ' ' GLY . 59.5 mt-10 -110.41 4.59 20.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 108.934 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.68 144.03 28.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.593 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 69' ' ' ASP . 2.0 p -67.41 125.5 26.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -50.69 -9.18 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 67' ' ' SER . 17.9 t0 -75.5 -44.12 45.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.494 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -87.25 -45.72 10.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.256 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.602 ' OG ' HD13 ' A' ' 62' ' ' LEU . 6.9 t -51.71 -50.34 60.71 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.92 -52.09 51.14 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.45 -39.15 6.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.84 -39.87 83.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.99 . . . . 0.0 109.213 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -67.49 -31.0 70.83 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.284 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.79 -48.55 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 0.0 110.181 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.33 -33.67 76.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 109.296 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -81.35 -47.14 13.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 75' ' ' ALA . 61.6 t -61.47 -45.66 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.903 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.22 -57.82 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.513 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 81' ' ' LEU . 2.2 tm? -52.33 -49.72 63.7 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.009 -1.057 . . . . 0.0 108.835 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 78' ' ' THR . 20.2 m-20 -46.56 -49.48 18.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 0.0 108.41 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 87' ' ' GLY . 7.6 m-20 -54.61 -31.95 57.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 81' ' ' LEU . 9.7 t80 -65.39 -28.81 69.53 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 81' ' ' LEU . 16.4 mt -83.92 -58.11 2.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 88' ' ' ARG . 9.2 t-20 -121.76 13.46 10.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.135 -0.978 . . . . 0.0 110.666 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 51.32 5.96 0.14 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 86' ' ' ASN . 34.1 mtp180 -147.19 -83.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.369 -1.077 . . . . 0.0 109.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 60.09 141.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 90' ' ' VAL . 2.8 t -73.94 139.61 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -102.59 138.14 39.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 58' ' ' LEU . 20.5 m-70 -140.09 135.71 32.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 7.8 ptp85 -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 22.5 mt-10 -129.26 81.04 2.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.313 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 95' ' ' VAL . 14.5 t -78.95 38.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.875 . . . . 0.0 109.575 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 63.19 72.39 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.605 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.425 ' O ' ' OE1' ' A' ' 99' ' ' GLU . . . 150.96 -60.86 0.41 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -88.32 57.94 4.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -1.135 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 18.9 mp0 -77.23 -165.14 0.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 94.2 p -133.98 159.9 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.19 78.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.1 m -61.34 -60.29 3.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 44.0 t80 -52.53 -38.0 58.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.06 -31.62 66.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.06 95.42 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.69 -52.38 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -1.196 . . . . 0.0 109.568 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.45 80.61 1.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -96.57 -37.74 10.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.583 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -102.43 9.93 39.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -89.98 -107.99 1.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.657 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.5 mm? 51.23 100.36 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.291 -1.123 . . . . 0.0 109.361 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -148.71 114.3 5.64 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.3 OUTLIER -81.93 111.55 18.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.76 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 1.8 mmpt? -105.49 113.14 26.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.315 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.419 -179.888 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.374 0.607 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -135.02 125.9 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -125.83 81.61 65.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.564 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.7 165.5 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.818 2.345 . . . . 0.0 112.273 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.426 ' OD1' ' CD ' ' A' ' 129' ' ' GLU . 12.3 t-20 -74.43 -173.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.653 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -77.17 -28.82 54.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.389 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.14 -31.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.631 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.81 -54.18 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.602 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.48 -28.52 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.511 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.34 0.591 . . . . 0.0 109.45 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -96.48 -59.79 1.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.569 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.639 ' HB3' HD21 ' A' ' 85' ' ' LEU . . . 59.38 136.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.78 . . . . 0.0 109.407 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.63 ' CA ' ' NE2' ' A' ' 15' ' ' GLN . . . 45.5 46.02 12.01 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLY . 25.9 mtmt -43.22 -33.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -1.11 . . . . 0.0 109.384 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.541 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -140.71 169.29 11.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.847 . . . . 0.0 109.392 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -46.07 134.17 14.82 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.755 2.303 . . . . 0.0 112.328 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.95 -168.48 26.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 tt -123.63 144.03 49.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -1.091 . . . . 0.0 109.393 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.63 ' NE2' ' CA ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -131.05 149.41 52.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 109.448 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.1 mp -124.56 133.0 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.7 m0 -142.08 126.64 17.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.284 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.88 143.89 26.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.089 -1.007 . . . . 0.0 109.363 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.11 143.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 53.5 tt0 -138.28 95.75 3.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 78.78 -62.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 109.009 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 12.1 m-85 -171.72 22.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.667 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.67 111.76 14.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.757 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp -74.03 132.78 42.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.16 112.33 11.14 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.252 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -45.56 135.04 12.85 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.424 2.083 . . . . 0.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 27' ' ' VAL . 1.2 p -78.64 127.54 80.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.12 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.26 122.61 1.26 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.441 2.094 . . . . 0.0 112.442 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 30' ' ' ASN . 7.3 m -64.04 -27.99 69.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.524 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -45.72 -43.3 12.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.079 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.691 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.2 mp -90.38 -53.63 4.36 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.302 -0.874 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.8 t80 51.62 92.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.542 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.53 -31.31 4.65 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.598 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 45.9 t0 -68.81 134.53 49.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.241 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 25.8 m-85 -142.36 139.89 31.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.623 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -77.74 104.27 8.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -0.868 . . . . 0.0 109.35 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.3 p -45.73 -27.38 0.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.382 -0.824 . . . . 0.0 109.775 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.86 -32.07 41.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.486 ' OD2' ' OE2' ' A' ' 70' ' ' GLU . 35.6 t0 -92.12 172.73 8.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.091 -1.24 . . . . 0.0 109.476 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.93 140.73 46.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.375 -0.828 . . . . 0.0 109.374 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CE1' ' A' ' 36' ' ' PHE . 46.0 m-85 -121.03 135.23 55.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.631 HG21 ' OG1' ' A' ' 78' ' ' THR . 33.7 t -111.16 144.21 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.54 146.19 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -126.51 121.37 32.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.51 94.17 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.935 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.538 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 8.6 m -77.46 103.37 7.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.384 -0.822 . . . . 0.0 109.551 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -91.5 164.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.243 -0.91 . . . . 0.0 109.316 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 179.963 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' HG23 ' A' ' 47' ' ' VAL . 6.5 tp60 -147.98 126.0 12.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.538 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 12.0 m-85 -90.97 130.98 36.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.044 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.26 124.76 37.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 108.781 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.54 HD11 ' CG ' ' A' ' 82' ' ' ASP . 9.3 mt -88.76 110.93 21.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.776 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.701 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 19.5 m-70 -124.26 108.7 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.324 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.712 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -103.25 121.3 42.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.165 -0.959 . . . . 0.0 108.668 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.827 ' C ' HD23 ' A' ' 62' ' ' LEU . 3.7 t90 -92.39 125.42 37.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.827 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -128.08 105.56 8.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.55 17.35 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.622 ' H ' ' C ' ' A' ' 62' ' ' LEU . 40.1 t30 65.95 1.74 1.98 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -1.078 . . . . 0.0 109.82 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -105.11 7.6 33.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.03 . . . . 0.0 109.101 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 15.5 t -101.82 131.02 48.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.602 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 m -52.3 153.76 2.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -73.25 -9.09 58.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.574 ' OD2' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -80.87 -38.2 28.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.588 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.574 ' N ' ' OD2' ' A' ' 69' ' ' ASP . 64.0 tt0 -87.34 -45.74 10.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.202 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.452 ' OG ' HD13 ' A' ' 62' ' ' LEU . 12.8 t -53.95 -50.34 66.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.498 -0.751 . . . . 0.0 109.266 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -46.42 93.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.89 -45.5 30.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.68 72.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.208 -0.933 . . . . 0.0 109.058 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.36 -20.28 64.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 109.023 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.3 -56.1 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.36 -0.837 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.85 -25.8 65.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.631 ' OG1' HG21 ' A' ' 42' ' ' VAL . 45.4 m -78.18 -42.55 31.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 0.0 109.438 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 75' ' ' ALA . 71.8 t -76.09 -41.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.707 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -69.06 -59.35 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 81' ' ' LEU . 2.1 tm? -53.51 -51.89 61.35 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.615 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.54 ' CG ' HD11 ' A' ' 58' ' ' LEU . 4.5 t70 -45.49 -46.39 13.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.39 -33.44 59.24 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' LEU . 28.5 t80 -66.3 -28.58 68.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.639 HD21 ' HB3' ' A' ' 8' ' ' ALA . 2.7 mp -76.1 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.175 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -121.75 -42.39 2.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.173 -0.954 . . . . 0.0 110.255 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.77 -20.15 8.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.647 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 34.0 mtt85 -128.25 -85.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.402 -1.058 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 72.57 162.64 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.613 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.18 150.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.567 ' NE2' ' N ' ' A' ' 91' ' ' GLN . 2.5 mp0 -109.77 132.7 53.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.701 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 33.1 m-70 -139.34 111.86 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -103.29 124.56 48.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 3.9 mt-10 -117.46 86.48 2.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 0.0 109.366 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.59 37.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.555 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 56.25 91.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.383 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 137.11 -54.55 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -100.37 56.0 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -1.126 . . . . 0.0 109.203 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 5.3 mp0 -83.95 158.26 21.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.9 . . . . 0.0 109.58 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.5 165.23 12.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.313 -0.867 . . . . 0.0 109.287 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.47 -30.22 66.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 m -61.92 -60.22 3.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.603 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 36.0 t80 -54.11 -46.61 72.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 109.35 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 104' ' ' LEU . 35.0 mt -67.88 -28.24 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 109.282 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.83 -42.93 99.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -69.42 -47.41 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -1.066 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -105.21 52.78 0.73 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -81.48 -30.08 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 m -57.89 -8.11 0.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.897 . . . . 0.0 109.742 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.6 111.6 3.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.676 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -75.89 -106.89 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.312 -1.111 . . . . 0.0 109.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 171.46 112.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.0 107.89 17.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -112.66 143.2 44.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.8 pttp . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.423 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.8 m80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 t -67.98 138.09 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 109.462 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.2 t -128.03 78.32 75.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.377 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.92 127.95 18.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 112.292 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -58.1 127.59 32.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.6 -19.23 57.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.38 -25.32 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.86 -54.13 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -51.8 -29.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.475 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 6' ' ' LEU . 35.9 tp . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttp -103.24 33.74 3.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.391 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.611 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -40.26 143.57 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.807 . . . . 0.0 109.619 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.667 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 52.43 56.98 14.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.77 -27.34 11.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.35 157.4 45.42 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.378 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.95 123.31 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.782 2.321 . . . . 0.0 112.272 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.7 -172.24 33.75 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.41 143.08 45.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.398 -1.06 . . . . 0.0 109.524 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.667 HE21 ' H ' ' A' ' 9' ' ' GLY . 13.9 mt-30 -133.89 145.01 49.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.898 . . . . 0.0 109.48 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.603 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 16.2 mt -118.3 139.46 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.611 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 6.7 m0 -143.37 110.91 5.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -77.9 139.6 39.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -84.6 143.08 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -0.896 . . . . 0.0 109.202 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' PHE . 24.4 tt0 -158.51 122.2 3.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.54 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 19.1 mmtt 40.59 22.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.51 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' GLU . 2.1 m-85 71.1 44.56 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m-20 -127.09 -13.92 5.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.7 mp 58.81 131.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.2 t -150.91 111.29 3.1 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.06 123.98 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.51 2.14 . . . . 0.0 112.272 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 27' ' ' VAL . 15.0 p -56.36 133.54 76.23 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 109.31 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.49 106.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -58.32 -25.46 61.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -51.74 -47.28 64.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.37 -54.74 4.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.3 t80 53.58 93.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.232 -0.918 . . . . 0.0 109.318 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.44 -4.91 9.4 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.437 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 24.6 t0 -108.23 131.72 54.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.382 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -146.08 167.52 23.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 109.662 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -99.31 122.27 42.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.232 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.7 p -59.64 -27.32 66.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.809 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 26.49 5.92 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.9 t70 -142.69 -166.99 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.308 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -141.04 140.95 34.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.639 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 23.8 m-85 -123.57 129.45 51.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -100.93 137.55 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.4 mt -132.89 146.39 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.3 mp -128.84 131.14 47.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.544 -0.723 . . . . 0.0 109.569 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -113.72 93.68 4.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.682 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.585 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 5.9 m -78.17 105.66 9.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.658 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -100.6 164.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.301 -0.874 . . . . 0.0 109.132 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.538 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 47' ' ' VAL . 6.1 tt0 -134.89 123.39 23.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.941 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 6.2 m-85 -95.36 126.01 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.594 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.6 m-20 -97.41 119.52 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.927 -1.108 . . . . 0.0 108.962 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.481 HD11 ' CG ' ' A' ' 82' ' ' ASP . 2.7 mt -83.1 141.35 32.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 11.8 m-70 -145.91 108.72 4.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.21 114.69 28.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 108.624 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.677 ' C ' HD23 ' A' ' 62' ' ' LEU . 77.3 t90 -90.51 125.55 35.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.913 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.677 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -129.13 114.35 16.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.449 ' O ' ' NE2' ' A' ' 96' ' ' GLN . . . -67.22 11.44 0.73 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.71 HD22 HG12 ' A' ' 95' ' ' VAL . 6.1 t-20 67.33 1.72 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.527 -0.984 . . . . 0.0 109.77 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -112.3 9.97 19.96 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.56 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 9.6 p -98.45 126.7 44.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -46.65 123.47 5.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.128 -0.982 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.455 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 8.3 pm0 -48.19 -25.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.511 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -53.94 -43.34 69.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -87.41 -31.52 20.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.152 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.524 ' OG ' HD13 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -62.18 -59.74 4.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.377 -0.827 . . . . 0.0 109.499 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -54.78 -52.3 47.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.66 -41.07 9.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.381 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.66 92.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.164 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -66.81 -38.51 86.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.209 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.58 -45.63 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 109.637 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -68.28 -35.68 78.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.5 m -75.64 -41.9 52.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 75' ' ' ALA . 80.7 t -74.18 -43.87 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.166 -0.959 . . . . 0.0 109.943 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -67.91 -59.35 3.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.8 tm? -53.92 -51.88 62.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.911 -1.118 . . . . 0.0 108.881 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.481 ' CG ' HD11 ' A' ' 58' ' ' LEU . 4.7 t70 -45.98 -45.81 15.96 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 108.567 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -58.64 -30.85 67.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 27.0 t80 -69.31 -23.15 63.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.436 HD21 HD11 ' A' ' 81' ' ' LEU . 46.2 mt -83.58 -61.28 1.88 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.422 -0.799 . . . . 0.0 110.948 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.513 ' ND2' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -123.04 -43.41 2.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.976 -1.078 . . . . 0.0 111.361 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.87 -3.37 58.74 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.57 62.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -1.191 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.941 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -102.63 168.37 9.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.288 -0.882 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.51 150.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -115.5 136.13 53.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.057 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.474 ' CB ' ' HD1' ' A' ' 59' ' ' HIS . 31.5 m-70 -136.45 124.22 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -114.09 121.54 44.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.862 . . . . 0.0 109.798 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -114.25 93.44 4.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.278 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.71 HG12 HD22 ' A' ' 64' ' ' ASN . 1.8 t -87.5 37.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.615 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 63' ' ' GLY . 4.0 tt0 61.53 110.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.42 -38.55 3.28 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.06 50.29 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.181 . . . . 0.0 109.534 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.87 155.91 39.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 153.8 21.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.57 70.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 m -65.71 -62.93 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 3.5 t80 -51.85 -30.74 24.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.353 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 105' ' ' GLY . 7.8 mt -73.13 -57.39 4.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 104' ' ' LEU . . . -45.19 -34.92 4.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -75.62 -59.71 2.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.492 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.482 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 19.6 m-85 -96.35 57.48 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.594 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -84.89 -33.39 22.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 t -96.06 -11.59 26.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -79.49 -104.11 0.24 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 110' ' ' GLY . 81.6 mt 48.5 98.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.21 -1.17 . . . . 0.0 109.329 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -152.93 116.23 4.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -91.87 107.82 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -112.27 108.74 18.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.0 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 -179.773 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.2 t60 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.0 t -80.09 130.37 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.94 87.72 6.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.579 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 129' ' ' GLU . 53.0 Cg_exo -51.46 130.15 32.0 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.698 2.265 . . . . 0.0 112.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.3 p-10 -60.49 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.155 -0.965 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 127' ' ' PRO . 29.9 mt-10 -87.97 -17.83 30.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.873 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.4 t -50.55 -47.94 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.524 HG13 ' N ' ' A' ' 132' ' ' VAL . 7.1 p -68.7 -42.65 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.524 ' N ' HG13 ' A' ' 131' ' ' VAL . 98.9 t -67.1 -28.13 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.497 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.468 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.604 ' O ' HD22 ' A' ' 85' ' ' LEU . 33.8 mmtt -108.51 -28.74 9.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 109.717 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.599 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 51.97 62.84 2.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.681 ' N ' ' NE2' ' A' ' 15' ' ' GLN . . . 106.74 38.46 2.2 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.9 pttp -41.66 -23.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.625 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -138.93 157.7 71.12 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.371 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -39.82 136.5 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.799 2.333 . . . . 0.0 112.184 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.14 179.37 24.05 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 4.3 tt -115.45 148.33 39.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -1.012 . . . . 0.0 109.735 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.681 ' NE2' ' N ' ' A' ' 9' ' ' GLY . 31.2 mt-30 -145.03 154.68 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 0.0 109.682 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.619 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -126.93 152.26 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.769 -0.582 . . . . 0.0 110.06 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.4 m-90 -155.08 110.91 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.425 -0.797 . . . . 0.0 109.233 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.469 HH11 ' CD ' ' A' ' 28' ' ' PRO . 3.1 ttp180 -75.49 127.64 33.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 109.345 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -69.8 144.17 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.159 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 22' ' ' PHE . 13.8 tp10 -155.83 121.44 4.94 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.547 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 43.6 tttt 44.07 23.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 109.399 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 70.19 41.46 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 24' ' ' LEU . 11.6 t70 -127.14 -13.14 5.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' ASP . 13.0 mt 56.43 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.6 t -138.02 125.04 13.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.219 -0.925 . . . . 0.0 109.183 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.44 140.93 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.477 2.118 . . . . 0.0 112.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 27' ' ' VAL . 14.2 p -79.3 134.27 59.13 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -0.847 . . . . 0.0 109.347 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.529 ' CB ' ' OD1' ' A' ' 30' ' ' ASN . 77.7 Cg_exo -40.2 103.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.477 2.118 . . . . 0.0 112.18 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -49.27 -37.93 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 1.2 p30 -45.52 -39.72 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 6.2 mp -86.15 -55.58 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 31' ' ' LEU . 44.2 t80 45.19 90.73 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.593 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.7 -31.3 4.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 1.1 m-20 -85.97 137.5 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.085 -1.244 . . . . 0.0 109.249 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 22.9 m-85 -146.07 153.72 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -76.91 128.21 34.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 108.901 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 p -74.22 -26.46 60.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 110.021 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.01 -22.9 62.57 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.1 t70 -94.94 -160.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.685 ' HB3' HG11 ' A' ' 19' ' ' VAL . . . -136.26 141.0 43.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.377 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -125.21 125.59 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.448 HG11 ' OG1' ' A' ' 78' ' ' THR . 16.9 t -93.87 127.83 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.476 HG23 HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -138.28 145.08 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 109.163 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -144.55 167.06 23.41 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.048 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 1.7 tmmm? -146.28 94.31 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.458 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 63.7 m -72.16 126.88 30.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.374 -0.829 . . . . 0.0 109.833 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.44 164.79 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.636 -0.665 . . . . 0.0 109.515 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.6 -0.687 . . . . 0.0 109.203 179.792 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.6 tt0 -127.21 117.39 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -0.949 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.531 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 5.2 m-85 -71.75 108.73 5.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 87.1 m-20 -72.56 118.05 15.0 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.924 -1.11 . . . . 0.0 108.152 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 1.7 mm? -102.81 119.21 38.43 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.071 -1.018 . . . . 0.0 109.747 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.473 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -144.29 116.91 8.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 109.657 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.734 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.45 140.33 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 108.819 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.777 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.2 t90 -100.65 127.02 47.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.777 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -127.69 108.67 10.95 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.537 ' O ' ' NE2' ' A' ' 96' ' ' GLN . . . -63.09 12.58 0.11 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.618 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.2 t-20 66.53 1.87 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -1.13 . . . . 0.0 109.845 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.97 5.32 32.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.067 -1.021 . . . . 0.0 108.973 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 67' ' ' SER . 34.5 t -101.15 116.8 33.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 66' ' ' CYS . 12.7 p -42.23 125.32 3.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.554 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 1.6 mp0 -45.01 -28.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.62 -42.11 82.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.596 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -87.5 -38.89 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.486 ' OG ' HD13 ' A' ' 62' ' ' LEU . 1.9 t -59.53 -57.59 12.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.13 -40.53 36.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.95 -52.65 62.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.294 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.98 65.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.181 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -72.59 -20.3 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -81.0 -46.89 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -66.38 -36.08 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.51 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.24 -41.46 61.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 75' ' ' ALA . 24.5 t -61.37 -52.12 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.731 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.91 -59.61 5.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 109.783 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.764 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -53.14 -44.37 67.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 108.738 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' LEU . 10.9 t0 -46.72 -48.25 20.38 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.923 -1.11 . . . . 0.0 108.114 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.77 -27.91 69.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.764 ' HB3' HD13 ' A' ' 81' ' ' LEU . 37.9 t80 -75.91 -24.09 55.57 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 7' ' ' LYS . 39.6 mt -81.03 -53.88 6.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.895 . . . . 0.0 109.574 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -121.84 -42.32 2.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.4 -0.812 . . . . 0.0 109.891 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.33 -22.42 7.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.4 mtp180 -142.39 -85.39 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.386 -1.067 . . . . 0.0 109.278 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 58.68 161.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.4 t -98.39 135.31 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.507 ' OE1' ' OH ' ' A' ' 60' ' ' TYR . 1.1 pp0? -121.98 133.28 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.301 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.634 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -135.59 159.83 40.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.308 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -121.75 136.54 54.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 96' ' ' GLN . 23.7 mt-10 -108.43 87.54 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.528 -0.733 . . . . 0.0 109.145 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.2 t -74.48 37.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.867 . . . . 0.0 109.885 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 63' ' ' GLY . 2.8 tt0 54.73 106.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.78 -54.87 0.69 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 99' ' ' GLU . 13.8 m-85 -115.19 36.53 3.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -1.104 . . . . 0.0 109.254 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 98' ' ' PHE . 13.1 mt-10 -44.28 169.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 t -95.98 165.81 12.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.96 67.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.4 m -66.76 -49.96 64.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' ' CD1' ' A' ' 61' ' ' TRP . 67.8 t80 -64.0 -46.45 84.5 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 108' ' ' LYS . 26.7 mt -68.77 -32.67 72.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.65 -55.13 32.52 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.76 -47.01 87.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -1.115 . . . . 0.0 109.327 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.45 48.89 0.85 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' LEU . 42.6 tttm -68.97 -23.61 64.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 t -76.21 3.69 10.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.71 110.58 2.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.728 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.1 -101.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -1.116 . . . . 0.0 109.188 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 172.07 107.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.107 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.69 107.94 17.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -105.18 122.59 46.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.67 146.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.482 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.35 86.18 21.34 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 109.343 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.04 126.01 14.37 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.767 2.311 . . . . 0.0 112.224 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -79.41 -172.57 3.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.33 -29.04 21.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.98 -27.38 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.08 -40.24 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.942 . . . . 0.0 109.416 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.58 -27.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.414 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.253 0.549 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 8' ' ' ALA . 33.4 tttm -82.56 -19.53 38.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.53 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -43.62 130.44 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.075 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.476 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 41.68 40.84 3.11 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -48.75 -26.12 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -1.11 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -135.18 157.96 75.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.88 118.9 5.24 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.792 2.328 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.5 -158.02 29.45 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.17 148.27 48.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -1.021 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.476 HE21 ' N ' ' A' ' 9' ' ' GLY . 20.6 mt-30 -143.98 141.77 30.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.221 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.36 123.98 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.927 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.53 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 1.9 m0 -131.06 129.75 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -87.17 144.92 26.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.917 . . . . 0.0 109.584 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.45 143.34 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' A' ' 23' ' ' ASP . 25.0 tt0 -151.54 99.89 2.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 6.4 ttmm 48.48 38.49 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.378 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 66.29 20.67 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 24' ' ' LEU . 7.0 m-20 -98.74 -21.67 16.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.1 mt 57.21 122.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.48 133.47 23.65 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 109.219 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.93 117.66 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.343 2.029 . . . . 0.0 112.379 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.24 134.62 90.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.17 136.07 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.275 1.983 . . . . 0.0 112.328 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -57.65 -30.26 65.26 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -45.86 -42.11 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 32' ' ' TYR . 8.4 mp -90.34 -55.73 3.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.208 -0.932 . . . . 0.0 109.268 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.8 t80 36.2 83.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.585 -0.697 . . . . 0.0 109.888 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.68 -31.38 4.6 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -91.48 126.22 36.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.248 . . . . 0.0 109.151 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.686 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.61 168.26 21.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.918 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.542 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -80.56 158.13 25.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.093 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -101.68 -11.19 19.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.64 -7.73 61.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.3 t70 -105.58 -155.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -1.149 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.71 141.4 31.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.543 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -124.36 121.94 36.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.22 135.7 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.529 ' O ' HD22 ' A' ' 44' ' ' LEU . 2.4 mt -121.52 146.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.796 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 43' ' ' ILE . 4.0 mm? -118.74 125.38 49.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' GLN . 7.6 ttpp -120.82 93.79 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.053 -1.03 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.655 HG23 ' CE2' ' A' ' 56' ' ' TYR . 91.7 m -85.98 101.34 12.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.581 -0.699 . . . . 0.0 109.455 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.22 164.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.35 -0.844 . . . . 0.0 109.15 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.748 . . . . 0.0 109.603 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.521 ' O ' ' O ' ' A' ' 45' ' ' LYS . 4.1 tp-100 -131.43 110.75 11.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.655 ' CE2' HG23 ' A' ' 46' ' ' THR . 7.7 m-85 -86.32 109.67 19.14 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.618 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -84.01 127.59 33.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 1.1 mm? -96.51 107.25 19.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.548 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.647 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 75.3 m-70 -115.96 108.57 16.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.717 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.7 120.27 39.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.676 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.686 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 56.5 t90 -102.34 124.91 48.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.987 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.719 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -128.93 118.67 23.04 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.0 16.95 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.719 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER 61.77 2.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -1.031 . . . . 0.0 109.815 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.3 mt-10 -109.4 13.14 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.165 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.7 t -99.91 140.16 34.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.604 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.2 t -61.25 146.54 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.67 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -62.68 -23.48 67.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.11 -49.77 76.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.731 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.49 -43.65 11.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.316 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -55.89 -53.82 52.13 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -60.18 -51.24 60.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.51 -35.14 3.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -1.191 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.19 -45.81 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.02 -31.77 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.2 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.48 -52.47 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -58.44 -44.41 89.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.249 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -67.15 -44.55 79.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 75' ' ' ALA . 58.4 t -69.62 -65.11 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' VAL . 6.1 mm-40 -43.36 -59.42 2.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.104 -0.998 . . . . 0.0 109.422 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -52.12 -37.05 53.02 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.069 -1.019 . . . . 0.0 108.641 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -52.01 -52.59 49.68 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.057 -1.027 . . . . 0.0 108.725 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.547 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 7.4 t70 -57.78 -30.52 65.72 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -79.24 -23.73 43.5 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.0 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.54 HD23 ' CD1' ' A' ' 56' ' ' TYR . 11.4 tp -84.74 -46.04 11.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 110.101 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -122.02 -42.21 2.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 109.987 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.93 -15.8 51.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -154.06 24.21 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -52.77 -179.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.63 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.45 150.19 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.442 ' HG2' ' H ' ' A' ' 91' ' ' GLN . 15.9 pt20 -108.44 133.31 52.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.953 . . . . 0.0 109.682 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.647 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 15.8 m-70 -132.35 121.2 23.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.243 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -108.48 127.75 54.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.963 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 96' ' ' GLN . 8.3 mp0 -126.62 78.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.416 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.8 t -68.75 37.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.507 ' O ' ' O ' ' A' ' 95' ' ' VAL . 7.2 tp-100 39.27 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.461 -0.775 . . . . 0.0 109.615 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 150.3 -19.24 1.05 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 29.9 m-85 -162.95 47.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.39 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' CE2' ' A' ' 103' ' ' PHE . 2.3 mt-10 -62.65 -179.41 0.26 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.17 172.39 7.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.434 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.35 -31.36 71.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.506 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -63.17 -62.62 1.57 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.582 ' CE2' ' OE1' ' A' ' 99' ' ' GLU . 16.6 t80 -52.52 -38.27 59.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.88 -24.72 61.71 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.06 -43.24 57.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -70.33 -42.54 71.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -1.214 . . . . 0.0 109.639 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.54 73.25 0.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -98.37 -31.55 11.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -104.12 7.99 36.35 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -102.14 -111.75 3.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 110' ' ' GLY . 8.5 mp 53.09 102.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.334 -1.097 . . . . 0.0 109.405 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -145.37 108.39 4.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -82.34 107.98 15.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 0.0 109.614 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.01 108.91 16.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 109.298 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.889 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.48 111.03 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 126' ' ' VAL . 12.2 p -100.64 117.33 62.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -44.77 129.2 9.29 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -62.6 136.41 57.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -52.31 -17.48 1.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.0 t -46.87 -34.92 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.7 t -49.66 -60.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.12 -27.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.522 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 6' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -64.85 -43.61 92.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -50.88 145.29 7.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.03 57.21 2.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 12.5 mmtp -132.89 -10.33 3.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.241 -1.152 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 58.0 mt-10 -160.17 150.41 15.03 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.284 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.61 156.36 57.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.55 2.166 . . . . 0.0 111.916 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.29 -141.47 15.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 15' ' ' GLN . 2.4 tt -127.86 144.9 51.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.406 -1.055 . . . . 0.0 110.062 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.409 ' N ' ' HG ' ' A' ' 14' ' ' LEU . 3.9 mt-30 -135.78 150.55 49.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 109.057 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.619 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.9 mp -124.96 145.32 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.83 . . . . 0.0 110.409 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -146.37 110.89 5.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.421 -0.799 . . . . 0.0 108.942 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' VAL . 12.4 ttp85 -81.09 129.63 34.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 0.0 109.672 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -87.06 143.64 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 12.2 tm-20 -153.8 88.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? 60.6 50.51 5.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 53.6 47.61 23.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.516 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 24' ' ' LEU . 49.9 t0 -126.99 -25.91 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.4 mp 59.39 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.4 -0.812 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' ARG . 51.7 t -145.94 103.22 4.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 27' ' ' VAL . 63.3 Cg_exo -47.77 108.28 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.287 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 26' ' ' PRO . 10.1 t -43.34 107.49 0.57 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.417 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.99 137.74 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.406 2.07 . . . . 0.0 112.223 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 m -62.0 -24.93 67.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.13 -45.29 32.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.258 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -94.94 -55.46 3.09 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 31' ' ' LEU . 12.4 t80 42.24 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 109.75 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.597 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.43 -30.87 4.82 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -79.83 137.66 37.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.083 -1.245 . . . . 0.0 109.392 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 57.2 m-85 -136.95 160.46 38.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.05 105.54 15.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.385 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.2 p -57.85 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.95 -30.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.8 m-20 -111.23 -153.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.45 -1.03 . . . . 0.0 109.014 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.7 145.38 44.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.532 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -121.2 127.62 51.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.419 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.68 103.87 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.61 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -121.39 144.34 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 109.193 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.736 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.1 pt? -147.55 172.43 14.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 110.193 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -145.82 99.88 3.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 111.489 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -72.52 118.91 16.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 108.908 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.07 164.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.497 -0.752 . . . . 0.0 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.538 -0.726 . . . . 0.0 109.258 179.708 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -126.05 114.11 17.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.653 ' CG ' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.61 109.87 17.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.079 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.612 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -86.76 103.0 14.78 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.636 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 1.1 mt -95.95 143.1 27.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.172 -0.955 . . . . 0.0 110.444 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 43' ' ' ILE . 1.5 p-80 -154.1 131.83 11.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.465 -0.772 . . . . 0.0 109.623 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.739 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -98.02 118.62 35.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 108.921 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.804 ' O ' HD23 ' A' ' 62' ' ' LEU . 12.1 t90 -85.35 130.36 34.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.302 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 61' ' ' TRP . 0.6 OUTLIER -131.4 111.51 11.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 15.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.616 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER 66.65 1.83 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.341 -1.093 . . . . 0.0 109.713 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -107.3 10.79 29.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 108.983 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 18.4 t -105.0 146.1 29.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -73.67 166.22 23.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.862 . . . . 0.0 109.359 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -76.35 -8.98 58.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.3 -46.52 49.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.12 -36.74 17.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 109.456 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.655 ' OG ' HD13 ' A' ' 62' ' ' LEU . 16.9 t -60.72 -58.31 9.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.13 -41.38 78.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -49.93 61.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.436 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.05 87.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -69.45 -20.46 63.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.134 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mm -79.49 -52.25 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -33.1 73.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 108.994 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 16.4 m -74.33 -36.55 63.67 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.242 -0.911 . . . . 0.0 109.6 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 75' ' ' ALA . 47.4 t -75.18 -54.61 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -61.75 -59.49 5.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.692 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.736 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -51.97 -47.14 64.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.101 -0.999 . . . . 0.0 108.792 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.728 ' OD1' ' HB3' ' A' ' 89' ' ' ALA . 5.0 t0 -46.37 -47.66 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.971 -1.08 . . . . 0.0 108.523 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.11 -30.77 69.49 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' A' ' 81' ' ' LEU . 31.7 t80 -75.86 -23.57 55.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.479 ' HB3' HD22 ' A' ' 86' ' ' ASN . 8.0 mt -78.07 -52.49 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.578 HD22 ' N ' ' A' ' 86' ' ' ASN . 1.1 m-80 -122.02 -42.2 2.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.04 -11.0 57.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 -150.2 18.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -1.175 . . . . 0.0 109.8 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.728 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . -63.51 -178.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.516 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.543 ' C ' ' NE2' ' A' ' 91' ' ' GLN . 3.7 t -114.1 145.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.357 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.584 ' NE2' ' OD2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -136.69 126.78 26.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.688 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -125.26 160.24 29.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.861 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.404 ' CB ' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -111.37 136.78 50.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.112 -0.993 . . . . 0.0 109.939 -179.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.9 mm-40 -118.81 101.81 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 95' ' ' VAL . 8.3 p -88.46 37.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.241 -0.912 . . . . 0.0 109.693 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 57.12 66.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.398 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.39 -59.7 0.29 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -92.22 33.12 1.1 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.457 ' OE2' ' CD1' ' A' ' 61' ' ' TRP . 2.6 mt-10 -72.28 -154.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.425 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -138.05 156.87 47.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 109.385 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.27 -21.07 12.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.6 m -61.6 -60.57 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.095 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.677 ' CE1' ' NE1' ' A' ' 61' ' ' TRP . 72.3 t80 -61.12 -50.28 73.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.525 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 104' ' ' LEU . 89.3 mt -70.34 -18.68 63.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.157 -0.964 . . . . 0.0 109.142 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -69.81 -41.95 71.78 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -71.92 -43.38 65.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -1.112 . . . . 0.0 109.052 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -107.51 54.21 0.67 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.532 ' C ' ' H ' ' A' ' 110' ' ' GLY . 25.8 tttm -81.39 -33.5 32.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.912 . . . . 0.0 109.678 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.0 t -60.7 3.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.74 109.58 2.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.481 HD13 ' H ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -72.39 -101.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -1.173 . . . . 0.0 109.15 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.481 ' H ' HD13 ' A' ' 111' ' ' LEU . 6.7 mttm 165.26 136.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.65 107.89 17.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.494 -0.754 . . . . 0.0 109.235 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -114.26 132.06 56.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.903 . . . . 0.0 109.554 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 109.385 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 125' ' ' VAL . 4.9 p -122.36 129.08 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.429 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.37 82.46 23.14 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' ASN . 59.4 Cg_endo -79.01 132.99 10.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.666 2.244 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' PRO . 10.5 m-20 -41.29 146.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -88.07 -17.2 31.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.36 -22.24 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.72 -34.65 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.3 -29.63 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.427 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.436 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 8' ' ' ALA . 8.4 ttmt -104.93 23.43 13.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.212 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.55 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -37.55 140.24 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.445 -0.784 . . . . 0.0 109.803 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 78.48 51.45 5.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -61.96 1.43 0.29 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -1.2 . . . . 0.0 109.172 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 9' ' ' GLY . 2.6 mt-10 176.35 138.66 0.21 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.448 -0.783 . . . . 0.0 108.938 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -39.77 125.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.574 2.183 . . . . 0.0 112.223 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.02 -157.18 27.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.414 HD12 ' NZ ' ' A' ' 45' ' ' LYS . 5.8 tt -112.43 133.65 54.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 5.2 mm100 -119.73 157.7 28.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.366 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.568 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.6 mt -134.98 142.59 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.707 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.3 m-90 -149.46 110.69 4.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' VAL . 6.3 ttt180 -89.21 139.41 30.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.88 143.33 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 69.5 tt0 -136.0 111.29 9.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.484 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 26.2 tttp 51.36 43.7 29.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 4.5 t80 73.88 25.72 1.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 20' ' ' GLU . 2.5 m-20 -126.96 111.76 14.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 tp -58.71 141.57 52.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.494 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 18' ' ' ARG . 73.8 t -138.64 121.42 10.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.185 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.25 115.2 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.34 2.026 . . . . 0.0 112.342 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.72 135.06 23.25 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.139 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 32' ' ' TYR . 31.0 Cg_endo -67.13 97.94 0.43 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.3 2.0 . . . . 0.0 112.183 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 46.9 m -52.19 -24.46 7.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.566 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -19.73 57.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mt -132.2 13.55 4.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.791 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -71.29 -104.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 67.76 -17.09 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.555 ' H ' ' C ' ' A' ' 32' ' ' TYR . 18.9 t0 -102.49 140.2 37.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.133 -1.216 . . . . 0.0 109.379 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -129.9 119.79 23.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.107 -0.996 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -76.32 102.78 6.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.52 HG21 ' HB3' ' A' ' 113' ' ' TYR . 82.1 p -61.32 -31.59 71.44 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 110.075 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.9 24.53 5.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 24.8 t0 -143.29 -156.42 0.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -1.124 . . . . 0.0 109.294 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.53 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.6 140.73 31.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CZ ' ' HD2' ' A' ' 18' ' ' ARG . 34.3 m-85 -121.87 124.35 43.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.623 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 46.5 t -101.47 115.11 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.074 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -116.14 145.22 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.264 -0.898 . . . . 0.0 109.872 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.4 mp -126.55 151.27 48.12 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -140.45 93.35 2.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.791 -1.193 . . . . 0.0 110.833 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.599 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 29.9 m -89.88 98.63 11.88 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.53 164.63 2.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.32 -0.862 . . . . 0.0 109.812 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.649 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' LYS . 8.7 tt0 -117.36 98.86 6.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.484 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 9.5 m-85 -75.83 123.53 25.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -103.0 147.59 26.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.932 -1.105 . . . . 0.0 108.64 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' HIS . 0.7 OUTLIER -124.66 109.1 12.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.361 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -131.17 116.17 17.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 109.528 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.714 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.87 129.32 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.793 ' C ' HD23 ' A' ' 62' ' ' LEU . 15.8 t90 -101.69 127.24 48.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 110.167 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.793 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -129.44 108.93 10.65 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -64.43 20.05 0.1 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.1 t-20 59.54 2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.079 . . . . 0.0 110.016 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 63' ' ' GLY . 17.8 mt-10 -102.29 2.38 36.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.968 -1.083 . . . . 0.0 108.898 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.437 ' SG ' ' CG ' ' A' ' 70' ' ' GLU . 48.1 t -100.72 140.13 35.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -67.28 155.35 39.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.594 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.9 -8.88 24.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.49 -52.1 20.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' CG ' ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -87.57 -37.15 17.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 62' ' ' LEU . 7.6 t -62.5 -60.08 4.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.514 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.53 37.4 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.8 -37.65 6.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.391 -1.064 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.54 -39.16 85.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.202 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -69.69 -32.82 71.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 109.446 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.411 HG22 ' OE1' ' A' ' 80' ' ' GLN . 3.3 mt -79.13 -43.51 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.42 -40.64 97.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.89 -44.31 32.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.694 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.9 t -62.79 -45.77 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 110.214 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 14.7 pt20 -67.62 -50.57 57.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.992 -1.068 . . . . 0.0 110.217 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -62.33 -47.04 85.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.779 -1.201 . . . . 0.0 108.357 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' LEU . 1.6 t0 -45.87 -46.95 16.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.74 -32.16 71.45 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.723 ' HB3' HD13 ' A' ' 81' ' ' LEU . 41.6 t80 -69.57 -23.05 63.5 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 8' ' ' ALA . 46.5 mt -83.08 -62.01 1.71 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.414 -0.803 . . . . 0.0 110.762 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -122.57 -43.19 2.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.995 -1.066 . . . . 0.0 111.293 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.57 6.67 63.93 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -149.52 10.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -1.12 . . . . 0.0 109.906 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -56.0 177.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.46 133.8 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.157 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.541 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 3.1 mp0 -97.63 138.0 35.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 110.193 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.549 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 9.7 m-70 -139.5 129.82 25.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -0.814 . . . . 0.0 109.249 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -113.25 126.02 54.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.985 . . . . 0.0 109.819 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.469 ' OE2' ' O ' ' A' ' 60' ' ' TYR . 2.0 mp0 -127.15 84.56 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 95' ' ' VAL . 8.9 p -81.64 37.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 2.0 tt0 70.66 52.66 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.39 -53.39 0.25 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -94.13 55.62 2.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.4 mp0 -78.99 -161.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -138.81 170.87 15.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.48 -30.46 64.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.8 m -66.38 -39.5 89.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.372 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -73.52 -51.1 18.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.36 -0.837 . . . . 0.0 109.491 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 104' ' ' LEU . 92.3 mt -68.53 -17.52 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.15 -40.65 13.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD1' HD13 ' A' ' 14' ' ' LEU . 1.6 t80 -82.43 -32.72 28.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -1.128 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -101.35 96.46 7.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.643 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -96.87 -63.63 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.173 -0.954 . . . . 0.0 109.402 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -100.96 11.96 38.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.395 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.714 ' C ' HD23 ' A' ' 111' ' ' LEU . . . -102.98 65.14 0.39 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.714 HD23 ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -147.07 95.05 2.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.316 -1.108 . . . . 0.0 109.0 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.61 114.32 21.01 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.52 ' HB3' HG21 ' A' ' 37' ' ' THR . 1.0 OUTLIER -81.43 107.65 14.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.382 -0.823 . . . . 0.0 109.8 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -111.86 109.03 18.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.313 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 pttt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.462 -179.887 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.275 0.559 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.97 147.1 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.21 71.86 76.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.452 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.02 150.66 9.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.814 2.343 . . . . 0.0 112.266 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -75.21 141.6 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.519 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -76.6 -26.34 54.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.486 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -65.4 -23.86 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.15 -30.71 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.03 -30.2 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.448 179.977 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.249 0.547 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -104.86 -56.89 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.437 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.545 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 59.47 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.402 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 50.68 27.08 11.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' GLY . 1.6 pttt -42.33 -21.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 109.231 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -130.98 157.99 76.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.53 119.92 7.37 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.7 2.267 . . . . 0.0 112.006 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.19 -150.25 21.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.499 HD13 ' CD2' ' A' ' 106' ' ' TYR . 3.4 tt -132.38 144.81 50.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 0.0 109.591 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.56 HE21 ' H ' ' A' ' 9' ' ' GLY . 24.4 mt-30 -136.61 148.21 47.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.458 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -121.3 138.41 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.593 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.6 m0 -141.98 111.0 6.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.458 HH22 HG11 ' A' ' 25' ' ' VAL . 3.6 ttt-85 -71.45 135.85 47.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -78.49 143.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -0.997 . . . . 0.0 109.426 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 89.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.311 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 63.38 28.56 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER 71.03 16.98 6.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 24' ' ' LEU . 73.0 m-20 -99.83 -14.29 18.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.6 mt 57.25 136.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.458 HG11 HH22 ' A' ' 18' ' ' ARG . 47.3 t -142.72 115.73 6.21 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.74 143.83 6.09 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.362 2.041 . . . . 0.0 112.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.44 125.02 81.89 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.45 111.84 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.487 2.125 . . . . 0.0 112.148 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.2 m -63.83 -25.51 68.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -45.71 -41.11 10.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.306 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.31 -54.98 2.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.4 t80 55.62 95.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.353 -0.842 . . . . 0.0 109.369 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.49 -31.03 4.76 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.4 m-20 -89.93 128.37 36.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -1.119 . . . . 0.0 109.191 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.698 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.27 167.92 22.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.915 . . . . 0.0 109.777 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CD1' ' OH ' ' A' ' 41' ' ' TYR . 3.9 m-85 -85.14 154.91 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.346 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.417 HG22 HE21 ' A' ' 96' ' ' GLN . 5.0 p -95.14 -9.44 33.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.528 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.0 26.79 22.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.09 -162.13 1.32 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -1.163 . . . . 0.0 109.324 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.35 141.08 33.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 22.2 m-85 -128.79 122.51 30.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.359 -0.838 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.506 HG21 ' OG1' ' A' ' 78' ' ' THR . 38.6 t -96.57 141.65 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.437 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.569 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 mt -137.71 146.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 109.363 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.3 mp -129.71 131.63 46.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.685 . . . . 0.0 109.586 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -114.53 94.19 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.595 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 7.6 m -77.24 101.77 6.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.323 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.449 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -99.14 164.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.6 -0.688 . . . . 0.0 109.274 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -137.96 134.8 35.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.805 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.595 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 11.7 m-85 -92.82 128.8 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 108.824 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.614 ' CG ' ' HE2' ' A' ' 59' ' ' HIS . 34.8 t0 -91.09 116.3 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 108.92 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' CD2' HG22 ' A' ' 78' ' ' THR . 6.0 mp -81.76 126.53 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.692 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.72 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 27.5 m-70 -142.44 108.53 5.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.112 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.713 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.42 129.17 50.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.022 . . . . 0.0 108.961 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.698 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 6.0 t90 -96.71 129.56 44.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.375 -0.828 . . . . 0.0 110.03 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.647 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.1 mt -134.44 106.34 7.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.7 9.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.647 ' H ' ' C ' ' A' ' 62' ' ' LEU . 4.7 t-20 69.23 1.22 3.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -1.091 . . . . 0.0 109.607 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -113.65 12.59 18.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.48 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 3.0 p -97.86 134.6 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.537 -0.727 . . . . 0.0 109.406 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 66' ' ' CYS . 1.3 m -43.65 152.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.18 -20.69 57.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.152 -0.967 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -68.59 -35.06 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -87.03 -28.63 22.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.518 ' OG ' HD13 ' A' ' 62' ' ' LEU . 22.8 t -64.32 -60.05 3.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 0.0 109.385 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.76 -46.49 91.76 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -46.6 -43.71 17.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -1.116 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.59 50.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 109.036 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.42 -20.09 41.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 108.89 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mm -81.59 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.33 -0.856 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.3 -26.8 68.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 108.446 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.599 HG22 ' CD2' ' A' ' 58' ' ' LEU . 37.5 m -76.78 -50.59 13.15 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.682 -0.636 . . . . 0.0 109.382 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 75' ' ' ALA . 87.1 t -67.89 -36.36 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.834 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -66.07 -58.84 4.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.744 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -55.04 -46.48 75.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.935 -1.103 . . . . 0.0 109.193 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.549 ' HB3' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -47.64 -47.41 29.24 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.741 -1.224 . . . . 0.0 108.145 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.7 t70 -63.01 -24.44 67.92 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.744 ' HB3' HD13 ' A' ' 81' ' ' LEU . 37.0 t80 -78.13 -23.71 47.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD21 HD12 ' A' ' 81' ' ' LEU . 36.1 mt -83.35 -53.94 5.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.232 -0.917 . . . . 0.0 109.777 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -122.0 -42.37 2.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.184 -0.948 . . . . 0.0 110.094 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.16 -8.42 8.52 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.575 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 59.8 mtt-85 -144.07 -84.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -1.099 . . . . 0.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 68.11 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.586 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.59 149.85 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.66 143.08 45.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.293 -0.879 . . . . 0.0 109.912 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.72 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 36.2 m-70 -142.39 121.91 13.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.468 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 15.7 ptt180 -108.9 121.24 44.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -112.52 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.554 HG12 ' ND2' ' A' ' 64' ' ' ASN . 2.1 t -80.45 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.417 HE21 HG22 ' A' ' 37' ' ' THR . 13.1 tt0 66.29 53.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.544 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 99' ' ' GLU . . . 162.78 -53.23 0.3 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -77.28 30.67 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.503 ' OE2' HD21 ' A' ' 104' ' ' LEU . 7.7 mt-10 -59.81 150.83 27.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.8 t -99.88 162.69 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.46 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.4 m -63.65 -62.71 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.364 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.559 ' CE1' ' CD2' ' A' ' 107' ' ' PHE . 69.4 t80 -54.69 -37.0 65.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.407 -0.808 . . . . 0.0 109.491 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.503 HD21 ' OE2' ' A' ' 99' ' ' GLU . 98.3 mt -71.84 -22.67 61.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.5 -30.16 46.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.499 ' CD2' HD13 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -85.81 -41.38 15.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.559 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 96.8 m-85 -105.11 76.15 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.508 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.9 -30.89 11.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -98.82 8.73 44.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -101.88 -111.06 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 110' ' ' GLY . 72.7 mt 44.52 96.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.272 -1.134 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -155.4 110.55 3.01 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 107.85 16.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.392 -0.818 . . . . 0.0 109.587 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -103.84 108.83 20.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.3 pttm . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 109.468 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.268 0.556 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.45 147.12 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 t -138.06 110.95 8.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 109.365 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 128' ' ' ASN . 78.3 Cg_exo -45.93 133.66 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.389 2.059 . . . . 0.0 112.335 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 127' ' ' PRO . 2.0 m120 -43.12 147.71 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.25 -22.93 59.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 130' ' ' VAL . 14.4 t -52.63 -37.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.29 -36.35 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.19 -27.4 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.503 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.417 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 8' ' ' ALA . 15.4 mtmm -125.16 -53.16 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.608 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.585 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 58.86 150.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.153 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.532 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 43.13 40.81 4.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HZ3' ' HB2' ' A' ' 10' ' ' LYS . 18.7 mtmm -42.06 -28.14 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.419 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.554 ' OE2' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -145.64 149.05 38.87 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.249 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -39.85 123.01 1.15 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.628 2.219 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 -168.04 34.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 14' ' ' LEU . 7.2 tt -120.65 129.54 53.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -1.018 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.66 ' N ' HD23 ' A' ' 14' ' ' LEU . 20.9 mt-30 -124.4 163.96 20.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.594 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.2 mt -136.42 137.02 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 109.778 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.594 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.2 m0 -141.6 131.36 24.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.458 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 25' ' ' VAL . 59.9 ttp180 -95.24 144.88 25.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.898 . . . . 0.0 109.599 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.428 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 0.4 OUTLIER -108.45 143.38 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.2 tp10 -130.04 91.5 3.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.5 tttp 78.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.606 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 77' ' ' PHE . 10.5 t80 -160.8 16.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.909 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -127.47 114.89 18.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 109.716 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.8 mp -59.6 149.0 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ARG . 60.5 t -154.1 118.29 2.67 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.11 152.16 0.66 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.455 2.104 . . . . 0.0 112.199 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 27' ' ' VAL . 12.7 p -102.13 132.78 21.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -42.42 136.79 3.99 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.536 2.157 . . . . 0.0 112.353 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -70.2 -28.42 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.335 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -60.68 -40.33 91.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' O ' ' C ' ' A' ' 32' ' ' TYR . 7.8 mp -76.85 -55.46 5.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.862 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 31' ' ' LEU . 9.9 t80 35.4 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.522 -0.736 . . . . 0.0 109.928 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.455 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 115.28 -31.45 6.21 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.23 120.48 27.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -1.186 . . . . 0.0 109.189 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.684 ' CD1' ' CH2' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.67 168.49 21.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 110.043 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' GLY . 22.6 m-85 -86.29 106.95 17.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 109.276 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -46.93 -10.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . -91.05 19.09 48.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.56 -164.65 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -1.175 . . . . 0.0 109.394 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.4 140.61 37.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.663 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -131.05 164.18 25.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.818 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.6 131.34 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.875 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.407 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -115.94 145.62 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.296 -0.878 . . . . 0.0 109.648 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -121.84 147.99 45.27 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HZ1' ' HB3' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -145.69 93.34 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.027 -1.046 . . . . 0.0 110.297 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.611 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 32.1 m -88.58 108.52 19.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.491 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.53 163.9 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.297 -0.877 . . . . 0.0 108.95 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.612 0.72 . . . . 0.0 110.657 -179.166 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -124.69 102.31 7.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.147 -0.971 . . . . 0.0 110.765 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.677 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 6.9 m-85 -82.08 109.47 16.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.455 ' HB3' ' HZ1' ' A' ' 45' ' ' LYS . 21.8 t0 -83.45 148.66 27.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.978 -1.076 . . . . 0.0 108.551 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.488 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -130.18 125.9 36.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -137.01 108.91 7.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 109.575 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.705 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.54 114.29 25.01 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 108.558 179.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.684 ' CH2' ' CD1' ' A' ' 35' ' ' PHE . 68.8 t90 -86.69 118.38 26.06 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.358 -0.839 . . . . 0.0 109.688 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' ASN . 1.0 OUTLIER -123.2 105.92 10.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.55 -0.719 . . . . 0.0 109.097 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 64' ' ' ASN . . . -56.58 1.19 0.11 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' LEU . 13.4 t-20 70.3 1.65 3.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.509 -0.995 . . . . 0.0 109.731 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -111.88 15.05 20.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 108.896 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.3 t -105.62 145.99 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 109.622 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.2 t -55.36 156.96 3.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.05 -26.45 48.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.184 -0.947 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -41.15 78.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.696 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 19' ' ' VAL . 33.4 tt0 -87.32 -42.66 12.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 t -57.71 -54.05 51.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.728 . . . . 0.0 109.512 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.52 -53.42 43.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.49 -39.27 7.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.462 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.33 86.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.179 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.7 -32.6 74.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.384 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.72 -48.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.802 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 22' ' ' PHE . 1.5 m-85 -62.75 -42.45 99.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.955 . . . . 0.0 109.372 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -68.73 -41.82 78.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.51 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 78' ' ' THR . 52.0 t -73.03 -61.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.438 -0.789 . . . . 0.0 110.02 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -56.87 -59.63 4.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.912 . . . . 0.0 110.06 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.5 tm? -51.82 -47.71 64.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.147 . . . . 0.0 108.937 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 81' ' ' LEU . 3.1 t0 -46.85 -48.69 20.95 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.876 -1.14 . . . . 0.0 108.496 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.24 -31.67 65.77 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.55 ' N ' ' O ' ' A' ' 81' ' ' LEU . 38.5 t80 -70.81 -23.67 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.11 -59.37 2.8 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -122.21 -42.4 2.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.343 -0.848 . . . . 0.0 110.14 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 -21.5 6.66 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 29.7 mtp85 -138.2 -85.5 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -1.114 . . . . 0.0 109.296 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 65.33 176.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.71 150.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -123.88 140.25 53.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -0.873 . . . . 0.0 109.818 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.506 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 11.5 m-70 -137.59 137.99 39.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 109.204 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 ptp180 -120.24 124.83 46.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -119.6 94.66 4.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.184 -0.948 . . . . 0.0 109.539 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.3 37.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 61.4 105.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.462 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 103.01 -36.29 4.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -107.2 32.09 4.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.8 mp0 -70.39 -177.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 p -110.6 168.02 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.358 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -69.65 -32.73 71.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.6 m -60.83 -57.65 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.094 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 40.4 t80 -53.91 -48.94 69.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.494 -0.754 . . . . 0.0 109.259 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.94 -24.36 64.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 109.042 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -60.68 -50.34 68.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 107' ' ' PHE . 22.2 m-85 -69.29 -44.32 72.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -134.29 86.81 2.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.169 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.526 ' O ' HD21 ' A' ' 111' ' ' LEU . 2.0 pttt -89.3 -63.84 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.401 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 2.0 t -105.86 9.81 32.71 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.527 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.37 63.16 0.28 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.704 ' O ' ' CB ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -137.81 -115.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.189 -1.183 . . . . 0.0 108.858 179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.704 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 6.6 tptm 138.28 121.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.476 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 1.8 p90 -103.22 107.98 19.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.472 -0.768 . . . . 0.0 109.524 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -101.93 120.54 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.4 mttt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.495 -179.903 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 126' ' ' VAL . 6.7 t -69.75 146.99 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 125' ' ' VAL . 75.7 t -155.34 88.25 3.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 128' ' ' ASN . 52.7 Cg_exo -49.06 166.17 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.626 2.217 . . . . 0.0 112.252 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 127' ' ' PRO . 84.2 m-20 -39.87 109.69 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.625 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -50.75 -25.67 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.496 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.3 t -50.67 -25.24 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.373 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.74 -47.69 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.477 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.5 -31.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.478 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.618 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -64.8 -31.12 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.55 161.35 30.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.363 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.476 ' CA ' HD21 ' A' ' 85' ' ' LEU . . . 61.37 53.21 46.11 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 20.2 mtpp -142.16 -8.68 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 63.9 mt-10 -158.52 149.69 16.47 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.409 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.82 170.34 20.59 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.627 2.218 . . . . 0.0 112.173 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.66 -137.2 13.9 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.3 142.17 35.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -1.127 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 3.7 mp0 -127.54 146.93 50.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.274 -0.891 . . . . 0.0 109.343 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.545 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 24.8 mt -117.63 135.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.72 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.8 m0 -141.84 110.85 6.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -83.09 131.31 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.543 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -91.95 143.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.353 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -152.81 111.85 3.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.2 ttmt 46.77 31.62 1.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.416 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.1 m-85 68.61 51.38 0.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 24' ' ' LEU . 66.5 m-20 -127.17 -24.54 3.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.3 mt 57.92 130.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -149.54 134.6 9.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.164 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.08 124.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.345 2.03 . . . . 0.0 112.289 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 t -60.09 114.77 10.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.374 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.33 123.89 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.327 2.018 . . . . 0.0 112.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.1 m -59.43 -23.71 62.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -49.18 -47.38 46.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.175 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 7.1 mp -92.01 -55.05 3.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.5 t80 44.95 89.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.567 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.63 3.3 8.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.22 143.19 27.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.154 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -140.3 123.04 16.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 109.921 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.2 m-30 -83.6 102.97 12.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' HH2' ' A' ' 61' ' ' TRP . 30.4 p -57.21 87.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 177.86 -29.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.06 -154.89 0.55 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.388 -1.066 . . . . 0.0 108.943 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.96 141.98 32.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.402 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 22.8 m-85 -115.82 124.37 50.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.787 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.83 118.51 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.841 . . . . 0.0 108.904 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HB ' ' NE2' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -118.91 144.91 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.072 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.896 HD11 HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -121.95 151.43 40.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -143.9 94.65 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.093 -1.005 . . . . 0.0 110.392 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.615 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 1.2 m -87.49 114.67 24.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.471 -0.768 . . . . 0.0 109.288 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -92.09 164.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.581 0.705 . . . . 0.0 110.558 -179.341 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 45' ' ' LYS . 49.1 tt0 -104.46 92.84 4.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.304 -0.873 . . . . 0.0 110.235 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.615 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 0.3 OUTLIER -79.0 116.72 19.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 109.073 179.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -100.13 119.74 38.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.982 HD11 ' OG1' ' A' ' 78' ' ' THR . 7.8 tt -110.64 133.85 52.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.985 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.607 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -152.63 133.78 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.358 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.723 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -100.6 126.08 47.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 0.0 108.775 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.934 ' O ' HD23 ' A' ' 62' ' ' LEU . 77.5 t90 -92.54 134.62 34.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.934 HD23 ' O ' ' A' ' 61' ' ' TRP . 2.3 mt -137.39 118.59 14.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.448 -0.783 . . . . 0.0 109.208 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' CA ' ' CH2' ' A' ' 61' ' ' TRP . . . -69.39 25.14 0.35 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.58 ' H ' ' C ' ' A' ' 62' ' ' LEU . 59.5 t30 58.86 6.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.442 -1.034 . . . . 0.0 110.089 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -110.38 10.93 23.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 109.143 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.2 t -105.09 146.1 29.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.682 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 t -85.9 170.4 12.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.463 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -69.16 -16.34 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 1.2 t70 -61.48 -58.31 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -87.85 -35.82 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.593 ' OG ' HD13 ' A' ' 62' ' ' LEU . 8.8 t -70.4 -60.61 2.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.577 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -52.79 -43.33 60.31 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.44 -52.04 63.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -1.162 . . . . 0.0 109.501 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.7 -47.69 63.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.288 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -61.8 -22.98 65.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 109.232 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -83.92 -55.84 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -61.36 -34.75 75.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.381 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.982 ' OG1' HD11 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -75.13 -43.81 50.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.872 . . . . 0.0 109.74 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 75' ' ' ALA . 27.9 t -63.62 -55.96 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.846 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.3 -59.62 5.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -53.11 -48.45 67.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.031 -1.043 . . . . 0.0 108.927 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 78' ' ' THR . 10.0 t0 -45.64 -45.02 13.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.103 -0.998 . . . . 0.0 108.807 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.28 -30.86 71.92 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 17.7 t80 -79.1 -22.92 44.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.476 HD21 ' CA ' ' A' ' 9' ' ' GLY . 3.2 tp -83.91 -47.7 10.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.333 -0.855 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -122.0 -41.92 2.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 110.025 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.86 -20.56 40.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' ALA . 3.6 ptt180 -136.55 -80.88 0.39 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.386 -1.067 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 88' ' ' ARG . . . 41.89 -155.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.328 -0.858 . . . . 0.0 109.388 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -146.44 133.31 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.589 ' NE2' ' O ' ' A' ' 91' ' ' GLN . 3.0 pp0? -118.85 115.84 25.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.702 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -120.8 159.61 25.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.725 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.567 ' HE ' HD11 ' A' ' 62' ' ' LEU . 42.3 ttt180 -110.52 130.05 55.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.892 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 96' ' ' GLN . 2.5 mm-40 -115.32 86.2 2.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.058 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.52 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.1 t -68.29 37.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.543 ' H ' ' C ' ' A' ' 94' ' ' GLU . 5.1 tm0? 48.82 103.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.496 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.91 -52.37 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 98' ' ' PHE . 60.0 t80 -108.77 31.29 5.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -1.043 . . . . 0.0 109.234 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 98' ' ' PHE . 4.1 mt-10 -53.18 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.391 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.7 t -115.85 170.51 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.93 65.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.1 m -68.56 -53.93 19.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.465 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 14.1 t80 -62.0 -39.18 91.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.443 HD21 ' OE2' ' A' ' 99' ' ' GLU . 94.8 mt -72.36 -36.36 68.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.81 -37.3 94.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.82 -50.52 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.515 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -103.43 61.95 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -84.75 -29.45 25.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -99.6 1.85 44.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.65 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.54 -109.18 2.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 110' ' ' GLY . 16.9 mt 53.34 100.6 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -144.13 100.86 3.63 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.78 108.04 15.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.875 . . . . 0.0 109.574 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -119.41 140.7 49.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 109.362 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.6 m170 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.9 t -89.77 122.91 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.451 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 126' ' ' VAL . 69.4 t -155.51 82.28 3.83 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.82 133.27 11.24 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.773 2.315 . . . . 0.0 112.325 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.67 ' N ' ' ND2' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -63.8 150.22 45.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.526 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 131' ' ' VAL . 1.5 pp20? -88.05 -21.89 24.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 109.552 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 p -47.04 -16.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 129' ' ' GLU . 61.4 t -68.57 -40.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.55 -29.42 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.521 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.428 0.633 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.919 ' O ' HD11 ' A' ' 85' ' ' LEU . 41.9 mttt -98.17 -55.83 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.379 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.551 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.91 134.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.631 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 56.98 54.2 38.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -63.4 0.42 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -1.086 . . . . 0.0 109.404 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' GLY . 11.6 pt-20 -176.44 150.72 1.02 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -39.89 126.29 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.639 2.226 . . . . 0.0 112.1 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.63 -158.5 27.78 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.8 141.81 51.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -1.062 . . . . 0.0 109.652 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 2.4 mm100 -127.84 156.64 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.247 -0.908 . . . . 0.0 109.35 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.9 mp -131.36 137.0 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.204 -0.935 . . . . 0.0 109.961 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.2 m-90 -144.9 113.41 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 0.0 109.32 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.414 HH11 ' CG ' ' A' ' 39' ' ' ASP . 46.2 ttt180 -80.98 140.03 35.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.0 143.18 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' PHE . 14.0 mm-40 -146.15 112.3 5.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.091 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 20.4 ttpp 57.86 -76.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.339 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 6.8 m-85 -175.83 33.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.318 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.7 t70 -127.31 -1.64 6.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 109.803 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.4 tp 59.25 146.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 109.312 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 24' ' ' LEU . 42.1 t -154.39 111.41 2.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.652 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.42 147.38 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.44 2.093 . . . . 0.0 112.173 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' THR . 6.8 p -76.93 133.34 69.66 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.102 -0.999 . . . . 0.0 109.394 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -41.27 89.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.527 2.151 . . . . 0.0 112.292 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 27' ' ' VAL . 24.4 m -51.74 -26.55 9.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.407 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.636 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -51.34 -43.46 61.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.408 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.6 mt -93.86 -54.19 3.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.299 -0.875 . . . . 0.0 109.639 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 65.47 100.44 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 123.67 -27.32 5.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -65.84 139.71 58.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.333 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 33' ' ' GLY . 73.7 m-85 -143.6 143.03 31.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.846 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.61 103.27 15.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.06 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.561 ' C ' ' H ' ' A' ' 39' ' ' ASP . 15.0 p -54.89 -45.26 74.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.808 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.19 10.13 0.29 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 37' ' ' THR . 3.4 m-20 -133.73 -156.24 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -1.173 . . . . 0.0 109.283 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.44 140.91 25.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 109.689 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 15.3 m-85 -123.83 146.21 48.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.825 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.83 116.09 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.168 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.441 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -112.37 142.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.252 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.621 HD11 ' CD2' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -122.3 145.25 48.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.568 -0.707 . . . . 0.0 109.891 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -125.47 93.21 3.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.452 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 86.2 m -73.86 106.76 5.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -107.02 164.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.414 179.865 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -134.1 144.8 48.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 2.3 m-85 -100.89 118.91 37.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 108.848 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.488 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 3.5 m-20 -77.81 120.39 22.64 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.621 ' CD2' HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -97.11 122.61 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.0 110.087 -178.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -138.24 110.98 7.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.44 129.94 35.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 108.95 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.34 111.49 23.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' A' ' 60' ' ' TYR . 1.1 mt -116.1 105.62 12.81 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -65.98 14.54 0.29 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 62.64 1.87 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 109.783 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.6 mt-10 -103.46 4.17 35.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.091 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 67' ' ' SER . 45.6 t -103.41 122.08 44.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 69' ' ' ASP . 69.6 m -43.02 126.16 3.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.43 -8.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 67' ' ' SER . 10.9 t0 -68.24 -43.38 78.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.613 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -87.35 -33.52 19.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.53 ' OG ' HD13 ' A' ' 62' ' ' LEU . 5.7 t -57.77 -56.61 19.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.84 82.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.81 -48.13 50.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.257 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.13 96.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.159 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -63.2 -20.59 65.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.01 -57.44 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 109.99 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -61.28 -32.91 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.334 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.76 -44.01 51.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.147 -0.971 . . . . 0.0 109.588 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.531 ' N ' ' CG2' ' A' ' 78' ' ' THR . 45.2 t -69.93 -52.52 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.9 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -60.92 -59.52 5.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.721 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -53.29 -48.66 68.16 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.98 -1.075 . . . . 0.0 108.66 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 4.4 t0 -44.89 -45.82 10.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.111 -0.993 . . . . 0.0 108.801 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.28 -31.93 72.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 81' ' ' LEU . 11.5 t80 -77.06 -23.17 52.0 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.919 HD11 ' O ' ' A' ' 7' ' ' LYS . 3.6 tp -82.89 -51.35 7.7 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.279 -0.888 . . . . 0.0 109.902 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -122.4 -42.05 2.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.255 -0.903 . . . . 0.0 109.985 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.03 -15.51 16.04 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.7 mtp-105 -144.52 -85.29 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.435 -1.039 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 56.58 156.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.647 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.454 ' C ' ' NE2' ' A' ' 91' ' ' GLN . 17.7 t -91.54 150.23 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.147 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.454 ' NE2' ' C ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -134.7 122.95 22.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.0 110.137 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.637 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -136.42 159.98 40.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.302 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -121.12 144.59 48.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.954 . . . . 0.0 109.931 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 96' ' ' GLN . 4.9 mm-40 -115.1 85.29 2.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.4 t -71.89 37.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.695 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 95' ' ' VAL . 1.7 tt0 58.14 118.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.51 -35.9 4.66 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -113.58 45.0 1.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -1.137 . . . . 0.0 109.436 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -71.04 178.93 2.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 m -101.14 160.13 14.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.0 109.441 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.39 65.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.489 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.7 m -71.77 -52.98 14.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -61.2 -37.69 83.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 109.594 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mt -72.19 -27.85 62.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.542 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.58 -25.21 39.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.87 -14.34 29.84 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.187 -1.184 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -134.88 93.81 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.637 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -78.19 -63.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -92.16 9.87 31.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.236 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 111' ' ' LEU . . . -80.46 56.97 4.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.71 92.03 2.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.471 -1.017 . . . . 0.0 109.218 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 35' ' ' PHE . 25.1 tttt -130.02 108.6 10.22 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.653 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -82.19 107.88 15.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.999 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -108.03 108.54 19.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 108.901 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 -179.853 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.5 138.16 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.478 ' H ' HG23 ' A' ' 126' ' ' VAL . 2.1 t -56.92 113.16 5.56 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.485 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 57.3 Cg_exo -46.89 153.29 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.443 ' O ' HG12 ' A' ' 131' ' ' VAL . 35.4 m-80 -165.67 102.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.538 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.1 -25.41 59.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.69 -20.21 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 128' ' ' ASN . 7.6 p -49.29 -23.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.817 . . . . 0.0 109.609 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.2 t -51.72 -32.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.439 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 8' ' ' ALA . 5.6 mptp? -94.82 -60.98 1.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 109.443 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.567 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 59.08 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.386 -0.821 . . . . 0.0 109.324 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.569 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 42.2 43.55 4.61 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' GLY . 2.4 pttm -45.56 -23.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' GLY . 11.2 pt-20 -146.48 149.98 39.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -39.78 123.58 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.679 2.252 . . . . 0.0 112.223 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.4 -167.7 31.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.17 147.03 40.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -1.024 . . . . 0.0 109.555 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.569 HE21 ' N ' ' A' ' 9' ' ' GLY . 17.2 mt-30 -141.98 151.58 42.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.05 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -128.81 135.86 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -141.94 110.58 6.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.501 ' CD ' ' CZ ' ' A' ' 41' ' ' TYR . 21.4 ttp180 -79.77 139.02 37.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.386 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -82.69 142.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.91 . . . . 0.0 109.352 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -159.62 97.09 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.441 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 12.2 ttmm 63.74 25.86 14.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.394 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.2 m-85 70.09 14.64 7.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.614 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' LEU . 9.8 t70 -98.29 -15.27 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' ASP . 1.9 mp 59.84 136.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.02 127.06 12.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.865 . . . . 0.0 109.012 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.57 126.05 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.29 1.993 . . . . 0.0 112.364 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.41 134.78 81.7 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.52 130.26 16.95 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.401 2.067 . . . . 0.0 112.145 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' ASN . 20.5 m -60.0 -26.37 66.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 29' ' ' THR . 57.1 t30 -44.17 -38.84 3.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.974 . . . . 0.0 109.229 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 32' ' ' TYR . 42.2 mt -108.81 -55.15 2.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.481 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 31' ' ' LEU . 6.2 t80 47.92 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.451 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 123.73 -30.74 4.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.597 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 15.3 m-20 -80.88 146.55 30.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.238 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 m-85 -146.1 152.22 38.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 0.0 109.843 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.54 ' CD2' ' C ' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -90.27 104.55 17.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.089 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.6 p -59.07 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.94 -30.66 0.06 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -107.44 -152.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.505 -0.997 . . . . 0.0 108.725 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -137.48 140.46 41.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.501 ' CZ ' ' CD ' ' A' ' 18' ' ' ARG . 18.8 m-85 -117.72 124.93 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.4 130.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.63 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.6 mt -123.46 145.95 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 43' ' ' ILE . 2.3 mm? -124.85 133.24 53.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 55' ' ' GLN . 12.0 ttpt -129.91 94.0 3.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.006 . . . . 0.0 110.031 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.613 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 64.5 m -84.99 106.75 16.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.22 164.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.356 -0.84 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.538 0.685 . . . . 0.0 110.627 -179.33 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.1 tt0 -105.31 96.59 6.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.054 -1.029 . . . . 0.0 110.513 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.673 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 27.8 m-85 -76.61 109.65 10.53 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.602 ' CG ' ' HE2' ' A' ' 59' ' ' HIS . 22.6 t0 -83.61 126.97 33.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.977 -1.077 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 82' ' ' ASP . 4.0 mp -97.19 119.82 36.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.69 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 18.7 m-70 -134.1 108.76 8.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.705 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.66 119.58 39.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.537 ' NE1' HD12 ' A' ' 111' ' ' LEU . 78.1 t90 -96.41 126.51 41.65 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 110.243 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.667 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.9 mt -122.52 109.39 14.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -59.3 10.32 0.03 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 62' ' ' LEU . 28.9 t30 67.45 1.79 2.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -108.32 11.29 27.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.549 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.4 t -104.45 146.02 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 m -77.38 164.88 25.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.616 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -68.96 -8.87 48.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -68.87 -56.11 8.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -87.22 -38.86 15.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 t -58.62 -56.04 27.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.482 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.91 50.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.29 -36.38 4.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -1.178 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.49 70.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.322 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -68.4 -33.63 74.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mt -79.57 -44.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.821 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.5 -40.24 96.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.984 -1.072 . . . . 0.0 109.452 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -76.34 -45.03 34.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 75' ' ' ALA . 49.9 t -61.72 -54.33 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.797 . . . . 0.0 110.143 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.572 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 12.0 pt20 -62.56 -50.55 70.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 110.143 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -59.82 -51.26 70.48 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.745 -1.222 . . . . 0.0 108.647 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.582 ' OD2' ' ND2' ' A' ' 86' ' ' ASN . 3.1 t0 -43.76 -43.47 6.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.004 -1.06 . . . . 0.0 108.358 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.08 -36.77 80.53 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.6 t80 -73.19 -23.6 60.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.501 HD11 ' O ' ' A' ' 7' ' ' LYS . 1.1 tt -81.38 -52.2 7.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.254 -0.904 . . . . 0.0 109.961 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.582 ' ND2' ' OD2' ' A' ' 82' ' ' ASP . 2.2 p30 -122.12 -42.33 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.112 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.18 -10.65 26.77 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -149.96 -81.1 0.12 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -1.083 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.673 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 56.89 170.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.9 t -97.99 150.16 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.241 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.445 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 7.1 pt20 -113.62 147.86 37.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 0.0 109.953 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.69 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 27.0 m-70 -146.23 122.78 11.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 23.7 ptt85 -111.5 118.75 36.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.821 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.6 mp0 -114.82 100.16 8.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.273 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 2.2 t -87.12 37.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.65 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 24.8 tt0 72.04 107.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.416 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 93.31 -29.81 7.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -97.38 37.57 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 1.1 mp0 -63.25 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.9 m -131.57 -169.97 2.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -61.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 98.5 m -55.45 -37.33 67.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -67.46 -45.96 74.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.63 -10.35 59.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.46 -39.06 8.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.26 -33.92 37.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.54 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -103.4 107.18 17.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -99.38 -12.54 20.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.1 m -53.43 -36.1 61.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.53 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 93.59 35.9 6.04 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.73 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.2 mm? 53.71 103.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -95.4 119.09 33.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -81.96 107.73 14.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.843 . . . . 0.0 109.645 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -115.84 108.57 16.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.233 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.5 mttp . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.499 -179.807 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -96.43 146.69 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.7 t -92.55 114.79 63.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 75.9 Cg_exo -45.24 143.03 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.424 2.083 . . . . 0.0 112.19 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 12.6 m-20 -44.32 169.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -80.07 -21.72 43.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.3 t -47.15 -33.93 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.05 -43.92 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.406 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.98 -27.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.405 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -69.34 -32.81 72.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.19 142.54 54.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.54 44.47 4.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -107.5 -23.24 12.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -1.098 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -152.14 150.99 26.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.868 . . . . 0.0 109.275 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.19 172.37 16.14 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.605 2.203 . . . . 0.0 112.314 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.47 -125.63 8.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 106' ' ' TYR . 4.0 tt -137.11 146.87 45.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.733 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 17.1 mt-30 -137.29 139.46 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.608 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 8.7 mt -111.3 145.2 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.938 . . . . 0.0 109.885 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.7 m0 -148.76 110.74 4.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' VAL . 3.4 tmm_? -85.92 131.44 34.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.187 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.3 143.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.164 -0.96 . . . . 0.0 110.111 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 22' ' ' PHE . 30.3 tt0 -144.46 124.69 13.74 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 24.0 tttp 60.99 -74.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.958 . . . . 0.0 109.016 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' GLU . 10.7 m-85 -168.57 19.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 109.877 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.99 111.27 13.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.11 -0.994 . . . . 0.0 109.693 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 25' ' ' VAL . 9.0 mp -48.99 159.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.362 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ARG . 48.0 t -153.6 90.79 3.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.605 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.32 127.17 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.722 2.281 . . . . 0.0 112.207 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.5 p -106.83 133.63 20.19 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 109.383 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -41.11 93.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.542 2.161 . . . . 0.0 112.318 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.602 ' OG1' HD12 ' A' ' 16' ' ' ILE . 28.0 m -71.38 -12.12 61.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.521 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -77.21 -23.62 51.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.616 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 31' ' ' LEU . 10.4 tp -136.25 13.53 3.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.256 -0.903 . . . . 0.0 109.605 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -56.63 -96.77 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.16 -0.963 . . . . 0.0 109.833 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 64.73 11.48 49.67 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' C ' ' OD2' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -161.84 147.01 13.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -1.081 . . . . 0.0 108.985 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.488 ' CE2' ' CH2' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -146.4 161.04 41.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.918 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -77.29 158.57 30.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 108.964 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 p -107.13 -30.26 8.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.673 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.36 20.46 5.97 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -139.43 -157.39 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -1.066 . . . . 0.0 109.312 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.83 140.8 31.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -119.44 121.91 40.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.574 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.56 130.82 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 139.87 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.651 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.609 HD23 ' CD1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -115.83 145.18 43.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -130.84 93.77 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.094 -1.004 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.636 HG23 ' CD2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -78.05 106.01 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -96.95 164.92 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.405 -0.809 . . . . 0.0 109.407 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 . . . . . 0 C--N 1.3 -1.559 0 O-C-N 121.664 -0.648 . . . . 0.0 109.288 179.833 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.5 tt0 -131.36 113.64 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.744 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.768 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -86.89 110.29 19.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 108.954 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 1.1 m-20 -88.47 119.15 28.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.012 -1.055 . . . . 0.0 108.84 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 58' ' ' LEU . 3.1 pp -96.81 131.46 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.844 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.573 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -135.35 127.88 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.538 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.65 114.84 29.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.096 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.566 ' CD1' ' CZ ' ' A' ' 103' ' ' PHE . 32.1 t90 -93.21 117.39 30.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 109.468 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.4 mt -117.69 118.53 32.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 108.994 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -67.78 21.5 0.26 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' LEU . 10.5 t30 57.01 1.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.019 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 63' ' ' GLY . 15.8 mm-40 -111.71 10.16 20.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 0.0 108.539 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.0 p -98.46 146.07 26.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.621 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 t -67.39 154.86 40.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.414 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -75.84 -9.02 58.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.657 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.32 -45.73 45.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.686 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -87.3 -35.77 18.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.303 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.595 ' OG ' HD22 ' A' ' 62' ' ' LEU . 2.9 t -58.7 -53.53 57.35 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.495 -0.753 . . . . 0.0 109.458 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.68 42.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.7 -38.71 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.655 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.11 83.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -67.93 -41.81 82.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.11 -39.43 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.31 -47.15 85.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.104 -0.998 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -75.54 -42.24 52.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 75' ' ' ALA . 54.1 t -62.38 -49.06 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.937 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -65.26 -59.85 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.875 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -56.03 -43.83 78.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 0.0 108.587 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 78' ' ' THR . 6.9 t70 -47.3 -46.98 25.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.139 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.49 -28.79 70.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.778 ' HB3' HD13 ' A' ' 81' ' ' LEU . 45.9 t80 -75.02 -24.37 58.34 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.64 -54.59 6.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 86' ' ' ASN . 22.5 t-20 -122.07 -42.03 2.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.939 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.48 1.95 24.52 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.9 mtm-85 -155.13 -78.27 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.425 -1.044 . . . . 0.0 109.263 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.768 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 55.7 178.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.59 146.84 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.63 140.09 38.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.424 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 52.9 m-70 -138.78 119.36 13.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.602 ' HE ' HG22 ' A' ' 95' ' ' VAL . 35.8 ttt180 -103.95 126.59 51.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 109.273 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 12.7 mp0 -127.27 78.67 1.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.948 . . . . 0.0 109.802 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.602 HG22 ' HE ' ' A' ' 93' ' ' ARG . 2.1 t -78.68 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.116 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.439 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 0.9 OUTLIER 42.28 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 98' ' ' PHE . . . 156.36 -35.5 0.6 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 97' ' ' GLY . 2.3 m-85 -135.88 54.68 1.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -1.077 . . . . 0.0 109.276 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.595 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 28.3 mt-10 -71.56 171.49 11.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.562 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 t -110.95 178.92 4.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.394 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -67.74 -26.37 66.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.594 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 m -63.39 -62.9 1.38 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.32 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD1' ' OE2' ' A' ' 99' ' ' GLU . 36.9 t80 -54.6 -41.98 70.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.69 -26.25 61.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.92 . . . . 0.0 109.384 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -63.95 -44.27 96.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' CD1' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -76.22 -50.96 13.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -1.114 . . . . 0.0 109.319 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.72 71.68 9.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -88.77 -40.78 12.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -105.7 8.03 32.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -90.18 -107.95 1.31 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.5 mm? 53.42 101.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.346 -1.091 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -166.07 95.96 0.59 Allowed 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.641 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -82.42 107.76 15.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.5 -0.75 . . . . 0.0 109.45 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -112.07 118.05 34.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 40.7 m80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.45 146.65 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.9 83.97 31.11 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 53.6 Cg_exo -48.45 149.82 6.36 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.74 2.293 . . . . 0.0 112.237 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 18.4 m120 -42.86 166.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -87.67 -28.58 21.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.406 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -48.55 -32.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 131' ' ' VAL . 17.6 t -50.15 -60.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -73.93 -27.77 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.951 . . . . 0.0 109.587 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.488 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 8' ' ' ALA . 47.8 mttt -103.94 -45.31 4.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.782 ' HB3' HD11 ' A' ' 85' ' ' LEU . . . 58.54 135.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.509 -0.745 . . . . 0.0 109.643 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.613 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 50.73 53.57 25.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -58.02 -0.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.17 . . . . 0.0 109.361 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 9' ' ' GLY . 9.8 pt-20 -170.04 149.15 3.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.49 122.05 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.682 2.255 . . . . 0.0 112.252 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.78 -156.4 27.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.5 144.76 49.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.613 HE21 ' H ' ' A' ' 9' ' ' GLY . 24.3 mt-30 -138.53 150.49 46.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.228 -0.92 . . . . 0.0 109.676 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.2 mt -119.05 137.58 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 0.0 109.779 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.7 m0 -142.27 110.82 6.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.3 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.03 137.73 37.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.588 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.58 143.28 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 0.0 109.496 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -155.77 88.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 tttm 65.53 33.85 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.492 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' N ' ' A' ' 22' ' ' PHE . 1.3 m-85 66.2 17.16 10.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 24' ' ' LEU . 55.7 m-20 -102.65 -14.89 16.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.7 mt 57.43 144.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 109.633 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.2 t -154.15 110.25 2.46 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.363 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.83 112.9 0.55 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.388 2.058 . . . . 0.0 112.164 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 27' ' ' VAL . 13.1 p -47.52 133.61 10.32 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -40.91 101.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.509 2.139 . . . . 0.0 112.325 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.5 m -59.0 -25.65 63.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -50.42 -47.29 56.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.56 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -88.17 -54.98 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.85 . . . . 0.0 109.444 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.0 t80 55.54 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 109.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.26 17.08 3.35 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -117.28 144.46 44.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -1.172 . . . . 0.0 109.358 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.581 ' N ' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -146.14 133.92 21.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.773 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 38' ' ' GLY . 26.6 m-85 -92.14 103.03 15.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.059 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.459 ' H ' HG23 ' A' ' 37' ' ' THR . 16.3 p -52.19 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.643 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . 177.96 -29.43 0.07 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.464 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 4.0 p30 -107.93 -154.3 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.369 -1.077 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.15 141.07 34.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.464 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.464 ' CE2' ' OD1' ' A' ' 39' ' ' ASP . 88.5 m-85 -116.52 122.04 43.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.24 114.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.463 ' HB ' ' ND1' ' A' ' 59' ' ' HIS . 1.8 mt -114.58 145.95 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.551 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 1.1 mp -123.0 143.6 49.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.797 -0.565 . . . . 0.0 109.566 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 55' ' ' GLN . 5.0 ttmm -127.23 94.17 3.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.672 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.594 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 43.0 m -81.2 110.96 17.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.12 164.36 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.695 0.76 . . . . 0.0 110.803 -179.245 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 45' ' ' LYS . 3.4 tt0 -100.59 98.85 9.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.101 -1.0 . . . . 0.0 110.422 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.825 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 29.6 m-85 -80.75 109.58 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.483 ' C ' HD22 ' A' ' 58' ' ' LEU . 35.9 t0 -76.33 140.8 41.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 108.684 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 82' ' ' ASP . 2.1 mm? -107.48 103.12 12.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.845 . . . . 0.0 109.546 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.68 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -122.24 112.19 17.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.72 125.99 48.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.582 ' O ' HD23 ' A' ' 62' ' ' LEU . 39.7 t90 -98.79 132.38 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.871 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.596 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.8 mt -134.88 115.41 13.59 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.85 17.79 0.19 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 62' ' ' LEU . 23.8 t30 63.12 1.91 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 109.887 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -106.06 10.33 32.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 109.242 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.11 131.85 46.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.442 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 t -49.74 157.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -75.69 -11.83 60.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.4 p30 -79.24 -40.39 30.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 36.2 tt0 -87.33 -33.81 19.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.286 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.59 ' OG ' HD13 ' A' ' 62' ' ' LEU . 37.5 t -68.11 -60.41 2.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.54 -39.0 29.27 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -58.07 -56.89 16.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -1.156 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.44 -40.88 19.14 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.118 -0.988 . . . . 0.0 109.028 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.621 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -70.64 -21.39 62.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.347 -0.846 . . . . 0.0 109.024 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.6 mm -84.51 -49.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -61.88 -36.58 81.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 109.322 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.29 -46.02 29.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.625 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.0 t -64.39 -52.38 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.96 -59.55 4.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.648 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -52.71 -48.85 66.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 108.764 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HB2' HD11 ' A' ' 58' ' ' LEU . 6.1 t70 -44.8 -45.93 10.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.565 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.71 -33.85 73.5 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 5.5 t80 -74.68 -23.43 58.63 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -80.22 -52.93 7.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.564 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 86' ' ' ASN . 3.1 t-20 -122.1 -42.01 2.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.12 -14.88 21.11 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -145.54 -72.9 0.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -1.036 . . . . 0.0 109.245 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 56.1 -171.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 109.472 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.84 150.15 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.389 -0.819 . . . . 0.0 109.391 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.562 ' N ' ' OE1' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -108.33 133.0 53.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.716 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.591 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 12.4 m-70 -139.74 124.39 18.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.403 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 7.9 ptm180 -110.0 132.37 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 109.688 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.595 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 2.7 mt-10 -130.47 91.71 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.18 37.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 56.45 90.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.46 -32.04 2.52 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -125.12 56.86 1.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.445 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -85.72 167.55 15.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.6 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -100.28 161.01 13.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.47 77.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -62.23 -60.66 3.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 51.1 t80 -52.76 -38.8 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.463 -0.773 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 104' ' ' LEU . 85.0 mt -69.29 -26.17 64.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.62 55.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -43.59 60.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.391 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 88.8 m-85 -106.33 76.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.551 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -100.8 -35.86 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -91.14 -3.31 57.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -91.09 -107.69 1.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 110' ' ' GLY . 85.0 mt 53.37 100.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.36 -1.083 . . . . 0.0 109.527 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.617 ' NZ ' ' HZ1' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -151.67 90.97 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.85 107.72 14.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.516 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.617 ' HZ1' ' NZ ' ' A' ' 112' ' ' LYS . 22.4 mttm -112.37 108.92 18.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 5.5 ptpp? . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.36 0.6 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.6 t -70.16 122.76 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.531 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.67 98.58 38.0 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 129' ' ' GLU . 58.9 Cg_endo -79.09 162.5 25.97 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.463 2.108 . . . . 0.0 112.253 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -59.09 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 127' ' ' PRO . 37.9 tt0 -88.07 -17.23 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 131' ' ' VAL . 9.4 p -57.13 -42.75 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.558 ' N ' HG13 ' A' ' 130' ' ' VAL . 12.9 p -46.95 -30.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.461 ' O ' ' NE2' ' A' ' 133' ' ' GLN . 15.0 t -71.66 -27.77 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 130' ' ' VAL . 85.1 mm-40 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.412 HD11 ' CE2' ' A' ' 84' ' ' TYR . 49.7 tp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.786 ' O ' HD11 ' A' ' 85' ' ' LEU . 27.4 mttm -102.4 -61.11 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.562 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.91 137.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.757 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 47.39 38.55 13.32 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HG3' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -42.74 -23.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -1.167 . . . . 0.0 109.62 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' GLY . 34.0 mm-40 -143.79 153.67 58.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -41.65 122.84 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.76 2.306 . . . . 0.0 112.341 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.38 -167.09 33.92 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.782 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.7 tt -124.3 124.0 41.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -1.081 . . . . 0.0 109.217 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.757 HE21 ' N ' ' A' ' 9' ' ' GLY . 15.3 mt-30 -115.08 150.05 36.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 109.575 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.607 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.8 OUTLIER -123.6 140.45 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.792 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.607 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.9 m-90 -144.89 111.78 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -79.93 146.01 32.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.707 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.0 143.31 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.11 -0.994 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.9 tp10 -142.9 95.05 2.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.438 -0.789 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.544 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.6 tptp 71.6 40.26 0.81 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.298 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 2.4 m-85 72.82 21.43 3.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.656 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 22' ' ' PHE . 1.4 m-20 -127.31 111.5 13.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.36 137.47 57.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.6 t -144.0 121.16 6.6 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.895 . . . . 0.0 109.283 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -44.08 148.06 1.19 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.271 1.981 . . . . 0.0 112.513 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 27' ' ' VAL . 11.7 p -92.41 134.21 28.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.186 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -39.15 108.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -61.17 -29.11 69.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -46.77 -41.93 16.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.344 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.437 HD22 ' OD1' ' A' ' 34' ' ' ASP . 13.3 mt -91.22 -53.13 4.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.22 -0.925 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.3 t80 50.26 91.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 16.44 3.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.607 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 1.3 m-20 -128.96 135.7 49.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -1.155 . . . . 0.0 109.159 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 1.9 m-85 -146.07 161.26 40.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -85.3 145.49 27.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.324 -0.86 . . . . 0.0 109.173 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 p -89.9 -22.37 22.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.94 -15.87 69.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -103.75 -161.51 0.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -1.103 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -134.53 140.88 46.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 9.4 m-85 -120.6 148.44 43.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.456 -0.777 . . . . 0.0 109.772 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.76 138.19 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 109.347 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.591 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.4 mt -136.39 146.32 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 43' ' ' ILE . 4.1 mp -127.15 124.21 38.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.64 -0.662 . . . . 0.0 109.572 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -105.26 93.99 4.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.658 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.498 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 5.7 m -79.28 109.85 14.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -104.34 164.76 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.211 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 C--N 1.3 -1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.542 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 47' ' ' VAL . 27.7 tt0 -133.14 112.61 11.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.053 -1.029 . . . . 0.0 109.89 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.519 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 18.8 m-85 -90.69 129.17 36.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 15.9 m-20 -95.11 126.6 40.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 108.964 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.1 mm? -86.99 102.54 14.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.727 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.716 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 23.7 m-70 -116.9 108.67 16.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 0.0 109.567 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.708 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.37 124.21 49.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -0.983 . . . . 0.0 108.686 179.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.776 ' O ' HD23 ' A' ' 62' ' ' LEU . 5.6 t90 -95.92 128.78 43.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.147 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.776 HD23 ' O ' ' A' ' 61' ' ' TRP . 0.7 OUTLIER -129.7 106.4 8.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.57 16.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.664 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 61.27 1.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.734 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 63' ' ' GLY . 40.0 mt-10 -104.88 5.82 33.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.98 . . . . 0.0 109.083 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.8 t -101.61 129.16 47.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.546 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 t -51.16 144.39 9.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.444 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -64.62 -8.7 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -73.58 -44.78 56.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -86.86 -37.98 17.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.301 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.613 ' OG ' HD13 ' A' ' 62' ' ' LEU . 8.6 t -60.08 -51.8 68.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.45 -0.781 . . . . 0.0 109.379 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.51 -40.5 69.86 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -57.0 -55.15 38.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.64 44.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.123 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -70.15 -20.28 63.16 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.2 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.5 mm -84.42 -49.19 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.35 -33.45 76.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.976 . . . . 0.0 109.373 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.536 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -77.85 -43.78 29.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 75' ' ' ALA . 53.1 t -68.09 -44.32 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -66.13 -59.62 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -54.45 -45.32 73.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.986 -1.071 . . . . 0.0 108.538 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.411 ' OD2' ' C ' ' A' ' 82' ' ' ASP . 3.5 t0 -47.16 -48.01 23.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 108.607 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.0 -30.58 70.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 81' ' ' LEU . 16.9 t80 -78.43 -23.1 46.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.786 HD11 ' O ' ' A' ' 7' ' ' LYS . 3.8 tp -83.94 -49.91 8.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.263 -0.898 . . . . 0.0 109.921 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -122.3 -42.21 2.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.204 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.71 -19.86 20.9 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -140.97 -68.78 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -1.056 . . . . 0.0 109.351 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 54.63 -169.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.858 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.06 150.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.326 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -107.73 129.42 55.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.814 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.716 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 24.0 m-70 -135.88 113.5 10.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.276 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.492 HH21 ' HB2' ' A' ' 93' ' ' ARG . 19.6 ttp-105 -107.63 125.53 51.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.751 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.593 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 22.2 mt-10 -122.21 89.03 3.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -85.92 37.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -0.875 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 53.9 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.02 -64.99 0.3 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 21.0 m-85 -122.89 49.25 1.67 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.4 -1.059 . . . . 0.0 109.338 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.5 mp0 -51.61 170.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.62 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -87.07 165.44 15.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -29.54 57.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.5 m -65.86 -50.2 65.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.109 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 38.9 t80 -63.48 -48.81 76.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.431 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 108' ' ' LYS . 29.8 mt -63.81 -38.38 90.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.174 -0.953 . . . . 0.0 109.305 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -69.77 -38.16 76.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.238 -1.154 . . . . 0.0 109.26 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -124.27 50.97 1.62 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.421 -0.799 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 110' ' ' GLY . 2.8 tptm -78.15 -28.99 48.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 m -59.51 0.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.75 110.31 2.68 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.674 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -74.48 -104.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -1.165 . . . . 0.0 109.301 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tptp 179.1 113.0 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 109.156 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.02 107.71 19.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.79 . . . . 0.0 109.416 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -110.53 128.02 55.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.284 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 pttt . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.245 -0.91 . . . . 0.0 109.613 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.464 ' CE1' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.74 115.16 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.464 ' CG2' ' CE1' ' A' ' 124' ' ' HIS . 21.1 t -142.11 72.79 22.55 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.29 165.17 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.842 2.361 . . . . 0.0 112.144 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -140.39 35.99 1.87 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.29 -26.39 65.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.421 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 131' ' ' VAL . 9.0 p -57.72 -35.85 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.411 ' N ' HG13 ' A' ' 130' ' ' VAL . 3.0 t -65.9 -39.56 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.13 -30.09 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.49 179.914 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.655 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -65.12 -31.7 73.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.22 -0.925 . . . . 0.0 109.307 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.42 ' CB ' ' CH2' ' A' ' 17' ' ' TRP . . . -74.19 113.5 11.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.314 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.447 ' H ' HE22 ' A' ' 15' ' ' GLN . . . 99.32 49.01 1.62 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -140.24 -14.09 1.02 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -155.01 148.05 18.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.0 109.298 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.49 170.81 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.648 2.232 . . . . 0.0 112.252 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.9 -163.03 12.67 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 106' ' ' TYR . 3.5 tt -110.86 117.06 32.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -1.07 . . . . 0.0 109.598 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.447 HE22 ' H ' ' A' ' 9' ' ' GLY . 27.1 mt-30 -96.63 157.32 15.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.393 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 43' ' ' ILE . 1.9 mt -143.87 113.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.594 ' HH2' HD22 ' A' ' 44' ' ' LEU . 8.2 p90 -140.76 137.09 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 0.0 109.113 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -90.04 146.43 24.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.81 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -85.19 143.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.174 -0.954 . . . . 0.0 109.316 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ASP . 24.2 tt0 -150.52 103.86 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.529 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 44.43 35.82 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.905 . . . . 0.0 109.461 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.3 m-85 68.76 26.89 5.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.633 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.9 t70 -109.42 -20.27 12.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' ASP . 2.3 mp 59.63 138.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.57 128.79 5.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.044 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.78 125.39 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.249 1.966 . . . . 0.0 112.041 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 27' ' ' VAL . 10.8 p -71.68 132.9 84.92 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.13 127.41 3.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.7 m -65.98 -25.71 67.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.26 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -53.3 -50.14 65.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.359 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.7 mp -78.0 -55.37 5.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.155 -0.966 . . . . 0.0 109.365 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' O ' ' A' ' 31' ' ' LEU . 34.6 t80 46.91 91.82 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.536 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.88 -30.96 4.69 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' OD1' HD23 ' A' ' 31' ' ' LEU . 2.5 m-20 -51.81 146.26 8.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.049 -1.266 . . . . 0.0 109.102 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 112' ' ' LYS . 28.6 m-85 -137.77 120.14 15.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.014 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.84 107.43 17.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 108.896 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 p -70.86 87.61 0.72 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.672 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.65 -30.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -112.45 -152.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.927 . . . . 0.0 108.625 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.76 140.11 45.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.002 . . . . 0.0 109.617 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -112.72 124.82 53.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.265 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' A' ' 78' ' ' THR . 74.8 t -102.99 119.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -118.97 146.21 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.246 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.704 HD23 ' CD1' ' A' ' 56' ' ' TYR . 1.5 mp -126.2 152.91 45.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 0.0 109.482 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -140.53 93.83 2.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.161 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.614 ' OG1' ' CE1' ' A' ' 56' ' ' TYR . 1.2 m -88.49 111.42 21.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -0.812 . . . . 0.0 109.212 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.32 164.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.762 . . . . 0.0 109.092 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.549 -0.719 . . . . 0.0 109.443 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -134.42 104.42 6.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 110.489 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.704 ' CD1' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -77.95 123.37 26.71 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.092 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.585 ' OD2' ' CD2' ' A' ' 92' ' ' HIS . 3.8 t0 -103.23 122.08 44.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.033 . . . . 0.0 108.494 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.826 HD23 HG22 ' A' ' 78' ' ' THR . 10.4 mp -94.78 143.18 26.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.427 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -149.1 108.42 3.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.04 115.22 28.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 108.857 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.53 ' CE2' HD12 ' A' ' 111' ' ' LEU . 26.8 t90 -90.13 126.79 35.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.359 -0.838 . . . . 0.0 109.991 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.665 HD13 ' OG ' ' A' ' 71' ' ' SER . 3.9 mt -122.6 108.02 12.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -63.44 15.7 0.1 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.64 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.1 t-20 62.53 1.9 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -1.083 . . . . 0.0 109.962 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 63' ' ' GLY . 9.7 mm-40 -106.01 8.99 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.0 . . . . 0.0 109.12 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.1 t -104.36 141.03 37.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 m -57.24 146.87 26.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -64.23 -26.75 68.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.02 -32.07 72.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -87.22 -45.16 10.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.295 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.665 ' OG ' HD13 ' A' ' 62' ' ' LEU . 33.2 t -53.34 -49.76 66.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -59.68 -48.27 86.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -46.0 -43.53 14.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -1.122 . . . . 0.0 109.24 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 19' ' ' VAL . . . -63.42 -56.09 19.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -57.41 -20.5 30.35 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.366 -0.834 . . . . 0.0 108.935 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -82.42 -59.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.269 -0.894 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -63.18 -25.28 68.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.893 . . . . 0.0 108.716 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.826 HG22 HD23 ' A' ' 58' ' ' LEU . 5.3 m -75.91 -50.4 15.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.627 -0.671 . . . . 0.0 109.535 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 75' ' ' ALA . 51.6 t -73.65 -27.81 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -71.56 -59.78 2.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -58.64 -46.96 85.97 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.986 -1.071 . . . . 0.0 108.414 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.726 ' HB2' HD21 ' A' ' 58' ' ' LEU . 5.4 t70 -47.22 -45.75 23.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 13.5 t70 -61.66 -27.85 68.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.731 ' HB3' HD13 ' A' ' 81' ' ' LEU . 20.4 t80 -74.85 -23.85 58.49 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.9 mt -83.88 -54.11 5.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.841 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.488 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -121.71 -42.36 2.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 109.994 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.408 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . 126.11 -44.28 1.27 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 52.7 mtt85 -112.34 -85.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . 71.69 150.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.64 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 90' ' ' VAL . 1.6 t -79.57 150.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -122.95 130.26 52.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 109.891 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.585 ' CD2' ' OD2' ' A' ' 57' ' ' ASP . 20.0 m-70 -124.99 129.46 50.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -107.32 126.86 52.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 109.86 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 100.54 7.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.42 HG12 HD22 ' A' ' 64' ' ' ASN . 2.3 t -96.49 38.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 1.8 tt0 52.23 80.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.1 -62.34 0.37 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -94.94 60.78 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.471 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -67.04 159.4 28.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 m -91.82 170.03 10.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.95 -61.06 1.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -48.91 -47.94 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 109.251 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.45 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 21.7 t80 -55.07 -49.52 71.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.63 -16.26 62.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.31 -31.88 26.92 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.405 ' CE2' HD22 ' A' ' 14' ' ' LEU . 2.5 t80 -82.45 -34.59 28.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.681 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -105.21 113.86 27.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 109.722 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -103.99 -12.49 16.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.9 p -53.27 -29.63 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 109.459 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 87.09 40.62 6.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.798 ' N ' HD22 ' A' ' 111' ' ' LEU . 2.8 mm? 52.01 102.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.095 -1.238 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 35' ' ' PHE . 4.2 tmtm? -94.23 117.53 30.25 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -81.81 107.77 14.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 0.0 109.736 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -107.98 108.83 20.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mptt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.863 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.591 ' C ' ' HD1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -103.54 120.88 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.65 113.39 59.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.386 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.473 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 61.0 Cg_endo -78.72 125.78 6.96 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.167 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.473 ' CG ' ' O ' ' A' ' 127' ' ' PRO . 15.9 m-20 -175.36 64.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.12 -17.28 62.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.01 -23.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.77 -26.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.11 -27.84 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.525 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tp . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' O ' ' O ' ' A' ' 8' ' ' ALA . 35.3 mttm -108.45 -61.37 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.621 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.64 133.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.614 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 56.3 44.66 89.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' GLY . 38.2 mttp -42.57 -22.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -1.066 . . . . 0.0 109.418 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' GLY . 33.3 mt-10 -152.87 152.95 29.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -39.68 120.09 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.665 2.243 . . . . 0.0 112.15 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.97 -162.08 32.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -126.55 143.22 51.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -1.05 . . . . 0.0 109.678 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.614 HE21 ' H ' ' A' ' 9' ' ' GLY . 25.5 mt-30 -137.52 156.17 48.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.591 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -126.49 137.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.0 109.808 -179.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.4 m0 -142.59 111.08 6.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.293 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.67 146.13 44.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.148 -0.97 . . . . 0.0 109.501 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' A' ' 74' ' ' ALA . 1.6 t -80.29 143.91 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.0 109.39 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 21' ' ' LYS . 6.6 tp10 -159.18 109.6 1.99 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.448 -0.783 . . . . 0.0 109.461 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 20' ' ' GLU . 19.3 mttp 41.54 41.11 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 55.78 45.95 23.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 24' ' ' LEU . 25.7 t0 -126.47 -19.38 4.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 23' ' ' ASP . 9.6 mp 57.2 123.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.64 122.18 10.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.142 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.22 139.6 3.97 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.386 2.057 . . . . 0.0 112.501 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.16 127.89 93.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -40.16 101.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.476 2.118 . . . . 0.0 112.346 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 m -49.41 -27.43 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.376 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.38 -41.94 14.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.212 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.98 -53.86 2.84 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 t80 51.51 91.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . 123.5 -22.35 7.0 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.592 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 11.1 m-20 -92.53 147.74 22.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -1.206 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 9.1 m-85 -145.68 150.44 36.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.95 . . . . 0.0 109.749 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 38' ' ' GLY . 67.9 m-85 -87.48 109.83 19.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.168 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 114' ' ' LYS . 16.6 p -60.28 87.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 179.02 -29.79 0.06 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.2 t0 -107.52 -153.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -1.058 . . . . 0.0 108.873 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -139.41 147.91 42.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 11.9 m-85 -128.54 141.1 51.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.585 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.439 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 47.1 t -115.8 128.18 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.581 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.6 mt -123.14 146.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.25 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' A' ' 56' ' ' TYR . 3.8 mp -124.58 151.86 44.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -142.8 93.77 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 109.95 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.618 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 94.6 m -85.6 117.24 24.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.738 . . . . 0.0 109.615 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.86 164.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.276 -0.89 . . . . 0.0 109.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.565 -0.709 . . . . 0.0 109.154 179.73 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -125.54 106.32 9.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 110.125 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 12.2 m-85 -77.83 130.02 36.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.599 ' OD1' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.1 117.84 33.72 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.8 mp -96.11 143.82 26.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 110.779 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.4 m-70 -145.6 111.84 5.72 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -93.2 116.17 28.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 0.0 108.842 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.782 ' C ' HD23 ' A' ' 62' ' ' LEU . 25.5 t90 -91.49 129.06 37.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 110.041 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.782 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -131.53 111.87 12.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.55 14.22 0.08 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.2 t-20 65.22 1.78 1.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.447 -1.031 . . . . 0.0 109.862 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -107.16 10.32 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 108.984 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 28.8 t -104.41 146.21 29.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.463 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 p -70.43 140.64 52.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.455 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLN . 34.0 tt0 -63.03 -8.86 8.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 47.1 t0 -70.73 -49.51 46.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -87.24 -40.41 14.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 109.417 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.6 t -57.05 -54.41 47.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.34 -45.32 35.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.19 -51.93 60.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 19' ' ' VAL . . . -50.68 -45.75 58.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.5 -21.54 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 109.224 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.27 -52.01 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -58.93 -38.95 80.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -0.972 . . . . 0.0 109.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.603 HG23 ' N ' ' A' ' 79' ' ' VAL . 4.8 t -72.6 -48.24 41.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.762 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.603 ' N ' HG23 ' A' ' 78' ' ' THR . 40.9 t -64.17 -56.26 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.855 . . . . 0.0 109.906 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -54.1 -58.91 5.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -50.24 -47.51 55.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.067 -1.02 . . . . 0.0 109.278 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.629 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -46.95 -47.6 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.861 -1.149 . . . . 0.0 108.399 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.59 -28.28 69.24 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LEU . 26.9 t80 -78.29 -23.47 47.15 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.49 -51.07 7.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.618 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.596 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -122.33 -42.16 2.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.221 -0.924 . . . . 0.0 109.955 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.18 -18.4 6.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.497 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.6 mmm180 -141.94 -84.56 0.18 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.411 -1.053 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.629 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . 65.34 145.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.6 150.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.307 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -124.56 158.01 34.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.599 ' CD2' ' OD1' ' A' ' 57' ' ' ASP . 26.2 m-70 -138.29 143.56 40.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 109.42 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -114.97 127.12 55.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.587 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -126.88 89.77 3.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.97 37.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.57 84.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 109.354 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.97 -54.99 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -94.32 58.6 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -93.13 150.78 20.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 109.371 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 m -91.11 176.99 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -73.73 -27.28 61.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -64.01 -53.39 50.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.003 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.47 ' C ' ' CD2' ' A' ' 103' ' ' PHE . 18.8 t80 -62.88 -50.38 71.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.453 -0.779 . . . . 0.0 109.38 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -66.92 -26.18 66.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.197 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -62.7 -48.16 83.48 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -48.79 69.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -1.16 . . . . 0.0 109.209 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -106.23 67.58 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -93.16 -16.96 24.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.935 . . . . 0.0 109.592 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 m -67.18 -3.91 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.918 . . . . 0.0 109.663 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.66 109.79 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.702 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.74 -102.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -1.159 . . . . 0.0 109.215 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 7.2 mttm 163.79 117.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.462 -0.773 . . . . 0.0 109.126 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 37' ' ' THR . 0.2 OUTLIER -94.31 107.99 19.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' THR . 69.1 mttt -113.77 136.2 53.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.438 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.1 mttp . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.932 . . . . 0.0 109.442 -179.903 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.337 0.589 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 t -140.96 132.27 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.14 113.25 64.54 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.12 142.72 8.22 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.373 2.048 . . . . 0.0 112.28 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.514 ' H ' ' ND2' ' A' ' 128' ' ' ASN . 1.7 p30 -64.9 130.53 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -87.96 -17.45 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 130' ' ' VAL . 23.0 t -49.13 -56.52 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 132' ' ' VAL . 14.2 p -52.35 -37.88 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.474 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.455 ' N ' HG13 ' A' ' 131' ' ' VAL . 16.6 t -69.89 -27.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.476 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.9 tp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.212 0.53 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.7 ptpp? -105.86 -42.47 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 109.794 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 58.55 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -0.816 . . . . 0.0 109.395 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.654 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 56.26 46.84 85.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -46.24 -27.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -1.167 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -149.78 154.82 38.0 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -40.65 129.52 2.64 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.754 2.303 . . . . 0.0 112.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.69 29.88 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.788 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.3 tt -124.78 127.06 46.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.123 . . . . 0.0 109.396 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.654 HE21 ' H ' ' A' ' 9' ' ' GLY . 22.4 mt-30 -118.07 138.9 51.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.9 OUTLIER -109.64 140.19 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.601 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 7.9 m0 -142.43 110.86 6.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.108 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -81.38 138.47 35.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.634 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -93.6 142.76 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 22' ' ' PHE . 10.3 tp10 -159.5 123.3 3.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.549 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 20' ' ' GLU . 11.4 tptm 42.48 26.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.6 m-85 66.57 44.88 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 24' ' ' LEU . 26.7 t0 -117.12 -25.11 7.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.512 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.8 mt 57.6 124.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -145.28 126.71 7.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.365 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.06 123.33 7.21 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.45 2.1 . . . . 0.0 112.339 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -97.75 130.43 29.02 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -42.48 103.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.486 2.124 . . . . 0.0 112.405 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -48.72 -40.12 27.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -63.14 -53.74 48.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 tp -84.71 12.7 6.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 34' ' ' ASP . 46.0 t80 -83.74 -110.37 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 109.074 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.57 ' N ' ' CG ' ' A' ' 32' ' ' TYR . . . 56.38 -3.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 32' ' ' TYR . 1.1 t70 -111.78 164.76 12.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 109.61 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.571 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 7.4 m-85 -144.75 120.07 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.6 114.45 17.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 ' HH2' ' A' ' 61' ' ' TRP . 17.3 p -75.57 87.14 2.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.41 -28.38 0.07 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -115.17 -155.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 108.807 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 140.91 38.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -112.3 121.85 46.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.646 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.0 t -96.77 121.28 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.407 -0.808 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.598 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.1 mt -121.28 145.9 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.765 HD11 HD23 ' A' ' 58' ' ' LEU . 2.0 mp -127.52 125.16 39.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.626 -0.671 . . . . 0.0 109.295 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 55' ' ' GLN . 16.9 ttpt -106.02 93.68 4.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.691 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.512 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 31.2 m -77.71 100.52 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -94.49 164.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.292 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.546 -0.721 . . . . 0.0 109.349 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' LYS . 42.9 tt0 -129.08 117.62 21.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.766 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 56' ' ' TYR . 5.9 m-85 -91.52 123.07 34.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.856 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -91.75 119.84 31.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.08 -1.012 . . . . 0.0 109.052 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.765 HD23 HD11 ' A' ' 44' ' ' LEU . 12.5 mt -82.72 128.99 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.889 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.684 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 22.1 m-70 -139.43 108.12 5.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -102.01 112.15 24.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 108.544 179.1 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.789 ' C ' HD23 ' A' ' 62' ' ' LEU . 73.3 t90 -93.66 129.18 40.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 110.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.789 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -127.79 130.55 48.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -82.81 23.83 5.56 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.7 t30 60.88 1.86 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -1.066 . . . . 0.0 109.896 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 63' ' ' GLY . 2.8 mm-40 -108.18 10.4 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -0.999 . . . . 0.0 108.848 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.487 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 7.2 p -105.34 132.6 51.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.526 -0.734 . . . . 0.0 109.558 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -54.52 155.98 3.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.54 -8.9 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.384 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 4.5 t0 -77.03 -36.4 56.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.728 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -87.09 -28.03 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.615 ' OG ' HD13 ' A' ' 62' ' ' LEU . 30.7 t -69.05 -60.01 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.51 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.97 49.18 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.4 -44.52 24.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -1.183 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.93 -57.35 10.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.154 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -59.03 -19.83 47.53 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 109.171 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mm -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.95 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -57.51 -35.53 70.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.641 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.579 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.5 t -80.13 -47.23 15.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.884 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.7 t -61.27 -47.47 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.741 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -69.72 -59.54 2.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.8 tm? -53.45 -51.8 61.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.93 -1.106 . . . . 0.0 108.807 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.632 ' HB2' HD21 ' A' ' 58' ' ' LEU . 6.1 t0 -46.01 -47.19 16.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.006 -1.059 . . . . 0.0 108.355 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -56.65 -30.07 62.94 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 81' ' ' LEU . 35.7 t80 -71.03 -23.94 62.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.46 HD21 HD11 ' A' ' 81' ' ' LEU . 46.8 mt -82.38 -55.19 4.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 110.211 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.692 ' ND2' ' H ' ' A' ' 88' ' ' ARG . 3.9 p-10 -121.62 -42.31 2.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.29 0.91 31.3 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.692 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 24.0 mtp180 -138.31 -83.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -1.127 . . . . 0.0 109.581 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.598 ' N ' ' ND2' ' A' ' 86' ' ' ASN . . . 56.3 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.849 . . . . 0.0 109.794 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 2.6 t -91.43 150.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.56 133.87 52.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.879 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.684 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 35.4 m-70 -138.14 122.31 18.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.235 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.423 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 14.4 ptp180 -110.6 122.17 47.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.957 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.588 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -117.75 90.54 3.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 108.996 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.4 37.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.625 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 68.55 77.8 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.31 -56.5 0.61 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.485 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 8.0 m-85 -87.69 55.22 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.106 . . . . 0.0 109.376 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 30.3 mm-40 -66.83 -178.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.458 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.0 m -117.49 157.2 26.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.4 -0.812 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.39 70.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.571 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.0 m -57.35 -52.08 66.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 44.7 t80 -56.5 -37.87 70.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.487 -0.758 . . . . 0.0 109.6 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -71.28 -31.14 67.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.515 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.23 81.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.432 ' CD2' HD13 ' A' ' 14' ' ' LEU . 1.7 t80 -74.86 -47.54 29.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -1.144 . . . . 0.0 109.568 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -109.49 82.62 1.62 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.521 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -98.28 -34.15 10.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.545 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -101.27 9.18 42.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.24 -108.89 2.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.613 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.4 mm? 53.1 101.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.243 -1.151 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -149.93 97.52 2.6 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.555 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -81.69 107.99 14.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.462 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -118.81 154.46 32.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.349 -0.845 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.52 ' H ' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 22.2 m170 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t -141.76 128.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.31 115.88 28.17 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.08 135.92 10.67 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.41 2.073 . . . . 0.0 112.214 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.0 t30 61.33 90.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.451 ' OE2' ' N ' ' A' ' 129' ' ' GLU . 54.8 mp0 -79.79 -17.77 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.429 ' H ' HG23 ' A' ' 130' ' ' VAL . 2.5 t -47.82 -19.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 129' ' ' GLU . 88.8 t -65.45 -44.35 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.94 -28.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.469 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.56 155.42 36.2 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.463 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.11 139.5 42.63 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.792 2.328 . . . . 0.0 112.219 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 7' ' ' LYS . 24.0 mt-10 -83.05 -53.12 6.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.685 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.434 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.7 OUTLIER -43.69 -37.32 2.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 109.492 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp -83.25 -21.78 33.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.287 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' GLU . 26.8 tttt -65.02 -41.41 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.32 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.48 142.38 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.36 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.7 43.07 3.46 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -119.02 2.63 11.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.49 ' OE2' ' O ' ' A' ' 12' ' ' PRO . 2.1 pp20? -171.52 141.45 1.29 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.25 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' O ' ' OE2' ' A' ' 11' ' ' GLU . 55.8 Cg_endo -73.27 178.33 6.74 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.42 2.08 . . . . 0.0 112.175 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -135.23 12.08 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.484 HD13 ' CD1' ' A' ' 106' ' ' TYR . 5.9 tt -134.57 133.06 39.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -1.091 . . . . 0.0 109.782 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 43' ' ' ILE . 3.3 mt-30 -124.56 145.47 49.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.353 -0.842 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.623 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.5 OUTLIER -125.23 137.95 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 110.167 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.9 m-90 -145.47 147.65 32.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.423 -0.798 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -106.64 130.68 54.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.445 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -81.7 143.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.0 . . . . 0.0 109.447 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -148.71 96.98 2.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.513 -0.742 . . . . 0.0 109.436 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.9 tttm 50.86 37.09 16.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.7 m-85 68.98 46.25 0.86 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 109.563 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 24' ' ' LEU . 2.8 m-20 -127.03 -21.25 4.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 23' ' ' ASP . 17.0 mt 56.03 122.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.516 -0.74 . . . . 0.0 109.665 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -140.29 108.16 6.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.431 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.84 117.94 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.448 2.099 . . . . 0.0 112.144 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 27' ' ' VAL . 14.5 p -59.34 133.84 88.24 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -40.78 117.88 0.56 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.484 2.122 . . . . 0.0 112.392 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -67.93 -25.66 65.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -53.57 -50.72 64.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.394 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -78.86 -53.8 6.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.396 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 54.75 93.61 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.381 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.51 -26.9 5.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 34' ' ' ASP . 19.3 p-10 -62.44 141.15 58.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.279 -1.13 . . . . 0.0 109.17 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 33' ' ' GLY . 62.8 m-85 -145.3 137.81 25.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.936 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.33 112.21 24.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 108.993 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 37' ' ' THR . 14.8 p -68.82 87.21 0.35 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.81 -29.73 0.06 OUTLIER Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -107.51 -153.48 0.5 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -1.049 . . . . 0.0 108.846 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.492 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -138.6 140.78 39.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -116.1 147.96 40.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.23 133.57 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.38 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 15' ' ' GLN . 2.0 mt -134.0 145.75 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.944 . . . . 0.0 109.715 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.637 ' CD2' HD23 ' A' ' 58' ' ' LEU . 41.4 mt -122.12 149.35 43.72 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' NZ ' ' CG2' ' A' ' 102' ' ' THR . 11.4 ttpt -137.31 94.17 2.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.938 -1.101 . . . . 0.0 110.901 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.599 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -81.56 106.94 13.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 109.013 178.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -91.36 164.76 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.453 -0.779 . . . . 0.0 109.264 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -116.28 116.44 27.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.522 -0.736 . . . . 0.0 109.428 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.433 HD12 ' HB3' ' A' ' 53' ' ' ASN . 12.0 mt -68.35 -98.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.59 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.416 ' H ' ' HB2' ' A' ' 49' ' ' LEU . 12.0 mtt-85 -84.93 -63.33 1.35 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.091 -1.006 . . . . 0.0 109.748 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -172.83 24.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.403 -0.811 . . . . 0.0 109.167 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.49 -53.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.682 HD22 ' N ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -64.74 152.51 42.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.491 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 54' ' ' LEU . 1.4 pt? -141.71 150.28 41.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.418 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.5 tt0 -132.77 115.97 15.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.224 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CE2' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.41 131.82 35.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -108.37 131.74 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.98 -1.075 . . . . 0.0 108.915 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.637 HD23 ' CD2' ' A' ' 44' ' ' LEU . 10.7 mt -93.5 134.51 35.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.61 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.713 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 43.3 m-70 -146.57 108.79 4.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 109.235 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.727 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.22 127.46 52.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.152 -0.967 . . . . 0.0 109.007 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -95.95 124.21 39.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -0.849 . . . . 0.0 110.114 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.659 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.4 mt -121.99 107.21 11.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.97 13.02 0.05 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.659 ' H ' ' C ' ' A' ' 62' ' ' LEU . 5.2 t-20 64.14 1.73 1.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 109.838 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.09 9.98 30.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 108.934 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.0 t -104.94 138.66 40.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.578 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.8 p -56.74 161.17 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -75.24 -25.95 58.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.42 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.81 -41.43 86.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.522 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -87.2 -34.81 18.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.579 ' OG ' HD13 ' A' ' 62' ' ' LEU . 3.3 t -59.21 -57.98 10.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 0.0 109.376 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.72 -40.65 96.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.01 -47.82 44.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -1.178 . . . . 0.0 109.391 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -49.85 69.81 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.277 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -60.03 -24.22 64.34 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mm -81.33 -57.77 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 109.673 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.46 -38.69 88.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 108.947 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.54 HG22 HD22 ' A' ' 58' ' ' LEU . 19.6 m -68.55 -41.5 79.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.386 -0.821 . . . . 0.0 109.757 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 75' ' ' ALA . 50.7 t -71.97 -55.34 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -52.28 -59.7 4.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.129 -0.982 . . . . 0.0 109.948 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.751 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -52.76 -41.98 64.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.05 -1.031 . . . . 0.0 109.012 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.609 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -47.13 -49.1 22.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.857 -1.152 . . . . 0.0 108.135 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.451 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.2 m-20 -60.39 -31.6 70.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.751 ' HB3' HD13 ' A' ' 81' ' ' LEU . 28.7 t80 -74.48 -23.5 58.88 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 81' ' ' LEU . 1.4 tp -83.69 -54.65 4.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.355 -0.841 . . . . 0.0 109.782 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.495 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 0.6 OUTLIER -122.33 -42.33 2.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.183 -0.948 . . . . 0.0 110.167 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.07 -33.06 3.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.726 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 2.2 mmp_? -127.9 -84.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -1.105 . . . . 0.0 109.236 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 78.82 178.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.759 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.94 150.61 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.865 . . . . 0.0 109.261 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.79 123.91 50.41 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.914 . . . . 0.0 109.863 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.713 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 36.5 m-70 -133.89 121.93 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.338 -0.851 . . . . 0.0 109.22 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -113.14 119.56 38.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 94' ' ' GLU . 57.2 mp0 -109.89 94.32 4.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 96' ' ' GLN . 8.5 t -83.6 37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 95' ' ' VAL . 2.9 tt0 49.81 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.42 -55.88 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -124.33 66.07 1.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -1.108 . . . . 0.0 109.474 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.417 ' OE2' ' CE1' ' A' ' 103' ' ' PHE . 13.7 mt-10 -69.9 -176.94 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.35 -0.844 . . . . 0.0 109.479 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.59 175.84 6.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.86 44.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.459 ' CG2' ' NZ ' ' A' ' 45' ' ' LYS . 22.4 m -63.16 -37.0 85.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CE1' ' OE2' ' A' ' 99' ' ' GLU . 41.8 t80 -68.59 -49.33 60.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.91 -19.11 65.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.179 -0.951 . . . . 0.0 109.442 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.43 8.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.484 ' CD1' HD13 ' A' ' 14' ' ' LEU . 4.3 t80 -78.12 -25.07 47.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.262 -1.14 . . . . 0.0 109.625 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -116.56 68.32 0.73 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.469 ' CB ' ' NZ ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -60.48 -58.7 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.905 . . . . 0.0 109.286 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.421 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 1.4 t -105.32 10.01 33.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.5 ' C ' HD12 ' A' ' 111' ' ' LEU . . . -75.62 55.76 2.95 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.57 91.88 2.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.314 -1.109 . . . . 0.0 109.322 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 35' ' ' PHE . 8.5 ttmt -126.21 110.19 13.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -81.81 107.97 14.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.297 -0.877 . . . . 0.0 109.743 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -124.66 108.93 12.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.392 -0.818 . . . . 0.0 109.176 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 115' ' ' LYS . 33.2 pttt -68.06 120.94 15.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.591 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 160.56 -149.15 18.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.49 -135.61 1.93 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.4 t -123.93 -65.2 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -1.135 . . . . 0.0 109.451 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.31 -29.49 57.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.589 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -86.57 6.12 32.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.309 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -21.34 78.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -75.85 -36.05 59.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -1.166 . . . . 0.0 109.46 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -86.27 -20.13 28.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 62.12 59.24 1.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.06 147.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.32 81.22 37.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.54 125.88 16.58 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 0.0 112.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.87 167.29 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.538 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -55.97 -17.27 6.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.421 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.43 -25.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -46.99 -43.31 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.95 -28.6 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.49 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -148.88 61.97 5.86 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 7' ' ' LYS . 56.9 Cg_endo -74.91 12.46 1.19 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.857 2.371 . . . . 0.0 112.193 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -50.97 -49.57 59.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -62.68 -34.95 78.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.903 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.686 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.4 mm? -80.82 -26.4 37.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.298 -0.876 . . . . 0.0 109.678 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 3' ' ' PRO . 6.1 mmtm -71.64 -31.58 67.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.88 156.59 36.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' ' 56' ' ' TYR . . . 87.86 17.0 58.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -142.09 -23.38 0.69 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -1.189 . . . . 0.0 109.704 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' O ' ' OH ' ' A' ' 56' ' ' TYR . 16.5 mm-40 -93.49 117.11 67.29 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.312 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.24 162.38 31.33 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.23 1.953 . . . . 0.0 112.21 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.29 -120.95 7.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.37 145.35 45.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -1.158 . . . . 0.0 109.988 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.429 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 14.1 mt-30 -136.62 144.63 44.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.835 . . . . 0.0 109.057 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.592 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 18.2 mt -124.52 134.02 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.095 -1.003 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.5 m0 -141.63 115.88 9.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.781 . . . . 0.0 108.995 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 25' ' ' VAL . 39.7 ttp180 -92.2 145.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.847 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.75 143.38 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.567 ' O ' ' N ' ' A' ' 22' ' ' PHE . 58.3 tt0 -129.08 112.29 13.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.0 109.35 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 tttp 62.82 -69.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.567 ' N ' ' O ' ' A' ' 20' ' ' GLU . 75.7 t80 -163.09 20.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.613 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 25' ' ' VAL . 2.8 p-10 -127.07 115.32 18.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -55.24 148.37 14.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.435 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 18' ' ' ARG . 44.4 t -142.48 134.18 13.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.253 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.83 161.82 42.74 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.308 2.005 . . . . 0.0 112.154 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.37 133.79 17.26 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.249 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.16 107.53 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.374 2.049 . . . . 0.0 112.14 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 96.4 m -56.07 -22.81 29.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 5.7 p-10 -82.29 -22.47 35.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.913 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 30' ' ' ASN . 6.6 mp -121.35 13.4 11.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.753 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.723 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.99 -105.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.649 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 56.75 7.65 2.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.603 ' OD2' ' N ' ' A' ' 35' ' ' PHE . 8.3 t0 -150.54 150.14 30.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -1.099 . . . . 0.0 109.426 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.697 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -146.39 161.11 41.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.726 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CE1' ' NH2' ' A' ' 18' ' ' ARG . 5.1 m-85 -90.72 128.34 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -77.23 -30.41 54.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.649 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -78.08 -17.6 78.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -101.11 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -1.157 . . . . 0.0 109.422 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.7 142.72 38.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 2.0 m-85 -118.12 121.7 41.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.561 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.38 135.89 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 108.966 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -129.74 143.42 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.709 HD12 ' CD2' ' A' ' 56' ' ' TYR . 2.0 mm? -115.43 118.58 33.58 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' NZ ' HG22 ' A' ' 102' ' ' THR . 17.1 ttmt -115.67 94.58 4.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.882 -1.136 . . . . 0.0 110.894 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.62 HG23 ' CD1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -80.35 105.12 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -96.82 164.79 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.624 -0.673 . . . . 0.0 109.69 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -108.62 104.38 13.68 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.578 -0.701 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.5 mt -46.13 -87.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.4 mtm105 -139.66 -63.31 0.51 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.259 -0.9 . . . . 0.0 109.605 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -152.81 40.38 0.56 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.379 -0.825 . . . . 0.0 109.477 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.26 -101.66 0.63 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -107.24 -162.11 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -1.08 . . . . 0.0 109.787 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -131.21 -173.33 3.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.101 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LYS . 12.6 tp60 -139.78 116.43 10.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.957 -1.089 . . . . 0.0 110.333 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.709 ' CD2' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -83.57 116.84 22.78 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 2.6 m-20 -89.01 128.36 35.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.623 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 1.7 mm? -99.69 102.9 14.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.843 . . . . 0.0 109.012 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.715 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 17.8 m-70 -111.72 108.69 18.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 110.15 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -108.71 112.32 24.56 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.903 ' C ' HD23 ' A' ' 62' ' ' LEU . 15.9 t90 -105.25 138.64 41.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 110.516 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.903 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -128.14 117.11 21.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -61.65 24.95 0.06 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.687 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.5 t-20 56.09 2.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.336 -1.097 . . . . 0.0 110.029 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 63' ' ' GLY . 78.2 mt-10 -103.09 2.47 34.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 108.902 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 36.1 t -95.38 145.82 24.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 109.512 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 69' ' ' ASP . 93.5 p -83.92 140.2 32.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.887 . . . . 0.0 109.554 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 67' ' ' SER . 17.7 pt20 -44.4 -24.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.4 m-20 -57.32 -57.96 10.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.369 -0.832 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -87.61 -39.68 14.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 108.921 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.72 -59.65 4.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 109.27 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.82 -40.18 48.88 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.58 59.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -1.125 . . . . 0.0 109.194 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.66 -46.16 70.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 0.0 109.005 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.87 -23.43 67.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.046 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -81.07 -53.99 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.862 . . . . 0.0 109.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 16.2 m-85 -67.29 -30.35 70.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.502 ' CG2' HD12 ' A' ' 58' ' ' LEU . 55.2 m -72.87 -41.71 64.43 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.35 -54.99 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.98 -1.075 . . . . 0.0 109.747 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -61.51 -59.59 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.783 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -53.42 -43.14 67.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.068 -1.02 . . . . 0.0 108.901 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' THR . 7.3 t0 -48.7 -48.68 40.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.088 -1.008 . . . . 0.0 108.749 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -59.28 -35.11 73.15 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.527 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 10.0 t80 -74.49 -22.43 59.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.3 tp -82.17 -54.78 4.99 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.599 -0.688 . . . . 0.0 110.368 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 89' ' ' ALA . 5.6 m120 -122.89 -42.7 2.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.735 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.23 -13.69 62.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -156.17 19.8 0.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.68 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -58.3 -172.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.63 150.02 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.19 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -110.9 110.7 21.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.997 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 7.7 m-70 -110.23 120.32 42.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 108.909 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 8.6 ptt180 -114.43 125.96 54.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.288 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.606 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -126.64 120.3 29.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.96 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 96' ' ' GLN . 3.6 t -112.55 37.98 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.36 -0.838 . . . . 0.0 109.841 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' O ' ' A' ' 95' ' ' VAL . 11.3 tt0 58.82 124.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.506 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.46 -36.87 4.1 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -132.21 51.97 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -1.104 . . . . 0.0 109.596 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -58.58 179.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.6 m -103.54 156.0 18.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.72 83.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.509 HG22 ' NZ ' ' A' ' 45' ' ' LYS . 1.3 m -65.42 -48.22 73.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.13 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 107' ' ' PHE . 30.1 t80 -58.33 -44.16 88.57 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.314 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.73 -30.74 71.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.85 -47.1 91.64 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -49.54 65.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -1.185 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.427 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 45.6 m-85 -98.13 65.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.594 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -87.52 -34.41 18.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.392 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -96.6 2.46 52.28 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -86.36 -104.44 0.77 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.7 mm? 54.57 101.69 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.328 -1.101 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 11.9 tttt -168.15 91.79 0.32 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.86 108.02 15.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.402 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -96.47 113.01 24.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.28 139.35 55.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 117' ' ' GLY . . . -151.62 -50.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 116' ' ' GLY . . . 42.97 31.28 1.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.4 t -49.63 -26.5 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 109.399 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.09 68.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -84.19 6.15 23.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.302 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -51.53 -24.8 12.37 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.51 -26.64 55.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.202 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -70.99 -51.5 25.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.426 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.597 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 0.5 OUTLIER -72.23 43.89 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.425 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.86 132.95 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.187 -0.945 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -99.12 110.99 59.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.369 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 128' ' ' ASN . 77.8 Cg_exo -46.38 150.83 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.419 2.079 . . . . 0.0 112.21 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -43.14 153.4 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 131' ' ' VAL . 25.0 tt0 -56.5 -17.11 7.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.2 t -46.91 -17.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 129' ' ' GLU . 10.8 p -57.0 -34.0 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.96 -28.15 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.427 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.489 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 2' ' ' HIS . 16.7 tt0 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.492 ' ND1' ' N ' ' A' ' 2' ' ' HIS . 1.0 OUTLIER -43.49 154.92 0.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.41 138.98 36.95 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.593 2.195 . . . . 0.0 112.281 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 4' ' ' GLU . 2.6 pt-20 -66.51 -25.22 66.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CD2' ' CD2' ' A' ' 24' ' ' LEU . 41.5 t80 -56.38 -24.83 47.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.1 tt -60.78 -31.17 70.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.232 -0.918 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 8' ' ' ALA . 81.9 mttt -104.65 -46.92 4.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.603 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.36 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -0.916 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.642 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 55.21 29.47 52.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.1 ptpt -42.3 -25.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 109.595 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 9' ' ' GLY . 6.0 mt-10 -147.86 148.96 31.85 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.5 134.67 6.9 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.725 2.283 . . . . 0.0 112.156 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -158.05 24.69 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.48 143.1 50.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -1.059 . . . . 0.0 109.4 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.642 HE21 ' H ' ' A' ' 9' ' ' GLY . 21.0 mt-30 -130.34 146.29 51.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 41.0 mt -116.07 137.7 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.852 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.603 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 6.2 m0 -142.44 111.71 6.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.16 145.23 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 109.645 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -84.83 143.58 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 17.5 tt0 -158.13 81.08 0.84 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.516 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.8 tttp 72.22 33.27 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER 66.57 17.0 10.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.5 t70 -95.74 -27.12 15.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' CD2' ' CD2' ' A' ' 5' ' ' PHE . 0.7 OUTLIER 62.9 134.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.383 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -149.63 134.11 9.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.087 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 27' ' ' VAL . 37.8 Cg_endo -69.99 110.14 2.53 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.282 1.988 . . . . 0.0 112.209 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' PRO . 9.8 p -40.8 135.59 1.59 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.081 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.66 127.74 24.64 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.271 1.98 . . . . 0.0 112.349 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 30' ' ' ASN . 17.6 m -63.21 -32.51 73.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.378 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 29' ' ' THR . 42.6 t30 -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 109.178 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.6 mp -99.19 -55.2 2.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 31' ' ' LEU . 2.7 t80 47.46 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.463 -0.773 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.579 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.82 -13.3 8.14 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.24 143.91 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -1.184 . . . . 0.0 109.185 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 18.2 m-85 -141.34 142.76 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.986 . . . . 0.0 109.864 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 114' ' ' LYS . 4.8 m-85 -86.8 106.81 17.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 0.0 108.941 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.557 ' C ' ' H ' ' A' ' 39' ' ' ASP . 23.8 p -51.93 -52.5 49.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.869 . . . . 0.0 110.035 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . -61.56 7.86 0.14 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 37' ' ' THR . 0.5 OUTLIER -133.81 172.51 12.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -1.182 . . . . 0.0 109.476 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.98 151.81 30.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.908 . . . . 0.0 109.546 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -131.06 121.86 25.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.616 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.47 HG11 ' OG1' ' A' ' 78' ' ' THR . 21.4 t -97.71 118.93 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.081 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -117.08 143.2 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -0.901 . . . . 0.0 109.553 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -124.96 129.46 50.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.77 -0.581 . . . . 0.0 109.836 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.12 93.61 4.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 109.648 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.421 ' CG2' HD22 ' A' ' 54' ' ' LEU . 2.4 m -72.78 103.06 3.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.513 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -102.63 164.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -125.43 129.93 50.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.559 -0.713 . . . . 0.0 109.28 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.4 mt -66.62 -98.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.472 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.0 mtp85 -134.75 -49.51 0.76 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -157.38 31.92 0.28 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.366 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' O ' ' ND2' ' A' ' 53' ' ' ASN . . . -116.33 -88.03 1.39 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 52' ' ' GLY . 3.7 m120 -143.32 -162.31 1.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -1.166 . . . . 0.0 109.433 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -132.45 163.81 27.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.322 -0.861 . . . . 0.0 109.439 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -135.45 141.27 45.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.573 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -99.71 119.36 37.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 0.0 109.208 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 6.6 m-20 -73.38 120.23 18.71 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.768 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.0 tm? -93.7 115.44 27.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.499 -0.751 . . . . 0.0 110.08 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.592 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -132.88 121.5 22.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.379 -0.826 . . . . 0.0 109.811 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 93' ' ' ARG . 0.3 OUTLIER -99.19 129.65 45.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.045 -1.034 . . . . 0.0 108.792 178.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.887 ' C ' HD23 ' A' ' 62' ' ' LEU . 18.3 t90 -108.85 126.65 53.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.831 . . . . 0.0 110.156 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.887 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -133.76 116.3 15.57 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 65' ' ' GLU . . . -68.24 34.25 0.25 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.579 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.0 t-20 49.73 10.9 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -1.025 . . . . 0.0 110.08 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 63' ' ' GLY . 59.5 mt-10 -110.41 4.59 20.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.044 -1.035 . . . . 0.0 108.934 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.68 144.03 28.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.593 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 69' ' ' ASP . 2.0 p -67.41 125.5 26.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -50.69 -9.18 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 67' ' ' SER . 17.9 t0 -75.5 -44.12 45.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.88 . . . . 0.0 109.494 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -87.25 -45.72 10.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.256 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.602 ' OG ' HD13 ' A' ' 62' ' ' LEU . 6.9 t -51.71 -50.34 60.71 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.291 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.92 -52.09 51.14 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.45 -39.15 6.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.84 -39.87 83.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.99 . . . . 0.0 109.213 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -67.49 -31.0 70.83 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.284 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.79 -48.55 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 0.0 110.181 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.33 -33.67 76.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.971 -1.081 . . . . 0.0 109.296 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -81.35 -47.14 13.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 75' ' ' ALA . 61.6 t -61.47 -45.66 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.903 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.22 -57.82 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.513 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 81' ' ' LEU . 2.2 tm? -52.33 -49.72 63.7 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.009 -1.057 . . . . 0.0 108.835 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 78' ' ' THR . 20.2 m-20 -46.56 -49.48 18.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.077 -1.014 . . . . 0.0 108.41 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 87' ' ' GLY . 7.6 m-20 -54.61 -31.95 57.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 81' ' ' LEU . 9.7 t80 -65.39 -28.81 69.53 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 81' ' ' LEU . 16.4 mt -83.92 -58.11 2.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 88' ' ' ARG . 9.2 t-20 -121.76 13.46 10.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.135 -0.978 . . . . 0.0 110.666 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 51.32 5.96 0.14 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 86' ' ' ASN . 34.1 mtp180 -147.19 -83.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.369 -1.077 . . . . 0.0 109.434 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 60.09 141.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 90' ' ' VAL . 2.8 t -73.94 139.61 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -102.59 138.14 39.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 58' ' ' LEU . 20.5 m-70 -140.09 135.71 32.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 7.8 ptp85 -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 22.5 mt-10 -129.26 81.04 2.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.313 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 95' ' ' VAL . 14.5 t -78.95 38.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.875 . . . . 0.0 109.575 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 63.19 72.39 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.605 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.425 ' O ' ' OE1' ' A' ' 99' ' ' GLU . . . 150.96 -60.86 0.41 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -88.32 57.94 4.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -1.135 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 18.9 mp0 -77.23 -165.14 0.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 94.2 p -133.98 159.9 39.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.19 78.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.615 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.1 m -61.34 -60.29 3.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 44.0 t80 -52.53 -38.0 58.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.359 -0.838 . . . . 0.0 109.54 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.06 -31.62 66.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.06 95.42 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.69 -52.38 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -1.196 . . . . 0.0 109.568 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.45 80.61 1.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -96.57 -37.74 10.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.583 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -102.43 9.93 39.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -89.98 -107.99 1.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.657 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.5 mm? 51.23 100.36 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.291 -1.123 . . . . 0.0 109.361 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -148.71 114.3 5.64 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.3 OUTLIER -81.93 111.55 18.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.76 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 1.8 mmpt? -105.49 113.14 26.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.315 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -53.9 125.56 19.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.419 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -101.03 -124.29 5.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.74 27.89 64.09 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.14 -19.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -1.175 . . . . 0.0 109.553 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.17 -24.43 66.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 t -104.3 6.01 35.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.99 -24.44 64.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.525 ' C ' ' H ' ' A' ' 124' ' ' HIS . 32.6 m-85 -57.35 -20.29 28.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -1.128 . . . . 0.0 109.419 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 124' ' ' HIS . 18.1 mtpp -62.13 4.19 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.525 ' H ' ' C ' ' A' ' 122' ' ' PHE . 1.6 t-80 77.36 111.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.454 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -135.02 125.9 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.975 . . . . 0.0 109.404 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -125.83 81.61 65.42 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.564 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.7 165.5 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.818 2.345 . . . . 0.0 112.273 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.426 ' OD1' ' CD ' ' A' ' 129' ' ' GLU . 12.3 t-20 -74.43 -173.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.653 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -77.17 -28.82 54.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.389 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.14 -31.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.631 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.81 -54.18 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.602 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.48 -28.52 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.511 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 48.93 63.53 10.25 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.487 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.2 24.29 0.31 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.821 2.347 . . . . 0.0 112.102 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -71.64 -41.08 69.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.454 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.408 ' CD2' ' C ' ' A' ' 5' ' ' PHE . 33.7 p90 -66.33 -27.55 67.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -68.67 -34.51 75.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.45 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -96.48 -59.79 1.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.569 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.639 ' HB3' HD21 ' A' ' 85' ' ' LEU . . . 59.38 136.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.78 . . . . 0.0 109.407 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.63 ' CA ' ' NE2' ' A' ' 15' ' ' GLN . . . 45.5 46.02 12.01 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' GLY . 25.9 mtmt -43.22 -33.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -1.11 . . . . 0.0 109.384 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.541 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -140.71 169.29 11.99 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.847 . . . . 0.0 109.392 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -46.07 134.17 14.82 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.755 2.303 . . . . 0.0 112.328 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.95 -168.48 26.47 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 tt -123.63 144.03 49.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -1.091 . . . . 0.0 109.393 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.63 ' NE2' ' CA ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -131.05 149.41 52.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 109.448 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.1 mp -124.56 133.0 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.7 m0 -142.08 126.64 17.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.284 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.88 143.89 26.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.089 -1.007 . . . . 0.0 109.363 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.11 143.64 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.784 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 53.5 tt0 -138.28 95.75 3.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 78.78 -62.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 109.009 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 12.1 m-85 -171.72 22.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.667 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.67 111.76 14.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.757 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp -74.03 132.78 42.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.16 112.33 11.14 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.252 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -45.56 135.04 12.85 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.424 2.083 . . . . 0.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 27' ' ' VAL . 1.2 p -78.64 127.54 80.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.12 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.26 122.61 1.26 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.441 2.094 . . . . 0.0 112.442 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 30' ' ' ASN . 7.3 m -64.04 -27.99 69.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.524 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -45.72 -43.3 12.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.079 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.691 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.2 mp -90.38 -53.63 4.36 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.302 -0.874 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.8 t80 51.62 92.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.542 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.53 -31.31 4.65 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.598 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 45.9 t0 -68.81 134.53 49.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.09 -1.241 . . . . 0.0 109.491 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 25.8 m-85 -142.36 139.89 31.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.623 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -77.74 104.27 8.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -0.868 . . . . 0.0 109.35 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.3 p -45.73 -27.38 0.81 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.382 -0.824 . . . . 0.0 109.775 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.86 -32.07 41.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.486 ' OD2' ' OE2' ' A' ' 70' ' ' GLU . 35.6 t0 -92.12 172.73 8.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.091 -1.24 . . . . 0.0 109.476 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.93 140.73 46.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.375 -0.828 . . . . 0.0 109.374 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CE1' ' A' ' 36' ' ' PHE . 46.0 m-85 -121.03 135.23 55.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.697 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.631 HG21 ' OG1' ' A' ' 78' ' ' THR . 33.7 t -111.16 144.21 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.399 -0.813 . . . . 0.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.54 146.19 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -126.51 121.37 32.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.51 94.17 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.935 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.538 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 8.6 m -77.46 103.37 7.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.384 -0.822 . . . . 0.0 109.551 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -91.5 164.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.243 -0.91 . . . . 0.0 109.316 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -111.46 103.29 11.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt -48.35 -57.37 6.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.443 ' O ' ' CG ' ' A' ' 51' ' ' ASN . 23.8 mtp180 -140.22 -63.35 0.49 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.348 -0.845 . . . . 0.0 109.54 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.443 ' CG ' ' O ' ' A' ' 50' ' ' ARG . 9.7 m120 -168.0 23.35 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.229 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 54' ' ' LEU . . . -156.89 -58.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -82.52 138.59 34.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -1.175 . . . . 0.0 109.719 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -130.75 176.97 7.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.322 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' HG23 ' A' ' 47' ' ' VAL . 6.5 tp60 -147.98 126.0 12.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.538 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 12.0 m-85 -90.97 130.98 36.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 109.044 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.26 124.76 37.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 108.781 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.54 HD11 ' CG ' ' A' ' 82' ' ' ASP . 9.3 mt -88.76 110.93 21.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.776 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.701 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 19.5 m-70 -124.26 108.7 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 0.0 109.324 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.712 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -103.25 121.3 42.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.165 -0.959 . . . . 0.0 108.668 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.827 ' C ' HD23 ' A' ' 62' ' ' LEU . 3.7 t90 -92.39 125.42 37.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.827 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -128.08 105.56 8.47 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.55 17.35 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.622 ' H ' ' C ' ' A' ' 62' ' ' LEU . 40.1 t30 65.95 1.74 1.98 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -1.078 . . . . 0.0 109.82 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -105.11 7.6 33.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.03 . . . . 0.0 109.101 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 15.5 t -101.82 131.02 48.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.602 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 m -52.3 153.76 2.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -73.25 -9.09 58.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.574 ' OD2' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -80.87 -38.2 28.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.588 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.574 ' N ' ' OD2' ' A' ' 69' ' ' ASP . 64.0 tt0 -87.34 -45.74 10.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.202 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.452 ' OG ' HD13 ' A' ' 62' ' ' LEU . 12.8 t -53.95 -50.34 66.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.498 -0.751 . . . . 0.0 109.266 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.41 -46.42 93.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.89 -45.5 30.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.68 72.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.208 -0.933 . . . . 0.0 109.058 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.36 -20.28 64.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.385 -0.822 . . . . 0.0 109.023 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.3 -56.1 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.36 -0.837 . . . . 0.0 109.463 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -67.85 -25.8 65.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 108.866 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.631 ' OG1' HG21 ' A' ' 42' ' ' VAL . 45.4 m -78.18 -42.55 31.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 0.0 109.438 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 75' ' ' ALA . 71.8 t -76.09 -41.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.707 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -69.06 -59.35 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 81' ' ' LEU . 2.1 tm? -53.51 -51.89 61.35 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.033 -1.042 . . . . 0.0 108.615 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.54 ' CG ' HD11 ' A' ' 58' ' ' LEU . 4.5 t70 -45.49 -46.39 13.73 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.39 -33.44 59.24 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' LEU . 28.5 t80 -66.3 -28.58 68.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.639 HD21 ' HB3' ' A' ' 8' ' ' ALA . 2.7 mp -76.1 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.175 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -121.75 -42.39 2.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.173 -0.954 . . . . 0.0 110.255 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.77 -20.15 8.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.647 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 34.0 mtt85 -128.25 -85.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.402 -1.058 . . . . 0.0 109.363 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 72.57 162.64 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.613 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.18 150.21 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.567 ' NE2' ' N ' ' A' ' 91' ' ' GLN . 2.5 mp0 -109.77 132.7 53.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.701 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 33.1 m-70 -139.34 111.86 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -103.29 124.56 48.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.603 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 3.9 mt-10 -117.46 86.48 2.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -0.84 . . . . 0.0 109.366 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.59 37.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.555 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 56.25 91.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.383 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 137.11 -54.55 0.71 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -100.37 56.0 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -1.126 . . . . 0.0 109.203 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 5.3 mp0 -83.95 158.26 21.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.9 . . . . 0.0 109.58 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.5 165.23 12.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.313 -0.867 . . . . 0.0 109.287 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.47 -30.22 66.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 m -61.92 -60.22 3.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.149 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.603 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 36.0 t80 -54.11 -46.61 72.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.479 -0.763 . . . . 0.0 109.35 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 104' ' ' LEU . 35.0 mt -67.88 -28.24 67.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 0.0 109.282 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.83 -42.93 99.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -69.42 -47.41 64.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -1.066 . . . . 0.0 109.305 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -105.21 52.78 0.73 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -81.48 -30.08 33.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 m -57.89 -8.11 0.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.897 . . . . 0.0 109.742 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.6 111.6 3.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.676 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -75.89 -106.89 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.312 -1.111 . . . . 0.0 109.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 171.46 112.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.0 107.89 17.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -112.66 143.2 44.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.8 pttp -70.33 137.07 50.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.423 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -86.07 178.68 49.6 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 140.35 56.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -92.04 -24.12 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -1.107 . . . . 0.0 109.474 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.86 -23.16 36.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.151 -0.968 . . . . 0.0 109.524 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.9 m -74.23 6.33 3.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 123' ' ' LYS . . . -71.67 -41.73 56.16 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 124' ' ' HIS . 1.2 p90 -46.11 -23.31 0.3 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.534 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 122' ' ' PHE . 35.3 ttpt -35.36 -30.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 109.806 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 122' ' ' PHE . 8.8 m80 -64.89 127.23 30.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.299 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 t -67.98 138.09 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 109.462 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.2 t -128.03 78.32 75.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.377 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.92 127.95 18.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 112.292 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -58.1 127.59 32.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.6 -19.23 57.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.38 -25.32 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.945 . . . . 0.0 109.456 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -47.86 -54.13 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -51.8 -29.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.475 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.7 pm0 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -81.92 149.76 63.96 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.375 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.14 84.87 1.28 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.622 2.214 . . . . 0.0 112.344 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -50.89 -24.75 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.157 -0.964 . . . . 0.0 109.272 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -45.43 -41.01 8.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.417 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 6' ' ' LEU . 35.9 tp -95.03 -32.23 13.24 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.346 -0.846 . . . . 0.0 109.422 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttp -103.24 33.74 3.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.832 . . . . 0.0 109.391 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.611 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -40.26 143.57 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.408 -0.807 . . . . 0.0 109.619 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.667 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 52.43 56.98 14.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.77 -27.34 11.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.35 157.4 45.42 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.378 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.95 123.31 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.782 2.321 . . . . 0.0 112.272 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.7 -172.24 33.75 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.41 143.08 45.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.398 -1.06 . . . . 0.0 109.524 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.667 HE21 ' H ' ' A' ' 9' ' ' GLY . 13.9 mt-30 -133.89 145.01 49.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.898 . . . . 0.0 109.48 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.603 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 16.2 mt -118.3 139.46 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.611 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 6.7 m0 -143.37 110.91 5.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -77.9 139.6 39.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.656 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -84.6 143.08 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.267 -0.896 . . . . 0.0 109.202 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 22' ' ' PHE . 24.4 tt0 -158.51 122.2 3.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.54 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 19.1 mmtt 40.59 22.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.829 . . . . 0.0 109.51 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' GLU . 2.1 m-85 71.1 44.56 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' O ' ' O ' ' A' ' 24' ' ' LEU . 1.2 m-20 -127.09 -13.92 5.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.491 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.7 mp 58.81 131.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.2 t -150.91 111.29 3.1 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.06 123.98 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.51 2.14 . . . . 0.0 112.272 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 27' ' ' VAL . 15.0 p -56.36 133.54 76.23 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.905 . . . . 0.0 109.31 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.49 106.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.468 2.112 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -58.32 -25.46 61.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -51.74 -47.28 64.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.37 -54.74 4.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.3 t80 53.58 93.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.232 -0.918 . . . . 0.0 109.318 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.44 -4.91 9.4 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 24.6 t0 -108.23 131.72 54.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.382 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -146.08 167.52 23.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 0.0 109.662 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -99.31 122.27 42.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.232 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.7 p -59.64 -27.32 66.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.35 -0.844 . . . . 0.0 109.809 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 26.49 5.92 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.9 t70 -142.69 -166.99 2.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.308 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -141.04 140.95 34.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 0.0 109.639 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 23.8 m-85 -123.57 129.45 51.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -100.93 137.55 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.4 mt -132.89 146.39 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.3 mp -128.84 131.14 47.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.544 -0.723 . . . . 0.0 109.569 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -113.72 93.68 4.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.682 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.585 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 5.9 m -78.17 105.66 9.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.658 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -100.6 164.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.301 -0.874 . . . . 0.0 109.132 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -121.13 140.78 51.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.741 . . . . 0.0 109.538 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.0 mt -80.19 -95.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -140.16 -34.05 0.55 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.235 -0.915 . . . . 0.0 109.524 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.493 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 29.0 t-20 -175.11 33.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.309 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.43 -89.5 1.12 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -136.45 -155.15 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -1.103 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.833 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -134.16 171.73 13.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 109.378 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 47' ' ' VAL . 6.1 tt0 -134.89 123.39 23.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.273 -0.892 . . . . 0.0 109.814 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.941 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 6.2 m-85 -95.36 126.01 40.37 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.594 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 2.6 m-20 -97.41 119.52 36.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.927 -1.108 . . . . 0.0 108.962 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.481 HD11 ' CG ' ' A' ' 82' ' ' ASP . 2.7 mt -83.1 141.35 32.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.387 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 11.8 m-70 -145.91 108.72 4.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.21 114.69 28.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 108.624 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.677 ' C ' HD23 ' A' ' 62' ' ' LEU . 77.3 t90 -90.51 125.55 35.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.913 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.677 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -129.13 114.35 16.23 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.449 ' O ' ' NE2' ' A' ' 96' ' ' GLN . . . -67.22 11.44 0.73 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.71 HD22 HG12 ' A' ' 95' ' ' VAL . 6.1 t-20 67.33 1.72 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.527 -0.984 . . . . 0.0 109.77 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -112.3 9.97 19.96 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.56 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 9.6 p -98.45 126.7 44.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.47 -0.769 . . . . 0.0 109.508 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -46.65 123.47 5.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.128 -0.982 . . . . 0.0 109.527 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.455 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 8.3 pm0 -48.19 -25.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.511 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -53.94 -43.34 69.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -87.41 -31.52 20.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.152 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.524 ' OG ' HD13 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -62.18 -59.74 4.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.377 -0.827 . . . . 0.0 109.499 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -54.78 -52.3 47.01 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.66 -41.07 9.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.165 . . . . 0.0 109.381 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.66 92.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.164 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -66.81 -38.51 86.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.209 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.58 -45.63 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 109.637 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -68.28 -35.68 78.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.5 m -75.64 -41.9 52.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 75' ' ' ALA . 80.7 t -74.18 -43.87 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.166 -0.959 . . . . 0.0 109.943 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -67.91 -59.35 3.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 110.064 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.8 tm? -53.92 -51.88 62.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.911 -1.118 . . . . 0.0 108.881 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.481 ' CG ' HD11 ' A' ' 58' ' ' LEU . 4.7 t70 -45.98 -45.81 15.96 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.013 -1.054 . . . . 0.0 108.567 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -58.64 -30.85 67.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 27.0 t80 -69.31 -23.15 63.76 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.436 HD21 HD11 ' A' ' 81' ' ' LEU . 46.2 mt -83.58 -61.28 1.88 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.422 -0.799 . . . . 0.0 110.948 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.513 ' ND2' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -123.04 -43.41 2.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.976 -1.078 . . . . 0.0 111.361 -178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.87 -3.37 58.74 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.57 62.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -1.191 . . . . 0.0 109.47 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.941 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -102.63 168.37 9.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.288 -0.882 . . . . 0.0 109.608 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.51 150.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -115.5 136.13 53.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.057 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.474 ' CB ' ' HD1' ' A' ' 59' ' ' HIS . 31.5 m-70 -136.45 124.22 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -114.09 121.54 44.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.32 -0.862 . . . . 0.0 109.798 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 0.8 OUTLIER -114.25 93.44 4.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.278 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.71 HG12 HD22 ' A' ' 64' ' ' ASN . 1.8 t -87.5 37.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.615 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.449 ' NE2' ' O ' ' A' ' 63' ' ' GLY . 4.0 tt0 61.53 110.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.42 -38.55 3.28 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -111.06 50.29 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.181 . . . . 0.0 109.534 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -69.87 155.91 39.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.61 153.8 21.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.57 70.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 m -65.71 -62.93 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 3.5 t80 -51.85 -30.74 24.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.43 -0.794 . . . . 0.0 109.353 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 105' ' ' GLY . 7.8 mt -73.13 -57.39 4.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 104' ' ' LEU . . . -45.19 -34.92 4.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -75.62 -59.71 2.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.492 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.482 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 19.6 m-85 -96.35 57.48 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.594 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -84.89 -33.39 22.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.2 t -96.06 -11.59 26.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -79.49 -104.11 0.24 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 110' ' ' GLY . 81.6 mt 48.5 98.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.21 -1.17 . . . . 0.0 109.329 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -152.93 116.23 4.66 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -91.87 107.82 19.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -112.27 108.74 18.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.0 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -54.14 120.27 6.24 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.411 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.91 -37.47 6.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 112.82 21.92 5.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.69 -16.69 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.205 -1.173 . . . . 0.0 109.43 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -55.32 -21.87 16.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.7 m -66.0 6.06 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.434 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -52.09 -19.98 6.11 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -59.72 -23.78 63.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -1.175 . . . . 0.0 109.432 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -52.64 -33.88 48.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.421 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -94.18 104.75 16.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.305 -0.872 . . . . 0.0 109.506 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.0 t -80.09 130.37 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.324 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.94 87.72 6.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.579 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 129' ' ' GLU . 53.0 Cg_exo -51.46 130.15 32.0 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.698 2.265 . . . . 0.0 112.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 1.3 p-10 -60.49 86.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.155 -0.965 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 127' ' ' PRO . 29.9 mt-10 -87.97 -17.83 30.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.873 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.4 t -50.55 -47.94 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.504 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.524 HG13 ' N ' ' A' ' 132' ' ' VAL . 7.1 p -68.7 -42.65 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.524 ' N ' HG13 ' A' ' 131' ' ' VAL . 98.9 t -67.1 -28.13 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.497 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.468 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.494 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -167.22 73.06 1.02 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.181 -0.949 . . . . 0.0 109.507 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.62 135.79 41.37 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.841 2.361 . . . . 0.0 112.175 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.06 -28.63 69.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -62.32 -30.58 71.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.51 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -48.72 -35.22 13.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 0.0 109.348 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.604 ' O ' HD22 ' A' ' 85' ' ' LEU . 33.8 mmtt -108.51 -28.74 9.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 109.717 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.599 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 51.97 62.84 2.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.681 ' N ' ' NE2' ' A' ' 15' ' ' GLN . . . 106.74 38.46 2.2 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 9' ' ' GLY . 6.9 pttp -41.66 -23.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -1.128 . . . . 0.0 109.625 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -138.93 157.7 71.12 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.371 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -39.82 136.5 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.799 2.333 . . . . 0.0 112.184 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.14 179.37 24.05 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 4.3 tt -115.45 148.33 39.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.479 -1.012 . . . . 0.0 109.735 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.681 ' NE2' ' N ' ' A' ' 9' ' ' GLY . 31.2 mt-30 -145.03 154.68 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 0.0 109.682 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.619 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -126.93 152.26 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.769 -0.582 . . . . 0.0 110.06 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.4 m-90 -155.08 110.91 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.425 -0.797 . . . . 0.0 109.233 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.469 HH11 ' CD ' ' A' ' 28' ' ' PRO . 3.1 ttp180 -75.49 127.64 33.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 109.345 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -69.8 144.17 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.182 -0.949 . . . . 0.0 110.159 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 22' ' ' PHE . 13.8 tp10 -155.83 121.44 4.94 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.547 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 43.6 tttt 44.07 23.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 109.399 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 70.19 41.46 1.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 24' ' ' LEU . 11.6 t70 -127.14 -13.14 5.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.634 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' ASP . 13.0 mt 56.43 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.6 t -138.02 125.04 13.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.219 -0.925 . . . . 0.0 109.183 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.44 140.93 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.477 2.118 . . . . 0.0 112.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 27' ' ' VAL . 14.2 p -79.3 134.27 59.13 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -0.847 . . . . 0.0 109.347 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.529 ' CB ' ' OD1' ' A' ' 30' ' ' ASN . 77.7 Cg_exo -40.2 103.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.477 2.118 . . . . 0.0 112.18 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -49.27 -37.93 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 1.2 p30 -45.52 -39.72 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 6.2 mp -86.15 -55.58 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 31' ' ' LEU . 44.2 t80 45.19 90.73 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.285 -0.884 . . . . 0.0 109.508 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.593 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.7 -31.3 4.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 1.1 m-20 -85.97 137.5 32.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.085 -1.244 . . . . 0.0 109.249 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 22.9 m-85 -146.07 153.72 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.889 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -76.91 128.21 34.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 108.901 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 p -74.22 -26.46 60.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 110.021 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.01 -22.9 62.57 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.1 t70 -94.94 -160.59 0.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.685 ' HB3' HG11 ' A' ' 19' ' ' VAL . . . -136.26 141.0 43.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.377 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -125.21 125.59 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.448 HG11 ' OG1' ' A' ' 78' ' ' THR . 16.9 t -93.87 127.83 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.476 HG23 HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -138.28 145.08 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 109.163 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -144.55 167.06 23.41 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.048 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 1.7 tmmm? -146.28 94.31 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.458 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 63.7 m -72.16 126.88 30.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.374 -0.829 . . . . 0.0 109.833 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.44 164.79 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.636 -0.665 . . . . 0.0 109.515 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.461 ' O ' ' C ' ' A' ' 49' ' ' LEU . 9.5 tt0 -126.26 102.01 6.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.6 -0.687 . . . . 0.0 109.203 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 48' ' ' GLN . 80.0 mt -40.09 -82.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -0.955 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 -139.72 -54.48 0.55 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.394 -0.816 . . . . 0.0 109.426 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.81 24.1 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.2 -78.58 1.05 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 18.2 p-10 -137.86 158.0 45.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -1.194 . . . . 0.0 109.597 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -110.9 167.15 10.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.354 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.6 tt0 -127.21 117.39 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -0.949 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.531 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 5.2 m-85 -71.75 108.73 5.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 87.1 m-20 -72.56 118.05 15.0 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.924 -1.11 . . . . 0.0 108.152 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 1.7 mm? -102.81 119.21 38.43 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.071 -1.018 . . . . 0.0 109.747 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.473 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -144.29 116.91 8.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 109.657 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.734 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.45 140.33 33.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 108.819 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.777 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.2 t90 -100.65 127.02 47.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 110.15 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.777 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -127.69 108.67 10.95 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.537 ' O ' ' NE2' ' A' ' 96' ' ' GLN . . . -63.09 12.58 0.11 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.618 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.2 t-20 66.53 1.87 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -1.13 . . . . 0.0 109.845 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -104.97 5.32 32.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.067 -1.021 . . . . 0.0 108.973 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 67' ' ' SER . 34.5 t -101.15 116.8 33.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.424 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 66' ' ' CYS . 12.7 p -42.23 125.32 3.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.554 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 1.6 mp0 -45.01 -28.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -57.62 -42.11 82.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.596 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -87.5 -38.89 15.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.486 ' OG ' HD13 ' A' ' 62' ' ' LEU . 1.9 t -59.53 -57.59 12.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.13 -40.53 36.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.95 -52.65 62.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -1.145 . . . . 0.0 109.294 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.93 -38.98 65.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.181 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -72.59 -20.3 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -81.0 -46.89 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -66.38 -36.08 81.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.51 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.24 -41.46 61.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.366 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 75' ' ' ALA . 24.5 t -61.37 -52.12 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.731 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.91 -59.61 5.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 0.0 109.783 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.764 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -53.14 -44.37 67.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.022 -1.049 . . . . 0.0 108.738 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 81' ' ' LEU . 10.9 t0 -46.72 -48.25 20.38 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.923 -1.11 . . . . 0.0 108.114 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.77 -27.91 69.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.764 ' HB3' HD13 ' A' ' 81' ' ' LEU . 37.9 t80 -75.91 -24.09 55.57 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 7' ' ' LYS . 39.6 mt -81.03 -53.88 6.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.895 . . . . 0.0 109.574 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -121.84 -42.32 2.41 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.4 -0.812 . . . . 0.0 109.891 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.33 -22.42 7.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.4 mtp180 -142.39 -85.39 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.386 -1.067 . . . . 0.0 109.278 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 58.68 161.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.561 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 82.4 t -98.39 135.31 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.093 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.507 ' OE1' ' OH ' ' A' ' 60' ' ' TYR . 1.1 pp0? -121.98 133.28 54.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.301 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.634 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -135.59 159.83 40.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.749 . . . . 0.0 109.308 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -121.75 136.54 54.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 96' ' ' GLN . 23.7 mt-10 -108.43 87.54 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.528 -0.733 . . . . 0.0 109.145 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.2 t -74.48 37.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.867 . . . . 0.0 109.885 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 63' ' ' GLY . 2.8 tt0 54.73 106.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.78 -54.87 0.69 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 99' ' ' GLU . 13.8 m-85 -115.19 36.53 3.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -1.104 . . . . 0.0 109.254 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 98' ' ' PHE . 13.1 mt-10 -44.28 169.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 t -95.98 165.81 12.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.96 67.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.4 m -66.76 -49.96 64.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' ' CD1' ' A' ' 61' ' ' TRP . 67.8 t80 -64.0 -46.45 84.5 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 108' ' ' LYS . 26.7 mt -68.77 -32.67 72.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.65 -55.13 32.52 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.76 -47.01 87.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -1.115 . . . . 0.0 109.327 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -109.45 48.89 0.85 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' LEU . 42.6 tttm -68.97 -23.61 64.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 t -76.21 3.69 10.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.18 -0.95 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.71 110.58 2.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.728 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.1 -101.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -1.116 . . . . 0.0 109.188 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 172.07 107.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.107 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.69 107.94 17.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.478 -0.764 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.8 tttm -105.18 122.59 46.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -60.39 166.18 3.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.1 124.7 1.35 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -102.24 24.12 32.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.8 t -51.77 -28.5 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -1.218 . . . . 0.0 109.442 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.2 -24.6 54.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.195 -0.941 . . . . 0.0 109.433 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.2 t -84.24 6.07 24.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 124' ' ' HIS . . . -75.95 -50.85 7.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -54.24 -30.31 49.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -1.189 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -78.93 1.43 23.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.892 . . . . 0.0 109.615 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 121' ' ' GLY . 2.4 t-160 -146.03 129.15 16.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.945 . . . . 0.0 109.393 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.67 146.9 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.482 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.35 86.18 21.34 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 109.343 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.04 126.01 14.37 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.767 2.311 . . . . 0.0 112.224 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -79.41 -172.57 3.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.33 -29.04 21.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.98 -27.38 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.0 t -67.08 -40.24 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.942 . . . . 0.0 109.416 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.58 -27.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.414 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.335 0.588 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -146.3 67.05 11.64 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.15 109.77 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.813 2.342 . . . . 0.0 112.242 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.12 -15.25 51.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 109.427 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.481 ' C ' HD22 ' A' ' 6' ' ' LEU . 8.2 m-85 -54.66 -35.4 63.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.408 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.622 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.8 mm? -95.46 -12.14 26.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.276 -0.89 . . . . 0.0 109.527 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 8' ' ' ALA . 33.4 tttm -82.56 -19.53 38.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.53 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -43.62 130.44 5.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.075 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.476 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 41.68 40.84 3.11 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -48.75 -26.12 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -1.11 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -135.18 157.96 75.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.88 118.9 5.24 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.792 2.328 . . . . 0.0 111.95 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 160.5 -158.02 29.45 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.17 148.27 48.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -1.021 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.476 HE21 ' N ' ' A' ' 9' ' ' GLY . 20.6 mt-30 -143.98 141.77 30.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.221 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.36 123.98 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 109.927 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.53 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 1.9 m0 -131.06 129.75 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -87.17 144.92 26.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.917 . . . . 0.0 109.584 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.45 143.34 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' A' ' 23' ' ' ASP . 25.0 tt0 -151.54 99.89 2.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.503 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 6.4 ttmm 48.48 38.49 10.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.378 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 66.29 20.67 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 24' ' ' LEU . 7.0 m-20 -98.74 -21.67 16.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.1 mt 57.21 122.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.48 133.47 23.65 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 109.219 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.93 117.66 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.343 2.029 . . . . 0.0 112.379 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.24 134.62 90.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.17 136.07 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.275 1.983 . . . . 0.0 112.328 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -57.65 -30.26 65.26 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -45.86 -42.11 12.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 32' ' ' TYR . 8.4 mp -90.34 -55.73 3.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.208 -0.932 . . . . 0.0 109.268 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.8 t80 36.2 83.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.585 -0.697 . . . . 0.0 109.888 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.68 -31.38 4.6 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -91.48 126.22 36.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.248 . . . . 0.0 109.151 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.686 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.61 168.26 21.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.918 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.542 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -80.56 158.13 25.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.093 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -101.68 -11.19 19.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.64 -7.73 61.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 15.3 t70 -105.58 -155.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -1.149 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.71 141.4 31.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.543 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -124.36 121.94 36.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.22 135.7 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.529 ' O ' HD22 ' A' ' 44' ' ' LEU . 2.4 mt -121.52 146.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.796 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 43' ' ' ILE . 4.0 mm? -118.74 125.38 49.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' GLN . 7.6 ttpp -120.82 93.79 4.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.053 -1.03 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.655 HG23 ' CE2' ' A' ' 56' ' ' TYR . 91.7 m -85.98 101.34 12.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.581 -0.699 . . . . 0.0 109.455 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.22 164.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.35 -0.844 . . . . 0.0 109.15 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.592 ' OE1' ' N ' ' A' ' 50' ' ' ARG . 1.1 tm0? -120.55 112.6 19.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.748 . . . . 0.0 109.603 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 48' ' ' GLN . 12.6 mt -46.27 -88.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.152 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.592 ' N ' ' OE1' ' A' ' 48' ' ' GLN . 6.8 mmt85 -134.85 -41.51 0.76 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.335 -0.853 . . . . 0.0 109.215 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -176.36 29.88 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.35 -103.42 2.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.542 ' CG ' ' H ' ' A' ' 54' ' ' LEU . 10.6 t-20 -102.19 -178.63 3.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 109.782 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.542 ' H ' ' CG ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -119.28 172.41 7.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.465 -0.772 . . . . 0.0 109.323 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.521 ' O ' ' O ' ' A' ' 45' ' ' LYS . 4.1 tp-100 -131.43 110.75 11.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.655 ' CE2' HG23 ' A' ' 46' ' ' THR . 7.7 m-85 -86.32 109.67 19.14 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.618 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -84.01 127.59 33.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.916 -1.115 . . . . 0.0 109.084 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 1.1 mm? -96.51 107.25 19.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.548 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.647 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 75.3 m-70 -115.96 108.57 16.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.717 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.7 120.27 39.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.676 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.686 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 56.5 t90 -102.34 124.91 48.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 109.987 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.719 ' C ' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -128.93 118.67 23.04 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.0 16.95 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.719 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER 61.77 2.05 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -1.031 . . . . 0.0 109.815 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.3 mt-10 -109.4 13.14 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.165 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.7 t -99.91 140.16 34.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.604 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.2 t -61.25 146.54 47.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.67 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -62.68 -23.48 67.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.11 -49.77 76.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.731 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.49 -43.65 11.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 109.316 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -55.89 -53.82 52.13 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -60.18 -51.24 60.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -45.51 -35.14 3.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -1.191 . . . . 0.0 109.404 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.19 -45.81 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.234 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.02 -31.77 72.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.2 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.48 -52.47 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.764 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -58.44 -44.41 89.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.249 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -67.15 -44.55 79.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.325 -0.859 . . . . 0.0 109.458 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 75' ' ' ALA . 58.4 t -69.62 -65.11 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' VAL . 6.1 mm-40 -43.36 -59.42 2.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.104 -0.998 . . . . 0.0 109.422 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.846 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -52.12 -37.05 53.02 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.069 -1.019 . . . . 0.0 108.641 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.547 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -52.01 -52.59 49.68 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.057 -1.027 . . . . 0.0 108.725 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.547 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 7.4 t70 -57.78 -30.52 65.72 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -79.24 -23.73 43.5 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.443 -0.786 . . . . 0.0 109.0 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.54 HD23 ' CD1' ' A' ' 56' ' ' TYR . 11.4 tp -84.74 -46.04 11.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 110.101 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -122.02 -42.21 2.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 109.987 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.93 -15.8 51.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -154.06 24.21 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.61 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.649 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -52.77 -179.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.63 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.45 150.19 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.323 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.442 ' HG2' ' H ' ' A' ' 91' ' ' GLN . 15.9 pt20 -108.44 133.31 52.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.953 . . . . 0.0 109.682 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.647 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 15.8 m-70 -132.35 121.2 23.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.243 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -108.48 127.75 54.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.963 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 96' ' ' GLN . 8.3 mp0 -126.62 78.29 1.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.416 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.8 t -68.75 37.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.635 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.507 ' O ' ' O ' ' A' ' 95' ' ' VAL . 7.2 tp-100 39.27 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.461 -0.775 . . . . 0.0 109.615 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 150.3 -19.24 1.05 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 29.9 m-85 -162.95 47.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.39 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.582 ' OE1' ' CE2' ' A' ' 103' ' ' PHE . 2.3 mt-10 -62.65 -179.41 0.26 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 m -97.17 172.39 7.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 109.434 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.35 -31.36 71.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 0.0 109.506 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -63.17 -62.62 1.57 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.582 ' CE2' ' OE1' ' A' ' 99' ' ' GLU . 16.6 t80 -52.52 -38.27 59.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.446 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.88 -24.72 61.71 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.06 -43.24 57.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -70.33 -42.54 71.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -1.214 . . . . 0.0 109.639 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.54 73.25 0.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -98.37 -31.55 11.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -104.12 7.99 36.35 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -102.14 -111.75 3.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 110' ' ' GLY . 8.5 mp 53.09 102.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.334 -1.097 . . . . 0.0 109.405 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -145.37 108.39 4.55 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -82.34 107.98 15.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 0.0 109.614 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.01 108.91 16.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 0.0 109.298 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -83.4 130.96 35.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 145.63 -133.4 5.01 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 120' ' ' SER . . . 168.55 86.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 117' ' ' GLY . 22.6 t -43.93 -28.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -78.56 -27.01 45.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 117' ' ' GLY . 70.7 m -65.53 6.15 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -82.13 -59.52 2.28 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.42 ' O ' ' C ' ' A' ' 123' ' ' LYS . 3.2 m-85 -85.84 -19.76 30.14 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.215 -1.167 . . . . 0.0 109.451 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 124' ' ' HIS . 20.6 tttp -42.87 -52.19 5.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 109.505 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.495 ' O ' ' O ' ' A' ' 123' ' ' LYS . 2.2 m-70 54.24 166.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.42 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.48 111.03 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 126' ' ' VAL . 12.2 p -100.64 117.33 62.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -44.77 129.2 9.29 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -62.6 136.41 57.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -52.31 -17.48 1.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.0 t -46.87 -34.92 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.7 t -49.66 -60.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.12 -27.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.522 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.628 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -77.11 -42.49 2.63 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 26.9 Cg_exo -59.53 -33.71 97.02 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.704 2.269 . . . . 0.0 112.149 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 7' ' ' LYS . 1.0 OUTLIER -53.94 -57.14 12.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -47.53 -36.14 9.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.138 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 6' ' ' LEU . 11.0 mp -79.89 -23.99 41.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.361 -0.837 . . . . 0.0 109.26 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 4' ' ' GLU . 2.0 ttmp? -64.85 -43.61 92.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -50.88 145.29 7.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.143 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.03 57.21 2.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 12.5 mmtp -132.89 -10.33 3.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.241 -1.152 . . . . 0.0 109.536 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 58.0 mt-10 -160.17 150.41 15.03 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.284 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.61 156.36 57.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.55 2.166 . . . . 0.0 111.916 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.29 -141.47 15.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 15' ' ' GLN . 2.4 tt -127.86 144.9 51.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.406 -1.055 . . . . 0.0 110.062 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.409 ' N ' ' HG ' ' A' ' 14' ' ' LEU . 3.9 mt-30 -135.78 150.55 49.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.337 -0.852 . . . . 0.0 109.057 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.619 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.9 mp -124.96 145.32 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.83 . . . . 0.0 110.409 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.619 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -146.37 110.89 5.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.421 -0.799 . . . . 0.0 108.942 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' VAL . 12.4 ttp85 -81.09 129.63 34.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 0.0 109.672 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -87.06 143.64 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 20' ' ' GLU . 12.2 tm-20 -153.8 88.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.386 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? 60.6 50.51 5.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 53.6 47.61 23.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.516 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 24' ' ' LEU . 49.9 t0 -126.99 -25.91 3.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.4 mp 59.39 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.4 -0.812 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' ARG . 51.7 t -145.94 103.22 4.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 27' ' ' VAL . 63.3 Cg_exo -47.77 108.28 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.287 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 26' ' ' PRO . 10.1 t -43.34 107.49 0.57 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.344 -0.847 . . . . 0.0 109.417 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.99 137.74 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.406 2.07 . . . . 0.0 112.223 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 m -62.0 -24.93 67.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.13 -45.29 32.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.179 -0.951 . . . . 0.0 109.258 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -94.94 -55.46 3.09 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 31' ' ' LEU . 12.4 t80 42.24 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 109.75 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.597 ' O ' ' CE2' ' A' ' 35' ' ' PHE . . . 123.43 -30.87 4.82 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -79.83 137.66 37.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.083 -1.245 . . . . 0.0 109.392 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CE2' ' O ' ' A' ' 33' ' ' GLY . 57.2 m-85 -136.95 160.46 38.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.576 ' N ' ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -105.05 105.54 15.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.321 -0.862 . . . . 0.0 109.385 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.2 p -57.85 87.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.95 -30.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.8 m-20 -111.23 -153.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.45 -1.03 . . . . 0.0 109.014 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.7 145.38 44.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.532 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -121.2 127.62 51.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.419 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.68 103.87 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.61 ' O ' ' CD2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -121.39 144.34 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.895 . . . . 0.0 109.193 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.736 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.1 pt? -147.55 172.43 14.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 110.193 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -145.82 99.88 3.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 111.489 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -72.52 118.91 16.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.392 -0.817 . . . . 0.0 108.908 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.07 164.67 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.497 -0.752 . . . . 0.0 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -126.97 120.88 30.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.538 -0.726 . . . . 0.0 109.258 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.95 -95.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.253 -0.905 . . . . 0.0 109.435 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -140.24 -34.9 0.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.936 . . . . 0.0 109.507 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.457 ' O ' ' CG ' ' A' ' 51' ' ' ASN . 18.5 t-20 -175.84 32.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.349 -0.845 . . . . 0.0 109.197 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -116.16 -82.69 0.98 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -142.22 -167.37 2.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -1.15 . . . . 0.0 109.526 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -126.65 158.94 35.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 109.321 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -126.05 114.11 17.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.653 ' CG ' ' OG1' ' A' ' 46' ' ' THR . 0.2 OUTLIER -83.61 109.87 17.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.079 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.612 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -86.76 103.0 14.78 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.636 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 1.1 mt -95.95 143.1 27.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.172 -0.955 . . . . 0.0 110.444 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 43' ' ' ILE . 1.5 p-80 -154.1 131.83 11.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.465 -0.772 . . . . 0.0 109.623 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.739 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -98.02 118.62 35.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 108.921 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.804 ' O ' HD23 ' A' ' 62' ' ' LEU . 12.1 t90 -85.35 130.36 34.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 110.302 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 61' ' ' TRP . 0.6 OUTLIER -131.4 111.51 11.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.63 15.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.616 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER 66.65 1.83 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.341 -1.093 . . . . 0.0 109.713 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -107.3 10.79 29.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 108.983 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 18.4 t -105.0 146.1 29.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -73.67 166.22 23.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.862 . . . . 0.0 109.359 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -76.35 -8.98 58.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.3 -46.52 49.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -87.12 -36.74 17.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 109.456 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.655 ' OG ' HD13 ' A' ' 62' ' ' LEU . 16.9 t -60.72 -58.31 9.02 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.13 -41.38 78.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.83 -49.93 61.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.436 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.05 87.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -69.45 -20.46 63.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.134 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mm -79.49 -52.25 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -33.1 73.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 108.994 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 82' ' ' ASP . 16.4 m -74.33 -36.55 63.67 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.242 -0.911 . . . . 0.0 109.6 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 75' ' ' ALA . 47.4 t -75.18 -54.61 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -61.75 -59.49 5.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.692 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.736 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -51.97 -47.14 64.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.101 -0.999 . . . . 0.0 108.792 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.728 ' OD1' ' HB3' ' A' ' 89' ' ' ALA . 5.0 t0 -46.37 -47.66 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.971 -1.08 . . . . 0.0 108.523 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.11 -30.77 69.49 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' A' ' 81' ' ' LEU . 31.7 t80 -75.86 -23.57 55.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.479 ' HB3' HD22 ' A' ' 86' ' ' ASN . 8.0 mt -78.07 -52.49 8.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.578 HD22 ' N ' ' A' ' 86' ' ' ASN . 1.1 m-80 -122.02 -42.2 2.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.332 -0.855 . . . . 0.0 109.897 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.04 -11.0 57.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 -150.2 18.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -1.175 . . . . 0.0 109.8 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.728 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . -63.51 -178.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 109.516 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.543 ' C ' ' NE2' ' A' ' 91' ' ' GLN . 3.7 t -114.1 145.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.357 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.584 ' NE2' ' OD2' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -136.69 126.78 26.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.688 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -125.26 160.24 29.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 109.861 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.404 ' CB ' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -111.37 136.78 50.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.112 -0.993 . . . . 0.0 109.939 -179.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.9 mm-40 -118.81 101.81 8.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 95' ' ' VAL . 8.3 p -88.46 37.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.241 -0.912 . . . . 0.0 109.693 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 57.12 66.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.398 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.39 -59.7 0.29 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -92.22 33.12 1.1 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.457 ' OE2' ' CD1' ' A' ' 61' ' ' TRP . 2.6 mt-10 -72.28 -154.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.425 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.1 p -138.05 156.87 47.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 109.385 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.27 -21.07 12.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.6 m -61.6 -60.57 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.095 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.677 ' CE1' ' NE1' ' A' ' 61' ' ' TRP . 72.3 t80 -61.12 -50.28 73.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.525 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 104' ' ' LEU . 89.3 mt -70.34 -18.68 63.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.157 -0.964 . . . . 0.0 109.142 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -69.81 -41.95 71.78 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -71.92 -43.38 65.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -1.112 . . . . 0.0 109.052 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -107.51 54.21 0.67 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.532 ' C ' ' H ' ' A' ' 110' ' ' GLY . 25.8 tttm -81.39 -33.5 32.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.912 . . . . 0.0 109.678 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.0 t -60.7 3.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.74 109.58 2.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.481 HD13 ' H ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -72.39 -101.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -1.173 . . . . 0.0 109.15 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.481 ' H ' HD13 ' A' ' 111' ' ' LEU . 6.7 mttm 165.26 136.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.0 109.383 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.65 107.89 17.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.494 -0.754 . . . . 0.0 109.235 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -114.26 132.06 56.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.903 . . . . 0.0 109.554 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 116' ' ' GLY . 29.0 mtmt -65.12 110.02 2.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.9 . . . . 0.0 109.385 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -42.77 161.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.17 60.21 5.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.36 -28.27 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.333 -1.098 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.76 71.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.439 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 m -97.63 6.18 48.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.329 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 124' ' ' HIS . . . -61.41 -27.9 68.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -62.52 -32.77 73.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -86.5 -4.89 59.24 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 121' ' ' GLY . 23.2 m-70 -134.77 117.67 16.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 109.385 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 125' ' ' VAL . 4.9 p -122.36 129.08 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.429 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.37 82.46 23.14 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' ASN . 59.4 Cg_endo -79.01 132.99 10.83 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.666 2.244 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' PRO . 10.5 m-20 -41.29 146.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -88.07 -17.2 31.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.36 -22.24 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.72 -34.65 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.3 -29.63 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.427 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.436 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.493 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.8 pm0 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -72.75 134.12 81.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.887 . . . . 0.0 109.373 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.66 95.19 0.87 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.515 2.143 . . . . 0.0 112.26 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 8' ' ' ALA . 15.4 mt-10 -83.05 -51.43 7.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.502 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 4' ' ' GLU . 12.5 p90 -44.86 -33.65 2.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.969 . . . . 0.0 109.393 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt -75.37 -36.72 60.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.492 ' O ' ' C ' ' A' ' 8' ' ' ALA . 8.4 ttmt -104.93 23.43 13.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.212 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.55 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . -37.55 140.24 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.445 -0.784 . . . . 0.0 109.803 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.507 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 78.48 51.45 5.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -61.96 1.43 0.29 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.16 -1.2 . . . . 0.0 109.172 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 9' ' ' GLY . 2.6 mt-10 176.35 138.66 0.21 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.448 -0.783 . . . . 0.0 108.938 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -39.77 125.24 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.574 2.183 . . . . 0.0 112.223 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.02 -157.18 27.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.414 HD12 ' NZ ' ' A' ' 45' ' ' LYS . 5.8 tt -112.43 133.65 54.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 5.2 mm100 -119.73 157.7 28.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.366 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.568 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.6 mt -134.98 142.59 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.276 -0.89 . . . . 0.0 109.707 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.3 m-90 -149.46 110.69 4.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' VAL . 6.3 ttt180 -89.21 139.41 30.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.88 143.33 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 69.5 tt0 -136.0 111.29 9.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.484 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 26.2 tttp 51.36 43.7 29.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CB ' ' O ' ' A' ' 21' ' ' LYS . 4.5 t80 73.88 25.72 1.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 20' ' ' GLU . 2.5 m-20 -126.96 111.76 14.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.405 HD22 ' HB3' ' A' ' 5' ' ' PHE . 3.9 tp -58.71 141.57 52.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.494 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 18' ' ' ARG . 73.8 t -138.64 121.42 10.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.185 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.25 115.2 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.34 2.026 . . . . 0.0 112.342 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.72 135.06 23.25 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.139 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 32' ' ' TYR . 31.0 Cg_endo -67.13 97.94 0.43 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.3 2.0 . . . . 0.0 112.183 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 46.9 m -52.19 -24.46 7.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.566 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -19.73 57.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mt -132.2 13.55 4.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.278 -0.889 . . . . 0.0 109.791 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -71.29 -104.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 67.76 -17.09 0.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.555 ' H ' ' C ' ' A' ' 32' ' ' TYR . 18.9 t0 -102.49 140.2 37.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.133 -1.216 . . . . 0.0 109.379 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -129.9 119.79 23.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.107 -0.996 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -76.32 102.78 6.03 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.52 HG21 ' HB3' ' A' ' 113' ' ' TYR . 82.1 p -61.32 -31.59 71.44 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 110.075 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.9 24.53 5.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 24.8 t0 -143.29 -156.42 0.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -1.124 . . . . 0.0 109.294 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.53 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -142.6 140.73 31.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CZ ' ' HD2' ' A' ' 18' ' ' ARG . 34.3 m-85 -121.87 124.35 43.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.623 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 46.5 t -101.47 115.11 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.074 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -116.14 145.22 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.264 -0.898 . . . . 0.0 109.872 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.4 mp -126.55 151.27 48.12 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -140.45 93.35 2.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.791 -1.193 . . . . 0.0 110.833 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.599 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 29.9 m -89.88 98.63 11.88 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.53 164.63 2.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.32 -0.862 . . . . 0.0 109.812 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -125.56 127.25 46.09 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.83 -100.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.133 -0.979 . . . . 0.0 109.491 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -140.23 -34.54 0.53 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.176 -0.953 . . . . 0.0 109.549 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -167.54 42.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.372 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.84 -98.24 0.96 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -134.06 -155.44 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -1.181 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -126.47 157.21 39.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.389 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 45' ' ' LYS . 8.7 tt0 -117.36 98.86 6.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.197 -0.939 . . . . 0.0 110.484 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 9.5 m-85 -75.83 123.53 25.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -103.0 147.59 26.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.932 -1.105 . . . . 0.0 108.64 179.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' HIS . 0.7 OUTLIER -124.66 109.1 12.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.361 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.626 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -131.17 116.17 17.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 109.528 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.714 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.87 129.32 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.793 ' C ' HD23 ' A' ' 62' ' ' LEU . 15.8 t90 -101.69 127.24 48.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 110.167 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.793 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -129.44 108.93 10.65 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -64.43 20.05 0.1 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.1 t-20 59.54 2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.079 . . . . 0.0 110.016 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 63' ' ' GLY . 17.8 mt-10 -102.29 2.38 36.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.968 -1.083 . . . . 0.0 108.898 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.437 ' SG ' ' CG ' ' A' ' 70' ' ' GLU . 48.1 t -100.72 140.13 35.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.7 m -67.28 155.35 39.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 109.594 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.9 -8.88 24.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.471 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -71.49 -52.1 20.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' CG ' ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -87.57 -37.15 17.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.184 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 62' ' ' LEU . 7.6 t -62.5 -60.08 4.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.514 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.3 -53.53 37.4 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.8 -37.65 6.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.391 -1.064 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.54 -39.16 85.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 109.202 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -69.69 -32.82 71.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.841 . . . . 0.0 109.446 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.411 HG22 ' OE1' ' A' ' 80' ' ' GLN . 3.3 mt -79.13 -43.51 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.21 -0.931 . . . . 0.0 109.801 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -62.42 -40.64 97.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.524 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.89 -44.31 32.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.694 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.9 t -62.79 -45.77 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 110.214 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.539 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 14.7 pt20 -67.62 -50.57 57.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.992 -1.068 . . . . 0.0 110.217 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -62.33 -47.04 85.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.779 -1.201 . . . . 0.0 108.357 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' LEU . 1.6 t0 -45.87 -46.95 16.09 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.74 -32.16 71.45 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.723 ' HB3' HD13 ' A' ' 81' ' ' LEU . 41.6 t80 -69.57 -23.05 63.5 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 8' ' ' ALA . 46.5 mt -83.08 -62.01 1.71 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.414 -0.803 . . . . 0.0 110.762 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -122.57 -43.19 2.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.995 -1.066 . . . . 0.0 111.293 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.57 6.67 63.93 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -149.52 10.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -1.12 . . . . 0.0 109.906 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -56.0 177.3 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.46 133.8 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.157 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.541 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 3.1 mp0 -97.63 138.0 35.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 110.193 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.549 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 9.7 m-70 -139.5 129.82 25.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -0.814 . . . . 0.0 109.249 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -113.25 126.02 54.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.985 . . . . 0.0 109.819 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.469 ' OE2' ' O ' ' A' ' 60' ' ' TYR . 2.0 mp0 -127.15 84.56 2.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 109.489 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 95' ' ' VAL . 8.9 p -81.64 37.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 2.0 tt0 70.66 52.66 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.39 -53.39 0.25 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -94.13 55.62 2.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.4 mp0 -78.99 -161.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.1 m -138.81 170.87 15.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.48 -30.46 64.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.8 m -66.38 -39.5 89.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.372 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -73.52 -51.1 18.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.36 -0.837 . . . . 0.0 109.491 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 104' ' ' LEU . 92.3 mt -68.53 -17.52 64.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.15 -40.65 13.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.401 ' CD1' HD13 ' A' ' 14' ' ' LEU . 1.6 t80 -82.43 -32.72 28.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -1.128 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -101.35 96.46 7.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.643 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -96.87 -63.63 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.173 -0.954 . . . . 0.0 109.402 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -100.96 11.96 38.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.395 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.714 ' C ' HD23 ' A' ' 111' ' ' LEU . . . -102.98 65.14 0.39 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.714 HD23 ' C ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -147.07 95.05 2.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.316 -1.108 . . . . 0.0 109.0 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.61 114.32 21.01 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.52 ' HB3' HG21 ' A' ' 37' ' ' THR . 1.0 OUTLIER -81.43 107.65 14.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.382 -0.823 . . . . 0.0 109.8 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -111.86 109.03 18.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.313 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -64.44 135.99 56.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.34 132.26 2.53 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 121' ' ' GLY . . . -137.25 101.82 0.36 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 117' ' ' GLY . 57.7 t -43.14 -31.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -1.121 . . . . 0.0 109.457 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.08 -32.17 39.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 117' ' ' GLY . 8.5 t -104.17 6.14 35.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.905 . . . . 0.0 109.414 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 117' ' ' GLY . . . -81.74 -20.89 62.68 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -80.03 -20.89 44.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.206 -1.173 . . . . 0.0 109.446 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -53.62 -53.28 54.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.441 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -99.7 168.59 9.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 109.531 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.97 147.1 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.21 71.86 76.49 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.452 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.02 150.66 9.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.814 2.343 . . . . 0.0 112.266 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -75.21 141.6 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.198 -0.939 . . . . 0.0 109.519 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -76.6 -26.34 54.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.486 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -65.4 -23.86 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.15 -30.71 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.03 -30.2 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.448 179.977 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.322 0.582 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.686 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.6 OUTLIER -92.81 -38.8 0.35 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 109.728 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 26.1 Cg_exo -60.04 113.16 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.619 2.213 . . . . 0.0 112.123 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -65.0 -12.87 55.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.446 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -50.92 -22.97 2.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 mt -67.82 -21.65 65.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.546 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -104.86 -56.89 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.886 . . . . 0.0 109.437 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.545 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 59.47 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.402 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 11' ' ' GLU . . . 50.68 27.08 11.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' GLY . 1.6 pttt -42.33 -21.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 109.231 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -130.98 157.99 76.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.267 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.53 119.92 7.37 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.7 2.267 . . . . 0.0 112.006 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.19 -150.25 21.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.499 HD13 ' CD2' ' A' ' 106' ' ' TYR . 3.4 tt -132.38 144.81 50.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 0.0 109.591 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.56 HE21 ' H ' ' A' ' 9' ' ' GLY . 24.4 mt-30 -136.61 148.21 47.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.458 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -121.3 138.41 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.868 . . . . 0.0 109.644 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.593 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.6 m0 -141.98 111.0 6.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.383 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.458 HH22 HG11 ' A' ' 25' ' ' VAL . 3.6 ttt-85 -71.45 135.85 47.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -78.49 143.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -0.997 . . . . 0.0 109.426 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 89.96 0.94 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.311 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 63.38 28.56 15.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER 71.03 16.98 6.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 24' ' ' LEU . 73.0 m-20 -99.83 -14.29 18.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.543 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.6 mt 57.25 136.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.458 HG11 HH22 ' A' ' 18' ' ' ARG . 47.3 t -142.72 115.73 6.21 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.74 143.83 6.09 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.362 2.041 . . . . 0.0 112.213 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.44 125.02 81.89 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.45 111.84 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.487 2.125 . . . . 0.0 112.148 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.2 m -63.83 -25.51 68.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -45.71 -41.11 10.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.158 -0.964 . . . . 0.0 109.306 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.0 mt -104.31 -54.98 2.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.4 t80 55.62 95.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.353 -0.842 . . . . 0.0 109.369 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.49 -31.03 4.76 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 1.4 m-20 -89.93 128.37 36.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -1.119 . . . . 0.0 109.191 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.698 ' CD2' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.27 167.92 22.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.915 . . . . 0.0 109.777 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CD1' ' OH ' ' A' ' 41' ' ' TYR . 3.9 m-85 -85.14 154.91 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.346 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.417 HG22 HE21 ' A' ' 96' ' ' GLN . 5.0 p -95.14 -9.44 33.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.528 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.0 26.79 22.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.09 -162.13 1.32 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -1.163 . . . . 0.0 109.324 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.35 141.08 33.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 22.2 m-85 -128.79 122.51 30.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.359 -0.838 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.506 HG21 ' OG1' ' A' ' 78' ' ' THR . 38.6 t -96.57 141.65 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.437 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.569 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 mt -137.71 146.42 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 109.363 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 43' ' ' ILE . 2.3 mp -129.71 131.63 46.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.603 -0.685 . . . . 0.0 109.586 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -114.53 94.19 4.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.595 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 7.6 m -77.24 101.77 6.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.323 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.449 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -99.14 164.8 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -126.47 117.44 22.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.6 -0.688 . . . . 0.0 109.274 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.4 mt -54.29 -92.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -140.31 -38.0 0.46 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.28 -0.887 . . . . 0.0 109.677 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -174.49 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.91 -82.9 1.2 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -145.44 160.28 41.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -1.177 . . . . 0.0 109.468 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -99.56 167.35 10.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.387 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -137.96 134.8 35.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.805 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.595 ' CD1' ' OG1' ' A' ' 46' ' ' THR . 11.7 m-85 -92.82 128.8 38.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 108.824 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.614 ' CG ' ' HE2' ' A' ' 59' ' ' HIS . 34.8 t0 -91.09 116.3 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 108.92 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' CD2' HG22 ' A' ' 78' ' ' THR . 6.0 mp -81.76 126.53 31.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.692 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.72 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 27.5 m-70 -142.44 108.53 5.21 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.112 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.713 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.42 129.17 50.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.022 . . . . 0.0 108.961 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.698 ' CZ3' ' CD2' ' A' ' 35' ' ' PHE . 6.0 t90 -96.71 129.56 44.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.375 -0.828 . . . . 0.0 110.03 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.647 ' C ' ' H ' ' A' ' 64' ' ' ASN . 3.1 mt -134.44 106.34 7.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.7 9.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.647 ' H ' ' C ' ' A' ' 62' ' ' LEU . 4.7 t-20 69.23 1.22 3.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -1.091 . . . . 0.0 109.607 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -113.65 12.59 18.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.48 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 3.0 p -97.86 134.6 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.537 -0.727 . . . . 0.0 109.406 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 66' ' ' CYS . 1.3 m -43.65 152.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -76.18 -20.69 57.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.152 -0.967 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -68.59 -35.06 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -87.03 -28.63 22.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.518 ' OG ' HD13 ' A' ' 62' ' ' LEU . 22.8 t -64.32 -60.05 3.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 0.0 109.385 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.76 -46.49 91.76 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -46.6 -43.71 17.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -1.116 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.59 50.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 109.036 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.42 -20.09 41.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 108.89 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mm -81.59 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.33 -0.856 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.3 -26.8 68.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 108.446 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.599 HG22 ' CD2' ' A' ' 58' ' ' LEU . 37.5 m -76.78 -50.59 13.15 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.682 -0.636 . . . . 0.0 109.382 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 75' ' ' ALA . 87.1 t -67.89 -36.36 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.071 -1.018 . . . . 0.0 109.834 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -66.07 -58.84 4.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.744 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -55.04 -46.48 75.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.935 -1.103 . . . . 0.0 109.193 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.549 ' HB3' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -47.64 -47.41 29.24 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.741 -1.224 . . . . 0.0 108.145 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' CG ' ' A' ' 82' ' ' ASP . 13.7 t70 -63.01 -24.44 67.92 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.744 ' HB3' HD13 ' A' ' 81' ' ' LEU . 37.0 t80 -78.13 -23.71 47.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD21 HD12 ' A' ' 81' ' ' LEU . 36.1 mt -83.35 -53.94 5.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.232 -0.917 . . . . 0.0 109.777 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -122.0 -42.37 2.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.184 -0.948 . . . . 0.0 110.094 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.16 -8.42 8.52 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.575 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 59.8 mtt-85 -144.07 -84.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -1.099 . . . . 0.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 88' ' ' ARG . . . 68.11 132.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.586 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.59 149.85 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.66 143.08 45.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.293 -0.879 . . . . 0.0 109.912 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.72 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 36.2 m-70 -142.39 121.91 13.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.468 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 15.7 ptt180 -108.9 121.24 44.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -112.52 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.554 HG12 ' ND2' ' A' ' 64' ' ' ASN . 2.1 t -80.45 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.417 HE21 HG22 ' A' ' 37' ' ' THR . 13.1 tt0 66.29 53.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.544 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 99' ' ' GLU . . . 162.78 -53.23 0.3 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -77.28 30.67 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -1.201 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.503 ' OE2' HD21 ' A' ' 104' ' ' LEU . 7.7 mt-10 -59.81 150.83 27.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.8 t -99.88 162.69 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.46 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.4 m -63.65 -62.71 1.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.364 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.559 ' CE1' ' CD2' ' A' ' 107' ' ' PHE . 69.4 t80 -54.69 -37.0 65.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.407 -0.808 . . . . 0.0 109.491 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.503 HD21 ' OE2' ' A' ' 99' ' ' GLU . 98.3 mt -71.84 -22.67 61.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.5 -30.16 46.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.499 ' CD2' HD13 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -85.81 -41.38 15.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.559 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 96.8 m-85 -105.11 76.15 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.508 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.9 -30.89 11.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -98.82 8.73 44.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.275 -0.891 . . . . 0.0 109.789 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -101.88 -111.06 3.42 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 110' ' ' GLY . 72.7 mt 44.52 96.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.272 -1.134 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -155.4 110.55 3.01 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -84.27 107.85 16.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.392 -0.818 . . . . 0.0 109.587 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -103.84 108.83 20.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -65.24 134.05 52.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.856 . . . . 0.0 109.468 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.33 176.8 14.54 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 120' ' ' SER . . . -152.33 117.11 0.79 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 117' ' ' GLY . 73.8 t -43.15 -65.15 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -1.124 . . . . 0.0 109.454 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.24 -25.97 4.22 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.497 -0.752 . . . . 0.0 109.493 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 117' ' ' GLY . 3.5 t -75.4 6.18 4.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.414 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -49.4 -40.38 30.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -72.91 -26.3 61.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -1.145 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -72.39 -33.23 67.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -143.56 117.9 9.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.45 147.12 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 t -138.06 110.95 8.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 109.365 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 128' ' ' ASN . 78.3 Cg_exo -45.93 133.66 14.34 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.389 2.059 . . . . 0.0 112.335 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 127' ' ' PRO . 2.0 m120 -43.12 147.71 0.33 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 109.516 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.25 -22.93 59.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.468 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 130' ' ' VAL . 14.4 t -52.63 -37.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.405 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.29 -36.35 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.19 -27.4 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.503 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.417 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.592 ' OE2' ' ND1' ' A' ' 2' ' ' HIS . 1.1 tm-20 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.592 ' ND1' ' OE2' ' A' ' 1' ' ' GLU . 6.4 m170 52.92 63.76 8.13 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.41 111.61 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.809 2.339 . . . . 0.0 112.151 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -80.53 -28.86 37.25 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.676 ' CD2' HD22 ' A' ' 24' ' ' LEU . 7.2 t80 -53.83 -22.94 10.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -79.63 -8.43 59.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.568 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 8' ' ' ALA . 15.4 mtmm -125.16 -53.16 1.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.608 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.585 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 58.86 150.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.153 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.532 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 43.13 40.81 4.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HZ3' ' HB2' ' A' ' 10' ' ' LYS . 18.7 mtmm -42.06 -28.14 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.419 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.554 ' OE2' ' N ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -145.64 149.05 38.87 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.249 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -39.85 123.01 1.15 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.628 2.219 . . . . 0.0 112.229 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 -168.04 34.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 14' ' ' LEU . 7.2 tt -120.65 129.54 53.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -1.018 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.66 ' N ' HD23 ' A' ' 14' ' ' LEU . 20.9 mt-30 -124.4 163.96 20.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.594 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.2 mt -136.42 137.02 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 109.778 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.594 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 3.2 m0 -141.6 131.36 24.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.458 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 25' ' ' VAL . 59.9 ttp180 -95.24 144.88 25.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.898 . . . . 0.0 109.599 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.428 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 0.4 OUTLIER -108.45 143.38 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.2 tp10 -130.04 91.5 3.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.76 . . . . 0.0 109.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.5 tttp 78.59 -67.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.606 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 77' ' ' PHE . 10.5 t80 -160.8 16.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.909 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -127.47 114.89 18.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 109.716 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.676 HD22 ' CD2' ' A' ' 5' ' ' PHE . 8.8 mp -59.6 149.0 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 18' ' ' ARG . 60.5 t -154.1 118.29 2.67 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.505 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.11 152.16 0.66 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.455 2.104 . . . . 0.0 112.199 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 27' ' ' VAL . 12.7 p -102.13 132.78 21.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -42.42 136.79 3.99 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.536 2.157 . . . . 0.0 112.353 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -70.2 -28.42 65.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.335 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -60.68 -40.33 91.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' O ' ' C ' ' A' ' 32' ' ' TYR . 7.8 mp -76.85 -55.46 5.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.862 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 31' ' ' LEU . 9.9 t80 35.4 78.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.522 -0.736 . . . . 0.0 109.928 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 115.28 -31.45 6.21 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -86.23 120.48 27.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -1.186 . . . . 0.0 109.189 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.684 ' CD1' ' CH2' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -146.67 168.49 21.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 110.043 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' GLY . 22.6 m-85 -86.29 106.95 17.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 109.276 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -46.93 -10.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . -91.05 19.09 48.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.56 -164.65 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -1.175 . . . . 0.0 109.394 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.4 140.61 37.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 109.663 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -131.05 164.18 25.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.818 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.6 131.34 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.875 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.407 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -115.94 145.62 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.296 -0.878 . . . . 0.0 109.648 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -121.84 147.99 45.27 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HZ1' ' HB3' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -145.69 93.34 2.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.027 -1.046 . . . . 0.0 110.297 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.611 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 32.1 m -88.58 108.52 19.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.491 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.53 163.9 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.297 -0.877 . . . . 0.0 108.95 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -67.58 157.8 33.56 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.612 0.72 . . . . 0.0 110.657 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.636 ' H ' HD12 ' A' ' 49' ' ' LEU . 2.9 mp -69.47 -34.13 73.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.551 -0.718 . . . . 0.0 109.52 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' H ' ' HG2' ' A' ' 50' ' ' ARG . 15.7 mmp_? -46.87 -34.13 5.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.3 -0.875 . . . . 0.0 108.95 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -76.85 -21.58 54.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.503 -0.748 . . . . 0.0 109.068 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 146.0 65.0 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 54' ' ' LEU . 3.8 t-20 62.18 139.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -1.177 . . . . 0.0 109.721 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.474 ' C ' ' O ' ' A' ' 53' ' ' ASN . 1.3 pp -41.42 128.39 3.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.444 -0.785 . . . . 0.0 108.944 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -124.69 102.31 7.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.147 -0.971 . . . . 0.0 110.765 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.677 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 6.9 m-85 -82.08 109.47 16.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.455 ' HB3' ' HZ1' ' A' ' 45' ' ' LYS . 21.8 t0 -83.45 148.66 27.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.978 -1.076 . . . . 0.0 108.551 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.488 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -130.18 125.9 36.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.488 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -137.01 108.91 7.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.421 -0.799 . . . . 0.0 109.575 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.705 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.54 114.29 25.01 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 108.558 179.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.684 ' CH2' ' CD1' ' A' ' 35' ' ' PHE . 68.8 t90 -86.69 118.38 26.06 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.358 -0.839 . . . . 0.0 109.688 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' ASN . 1.0 OUTLIER -123.2 105.92 10.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.55 -0.719 . . . . 0.0 109.097 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 64' ' ' ASN . . . -56.58 1.19 0.11 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' LEU . 13.4 t-20 70.3 1.65 3.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.509 -0.995 . . . . 0.0 109.731 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -111.88 15.05 20.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 108.896 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.3 t -105.62 145.99 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.807 . . . . 0.0 109.622 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.2 t -55.36 156.96 3.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.05 -26.45 48.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.184 -0.947 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -41.15 78.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.696 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 19' ' ' VAL . 33.4 tt0 -87.32 -42.66 12.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.5 t -57.71 -54.05 51.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.728 . . . . 0.0 109.512 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.52 -53.42 43.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.49 -39.27 7.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -1.172 . . . . 0.0 109.462 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.33 86.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.179 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.7 -32.6 74.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.384 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mt -78.72 -48.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.802 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.505 ' CZ ' ' CZ ' ' A' ' 22' ' ' PHE . 1.5 m-85 -62.75 -42.45 99.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.955 . . . . 0.0 109.372 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -68.73 -41.82 78.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.51 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 78' ' ' THR . 52.0 t -73.03 -61.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.438 -0.789 . . . . 0.0 110.02 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -56.87 -59.63 4.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.912 . . . . 0.0 110.06 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.5 tm? -51.82 -47.71 64.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.864 -1.147 . . . . 0.0 108.937 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 81' ' ' LEU . 3.1 t0 -46.85 -48.69 20.95 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.876 -1.14 . . . . 0.0 108.496 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.24 -31.67 65.77 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.55 ' N ' ' O ' ' A' ' 81' ' ' LEU . 38.5 t80 -70.81 -23.67 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.11 -59.37 2.8 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -122.21 -42.4 2.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.343 -0.848 . . . . 0.0 110.14 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 -21.5 6.66 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 29.7 mtp85 -138.2 -85.5 0.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -1.114 . . . . 0.0 109.296 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 65.33 176.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.71 150.2 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -123.88 140.25 53.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -0.873 . . . . 0.0 109.818 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.506 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 11.5 m-70 -137.59 137.99 39.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 109.204 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 8.5 ptp180 -120.24 124.83 46.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -119.6 94.66 4.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.184 -0.948 . . . . 0.0 109.539 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.3 37.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.406 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 61.4 105.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.462 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 103.01 -36.29 4.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -107.2 32.09 4.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 3.8 mp0 -70.39 -177.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 p -110.6 168.02 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.358 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -69.65 -32.73 71.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.6 m -60.83 -57.65 11.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.094 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.608 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 40.4 t80 -53.91 -48.94 69.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.494 -0.754 . . . . 0.0 109.259 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.94 -24.36 64.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 109.042 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -60.68 -50.34 68.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 107' ' ' PHE . 22.2 m-85 -69.29 -44.32 72.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -1.173 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -134.29 86.81 2.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.169 179.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.526 ' O ' HD21 ' A' ' 111' ' ' LEU . 2.0 pttt -89.3 -63.84 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.401 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 2.0 t -105.86 9.81 32.71 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.527 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.37 63.16 0.28 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.704 ' O ' ' CB ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -137.81 -115.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.189 -1.183 . . . . 0.0 108.858 179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.704 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 6.6 tptm 138.28 121.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.476 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 1.8 p90 -103.22 107.98 19.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.472 -0.768 . . . . 0.0 109.524 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -101.93 120.54 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -53.8 132.92 42.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.495 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.03 -123.48 2.23 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.53 17.27 60.57 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.12 -53.48 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -1.163 . . . . 0.0 109.556 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.4 -32.11 64.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.381 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.8 m -101.38 6.15 42.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.77 -28.04 71.4 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -66.24 -29.81 70.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.271 -1.135 . . . . 0.0 109.458 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.48 -3.34 36.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -66.13 86.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.412 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 126' ' ' VAL . 6.7 t -69.75 146.99 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 125' ' ' VAL . 75.7 t -155.34 88.25 3.13 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 128' ' ' ASN . 52.7 Cg_exo -49.06 166.17 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.626 2.217 . . . . 0.0 112.252 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 127' ' ' PRO . 84.2 m-20 -39.87 109.69 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.625 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -50.75 -25.67 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.496 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.3 t -50.67 -25.24 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.373 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.74 -47.69 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.477 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.5 -31.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.478 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.586 ' O ' ' ND1' ' A' ' 2' ' ' HIS . 23.4 tt0 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.586 ' ND1' ' O ' ' A' ' 1' ' ' GLU . 2.8 m-70 -141.77 65.68 20.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.154 -0.966 . . . . 0.0 109.424 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.59 59.76 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.755 2.303 . . . . 0.0 112.348 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.01 -30.97 27.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.377 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -48.37 -31.81 6.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.618 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.8 mm? -82.41 -29.6 30.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -64.8 -31.12 72.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.55 161.35 30.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.363 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.476 ' CA ' HD21 ' A' ' 85' ' ' LEU . . . 61.37 53.21 46.11 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 20.2 mtpp -142.16 -8.68 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 63.9 mt-10 -158.52 149.69 16.47 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.409 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.82 170.34 20.59 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.627 2.218 . . . . 0.0 112.173 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.66 -137.2 13.9 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.3 142.17 35.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.284 -1.127 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 3.7 mp0 -127.54 146.93 50.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.274 -0.891 . . . . 0.0 109.343 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.545 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 24.8 mt -117.63 135.37 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 109.72 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.8 m0 -141.84 110.85 6.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -83.09 131.31 35.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.543 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -91.95 143.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.353 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -152.81 111.85 3.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.2 ttmt 46.77 31.62 1.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.416 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.1 m-85 68.61 51.38 0.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 24' ' ' LEU . 66.5 m-20 -127.17 -24.54 3.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 23' ' ' ASP . 6.3 mt 57.92 130.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -149.54 134.6 9.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.164 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.08 124.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.345 2.03 . . . . 0.0 112.289 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 t -60.09 114.77 10.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.374 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.33 123.89 7.16 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.327 2.018 . . . . 0.0 112.126 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.1 m -59.43 -23.71 62.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.364 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -49.18 -47.38 46.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.175 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 7.1 mp -92.01 -55.05 3.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.5 t80 44.95 89.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.567 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.63 3.3 8.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.22 143.19 27.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -1.141 . . . . 0.0 109.154 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -140.3 123.04 16.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.117 -0.99 . . . . 0.0 109.921 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 38' ' ' GLY . 3.2 m-30 -83.6 102.97 12.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' HH2' ' A' ' 61' ' ' TRP . 30.4 p -57.21 87.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 177.86 -29.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.06 -154.89 0.55 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.388 -1.066 . . . . 0.0 108.943 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.96 141.98 32.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.125 -0.984 . . . . 0.0 109.402 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 22.8 m-85 -115.82 124.37 50.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.787 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.9 t -93.83 118.51 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.355 -0.841 . . . . 0.0 108.904 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HB ' ' NE2' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -118.91 144.91 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 110.072 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.896 HD11 HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -121.95 151.43 40.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -143.9 94.65 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.093 -1.005 . . . . 0.0 110.392 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.615 ' OG1' ' CZ ' ' A' ' 56' ' ' TYR . 1.2 m -87.49 114.67 24.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.471 -0.768 . . . . 0.0 109.288 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -92.09 164.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.191 -0.943 . . . . 0.0 109.011 179.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.44 ' NE2' ' ND2' ' A' ' 51' ' ' ASN . 11.4 pt20 -58.29 157.71 8.16 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.581 0.705 . . . . 0.0 110.558 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 49' ' ' LEU . 4.8 mp -71.73 -38.28 70.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.33 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' HB2' HE21 ' A' ' 48' ' ' GLN . 62.1 mtt85 -43.54 -33.52 1.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.316 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 51' ' ' ASN . 1.1 m120 -76.73 -27.21 55.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 109.162 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 153.55 61.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' C ' ' A' ' 54' ' ' LEU . 6.6 t-20 60.21 149.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -1.134 . . . . 0.0 109.426 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.778 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -39.36 114.59 0.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 108.951 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 45' ' ' LYS . 49.1 tt0 -104.46 92.84 4.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.304 -0.873 . . . . 0.0 110.235 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.615 ' CZ ' ' OG1' ' A' ' 46' ' ' THR . 0.3 OUTLIER -79.0 116.72 19.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 109.073 179.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -100.13 119.74 38.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.982 HD11 ' OG1' ' A' ' 78' ' ' THR . 7.8 tt -110.64 133.85 52.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.985 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.607 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -152.63 133.78 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.358 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.723 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -100.6 126.08 47.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 0.0 108.775 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.934 ' O ' HD23 ' A' ' 62' ' ' LEU . 77.5 t90 -92.54 134.62 34.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.934 HD23 ' O ' ' A' ' 61' ' ' TRP . 2.3 mt -137.39 118.59 14.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.448 -0.783 . . . . 0.0 109.208 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' CA ' ' CH2' ' A' ' 61' ' ' TRP . . . -69.39 25.14 0.35 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.58 ' H ' ' C ' ' A' ' 62' ' ' LEU . 59.5 t30 58.86 6.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.442 -1.034 . . . . 0.0 110.089 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -110.38 10.93 23.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 109.143 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 20.2 t -105.09 146.1 29.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.682 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 t -85.9 170.4 12.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.463 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -69.16 -16.34 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 1.2 t70 -61.48 -58.31 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -87.85 -35.82 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.593 ' OG ' HD13 ' A' ' 62' ' ' LEU . 8.8 t -70.4 -60.61 2.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.577 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -52.79 -43.33 60.31 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.44 -52.04 63.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -1.162 . . . . 0.0 109.501 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.7 -47.69 63.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.151 -0.968 . . . . 0.0 109.288 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.628 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -61.8 -22.98 65.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 109.232 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mm -83.92 -55.84 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -61.36 -34.75 75.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.381 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.982 ' OG1' HD11 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -75.13 -43.81 50.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.872 . . . . 0.0 109.74 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 75' ' ' ALA . 27.9 t -63.62 -55.96 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.846 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.3 -59.62 5.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.846 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -53.11 -48.45 67.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.031 -1.043 . . . . 0.0 108.927 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 78' ' ' THR . 10.0 t0 -45.64 -45.02 13.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.103 -0.998 . . . . 0.0 108.807 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.28 -30.86 71.92 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 17.7 t80 -79.1 -22.92 44.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.476 HD21 ' CA ' ' A' ' 9' ' ' GLY . 3.2 tp -83.91 -47.7 10.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.333 -0.855 . . . . 0.0 110.018 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -122.0 -41.92 2.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.288 -0.883 . . . . 0.0 110.025 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.86 -20.56 40.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' ALA . 3.6 ptt180 -136.55 -80.88 0.39 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.386 -1.067 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 88' ' ' ARG . . . 41.89 -155.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.328 -0.858 . . . . 0.0 109.388 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -146.44 133.31 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.589 ' NE2' ' O ' ' A' ' 91' ' ' GLN . 3.0 pp0? -118.85 115.84 25.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.702 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -120.8 159.61 25.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.725 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.567 ' HE ' HD11 ' A' ' 62' ' ' LEU . 42.3 ttt180 -110.52 130.05 55.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.892 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 96' ' ' GLN . 2.5 mm-40 -115.32 86.2 2.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.058 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.52 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.1 t -68.29 37.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.543 ' H ' ' C ' ' A' ' 94' ' ' GLU . 5.1 tm0? 48.82 103.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.496 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.91 -52.37 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 98' ' ' PHE . 60.0 t80 -108.77 31.29 5.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -1.043 . . . . 0.0 109.234 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 98' ' ' PHE . 4.1 mt-10 -53.18 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.391 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.7 t -115.85 170.51 8.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.05 -23.93 65.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.1 m -68.56 -53.93 19.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.465 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 14.1 t80 -62.0 -39.18 91.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.443 HD21 ' OE2' ' A' ' 99' ' ' GLU . 94.8 mt -72.36 -36.36 68.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.81 -37.3 94.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.82 -50.52 12.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.515 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -103.43 61.95 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -84.75 -29.45 25.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -99.6 1.85 44.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.65 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.54 -109.18 2.36 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 110' ' ' GLY . 16.9 mt 53.34 100.6 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -144.13 100.86 3.63 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.78 108.04 15.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.875 . . . . 0.0 109.574 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -119.41 140.7 49.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.399 -0.813 . . . . 0.0 109.362 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -54.16 145.58 16.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.46 -2.61 90.64 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.37 128.27 9.42 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.17 -18.83 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 109.51 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.5 -23.41 6.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.554 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 t -76.91 6.22 6.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.934 . . . . 0.0 109.411 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.99 -47.25 39.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -51.23 -26.25 6.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -1.143 . . . . 0.0 109.443 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -73.38 -38.12 65.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -99.7 88.88 3.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.506 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.9 t -89.77 122.91 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.451 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 126' ' ' VAL . 69.4 t -155.51 82.28 3.83 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -78.82 133.27 11.24 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.773 2.315 . . . . 0.0 112.325 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.67 ' N ' ' ND2' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -63.8 150.22 45.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.526 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 131' ' ' VAL . 1.5 pp20? -88.05 -21.89 24.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 109.552 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 p -47.04 -16.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.414 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 129' ' ' GLU . 61.4 t -68.57 -40.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.55 -29.42 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.521 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 2.2 mp0 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.7 m80 52.65 82.95 0.23 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.539 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.4 -16.59 13.48 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.629 2.219 . . . . 0.0 112.208 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -64.13 -39.47 94.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.382 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.506 ' CG ' HD22 ' A' ' 24' ' ' LEU . 29.0 t80 -72.79 -32.93 65.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 tp -55.23 -21.94 16.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.896 . . . . 0.0 109.299 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.919 ' O ' HD11 ' A' ' 85' ' ' LEU . 41.9 mttt -98.17 -55.83 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.379 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.551 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.91 134.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 109.631 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 56.98 54.2 38.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -63.4 0.42 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -1.086 . . . . 0.0 109.404 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' GLY . 11.6 pt-20 -176.44 150.72 1.02 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -39.89 126.29 1.75 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.639 2.226 . . . . 0.0 112.1 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.63 -158.5 27.78 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.8 141.81 51.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -1.062 . . . . 0.0 109.652 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 2.4 mm100 -127.84 156.64 42.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.247 -0.908 . . . . 0.0 109.35 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 1.9 mp -131.36 137.0 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.204 -0.935 . . . . 0.0 109.961 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 5.2 m-90 -144.9 113.41 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.388 -0.82 . . . . 0.0 109.32 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.414 HH11 ' CG ' ' A' ' 39' ' ' ASP . 46.2 ttt180 -80.98 140.03 35.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.0 143.18 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' PHE . 14.0 mm-40 -146.15 112.3 5.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 109.091 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 20.4 ttpp 57.86 -76.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.339 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 6.8 m-85 -175.83 33.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.318 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 24' ' ' LEU . 6.7 t70 -127.31 -1.64 6.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.94 . . . . 0.0 109.803 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.506 HD22 ' CG ' ' A' ' 5' ' ' PHE . 4.4 tp 59.25 146.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 109.312 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 24' ' ' LEU . 42.1 t -154.39 111.41 2.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.652 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -46.42 147.38 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.44 2.093 . . . . 0.0 112.173 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' THR . 6.8 p -76.93 133.34 69.66 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.102 -0.999 . . . . 0.0 109.394 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -41.27 89.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.527 2.151 . . . . 0.0 112.292 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 27' ' ' VAL . 24.4 m -51.74 -26.55 9.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.407 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.636 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -51.34 -43.46 61.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.408 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.6 mt -93.86 -54.19 3.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.299 -0.875 . . . . 0.0 109.639 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 65.47 100.44 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 123.67 -27.32 5.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -65.84 139.71 58.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.333 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 33' ' ' GLY . 73.7 m-85 -143.6 143.03 31.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.846 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.61 103.27 15.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.06 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.561 ' C ' ' H ' ' A' ' 39' ' ' ASP . 15.0 p -54.89 -45.26 74.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.808 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.19 10.13 0.29 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 37' ' ' THR . 3.4 m-20 -133.73 -156.24 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -1.173 . . . . 0.0 109.283 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.44 140.91 25.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 109.689 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 15.3 m-85 -123.83 146.21 48.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.381 -0.825 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.83 116.09 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.168 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.441 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -112.37 142.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.252 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.621 HD11 ' CD2' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -122.3 145.25 48.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.568 -0.707 . . . . 0.0 109.891 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -125.47 93.21 3.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.452 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 86.2 m -73.86 106.76 5.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -107.02 164.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -121.78 137.0 54.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.414 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.94 -101.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -140.08 -34.01 0.56 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.45 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -171.49 36.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.34 -79.05 0.27 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.581 ' ND2' ' H ' ' A' ' 54' ' ' LEU . 9.0 t30 -152.06 -165.13 2.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -1.133 . . . . 0.0 109.514 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.581 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -130.45 164.97 23.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 109.369 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -134.1 144.8 48.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.594 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 56' ' ' TYR . 2.3 m-85 -100.89 118.91 37.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.391 -0.818 . . . . 0.0 108.848 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.488 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 3.5 m-20 -77.81 120.39 22.64 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.621 ' CD2' HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -97.11 122.61 40.31 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.0 110.087 -178.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -138.24 110.98 7.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.726 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -88.44 129.94 35.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 108.95 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.34 111.49 23.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' A' ' 60' ' ' TYR . 1.1 mt -116.1 105.62 12.81 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -65.98 14.54 0.29 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 62.64 1.87 0.85 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 109.783 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 63' ' ' GLY . 44.6 mt-10 -103.46 4.17 35.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.091 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 67' ' ' SER . 45.6 t -103.41 122.08 44.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 69' ' ' ASP . 69.6 m -43.02 126.16 3.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.43 -8.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 67' ' ' SER . 10.9 t0 -68.24 -43.38 78.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.613 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -87.35 -33.52 19.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.325 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.53 ' OG ' HD13 ' A' ' 62' ' ' LEU . 5.7 t -57.77 -56.61 19.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.84 82.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.81 -48.13 50.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.257 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.13 96.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.159 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -63.2 -20.59 65.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.3 mm -83.01 -57.44 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 109.99 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -61.28 -32.91 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.968 . . . . 0.0 109.334 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -74.76 -44.01 51.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.147 -0.971 . . . . 0.0 109.588 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.531 ' N ' ' CG2' ' A' ' 78' ' ' THR . 45.2 t -69.93 -52.52 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.9 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -60.92 -59.52 5.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.721 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -53.29 -48.66 68.16 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.98 -1.075 . . . . 0.0 108.66 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 4.4 t0 -44.89 -45.82 10.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.111 -0.993 . . . . 0.0 108.801 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.28 -31.93 72.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 81' ' ' LEU . 11.5 t80 -77.06 -23.17 52.0 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.919 HD11 ' O ' ' A' ' 7' ' ' LYS . 3.6 tp -82.89 -51.35 7.7 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.279 -0.888 . . . . 0.0 109.902 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -122.4 -42.05 2.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.255 -0.903 . . . . 0.0 109.985 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.03 -15.51 16.04 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 89' ' ' ALA . 18.7 mtp-105 -144.52 -85.29 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.435 -1.039 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 88' ' ' ARG . . . 56.58 156.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.647 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.454 ' C ' ' NE2' ' A' ' 91' ' ' GLN . 17.7 t -91.54 150.23 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.147 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.454 ' NE2' ' C ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -134.7 122.95 22.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.103 -0.998 . . . . 0.0 110.137 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.637 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -136.42 159.98 40.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.302 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -121.12 144.59 48.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.954 . . . . 0.0 109.931 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 96' ' ' GLN . 4.9 mm-40 -115.1 85.29 2.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' A' ' 96' ' ' GLN . 2.4 t -71.89 37.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.695 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 95' ' ' VAL . 1.7 tt0 58.14 118.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.51 -35.9 4.66 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -113.58 45.0 1.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -1.137 . . . . 0.0 109.436 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -71.04 178.93 2.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 m -101.14 160.13 14.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.0 109.441 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.39 65.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.489 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.7 m -71.77 -52.98 14.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.446 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -61.2 -37.69 83.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 109.594 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 mt -72.19 -27.85 62.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.542 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.58 -25.21 39.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.87 -14.34 29.84 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.187 -1.184 . . . . 0.0 109.693 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -134.88 93.81 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.637 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -78.19 -63.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.312 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -92.16 9.87 31.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.236 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 111' ' ' LEU . . . -80.46 56.97 4.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 110' ' ' GLY . 5.2 mp -144.71 92.03 2.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.471 -1.017 . . . . 0.0 109.218 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 35' ' ' PHE . 25.1 tttt -130.02 108.6 10.22 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.653 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.4 OUTLIER -82.19 107.88 15.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.999 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -108.03 108.54 19.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 108.901 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.82 109.99 1.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.29 61.2 1.47 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.37 33.94 5.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -94.59 -34.33 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -1.111 . . . . 0.0 109.376 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -82.54 -25.48 33.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.6 m -71.22 6.02 1.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.817 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -60.63 -27.49 66.31 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -83.8 -27.28 28.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -1.133 . . . . 0.0 109.526 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -57.8 -30.11 65.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.447 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -89.36 94.78 10.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.334 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.5 138.16 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.43 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.478 ' H ' HG23 ' A' ' 126' ' ' VAL . 2.1 t -56.92 113.16 5.56 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.485 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 57.3 Cg_exo -46.89 153.29 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.135 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.443 ' O ' HG12 ' A' ' 131' ' ' VAL . 35.4 m-80 -165.67 102.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.538 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.1 -25.41 59.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.69 -20.21 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 128' ' ' ASN . 7.6 p -49.29 -23.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.817 . . . . 0.0 109.609 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.2 t -51.72 -32.23 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.439 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -141.18 70.93 27.88 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.462 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.57 5.84 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.705 2.27 . . . . 0.0 112.271 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -52.46 -15.63 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.359 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.42 ' CD2' HD21 ' A' ' 24' ' ' LEU . 46.9 t80 -63.29 -28.84 70.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.469 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -62.42 -23.24 66.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.402 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 8' ' ' ALA . 5.6 mptp? -94.82 -60.98 1.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 109.443 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.567 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 59.08 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.386 -0.821 . . . . 0.0 109.324 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.569 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 42.2 43.55 4.61 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' GLY . 2.4 pttm -45.56 -23.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' GLY . 11.2 pt-20 -146.48 149.98 39.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -39.78 123.58 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.679 2.252 . . . . 0.0 112.223 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.4 -167.7 31.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.17 147.03 40.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -1.024 . . . . 0.0 109.555 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.569 HE21 ' N ' ' A' ' 9' ' ' GLY . 17.2 mt-30 -141.98 151.58 42.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.05 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.576 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -128.81 135.86 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.801 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 2.7 m-90 -141.94 110.58 6.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.215 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.501 ' CD ' ' CZ ' ' A' ' 41' ' ' TYR . 21.4 ttp180 -79.77 139.02 37.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.386 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -82.69 142.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.91 . . . . 0.0 109.352 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -159.62 97.09 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.441 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 12.2 ttmm 63.74 25.86 14.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.394 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.2 m-85 70.09 14.64 7.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.614 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' LEU . 9.8 t70 -98.29 -15.27 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.315 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' ASP . 1.9 mp 59.84 136.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.55 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.2 t -140.02 127.06 12.47 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.865 . . . . 0.0 109.012 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.57 126.05 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.29 1.993 . . . . 0.0 112.364 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.41 134.78 81.7 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.52 130.26 16.95 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.401 2.067 . . . . 0.0 112.145 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 30' ' ' ASN . 20.5 m -60.0 -26.37 66.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.263 -0.898 . . . . 0.0 109.419 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 29' ' ' THR . 57.1 t30 -44.17 -38.84 3.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.974 . . . . 0.0 109.229 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 32' ' ' TYR . 42.2 mt -108.81 -55.15 2.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.481 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 31' ' ' LEU . 6.2 t80 47.92 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 0.0 109.451 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.589 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 123.73 -30.74 4.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.597 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 15.3 m-20 -80.88 146.55 30.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.238 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 m-85 -146.1 152.22 38.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.099 -1.001 . . . . 0.0 109.843 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.546 ' CE1' ' O ' ' A' ' 116' ' ' GLY . 0.5 OUTLIER -90.27 104.55 17.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.089 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.6 p -59.07 87.3 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -179.94 -30.66 0.06 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -107.44 -152.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.505 -0.997 . . . . 0.0 108.725 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -137.48 140.46 41.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.588 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.501 ' CZ ' ' CD ' ' A' ' 18' ' ' ARG . 18.8 m-85 -117.72 124.93 49.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.4 130.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.63 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.6 mt -123.46 145.95 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 43' ' ' ILE . 2.3 mm? -124.85 133.24 53.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 55' ' ' GLN . 12.0 ttpt -129.91 94.0 3.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.091 -1.006 . . . . 0.0 110.031 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.613 ' OG1' ' CE2' ' A' ' 56' ' ' TYR . 64.5 m -84.99 106.75 16.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.22 164.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.356 -0.84 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -60.79 157.76 14.28 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.538 0.685 . . . . 0.0 110.627 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.709 ' H ' HD12 ' A' ' 49' ' ' LEU . 2.7 mp -67.97 -34.8 77.24 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 49' ' ' LEU . 36.1 mtp180 -42.84 -34.21 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.223 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -78.3 -28.1 47.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.855 . . . . 0.0 109.174 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 152.65 67.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' C ' ' A' ' 54' ' ' LEU . 8.3 t-20 58.98 150.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -1.121 . . . . 0.0 109.48 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.499 ' C ' ' O ' ' A' ' 53' ' ' ASN . 14.2 mt -39.95 113.73 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.927 . . . . 0.0 108.787 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.1 tt0 -105.31 96.59 6.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.054 -1.029 . . . . 0.0 110.513 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.673 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 27.8 m-85 -76.61 109.65 10.53 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.602 ' CG ' ' HE2' ' A' ' 59' ' ' HIS . 22.6 t0 -83.61 126.97 33.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.977 -1.077 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 82' ' ' ASP . 4.0 mp -97.19 119.82 36.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.69 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 18.7 m-70 -134.1 108.76 8.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.705 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -103.66 119.58 39.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.537 ' NE1' HD12 ' A' ' 111' ' ' LEU . 78.1 t90 -96.41 126.51 41.65 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 110.243 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.667 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.9 mt -122.52 109.39 14.28 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.488 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -59.3 10.32 0.03 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 62' ' ' LEU . 28.9 t30 67.45 1.79 2.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -108.32 11.29 27.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.002 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.549 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.4 t -104.45 146.02 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 m -77.38 164.88 25.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.616 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -68.96 -8.87 48.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -68.87 -56.11 8.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -87.22 -38.86 15.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.512 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.3 t -58.62 -56.04 27.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.482 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.91 50.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.29 -36.38 4.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -1.178 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.49 70.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.322 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -68.4 -33.63 74.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mt -79.57 -44.8 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.821 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.5 -40.24 96.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.984 -1.072 . . . . 0.0 109.452 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.9 t -76.34 -45.03 34.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 75' ' ' ALA . 49.9 t -61.72 -54.33 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.797 . . . . 0.0 110.143 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.572 ' CG ' ' N ' ' A' ' 81' ' ' LEU . 12.0 pt20 -62.56 -50.55 70.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 110.143 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -59.82 -51.26 70.48 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.745 -1.222 . . . . 0.0 108.647 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.582 ' OD2' ' ND2' ' A' ' 86' ' ' ASN . 3.1 t0 -43.76 -43.47 6.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.004 -1.06 . . . . 0.0 108.358 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.08 -36.77 80.53 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.615 ' N ' ' O ' ' A' ' 81' ' ' LEU . 3.6 t80 -73.19 -23.6 60.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.501 HD11 ' O ' ' A' ' 7' ' ' LYS . 1.1 tt -81.38 -52.2 7.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.254 -0.904 . . . . 0.0 109.961 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.582 ' ND2' ' OD2' ' A' ' 82' ' ' ASP . 2.2 p30 -122.12 -42.33 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.112 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.18 -10.65 26.77 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -149.96 -81.1 0.12 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -1.083 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.673 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 56.89 170.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.9 t -97.99 150.16 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.241 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.445 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 7.1 pt20 -113.62 147.86 37.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.883 . . . . 0.0 109.953 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.69 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 27.0 m-70 -146.23 122.78 11.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 23.7 ptt85 -111.5 118.75 36.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.821 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.6 mp0 -114.82 100.16 8.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.273 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 96' ' ' GLN . 2.2 t -87.12 37.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 0.0 109.65 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.488 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 24.8 tt0 72.04 107.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.866 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' N ' ' OE1' ' A' ' 99' ' ' GLU . . . 93.31 -29.81 7.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -97.38 37.57 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 1.1 mp0 -63.25 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.9 m -131.57 -169.97 2.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -61.33 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 98.5 m -55.45 -37.33 67.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -67.46 -45.96 74.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.7 mt -74.63 -10.35 59.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.46 -39.06 8.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -80.26 -33.92 37.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.54 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -103.4 107.18 17.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -99.38 -12.54 20.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.1 m -53.43 -36.1 61.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.53 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 93.59 35.9 6.04 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.73 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.2 mm? 53.71 103.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -95.4 119.09 33.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -81.96 107.73 14.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.843 . . . . 0.0 109.645 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -115.84 108.57 16.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.233 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -60.84 112.31 1.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.499 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.546 ' O ' ' CE1' ' A' ' 36' ' ' PHE . . . -128.05 144.41 15.2 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.04 -27.68 14.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.445 ' H ' HG22 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -54.87 -33.32 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -1.137 . . . . 0.0 109.423 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.63 -35.1 63.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.501 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.1 m -111.11 6.12 20.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.64 -26.37 65.42 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -80.55 -22.71 40.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -1.207 . . . . 0.0 109.483 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 124' ' ' HIS . 28.4 tttp -76.7 -30.42 56.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.879 . . . . 0.0 109.53 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.472 ' O ' ' O ' ' A' ' 123' ' ' LYS . 17.7 m-70 -53.22 -170.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.337 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -96.43 146.69 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.7 t -92.55 114.79 63.45 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 75.9 Cg_exo -45.24 143.03 5.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.424 2.083 . . . . 0.0 112.19 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 12.6 m-20 -44.32 169.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -80.07 -21.72 43.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.3 t -47.15 -33.93 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.05 -43.92 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.406 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.98 -27.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.405 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 4' ' ' GLU . 5.6 t-80 44.96 65.31 6.49 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.71 75.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.894 2.396 . . . . 0.0 112.31 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 2' ' ' HIS . 29.4 mt-10 -61.52 -29.5 70.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.129 -0.982 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -47.38 -35.11 7.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.079 -1.013 . . . . 0.0 109.429 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.7 mm? -84.61 -21.87 30.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.273 -0.892 . . . . 0.0 109.42 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 4' ' ' GLU . 12.1 tttm -69.34 -32.81 72.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.19 142.54 54.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.54 44.47 4.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -107.5 -23.24 12.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -1.098 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -152.14 150.99 26.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.868 . . . . 0.0 109.275 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.19 172.37 16.14 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.605 2.203 . . . . 0.0 112.314 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.47 -125.63 8.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.46 HD13 ' CD1' ' A' ' 106' ' ' TYR . 4.0 tt -137.11 146.87 45.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.733 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 17' ' ' TRP . 17.1 mt-30 -137.29 139.46 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.608 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 8.7 mt -111.3 145.2 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.938 . . . . 0.0 109.885 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.7 m0 -148.76 110.74 4.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' VAL . 3.4 tmm_? -85.92 131.44 34.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.187 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.3 143.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.164 -0.96 . . . . 0.0 110.111 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 22' ' ' PHE . 30.3 tt0 -144.46 124.69 13.74 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 24.0 tttp 60.99 -74.07 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.958 . . . . 0.0 109.016 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' GLU . 10.7 m-85 -168.57 19.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 109.877 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.99 111.27 13.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.11 -0.994 . . . . 0.0 109.693 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 25' ' ' VAL . 9.0 mp -48.99 159.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.362 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ARG . 48.0 t -153.6 90.79 3.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.161 -0.962 . . . . 0.0 109.605 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.32 127.17 21.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.722 2.281 . . . . 0.0 112.207 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.5 p -106.83 133.63 20.19 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 109.383 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -41.11 93.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.542 2.161 . . . . 0.0 112.318 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.602 ' OG1' HD12 ' A' ' 16' ' ' ILE . 28.0 m -71.38 -12.12 61.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.521 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -77.21 -23.62 51.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.616 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 31' ' ' LEU . 10.4 tp -136.25 13.53 3.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.256 -0.903 . . . . 0.0 109.605 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -56.63 -96.77 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.16 -0.963 . . . . 0.0 109.833 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.72 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 64.73 11.48 49.67 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' C ' ' OD2' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -161.84 147.01 13.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -1.081 . . . . 0.0 108.985 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.488 ' CE2' ' CH2' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -146.4 161.04 41.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.918 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -77.29 158.57 30.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 108.964 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 p -107.13 -30.26 8.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.673 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.36 20.46 5.97 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -139.43 -157.39 0.76 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -1.066 . . . . 0.0 109.312 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.83 140.8 31.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -119.44 121.91 40.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 109.574 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.56 130.82 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 139.87 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.651 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.609 HD23 ' CD1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -115.83 145.18 43.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -130.84 93.77 3.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.094 -1.004 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.636 HG23 ' CD2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -78.05 106.01 9.65 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -96.95 164.92 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.405 -0.809 . . . . 0.0 109.407 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 49' ' ' LEU . 30.8 tt0 -120.37 101.56 7.87 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.664 -0.648 . . . . 0.0 109.288 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 48' ' ' GLN . 14.1 mt -43.22 -86.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 109.377 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -140.21 -43.53 0.42 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.328 -0.857 . . . . 0.0 109.502 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -174.62 26.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.287 -0.883 . . . . 0.0 109.266 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.96 -95.66 2.36 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -118.62 -163.45 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.368 -1.078 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -124.94 168.48 13.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 109.443 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 45' ' ' LYS . 2.5 tt0 -131.36 113.64 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.744 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.768 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -86.89 110.29 19.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 108.954 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 1.1 m-20 -88.47 119.15 28.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.012 -1.055 . . . . 0.0 108.84 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 58' ' ' LEU . 3.1 pp -96.81 131.46 43.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.844 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.573 ' NE2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -135.35 127.88 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.538 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.694 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.65 114.84 29.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.096 179.387 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.566 ' CD1' ' CZ ' ' A' ' 103' ' ' PHE . 32.1 t90 -93.21 117.39 30.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 109.468 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.4 mt -117.69 118.53 32.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 108.994 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -67.78 21.5 0.26 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' LEU . 10.5 t30 57.01 1.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.718 -0.872 . . . . 0.0 110.019 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 63' ' ' GLY . 15.8 mm-40 -111.71 10.16 20.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 0.0 108.539 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 17.0 p -98.46 146.07 26.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.519 -0.738 . . . . 0.0 109.621 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 t -67.39 154.86 40.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.414 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -75.84 -9.02 58.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.657 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.32 -45.73 45.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.686 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -87.3 -35.77 18.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.947 . . . . 0.0 109.303 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.595 ' OG ' HD22 ' A' ' 62' ' ' LEU . 2.9 t -58.7 -53.53 57.35 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.495 -0.753 . . . . 0.0 109.458 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.09 -53.68 42.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -45.7 -38.71 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.655 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.11 83.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -67.93 -41.81 82.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.346 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.11 -39.43 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.302 -0.874 . . . . 0.0 109.752 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.31 -47.15 85.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.104 -0.998 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -75.54 -42.24 52.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 109.698 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 75' ' ' ALA . 54.1 t -62.38 -49.06 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.937 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -65.26 -59.85 3.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.875 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -56.03 -43.83 78.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 0.0 108.587 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 78' ' ' THR . 6.9 t70 -47.3 -46.98 25.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.139 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.49 -28.79 70.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.778 ' HB3' HD13 ' A' ' 81' ' ' LEU . 45.9 t80 -75.02 -24.37 58.34 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.64 -54.59 6.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 86' ' ' ASN . 22.5 t-20 -122.07 -42.03 2.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.939 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.48 1.95 24.52 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.9 mtm-85 -155.13 -78.27 0.09 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.425 -1.044 . . . . 0.0 109.263 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.768 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 55.7 178.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.59 146.84 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.585 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.63 140.09 38.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.483 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.424 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 52.9 m-70 -138.78 119.36 13.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.602 ' HE ' HG22 ' A' ' 95' ' ' VAL . 35.8 ttt180 -103.95 126.59 51.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 109.273 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 12.7 mp0 -127.27 78.67 1.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.948 . . . . 0.0 109.802 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.602 HG22 ' HE ' ' A' ' 93' ' ' ARG . 2.1 t -78.68 37.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.116 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.439 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 0.9 OUTLIER 42.28 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 98' ' ' PHE . . . 156.36 -35.5 0.6 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 97' ' ' GLY . 2.3 m-85 -135.88 54.68 1.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -1.077 . . . . 0.0 109.276 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.595 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 28.3 mt-10 -71.56 171.49 11.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.562 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 t -110.95 178.92 4.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.394 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -67.74 -26.37 66.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.594 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.3 m -63.39 -62.9 1.38 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.32 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD1' ' OE2' ' A' ' 99' ' ' GLU . 36.9 t80 -54.6 -41.98 70.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.69 -26.25 61.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.92 . . . . 0.0 109.384 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -63.95 -44.27 96.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' CD1' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -76.22 -50.96 13.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -1.114 . . . . 0.0 109.319 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.72 71.68 9.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -88.77 -40.78 12.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -105.7 8.03 32.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -90.18 -107.95 1.31 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 3.5 mm? 53.42 101.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.346 -1.091 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -166.07 95.96 0.59 Allowed 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.641 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -82.42 107.76 15.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.5 -0.75 . . . . 0.0 109.45 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -112.07 118.05 34.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.04 136.55 55.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 118' ' ' VAL . . . -93.76 0.4 67.4 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.73 -1.7 2.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' A' ' 116' ' ' GLY . 94.0 t -64.12 -13.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -1.147 . . . . 0.0 109.462 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -51.48 -27.58 10.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.4 t -66.85 6.19 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -55.11 -24.31 35.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -69.4 -29.95 67.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -1.183 . . . . 0.0 109.473 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -59.5 -33.42 71.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -67.94 164.53 19.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.45 146.65 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.9 83.97 31.11 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.359 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' ASN . 53.6 Cg_exo -48.45 149.82 6.36 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.74 2.293 . . . . 0.0 112.237 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' PRO . 18.4 m120 -42.86 166.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -87.67 -28.58 21.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.406 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.7 p -48.55 -32.37 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 131' ' ' VAL . 17.6 t -50.15 -60.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -73.93 -27.77 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.951 . . . . 0.0 109.587 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.488 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.487 ' OE2' ' O ' ' A' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.586 ' O ' ' N ' ' A' ' 4' ' ' GLU . 19.6 m-70 -144.77 75.17 14.61 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.91 75.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.863 2.375 . . . . 0.0 112.169 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 2' ' ' HIS . 31.8 tt0 -79.56 -45.62 18.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.452 ' CG ' HD13 ' A' ' 24' ' ' LEU . 39.2 t80 -45.99 -23.28 0.28 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 109.395 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -66.28 -35.35 80.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.233 -0.917 . . . . 0.0 109.247 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 8' ' ' ALA . 47.8 mttt -103.94 -45.31 4.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.341 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.782 ' HB3' HD11 ' A' ' 85' ' ' LEU . . . 58.54 135.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.509 -0.745 . . . . 0.0 109.643 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.613 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 50.73 53.57 25.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -58.02 -0.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.17 . . . . 0.0 109.361 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 9' ' ' GLY . 9.8 pt-20 -170.04 149.15 3.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.238 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.49 122.05 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.682 2.255 . . . . 0.0 112.252 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.78 -156.4 27.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.5 144.76 49.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.33 -1.1 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.613 HE21 ' H ' ' A' ' 9' ' ' GLY . 24.3 mt-30 -138.53 150.49 46.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.228 -0.92 . . . . 0.0 109.676 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.2 mt -119.05 137.58 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 0.0 109.779 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.7 m0 -142.27 110.82 6.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.3 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -79.03 137.73 37.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.588 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.58 143.28 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 0.0 109.496 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -155.77 88.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.43 -0.794 . . . . 0.0 109.357 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 tttm 65.53 33.85 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.492 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.426 ' CD2' ' N ' ' A' ' 22' ' ' PHE . 1.3 m-85 66.2 17.16 10.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 24' ' ' LEU . 55.7 m-20 -102.65 -14.89 16.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' ASP . 15.7 mt 57.43 144.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 109.633 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.2 t -154.15 110.25 2.46 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.363 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -46.83 112.9 0.55 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.388 2.058 . . . . 0.0 112.164 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 27' ' ' VAL . 13.1 p -47.52 133.61 10.32 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -40.91 101.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.509 2.139 . . . . 0.0 112.325 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.5 m -59.0 -25.65 63.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -50.42 -47.29 56.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.56 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -88.17 -54.98 3.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.85 . . . . 0.0 109.444 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.0 t80 55.54 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 109.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.26 17.08 3.35 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -117.28 144.46 44.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -1.172 . . . . 0.0 109.358 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.581 ' N ' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -146.14 133.92 21.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.773 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 38' ' ' GLY . 26.6 m-85 -92.14 103.03 15.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.059 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.459 ' H ' HG23 ' A' ' 37' ' ' THR . 16.3 p -52.19 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.643 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' PHE . . . 177.96 -29.43 0.07 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.464 ' OD1' ' CE2' ' A' ' 41' ' ' TYR . 4.0 p30 -107.93 -154.3 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.369 -1.077 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.15 141.07 34.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.464 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.464 ' CE2' ' OD1' ' A' ' 39' ' ' ASP . 88.5 m-85 -116.52 122.04 43.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.638 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.24 114.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.348 -0.845 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.463 ' HB ' ' ND1' ' A' ' 59' ' ' HIS . 1.8 mt -114.58 145.95 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.551 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 57' ' ' ASP . 1.1 mp -123.0 143.6 49.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.797 -0.565 . . . . 0.0 109.566 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 55' ' ' GLN . 5.0 ttmm -127.23 94.17 3.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.672 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.594 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 43.0 m -81.2 110.96 17.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.506 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.12 164.36 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -54.11 158.0 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.695 0.76 . . . . 0.0 110.803 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.681 ' H ' HD12 ' A' ' 49' ' ' LEU . 4.5 mp -67.52 -33.66 75.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.547 -0.721 . . . . 0.0 109.44 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LEU . 2.3 mtm180 -44.87 -38.7 4.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.359 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.53 -23.24 61.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.191 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 146.01 64.87 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.707 HD22 ' N ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER 57.99 153.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.275 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.707 ' N ' HD22 ' A' ' 53' ' ' ASN . 11.8 mt -36.4 107.0 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 108.815 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 45' ' ' LYS . 3.4 tt0 -100.59 98.85 9.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.101 -1.0 . . . . 0.0 110.422 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.825 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 29.6 m-85 -80.75 109.58 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 108.851 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.483 ' C ' HD22 ' A' ' 58' ' ' LEU . 35.9 t0 -76.33 140.8 41.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 108.684 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 82' ' ' ASP . 2.1 mm? -107.48 103.12 12.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.845 . . . . 0.0 109.546 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.68 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -122.24 112.19 17.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -101.72 125.99 48.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.582 ' O ' HD23 ' A' ' 62' ' ' LEU . 39.7 t90 -98.79 132.38 44.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.877 . . . . 0.0 109.871 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.596 ' C ' ' H ' ' A' ' 64' ' ' ASN . 2.8 mt -134.88 115.41 13.59 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.85 17.79 0.19 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 62' ' ' LEU . 23.8 t30 63.12 1.91 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 109.887 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -106.06 10.33 32.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 109.242 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.11 131.85 46.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.442 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 t -49.74 157.22 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -75.69 -11.83 60.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.469 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.4 p30 -79.24 -40.39 30.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.234 -0.916 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 36.2 tt0 -87.33 -33.81 19.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 0.0 109.286 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.59 ' OG ' HD13 ' A' ' 62' ' ' LEU . 37.5 t -68.11 -60.41 2.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.54 -39.0 29.27 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -58.07 -56.89 16.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -1.156 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.44 -40.88 19.14 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.118 -0.988 . . . . 0.0 109.028 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.621 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -70.64 -21.39 62.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.347 -0.846 . . . . 0.0 109.024 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.6 mm -84.51 -49.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -61.88 -36.58 81.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 109.322 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.8 t -76.29 -46.02 29.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.625 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.0 t -64.39 -52.38 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.96 -59.55 4.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 109.648 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.1 tm? -52.71 -48.85 66.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 108.764 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HB2' HD11 ' A' ' 58' ' ' LEU . 6.1 t70 -44.8 -45.93 10.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.565 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.71 -33.85 73.5 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 81' ' ' LEU . 5.5 t80 -74.68 -23.43 58.63 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -80.22 -52.93 7.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.564 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 86' ' ' ASN . 3.1 t-20 -122.1 -42.01 2.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.048 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.12 -14.88 21.11 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -145.54 -72.9 0.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -1.036 . . . . 0.0 109.245 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 56.1 -171.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 109.472 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.84 150.15 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.389 -0.819 . . . . 0.0 109.391 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.562 ' N ' ' OE1' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -108.33 133.0 53.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.716 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.591 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 12.4 m-70 -139.74 124.39 18.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.403 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 7.9 ptm180 -110.0 132.37 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 109.688 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.595 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 2.7 mt-10 -130.47 91.71 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.18 37.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 56.45 90.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.46 -32.04 2.52 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -125.12 56.86 1.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.445 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -85.72 167.55 15.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.6 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -100.28 161.01 13.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.47 77.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.54 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -62.23 -60.66 3.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.595 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 51.1 t80 -52.76 -38.8 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.463 -0.773 . . . . 0.0 109.465 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 104' ' ' LEU . 85.0 mt -69.29 -26.17 64.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.62 55.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -43.59 60.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.391 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.436 ' CD2' ' CE1' ' A' ' 103' ' ' PHE . 88.8 m-85 -106.33 76.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.551 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -100.8 -35.86 9.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.6 m -91.14 -3.31 57.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -91.09 -107.69 1.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 110' ' ' GLY . 85.0 mt 53.37 100.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.36 -1.083 . . . . 0.0 109.527 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.617 ' NZ ' ' HZ1' ' A' ' 114' ' ' LYS . 0.3 OUTLIER -151.67 90.97 1.6 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.85 107.72 14.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.516 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.617 ' HZ1' ' NZ ' ' A' ' 112' ' ' LYS . 22.4 mttm -112.37 108.92 18.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.383 -0.823 . . . . 0.0 109.389 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 5.5 ptpp? -63.61 127.07 29.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.19 -51.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.51 75.95 0.21 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.92 -12.05 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 0.0 109.498 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.44 -25.3 50.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 109.511 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.9 t -88.66 6.14 39.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.33 -0.856 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.89 71.5 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -53.57 -26.39 21.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -1.154 . . . . 0.0 109.503 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -57.71 -23.23 50.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -70.68 72.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.6 t -70.16 122.76 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.531 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.67 98.58 38.0 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.419 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 129' ' ' GLU . 58.9 Cg_endo -79.09 162.5 25.97 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.463 2.108 . . . . 0.0 112.253 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -59.09 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 127' ' ' PRO . 37.9 tt0 -88.07 -17.23 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.42 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 131' ' ' VAL . 9.4 p -57.13 -42.75 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.558 ' N ' HG13 ' A' ' 130' ' ' VAL . 12.9 p -46.95 -30.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.461 ' O ' ' NE2' ' A' ' 133' ' ' GLN . 15.0 t -71.66 -27.77 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 130' ' ' VAL . 85.1 mm-40 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.463 ' C ' ' CG ' ' A' ' 2' ' ' HIS . 27.6 tp10 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.345 0.593 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.591 ' CD2' ' N ' ' A' ' 2' ' ' HIS . 0.2 OUTLIER 61.88 149.15 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.421 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.26 76.91 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.705 2.27 . . . . 0.0 112.242 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -68.81 -26.03 64.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.887 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 6' ' ' LEU . 41.1 p90 -63.57 -31.3 72.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.334 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 5' ' ' PHE . 49.7 tp -49.78 -29.41 7.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.341 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.786 ' O ' HD11 ' A' ' 85' ' ' LEU . 27.4 mttm -102.4 -61.11 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.562 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 57.91 137.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 109.562 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.757 ' N ' HE21 ' A' ' 15' ' ' GLN . . . 47.39 38.55 13.32 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HG3' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -42.74 -23.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -1.167 . . . . 0.0 109.62 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 9' ' ' GLY . 34.0 mm-40 -143.79 153.67 58.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.469 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -41.65 122.84 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.76 2.306 . . . . 0.0 112.341 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.38 -167.09 33.92 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.782 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.7 tt -124.3 124.0 41.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -1.081 . . . . 0.0 109.217 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.757 HE21 ' N ' ' A' ' 9' ' ' GLY . 15.3 mt-30 -115.08 150.05 36.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 109.575 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.607 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.8 OUTLIER -123.6 140.45 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.792 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.607 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.9 m-90 -144.89 111.78 5.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -79.93 146.01 32.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.707 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.0 143.31 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.11 -0.994 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 2.9 tp10 -142.9 95.05 2.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.438 -0.789 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.544 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 8.6 tptp 71.6 40.26 0.81 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.298 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 2.4 m-85 72.82 21.43 3.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.656 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 22' ' ' PHE . 1.4 m-20 -127.31 111.5 13.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 mt -65.36 137.47 57.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.6 t -144.0 121.16 6.6 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.895 . . . . 0.0 109.283 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -44.08 148.06 1.19 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.271 1.981 . . . . 0.0 112.513 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 27' ' ' VAL . 11.7 p -92.41 134.21 28.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.186 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -39.15 108.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.651 2.234 . . . . 0.0 112.318 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.8 m -61.17 -29.11 69.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -46.77 -41.93 16.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.344 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.437 HD22 ' OD1' ' A' ' 34' ' ' ASP . 13.3 mt -91.22 -53.13 4.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.22 -0.925 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.3 t80 50.26 91.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.29 16.44 3.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.607 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 1.3 m-20 -128.96 135.7 49.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -1.155 . . . . 0.0 109.159 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 1.9 m-85 -146.07 161.26 40.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 109.897 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -85.3 145.49 27.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.324 -0.86 . . . . 0.0 109.173 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 p -89.9 -22.37 22.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.601 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.94 -15.87 69.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 13.0 t70 -103.75 -161.51 0.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -1.103 . . . . 0.0 109.327 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' H ' ' CG ' ' A' ' 39' ' ' ASP . . . -134.53 140.88 46.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 9.4 m-85 -120.6 148.44 43.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.456 -0.777 . . . . 0.0 109.772 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.76 138.19 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 109.347 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.591 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.4 mt -136.39 146.32 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 43' ' ' ILE . 4.1 mp -127.15 124.21 38.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.64 -0.662 . . . . 0.0 109.572 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -105.26 93.99 4.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.658 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.498 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 5.7 m -79.28 109.85 14.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -104.34 164.76 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.211 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -97.19 107.12 19.58 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.445 -0.784 . . . . 0.0 109.542 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.3 mt -56.78 -92.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.216 -0.927 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HG3' HH21 ' A' ' 50' ' ' ARG . 44.1 mtt85 -102.68 -63.38 1.17 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.227 -0.92 . . . . 0.0 109.614 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -172.32 24.91 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.527 -0.733 . . . . 0.0 109.149 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -148.79 -64.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.004 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.66 HD21 HD21 ' A' ' 86' ' ' ASN . 4.0 t30 -87.4 155.26 20.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -1.154 . . . . 0.0 109.736 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.511 HD23 ' C ' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -118.92 175.89 5.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.837 . . . . 0.0 109.182 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 47' ' ' VAL . 27.7 tt0 -133.14 112.61 11.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.053 -1.029 . . . . 0.0 109.89 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.519 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 18.8 m-85 -90.69 129.17 36.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 15.9 m-20 -95.11 126.6 40.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 108.964 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 58' ' ' LEU . 4.1 mm? -86.99 102.54 14.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.37 -0.831 . . . . 0.0 109.727 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.716 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 23.7 m-70 -116.9 108.67 16.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 0.0 109.567 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.708 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.37 124.21 49.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -0.983 . . . . 0.0 108.686 179.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.776 ' O ' HD23 ' A' ' 62' ' ' LEU . 5.6 t90 -95.92 128.78 43.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.147 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.776 HD23 ' O ' ' A' ' 61' ' ' TRP . 0.7 OUTLIER -129.7 106.4 8.69 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -60.57 16.94 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.664 ' H ' ' C ' ' A' ' 62' ' ' LEU . 35.1 t30 61.27 1.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.734 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 63' ' ' GLY . 40.0 mt-10 -104.88 5.82 33.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.98 . . . . 0.0 109.083 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 43.8 t -101.61 129.16 47.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.546 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 t -51.16 144.39 9.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.444 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -64.62 -8.7 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.572 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -73.58 -44.78 56.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -86.86 -37.98 17.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.301 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.613 ' OG ' HD13 ' A' ' 62' ' ' LEU . 8.6 t -60.08 -51.8 68.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.45 -0.781 . . . . 0.0 109.379 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -54.51 -40.5 69.86 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 76' ' ' ILE . . . -57.0 -55.15 38.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -1.156 . . . . 0.0 109.422 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.78 -41.64 44.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.924 . . . . 0.0 109.123 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -70.15 -20.28 63.16 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.2 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 73' ' ' ALA . 3.5 mm -84.42 -49.19 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.35 -33.45 76.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.976 . . . . 0.0 109.373 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.536 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.2 t -77.85 -43.78 29.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 75' ' ' ALA . 53.1 t -68.09 -44.32 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -66.13 -59.62 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -54.45 -45.32 73.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.986 -1.071 . . . . 0.0 108.538 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.411 ' OD2' ' C ' ' A' ' 82' ' ' ASP . 3.5 t0 -47.16 -48.01 23.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 108.607 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.0 -30.58 70.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 81' ' ' LEU . 16.9 t80 -78.43 -23.1 46.8 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.786 HD11 ' O ' ' A' ' 7' ' ' LYS . 3.8 tp -83.94 -49.91 8.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.263 -0.898 . . . . 0.0 109.921 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.66 HD21 HD21 ' A' ' 53' ' ' ASN . 13.5 t-20 -122.3 -42.21 2.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.336 -0.853 . . . . 0.0 110.204 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.71 -19.86 20.9 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -140.97 -68.78 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -1.056 . . . . 0.0 109.351 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . 54.63 -169.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.858 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.06 150.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.326 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -107.73 129.42 55.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.814 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.716 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 24.0 m-70 -135.88 113.5 10.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.276 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.492 HH21 ' HB2' ' A' ' 93' ' ' ARG . 19.6 ttp-105 -107.63 125.53 51.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.751 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.593 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 22.2 mt-10 -122.21 89.03 3.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.7 t -85.92 37.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -0.875 . . . . 0.0 109.588 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 53.9 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 158.02 -64.99 0.3 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 21.0 m-85 -122.89 49.25 1.67 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.4 -1.059 . . . . 0.0 109.338 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.5 mp0 -51.61 170.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.62 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t -87.07 165.44 15.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.19 -29.54 57.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.161 -0.962 . . . . 0.0 109.636 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.5 m -65.86 -50.2 65.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.125 -0.984 . . . . 0.0 109.109 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 38.9 t80 -63.48 -48.81 76.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.431 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 108' ' ' LYS . 29.8 mt -63.81 -38.38 90.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.174 -0.953 . . . . 0.0 109.305 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -69.77 -38.16 76.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.238 -1.154 . . . . 0.0 109.26 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -124.27 50.97 1.62 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.421 -0.799 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 110' ' ' GLY . 2.8 tptm -78.15 -28.99 48.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 m -59.51 0.58 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 96.75 110.31 2.68 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.674 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -74.48 -104.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -1.165 . . . . 0.0 109.301 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tptp 179.1 113.0 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 109.156 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.02 107.71 19.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.79 . . . . 0.0 109.416 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -110.53 128.02 55.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.284 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -77.47 156.05 31.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.245 -0.91 . . . . 0.0 109.613 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.33 115.27 3.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 178.5 -38.34 0.08 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.5 t -55.58 -31.01 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -1.112 . . . . 0.0 109.3 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.19 -28.87 31.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.331 -0.855 . . . . 0.0 109.414 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.1 m -78.49 6.06 9.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.7 -19.89 69.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -76.49 -29.53 56.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -1.162 . . . . 0.0 109.369 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 124' ' ' HIS . 38.1 mttp -74.09 -2.66 25.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.464 ' CE1' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER 54.29 101.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 109.468 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.74 115.16 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.464 ' CG2' ' CE1' ' A' ' 124' ' ' HIS . 21.1 t -142.11 72.79 22.55 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.29 165.17 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.842 2.361 . . . . 0.0 112.144 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -140.39 35.99 1.87 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.29 -26.39 65.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.421 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 131' ' ' VAL . 9.0 p -57.72 -35.85 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.411 ' N ' HG13 ' A' ' 130' ' ' VAL . 3.0 t -65.9 -39.56 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.13 -30.09 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.49 179.914 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.324 0.583 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.548 ' C ' ' H ' ' A' ' 4' ' ' GLU . 3.8 m-70 -129.99 90.26 43.11 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 4' ' ' GLU . 52.5 Cg_exo -49.09 -1.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.677 2.251 . . . . 0.0 112.278 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.548 ' H ' ' C ' ' A' ' 2' ' ' HIS . 59.1 mm-40 -43.32 -44.87 5.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.394 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -48.42 -40.96 27.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.406 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.655 ' N ' HD22 ' A' ' 6' ' ' LEU . 3.6 mm? -78.75 -24.86 44.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.347 -0.845 . . . . 0.0 109.342 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -65.12 -31.7 73.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.22 -0.925 . . . . 0.0 109.307 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' CB ' ' CH2' ' A' ' 17' ' ' TRP . . . -74.19 113.5 11.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.314 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.447 ' H ' HE22 ' A' ' 15' ' ' GLN . . . 99.32 49.01 1.62 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -140.24 -14.09 1.02 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -155.01 148.05 18.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.0 109.298 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.49 170.81 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.648 2.232 . . . . 0.0 112.252 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.9 -163.03 12.67 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 106' ' ' TYR . 3.5 tt -110.86 117.06 32.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -1.07 . . . . 0.0 109.598 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.447 HE22 ' H ' ' A' ' 9' ' ' GLY . 27.1 mt-30 -96.63 157.32 15.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 109.393 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 43' ' ' ILE . 1.9 mt -143.87 113.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.594 ' HH2' HD22 ' A' ' 44' ' ' LEU . 8.2 p90 -140.76 137.09 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.099 -1.001 . . . . 0.0 109.113 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -90.04 146.43 24.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.81 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -85.19 143.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.174 -0.954 . . . . 0.0 109.316 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ASP . 24.2 tt0 -150.52 103.86 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.529 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER 44.43 35.82 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.905 . . . . 0.0 109.461 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 1.3 m-85 68.76 26.89 5.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.633 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.9 t70 -109.42 -20.27 12.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' ASP . 2.3 mp 59.63 138.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.342 -0.849 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.57 128.79 5.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.044 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.78 125.39 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.249 1.966 . . . . 0.0 112.041 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 27' ' ' VAL . 10.8 p -71.68 132.9 84.92 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.13 127.41 3.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.7 m -65.98 -25.71 67.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.26 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -53.3 -50.14 65.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.359 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.7 mp -78.0 -55.37 5.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.155 -0.966 . . . . 0.0 109.365 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' O ' ' A' ' 31' ' ' LEU . 34.6 t80 46.91 91.82 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 109.536 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 35' ' ' PHE . . . 123.88 -30.96 4.69 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' OD1' HD23 ' A' ' 31' ' ' LEU . 2.5 m-20 -51.81 146.26 8.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.049 -1.266 . . . . 0.0 109.102 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 112' ' ' LYS . 28.6 m-85 -137.77 120.14 15.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.077 -1.014 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.84 107.43 17.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 108.896 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.6 p -70.86 87.61 0.72 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.672 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 178.65 -30.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -112.45 -152.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.927 . . . . 0.0 108.625 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.76 140.11 45.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.002 . . . . 0.0 109.617 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -112.72 124.82 53.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.265 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' A' ' 78' ' ' THR . 74.8 t -102.99 119.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.679 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -118.97 146.21 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.246 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.704 HD23 ' CD1' ' A' ' 56' ' ' TYR . 1.5 mp -126.2 152.91 45.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.556 -0.715 . . . . 0.0 109.482 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -140.53 93.83 2.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.161 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.614 ' OG1' ' CE1' ' A' ' 56' ' ' TYR . 1.2 m -88.49 111.42 21.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -0.812 . . . . 0.0 109.212 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.32 164.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.482 -0.762 . . . . 0.0 109.092 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' A' ' 51' ' ' ASN . 34.7 tt0 -104.51 119.23 38.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.549 -0.719 . . . . 0.0 109.443 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.6 mt -74.32 -99.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 51' ' ' ASN . 83.3 mtt180 -88.72 -63.37 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.713 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.447 ' HA ' HE21 ' A' ' 48' ' ' GLN . 51.8 m-20 -168.54 23.21 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.414 -0.804 . . . . 0.0 109.326 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.71 -52.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -70.69 144.99 50.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -1.196 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.782 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -133.52 168.25 18.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 109.297 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -134.42 104.42 6.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 110.489 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.704 ' CD1' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -77.95 123.37 26.71 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.092 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.585 ' OD2' ' CD2' ' A' ' 92' ' ' HIS . 3.8 t0 -103.23 122.08 44.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.033 . . . . 0.0 108.494 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.826 HD23 HG22 ' A' ' 78' ' ' THR . 10.4 mp -94.78 143.18 26.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.427 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -149.1 108.42 3.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -99.04 115.22 28.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 108.857 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.53 ' CE2' HD12 ' A' ' 111' ' ' LEU . 26.8 t90 -90.13 126.79 35.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.359 -0.838 . . . . 0.0 109.991 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.665 HD13 ' OG ' ' A' ' 71' ' ' SER . 3.9 mt -122.6 108.02 12.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' OE1' ' A' ' 96' ' ' GLN . . . -63.44 15.7 0.1 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.64 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.1 t-20 62.53 1.9 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -1.083 . . . . 0.0 109.962 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 63' ' ' GLY . 9.7 mm-40 -106.01 8.99 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.0 . . . . 0.0 109.12 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 19.1 t -104.36 141.03 37.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 m -57.24 146.87 26.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -64.23 -26.75 68.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.02 -32.07 72.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.543 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -87.22 -45.16 10.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.295 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.665 ' OG ' HD13 ' A' ' 62' ' ' LEU . 33.2 t -53.34 -49.76 66.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 73' ' ' ALA . . . -59.68 -48.27 86.85 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 72' ' ' GLY . . . -46.0 -43.53 14.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -1.122 . . . . 0.0 109.24 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 19' ' ' VAL . . . -63.42 -56.09 19.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -57.41 -20.5 30.35 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.366 -0.834 . . . . 0.0 108.935 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.5 mm -82.42 -59.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.269 -0.894 . . . . 0.0 109.395 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -63.18 -25.28 68.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.893 . . . . 0.0 108.716 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.826 HG22 HD23 ' A' ' 58' ' ' LEU . 5.3 m -75.91 -50.4 15.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.627 -0.671 . . . . 0.0 109.535 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 75' ' ' ALA . 51.6 t -73.65 -27.81 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -71.56 -59.78 2.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -58.64 -46.96 85.97 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.986 -1.071 . . . . 0.0 108.414 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.726 ' HB2' HD21 ' A' ' 58' ' ' LEU . 5.4 t70 -47.22 -45.75 23.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 87' ' ' GLY . 13.5 t70 -61.66 -27.85 68.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.731 ' HB3' HD13 ' A' ' 81' ' ' LEU . 20.4 t80 -74.85 -23.85 58.49 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.9 mt -83.88 -54.11 5.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.841 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.488 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -121.71 -42.36 2.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.256 -0.902 . . . . 0.0 109.994 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.408 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . 126.11 -44.28 1.27 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 52.7 mtt85 -112.34 -85.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -1.048 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . . . 71.69 150.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.64 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 90' ' ' VAL . 1.6 t -79.57 150.54 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -122.95 130.26 52.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 109.891 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.585 ' CD2' ' OD2' ' A' ' 57' ' ' ASP . 20.0 m-70 -124.99 129.46 50.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.043 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -107.32 126.86 52.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 109.86 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 100.54 7.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.42 HG12 HD22 ' A' ' 64' ' ' ASN . 2.3 t -96.49 38.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 63' ' ' GLY . 1.8 tt0 52.23 80.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.1 -62.34 0.37 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -94.94 60.78 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.471 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -67.04 159.4 28.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 m -91.82 170.03 10.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.95 -61.06 1.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.2 m -48.91 -47.94 42.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 109.251 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.45 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 21.7 t80 -55.07 -49.52 71.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.63 -16.26 62.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.31 -31.88 26.92 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.405 ' CE2' HD22 ' A' ' 14' ' ' LEU . 2.5 t80 -82.45 -34.59 28.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.681 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -105.21 113.86 27.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 109.722 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -103.99 -12.49 16.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.9 p -53.27 -29.63 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 109.459 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 87.09 40.62 6.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.798 ' N ' HD22 ' A' ' 111' ' ' LEU . 2.8 mm? 52.01 102.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.095 -1.238 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 35' ' ' PHE . 4.2 tmtm? -94.23 117.53 30.25 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -81.81 107.77 14.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.366 -0.834 . . . . 0.0 109.736 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -107.98 108.83 20.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.478 ' O ' ' CG2' ' A' ' 118' ' ' VAL . 14.3 mptt -57.38 117.76 4.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.63 -178.76 46.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.84 18.11 79.75 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 115' ' ' LYS . 2.1 t -81.71 -20.5 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -1.173 . . . . 0.0 109.521 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -46.48 -25.66 0.72 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.202 -0.936 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.3 m -72.17 6.13 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.584 ' O ' ' CG ' ' A' ' 124' ' ' HIS . . . -69.84 -51.48 24.26 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -50.26 -26.53 4.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -1.167 . . . . 0.0 109.428 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -72.98 2.92 6.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.405 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.591 ' C ' ' HD1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -75.15 167.13 22.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.518 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -103.54 120.88 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.65 113.39 59.42 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.386 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.473 ' O ' ' CG ' ' A' ' 128' ' ' ASN . 61.0 Cg_endo -78.72 125.78 6.96 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 112.167 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.473 ' CG ' ' O ' ' A' ' 127' ' ' PRO . 15.9 m-20 -175.36 64.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.288 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.12 -17.28 62.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.01 -23.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.77 -26.63 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -73.11 -27.84 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.525 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.458 ' ND1' ' N ' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -142.36 65.86 18.55 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 0.0 109.569 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 7' ' ' LYS . 48.9 Cg_exo -51.84 -29.64 35.34 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.77 2.314 . . . . 0.0 112.052 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.528 ' HA ' ' H ' ' A' ' 8' ' ' ALA . 12.7 pt-20 -56.99 -29.36 63.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 3.8 t80 -66.79 -44.19 81.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tp -89.66 -19.26 25.08 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' O ' ' O ' ' A' ' 8' ' ' ALA . 35.3 mttm -108.45 -61.37 1.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.621 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 57.64 133.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.614 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 56.3 44.66 89.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' GLY . 38.2 mttp -42.57 -22.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -1.066 . . . . 0.0 109.418 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' GLY . 33.3 mt-10 -152.87 152.95 29.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -39.68 120.09 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.665 2.243 . . . . 0.0 112.15 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.97 -162.08 32.85 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -126.55 143.22 51.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -1.05 . . . . 0.0 109.678 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.614 HE21 ' H ' ' A' ' 9' ' ' GLY . 25.5 mt-30 -137.52 156.17 48.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.591 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.6 OUTLIER -126.49 137.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.0 109.808 -179.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 4.4 m0 -142.59 111.08 6.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.293 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.67 146.13 44.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.148 -0.97 . . . . 0.0 109.501 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' A' ' 74' ' ' ALA . 1.6 t -80.29 143.91 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.0 109.39 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 21' ' ' LYS . 6.6 tp10 -159.18 109.6 1.99 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.448 -0.783 . . . . 0.0 109.461 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 20' ' ' GLU . 19.3 mttp 41.54 41.11 1.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.882 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 55.78 45.95 23.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 24' ' ' LEU . 25.7 t0 -126.47 -19.38 4.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 23' ' ' ASP . 9.6 mp 57.2 123.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.64 122.18 10.22 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.88 . . . . 0.0 109.142 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.22 139.6 3.97 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.386 2.057 . . . . 0.0 112.501 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.16 127.89 93.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -40.16 101.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.476 2.118 . . . . 0.0 112.346 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 m -49.41 -27.43 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.376 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.38 -41.94 14.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.212 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 mt -101.98 -53.86 2.84 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 t80 51.51 91.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 109.501 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . 123.5 -22.35 7.0 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.592 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 11.1 m-20 -92.53 147.74 22.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -1.206 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 34' ' ' ASP . 9.1 m-85 -145.68 150.44 36.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.95 . . . . 0.0 109.749 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 38' ' ' GLY . 67.9 m-85 -87.48 109.83 19.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 109.168 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 114' ' ' LYS . 16.6 p -60.28 87.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.185 -0.947 . . . . 0.0 109.527 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . 179.02 -29.79 0.06 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 40' ' ' ALA . 14.2 t0 -107.52 -153.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -1.058 . . . . 0.0 108.873 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -139.41 147.91 42.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 11.9 m-85 -128.54 141.1 51.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.585 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.439 ' CG1' ' OG1' ' A' ' 78' ' ' THR . 47.1 t -115.8 128.18 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.581 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.6 mt -123.14 146.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.319 -0.863 . . . . 0.0 109.25 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' A' ' 56' ' ' TYR . 3.8 mp -124.58 151.86 44.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -142.8 93.77 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 109.95 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.618 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 94.6 m -85.6 117.24 24.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.518 -0.738 . . . . 0.0 109.615 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.86 164.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.276 -0.89 . . . . 0.0 109.261 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -125.64 110.8 14.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.565 -0.709 . . . . 0.0 109.154 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -52.3 -91.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.234 -0.916 . . . . 0.0 109.418 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.23 -38.03 0.46 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.179 -0.951 . . . . 0.0 109.54 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 14.1 t30 -173.7 30.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -0.85 . . . . 0.0 109.365 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.47 -97.13 2.31 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -125.44 -165.33 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -1.16 . . . . 0.0 109.509 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.627 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -125.13 161.12 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.796 . . . . 0.0 109.305 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -125.54 106.32 9.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 110.125 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 12.2 m-85 -77.83 130.02 36.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.599 ' OD1' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.1 117.84 33.72 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 58' ' ' LEU . 5.8 mp -96.11 143.82 26.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 110.779 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 1.4 m-70 -145.6 111.84 5.72 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -93.2 116.17 28.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 0.0 108.842 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.782 ' C ' HD23 ' A' ' 62' ' ' LEU . 25.5 t90 -91.49 129.06 37.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.361 -0.837 . . . . 0.0 110.041 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.782 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.3 OUTLIER -131.53 111.87 12.14 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.55 14.22 0.08 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.2 t-20 65.22 1.78 1.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.447 -1.031 . . . . 0.0 109.862 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -107.16 10.32 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 108.984 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 28.8 t -104.41 146.21 29.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.463 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 p -70.43 140.64 52.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.455 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLN . 34.0 tt0 -63.03 -8.86 8.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.903 . . . . 0.0 109.438 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 47.1 t0 -70.73 -49.51 46.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.671 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -87.24 -40.41 14.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 109.417 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.6 t -57.05 -54.41 47.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.43 -0.794 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.34 -45.32 35.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.19 -51.93 60.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.257 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 19' ' ' VAL . . . -50.68 -45.75 58.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.5 -21.54 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 109.224 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mm -84.27 -52.01 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -58.93 -38.95 80.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -0.972 . . . . 0.0 109.345 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.603 HG23 ' N ' ' A' ' 79' ' ' VAL . 4.8 t -72.6 -48.24 41.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.762 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.603 ' N ' HG23 ' A' ' 78' ' ' THR . 40.9 t -64.17 -56.26 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.855 . . . . 0.0 109.906 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -54.1 -58.91 5.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -50.24 -47.51 55.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.067 -1.02 . . . . 0.0 109.278 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.629 ' OD2' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -46.95 -47.6 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.861 -1.149 . . . . 0.0 108.399 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.59 -28.28 69.24 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LEU . 26.9 t80 -78.29 -23.47 47.15 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.49 -51.07 7.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.618 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.596 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -122.33 -42.16 2.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.221 -0.924 . . . . 0.0 109.955 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.18 -18.4 6.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.497 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.6 mmm180 -141.94 -84.56 0.18 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.411 -1.053 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.629 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . . . 65.34 145.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t -82.6 150.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.307 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -124.56 158.01 34.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.599 ' CD2' ' OD1' ' A' ' 57' ' ' ASP . 26.2 m-70 -138.29 143.56 40.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.836 . . . . 0.0 109.42 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -114.97 127.12 55.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.587 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -126.88 89.77 3.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.97 37.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.57 84.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 109.354 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.97 -54.99 0.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -94.32 58.6 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -93.13 150.78 20.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 109.371 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 m -91.11 176.99 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -73.73 -27.28 61.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -64.01 -53.39 50.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.003 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.47 ' C ' ' CD2' ' A' ' 103' ' ' PHE . 18.8 t80 -62.88 -50.38 71.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.453 -0.779 . . . . 0.0 109.38 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -66.92 -26.18 66.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.197 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -62.7 -48.16 83.48 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -48.79 69.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.228 -1.16 . . . . 0.0 109.209 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -106.23 67.58 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -93.16 -16.96 24.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.935 . . . . 0.0 109.592 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 m -67.18 -3.91 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.918 . . . . 0.0 109.663 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.66 109.79 2.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.702 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.74 -102.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -1.159 . . . . 0.0 109.215 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 111' ' ' LEU . 7.2 mttm 163.79 117.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.462 -0.773 . . . . 0.0 109.126 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.414 ' HB2' HG21 ' A' ' 37' ' ' THR . 0.2 OUTLIER -94.31 107.99 19.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' THR . 69.1 mttt -113.77 136.2 53.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 109.438 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -62.79 114.63 3.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.932 . . . . 0.0 109.442 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.39 128.79 9.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 119' ' ' ALA . . . -179.3 37.17 0.07 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 117' ' ' GLY . 41.0 t -42.78 -21.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.125 . . . . 0.0 109.436 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 117' ' ' GLY . . . -53.28 -21.88 6.17 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.1 t -67.88 6.26 0.72 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.415 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . -80.7 -23.34 60.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -49.86 -17.94 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -1.173 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 124' ' ' HIS . 32.4 tttm -69.32 -42.59 75.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.487 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.531 ' O ' ' O ' ' A' ' 123' ' ' LYS . 16.1 m-70 57.99 137.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.83 . . . . 0.0 109.635 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 t -140.96 132.27 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.14 113.25 64.54 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.12 142.72 8.22 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.373 2.048 . . . . 0.0 112.28 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.514 ' H ' ' ND2' ' A' ' 128' ' ' ASN . 1.7 p30 -64.9 130.53 43.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -87.96 -17.45 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 130' ' ' VAL . 23.0 t -49.13 -56.52 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 132' ' ' VAL . 14.2 p -52.35 -37.88 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.474 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.455 ' N ' HG13 ' A' ' 131' ' ' VAL . 16.6 t -69.89 -27.89 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.476 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -136.44 72.89 57.3 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.21 143.02 24.94 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.697 2.265 . . . . 0.0 112.26 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 6' ' ' LEU . 55.6 mt-10 -56.82 -18.69 13.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.603 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 4' ' ' GLU . 73.5 t80 -41.62 -22.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.498 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 4' ' ' GLU . 27.9 tp -74.25 -33.46 63.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.824 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.7 ptpp? -105.86 -42.47 5.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 0.0 109.794 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB1' ' CH2' ' A' ' 17' ' ' TRP . . . 58.55 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -0.816 . . . . 0.0 109.395 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.654 ' H ' HE21 ' A' ' 15' ' ' GLN . . . 56.26 46.84 85.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -46.24 -27.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -1.167 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -149.78 154.82 38.0 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -40.65 129.52 2.64 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.754 2.303 . . . . 0.0 112.329 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.69 29.88 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.788 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.3 tt -124.78 127.06 46.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.123 . . . . 0.0 109.396 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.654 HE21 ' H ' ' A' ' 9' ' ' GLY . 22.4 mt-30 -118.07 138.9 51.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 0.9 OUTLIER -109.64 140.19 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.601 ' CH2' ' HB1' ' A' ' 8' ' ' ALA . 7.9 m0 -142.43 110.86 6.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.108 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -81.38 138.47 35.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.634 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -93.6 142.76 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 22' ' ' PHE . 10.3 tp10 -159.5 123.3 3.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.549 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 20' ' ' GLU . 11.4 tptm 42.48 26.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.6 m-85 66.57 44.88 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 24' ' ' LEU . 26.7 t0 -117.12 -25.11 7.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.512 ' O ' ' O ' ' A' ' 23' ' ' ASP . 4.8 mt 57.6 124.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 t -145.28 126.71 7.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 109.365 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.06 123.33 7.21 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.45 2.1 . . . . 0.0 112.339 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -97.75 130.43 29.02 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -42.48 103.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.486 2.124 . . . . 0.0 112.405 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -48.72 -40.12 27.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -63.14 -53.74 48.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.848 . . . . 0.0 109.412 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.6 tp -84.71 12.7 6.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.126 -0.984 . . . . 0.0 109.563 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 34' ' ' ASP . 46.0 t80 -83.74 -110.37 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 109.074 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.57 ' N ' ' CG ' ' A' ' 32' ' ' TYR . . . 56.38 -3.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 32' ' ' TYR . 1.1 t70 -111.78 164.76 12.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 109.61 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.571 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 7.4 m-85 -144.75 120.07 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -78.6 114.45 17.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 108.952 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 ' HH2' ' A' ' 61' ' ' TRP . 17.3 p -75.57 87.14 2.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.41 -28.38 0.07 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -115.17 -155.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -1.062 . . . . 0.0 108.807 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 140.91 38.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -112.3 121.85 46.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.646 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.0 t -96.77 121.28 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.407 -0.808 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.598 ' CG2' HD21 ' A' ' 14' ' ' LEU . 1.1 mt -121.28 145.9 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.763 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.765 HD11 HD23 ' A' ' 58' ' ' LEU . 2.0 mp -127.52 125.16 39.9 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.626 -0.671 . . . . 0.0 109.295 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 55' ' ' GLN . 16.9 ttpt -106.02 93.68 4.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.691 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.512 ' OG1' ' CD2' ' A' ' 56' ' ' TYR . 31.2 m -77.71 100.52 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.46 -0.775 . . . . 0.0 109.468 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -94.49 164.84 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.292 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -123.44 124.87 43.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.546 -0.721 . . . . 0.0 109.349 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.8 mt -65.28 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 69.3 mtm-85 -140.04 -34.73 0.54 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.254 -0.904 . . . . 0.0 109.497 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -173.74 32.17 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 109.395 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -116.26 -98.13 2.08 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -127.6 -160.06 0.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.115 . . . . 0.0 109.419 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.528 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.68 164.52 18.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.434 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' LYS . 42.9 tt0 -129.08 117.62 21.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.766 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 56' ' ' TYR . 5.9 m-85 -91.52 123.07 34.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 108.856 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -91.75 119.84 31.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.08 -1.012 . . . . 0.0 109.052 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.765 HD23 HD11 ' A' ' 44' ' ' LEU . 12.5 mt -82.72 128.99 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.889 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.684 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 22.1 m-70 -139.43 108.12 5.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -102.01 112.15 24.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 108.544 179.1 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.789 ' C ' HD23 ' A' ' 62' ' ' LEU . 73.3 t90 -93.66 129.18 40.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 110.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.789 HD23 ' C ' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -127.79 130.55 48.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 65' ' ' GLU . . . -82.81 23.83 5.56 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.7 t30 60.88 1.86 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -1.066 . . . . 0.0 109.896 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 63' ' ' GLY . 2.8 mm-40 -108.18 10.4 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -0.999 . . . . 0.0 108.848 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.487 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 7.2 p -105.34 132.6 51.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.526 -0.734 . . . . 0.0 109.558 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -54.52 155.98 3.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -66.54 -8.9 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.384 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 4.5 t0 -77.03 -36.4 56.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.728 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -87.09 -28.03 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.615 ' OG ' HD13 ' A' ' 62' ' ' LEU . 30.7 t -69.05 -60.01 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.51 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.66 -52.97 49.18 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.4 -44.52 24.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -1.183 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.93 -57.35 10.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.154 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -59.03 -19.83 47.53 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 109.171 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mm -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 109.95 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -57.51 -35.53 70.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.641 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.579 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 1.5 t -80.13 -47.23 15.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.884 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.7 t -61.27 -47.47 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.741 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -69.72 -59.54 2.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 81' ' ' LEU . 1.8 tm? -53.45 -51.8 61.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.93 -1.106 . . . . 0.0 108.807 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.632 ' HB2' HD21 ' A' ' 58' ' ' LEU . 6.1 t0 -46.01 -47.19 16.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.006 -1.059 . . . . 0.0 108.355 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -56.65 -30.07 62.94 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 81' ' ' LEU . 35.7 t80 -71.03 -23.94 62.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.46 HD21 HD11 ' A' ' 81' ' ' LEU . 46.8 mt -82.38 -55.19 4.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 110.211 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.692 ' ND2' ' H ' ' A' ' 88' ' ' ARG . 3.9 p-10 -121.62 -42.31 2.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.29 0.91 31.3 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.692 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 24.0 mtp180 -138.31 -83.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -1.127 . . . . 0.0 109.581 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.598 ' N ' ' ND2' ' A' ' 86' ' ' ASN . . . 56.3 155.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.849 . . . . 0.0 109.794 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 2.6 t -91.43 150.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.56 133.87 52.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.879 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.684 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 35.4 m-70 -138.14 122.31 18.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.235 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.423 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 14.4 ptp180 -110.6 122.17 47.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.957 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.588 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -117.75 90.54 3.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 108.996 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.4 37.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.625 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 68.55 77.8 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.31 -56.5 0.61 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.485 ' N ' ' CD2' ' A' ' 98' ' ' PHE . 8.0 m-85 -87.69 55.22 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -1.106 . . . . 0.0 109.376 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 30.3 mm-40 -66.83 -178.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.458 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.0 m -117.49 157.2 26.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.4 -0.812 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.39 70.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.571 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.0 m -57.35 -52.08 66.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 44.7 t80 -56.5 -37.87 70.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.487 -0.758 . . . . 0.0 109.6 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -71.28 -31.14 67.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.515 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.23 81.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.432 ' CD2' HD13 ' A' ' 14' ' ' LEU . 1.7 t80 -74.86 -47.54 29.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -1.144 . . . . 0.0 109.568 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -109.49 82.62 1.62 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.521 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -98.28 -34.15 10.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.545 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -101.27 9.18 42.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . -95.24 -108.89 2.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.613 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.4 mm? 53.1 101.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.243 -1.151 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -149.93 97.52 2.6 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.555 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -81.69 107.99 14.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.462 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -118.81 154.46 32.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.349 -0.845 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.52 ' H ' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -73.07 160.19 32.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -145.77 99.48 0.21 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.8 34.84 4.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.7 -34.57 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -1.153 . . . . 0.0 109.387 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.69 -30.54 32.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.302 -0.874 . . . . 0.0 109.488 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.7 m -86.28 6.13 31.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.37 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.42 -34.8 39.21 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.32 -27.26 27.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -1.21 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -71.18 0.62 7.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.183 -0.948 . . . . 0.0 109.419 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -82.26 125.31 30.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.87 . . . . 0.0 109.351 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.7 t -141.76 128.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.31 115.88 28.17 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.08 135.92 10.67 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.41 2.073 . . . . 0.0 112.214 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.0 t30 61.33 90.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' OE2' ' N ' ' A' ' 129' ' ' GLU . 54.8 mp0 -79.79 -17.77 52.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.429 ' H ' HG23 ' A' ' 130' ' ' VAL . 2.5 t -47.82 -19.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 129' ' ' GLU . 88.8 t -65.45 -44.35 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.94 -28.47 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.467 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.469 179.948 . . . . . . . . 0 0 . 1 stop_ save_